Clustering O 0 4.700228600995615e-06
of O 0 1.3142864645487862e-06
missense O 0 3.109238832621486e-06
mutations O 0 2.998270431930905e-08
in O 0 8.666433792825501e-09
the O 0 1.4981175127104507e-06
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
gene O 0 8.048192285059486e-06
in O 0 2.3029524953699365e-08
a O 0 2.0587501481372783e-08
sporadic B-Disease 0 3.770538569369819e-06
T I-Disease 1 0.9997476935386658
- I-Disease 0 0.2549821436405182
cell I-Disease 0 0.29835572838783264
leukaemia I-Disease 1 0.9988418221473694
. O 0 4.1620634760874964e-07

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9999973773956299
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 4.039641865460908e-08
is O 0 1.2146329497753072e-09
a O 0 3.2360387702823346e-09
recessive B-Disease 0 2.7232144361732935e-07
multi I-Disease 1 0.9999990463256836
- I-Disease 1 0.9999998807907104
system I-Disease 1 0.98203045129776
disorder I-Disease 0 6.962242332519963e-05
caused O 0 1.2446526476139752e-08
by O 0 5.8606869357547e-11
mutations O 0 6.122823081877726e-11
in O 0 1.3350411054435796e-10
the O 0 3.183535879358601e-09
ATM O 0 1.5030632027901447e-07
gene O 0 5.1372976983543595e-09
at O 0 7.21638304668204e-09
11q22 O 0 1.8568991322354123e-07
- O 0 1.1791210141609554e-07
q23 O 0 1.1790451708293403e-06
( O 0 1.2189549813967915e-08
ref O 0 1.0875838597712573e-05
. O 0 6.101087635101976e-09
3 O 0 5.177434658776292e-08
) O 0 3.5696507971749725e-09
. O 0 4.631648664599197e-08

The O 0 8.631544687887072e-07
risk O 0 5.023131279813242e-07
of O 0 4.237442681187531e-07
cancer B-Disease 0 1.2354422324278858e-05
, O 0 9.778297060947239e-10
especially O 0 4.99074470639016e-09
lymphoid B-Disease 0 0.0002935099182650447
neoplasias I-Disease 0 0.2454995959997177
, O 0 1.1092358143116599e-09
is O 0 1.21111148887465e-10
substantially O 0 5.9356266568499905e-09
elevated O 0 1.4094026482780464e-05
in O 0 8.506403759156456e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 0.00016366901400033385
and O 0 1.9665124639800524e-08
has O 0 2.0379554988014803e-10
long O 0 1.0448840404020387e-10
been O 0 4.901477834717838e-11
associated O 0 1.0582261733560472e-09
with O 0 1.348312905768978e-09
chromosomal O 1 1.0
instability O 1 1.0
. O 0 1.4815827853453811e-05

By O 0 4.6456367641667384e-08
analysing O 0 7.337558827202884e-07
tumour B-Disease 1 0.8931015133857727
DNA O 0 2.6341064085499966e-07
from O 0 8.143814511640812e-09
patients O 0 1.8684369607058215e-09
with O 0 2.581115876587603e-10
sporadic B-Disease 0 1.2283301202842267e-06
T I-Disease 0 0.0006138386088423431
- I-Disease 0 2.2041891497792676e-05
cell I-Disease 0 1.2301259630476125e-05
prolymphocytic I-Disease 0 3.461764572421089e-05
leukaemia I-Disease 0 0.00010656524682417512
( O 0 7.135697810412012e-09
T B-Disease 0 4.2972001779162383e-07
- I-Disease 0 1.1726427118219362e-07
PLL I-Disease 0 2.2106651158537716e-06
) O 0 8.227589165521465e-10
, O 0 6.640546446057272e-11
a O 0 4.1492456692715507e-10
rare O 0 3.5837315337516884e-09
clonal B-Disease 0 9.967514813524758e-08
malignancy I-Disease 0 2.8074435931557673e-07
with O 0 1.065756788376504e-10
similarities O 0 1.4580350260473551e-09
to O 0 3.117569535859843e-09
a O 0 2.8825228426399008e-08
mature B-Disease 0 1.1973229163686483e-07
T I-Disease 0 5.717785370507045e-06
- I-Disease 0 9.49962554841477e-07
cell I-Disease 0 7.096135732354014e-07
leukaemia I-Disease 0 1.0095945981447585e-05
seen O 0 6.797692631010932e-09
in O 0 1.6131468383306924e-09
A B-Disease 1 0.9999967813491821
- I-Disease 0 0.16402417421340942
T I-Disease 1 1.0
, O 0 2.9618629771022142e-09
we O 0 1.772958585499751e-10
demonstrate O 0 9.113557686291074e-10
a O 0 4.0982001126010914e-10
high O 0 2.7975790573009363e-09
frequency O 0 1.6942431901867394e-09
of O 0 4.002442821615659e-09
ATM O 0 2.396259617398755e-07
mutations O 0 4.6495700622983804e-09
in O 0 3.380317181722603e-08
T B-Disease 0 3.8245336327236146e-05
- I-Disease 0 1.877178692666348e-05
PLL I-Disease 0 0.0006578081520274282
. O 0 1.0765676279334002e-06

In O 0 1.800575262222992e-07
marked O 0 7.678301727764847e-08
contrast O 0 3.286624661313908e-08
to O 0 5.836619187959968e-09
the O 0 1.9504051707031067e-08
ATM O 0 2.2060012838664989e-07
mutation O 0 9.27167120856609e-10
pattern O 0 4.091703864617102e-09
in O 0 7.880770702684003e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
, O 0 2.7221189746740038e-09
the O 0 1.440784491713032e-09
most O 0 7.227188292269204e-11
frequent O 0 7.269881224791774e-11
nucleotide O 0 9.174544457479783e-11
changes O 0 8.925249428415327e-12
in O 0 3.349831870225195e-11
this O 0 1.6708986971814e-10
leukaemia B-Disease 0 5.7786059187492356e-05
were O 0 3.868263576123354e-08
missense O 0 2.4245712211268255e-06
mutations O 0 7.918683309071639e-08
. O 0 1.1329832005912976e-07

These O 0 8.465372758337253e-08
clustered O 0 3.963054098221619e-07
in O 0 1.7333495749838335e-09
the O 0 1.7585516376428245e-09
region O 0 8.657937144995742e-10
corresponding O 0 2.2607311578326517e-09
to O 0 6.677309816183197e-09
the O 0 5.586025508819148e-08
kinase O 0 1.783563732260518e-07
domain O 0 1.055682474770947e-08
, O 0 4.343438109177811e-11
which O 0 1.6718541481774984e-11
is O 0 6.081215392361727e-11
highly O 0 3.478150267799407e-10
conserved O 0 7.391076084495296e-10
in O 0 2.899697149061353e-10
ATM O 0 4.1001587902655956e-08
- O 0 3.029292150458218e-09
related O 0 7.917724254014047e-10
proteins O 0 3.867697134785075e-11
in O 0 1.484303652210528e-10
mouse O 0 2.72747353591285e-08
, O 0 3.6084768506583487e-10
yeast O 0 2.748551537479216e-07
and O 0 6.899188065290218e-08
Drosophila O 0 6.511097581096692e-07
. O 0 1.1772266361731454e-07

The O 0 8.607516974734608e-07
resulting O 0 3.128683943032229e-07
amino O 0 3.1952964718584553e-08
- O 0 5.1142276191740166e-08
acid O 0 9.291804659028458e-09
substitutions O 0 2.7714927242072918e-08
are O 0 4.3944131666862063e-10
predicted O 0 5.964454885543091e-08
to O 0 4.255282792797743e-09
interfere O 0 4.870470959872364e-08
with O 0 2.262767306859814e-09
ATP O 0 8.046773700698395e-07
binding O 0 1.4488320765337903e-08
or O 0 1.4664976788480999e-08
substrate O 0 9.810435130930273e-07
recognition O 0 9.64922577395555e-08
. O 0 1.2874171773091803e-07

Two O 0 1.6057791754064965e-06
of O 0 2.4176238184736576e-06
seventeen O 0 1.3097607052259264e-06
mutated O 0 4.7655666435275634e-07
T B-Disease 0 1.464727688471612e-06
- I-Disease 0 3.5014582522308046e-07
PLL I-Disease 0 1.912432935569086e-06
samples O 0 4.565556821489736e-09
had O 0 4.0880450136171476e-09
a O 0 1.098192092818806e-09
previously O 0 1.5980376133484242e-08
reported O 0 1.114479104558086e-07
A B-Disease 1 1.0
- I-Disease 1 0.9999829530715942
T I-Disease 1 1.0
allele O 0 6.534015483339317e-06
. O 0 6.026124310665182e-07

In O 0 7.609225605165193e-08
contrast O 0 1.2482145450576354e-07
, O 0 1.5039680612005668e-09
no O 0 5.078102383038186e-10
mutations O 0 3.4944752647092514e-10
were O 0 7.669570534218906e-10
detected O 0 9.403628986603962e-09
in O 0 7.873944829484003e-10
the O 0 2.6004332021045684e-09
p53 O 0 8.788846872498368e-10
gene O 0 1.1002887490008106e-09
, O 0 8.034388432331951e-11
suggesting O 0 4.83481310542544e-10
that O 0 1.2517556435831523e-10
this O 0 2.306789204098436e-09
tumour B-Disease 1 1.0
suppressor O 0 1.2433425581548363e-05
is O 0 1.1583699555117732e-09
not O 0 2.179092184473319e-10
frequently O 0 6.562259069475829e-10
altered O 0 8.364176018460512e-09
in O 0 8.092342351773141e-10
this O 0 6.808852148765254e-09
leukaemia B-Disease 0 0.0015645407838746905
. O 0 3.752126360723196e-07

Occasional O 0 3.7563829664577497e-06
missense O 0 8.237258043664042e-06
mutations O 0 3.016229044305874e-08
in O 0 1.1369909458380789e-08
ATM O 0 1.1763139809772838e-05
were O 0 7.685774505716836e-08
also O 0 3.7381520101575916e-09
found O 0 2.7653448420039695e-09
in O 0 1.7847735511722362e-09
tumour B-Disease 1 0.6471473574638367
DNA O 0 5.806165503940974e-08
from O 0 2.1131014715791707e-09
patients O 0 2.240092833449836e-10
with O 0 1.7446724620562293e-10
B B-Disease 0 1.9286476344859693e-06
- I-Disease 0 2.50017546932213e-06
cell I-Disease 0 0.0002986575127579272
non I-Disease 0 0.00010760557051980868
- I-Disease 0 3.164327426929958e-05
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 0 1.0291486432834063e-05
( O 0 1.1553425993682254e-09
B B-Disease 0 3.0197750078286845e-08
- I-Disease 0 5.6850821827936215e-09
NHL I-Disease 0 8.105201487751401e-08
) O 0 2.755897177131317e-10
and O 0 5.214474407821967e-10
a O 0 5.854905449353964e-09
B B-Disease 0 8.55155974477384e-07
- I-Disease 0 6.841633535259461e-07
NHL I-Disease 0 5.25329596712254e-05
cell O 0 2.6202707886113785e-05
line O 0 8.829296348267235e-06
. O 0 3.3385791198270454e-07

The O 0 2.326986106027107e-07
evidence O 0 1.420660709072763e-07
of O 0 8.035825516117256e-08
a O 0 7.753856223757793e-09
significant O 0 2.5721629270947233e-09
proportion O 0 3.0381859250638854e-09
of O 0 2.122146014471582e-08
loss O 0 1.1716421965957124e-07
- O 0 2.583794014299201e-07
of O 0 7.367549414993846e-07
- O 0 1.416064350223678e-07
function O 0 7.099609233840454e-10
mutations O 0 1.6276471836995654e-10
and O 0 1.1837150704074872e-10
a O 0 6.775450756002499e-10
complete O 0 5.323696594672356e-09
absence O 0 2.7883963582553406e-08
of O 0 2.0840669634480946e-08
the O 0 1.9363484149437227e-09
normal O 0 2.5980870232977793e-10
copy O 0 1.999194587654074e-09
of O 0 2.0850441373454487e-09
ATM O 0 6.7945578052786e-08
in O 0 4.781403606379797e-10
the O 0 1.3591054948136616e-09
majority O 0 1.0353817803121501e-09
of O 0 1.3773739482303426e-08
mutated O 0 3.094738474374026e-07
tumours B-Disease 1 0.9961728453636169
establishes O 0 3.2061329591215326e-08
somatic O 0 3.3536981192128223e-08
inactivation O 0 1.6591189933023998e-07
of O 0 2.252656283729948e-09
this O 0 7.411146002445079e-11
gene O 0 1.1020524076643667e-10
in O 0 7.258990630809592e-11
the O 0 5.665216074035584e-10
pathogenesis O 0 2.8521458261820953e-06
of O 0 1.6912422040604724e-07
sporadic B-Disease 0 5.0907574404845946e-06
T I-Disease 0 0.0004498333437368274
- I-Disease 0 1.336884338343225e-06
PLL I-Disease 0 3.87449154004571e-06
and O 0 8.871880452510084e-10
suggests O 0 2.4101176610002994e-10
that O 0 2.9695645248351e-11
ATM O 0 2.69948436937284e-08
acts O 0 1.005918015550833e-09
as O 0 3.4004463689285558e-09
a O 0 5.7487977045411753e-08
tumour B-Disease 1 0.9999997615814209
suppressor O 0 8.019751112442464e-05
. O 0 5.698730660697038e-07

As O 0 3.8138423974487523e-07
constitutional O 0 3.2740518918217276e-07
DNA O 0 1.0222724711184128e-07
was O 0 2.5465363151511156e-08
not O 0 5.1633440578680023e-11
available O 0 4.1711142872991047e-10
, O 0 1.711792513292565e-10
a O 0 5.084240140007523e-09
putative O 0 8.271819388028234e-05
hereditary O 1 1.0
predisposition O 1 0.999969482421875
to O 0 7.793231634423137e-05
T B-Disease 1 0.9999996423721313
- I-Disease 0 0.45254281163215637
PLL I-Disease 0 0.000519230670761317
will O 0 3.3484106598535845e-09
require O 0 4.628756267166523e-10
further O 0 1.511730296499536e-09
investigation O 0 1.0890937929275424e-08
. O 0 1.002719018927678e-09
. O 0 1.5314162382651375e-08

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 0 1.8968783479067497e-05
kinase O 0 4.5504455670197785e-07
is O 0 5.565873456570003e-11
involved O 0 8.131261289290315e-12
in O 0 1.3526542733122149e-11
the O 0 1.5267191677548198e-10
modulation O 0 7.90325938027081e-09
of O 0 3.564581962933744e-09
the O 0 6.374524019747696e-09
Ca2 O 0 2.2850619529890537e-07
+ O 0 3.6696081906484324e-07
homeostasis O 0 5.406719765232992e-07
in O 0 3.8994416584614555e-09
skeletal O 0 1.0807872286022757e-06
muscle O 0 9.893003749539275e-08
cells O 0 2.760664870038454e-07
. O 0 2.2928504961328144e-07

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.8451619744300842
DM B-Disease 1 1.0
) O 0 1.4934613545847242e-07
, O 0 1.1528485943657074e-09
the O 0 4.912002360413226e-09
most O 0 1.1646622333216783e-08
prevalent O 1 0.9770764708518982
muscular B-Disease 1 1.0
disorder I-Disease 1 0.9999353885650635
in O 0 2.339606908208225e-08
adults O 0 9.160769365301746e-10
, O 0 5.827469756747305e-11
is O 0 4.540914172457278e-11
caused O 0 2.0252042265411774e-09
by O 0 7.8270473435893e-10
( O 0 2.67509570051061e-09
CTG O 0 1.8932481680167257e-06
) O 0 7.289406855903735e-10
n O 0 4.798435426778269e-09
- O 0 5.955517856648385e-09
repeat O 0 1.6570682603855857e-09
expansion O 0 5.4197792920263055e-09
in O 0 9.1985315198162e-11
a O 0 1.5477739923053235e-10
gene O 0 2.4269676546229135e-11
encoding O 0 1.6748751274775486e-09
a O 0 2.2711512670525735e-09
protein O 0 9.190245009449427e-09
kinase O 0 4.116756002758848e-08
( O 0 4.165892519836234e-09
DM B-Disease 1 0.9999985694885254
protein O 0 9.915520848835513e-08
kinase O 0 6.4065957872117e-08
; O 0 3.8621705833463693e-10
DMPK O 0 8.749196922508418e-07
) O 0 9.029239855795623e-11
and O 0 4.903534869815651e-11
involves O 0 1.3076667526590313e-10
changes O 0 1.9913387605541288e-10
in O 0 2.564773948776633e-10
cytoarchitecture O 0 3.690961705160589e-07
and O 0 7.248317057673148e-09
ion O 0 1.5150093304328038e-06
homeostasis O 0 7.420056135742925e-06
. O 0 3.7341132497203944e-07

To O 0 1.458137859344788e-07
obtain O 0 4.313327792715427e-07
clues O 0 9.93596472653735e-07
to O 0 4.9240842514564065e-09
the O 0 9.752002760876621e-09
normal O 0 2.6720565760030013e-09
biological O 0 1.0221570256874202e-08
role O 0 1.0163481611868974e-08
of O 0 4.515149498729443e-08
DMPK O 0 0.019455503672361374
in O 0 2.266829035590945e-08
cellular O 0 7.736353779819183e-08
ion O 0 9.570940306957709e-08
homeostasis O 0 9.577239978852958e-08
, O 0 5.408767878023468e-10
we O 0 1.3390703823557004e-10
have O 0 9.10863537373352e-11
compared O 0 1.3808243437551937e-09
the O 0 2.899217532714715e-09
resting O 0 4.117823948490695e-08
[ O 0 3.537604653658377e-09
Ca2 O 0 2.6168178735019865e-09
+ O 0 2.005198007637432e-09
] O 0 8.255160999226518e-10
i O 0 6.457317458519185e-10
, O 0 3.553777758180665e-11
the O 0 2.423272971174839e-10
amplitude O 0 3.7255674101288605e-09
and O 0 1.7046668243647645e-10
shape O 0 5.235685218707431e-09
of O 0 2.75941349769937e-08
depolarization O 0 9.792976385369911e-08
- O 0 1.1698758584088864e-07
induced O 0 2.209705058930922e-07
Ca2 O 0 5.201884434313797e-08
+ O 0 1.5862188007531586e-08
transients O 0 2.0750196227936613e-08
, O 0 5.530549282428687e-11
and O 0 4.553993987466143e-11
the O 0 4.857644841926856e-10
content O 0 7.429237225409224e-10
of O 0 6.6694436640091226e-09
ATP O 0 6.14066777870903e-07
- O 0 1.0002175798717872e-07
driven O 0 1.6212885611821548e-07
ion O 0 5.228712325333618e-07
pumps O 0 2.701772245927714e-07
in O 0 1.1081007222912831e-08
cultured O 0 2.7694403570421855e-07
skeletal O 0 4.283436112473282e-07
muscle O 0 5.046916218276465e-09
cells O 0 4.672497944113729e-09
of O 0 3.804255399586509e-08
wild O 0 1.863750220820748e-08
- O 0 4.00842470327234e-09
type O 0 3.3196752013964215e-08
and O 0 3.1310687376162605e-08
DMPK O 0 2.9918357540736906e-05
[ O 0 8.73355929797981e-08
- O 0 2.472673941156245e-07
/ O 0 4.273445938451914e-06
- O 0 1.3716477269554161e-06
] O 0 6.196571575856069e-07
knockout O 0 2.8654656489379704e-05
mice O 0 2.5560942162883293e-07
. O 0 4.2113285303457815e-08

In O 0 5.7073361858783755e-06
vitro O 0 6.699485311401077e-06
- O 0 1.0326673418603605e-06
differentiated O 0 2.4855548872437794e-06
DMPK O 0 0.00019514630548655987
[ O 0 3.767832197354437e-07
- O 0 6.694879175483948e-07
/ O 0 3.6049148093297845e-06
- O 0 8.297598697026842e-07
] O 0 2.3741856125525373e-07
myotubes O 0 1.1015113159373868e-06
exhibit O 0 1.8192461981314523e-09
a O 0 1.6144519054961393e-09
higher O 0 1.0146940176980479e-08
resting O 0 1.1043496783713636e-07
[ O 0 3.26641362846658e-08
Ca2 O 0 3.2104225056173163e-08
+ O 0 2.323198167175633e-08
] O 0 1.350547584877404e-08
i O 0 3.6822471738418017e-09
than O 0 1.2231085588787494e-10
do O 0 1.4799106384799643e-10
wild O 0 3.4187725983514383e-09
- O 0 2.9896285447250648e-09
type O 0 1.6539113190106036e-08
myotubes O 0 1.0133169325854396e-06
because O 0 2.757591710533802e-09
of O 0 6.586514000872512e-09
an O 0 1.3311914071056918e-10
altered O 0 3.757323341346819e-09
open O 0 5.125396551619588e-09
probability O 0 1.4134293735423853e-09
of O 0 7.185986916624643e-09
voltage O 0 3.515511366458668e-07
- O 0 6.845028366342376e-08
dependent O 0 3.233424195059342e-08
l O 0 9.272966394746618e-09
- O 0 2.53452725473835e-09
type O 0 3.6503318145975072e-09
Ca2 O 0 8.410569130035128e-09
+ O 0 6.924655515661016e-09
and O 0 3.2766580559950853e-09
Na O 0 5.539361609407933e-07
+ O 0 3.142801574540499e-08
channels O 0 3.367042467061765e-08
. O 0 6.633426696822653e-09

The O 0 2.0348583348095417e-05
mutant O 0 1.1622008059930522e-05
myotubes O 0 1.1102215466962662e-05
exhibit O 0 1.1325906434933586e-08
smaller O 0 8.735738354914702e-09
and O 0 4.146462728726874e-09
slower O 0 2.0608329975857487e-07
Ca2 O 0 1.8228217868454522e-07
+ O 0 5.726600971200924e-09
responses O 0 1.5563085542513733e-10
upon O 0 1.4318700669591067e-09
triggering O 0 1.8709331861543887e-09
by O 0 4.146189988563087e-11
acetylcholine O 0 3.3433371626756525e-09
or O 0 7.380778765941898e-10
high O 0 9.692773694780499e-09
external O 0 1.2160110429704218e-07
K O 0 1.9769962023019616e-07
+ O 0 1.3008299504235765e-07
. O 0 3.84877587578103e-08

In O 0 8.045532950973211e-08
addition O 0 1.4970142458992086e-08
, O 0 1.1204587258006882e-09
we O 0 1.167664021028969e-10
observed O 0 3.6215777599046817e-10
that O 0 2.070276589050124e-11
these O 0 3.6176012185862305e-10
Ca2 O 0 3.587348089695297e-07
+ O 0 4.510553424097452e-07
transients O 0 1.7202640378854994e-07
partially O 0 3.4956968431032465e-09
result O 0 1.5607021230934492e-10
from O 0 2.172224483620866e-10
an O 0 2.2440086247521585e-11
influx O 0 2.1338573963358698e-10
of O 0 1.9483592517133275e-09
extracellular O 0 1.5373123884998563e-09
Ca2 O 0 6.504243810212529e-09
+ O 0 1.2667048521208812e-09
through O 0 8.194227241187235e-11
the O 0 4.458169666765599e-10
l O 0 9.32816712762019e-10
- O 0 1.9889483393598084e-09
type O 0 8.838915377396006e-09
Ca2 O 0 1.5495544403165695e-07
+ O 0 2.4652194952068385e-07
channel O 0 4.779306550517504e-07
. O 0 2.1648064674195666e-08

Neither O 0 5.574674560193671e-06
the O 0 3.2746734746069706e-07
content O 0 2.4697181189026196e-08
nor O 0 2.9580593974287694e-08
the O 0 3.186403141341998e-09
activity O 0 1.1880948447284823e-09
of O 0 4.952000587366001e-09
Na O 0 1.4057977182346804e-07
+ O 0 8.516594540708411e-09
/ O 0 9.007231405178118e-09
K O 0 9.75289538018842e-09
+ O 0 5.1598250117024236e-09
ATPase O 0 7.245331445915326e-09
and O 0 5.681513037814057e-10
sarcoplasmic O 0 1.2535078894870821e-06
reticulum O 0 1.6733198435758823e-06
Ca2 O 0 1.008160452897755e-07
+ O 0 3.828684924656045e-08
- O 0 2.468917337239418e-08
ATPase O 0 1.2007208560760319e-08
are O 0 2.6345890746792833e-11
affected O 0 1.5804006714414953e-10
by O 0 4.777957474111361e-10
DMPK O 0 0.00013032503193244338
absence O 0 3.5164439395884983e-06
. O 0 7.044768040032068e-07

In O 0 2.5324177954644256e-07
conclusion O 0 2.3520640013430238e-07
, O 0 1.217096468053569e-08
our O 0 7.817145153410365e-09
data O 0 4.0771666043326604e-09
suggest O 0 1.68804359379493e-09
that O 0 2.93324559086372e-10
DMPK O 0 0.00032346576335839927
is O 0 1.1425012047538985e-09
involved O 0 3.476081089637262e-10
in O 0 1.9626658631644034e-10
modulating O 0 2.9994541961286814e-08
the O 0 3.489208699747337e-09
initial O 0 4.870468472972789e-09
events O 0 1.3182194225080934e-10
of O 0 1.8860961681355093e-09
excitation O 0 1.6601272534444433e-07
- O 0 2.2656948317489878e-07
contraction O 0 9.197206551903037e-09
coupling O 0 1.2801979032417421e-08
in O 0 1.984575392910415e-09
skeletal O 0 4.276053005014546e-07
muscle O 0 5.8977683181637985e-08
. O 0 1.6246959333443556e-08
. O 0 6.234751737110855e-08

Constitutional O 0 9.544374916004017e-05
RB1 O 0 0.09649898111820221
- O 0 2.4696702894289047e-05
gene O 0 1.8351459019072536e-08
mutations O 0 1.7754466785646628e-09
in O 0 4.3959974549423464e-10
patients O 0 2.2886019745982367e-09
with O 0 1.2497952672774204e-09
isolated O 0 4.599933618010255e-06
unilateral B-Disease 0 0.0001300201693084091
retinoblastoma I-Disease 1 1.0
. O 0 7.970856677275151e-05

In O 0 2.6809615860656777e-07
most O 0 1.4275022941490079e-08
patients O 0 4.177135526362008e-09
with O 0 3.322395691895963e-10
isolated O 0 8.639057824666452e-08
unilateral B-Disease 0 1.1471942116259015e-06
retinoblastoma I-Disease 1 0.9999995231628418
, O 0 9.690037217069403e-09
tumor B-Disease 0 5.717468809507409e-08
development O 0 2.067855664478202e-09
is O 0 1.4343396262384012e-11
initiated O 0 1.0528622418348732e-10
by O 0 2.288999935776137e-12
somatic O 0 1.4315150176358316e-09
inactivation O 0 2.5471967646240046e-08
of O 0 1.027046114820962e-09
both O 0 9.046392107636692e-11
alleles O 0 1.54221621584405e-10
of O 0 2.636195262084584e-09
the O 0 2.6852648105091248e-08
RB1 O 0 2.1560435925493948e-05
gene O 0 1.0586127530132217e-07
. O 0 9.501549413926114e-08

However O 0 2.732032839958265e-07
, O 0 2.4842823354020993e-09
some O 0 1.0662588867393907e-10
of O 0 2.0143673395978112e-09
these O 0 4.227299066350554e-10
patients O 0 4.0159475744872e-09
can O 0 2.3491211198489736e-09
transmit O 0 1.1947307712034672e-06
retinoblastoma B-Disease 0 0.32505735754966736
predisposition O 0 0.00018807534070219845
to O 0 1.6098809396680736e-07
their O 0 3.978257723247225e-07
offspring O 0 6.242109520826489e-06
. O 0 2.0987792481719225e-07

To O 0 7.622546149832488e-08
determine O 0 1.6335579999804395e-08
the O 0 6.46715703211953e-09
frequency O 0 1.3777416540960985e-08
and O 0 2.7796634438637113e-10
nature O 0 7.219118081103204e-10
of O 0 3.5501432904538888e-09
constitutional O 0 1.6408267811129917e-07
RB1 O 0 7.59673275751993e-05
- O 0 2.486555104042054e-07
gene O 0 7.747406605140839e-10
mutations O 0 1.319170328528685e-10
in O 0 3.551189550754508e-11
patients O 0 1.6302509342480676e-10
with O 0 1.596500570633097e-10
isolated O 0 5.119409962617283e-08
unilateral B-Disease 0 3.669545378670591e-07
retinoblastoma I-Disease 1 0.9999333620071411
, O 0 3.716312590995585e-09
we O 0 1.260096749167161e-10
analyzed O 0 1.1740242111812904e-10
DNA O 0 1.2783648584147045e-09
from O 0 1.040310726452276e-09
peripheral O 0 1.0588969416858163e-06
blood O 0 4.361924865747824e-08
and O 0 2.4290738309673543e-08
from O 0 5.724561447095766e-08
tumor B-Disease 0 6.262071110541001e-06
tissue O 0 4.804125637747347e-06
. O 0 3.905033736373298e-07

The O 0 3.793083749314974e-07
analysis O 0 4.531525021889138e-08
of O 0 6.097205300648056e-07
tumors B-Disease 1 1.0
from O 0 2.7113173928228207e-07
54 O 0 1.0924291871106107e-07
( O 0 9.274659928948381e-10
71 O 0 1.070198507591158e-08
% O 0 2.7742083630322156e-10
) O 0 4.7653769819078207e-11
of O 0 2.991425551712723e-09
76 O 0 9.449660609561761e-08
informative O 0 5.2977959796862706e-09
patients O 0 1.755043332885009e-09
showed O 0 7.853246941635916e-10
loss O 0 1.0866121336050583e-08
of O 0 1.1394989485324913e-07
constitutional O 0 6.599270363949472e-06
heterozygosity O 1 0.9999953508377075
( O 0 1.532297937956173e-05
LOH O 1 1.0
) O 0 1.341300759349906e-08
at O 0 3.7300342370372164e-08
intragenic O 0 1.2177836197224678e-06
loci O 0 1.3329348291790666e-07
. O 0 1.629127979185796e-07

Three O 0 3.023250769729202e-07
of O 0 4.814435783373483e-07
13 O 0 5.500963311533269e-07
uninformative O 0 0.0018829198088496923
patients O 0 2.9257221285661217e-06
had O 0 3.542785975696461e-07
constitutional O 0 3.922796167898923e-06
deletions O 0 2.301890890521463e-05
. O 0 1.2643948821278173e-06

For O 0 7.537914825661574e-07
39 O 0 1.2803342315237387e-06
randomly O 0 1.4803074321889653e-08
selected O 0 2.758667108082591e-07
tumors B-Disease 1 1.0
, O 0 8.260681028104955e-08
SSCP O 1 0.9995044469833374
, O 0 9.892097807551181e-08
hetero O 0 4.081225597474258e-06
- O 0 1.7477509572927374e-07
duplex O 0 2.137921768508022e-07
analysis O 0 1.0022753738070378e-09
, O 0 2.5850561274909367e-11
sequencing O 0 7.40815353506008e-10
, O 0 8.006270646454539e-11
and O 0 2.9334470963426895e-10
Southern O 0 2.704421575572269e-08
blot O 0 6.672372592220199e-07
analysis O 0 6.914384065304091e-10
were O 0 1.339009181311468e-10
used O 0 2.3661267389840646e-10
to O 0 4.2117098697502797e-10
identify O 0 1.6486044529528954e-08
mutations O 0 3.743904741781989e-08
. O 0 3.6521240076581307e-07

Mutations O 0 2.3794082437689212e-07
were O 0 5.6427694516969495e-08
detected O 0 9.376087461987481e-08
in O 0 5.589070095624038e-09
21 O 0 3.8874873098393437e-08
( O 0 1.4319546659535831e-09
91 O 0 8.326518496915014e-08
% O 0 3.7054688206694664e-09
) O 0 8.872912404811473e-10
of O 0 3.033011637398886e-07
23 O 0 0.00039280534838326275
tumors B-Disease 1 1.0
with O 0 0.026134615764021873
LOH O 1 1.0
. O 0 0.00010682469292078167

In O 0 7.415101208607666e-07
6 O 0 6.277601869442151e-07
( O 0 2.7550262071684983e-09
38 O 0 1.3882402782883219e-08
% O 0 9.983868176632882e-10
) O 0 6.938203345185912e-10
of O 0 8.697735154328257e-08
16 O 0 2.323234366485849e-05
tumors B-Disease 1 1.0
without O 0 0.029423246160149574
LOH O 1 1.0
, O 0 6.8764314242741875e-09
one O 0 5.034933581171686e-10
mutation O 0 9.284638335937956e-11
was O 0 1.2340054533765965e-09
detected O 0 7.146794822610048e-10
, O 0 3.1763154606512245e-11
and O 0 1.5448865797740297e-10
in O 0 1.3398324671953787e-09
9 O 0 4.337947245858231e-08
( O 0 5.225386789931008e-10
56 O 0 4.028083644413982e-09
% O 0 3.301221795926068e-10
) O 0 3.3942301747025283e-10
of O 0 2.3196429665972573e-08
the O 0 2.7625212624116102e-06
tumors B-Disease 1 1.0
without O 1 0.6317214965820312
LOH O 1 1.0
, O 0 4.1489789381898845e-09
both O 0 8.447638144559733e-10
mutations O 0 7.409015623238702e-10
were O 0 3.188251440633394e-09
found O 0 1.3829599687653626e-08
. O 0 8.382833982523152e-08

Thus O 0 2.0790098176348693e-07
, O 0 3.894320421693465e-09
a O 0 1.0823856255726128e-09
total O 0 1.3826262357241603e-10
of O 0 1.5822112509056296e-09
45 O 0 1.3545481403198778e-09
mutations O 0 5.426207053127463e-11
were O 0 3.98946875534989e-10
identified O 0 7.620115205497768e-09
in O 0 1.054358378382858e-08
tumors B-Disease 1 1.0
of O 0 0.01540191750973463
36 O 0 1.6083162336144596e-05
patients O 0 1.0844391908904072e-06
. O 0 9.434593266632874e-07

Thirty O 0 1.6405874703195877e-05
- O 0 1.5855615629334352e-06
nine O 0 2.603973747739019e-08
of O 0 8.94419649455358e-09
the O 0 2.61717736371736e-09
mutations O 0 8.568943332676326e-10
- O 0 8.098893111707639e-09
including O 0 1.5475297709954816e-09
34 O 0 2.0144296897228742e-08
small O 0 2.874439797295736e-09
mutations O 0 7.417230163397903e-10
, O 0 4.73388106492223e-10
2 O 0 1.1255099963136672e-08
large O 0 2.8868130108605783e-09
structural O 0 3.8455883100141364e-07
alterations O 0 4.505189281189814e-06
, O 0 3.575620244333777e-09
and O 0 5.88942450363561e-09
hypermethylation O 0 0.06145612895488739
in O 0 4.428435715908563e-07
3 O 0 3.711429235409014e-05
tumors O 1 1.0
- O 0 3.3248022646148456e-07
were O 0 3.4139440163727386e-09
not O 0 2.200367665849967e-10
detected O 0 3.209325027953014e-09
in O 0 6.041790678867898e-11
the O 0 6.092502613519457e-10
corresponding O 0 2.2253845433084507e-09
peripheral O 0 4.24660402131849e-06
blood O 0 1.402871419031726e-07
DNA O 0 1.2296779914322542e-06
. O 0 1.9688867780587316e-07

In O 0 1.47290108998277e-06
6 O 0 1.1110932973679155e-06
( O 0 3.12720538353517e-09
17 O 0 3.4715110786009973e-09
% O 0 2.559930600831706e-10
) O 0 4.604951836517657e-11
of O 0 2.1007240391668347e-09
the O 0 1.8031968807008525e-08
36 O 0 2.3109917535180102e-08
patients O 0 3.522455438442762e-09
, O 0 2.4029112033474576e-10
a O 0 1.967547014203319e-09
mutation O 0 1.4539249804101928e-09
was O 0 2.152922640163979e-08
detected O 0 2.398736098641052e-09
in O 0 9.92814858102875e-11
constitutional O 0 1.9789132554848265e-09
DNA O 0 7.215433139862171e-09
, O 0 6.445452505055016e-11
and O 0 7.072277485864475e-11
1 O 0 1.8062872308988176e-09
of O 0 2.9994626227214383e-10
these O 0 4.79093154037713e-11
mutations O 0 1.6355143628299373e-10
is O 0 2.8721790570895855e-11
known O 0 1.3835760315217271e-10
to O 0 1.0513531711886515e-10
be O 0 2.030021845067509e-10
associated O 0 4.761620431281699e-09
with O 0 1.3592325043276787e-09
reduced O 0 8.1436604659757e-07
expressivity O 0 7.489791460102424e-05
. O 0 6.114149755376275e-07

The O 0 8.487747322760697e-07
presence O 0 3.427602024430598e-08
of O 0 1.0891440638260974e-07
a O 0 6.748408498680192e-09
constitutional O 0 2.014898647928476e-08
mutation O 0 1.1462597537814645e-09
was O 0 9.869097761239232e-10
not O 0 3.5698770328718155e-12
associated O 0 1.1812342770589623e-10
with O 0 2.9568927167877845e-11
an O 0 5.826113896878482e-11
early O 0 5.2041965403759605e-08
age O 0 1.0807873707108229e-08
at O 0 2.1475624834010887e-08
treatment O 0 1.3025753275996976e-07
. O 0 1.264868672024022e-07

In O 0 4.224208680625452e-07
1 O 0 9.631360171624692e-07
patient O 0 5.874404678252176e-07
, O 0 5.8599547436699595e-09
somatic O 0 7.957047273521312e-06
mosaicism O 0 0.09285742044448853
was O 0 1.618038538708788e-07
demonstrated O 0 1.3572869494993256e-09
by O 0 1.0830020040486499e-11
molecular O 0 1.8673672330660196e-10
analysis O 0 5.6652564583981047e-11
of O 0 1.7584232681056022e-10
DNA O 0 1.8980197413753785e-09
and O 0 6.93432644638392e-10
RNA O 0 9.070091522289658e-08
from O 0 1.246860037440456e-08
peripheral O 0 3.0564544431399554e-05
blood O 0 1.2698316140813404e-06
. O 0 7.234673375933198e-07

In O 0 1.2920988865516847e-06
2 O 0 2.8082035896659363e-06
patients O 0 8.439879906063652e-09
without O 0 3.622138811110176e-09
a O 0 4.456853552881057e-09
detectable O 0 1.0712342657370755e-07
mutation O 0 2.671959542510649e-09
in O 0 1.5119553387066276e-09
peripheral O 0 2.5052424462046474e-05
blood O 0 1.8053825669994694e-06
, O 0 4.571316658541491e-09
mosaicism O 0 6.392227805918083e-05
was O 0 1.0099522285145213e-07
suggested O 0 1.0330382105294689e-09
because O 0 3.310749729923401e-10
1 O 0 6.313273903657546e-09
of O 0 1.5253897034384067e-09
the O 0 1.1910336716880465e-08
patients O 0 1.0376285075608394e-07
showed O 0 4.705196943177725e-07
multifocal O 1 1.0
tumors B-Disease 1 1.0
and O 0 9.567654757347555e-08
the O 0 1.161461327114921e-08
other O 0 3.589927799474424e-10
later O 0 1.330786503217496e-08
developed O 0 1.102853062207032e-07
bilateral B-Disease 0 2.4841190224833554e-06
retinoblastoma I-Disease 0 0.011726140044629574
. O 0 1.9374301700736396e-06

In O 0 1.3365868767323263e-07
conclusion O 0 2.2291098389359831e-07
, O 0 7.2474186652016215e-09
our O 0 8.074508173194772e-09
results O 0 1.1006455746809252e-09
emphasize O 0 8.69895888655492e-09
that O 0 1.866195670219284e-10
the O 0 2.720406122591612e-09
manifestation O 0 1.7387181969752419e-06
and O 0 1.152860118480703e-08
transmissibility O 0 5.40001128683798e-05
of O 0 2.456350784996175e-07
retinoblastoma B-Disease 0 7.209710929600988e-06
depend O 0 6.982310907233114e-08
on O 0 2.4615680160877673e-08
the O 0 8.150368713266687e-10
nature O 0 4.887961702060295e-10
of O 0 8.399438922168656e-10
the O 0 5.338855468828285e-10
first O 0 2.4755208993809674e-10
mutation O 0 3.315114502355776e-11
, O 0 1.1629513324562524e-11
its O 0 6.100139143816463e-11
time O 0 3.0472435685879873e-10
in O 0 1.4913925650006377e-10
development O 0 1.6819564629955153e-09
, O 0 8.974400389494264e-11
and O 0 1.1149750567263084e-10
the O 0 3.3175451275013756e-10
number O 0 1.3658895195445275e-11
and O 0 3.9402064944127346e-11
types O 0 3.4449207375608637e-10
of O 0 1.8226776754559637e-09
cells O 0 1.045688091672048e-09
that O 0 3.877366136495475e-11
are O 0 4.644052850610869e-11
affected O 0 8.444190902068271e-10
. O 0 2.9971309878362717e-09
. O 0 4.559285216032549e-08

Hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.999796450138092
the I-Disease 0 4.457624891074374e-05
fifth I-Disease 0 3.306782218714943e-06
component I-Disease 0 1.225790242642688e-07
of I-Disease 0 3.4147468852552265e-08
complement I-Disease 0 7.909535781891464e-08
in O 0 7.75053194956854e-08
man O 0 2.2367436031345278e-05
. O 0 1.0157957603951218e-06

I O 0 0.05160009488463402
. O 0 1.1870049092976842e-05

Clinical O 0 1.1785429705923889e-05
, O 0 6.886435954811532e-08
immunochemical O 0 0.0006075674900785089
, O 0 1.1344500450150008e-08
and O 0 1.144211481118873e-08
family O 0 1.079399254422242e-07
studies O 0 1.2014081285371958e-08
. O 0 3.688709071525409e-08

The O 0 8.941468081502535e-07
first O 0 7.005094460055261e-08
recognized O 0 2.5393770641812807e-08
human O 0 6.160728105442104e-08
kindred O 0 0.0008264812640845776
with O 0 2.9225709852198634e-08
hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 1.0
the I-Disease 0 0.0031144488602876663
fifth I-Disease 0 3.1823833523958456e-06
component I-Disease 0 1.3606434379198618e-07
of I-Disease 0 6.79857663499206e-08
complement I-Disease 0 1.2391174664116988e-07
( O 0 1.1707297176144493e-07
C5 O 1 0.9866029024124146
) O 0 2.123452524926961e-09
is O 0 1.9781130067286767e-09
described O 0 4.9581274197407765e-08
. O 0 1.0250509063780555e-07

The O 0 1.334761873295065e-05
proband O 0 0.00012997331214137375
, O 0 5.803940084092574e-08
a O 0 4.034482614656554e-08
20 O 0 2.4048759428296762e-08
- O 0 3.117582636491534e-08
year O 0 1.9860568301055537e-08
- O 0 7.876676590967691e-07
old O 0 3.008309022334288e-06
black O 0 2.0429235192409578e-08
female O 0 8.975397647326133e-10
with O 0 4.500116668193499e-10
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 1 1.0
age O 0 1.1461725989647675e-05
11 O 0 2.4094811479358214e-08
, O 0 7.232676263457805e-11
lacked O 0 3.3438997348866906e-08
serum O 0 1.2021455120247992e-07
hemolytic O 0 0.00030440688715316355
complement O 0 1.2023943440908624e-07
activity O 0 1.228262380692513e-08
, O 0 3.0274421858322853e-10
even O 0 4.748539894627868e-10
during O 0 2.026333412175063e-08
remission O 0 3.2780198466753063e-07
. O 0 4.640615358653122e-08

C5 O 1 0.9983227849006653
was O 0 9.129881618719082e-06
undetectable O 0 1.4956334553062334e-06
in O 0 3.200308684725428e-09
her O 0 4.216146598512438e-10
serum O 0 7.878545815742655e-09
by O 0 1.7014412101445942e-10
both O 0 1.224481738226757e-09
immunodiffusion O 0 1.2358582353044767e-05
and O 0 7.225379050623815e-08
hemolytic O 1 0.9999998807907104
assays O 0 0.0011762380599975586
. O 0 5.862255420652218e-06

Other O 0 4.5939049897469886e-08
complement O 0 5.949151571371658e-08
components O 0 2.0749847351453354e-07
were O 0 2.6548248044377942e-09
normal O 0 1.518567827041295e-09
during O 0 1.3616430205587449e-09
remission O 0 1.6717802253651826e-08
of O 0 1.3177531954511323e-08
lupus O 0 1.0323255082766991e-05
, O 0 1.083924838773953e-09
but O 0 1.0186338439410747e-09
C1 O 0 3.17097544666467e-07
, O 0 2.347683158987479e-09
C4 O 0 1.3238797009762493e-06
, O 0 6.884433023657266e-10
C2 O 0 1.504046878153531e-07
, O 0 1.283451456224327e-09
and O 0 1.4157774508305465e-08
C3 O 0 0.10713265091180801
levels O 0 6.338892717394629e-07
fell O 0 3.6547062336467206e-05
during O 0 1.8288621106421488e-07
exacerbations O 0 0.011759652756154537
. O 0 9.772317071110592e-07

A O 0 6.371184281306341e-05
younger O 0 8.605838047515135e-06
half O 0 4.1480004142613325e-07
- O 0 1.0074825240735663e-06
sister O 0 5.78277376916958e-06
, O 0 3.1430877900362475e-09
who O 0 9.722583627080894e-09
had O 0 1.420088491244087e-08
no O 0 8.113086202854447e-09
underlying O 0 0.259741872549057
disease O 0 0.06005823239684105
, O 0 4.554569776882289e-10
was O 0 7.556032244337985e-08
also O 0 2.957142586357264e-10
found O 0 8.770292825310833e-10
to O 0 2.4855049129968165e-09
lack O 0 0.00012488345964811742
immunochemically O 1 0.9885497689247131
detectable O 0 0.021632593125104904
C5 O 1 0.9987788796424866
. O 0 1.0640068239808897e-06

By O 0 1.83747744131324e-07
hemolytic O 1 0.9998806715011597
assay O 0 0.0006575545412488282
, O 0 1.0843268682947382e-07
she O 0 4.643641027257672e-09
exhibited O 0 6.255332252180779e-09
1 O 0 3.9195466428054715e-08
- O 0 2.6960883303672745e-08
2 O 0 3.1279466128353306e-08
% O 0 5.338275377297919e-10
of O 0 1.973530450172234e-09
the O 0 2.1640458314209354e-09
normal O 0 1.9630347125598746e-08
serum O 0 1.6163852478712215e-07
C5 O 0 8.076318408711813e-06
level O 0 6.814464548199339e-09
and O 0 5.0757759106900835e-11
normal O 0 1.4260530256660076e-10
concentrations O 0 2.2334885330099752e-10
of O 0 2.036914109604382e-10
other O 0 5.7900441385871915e-11
complement O 0 6.378829464637192e-09
components O 0 5.174206876290555e-07
. O 0 3.3197233051396324e-07

C5 O 1 0.9838570356369019
levels O 0 4.563226525533537e-07
of O 0 1.563932983117411e-07
other O 0 1.4830648931152268e-09
family O 0 3.835143758124104e-09
members O 0 4.45081783928547e-11
were O 0 2.1791130011550308e-10
either O 0 2.61223875863692e-10
normal O 0 1.6173304917543874e-09
or O 0 5.539093073103629e-10
approximately O 0 8.682374263990766e-11
half O 0 9.404198531015595e-10
- O 0 2.5415658466698687e-09
normal O 0 1.1129444033031177e-09
, O 0 4.637334613533106e-11
consistent O 0 4.923292884484454e-10
with O 0 1.4429840655694193e-10
autosomal O 0 1.2318942310685088e-08
codominant O 0 2.379730403845315e-07
inheritance O 0 5.119143775544899e-09
of O 0 1.8359187503591556e-09
the O 0 1.5382012330533712e-09
gene O 0 5.240940570416797e-09
determining O 0 1.8094851839123294e-07
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 8.662322215968743e-06

Normal O 0 3.9212307456182316e-05
hemolytic O 1 0.987864077091217
titers O 0 0.0014073416823521256
were O 0 1.301633233197208e-06
restored O 0 8.81737196323229e-06
to O 0 1.1080817152731015e-08
both O 0 1.9645067794726856e-08
homozygous O 0 5.786889232695103e-06
C5 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
( O 0 4.834402716369368e-06
C5D B-Disease 1 1.0
) O 0 6.016956710652721e-09
sera O 0 2.6530646124456325e-08
by O 0 4.4138064730914195e-11
addition O 0 1.34963984432801e-10
of O 0 2.6784243711830413e-09
highly O 0 2.8077586478048033e-08
purified O 0 1.9117824479053525e-07
human O 0 1.0668971839322694e-07
C5 O 0 0.00029100774554535747
. O 0 3.6456756902225607e-07

In O 0 2.0167890113498288e-07
specific O 0 1.5122249408250354e-07
C5 O 0 0.0019387205829843879
titrations O 0 8.841623639455065e-06
, O 0 2.100900342583145e-09
however O 0 2.8838411658682617e-09
, O 0 1.819890627086096e-10
it O 0 5.043043066477182e-11
was O 0 3.782908208904701e-09
noted O 0 1.5738430003686688e-10
that O 0 8.214785622573384e-12
when O 0 2.0801850519891474e-10
limited O 0 8.065868528639442e-10
amounts O 0 6.748495096076113e-10
of O 0 1.597214982496098e-08
C5 O 0 1.3795812265016139e-05
were O 0 9.836459646805906e-09
assayed O 0 4.0862619954395996e-08
in O 0 3.523468183885825e-10
the O 0 5.693587268318367e-10
presence O 0 3.9994343947746813e-10
of O 0 6.04409056137456e-09
low O 0 2.260241416252029e-07
dilutions O 0 1.6542462617508136e-05
of O 0 1.0850841647425113e-07
either O 0 9.787093802060554e-08
C5D B-Disease 1 1.0
serum O 0 8.056256888266944e-07
, O 0 6.221785309179495e-10
curving O 0 3.222057953777835e-09
rather O 0 2.8150806685722785e-10
than O 0 2.2868455393232345e-11
linear O 0 5.061046026710869e-10
dose O 0 2.46051179431106e-08
- O 0 5.171687966765148e-09
response O 0 1.1359910789821015e-09
plots O 0 1.707623376034917e-08
were O 0 4.1980596776625134e-10
consistently O 0 3.3147748434991797e-10
obtained O 0 1.9209342450032807e-10
, O 0 3.0473932405294946e-11
suggesting O 0 3.410356441690965e-10
some O 0 5.409672709788538e-11
inhibitory O 0 3.437448725662762e-08
effect O 0 3.648176161163974e-08
. O 0 1.0392803773129344e-07

Further O 0 1.286722408622154e-07
studies O 0 4.55846560498685e-09
suggested O 0 4.10826661578767e-09
that O 0 1.5503415218276473e-10
low O 0 1.424811131300885e-07
dilutions O 0 0.0013956225011497736
of O 0 1.7260816093767062e-05
C5D B-Disease 1 1.0
serum O 0 8.88525619302527e-07
contain O 0 6.225955306859987e-09
a O 0 1.6163622662546118e-09
factor O 0 1.1922627329852276e-09
( O 0 2.79210682352371e-11
or O 0 8.9570600936284e-11
factors O 0 4.966906330672316e-10
) O 0 7.465811302509451e-11
interfering O 0 7.297252802018761e-10
at O 0 8.299619325136121e-10
some O 0 2.7854154746598248e-11
step O 0 2.2782713493540996e-09
in O 0 2.7548777148389547e-10
the O 0 3.6999745489652014e-09
hemolytic O 0 0.00015269682626239955
assay O 0 1.4881319657433778e-05
of O 0 1.4545767044182867e-05
C5 O 1 0.8925284743309021
, O 0 8.15851886049046e-10
rather O 0 2.3789875625013224e-10
than O 0 1.202656446652739e-10
a O 0 2.918330466172847e-09
true O 0 1.0702600405920748e-07
C5 O 0 0.00021891604410484433
inhibitor O 0 5.192635512685229e-07
or O 0 4.5101831602778475e-08
inactivator O 0 9.059559488378e-06
. O 0 1.0267728356438965e-07

Of O 0 3.962887149100425e-06
clinical O 0 4.411029294715263e-06
interest O 0 6.117274864436695e-08
are O 0 5.43370848316016e-10
( O 0 3.270113346776071e-10
a O 0 8.613267321599949e-10
) O 0 8.519933369921517e-11
the O 0 3.0348656920864414e-10
documentation O 0 3.8903429810943635e-08
of O 0 1.2428075990555953e-07
membranous O 1 1.0
glomerulonephritis B-Disease 1 1.0
, O 0 4.186190381005872e-07
vasculitis B-Disease 1 1.0
, O 0 4.2164082003637304e-08
and O 0 9.083436793844157e-07
arthritis B-Disease 1 1.0
in O 0 7.855693411329412e-07
an O 0 1.1850824765957668e-09
individual O 0 1.9121464134297383e-10
lacking O 0 7.945989750623994e-07
C5 O 0 0.0001263140293303877
( O 0 4.1701439523755823e-10
and O 0 2.0919663223928353e-10
its O 0 4.0330400130628163e-10
biologic O 0 1.4986461849275656e-07
functions O 0 2.423578004950855e-10
) O 0 1.293373307759138e-11
, O 0 7.128775868225912e-12
and O 0 1.1883458106431988e-10
( O 0 1.4548895421739871e-10
b O 0 4.599373326641398e-09
) O 0 1.0594111005124418e-10
a O 0 4.798817454521043e-10
remarkable O 0 1.014302641877407e-09
propensity O 0 6.51924949579552e-08
to O 0 4.0305736526136116e-09
bacterial B-Disease 1 1.0
infections I-Disease 1 1.0
in O 0 5.526010760092959e-09
the O 0 4.346699444823798e-09
proband O 0 2.5994140173679625e-07
, O 0 5.871349240127444e-11
even O 0 6.822117870619593e-11
during O 0 4.1634362624165533e-10
periods O 0 1.3279416677391964e-08
of O 0 3.1630362773427123e-09
low O 0 2.2673134481010493e-08
- O 0 1.0405091233067765e-09
dose O 0 4.4030565859998205e-09
or O 0 5.358800625465676e-10
alternate O 0 1.8741557639145867e-08
- O 0 2.7040915284715084e-08
day O 0 1.8462966266952208e-08
corticosteroid O 0 6.516329904115992e-06
therapy O 0 2.5140552679658867e-06
. O 0 1.0341727829654701e-07

Other O 0 5.595686758397278e-08
observations O 0 2.6977858169630053e-08
indicate O 0 3.999817366207026e-09
that O 0 9.196237660269446e-10
the O 0 6.14486168615258e-08
C5D B-Disease 1 1.0
state O 0 5.6649920310292146e-09
is O 0 2.6100074879131796e-10
compatible O 0 2.110073715755334e-08
with O 0 1.0736178612802405e-10
normal O 0 2.7114341882850113e-09
coagulation O 0 7.716500327603626e-09
function O 0 1.5165235733860527e-10
and O 0 8.67787092184713e-11
the O 0 6.810770836196411e-10
capacity O 0 8.799095896350195e-10
to O 0 1.0984058107510464e-09
mount O 0 3.947870027332101e-06
a O 0 2.682731405911909e-07
neutrophilic O 0 0.0016119149513542652
leukocytosis O 0 0.0001515985932201147
during O 0 1.3497359532266273e-06
pyogenic B-Disease 0 0.00010806810314534232
infection I-Disease 0 2.1032967651990475e-06
. O 0 1.1450629777698396e-08
. O 0 6.029113563954525e-08

Susceptibility O 0 0.0006280454690568149
to O 0 1.2112614967918489e-05
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 0.007061544805765152
twins O 0 1.8503018509363756e-05
: O 0 2.3773094603996014e-10
the O 0 1.1024565704786937e-09
role O 0 1.7419069520130392e-09
of O 0 4.088598792861831e-09
genes O 0 6.876205160821769e-10
, O 0 2.2886313677528136e-10
HLA O 0 1.0839811466212268e-06
, O 0 1.1229490670672249e-09
and O 0 4.072845616320819e-09
the O 0 3.275578563943782e-08
environment O 0 2.861442283119686e-07
. O 0 8.007152985101129e-08

OBJECTIVE O 0 1.516328029538272e-05
To O 0 1.4891599064981165e-08
determine O 0 9.842220372036081e-09
the O 0 3.942992155003822e-09
relative O 0 6.313432976412514e-08
effects O 0 1.3276520860472374e-07
of O 0 2.2411505540276266e-08
genetic O 0 6.813480268874628e-08
and O 0 4.2967615576650076e-10
environmental O 0 1.2883026867527292e-09
factors O 0 8.245022026232007e-11
in O 0 7.596626799832862e-11
susceptibility O 0 2.7481530651130015e-07
to O 0 3.973449906879978e-07
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 1 0.9992294311523438
AS B-Disease 1 1.0
) O 0 1.0107226167122008e-08
. O 0 2.8977153121445554e-08

METHODS O 0 1.006487673294032e-05
Twins O 0 5.0070855650119483e-05
with O 0 5.9789524442521724e-09
AS B-Disease 1 0.9999998807907104
were O 0 2.6085755777671693e-09
identified O 0 7.280291924871563e-10
from O 0 4.938293662881676e-10
the O 0 2.4716251267875577e-09
Royal O 0 1.202847784043115e-06
National O 0 7.526688250436564e-08
Hospital O 0 7.1145250331028365e-06
for O 0 2.1912857306460864e-08
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 1.0
database O 0 1.528880966361612e-05
. O 0 3.2913530958467163e-06

Clinical O 0 1.085831354430411e-05
and O 0 6.375717731543773e-08
radiographic O 0 2.5980905775213614e-05
examinations O 0 9.596639074516133e-07
were O 0 3.3659750542369693e-09
performed O 0 3.238692092288886e-10
to O 0 8.141631813174399e-11
establish O 0 3.455932873208667e-09
diagnoses O 0 0.44984742999076843
, O 0 6.930734208765443e-09
and O 0 1.933338111825833e-08
disease O 0 2.8309892513789237e-05
severity O 0 0.001998357241973281
was O 0 4.467852647849213e-07
assessed O 0 8.975693077672986e-09
using O 0 5.553024706728138e-10
a O 0 5.100778688316154e-10
combination O 0 5.045530659941733e-09
of O 0 1.982741260064813e-08
validated O 0 2.3568780704863457e-07
scoring O 0 2.1111168280185666e-07
systems O 0 1.998880361497868e-05
. O 0 2.579423892257182e-07

HLA O 0 0.0002380936057306826
typing O 0 4.666952463594498e-06
for O 0 4.341796255857844e-08
HLA O 0 1.7597388932699687e-06
- O 0 2.754537149485259e-07
B27 O 0 1.4746439092050423e-06
, O 0 7.577359184551824e-09
HLA O 0 2.1973505681671668e-07
- O 0 8.157265796171487e-08
B60 O 0 6.755493018317793e-07
, O 0 1.4636969414283385e-09
and O 0 5.0559925135473804e-09
HLA O 0 4.6190871216822416e-06
- O 0 2.5692206691019237e-06
DR1 O 0 0.0005212269607000053
was O 0 4.089427463327411e-08
performed O 0 8.61816451536157e-10
by O 0 9.700105302323792e-11
polymerase O 0 5.5029893530900154e-08
chain O 0 3.4651075342395643e-09
reaction O 0 2.437560153722984e-10
with O 0 4.0020417535480135e-11
sequence O 0 8.123421380012985e-11
- O 0 2.8637725524305324e-10
specific O 0 1.691604356590659e-10
primers O 0 1.831593188228453e-08
, O 0 2.399545007136794e-10
and O 0 7.851794214808194e-10
zygosity O 0 8.254159524767601e-07
was O 0 2.8360695125684288e-08
assessed O 0 1.2918319747257101e-08
using O 0 9.467915340621857e-09
microsatellite O 0 1.343505005024781e-06
markers O 0 2.1277375594763726e-07
. O 0 2.1213450906998332e-07

Genetic O 0 7.665484190511052e-06
and O 0 1.9526980921114045e-08
environmental O 0 1.4094887923477017e-08
variance O 0 2.220894135263052e-09
components O 0 1.8078667451959518e-08
were O 0 2.288091272006909e-09
assessed O 0 1.3440666357666942e-08
with O 0 2.802378606947542e-10
the O 0 4.481087501062575e-09
program O 0 1.5746124404358852e-09
Mx O 0 2.3688114580977526e-08
, O 0 2.854526294157611e-12
using O 0 1.6247369769017972e-11
data O 0 2.67916765162024e-11
from O 0 2.4062762199461574e-11
this O 0 3.2084875121324297e-12
and O 0 2.1567090127683208e-11
previous O 0 2.414313471366114e-10
studies O 0 8.565164549834137e-11
of O 0 1.18462140097364e-09
twins O 0 6.669878871434776e-08
with O 0 2.3296977680331565e-09
AS B-Disease 1 1.0
. O 0 1.489143642174895e-06

RESULTS O 0 2.279812406413839e-06
Six O 0 5.64942979508487e-07
of O 0 5.83696703415626e-07
8 O 0 6.099112965785025e-07
monozygotic O 0 4.1749623051146045e-05
( O 0 7.404290158774529e-08
MZ O 0 0.0013089097337797284
) O 0 4.35667635301229e-09
twin O 0 2.723243142099818e-07
pairs O 0 5.766813693242057e-10
were O 0 1.640451330331416e-09
disease O 0 4.556146748768697e-08
concordant O 0 2.197353751398623e-06
, O 0 6.865419344137536e-10
compared O 0 1.1522836018684757e-09
with O 0 4.3351386369572253e-10
4 O 0 4.17699403953975e-08
of O 0 2.6016504506287674e-08
15 O 0 1.6827145898901108e-08
B27 O 0 1.3447863977944507e-07
- O 0 1.1052595283445044e-08
positive O 0 7.301401150350273e-10
dizygotic O 0 1.0396248626420856e-06
( O 0 5.904743805018597e-09
DZ O 0 2.809891157085076e-06
) O 0 1.1096589203063445e-09
twin O 0 6.931516338681831e-08
pairs O 0 2.0142433554415362e-10
( O 0 1.7581146261047564e-10
27 O 0 5.007144476820713e-09
% O 0 2.0942579614935397e-10
) O 0 3.866236844562998e-11
and O 0 3.920604674245709e-10
4 O 0 2.2789979681192563e-08
of O 0 3.9587963129861237e-08
32 O 0 2.819942324094882e-07
DZ O 0 3.276338611613028e-05
twin O 0 5.894810328754829e-07
pairs O 0 9.707495918220843e-10
overall O 0 7.75972974764727e-09
( O 0 1.2051392106471326e-09
12 O 0 5.461516128235644e-09
. O 0 1.1038200353752359e-09
5 O 0 1.8185117411917417e-08
% O 0 2.142422683704126e-09
) O 0 2.071345095444599e-09
. O 0 2.667179721527191e-08

Nonsignificant O 0 0.0006727011641487479
increases O 0 1.437903165424359e-07
in O 0 1.714247077622133e-09
similarity O 0 5.347306597514034e-09
with O 0 8.285475083802396e-11
regard O 0 5.825697702022126e-09
to O 0 7.816842728658457e-10
age O 0 1.3743455262726911e-08
at O 0 4.010726861736202e-09
disease O 0 8.979545995657645e-09
onset O 0 4.761312447953969e-05
and O 0 1.826045981090374e-09
all O 0 1.626300344392817e-10
of O 0 2.714782398882676e-09
the O 0 2.7184559048265555e-09
disease O 0 2.5248979795833293e-08
severity O 0 1.1562651280883074e-07
scores O 0 2.9794788858339416e-09
assessed O 0 5.360858423841819e-09
were O 0 8.745302815249545e-10
noted O 0 1.7205888935833968e-09
in O 0 8.621847680245764e-10
disease O 0 1.2230741219809715e-07
- O 0 1.9632281578196853e-07
concordant O 0 6.588305404875427e-05
MZ O 1 0.5658406615257263
twins O 0 2.3769071049173363e-06
compared O 0 1.4806066594985623e-08
with O 0 3.2755707035647674e-09
concordant O 0 0.0001226208987645805
DZ O 1 0.999933123588562
twins O 0 0.0001703302696114406
. O 0 1.4005134971739608e-06

HLA O 0 0.0018141657346859574
- O 0 2.676871736184694e-05
B27 O 0 6.291960289672716e-06
and O 0 1.4249777358088522e-08
B60 O 0 3.892436666319554e-07
were O 0 1.736970234311741e-09
associated O 0 4.717469526127616e-09
with O 0 2.862718673224407e-10
the O 0 8.436821907764624e-09
disease O 0 5.837156322741066e-07
in O 0 2.0777710663111293e-09
probands O 0 6.341145308397245e-06
, O 0 3.304119755576096e-10
and O 0 2.7006299974097203e-10
the O 0 1.4664075509429608e-09
rate O 0 1.7355394898999066e-09
of O 0 2.3778365942916935e-09
disease O 0 1.3554560140960348e-08
concordance O 0 1.19493421379957e-07
was O 0 1.0305949160738237e-07
significantly O 0 4.948393694803599e-09
increased O 0 1.3127653408773199e-09
among O 0 2.698885781526883e-09
DZ O 0 3.759906348932418e-06
twin O 0 6.531795548880837e-08
pairs O 0 8.695035663697226e-11
in O 0 9.481314344750302e-11
which O 0 9.653391280783907e-11
the O 0 4.063549496891028e-09
co O 0 4.411229781453585e-08
- O 0 4.8308177014178e-08
twin O 0 6.266697027967894e-07
was O 0 3.099546574958367e-08
positive O 0 7.981692390357509e-11
for O 0 1.7801997376221124e-10
both O 0 1.5140475539965337e-09
B27 O 0 1.0793678484333213e-06
and O 0 1.4357395627939695e-07
DR1 O 0 0.006100192200392485
. O 0 4.301242881865619e-07

Additive O 0 1.4734363276147633e-06
genetic O 0 1.8896068354479212e-07
effects O 0 6.976253530410759e-08
were O 0 3.6288811955387246e-09
estimated O 0 1.8025624048956246e-10
to O 0 1.0564992630746062e-10
contribute O 0 4.748865745085595e-10
97 O 0 7.598188744850631e-08
% O 0 3.9120368056089205e-10
of O 0 1.0913659975742007e-09
the O 0 7.522160117012788e-10
population O 0 7.511873068022368e-12
variance O 0 4.5612463805966286e-10
. O 0 7.639382459956323e-09

CONCLUSION O 0 1.887889447971247e-05
Susceptibility O 0 0.0003008824132848531
to O 0 3.441268063397729e-06
AS B-Disease 1 1.0
is O 0 9.485629171024357e-09
largely O 0 3.246975799342522e-09
genetically O 0 7.254233325149073e-10
determined O 0 1.430434215521359e-09
, O 0 9.947178497560216e-11
and O 0 3.269576831499421e-10
the O 0 2.8326729850647325e-09
environmental O 0 1.5456071977837382e-08
trigger O 0 9.457230554232865e-09
for O 0 4.6154882693549837e-10
the O 0 1.7807755270382586e-08
disease O 0 1.7606822666493827e-06
is O 0 2.8016478026415825e-09
probably O 0 9.019096580686892e-08
ubiquitous O 0 1.9052442894462729e-06
. O 0 2.4622354999337404e-07

HLA O 0 0.00028393857064656913
- O 0 3.296819386378047e-06
B27 O 0 1.0624656852087355e-06
accounts O 0 1.157217210945305e-09
for O 0 2.486537642454323e-10
a O 0 1.466916699222054e-09
minority O 0 7.413651914589536e-10
of O 0 3.808493520551792e-09
the O 0 1.7765204862740802e-09
overall O 0 1.908995184152218e-09
genetic O 0 6.262327545414337e-09
susceptibility O 0 1.0790554938466812e-07
to O 0 1.840540697628512e-08
AS B-Disease 1 1.0
. O 0 1.171605345007265e-05

Cell O 0 1.3892057722841855e-05
cycle O 0 1.2551797112791974e-07
- O 0 7.02671982821812e-08
dependent O 0 5.3829310786568385e-08
colocalization O 0 2.395398723820108e-06
of O 0 1.1674450917098511e-07
BARD1 O 0 0.02955317124724388
and O 0 1.5446936174612347e-08
BRCA1 O 0 3.906357015637241e-09
proteins O 0 7.03479635655313e-11
in O 0 9.214458362993838e-11
discrete O 0 2.2169297508867203e-08
nuclear O 0 8.053713713707111e-07
domains O 0 1.705781755845237e-07
. O 0 1.6079353315490152e-07

Germ O 0 0.015155347064137459
- O 0 4.5828935981262475e-05
line O 0 9.090481967177766e-07
mutations O 0 7.903921961371907e-09
of O 0 3.378183777158483e-08
the O 0 2.7668233926192443e-08
BRCA1 O 0 1.1166106261839559e-08
gene O 0 1.3808058030306825e-09
predispose O 0 1.0605909039895778e-08
women O 0 1.0665167533840947e-11
to O 0 1.3180988245320435e-10
early O 0 4.9573886826692615e-06
- O 0 0.0002876090875361115
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9981946349143982
by O 0 7.633665227713138e-11
compromising O 0 3.0832649766665554e-09
the O 0 7.350755559798472e-10
genes O 0 2.9025801207005486e-10
presumptive O 0 2.399538914232835e-07
function O 0 3.681971394442485e-10
as O 0 5.065024510919613e-10
a O 0 4.204729009416042e-09
tumor B-Disease 0 1.088313979380473e-06
suppressor O 0 3.981353438575752e-05
. O 0 4.6937282149883686e-07

Although O 0 5.842090331498184e-07
the O 0 9.091221642165692e-08
biochemical O 0 8.151485531016078e-07
properties O 0 4.2530217569947126e-07
of O 0 9.975541104267904e-08
BRCA1 O 0 2.260934905962131e-08
polypeptides O 0 6.0757949782441756e-09
are O 0 1.1013941494941726e-11
not O 0 4.408783407794381e-11
understood O 0 5.531926916546581e-09
, O 0 5.729818008948229e-11
their O 0 4.663634062263e-11
expression O 0 3.1989583204605765e-10
pattern O 0 1.2948579986016284e-09
and O 0 6.266268059995639e-10
subcellular O 0 1.8270439738898858e-07
localization O 0 6.934517955414776e-07
suggest O 0 2.6164685973384394e-09
a O 0 2.1636163971550104e-09
role O 0 6.725805690166453e-09
in O 0 4.69651517676084e-09
cell O 0 1.0437017863296205e-06
- O 0 5.356864676286932e-07
cycle O 0 1.1323211168701164e-07
regulation O 0 4.064997938257875e-07
. O 0 9.402467071595311e-08

When O 0 3.1366118946607457e-06
resting O 0 1.8053731764666736e-05
cells O 0 3.9493162518056124e-08
are O 0 1.870129606729165e-10
induced O 0 8.276484209090995e-08
to O 0 2.325910575251555e-09
proliferate O 0 2.4520367958302813e-08
, O 0 1.3792975650517292e-09
the O 0 5.975874461938702e-09
steady O 0 7.679386015979617e-08
- O 0 8.877301560517026e-09
state O 0 2.0916073040222471e-10
levels O 0 4.229904204677837e-10
of O 0 9.851268689686776e-10
BRCA1 O 0 2.96389024434518e-10
increase O 0 5.075524375786067e-11
in O 0 2.2825150103322756e-10
late O 0 2.1118499660133239e-07
G1 O 0 1.280568540096283e-07
and O 0 8.409553609034504e-10
reach O 0 2.563562251367557e-09
a O 0 2.9674823709413545e-10
maximum O 0 2.2290549406278615e-09
during O 0 1.0756111556986525e-08
S O 0 7.794620273671171e-07
phase O 0 5.187339411349967e-07
. O 0 1.1057512949719239e-07

Moreover O 0 5.746483680013625e-07
, O 0 8.757859326635753e-09
in O 0 3.4994458442128007e-09
S O 0 8.07694277682458e-07
phase O 0 2.0785557808267185e-07
cells O 0 1.378853831113247e-08
, O 0 6.71159072762606e-10
BRCA1 O 0 1.015750816790728e-09
polypeptides O 0 1.3348635530263664e-09
are O 0 5.770221106482509e-11
hyperphosphorylated O 0 2.1249917381283012e-07
and O 0 1.7435356491901643e-09
accumulate O 0 1.606674615572956e-08
into O 0 1.073989608357806e-08
discrete O 0 5.444586292924214e-08
subnuclear O 0 1.8739539200396393e-06
foci O 0 6.52305573112244e-07
termed O 0 4.93522406941338e-07
" O 0 2.4982114155136514e-07
BRCA1 O 0 1.8960095360398554e-07
nuclear O 0 2.977383928737254e-06
dots O 0 1.5552840295640635e-06
. O 0 2.4178672219932196e-07

" O 0 1.26388458738802e-05
BRCA1 O 0 2.111391950165853e-06
associates O 0 4.533725359578966e-07
in O 0 3.89812537804346e-09
vivo O 0 4.2052363369293744e-08
with O 0 3.6090552768541784e-10
a O 0 9.79480319074355e-09
structurally O 0 1.1438021374488017e-06
related O 0 3.2156566476260195e-07
protein O 0 1.2262818245289964e-06
termed O 0 3.871489752782509e-06
BARD1 O 0 0.49562203884124756
. O 0 8.357145020454482e-07

Here O 0 8.086815796559677e-06
we O 0 4.9137476310079364e-08
show O 0 2.364891837913774e-09
that O 0 1.3931991671434218e-10
the O 0 5.812733405718973e-09
steady O 0 8.53565822467317e-08
- O 0 1.330913423913671e-08
state O 0 2.3809942906183323e-10
levels O 0 1.5471638414865652e-09
of O 0 3.894580213881227e-09
BARD1 O 0 1.6310417777276598e-05
, O 0 1.390496606745728e-10
unlike O 0 2.6838745115220775e-10
those O 0 7.855011086022046e-11
of O 0 2.2255544074312184e-09
BRCA1 O 0 1.9348864732648963e-09
, O 0 6.839824540083583e-11
remain O 0 2.8608956870179725e-10
relatively O 0 3.374368007236228e-10
constant O 0 2.551854061394465e-09
during O 0 1.0606677314228818e-08
cell O 0 1.0366868963274101e-07
cycle O 0 1.0998990163102462e-08
progression O 0 2.164583534636222e-08
. O 0 1.83494286432051e-08

However O 0 1.9699227777891792e-06
, O 0 1.2283331329854263e-07
immunostaining O 0 2.341323488508351e-05
revealed O 0 4.431274760463566e-07
that O 0 9.365145992035195e-09
BARD1 O 1 0.7461488246917725
resides O 0 6.17200726082956e-07
within O 0 2.6505761141493167e-08
BRCA1 O 0 2.3904979329358866e-08
nuclear O 0 3.1556984936287336e-07
dots O 0 2.405353072276739e-08
during O 0 2.1525202953398548e-08
S O 0 6.629570634686388e-07
phase O 0 2.363261160098773e-07
of O 0 1.9530556727431758e-08
the O 0 2.9178461868895056e-09
cell O 0 5.061492114322164e-09
cycle O 0 1.3507059359874063e-10
, O 0 3.0005125987997427e-12
but O 0 9.215455655520177e-12
not O 0 2.0331866398826115e-11
during O 0 5.2953410545342194e-09
the O 0 1.3516505248389876e-08
G1 O 0 3.510505734993785e-07
phase O 0 2.812846275901393e-07
. O 0 6.922439865775232e-08

Nevertheless O 0 2.9014130632276647e-05
, O 0 2.1795396776269627e-07
BARD1 O 0 0.00011941065895371139
polypeptides O 0 3.1632552577320894e-07
are O 0 4.96990060216973e-10
found O 0 4.165247313725473e-10
exclusively O 0 2.988675140702668e-10
in O 0 1.7418262665547246e-10
the O 0 4.461829572477427e-09
nuclear O 0 1.9896272362984746e-07
fractions O 0 1.1539865951704087e-08
of O 0 2.6217902515668357e-08
both O 0 2.8566220500181316e-09
G1 O 0 1.2120963788220251e-07
- O 0 3.381484248166089e-08
and O 0 5.278641523887018e-09
S O 0 1.4831132375547895e-06
- O 0 9.079629137431766e-08
phase O 0 1.4980545870457718e-07
cells O 0 4.982662460406573e-08
. O 0 3.6728916796846534e-08

Therefore O 0 4.83027406517067e-07
, O 0 1.5788145901751705e-08
progression O 0 3.087957267666752e-08
to O 0 6.212100611691085e-09
S O 0 9.551852144795703e-07
phase O 0 1.913327309921442e-07
is O 0 2.3275159577451632e-10
accompanied O 0 3.381997182305696e-10
by O 0 2.7942910138523125e-11
the O 0 1.471905486383207e-09
aggregation O 0 4.896511640595236e-09
of O 0 1.2227366674721907e-08
nuclear O 0 7.887004471740511e-07
BARD1 O 0 5.723898721043952e-05
polypeptides O 0 6.372557095346565e-07
into O 0 1.991451483718265e-07
BRCA1 O 0 1.178714015281912e-07
nuclear O 0 1.8352548067923635e-06
dots O 0 7.455220156771247e-07
. O 0 1.1107101727247937e-07

This O 0 2.99712127116436e-07
cell O 0 1.0447912472955068e-06
cycle O 0 5.093376032050401e-08
- O 0 2.577266577930004e-08
dependent O 0 2.70954867431783e-08
colocalization O 0 1.5400653410324594e-06
of O 0 8.430021836147716e-08
BARD1 O 0 0.0017763881478458643
and O 0 1.1962770329887462e-08
BRCA1 O 0 2.0157355784533593e-09
indicates O 0 2.5794524849409584e-10
a O 0 4.464193736897215e-10
role O 0 2.275978072674434e-09
for O 0 2.3568225149261934e-09
BARD1 O 0 0.017208291217684746
in O 0 1.0635083214083352e-07
BRCA1 O 0 1.1779717397075729e-06
- O 0 1.7670002989689237e-06
mediated O 0 5.127940676175058e-05
tumor B-Disease 0 0.0004545937990769744
suppression O 0 0.0002489596663508564
. O 0 4.4074201355215337e-07

Ethnic O 0 2.465604893586715e-07
differences O 0 1.9049376476232283e-07
in O 0 1.302406005265766e-08
the O 0 6.522458306790213e-08
HFE O 0 0.00040724879363551736
codon O 0 5.80788196202775e-07
282 O 0 1.4041204394743545e-06
( O 0 5.1020876412621874e-08
Cys O 0 0.005234817508608103
/ O 0 0.00015920096484478563
Tyr O 0 0.00035018339985981584
) O 0 4.1580275222941054e-08
polymorphism O 0 1.0668213690223638e-06
. O 0 1.5454634194611572e-07

Recent O 0 1.1134082456010219e-07
studies O 0 1.1678833899964047e-08
have O 0 1.1959067069966522e-09
shown O 0 9.641698106577223e-09
that O 0 3.957233474238819e-08
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 0 0.0007528127753175795
HH B-Disease 1 0.9999998807907104
) O 0 1.508892788493199e-09
is O 0 4.0108909249436664e-11
likely O 0 4.1548448015404915e-10
to O 0 2.238320362391022e-10
be O 0 3.294265138453767e-10
caused O 0 1.0555335272499633e-08
by O 0 4.148612564591758e-10
homozygosity O 0 1.1864416649132181e-07
for O 0 4.131792130657175e-10
a O 0 2.189938896890453e-09
Cys282Tyr O 0 1.9506158821513964e-07
mutation O 0 3.0532942840721944e-10
in O 0 2.5889357324615503e-10
the O 0 4.683132992511219e-09
HFE O 0 8.46600960358046e-05
gene O 0 9.87102595217948e-08
located O 0 1.3136883580955327e-07
4 O 0 2.1350571444145316e-07
. O 0 1.0288430019045336e-07

5 O 0 3.140083572361618e-05
Mb O 0 0.00016322670853696764
telomeric O 0 5.95575402257964e-05
to O 0 5.316971964930417e-07
HLA O 0 0.00012170575791969895
- O 0 7.071383151924238e-06
A O 0 5.755551228503464e-06
. O 0 7.9108912132142e-07

Population O 0 2.599605197772803e-09
studies O 0 7.427111703428579e-10
of O 0 1.0963315810741392e-09
this O 0 4.377470608218914e-11
polymorphism O 0 2.0898895947141227e-09
are O 0 6.8185366207396125e-12
facilitated O 0 1.0422331886417169e-09
by O 0 9.471771283964259e-11
the O 0 4.14690393135686e-10
fact O 0 3.166511497454394e-10
that O 0 8.337695117655031e-11
the O 0 2.849482649835977e-09
Cys282Tyr O 0 8.887756166586769e-07
mutation O 0 9.74475167225819e-09
creates O 0 7.490951858812878e-09
a O 0 1.166925933659968e-08
Rsal O 0 3.7065849483042257e-06
restriction O 0 7.367662391288832e-08
site O 0 4.841375016439997e-07
. O 0 8.933425021950825e-08

We O 0 2.4322966396539414e-07
have O 0 6.351561498973979e-09
studied O 0 4.559893795885728e-08
the O 0 1.445894781682e-08
codon O 0 3.788650815295114e-08
282 O 0 4.970484610566928e-07
( O 0 9.654141308601538e-08
Cys O 0 0.002120040822774172
/ O 0 5.6190274335676804e-05
Tyr O 0 7.648181053809822e-05
) O 0 1.8516560507109148e-09
polymorphism O 0 7.247225042306127e-09
in O 0 5.114180606780039e-11
different O 0 1.9847436194542212e-11
ethnic O 0 6.467372470897459e-11
groups O 0 4.9701444349015134e-11
. O 0 7.05579283888369e-09

In O 0 1.0288822238635476e-07
agreement O 0 1.2214457001391565e-07
with O 0 2.0493227115281343e-09
previous O 0 3.734291098567155e-08
observations O 0 4.8058570456532834e-08
the O 0 1.439494301536115e-08
Tyr O 0 3.5551772725739283e-06
allele O 0 1.8691116210334258e-08
appeared O 0 5.2056328136984575e-09
to O 0 1.3392338626960765e-10
be O 0 2.038585411590077e-10
rare O 0 4.043347878734949e-09
or O 0 2.208614180432278e-09
absent O 0 2.400220289189292e-08
in O 0 7.788670264297082e-10
Asiatic O 0 1.7195135981751264e-08
( O 0 4.216643353927019e-11
Indian O 0 2.5188549024335316e-09
, O 0 1.3385240138497068e-10
Chinese O 0 2.34488162220714e-09
) O 0 6.020030585141001e-10
populations O 0 3.5409326581969935e-09
. O 0 5.721177487316709e-08

The O 0 3.8203731378416705e-07
highest O 0 2.110609642613781e-07
allele O 0 3.124403180621016e-09
frequency O 0 2.519623842900387e-09
( O 0 1.1449176329225708e-10
7 O 0 2.357910533490326e-09
. O 0 1.4261455905106857e-10
5 O 0 1.1517474751698842e-09
% O 0 1.43729528279124e-10
) O 0 8.497196002377194e-11
was O 0 3.855842312106006e-09
found O 0 1.6006602709950357e-09
in O 0 7.732588791498074e-09
Swedes O 0 1.295928541367175e-05
. O 0 1.0013989140134072e-06

Saamis O 0 0.00032713112886995077
( O 0 1.2436518659342255e-07
2 O 0 1.633054154126512e-07
% O 0 1.5557097832186173e-09
) O 0 1.939452209942516e-10
and O 0 6.277692254919032e-10
Mordvinians O 0 1.7797623286242015e-06
( O 0 9.998923911069824e-10
1 O 0 6.513331207713691e-09
. O 0 2.2427862345075766e-10
8 O 0 2.047342073652203e-09
% O 0 7.771986526572405e-11
) O 0 1.3562375181241926e-11
had O 0 1.427522683394855e-10
significantly O 0 1.1841899683062707e-09
lower O 0 5.00311827522637e-08
frequencies O 0 9.880251283789221e-09
of O 0 7.595809314864255e-09
the O 0 1.0759702462337373e-08
Tyr O 0 6.9412067205121275e-06
allele O 0 1.5830669042316003e-07
. O 0 1.0925020887952996e-07

Comparisons O 0 4.2198195160381147e-07
with O 0 2.9444355842400682e-09
allele O 0 2.5745398701815247e-08
frequencies O 0 1.6539745573140863e-08
based O 0 2.40842790155682e-09
on O 0 2.0882080509210255e-09
prevalence O 0 3.808900306268015e-09
estimates O 0 7.704201721026038e-10
of O 0 1.9034807507978257e-08
HH B-Disease 1 0.9999998807907104
showed O 0 5.826744953196794e-08
some O 0 4.365074968148974e-10
disagreements O 0 2.6660812224577057e-08
with O 0 1.455100623326544e-10
the O 0 1.7832354481939205e-09
RFLP O 0 9.588170257757156e-08
data O 0 3.6784986168214573e-09
, O 0 1.4613529830675986e-10
particularly O 0 1.5875314396396334e-09
in O 0 5.620821141860688e-09
Finns O 0 2.809435727613163e-06
. O 0 4.39518032635533e-07

The O 0 2.9937900762888603e-06
newly O 0 5.551934918912593e-06
described O 0 7.317482868529623e-07
HFE O 0 0.004023968242108822
marker O 0 3.9428732634405605e-06
provides O 0 2.1747636580471408e-08
a O 0 4.33629887552911e-09
new O 0 1.9189065891822565e-09
approach O 0 8.100407455913228e-09
to O 0 6.121179674245525e-10
the O 0 1.8445286409374262e-09
screening O 0 3.6785550161511082e-09
of O 0 8.984531341127422e-09
HH B-Disease 0 0.29183200001716614
as O 0 6.148388020932316e-09
well O 0 2.92500496046344e-10
as O 0 6.013577136254611e-11
studies O 0 2.7510431432897775e-11
of O 0 1.5948449505476248e-10
the O 0 2.5140828308067853e-10
relationship O 0 3.727939346109821e-10
between O 0 8.333231882318159e-10
the O 0 9.841318870940086e-09
HFE O 0 0.0002021859254455194
Tyr O 0 1.865190643002279e-05
allele O 0 3.654416147469419e-08
and O 0 1.3343314231306636e-09
different O 0 6.772508331920335e-09
disorders O 0 0.0001611116895219311
including O 0 2.296529402201486e-07
cancer B-Disease 1 0.9999030828475952

Autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9979428648948669
associated O 0 9.855392590907286e-08
with O 0 1.4638086298646158e-09
a O 0 6.428246379641678e-09
missense O 0 5.867160268735461e-08
mutation O 0 1.232105195647648e-09
encoding O 0 2.7118803203052266e-08
Gly23 O 0 1.039501694322098e-05
- O 0 1.4037508435649215e-06
- O 0 2.310320951437461e-06
> O 0 6.224572643986903e-06
Val O 0 6.737022886227351e-06
in O 0 1.4068379350362648e-08
neurophysin O 0 2.4020735509111546e-05
II O 1 1.0
. O 0 1.9052187099077855e-06

Autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 5.910042091272771e-07
ADNDI B-Disease 1 0.9999997615814209
) O 0 5.156126192673582e-09
is O 0 2.876039684185372e-10
an O 0 9.037169901304765e-10
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 0.28269320726394653
by O 0 2.341039895270569e-08
progressive O 0 0.0013472004793584347
degeneration O 1 0.9999862909317017
of O 0 1.7587170759725268e-06
the O 0 2.943999959370558e-07
magnocellular O 0 1.7439646398997866e-05
neurons O 0 3.31621983207242e-08
of O 0 2.6677852815737424e-08
the O 0 7.933392964787345e-08
hypothalamus O 0 1.4543728354965424e-07
leading O 0 3.246092106223841e-08
to O 0 7.100990351283087e-10
decreased O 0 8.169329213103538e-09
ability O 0 4.641135031846488e-09
to O 0 2.86678547567476e-09
produce O 0 1.3899174255982416e-08
the O 0 1.1052726023308423e-07
hormone O 0 6.59399574942654e-08
arginine O 0 1.753432172790781e-07
vasopressin O 0 2.6037037059722934e-07
( O 0 1.3590931935425488e-08
AVP O 0 1.8405042965241591e-06
) O 0 3.892835387375726e-09
. O 0 2.5849516305243014e-08

Affected O 0 2.1409169903563452e-07
individuals O 0 3.364156730967238e-10
are O 0 4.428995017957682e-11
not O 0 1.1758997942035165e-10
symptomatic O 0 4.0797236579237506e-05
at O 0 1.1826579715545904e-08
birth O 0 4.7117416634989695e-09
, O 0 9.45657163686775e-11
but O 0 1.2455277087486394e-10
usually O 0 4.547731524695564e-09
develop O 0 3.007500026797061e-06
diabetes B-Disease 1 0.9999995231628418
insipidus I-Disease 1 0.9716723561286926
at O 0 2.0363429484859807e-06
1 O 0 2.147482291547931e-06
- O 0 1.0365203024775838e-06
6 O 0 3.888002538587898e-06
yr O 0 8.875075582182035e-05
of O 0 5.944433212334843e-08
age O 0 3.105890655774601e-08
. O 0 5.900378496903613e-08

The O 0 5.88071657148248e-07
genetic O 0 3.688252547817683e-07
locus O 0 2.2129717081043054e-07
of O 0 1.0137426187384335e-07
the O 0 1.1459155047077729e-07
disease O 0 1.1089465260738507e-05
is O 0 1.3226181039271978e-08
the O 0 2.727409196268127e-07
AVP O 0 0.0001571950560901314
- O 0 4.866700692218728e-06
neurophysin O 0 0.0011559074046090245
II O 1 1.0
( O 0 1.203094086577039e-07
NPII O 0 3.053348700632341e-05
) O 0 3.600762743527497e-10
gene O 0 2.480947669525335e-10
, O 0 4.1890595159355115e-11
and O 0 1.451270076335831e-10
mutations O 0 5.082850806914507e-10
that O 0 1.5211819304195018e-10
cause O 0 2.17406949332144e-07
ADNDI B-Disease 1 0.998318076133728
have O 0 1.3760497186154907e-09
been O 0 3.5722780289404454e-10
found O 0 8.357056019425713e-11
in O 0 2.8598356321962726e-11
both O 0 3.5063171116567204e-11
the O 0 9.974238102117283e-10
signal O 0 3.9902335657870935e-08
peptide O 0 2.137301713389661e-08
of O 0 8.782168947618629e-08
the O 0 3.075795689255756e-07
prepro O 0 4.32465567428153e-05
- O 0 8.235058885475155e-06
AVP O 0 0.0001534511538920924
- O 0 2.1664232008333784e-06
NPII O 0 0.00012634006270673126
precursor O 0 9.522537993689184e-07
and O 0 1.87264781459362e-08
within O 0 5.378241141329454e-08
NPII O 0 0.00018294848268851638
itself O 0 8.784983407394975e-08
. O 0 7.652306521777064e-08

An O 0 7.691537717846586e-08
affected O 0 7.195274775995131e-08
girl O 0 1.610364677162579e-07
who O 0 5.697109450863991e-09
presented O 0 3.500582579363254e-08
at O 0 5.0727059885957715e-08
9 O 0 1.4494622391225676e-08
months O 0 1.158445006588238e-09
of O 0 6.699072852001109e-09
age O 0 5.534734448531253e-09
and O 0 1.8982371230436e-09
her O 0 2.349021532843665e-10
similarly O 0 7.62246599173011e-10
affected O 0 6.122125584262506e-10
younger O 0 1.813682892759516e-08
brother O 0 4.821603170057642e-07
and O 0 3.354803324029376e-09
father O 0 1.2008175076516636e-07
were O 0 1.6323115081817718e-09
all O 0 4.236587469730324e-11
found O 0 2.115205371966411e-10
to O 0 1.5942730469120647e-10
have O 0 2.1789052506715478e-10
a O 0 3.5836220657614604e-09
novel O 0 3.653649471857534e-08
missense O 0 6.685927900207389e-08
mutation O 0 2.422410050328949e-09
( O 0 2.9403765533508874e-10
G1758 O 0 5.160240945656369e-08
- O 0 3.077644095128562e-08
- O 0 8.295416620285323e-08
> O 0 1.1501635555077883e-07
T O 0 5.1075016216373115e-08
) O 0 1.3413915811444355e-10
encoding O 0 1.2304706142884925e-09
the O 0 1.5776547845902655e-09
amino O 0 2.0088719576705216e-10
acid O 0 5.931787283586232e-10
substitution O 0 4.679026055498525e-09
Gly23 O 0 2.6664579308999237e-06
- O 0 6.907666829647496e-07
- O 0 2.33630839829857e-06
> O 0 8.333409823535476e-06
Val O 0 6.530620339617599e-06
within O 0 1.7770067017863767e-07
NPII O 0 0.000300981686450541
. O 0 2.3556962958082295e-07

The O 0 8.933210438044625e-07
mutation O 0 8.361116954347381e-08
was O 0 1.0802024519307452e-07
confirmed O 0 5.3795101706555215e-09
by O 0 3.3212743666410915e-10
restriction O 0 7.192706430458884e-09
endonuclease O 0 3.7371702887867286e-07
analysis O 0 4.292383337656247e-08
. O 0 8.732110501341594e-08

A O 0 0.00015018972044344991
T1 O 0 0.0014514721697196364
- O 0 3.978514996560989e-06
weighted O 0 1.4843709550405038e-07
magnetic O 0 2.879185672099993e-07
resonance O 0 5.059304157839506e-07
imaging O 0 5.023293397243833e-06
of O 0 1.6375844325011712e-06
the O 0 4.368716872704681e-06
fathers O 0 7.184936839621514e-05
pituitary O 0 7.205129804788157e-05
gland O 0 2.1613548142340733e-06
demonstrates O 0 6.103348226815797e-08
an O 0 2.9674043222627233e-09
attenuated O 0 1.4373305248227553e-06
posterior O 0 4.25543794335681e-06
pituitary O 0 3.36600023729261e-05
bright O 0 6.816288805566728e-05
spot O 0 8.122446160996333e-05
. O 0 8.876032779880916e-07

This O 0 1.2601886112406646e-07
mutation O 0 4.246844653721382e-08
may O 0 5.709074990534191e-09
be O 0 4.668309072641819e-10
valuable O 0 2.7644498246104376e-08
for O 0 1.4310556906149685e-10
developing O 0 2.7773545685505496e-09
models O 0 3.0550200147416717e-09
of O 0 1.1482894279879474e-07
dominantly B-Disease 1 0.9990074038505554
inherited I-Disease 1 1.0
neurodegeneration I-Disease 1 1.0
, O 0 3.924295111090714e-09
as O 0 2.1791546345184543e-10
the O 0 1.4609963239209378e-10
early O 0 8.204334434047666e-10
age O 0 1.2453851838678531e-10
of O 0 3.6885716703238813e-10
onset O 0 1.0748055501608178e-05
of O 0 4.053666202707973e-08
symptoms O 0 9.386035770830858e-08
suggests O 0 1.2044728547877526e-09
that O 0 1.2283682751523806e-11
this O 0 2.2951741202037468e-11
mutation O 0 2.103385104978983e-10
may O 0 2.685333899687947e-10
be O 0 1.693395978996648e-10
particularly O 0 3.2107392300417814e-09
deleterious O 0 5.421001958438865e-08
to O 0 6.212764525059811e-09
the O 0 1.1822208278999824e-07
magnocellular O 0 3.083631963818334e-05
neuron O 0 8.821661481306364e-07
. O 0 1.075088196245133e-08
. O 0 6.569327837269157e-08

Frequent O 0 2.1998259853717173e-06
inactivation O 0 9.286966087529436e-05
of O 0 9.555757060297765e-06
PTEN O 1 0.9999998807907104
/ O 1 0.9999905824661255
MMAC1 O 1 1.0
in O 0 3.9500477555520774e-07
primary O 1 0.9996873140335083
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.67653365174192e-06

Sporadic B-Disease 1 1.0
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 1.3713515727431513e-05
the O 0 5.220690013629792e-08
most O 0 4.4614187344471645e-10
common O 0 2.6874269920540428e-08
male B-Disease 0 8.410921736867749e-09
cancer I-Disease 0 1.0150196061431416e-07
in O 0 3.374831525349009e-10
the O 0 1.4719791607831212e-08
Western O 0 4.931525836582296e-06
world O 0 6.396446927681154e-09
, O 0 4.8471931329840956e-11
yet O 0 7.067019192064095e-11
many O 0 1.314733565072057e-11
of O 0 2.3530527526460787e-10
the O 0 4.707436107587171e-10
major O 0 5.132966274246087e-10
genetic O 0 2.757890305016275e-10
events O 0 2.7920948972998128e-12
involved O 0 6.920288127265639e-12
in O 0 1.4671390838327802e-11
the O 0 1.4860486452494825e-10
progression O 0 1.8916010979808107e-09
of O 0 1.3446915803072557e-09
this O 0 2.9875180107552524e-10
often O 0 1.1641780872650997e-08
fatal O 0 1.2184411389171146e-05
cancer B-Disease 0 1.263270041818032e-05
remain O 0 1.6000512914615683e-07
to O 0 1.7162371079848526e-08
be O 0 9.785843246845616e-08
elucidated O 0 0.0016058963956311345
. O 0 1.970448920474155e-06

Numerous O 0 2.4475145892211003e-06
cytogenetic O 0 0.00015585774963255972
and O 0 1.7523322526358243e-07
allelotype O 0 1.0777246643556282e-05
studies O 0 3.8432648175046324e-09
have O 0 3.1563990310345957e-10
reported O 0 1.5423288202143226e-09
frequent O 0 4.484096649548519e-09
loss O 0 1.0712424369785367e-07
of O 0 1.896179014693189e-06
heterozygosity O 1 0.9999974966049194
on O 0 3.6135832488071173e-05
chromosomal O 0 1.352757590211695e-05
arm O 0 4.6569020923925564e-05
10q O 0 9.13467192731332e-06
in O 0 6.244963657309199e-08
sporadic B-Disease 1 0.9999926090240479
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.3188328921387438e-05

Deletion O 0 5.231338491284987e-06
mapping O 0 2.748818985764956e-07
studies O 0 3.3822376011016786e-09
have O 0 8.726241396139756e-10
unambiguously O 0 1.4376944079685927e-08
identified O 0 6.115347783719471e-09
a O 0 6.571531319110591e-09
region O 0 4.14963743367025e-08
of O 0 1.3034438950398908e-07
chromosome O 0 3.7425767374088537e-08
10q23 O 0 1.0343562450998434e-07
to O 0 6.194326163111441e-10
be O 0 3.231497291977803e-10
the O 0 2.0930530642004896e-09
minimal O 0 2.525951003917726e-07
area O 0 9.000417122706494e-08
of O 0 1.1953600775882478e-08
loss O 0 2.6429890453982807e-07
. O 0 1.8818307978563098e-07

A O 0 7.731382538622711e-06
new O 0 4.280961434233177e-07
tumor B-Disease 0 8.825153372526984e-07
suppressor O 0 1.0632562634782516e-06
gene O 0 1.5163312383492666e-08
, O 0 3.961581729328145e-09
PTEN O 0 0.000873572425916791
/ O 0 0.0001339706068392843
MMAC1 O 1 0.999976634979248
, O 0 1.98654177552271e-08
was O 0 3.3013330380526895e-07
isolated O 0 6.27794918273139e-08
recently O 0 6.275719943715785e-09
at O 0 4.3231659918596677e-10
this O 0 1.937550987707315e-11
region O 0 1.2044798491928077e-09
of O 0 6.636122318326443e-09
chromosome O 0 6.981655698012901e-09
10q23 O 0 8.054714584204703e-08
and O 0 2.7327509699581753e-10
found O 0 9.147285706667674e-11
to O 0 5.455555104894039e-11
be O 0 3.0075844592580836e-11
inactivated O 0 2.9226920883473895e-09
by O 0 5.009565678948391e-11
mutation O 0 2.5773180811761165e-10
in O 0 1.1730756366290507e-09
three O 0 1.5666303454509034e-07
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 0 0.00018799449026118964
lines O 0 1.6993567442114e-07
. O 0 9.871401829286697e-08

We O 0 5.089383193990216e-06
screened O 0 2.749349550867919e-05
80 O 0 1.390136094414629e-05
prostate B-Disease 1 0.999990701675415
tumors I-Disease 1 1.0
by O 0 1.0881012535435275e-08
microsatellite O 0 2.103350880133803e-06
analysis O 0 5.7392304242398495e-09
and O 0 2.3539112881110213e-09
found O 0 2.6866107116774174e-09
chromosome O 0 3.931757142083825e-09
10q23 O 0 6.367295668496809e-08
to O 0 8.862442446577745e-10
be O 0 1.0277162454386257e-09
deleted O 0 2.079516470132603e-08
in O 0 2.0942110268151737e-09
23 O 0 1.9927313132939162e-08
cases O 0 5.456164409167741e-09
. O 0 8.070276891203321e-08

We O 0 1.4634470346663875e-07
then O 0 8.210599311553324e-09
proceeded O 0 5.726262131133808e-09
with O 0 5.173732102459194e-12
sequence O 0 1.494253505651688e-11
analysis O 0 2.1186363427516675e-11
of O 0 1.4770266121288955e-09
the O 0 7.382753075546589e-09
entire O 0 6.802415555284824e-07
PTEN O 0 0.1404886394739151
/ O 0 9.622713696444407e-05
MMAC1 O 0 0.0005714212893508375
coding O 0 1.8817548834704212e-06
region O 0 3.239659207565637e-08
and O 0 8.908981885547007e-10
tested O 0 1.5152319399192038e-09
for O 0 2.370336704693443e-10
homozygous O 0 3.084394295527204e-09
deletion O 0 4.403661435503636e-09
with O 0 1.3238635188095316e-10
new O 0 6.964578247448117e-09
intragenic O 0 2.127379275407293e-06
markers O 0 1.0629441327125733e-08
in O 0 2.3173010732513433e-10
these O 0 5.0788751676522637e-11
23 O 0 1.0565601726852947e-09
cases O 0 8.668772644160327e-11
with O 0 2.994489656238386e-10
10q23 O 0 2.049974682449829e-06
loss O 0 4.193502434191032e-07
of O 0 2.3331110696744872e-06
heterozygosity O 1 0.9997332692146301
. O 0 1.1100342817371711e-05

The O 0 1.2525262604867748e-07
identification O 0 4.2702456681809053e-08
of O 0 1.026441935891853e-07
the O 0 4.585623258890337e-08
second O 0 9.633760100768995e-08
mutational O 0 4.919974344375078e-06
event O 0 1.1097738727983142e-08
in O 0 2.6632438476781317e-09
10 O 0 2.5482451704306186e-09
( O 0 4.713213153095808e-10
43 O 0 3.0987013843741806e-08
% O 0 1.7568057231187595e-08
) O 0 7.627010489841268e-08
tumors B-Disease 1 1.0
establishes O 0 2.964092345791869e-05
PTEN O 1 0.999996542930603
/ O 0 0.0020328860264271498
MMAC1 O 0 0.0007153080659918487
as O 0 8.182240662790718e-09
a O 0 1.8244724619975727e-09
main O 0 5.108901746098127e-09
inactivation O 0 2.4735978598755537e-08
target O 0 8.718788468975447e-10
of O 0 1.5653653928637823e-09
10q O 0 4.090512675247737e-07
loss O 0 3.7518180562301495e-08
in O 0 1.1779842878922864e-08
sporadic B-Disease 1 0.9997583031654358
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 6.377274530677823e-08
. O 0 5.698938565501521e-08

Risk O 0 7.4845161179837305e-06
reversals O 0 5.884480287932092e-06
in O 0 1.0331412170216936e-08
predictive O 0 6.14822681654914e-07
testing O 0 5.172312853574113e-07
for O 0 6.81453798279108e-07
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 7.788656148477457e-06

The O 0 1.5163753630531573e-07
first O 0 2.1692858620525612e-09
predictive O 0 1.786490777533345e-08
testing O 0 1.2776781410650528e-08
for O 0 2.3769219481550863e-08
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 9.226268637974044e-09
HD B-Disease 0 9.272656461689621e-05
) O 0 7.216640618423753e-10
was O 0 2.55828203066244e-09
based O 0 1.4301443362896293e-10
on O 0 4.90759821669684e-10
analysis O 0 2.9546728952389856e-10
of O 0 4.880034709664471e-10
linked O 0 3.1383611265312084e-09
polymorphic O 0 3.354158906176963e-08
DNA O 0 2.5492575161933928e-08
markers O 0 1.7632334481376688e-09
to O 0 1.410138117385884e-10
estimate O 0 1.1862426596565001e-09
the O 0 8.073241519745977e-10
likelihood O 0 2.262418874465766e-08
of O 0 5.0810527341127454e-08
inheriting O 0 1.8856283645618532e-07
the O 0 1.2521963022038562e-08
mutation O 0 2.1737671662691582e-09
for O 0 4.236317074912677e-09
HD B-Disease 0 3.543020284269005e-05
. O 0 3.7749606462966767e-07

Limits O 0 3.9101877291614073e-07
to O 0 7.617252606451075e-09
accuracy O 0 1.041741271023966e-07
included O 0 3.698281236808043e-09
recombination O 0 2.3836808082933203e-09
between O 0 4.78120265601234e-10
the O 0 3.4553115924040867e-10
DNA O 0 9.139516699008254e-09
markers O 0 1.5951804321900909e-09
and O 0 2.959207323627311e-10
the O 0 1.8038358584604453e-09
mutation O 0 1.767374913086428e-09
, O 0 2.686045830202488e-10
pedigree O 0 7.549387781580208e-09
structure O 0 8.967957931815818e-09
, O 0 1.5827597565909457e-10
and O 0 6.980477307294564e-11
whether O 0 2.821556877030673e-11
DNA O 0 9.443562598576705e-10
samples O 0 1.1648433606570308e-10
were O 0 1.655292014568488e-10
available O 0 2.0090376029457957e-09
from O 0 9.587289184764813e-09
family O 0 6.862702406351673e-08
members O 0 3.803238168842427e-09
. O 0 5.972013639166107e-08

With O 0 7.54292450722005e-09
direct O 0 2.622035211174989e-08
tests O 0 3.299826190072963e-09
for O 0 8.334248846608716e-10
the O 0 1.120072568028263e-08
HD B-Disease 0 1.949302532011643e-05
mutation O 0 8.514060567677006e-09
, O 0 3.9092770687254585e-10
we O 0 1.0013347095938485e-10
have O 0 7.441997712520632e-11
assessed O 0 3.9416687691584684e-09
the O 0 1.2744452160262654e-09
accuracy O 0 9.344875984140799e-09
of O 0 1.487234668751114e-09
results O 0 8.536785167656546e-11
obtained O 0 8.432602949248746e-10
by O 0 1.7154695719501234e-10
linkage O 0 1.8484778152583203e-08
approaches O 0 3.15588479793405e-08
when O 0 1.3239198626280313e-09
requested O 0 6.707639332859117e-09
to O 0 6.157480081370181e-10
do O 0 2.586635627910283e-10
so O 0 1.0117825327560226e-10
by O 0 5.659327173557216e-11
the O 0 1.019854756201255e-09
test O 0 2.930607756468362e-09
individuals O 0 1.484603828760811e-10
. O 0 4.425311317390879e-08

For O 0 1.4920208002422441e-07
six O 0 1.1437925273583005e-08
such O 0 4.606605374934958e-10
individuals O 0 6.849616013271387e-11
, O 0 1.6406133396262845e-10
there O 0 1.1432679108969168e-10
was O 0 5.455602192228071e-09
significant O 0 8.754515445907884e-10
disparity O 0 8.895912451123422e-09
between O 0 2.741763704960931e-09
the O 0 1.7929425055740467e-08
tests O 0 2.763669471050889e-08
. O 0 8.38846361261858e-08

Three O 0 2.071180233542691e-06
went O 0 5.077919240648043e-07
from O 0 6.241626770986386e-09
a O 0 3.3487810302545995e-09
decreased O 0 8.12172551434287e-09
risk O 0 1.5243049045210455e-09
to O 0 1.1558181495230357e-10
an O 0 1.2632845290683203e-11
increased O 0 1.6577691996921828e-10
risk O 0 1.1539881272781827e-09
, O 0 3.176812285454744e-11
while O 0 3.5200609788121895e-11
in O 0 7.139461244420886e-11
another O 0 2.392867570755186e-10
three O 0 1.2398700122151496e-10
the O 0 3.832940631554038e-10
risk O 0 2.6809594544374704e-09
was O 0 2.1282259510257973e-08
decreased O 0 1.540721328296968e-08
. O 0 4.23864676690755e-08

Knowledge O 0 1.1681043361022603e-05
of O 0 2.9253958473418606e-06
the O 0 6.124501794602111e-08
potential O 0 1.3435180967746874e-08
reasons O 0 6.1155813746438525e-09
for O 0 9.488388547085336e-11
these O 0 3.515410879062486e-11
changes O 0 4.1518186111311195e-10
in O 0 3.6729441710292576e-10
results O 0 3.379843349637923e-10
and O 0 6.737717050953052e-10
impact O 0 1.0880596867934855e-08
of O 0 4.25724744346212e-09
these O 0 4.2943851252807974e-10
risk O 0 4.964597621892608e-09
reversals O 0 6.175021383114654e-08
on O 0 1.0688337326314468e-08
both O 0 1.8601509221838342e-10
patients O 0 9.626478503221847e-10
and O 0 1.519164571917031e-09
the O 0 6.880078284865476e-09
counseling O 0 5.427806648583555e-09
team O 0 2.74384431842023e-10
can O 0 4.995387090089842e-11
assist O 0 2.729241499466184e-09
in O 0 5.700106497918966e-10
the O 0 1.7591621492840659e-09
development O 0 4.44102798979884e-09
of O 0 1.0504276337641727e-09
strategies O 0 1.0057991106648956e-09
for O 0 7.523146688948046e-11
the O 0 3.153504402053642e-10
prevention O 0 1.037653785118664e-08
and O 0 7.515617295172916e-11
, O 0 1.0978978143283413e-11
where O 0 1.3316021028886293e-11
necessary O 0 4.0461461958685163e-10
, O 0 3.461114381209107e-11
management O 0 5.976144579200593e-10
of O 0 7.816186586850904e-10
a O 0 7.306277249874427e-10
risk O 0 2.000781540445473e-09
reversal O 0 6.119595052922477e-09
in O 0 1.3454708180926644e-10
any O 0 1.7971246712988886e-10
predictive O 0 9.105969311917761e-09
testing O 0 5.948320058735135e-09
program O 0 4.563328381834708e-09
. O 0 1.8569118465094903e-09
. O 0 2.462220649590563e-08

A O 0 4.6158593249856494e-06
novel O 0 4.3946354821855493e-07
common O 0 1.7667564122803014e-07
missense O 0 1.4135778201307403e-06
mutation O 0 1.7304270016893497e-08
G301C O 0 3.489477364837512e-07
in O 0 2.5322659524817936e-09
the O 0 2.333398896325889e-08
N O 0 1.294291394060565e-07
- O 0 7.645945743206539e-08
acetylgalactosamine O 0 2.944526386272628e-06
- O 0 1.4852417962174513e-07
6 O 0 1.51756879063214e-07
- O 0 3.106862322965753e-08
sulfate O 0 3.8311767980303557e-07
sulfatase O 0 6.838171429990325e-06
gene O 0 2.362395434829523e-08
in O 0 1.4096447564782011e-08
mucopolysaccharidosis B-Disease 0 0.00012466430780477822
IVA I-Disease 1 0.9992119073867798
. O 0 3.286369292254676e-06

Mucopolysaccharidosis B-Disease 1 0.9962486624717712
IVA I-Disease 1 1.0
( O 0 0.001870079548098147
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 2.0741379103128565e-07
is O 0 5.759451582321162e-09
an O 0 3.1201272676639746e-09
autosomal B-Disease 1 0.9992208480834961
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 1 0.9988982677459717
by O 0 1.83506088546892e-07
a O 0 1.6078407497843727e-05
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 2.9319733130250825e-06
N O 0 7.374962024186971e-06
- O 0 1.9898998289136216e-06
acetylgalactosamine O 0 9.34425406740047e-05
- O 0 1.7234477809324744e-06
6 O 0 1.0956287042063195e-06
- O 0 3.765823919366085e-07
sulfate O 0 8.66829668666469e-06
sulfatase O 0 0.0002679225872270763
( O 0 6.835295351947934e-08
GALNS O 0 0.0002179014845751226
) O 0 2.2115743902872964e-08
. O 0 4.1748592138901586e-08

In O 0 7.363897225332039e-08
previous O 0 4.9921467848434986e-08
studies O 0 4.280779730692075e-09
, O 0 5.788324264344169e-10
we O 0 2.9272709256567e-10
have O 0 6.142579500600931e-11
found O 0 1.950391931293538e-10
two O 0 7.662840501021506e-11
common O 0 1.653998937811707e-09
mutations O 0 7.695448722699894e-10
in O 0 4.190763569500433e-10
Caucasians O 0 4.382799190238984e-08
and O 0 8.278816743256812e-09
Japanese O 0 7.124050625861855e-06
, O 0 4.9140078672849086e-09
respectively O 0 6.183778822332897e-08
. O 0 2.3281560856958095e-07

To O 0 3.054142325709108e-07
characterize O 0 2.882248509195051e-06
the O 0 7.576089728900115e-07
mutational O 0 0.0004423675127327442
spectrum O 0 1.7579171753823175e-06
in O 0 3.6220890176075216e-10
various O 0 1.2929940451655852e-10
ethnic O 0 3.917665150621197e-11
groups O 0 1.7045675851715125e-12
, O 0 7.0328339506209314e-12
mutations O 0 2.2638097993410433e-11
in O 0 8.930550743357912e-11
the O 0 4.262699526691449e-09
GALNS O 0 8.656376849103253e-06
gene O 0 4.577720869036739e-09
in O 0 3.147635263545112e-09
Colombian O 0 1.4549053958035074e-05
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 0.00024365691933780909
were O 0 3.5986378321695156e-08
investigated O 0 4.1969428821175825e-08
, O 0 3.698406303431767e-10
and O 0 5.631560218155585e-10
genetic O 0 4.2728425242444246e-09
backgrounds O 0 3.3341795990793344e-09
were O 0 1.4161521955102785e-09
extensively O 0 1.4595151753837854e-09
analyzed O 0 9.332830064323616e-10
to O 0 1.611940164680803e-10
identify O 0 6.015851705676312e-10
racial O 0 2.9977009763371143e-10
origin O 0 6.642855709948492e-10
, O 0 9.55389170553822e-11
based O 0 4.938962572254013e-10
on O 0 3.411685378651441e-09
mitochondrial O 0 7.049924533042429e-10
DNA O 0 1.6845859152070375e-09
( O 0 1.756432083110937e-10
mtDNA O 0 1.3332656090270234e-09
) O 0 3.810954884997386e-10
lineages O 0 2.1225060820029285e-08
. O 0 4.4136363896996045e-08

Three O 0 6.764350928278873e-07
novel O 0 4.410077281136182e-07
missense O 0 1.3647244259118452e-06
mutations O 0 9.743263973405192e-09
never O 0 1.769602064882747e-08
identified O 0 1.0075506651219257e-08
previously O 0 8.063042677974863e-09
in O 0 3.5676750442803495e-10
other O 0 1.5609938341931695e-10
populations O 0 6.327589147092638e-11
and O 0 1.559419537944251e-10
found O 0 2.8168745114243166e-10
in O 0 4.872110492826209e-10
16 O 0 5.138101499824188e-09
out O 0 8.413035268439728e-10
of O 0 1.6706900751728426e-08
19 O 0 1.2171445007425064e-07
Colombian O 0 7.1233644121093675e-06
MPS B-Disease 1 0.9999997615814209
IVA I-Disease 1 1.0
unrelated O 0 2.7045408046433295e-07
alleles O 0 9.35537536328468e-10
account O 0 2.932977194447517e-10
for O 0 1.1361276364141304e-09
84 O 0 3.579259271191404e-07
. O 0 3.354930129262357e-07

2 O 0 1.9688147858687444e-06
% O 0 7.978807836650503e-09
of O 0 1.0833258734521678e-08
the O 0 3.812759885590822e-09
alleles O 0 9.94653914787591e-10
in O 0 4.224905147953706e-10
this O 0 2.868556225887886e-10
study O 0 1.8828292258632473e-09
. O 0 1.568025886911073e-08

The O 0 7.853544957470149e-06
G301C O 0 2.5568169803591445e-05
and O 0 1.0816292217441514e-07
S162F O 0 1.3219810170994606e-06
mutations O 0 1.9276149565428113e-09
account O 0 9.375579201886808e-10
for O 0 5.0377413352009626e-09
68 O 0 1.2703609399977722e-06
. O 0 3.878448922023381e-07

4 O 0 1.0387862857896835e-05
% O 0 8.407332785509425e-08
and O 0 1.6904479593904398e-08
10 O 0 9.206723916577175e-08
. O 0 1.6157487436885276e-07

5 O 0 8.900903480935085e-07
% O 0 5.325849983250919e-09
of O 0 3.5950278309826444e-09
mutations O 0 3.635745038366167e-10
, O 0 1.2979409214075588e-10
respectively O 0 9.544079970780217e-10
, O 0 1.0156340352063253e-10
whereas O 0 2.631975082323379e-09
the O 0 4.379289464395697e-08
remaining O 0 6.176547344693972e-07
F69V O 0 2.1646534150931984e-05
is O 0 4.41276515328326e-10
limited O 0 3.123889202871766e-10
to O 0 2.412656185946105e-10
a O 0 2.090069006754902e-09
single O 0 8.615703706027489e-09
allele O 0 5.6608367771104895e-08
. O 0 5.6932453418312434e-08

The O 0 1.1948606015721452e-06
skewed O 0 1.1995142585874419e-06
prevalence O 0 6.771832090635144e-07
of O 0 6.900609150761738e-08
G301C O 0 7.365062515418686e-07
in O 0 7.719925809723804e-10
only O 0 1.718928194227587e-10
Colombian O 0 1.9024714248416785e-08
patients O 0 1.7024387455322199e-09
and O 0 6.780984107557231e-10
haplotype O 0 5.794316848550807e-08
analysis O 0 3.275419102610755e-10
by O 0 2.3697930770505415e-11
restriction O 0 4.0650049992763115e-10
fragment O 0 2.7474906794111575e-09
length O 0 9.90855508753441e-10
polymorphisms O 0 2.816988642351248e-09
in O 0 3.7309696998555353e-10
the O 0 5.4887721034901915e-09
GALNS O 0 9.673006388766225e-06
gene O 0 2.8573305943524474e-09
suggest O 0 7.847347216483058e-10
that O 0 1.6514541123502369e-10
G301C O 0 9.61918118491667e-08
originated O 0 6.219629256065673e-09
from O 0 2.799777076845089e-10
a O 0 8.018593011804853e-10
common O 0 1.9930126882172772e-08
ancestor O 0 5.175666046852712e-06
. O 0 2.6514010187383974e-07

Investigation O 0 3.6902897591062356e-06
of O 0 5.523099275706045e-07
the O 0 1.6166959326824326e-08
genetic O 0 3.769482948001723e-09
background O 0 7.085229625225509e-10
by O 0 4.042595425080009e-11
means O 0 2.4304118717566325e-09
of O 0 1.0890875756786045e-08
mtDNA O 0 2.9263849121718977e-09
lineages O 0 2.558373513039669e-10
indicate O 0 5.300974589839136e-11
that O 0 5.0652343430712676e-11
all O 0 3.0865998645879245e-10
our O 0 8.4556708301875e-09
patients O 0 1.4674176318507648e-09
are O 0 3.5450444663132075e-11
probably O 0 7.926145073611224e-09
of O 0 2.16953512932605e-08
native O 0 4.249753615681584e-08
American O 0 9.379343168802734e-08
descent O 0 1.1543371329025831e-05

Low O 0 3.080797114307643e-06
frequency O 0 2.275217809710739e-07
of O 0 7.828145243138351e-08
BRCA1 O 0 1.4160637995530578e-08
germline O 0 4.2228144536693435e-08
mutations O 0 2.527733578006064e-10
in O 0 7.39392019832863e-11
45 O 0 8.490999903187912e-09
German O 1 0.9999972581863403
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.3380356733705412e-07
. O 0 7.12371956979041e-08

In O 0 7.411028946080478e-08
this O 0 9.300772374487565e-10
study O 0 1.8507725907390693e-10
we O 0 5.788530765826749e-11
investigated O 0 1.6526807700145696e-09
45 O 0 5.039384909366618e-09
German O 1 0.8185997009277344
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 6.321825840593931e-10
for O 0 6.479101977152624e-11
germline O 0 1.1985334502639944e-08
mutations O 0 1.5175073697637487e-10
in O 0 2.4914176277590627e-10
the O 0 7.209517427497758e-09
BRCA1 O 0 2.896140571806427e-08
gene O 0 1.6321129336915874e-08
. O 0 3.7017130694039224e-08

We O 0 8.292158071299127e-08
identified O 0 4.887295901312427e-08
four O 0 4.3594523546630626e-09
germline O 0 3.576508902369824e-07
mutations O 0 4.862059199695068e-09
in O 0 7.38366834340809e-09
three O 0 3.9209002267170945e-08
breast B-Disease 0 0.00025782594457268715
cancer I-Disease 0 1.1593426279432606e-05
families O 0 1.5413201825964506e-09
and O 0 3.987279839634539e-09
in O 0 1.8503754972698516e-08
one O 0 0.016367152333259583
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 1.39309619839878e-07
. O 0 3.759226263611026e-11
among O 0 3.2214385239232035e-12
these O 0 5.2654807597418696e-12
were O 0 2.6828714250193286e-10
one O 0 2.4915128293834243e-10
frameshift O 0 8.07356848042673e-09
mutation O 0 4.230711059260983e-10
, O 0 8.188758698901566e-11
one O 0 2.1591879673099612e-10
nonsense O 0 3.813780224959373e-08
mutation O 0 1.4428608308136859e-09
, O 0 1.675219546415363e-10
one O 0 1.9484250324275365e-10
novel O 0 1.2422999517980315e-08
splice O 0 8.952364396463963e-07
site O 0 3.0974543818729217e-08
mutation O 0 7.246751532186124e-10
, O 0 1.9507082060776781e-10
and O 0 2.131763654489305e-09
one O 0 1.472669985957964e-08
missense O 0 3.093447958235629e-06
mutation O 0 3.833194170965726e-07
. O 0 5.542849521589233e-07

The O 0 2.120848421327537e-06
missense O 0 7.839447789592668e-06
mutation O 0 1.2796735404663195e-07
was O 0 3.2328728138963925e-07
also O 0 9.535618961109549e-10
found O 0 2.2089174933626055e-09
in O 0 5.9484337455728564e-09
2 O 0 6.211214440554613e-07
. O 0 2.7113844680570764e-07

8 O 0 3.70858265341667e-06
% O 0 2.270290622163884e-08
of O 0 1.8448602645548817e-08
the O 0 2.295377887762129e-09
general O 0 7.829888737376223e-09
population O 0 3.991635841305019e-11
, O 0 1.80478392647343e-11
suggesting O 0 9.836092357273785e-11
that O 0 1.6202589617209107e-11
it O 0 6.19011925051538e-11
is O 0 1.7937343277374396e-10
not O 0 4.4510495289529217e-10
disease O 0 2.1143929984646093e-07
associated O 0 2.5774124878807925e-07
. O 0 6.378880357260641e-07

The O 0 5.412240398072754e-07
average O 0 1.638713520435431e-08
age O 0 4.874222803152861e-09
of O 0 1.2737167764953483e-08
disease O 0 1.5368873391707893e-06
onset O 0 0.1259804219007492
in O 0 5.4593702891736484e-09
those O 0 8.748473057096362e-10
families O 0 7.932129397758558e-10
harbouring O 0 7.107392718808114e-08
causative O 0 3.32084688636769e-08
mutations O 0 1.5475651871099672e-09
was O 0 5.0087422209799115e-08
between O 0 1.8063328610651297e-08
32 O 0 4.5799984604855126e-07
. O 0 3.215647552679002e-07

3 O 0 1.0076323633256834e-05
and O 0 2.8320974365669827e-07
37 O 0 2.7078208404418547e-06
. O 0 6.669000072179188e-07

4 O 0 4.5622878133144695e-06
years O 0 5.3038853309317346e-08
, O 0 1.3072284366089093e-09
whereas O 0 5.654132717580751e-09
the O 0 1.9625405300871535e-08
family O 0 2.2200355331847277e-08
harbouring O 0 4.4023289547112654e-07
the O 0 2.3292857420642576e-08
missense O 0 2.077691618751487e-07
mutation O 0 2.515139208014716e-09
had O 0 5.199599417693435e-09
an O 0 5.257404928071807e-11
average O 0 2.399526688456888e-10
age O 0 3.532599768263367e-10
of O 0 1.3894058348284943e-08
onset O 0 0.0032272604294121265
of O 0 1.6257261449936777e-05
51 O 0 3.2930233828665223e-06
. O 0 2.684471951397427e-07

2 O 0 5.903534474782646e-05
years O 0 1.3871982673663297e-06
. O 0 9.554877351547475e-07

These O 0 6.279434217049129e-08
findings O 0 6.524075502056803e-08
show O 0 7.979903848820413e-09
that O 0 2.945675370291667e-10
BRCA1 O 0 6.6198393433580804e-09
is O 0 3.3769950724682474e-10
implicated O 0 4.870607916984682e-09
in O 0 4.5384487834532194e-10
a O 0 1.0652125848054084e-09
small O 0 2.1517752857302952e-10
fraction O 0 2.795754738826872e-09
of O 0 8.258481898337777e-07
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 4.185307656001669e-10
suggesting O 0 4.8854618267535344e-11
the O 0 2.6380436030093435e-11
involvement O 0 2.2402807386967538e-10
of O 0 3.153895478114066e-10
another O 0 1.38787883963154e-10
susceptibility O 0 3.820337823867703e-09
gene O 0 2.309668456490499e-09
( O 0 3.743288790047927e-09
s O 0 4.814454314328032e-06
) O 0 8.256772616732633e-07

Paternal O 0 0.008579983375966549
transmission O 1 0.9185491800308228
of O 0 0.10139668732881546
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.9997723698616028

We O 0 1.3631996864660323e-07
report O 0 5.225728294533383e-09
a O 0 1.4418346516720248e-09
rare O 0 6.39666630775082e-09
case O 0 1.9883577451196288e-08
of O 0 3.482436170543224e-07
paternally O 1 0.9999983310699463
transmitted O 1 1.0
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9911226034164429
DM B-Disease 1 1.0
) O 0 5.273326451060711e-07
. O 0 2.947607242731465e-07

The O 0 3.688192919071298e-06
proband O 0 2.9302789698704146e-05
is O 0 5.589325891008912e-09
a O 0 8.54399395677774e-09
23 O 0 2.324457071267716e-08
year O 0 5.030645677805978e-09
old O 0 0.00021012136130593717
, O 0 1.9289125248178607e-06
mentally B-Disease 1 1.0
retarded I-Disease 1 1.0
male O 0 2.5867971999105066e-05
who O 0 1.6700327876151277e-07
suffers O 1 0.6918367743492126
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 1 0.9999945163726807

He O 0 2.813916921695636e-07
presented O 0 2.91735631208212e-07
with O 0 2.901830242763026e-08
respiratory O 1 1.0
and O 0 1.0827185406014905e-06
feeding O 0 1.7913039300765377e-06
difficulties O 0 5.342086751625175e-06
at O 0 6.60656553463923e-07
birth O 0 2.6062102733703796e-06
. O 0 1.2700533034148975e-06

His O 0 1.511027312517399e-05
two O 0 2.6212710508843884e-06
sibs O 1 0.9959309697151184
suffer O 0 4.1052171582123265e-06
from O 0 3.327031947719661e-07
childhood O 0 0.13833244144916534
onset O 1 1.0
DM B-Disease 1 1.0
. O 0 0.00041154035716317594

Their O 0 4.170475165210519e-07
late O 0 2.772783955151681e-05
father O 0 2.7930223041039426e-06
had O 0 2.590301662053207e-08
the O 0 1.455489839763402e-09
adult O 0 1.3575245094710198e-10
type O 0 7.384650668740278e-10
of O 0 2.2409411215562614e-08
DM B-Disease 1 1.0
, O 0 3.325307362800345e-09
with O 0 5.692664117873392e-10
onset O 1 0.9691401720046997
around O 0 2.045754321500226e-08
30 O 0 9.541554213399195e-09
years O 0 4.757898519613946e-09
. O 0 1.6648971978838745e-08

Only O 0 4.6600046488265434e-08
six O 0 1.4980474638548458e-09
other O 0 1.0167654045101227e-11
cases O 0 3.249103416869126e-11
of O 0 7.199276730318616e-10
paternal O 0 8.172401066985913e-07
transmission O 0 0.00015156043809838593
of O 0 5.3803141781827435e-05
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 6.85758568579331e-05
been O 0 1.4606180798182322e-07
reported O 0 2.1661694660224384e-08
recently O 0 5.792615098698661e-08
. O 0 2.0663584621161135e-08

We O 0 1.4242229440242227e-07
review O 0 2.788066666425948e-08
the O 0 2.825092160207987e-09
sex O 0 2.77096651180031e-10
related O 0 7.760095899200792e-10
effects O 0 2.0863499372580918e-08
on O 0 3.7587010837114576e-08
transmission O 0 4.304075901018223e-06
of O 0 3.1453075735043967e-06
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.1473330408334732

Decreased O 0 1.8735589719653944e-06
fertility O 0 4.999583893550152e-07
of O 0 5.9297087240395285e-09
males O 0 2.4406107343444283e-11
with O 0 2.052054880186116e-11
adult O 0 2.9213320651422237e-09
onset O 0 0.000993270194157958
DM B-Disease 1 1.0
and O 0 2.4031427514614734e-08
contraction O 0 1.8247030553197874e-08
of O 0 3.9842538157586205e-09
the O 0 1.635203306094013e-09
repeat O 0 6.175969735622289e-10
upon O 0 1.1116629838880954e-09
male O 0 6.879192354647401e-11
transmission O 0 1.7334875201946431e-10
contribute O 0 1.2923943165654705e-11
to O 0 5.188083643248298e-11
the O 0 1.1186863657641766e-09
almost O 0 3.5037386880709676e-10
absent O 0 2.2911088581878403e-09
occurrence O 0 7.431618653797045e-10
of O 0 1.6386688672653804e-09
paternal O 0 3.1849472748035623e-07
transmission O 0 3.524471139826346e-06
of O 0 3.1861943625699496e-06
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.0009162569767795503

Also O 0 4.2600973415574117e-07
the O 0 5.606337794006322e-08
fathers O 0 1.1221322893106844e-07
of O 0 3.266114489974825e-08
the O 0 2.2362698359756905e-08
reported O 0 6.75604852062861e-08
congenitally O 0 0.05323664844036102
affected O 0 3.192950970287711e-08
children O 0 2.5375650469783295e-09
showed O 0 3.4855105468523107e-09
, O 0 7.121784273422804e-10
on O 0 1.9372027537656322e-08
average O 0 5.137493985785113e-09
, O 0 2.0868982097965727e-09
shorter O 0 1.2407343774611945e-06
CTG O 0 0.0024754544720053673
repeat O 0 7.737444889244216e-07
lengths O 0 5.535174523174646e-07
and O 0 4.801893882522279e-10
hence O 0 1.9451362742728406e-09
less O 0 6.147599096451017e-10
severe O 0 1.2911969804463297e-07
clinical O 0 2.2345396644141147e-07
symptoms O 0 2.4450483238069864e-07
than O 0 2.0128530786589494e-10
the O 0 3.860522568288616e-09
mothers O 0 2.1172678887904084e-10
of O 0 1.8753051889142114e-10
children O 0 2.4125734743307703e-10
with O 0 3.0052593746887624e-09
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.622732400894165

We O 0 1.266802627242214e-07
conclude O 0 9.261410838234951e-08
that O 0 4.119689589465736e-10
paternal O 0 2.087698931063642e-06
transmission O 0 3.3700114727253094e-05
of O 0 1.2913073078379966e-05
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 0 4.655332759284647e-06
rare O 0 2.3612331645495033e-08
and O 0 3.2030733621013496e-10
preferentially O 0 4.01818245343577e-10
occurs O 0 2.910872931582986e-11
with O 0 4.686611342064051e-12
onset O 0 1.2776679341186536e-06
of O 0 4.435055870999349e-06
DM B-Disease 1 1.0
past O 0 4.0523215716348204e-07
30 O 0 2.3057071807386365e-09
years O 0 1.4030500372630428e-10
in O 0 3.823702118821437e-11
the O 0 3.7707612032811255e-10
father O 0 1.1744687888892713e-08
. O 0 2.3094837153792014e-09
. O 0 1.9634915915389684e-08

The O 0 1.652986270528345e-06
RB1 O 0 6.0887956351507455e-05
gene O 0 2.445670332917871e-08
mutation O 0 2.8281383901429535e-09
in O 0 5.550069848148098e-10
a O 0 4.620934301868829e-09
child O 0 1.0449572585002898e-07
with O 0 2.0558383440061334e-08
ectopic B-Disease 1 0.9997988343238831
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 1.0
. O 0 1.952193633769639e-05

The O 0 3.8077655517554376e-06
RB1 O 0 0.0001298704883083701
gene O 0 4.529018937660112e-08
mutation O 0 1.0729515942387025e-08
was O 0 1.712234976025684e-08
investigated O 0 8.804421192110112e-09
in O 0 8.664148287707008e-10
a O 0 1.5110247275629263e-08
child O 0 3.090980555953138e-07
with O 0 7.72175923202667e-08
ectopic B-Disease 0 0.000933503673877567
intracranial I-Disease 0 0.08023267239332199
retinoblastoma I-Disease 0 2.7030141609429847e-06
using O 0 1.7193980683671839e-09
DNA O 0 2.5342274945217014e-09
obtained O 0 4.784176388383798e-10
from O 0 3.641081602889784e-10
both O 0 5.603669750442464e-10
the O 0 9.179104587531128e-09
pineal B-Disease 0 0.001875311485491693
and I-Disease 0 1.3273482579734264e-07
retinal I-Disease 1 0.9999926090240479
tumours I-Disease 1 1.0
of O 0 0.0002536722458899021
the O 0 2.126328809026745e-06
patient O 0 5.833522209286457e-06
. O 0 2.6487043669476407e-07

A O 0 8.653899385535624e-06
nonsense O 0 3.880397343891673e-06
mutation O 0 4.924838137299048e-08
in O 0 1.046885866884395e-08
exon O 0 5.299683607518091e-07
17 O 0 3.130161019271327e-08
( O 0 2.37218189536037e-10
codon O 0 1.9079797741738957e-09
556 O 0 1.2456169429242436e-08
) O 0 2.27105056982424e-10
of O 0 5.899621680072187e-09
the O 0 2.0857253701933587e-08
RB1 O 0 1.880965101008769e-05
gene O 0 1.6940761682349148e-08
was O 0 1.9493267444659068e-08
found O 0 6.853265177575452e-10
to O 0 1.7369494731411805e-10
be O 0 1.4600741449211085e-10
present O 0 2.84252887894354e-09
homozygously O 0 4.495129815040855e-06
in O 0 1.020512452321043e-09
both O 0 4.912533713152811e-10
the O 0 4.512521467603392e-09
retinal B-Disease 0 7.771553100610618e-06
and I-Disease 0 1.9362465764061199e-07
the I-Disease 0 5.888410214538453e-06
pineal I-Disease 1 0.9999998807907104
tumours I-Disease 1 1.0
. O 0 5.800204689876409e-06

The O 0 4.781061875291925e-07
same O 0 2.288559564078696e-08
mutation O 0 1.1681885681014137e-08
was O 0 2.890098116381523e-08
present O 0 5.7983604584421755e-09
heterozygously O 0 7.713537115705549e-07
in O 0 8.432120557344547e-10
the O 0 7.392429446362314e-10
DNA O 0 2.770455198586319e-09
from O 0 1.0178646814296144e-09
the O 0 9.41784095154219e-10
constitutional O 0 6.866928803361816e-09
cells O 0 3.791077674009102e-09
of O 0 8.77504913177063e-09
the O 0 3.6926492974487246e-09
patient O 0 3.1993888427450656e-08
, O 0 2.5282301252538275e-10
proving O 0 3.203247800342979e-08
it O 0 1.7622776848913446e-10
to O 0 2.1860067922485626e-10
be O 0 1.0482700263381162e-09
of O 0 4.9297440796181036e-08
germline O 0 1.0410893764856155e-06
origin O 0 2.4798293907224433e-07
. O 0 3.12094471155433e-07

The O 0 1.8189041384175653e-07
initial O 0 3.764082023849369e-08
mutation O 0 1.1093463037070705e-08
was O 0 1.8866440854026223e-08
shown O 0 2.5901014666374067e-10
to O 0 4.104301620788675e-10
have O 0 3.20906606843252e-10
occurred O 0 2.151092104440977e-08
in O 0 1.2153745787557568e-09
the O 0 4.457398006252333e-09
paternally O 0 2.3815762517642725e-07
derived O 0 1.2662748360980913e-07
RB1 O 0 5.588801286648959e-05
allele O 0 5.583409574683174e-07
. O 0 9.990488081257354e-08

The O 0 5.933728175477881e-07
mutation O 0 1.9056384914506452e-08
is O 0 8.07840072614141e-10
in O 0 1.564743751236719e-10
an O 0 3.921829527797627e-11
area O 0 2.8503521765088635e-09
of O 0 2.4630788519885982e-09
the O 0 2.3472310761718518e-09
gene O 0 2.787043096308395e-10
that O 0 1.6609974506920366e-10
encodes O 0 5.943112113548921e-10
the O 0 2.5040725049052526e-09
protein O 0 2.111397279236371e-09
- O 0 2.6734532365679797e-09
binding O 0 5.096210564659032e-09
region O 0 2.3970084583879725e-08
known O 0 4.767466421640165e-08
as O 0 5.592354579420089e-09
the O 0 1.1419701628767598e-08
pocket O 0 2.4573080736445263e-05
region O 0 1.2780088809449808e-07
and O 0 9.747242124547029e-09
has O 0 8.036046827974985e-10
been O 0 4.6536757780657467e-10
detected O 0 1.3007170895917852e-09
in O 0 3.534930334558872e-11
other O 0 2.368898133209285e-11
cases O 0 2.4911706031360836e-10
of O 0 1.867055665627504e-08
retinoblastoma B-Disease 0 0.00010259419650537893
. O 0 6.689651854685508e-08
. O 0 1.7027910814704228e-07

Low O 0 1.166433412436163e-05
levels O 0 7.657912703962211e-08
of O 0 6.307619315748525e-08
beta O 0 1.4284152882737544e-07
hexosaminidase O 0 2.188156940974295e-06
A O 0 5.667351032911938e-08
in O 0 4.758349825273456e-10
healthy O 0 2.1996460208839608e-10
individuals O 0 6.416950846556413e-13
with O 0 8.873834826672589e-12
apparent O 0 1.16599585453514e-06
deficiency O 1 0.9999507665634155
of O 0 0.00016315715038217604
this O 0 3.0294899033833644e-08
enzyme O 0 9.86251933454696e-08
. O 0 3.6444902207222185e-08

Appreciable O 0 3.2017451303545386e-05
beta O 0 9.62275134952506e-06
hexosaminidase O 0 2.438892624923028e-05
A O 0 2.3181119104265235e-06
( O 0 2.7643233480034723e-08
hex O 0 1.6368038586733746e-06
A O 0 1.6042960169215803e-06
) O 0 3.582849794625531e-09
activity O 0 1.430194185303435e-09
has O 0 8.928221495452249e-10
been O 0 1.1562640844786642e-09
detected O 0 4.8003510499938784e-08
in O 0 4.204167680654791e-09
cultured O 0 1.021622892949381e-06
skin O 0 3.752366410481045e-06
fibroblasts O 0 6.884031904519361e-07
and O 0 4.9157911519159825e-08
melanoma B-Disease 1 0.9999951124191284
tissue O 0 2.7026014777220553e-06
from O 0 1.3745866667136397e-08
healthy O 0 4.2426545610041444e-10
individuals O 0 1.4103089356065635e-12
previously O 0 7.39843908359461e-10
reported O 0 3.858724728633689e-10
as O 0 1.0269638472948373e-09
having O 0 2.0452588955777173e-08
deficiency B-Disease 0 0.2916000187397003
of I-Disease 0 0.0006733762566000223
hex I-Disease 0 2.9673166864085943e-05
A I-Disease 0 2.6609913561514986e-07
activity O 0 9.917819898674907e-10
indistinguishable O 0 7.117330058648008e-10
from O 0 3.3158861073578905e-11
that O 0 2.7686867555554162e-12
of O 0 1.6943457747942148e-10
patients O 0 1.2779357572156869e-09
with O 0 2.8589710154847126e-07
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 4.7516343215647794e-07
TSD B-Disease 1 0.9983862638473511
) O 0 4.02172162239367e-08
. O 0 1.269063858444497e-07

Identification O 0 1.4272566204454051e-06
and O 0 1.8200927343059448e-07
quantitation O 0 0.06829587370157242
of O 0 9.32689436012879e-05
hex O 0 6.490673695225269e-05
A O 0 1.052374386745214e-06
, O 0 1.4479805132694423e-09
amounting O 0 1.5006220266400305e-08
to O 0 1.6141171954586753e-08
3 O 0 9.720952220959589e-07
. O 0 3.0931479955143004e-07

5 O 0 4.05549462811905e-06
% O 0 3.5829819466925983e-07
- O 0 1.6146409507200588e-06
6 O 0 1.5880538057899685e-06
. O 0 3.19085131650354e-07

9 O 0 2.7173848593520233e-06
% O 0 1.5846039147504598e-08
of O 0 1.1650134190688277e-08
total O 0 7.278431191082291e-10
beta O 0 3.783617330554989e-08
hexosaminidase O 0 3.3892661122081336e-07
activity O 0 2.1691368701226565e-09
, O 0 2.375424024148032e-10
has O 0 6.547727637862266e-11
been O 0 9.877396817126183e-11
obtained O 0 4.5483192212536494e-10
by O 0 2.5188923169494615e-10
cellulose O 0 2.095528316203854e-06
acetate O 0 5.500071438291343e-07
gel O 0 2.6995135726792796e-07
electrophoresis O 0 2.2440298153014737e-07
, O 0 6.328464863258887e-09
DEAE O 0 1.277555293199839e-05
- O 0 1.6711798878077389e-07
cellulose O 0 4.812594852410257e-06
ion O 0 2.0075874829217355e-07
- O 0 2.5845571016702706e-08
exchange O 0 5.664754887391155e-09
chromatography O 0 2.2071665384260086e-08
, O 0 3.716296437250577e-10
radial O 0 4.29678195246197e-08
immunodiffusion O 0 1.8199136775365332e-06
, O 0 1.300637819667827e-09
and O 0 6.512287598070543e-09
radioimmunoassay O 0 2.7145846615894698e-05
. O 0 5.110113079354051e-07

Previous O 0 2.0715473510790616e-05
family O 0 9.588499239043813e-08
studies O 0 7.243435296011569e-10
suggested O 0 3.426565420294736e-10
that O 0 5.4371446581158445e-12
these O 0 9.129206939018086e-12
individuals O 0 4.253256167402464e-12
may O 0 6.99024615968824e-10
be O 0 3.383971713954992e-10
compound O 0 8.052840883010504e-08
heterozygotes O 0 3.7738516311947023e-08
for O 0 3.1378868947662397e-10
the O 0 2.5037858453202944e-09
common O 0 2.1005970296528176e-08
mutant O 0 4.9455756823135744e-08
TSD B-Disease 0 5.456088274513604e-07
gene O 0 1.0269032291176927e-09
and O 0 5.744177355992974e-10
a O 0 1.149033312941583e-09
rare O 0 3.904777834407014e-09
( O 0 1.0738068212390317e-09
allelic O 0 7.567454929358064e-08
) O 0 4.49908021948886e-09
mutant O 0 5.461352259317209e-08
gene O 0 3.4325740472240795e-08
. O 0 5.55268080404403e-08

Thus O 0 9.563127605360933e-07
, O 0 1.4438554352125266e-08
the O 0 2.148820321679068e-08
postulated O 0 9.494643791185808e-07
rate O 0 2.483895045202189e-08
mutant O 0 1.0305669206900347e-08
gene O 0 3.2100946900648353e-10
appears O 0 9.55269308100526e-10
to O 0 2.484678851555344e-10
code O 0 6.434744403982506e-10
for O 0 3.4391631209551576e-10
the O 0 1.4205591147842256e-09
expression O 0 1.2484895339781588e-09
of O 0 3.5489244876174553e-09
low O 0 2.0655859245266583e-08
amounts O 0 1.5700780675587112e-09
of O 0 1.6422804449689465e-08
hex O 0 1.4750110040040454e-06
A O 0 6.151299771772756e-07
. O 0 2.878232976399886e-07

Heterozygotes O 0 6.453957030316815e-05
for O 0 2.671564232059609e-07
the O 0 3.980846088325052e-07
rare O 0 4.194086500319827e-07
mutant O 0 1.164897156513689e-07
may O 0 3.73164077416277e-09
be O 0 2.816992750176439e-10
indistinguishable O 0 9.674395506920064e-09
from O 0 4.42175462911365e-10
heterozygotes O 0 2.576298463452531e-08
for O 0 8.197936218756752e-10
the O 0 1.6338074004806913e-08
common O 0 1.8782766346703283e-06
TSD B-Disease 0 0.07468152046203613
mutant O 0 2.163749286410166e-06
. O 0 1.8761413400625315e-07

However O 0 3.6073731735086767e-07
, O 0 5.452689411100664e-09
direct O 0 1.81686470313025e-08
visualization O 0 1.086898123503488e-06
and O 0 2.6892884363860503e-08
quantitation O 1 0.9833071231842041
of O 0 3.404970993869938e-05
hex O 0 8.377034646400716e-06
A O 0 8.763512227005776e-08
by O 0 2.6232432892570046e-10
the O 0 5.661467961104449e-10
methods O 0 8.537445417289291e-09
described O 0 2.0254320443058305e-09
may O 0 3.0100652526066085e-10
prevent O 0 8.459393185944464e-10
false O 0 2.099659468512982e-08
- O 0 1.0342058764933881e-08
positive O 0 1.623034207032248e-10
prenatal O 0 9.765389563654026e-08
diagnosis O 0 8.904197557058069e-07
of O 0 9.362577202409739e-08
TSD B-Disease 0 0.0024977088905870914
in O 0 2.6465750480042516e-08
fetuses O 0 4.603816705639474e-08
having O 0 3.067047282812041e-09
the O 0 6.16985085244437e-09
incomplete O 0 4.6738730929973826e-07
hex B-Disease 0 2.1170182662899606e-05
A I-Disease 0 4.85410237160977e-06
deficiency I-Disease 1 0.637718915939331
of O 0 9.560681792208925e-05
the O 0 1.9067242362780235e-07
type O 0 3.2319204024133796e-07
described O 0 3.155920680342206e-08
in O 0 1.2833339946283218e-09
the O 0 2.2755536122076592e-08
four O 0 1.9760738823038082e-08
healthy O 0 3.4673966808895784e-08
individuals O 0 7.968071535913168e-09

The O 0 6.753774869139306e-06
tumor B-Disease 0 1.2602882634382695e-05
suppressor O 0 1.3700155250262469e-05
gene O 0 1.4818787974490988e-07
Smad4 O 0 3.267334250267595e-05
/ O 0 2.31220565183321e-06
Dpc4 O 0 1.9504184365359833e-06
is O 0 1.6527051949211113e-10
required O 0 6.094940524503656e-11
for O 0 4.727363986378741e-11
gastrulation O 0 5.4677105509881585e-08
and O 0 6.817477693488172e-10
later O 0 6.72516442534743e-09
for O 0 1.6464188345999275e-10
anterior O 0 1.0411807416232932e-08
development O 0 5.302094763237619e-08
of O 0 4.116968099765472e-08
the O 0 1.0902705582793715e-07
mouse O 0 2.0738505099870963e-06
embryo O 0 4.0542118995290366e-07
. O 0 2.015310371916712e-07

Mutations O 0 7.731514415354468e-07
in O 0 4.115727492148835e-08
the O 0 1.726996998741015e-07
SMAD4 O 1 0.9965308308601379
/ O 0 0.0006040935404598713
DPC4 O 0 0.0016323988093063235
tumor B-Disease 0 9.303261094828486e-07
suppressor O 0 1.7091312543016102e-07
gene O 0 7.883442232348159e-10
, O 0 1.0346271062111612e-10
a O 0 2.7323197038242597e-09
key O 0 8.013644219317939e-07
signal O 0 1.0940521860902663e-05
transducer O 0 2.4482710614393e-06
in O 0 2.100989604514325e-08
most O 0 5.7253664031975404e-09
TGFbeta O 0 4.452809207577957e-06
- O 0 4.096609984571842e-08
related O 0 7.455331463290804e-09
pathways O 0 5.737522901227976e-09
, O 0 7.047820226729895e-12
are O 0 5.391702709300894e-13
involved O 0 3.4950133065425604e-11
in O 0 6.254251977422243e-11
50 O 0 6.780078720680649e-10
% O 0 1.0415933671126254e-09
of O 0 3.329536468754668e-07
pancreatic B-Disease 1 1.0
cancers I-Disease 1 0.9999971389770508
. O 0 4.313362296670675e-06

Homozygous O 0 0.00016782819875515997
Smad4 O 0 0.0013988780556246638
mutant O 0 1.4533162357110996e-05
mice O 0 3.6339466191748215e-07
die O 0 3.3541240895829105e-07
before O 0 1.2621381983990432e-07
day O 0 4.532895161446504e-07
7 O 0 1.2828838862333214e-06
. O 0 2.4924167973949807e-07

5 O 0 3.3880617138493108e-06
of O 0 9.220885317517968e-07
embryogenesis O 0 6.67670537950471e-05
. O 0 3.0285309549071826e-06

Mutant O 0 1.0403278793091886e-05
embryos O 0 3.136630937206064e-07
have O 0 1.4998944308786122e-09
reduced O 0 1.450482844944645e-08
size O 0 5.9510782968175135e-09
, O 0 4.994151203696617e-10
fail O 0 1.2449304698236574e-08
to O 0 6.099435623241334e-09
gastrulate O 0 1.1573386473173741e-05
or O 0 2.9918894028924115e-08
express O 0 1.188485310166243e-08
a O 0 4.544696619035449e-09
mesodermal O 0 1.0695515584302484e-06
marker O 0 3.4488269307075825e-07
, O 0 3.967752348899012e-09
and O 0 5.448842710364943e-09
show O 0 6.7901768652234296e-09
abnormal O 0 8.16562106820129e-09
visceral O 0 2.5498227387288352e-06
endoderm O 0 0.0018373127095401287
development O 0 4.247855486028129e-06
. O 0 1.0167712360953374e-07

Growth B-Disease 1 1.0
retardation I-Disease 1 1.0
of O 0 0.0029997231904417276
the O 0 8.530751074431464e-06
Smad4 O 1 0.9882636070251465
- O 0 1.4019236914464273e-05
deficient O 0 5.277846867102198e-06
embryos O 0 2.657419884144474e-08
results O 0 3.3899277829263497e-10
from O 0 6.761404769406454e-10
reduced O 0 2.3297033635572006e-08
cell O 0 7.03617502040288e-08
proliferation O 0 1.841829622151181e-08
rather O 0 2.759189821066599e-10
than O 0 8.977379256647211e-11
increased O 0 1.6404451130824782e-09
apoptosis O 0 1.5097522521045903e-07
. O 0 4.0575415027888084e-08

Aggregation O 0 9.495001904724631e-06
of O 0 4.763962351717055e-06
mutant O 0 3.5841139833792113e-06
Smad4 O 0 4.5711651182500646e-05
ES O 0 6.213611868588487e-06
cells O 0 9.193664496365272e-09
with O 0 1.2606141686077876e-09
wild O 0 6.830069310126419e-08
- O 0 1.863569032423129e-08
type O 0 4.146489516188012e-07
tetraploid O 0 0.00011637854186119512
morulae O 0 0.00018388466560281813
rescues O 0 5.638752554659732e-06
the O 0 9.30752364070031e-08
gastrulation B-Disease 0 9.088918886845931e-05
defect I-Disease 0 2.2853240807307884e-05
. O 0 6.644863219662511e-07

These O 0 7.726517736728056e-08
results O 0 6.786214701293147e-09
indicate O 0 4.513184492793698e-09
that O 0 5.200846975306206e-10
Smad4 O 0 2.745706296991557e-06
is O 0 4.819272203526737e-10
initially O 0 5.941887537552759e-10
required O 0 1.133149199472605e-10
for O 0 9.352783825189448e-11
the O 0 4.663681107963669e-10
differentiation O 0 3.459454722687383e-09
of O 0 4.807688025465495e-09
the O 0 2.8898983206460116e-09
visceral O 0 1.5588923929499288e-07
endoderm O 0 2.9501674362109043e-05
and O 0 3.925193503562241e-09
that O 0 7.380704380999248e-11
the O 0 1.4388923386121633e-09
gastrulation B-Disease 0 1.0302563850927982e-06
defect I-Disease 0 8.363350190165875e-08
in O 0 1.3523125952374926e-09
the O 0 1.5293496247181793e-08
epiblast O 0 8.84991641214583e-06
is O 0 1.011449257681818e-09
secondary O 0 2.6160059007906966e-08
and O 0 1.8138791579858093e-09
non O 0 1.6584198192504118e-07
- O 0 3.5616183140518842e-06
cell O 0 2.942417995654978e-05
autonomous O 0 6.731159487571858e-07
. O 0 2.8144080488345935e-07

Rescued O 0 0.0011004358530044556
embryos O 0 8.233991138695274e-06
show O 0 1.818090709093667e-07
severe O 0 2.193863338106894e-06
anterior O 0 5.277584932628088e-06
truncations O 1 0.9997977614402771
, O 0 5.5520132491437835e-08
indicating O 0 1.2020640838272811e-07
a O 0 3.243288304588532e-08
second O 0 9.140026691056846e-08
important O 0 1.6527067714378063e-08
role O 0 7.322579165247589e-08
for O 0 1.516623449049348e-08
Smad4 O 0 0.0017653366085141897
in O 0 3.633869738450812e-08
anterior O 0 1.7050950873453985e-06
patterning O 0 7.324373291339725e-05
during O 0 4.106759661226533e-06
embryogenesis O 0 1.6845435311552137e-05
. O 0 2.81444016536625e-07

Prevalence O 0 1.9469749531708658e-05
of O 0 1.6336784938175697e-06
p16 O 0 7.026585535641061e-07
and O 0 9.531299127729653e-08
CDK4 O 0 0.002097979187965393
germline O 0 1.1791320503107272e-05
mutations O 0 4.5536712178773087e-08
in O 0 1.7021667630956472e-08
48 O 0 1.167404434454511e-06
melanoma B-Disease 1 1.0
- O 0 0.1726991832256317
prone O 0 0.002991535933688283
families O 0 7.463586371159181e-08
in O 0 1.5074610004717215e-08
France O 0 2.158568719323739e-07
. O 0 3.7408571529340406e-07

The O 0 3.678715302157798e-06
French O 0 3.2633106457069516e-05
Familial B-Disease 1 0.9972694516181946
Melanoma I-Disease 1 1.0
Study O 0 4.4246027641747787e-07
Group O 0 2.7540240310486297e-08
. O 0 5.95010476445168e-08

Germline O 0 8.130412606988102e-05
mutations O 0 1.0988929233235467e-07
in O 0 1.2827668705028827e-08
the O 0 4.652224916412706e-08
p16 O 0 1.4416642102332844e-07
and O 0 3.278097437942051e-08
CDK4 O 0 0.005530092865228653
genes O 0 1.2894784795491887e-08
have O 0 7.723372497103753e-10
been O 0 1.3307350776869953e-09
reported O 0 1.0541447714729202e-09
in O 0 3.042556762089532e-10
a O 0 1.501359814248815e-09
subset O 0 8.458380662546006e-09
of O 0 1.602729327032648e-08
melanoma B-Disease 0 0.008184162899851799
pedigrees O 0 2.414629705072002e-07
, O 0 2.573319612952929e-10
but O 0 4.217954110985467e-11
their O 0 7.961470371853352e-11
prevalence O 0 2.1680448547556352e-09
is O 0 6.6120213471077e-11
not O 0 5.34176591848734e-11
well O 0 1.5407587428128977e-09
known O 0 6.631139370938399e-08
. O 0 1.2872722265910852e-07

We O 0 1.6655236834139941e-07
searched O 0 1.936326157192525e-07
for O 0 7.138797886163673e-10
such O 0 1.895017476272187e-09
germline O 0 5.054904249846004e-06
mutations O 0 6.854592271565707e-08
in O 0 1.8903039133988386e-08
48 O 0 1.1648987765511265e-06
French O 0 0.00011721919145202264
melanoma B-Disease 1 1.0
- O 0 0.37540310621261597
prone O 0 1.418411102349637e-05
families O 0 1.238580016327262e-09
selected O 0 1.1250838455323375e-10
according O 0 2.563965706414706e-11
to O 0 5.2565528319004073e-11
two O 0 7.391974532477974e-11
major O 0 9.43646827344935e-10
criteria O 0 1.9154764441253747e-09
families O 0 3.028262363091727e-10
with O 0 1.456889053841337e-10
at O 0 4.087195470958704e-09
least O 0 1.1196677612845818e-10
three O 0 1.855714193421676e-10
affected O 0 2.9823601921386e-10
members O 0 8.604626039465657e-11
( O 0 3.7543054776101314e-10
n O 0 6.485500581021597e-09
= O 0 4.939077591359364e-09
20 O 0 7.8708067841049e-10
) O 0 2.9813346236196026e-11
or O 0 1.815127631532576e-10
families O 0 2.9459171213552793e-10
with O 0 5.2549086609898765e-11
two O 0 1.9883934776476764e-10
affected O 0 5.021047466691186e-10
members O 0 3.729267589180907e-11
, O 0 6.648302741663059e-11
one O 0 4.5873485565728345e-11
of O 0 7.260267942399423e-10
them O 0 1.456175041658625e-10
affected O 0 3.0558286456816575e-10
before O 0 1.4434526907081136e-09
the O 0 9.409635293167184e-10
age O 0 2.485873451529841e-10
of O 0 1.2302828755750284e-09
50 O 0 3.252894065219891e-10
( O 0 3.859944655570935e-11
n O 0 8.370251713962773e-10
= O 0 1.5180118273505627e-09
28 O 0 2.2873014593471908e-09
) O 0 3.6078282722451505e-11
, O 0 1.8678043486874962e-11
and O 0 4.549774446083177e-11
one O 0 7.782948591161798e-11
additional O 0 5.604247066415269e-10
minor O 0 9.076252638351434e-08
criterion O 0 6.450260571000399e-06
. O 0 2.665919112132542e-07

Sixteen O 0 7.6168280429556035e-06
different O 0 7.418228165079199e-08
p16 O 0 4.87343584154587e-07
germline O 0 2.9924746058895835e-07
mutations O 0 1.2456875531086098e-09
were O 0 1.2039996777346573e-09
found O 0 5.432868599442031e-10
in O 0 5.03962260811619e-10
21 O 0 4.918583762503204e-09
families O 0 4.129649400219648e-10
, O 0 1.2656270476085751e-10
while O 0 3.692147698686199e-10
one O 0 8.105317528261935e-10
germline O 0 5.7894339988706633e-08
mutation O 0 1.491717638302248e-09
, O 0 7.498782150783256e-10
Arg24His O 0 5.079578386357753e-06
, O 0 5.067771091660234e-09
was O 0 7.651372158079539e-08
detected O 0 3.739294740512378e-08
in O 0 2.080055017117388e-09
the O 0 4.4524803399781376e-08
CDK4 O 0 0.0003048817743547261
gene O 0 2.852421232546476e-07
. O 0 1.5736367231511394e-07

The O 0 1.4809434389917442e-07
frequency O 0 1.0162361263610364e-07
of O 0 1.742273170179942e-08
p16 O 0 9.916954368804909e-09
gene O 0 3.5089883776429076e-10
mutation O 0 1.8803840429182372e-10
in O 0 7.777725685720327e-11
our O 0 8.552989427812463e-10
sample O 0 1.2076098454549822e-10
( O 0 9.808421436163783e-11
44 O 0 1.2571349516932173e-09
% O 0 3.5154598676534476e-10
) O 0 1.0080052764704917e-10
is O 0 6.299002291987321e-11
among O 0 4.939242417845158e-11
the O 0 6.17521644930008e-10
highest O 0 8.274807505870285e-09
rates O 0 4.851514745496388e-10
yet O 0 1.134262683777365e-10
reported O 0 2.506154450632181e-10
and O 0 1.2595152698580137e-10
the O 0 8.566671261256431e-10
CDK4 O 0 1.1176449561389745e-06
mutation O 0 4.5442610785428883e-10
is O 0 7.900417819950434e-11
the O 0 3.644083090836858e-10
second O 0 2.842848845219237e-09
mutation O 0 3.1889368923287975e-10
detected O 0 2.4251050056989243e-09
in O 0 1.55054857842174e-10
this O 0 4.025186017830862e-10
gene O 0 1.548510830673422e-08
worldwide O 0 1.0479827672327247e-08
. O 0 2.0406147882567893e-07

In O 0 1.4049426511064667e-07
summary O 0 7.403717745546601e-07
, O 0 7.63882912480085e-09
our O 0 1.1649400555313605e-08
results O 0 1.4044001517277138e-09
show O 0 1.0081326884403552e-09
frequent O 0 1.0677246864432277e-09
involvement O 0 7.150711578418623e-09
of O 0 7.585341244009669e-09
the O 0 1.0436779440681221e-08
p16 O 0 1.8970000681406418e-08
gene O 0 2.6003093012150202e-09
in O 0 7.082783803902259e-10
familial B-Disease 0 3.376564450263686e-07
melanoma I-Disease 1 0.9084323644638062
and O 0 4.9461292839225734e-09
confirm O 0 4.386878416084983e-09
the O 0 2.078698546625901e-09
role O 0 2.108539787215591e-09
of O 0 4.624161054067599e-09
the O 0 1.2084130140976868e-08
CDK4 O 0 2.368121931795031e-05
gene O 0 4.0253493871489354e-09
as O 0 2.319362923941526e-09
a O 0 6.8948176057404e-09
melanoma B-Disease 1 0.7583116888999939
- O 0 1.187134898827935e-06
predisposing O 0 1.2877404742539511e-06
gene O 0 1.4099890144336769e-08
. O 0 5.730238950008015e-09
. O 0 6.53396341476764e-08

Progression O 0 3.971729529439472e-05
of O 0 8.678909580339678e-06
somatic O 0 0.00011743333016056567
CTG O 0 0.0001008371909847483
repeat O 0 6.349311121311985e-08
length O 0 2.8691486964049773e-09
heterogeneity O 0 4.276587262097564e-08
in O 0 4.741064763003067e-10
the O 0 1.1638044972173134e-09
blood O 0 4.971268285913766e-09
cells O 0 2.219942452086343e-08
of O 0 4.5937559889352997e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 0.017783503979444504
. O 0 8.509241524734534e-07

The O 0 1.207598927521758e-07
genetic O 0 5.544119119349489e-08
basis O 0 3.711440754727846e-08
of O 0 4.737769927487534e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.00020985507580917329
DM B-Disease 1 1.0
) O 0 7.24757054371139e-09
is O 0 4.758149985129023e-10
the O 0 1.1771459362819314e-09
expansion O 0 1.4337729226099327e-08
of O 0 1.150487793921684e-08
an O 0 9.969843839385817e-10
unstable O 0 6.7562211825134e-07
CTG O 0 4.8037404667411465e-06
repeat O 0 1.913082314786152e-08
in O 0 1.227666857062104e-09
the O 0 6.284356146579739e-09
34 O 0 1.0795141669461827e-08
UTR O 0 8.717842865735292e-05
of O 0 1.0473915779130039e-07
the O 0 1.762115573455958e-07
DM B-Disease 1 0.9999996423721313
protein O 0 3.309958174213534e-07
kinase O 0 9.786478472051385e-08
gene O 0 3.61669227899597e-09
on O 0 8.088396619143623e-09
chromosome O 0 2.022661149680971e-08
19 O 0 6.723089285287642e-08
. O 0 9.235585451961015e-08

One O 0 1.566491505400336e-07
of O 0 6.521923978652922e-08
the O 0 1.5601440139789702e-08
principal O 0 7.514925215446056e-08
features O 0 2.3662181103389912e-09
of O 0 1.0606070688368163e-08
the O 0 1.2407718941176427e-07
DM B-Disease 1 1.0
mutation O 0 5.0905594406458476e-08
is O 0 1.0631503455371671e-09
an O 0 8.282899366385266e-11
extraordinarily O 0 1.4660447078540528e-08
high O 0 2.178367175531548e-08
level O 0 2.4746265481212504e-08
of O 0 1.5337137782012178e-08
somatic O 0 5.679914352185733e-07
mosaicism O 0 6.187564849824412e-06
, O 0 2.732031545438218e-10
due O 0 4.930982733242217e-09
to O 0 6.961600185206862e-10
an O 0 8.844065757518393e-11
extremely O 0 1.2409825389525508e-09
high O 0 3.870268994177195e-09
degree O 0 2.0537612499538227e-08
of O 0 1.2933357496081044e-08
somatic O 0 1.3727047587508423e-07
instability O 0 3.809280002542437e-08
both O 0 2.5903285072459425e-10
within O 0 9.95961868532902e-10
and O 0 2.0941220979509012e-10
between O 0 2.503221241401121e-10
different O 0 6.71721234191125e-10
tissues O 0 2.610598528463015e-07
. O 0 1.6670826141762518e-07

This O 0 3.93111832863724e-07
instability O 0 1.3651834706251975e-05
appears O 0 1.4418057503462478e-07
to O 0 1.2908188962157396e-09
be O 0 3.2249397596828544e-10
biased O 0 5.899408073162249e-09
towards O 0 6.581817313389138e-09
further O 0 5.310347717113473e-10
expansion O 0 3.586309471614868e-09
and O 0 2.512098584706024e-10
continuous O 0 2.5943696080332757e-09
throughout O 0 4.683202714517165e-10
the O 0 9.017609992056919e-10
life O 0 6.723082646153955e-10
of O 0 2.5423307903338355e-10
an O 0 6.392753514050664e-12
individual O 0 1.3819183427785098e-12
, O 0 2.7644969646800632e-12
features O 0 2.1642746622640985e-11
that O 0 4.3483511062702984e-12
could O 0 1.0359205160348495e-10
be O 0 7.156366471638975e-11
associated O 0 3.0170503872994914e-09
with O 0 4.336792869263917e-10
the O 0 2.499483287010662e-08
progressive O 0 6.243658958737797e-07
nature O 0 3.499098788495303e-09
of O 0 6.5319052389156695e-09
the O 0 3.4395014836263726e-08
disease O 0 8.553860197935137e-07
. O 0 1.4387551061645354e-07

Although O 0 1.832783738109356e-07
increasing O 0 2.697796119832674e-08
measured O 0 1.3016038913349348e-08
allele O 0 2.990415914894129e-09
size O 0 7.027021742267436e-10
between O 0 1.7105693528307597e-09
patients O 0 9.216576835058277e-09
clearly O 0 1.1693762624886972e-09
correlates O 0 1.874262078871425e-09
with O 0 6.6311019175646635e-12
an O 0 2.678716623516486e-12
increased O 0 5.422017348988284e-11
severity O 0 1.761080739015597e-07
of O 0 2.403179522048049e-08
symptoms O 0 1.8832132298030047e-07
and O 0 6.699324983650001e-10
an O 0 6.895044431243225e-12
earlier O 0 1.7016618669707384e-10
age O 0 9.028654213150134e-11
of O 0 3.4119243541574917e-10
onset O 0 9.586049287690912e-08
, O 0 1.68882130502368e-11
this O 0 2.827788784381946e-12
correlation O 0 2.8590940379102925e-11
is O 0 3.4067640201917992e-12
not O 0 4.161383477391256e-12
precise O 0 1.6777657041444627e-09
and O 0 2.756533334924427e-10
measured O 0 1.8030240633848393e-09
allele O 0 1.9071563772676825e-10
length O 0 6.850661010693315e-11
cannot O 0 6.525734119744442e-11
be O 0 2.8142847427470308e-11
used O 0 6.226451021440482e-10
as O 0 4.953812360319887e-10
an O 0 3.241978560608594e-11
accurate O 0 1.0555778473531063e-08
predictor O 0 1.3052040515049157e-07
of O 0 1.52623158555798e-08
age O 0 1.5111343287799173e-08
of O 0 8.641875837156476e-08
onset O 0 0.0009205828537233174
. O 0 5.372365308176086e-07

In O 0 9.124054400899695e-08
order O 0 2.574559587742442e-08
to O 0 2.166366641631612e-09
further O 0 2.1297559271715727e-09
characterize O 0 3.384220548241501e-08
the O 0 1.560810680700797e-08
dynamics O 0 4.622033884515986e-07
of O 0 6.196924459800357e-06
DM B-Disease 1 1.0
CTG O 0 0.012045451439917088
repeat O 0 3.350380666233832e-07
somatic O 0 1.8332099216422648e-06
instability O 0 4.246209073244245e-07
, O 0 4.917642959512136e-10
we O 0 8.023928049771811e-11
have O 0 5.886868770232923e-11
studied O 0 8.627901171287533e-10
repeat O 0 2.5248184098991544e-10
length O 0 6.87102250096494e-11
changes O 0 4.5879435667250945e-11
over O 0 6.743139380205321e-11
time O 0 1.279896327810448e-10
in O 0 3.2256289306253905e-10
111 O 0 1.0586284133751178e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 5.470422337339187e-08
with O 0 3.029971065715564e-11
varying O 0 7.275350322188956e-10
clinical O 0 4.983289869642249e-08
severity O 0 1.3479013432515785e-05
and O 0 5.9515578243463096e-08
CTG O 0 2.3700147266936256e-06
repeat O 0 6.472117508593556e-09
size O 0 5.578406625517118e-10
over O 0 1.0514254050741911e-10
time O 0 6.582237532803958e-11
intervals O 0 9.910137294122379e-11
of O 0 1.3542356125384458e-09
1 O 0 2.7767415033963516e-08
- O 0 1.923605452702759e-08
7 O 0 4.159788957736055e-08
years O 0 1.2026461604364158e-08
. O 0 3.029767370321679e-08

We O 0 2.5781275780900614e-07
have O 0 2.411516764055932e-09
found O 0 1.561822560169901e-09
a O 0 7.698267023847905e-10
direct O 0 3.541905213566565e-09
progression O 0 1.6321566320698366e-08
of O 0 1.8288702108293364e-08
the O 0 6.417343101361439e-09
size O 0 4.5070938092806045e-09
heterogeneity O 0 1.4922962421337616e-08
over O 0 8.720983379895131e-10
time O 0 2.8076968527912527e-10
related O 0 5.86111437161918e-10
to O 0 1.6737254915355493e-09
initial O 0 9.980146131738366e-08
CTG O 0 3.379568170203129e-06
repeat O 0 9.064518913248776e-09
size O 0 1.2675193117317463e-09
and O 0 1.1413113509828321e-10
the O 0 4.847889312209475e-10
time O 0 1.8400229950810143e-10
interval O 0 1.4214861510097876e-09
and O 0 1.2958630002390947e-10
always O 0 5.939950198374788e-10
biased O 0 3.002595061474267e-09
towards O 0 2.8616393699110176e-09
further O 0 1.907288327274159e-09
expansion O 0 5.03812849217411e-08
. O 0 5.99555889380099e-08

Attempts O 0 1.0273952284478582e-05
to O 0 1.1527022536483855e-07
mathematically O 0 2.858848233699973e-07
model O 0 6.639847072165139e-08
the O 0 3.827458172622755e-08
dynamics O 0 3.082814430399594e-07
have O 0 9.744862694560652e-09
proved O 0 1.1042765208912897e-06
only O 0 2.5941271353246975e-09
partially O 0 4.4844924218523374e-08
successful O 0 5.460953911295974e-09
suggesting O 0 8.026794229287759e-10
that O 0 6.6307983409563676e-12
individual O 0 2.074220135928062e-12
specific O 0 2.3513736097102722e-11
genetic O 0 3.243266488706098e-10
and O 0 2.2118337716925396e-10
/ O 0 4.899831083093886e-07
or O 0 6.231658300492882e-09
environmental O 0 2.7404475133607775e-08
factors O 0 5.17594855864445e-10
also O 0 1.421029960368969e-10
play O 0 7.372125132576457e-10
a O 0 1.6265432334350294e-09
role O 0 8.240046867058481e-09
in O 0 7.606668184223508e-09
somatic O 0 4.8680376494303346e-06
mosaicism O 0 0.00017148077313322574
. O 0 4.3298051366491563e-08
. O 0 1.4375412149547628e-07

Aspartylglucosaminuria B-Disease 1 1.0
among O 0 5.154573500476545e-06
Palestinian O 0 1.4430465853365604e-05
Arabs O 0 8.785050340520684e-06
. O 0 1.3047999800619436e-06

Aspartylglucosaminuria B-Disease 1 1.0
( O 1 0.8192354440689087
AGU B-Disease 1 1.0
) O 0 1.4543270765443594e-07
is O 0 4.1067313993892185e-09
a O 0 2.213287686458898e-08
rare O 0 5.611928827420343e-06
disorder B-Disease 1 1.0
of I-Disease 1 0.9999996423721313
glycoprotein I-Disease 1 0.9999284744262695
metabolism I-Disease 0 4.2133073293371126e-05
caused O 0 8.379249294421243e-09
by O 0 1.312018826915562e-10
the O 0 1.2081687650322692e-08
deficiency B-Disease 0 0.00012964651978109032
of I-Disease 0 6.0640859373961575e-06
the I-Disease 0 9.55879613684374e-07
lysosomal I-Disease 0 1.1292059753031936e-05
enzyme I-Disease 0 8.262225748012497e-08
aspartylglucosaminidase I-Disease 0 7.477385679521831e-07
( O 0 3.1334026484586275e-09
AGA O 0 0.00011252182594034821
) O 0 1.9174585474956984e-08
. O 0 9.276190127138761e-08

AGU B-Disease 1 1.0
is O 0 5.284303369990084e-06
inherited O 1 0.9909981489181519
as O 0 2.9444913707266096e-07
an O 0 8.234092518932812e-09
autosomal O 0 1.0405639841337688e-05
recessive O 0 6.396061053237645e-06
trait O 0 1.8506672461171547e-07
and O 0 4.586828250552344e-09
occurs O 0 7.755183162316825e-10
with O 0 4.8779195960246824e-11
a O 0 2.2952990619273805e-09
high O 0 5.5697903178497654e-08
frequency O 0 3.259095038288251e-08
in O 0 1.5827665844625471e-09
Finland O 0 5.860536056445653e-09
because O 0 6.415382114433044e-10
of O 0 1.4551186922062698e-08
a O 0 3.277934723655562e-08
founder O 0 5.546667694034113e-07
effect O 0 3.321898489616615e-08
. O 0 5.715593687227738e-08

While O 0 6.191125976329204e-07
very O 0 3.549420668491621e-08
few O 0 2.1568315133890792e-08
patients O 0 2.9048649707874574e-08
with O 0 1.9156162878175564e-08
AGU B-Disease 1 1.0
have O 0 3.096199634455843e-07
been O 0 1.6949810444089053e-08
reported O 0 1.3636729523369695e-09
from O 0 1.1399718946591975e-09
non O 0 1.1947925315780594e-08
- O 0 1.2390461101574601e-08
Finnish O 0 3.828400849670288e-07
origin O 0 9.43485378712694e-09
, O 0 1.2890400968856852e-09
we O 0 1.3583643099224219e-09
diagnosed O 0 1.389973931509303e-06
the O 0 3.3789444131571145e-08
disorder O 0 1.113326902668632e-06
in O 0 2.5024682326346692e-09
8 O 0 7.644600508172061e-09
patients O 0 2.1345453182775032e-10
originating O 0 1.4849047547116356e-09
from O 0 1.1475679295713803e-09
3 O 0 7.48155670748929e-09
unrelated O 0 1.7455820122691534e-09
families O 0 1.2295221785141308e-10
, O 0 7.517925171285356e-11
all O 0 7.698057469252007e-11
Palestinian O 0 8.746441793050508e-09
Arabs O 0 6.058182844270732e-09
from O 0 6.50034581717307e-10
the O 0 1.3756928929353762e-09
region O 0 1.7427642662326548e-09
of O 0 1.1176994441086663e-08
Jerusalem O 0 2.915503046097001e-06
. O 0 2.5396298042323906e-07

The O 0 6.224159392331785e-07
clinical O 0 5.739912467106478e-06
diagnosis O 1 1.0
of O 1 1.0
AGU B-Disease 1 1.0
is O 0 5.858761937815871e-07
often O 0 2.405989851794743e-09
difficult O 0 5.435120797869786e-09
, O 0 7.745038638207191e-11
in O 0 9.357815911048561e-11
particular O 0 1.3063909953814345e-09
early O 0 1.211998181815943e-07
in O 0 5.152564486188282e-10
the O 0 1.2272103333543782e-09
course O 0 3.958137817505758e-09
of O 0 1.151716721992102e-09
the O 0 1.0263138117139192e-09
disease O 0 4.258533081724636e-08
, O 0 5.923655316264487e-11
and O 0 1.703145818821028e-10
most O 0 2.5603261177842285e-10
of O 0 1.0379407555660691e-08
the O 0 1.5611799852877084e-08
patients O 0 3.730857844885804e-09
are O 0 1.5306263201342318e-10
diagnosed O 0 3.7794197993434864e-08
after O 0 8.84488482455481e-09
the O 0 3.9026257780960805e-09
age O 0 2.4323041358798037e-09
of O 0 1.3120001085553668e-08
5 O 0 2.3345608113345406e-08
years O 0 1.1578117131705312e-08
. O 0 4.1993772015302966e-08

However O 0 6.240658763090323e-07
, O 0 7.938944612817522e-09
since O 0 2.842241553224767e-09
these O 0 4.027912448023585e-10
patients O 0 5.5003943622011775e-09
excrete O 0 7.489026643270336e-08
early O 0 2.2294644352882642e-08
large O 0 5.274351511097564e-10
amounts O 0 1.1918579456704492e-09
of O 0 1.613664579735996e-08
aspartylglucosamine O 0 1.5011852383395308e-06
in O 0 1.653052694727819e-09
urine O 0 4.099781403255065e-09
, O 0 1.6284606996208595e-10
biochemical O 0 8.936352990929208e-09
screening O 0 1.5717777301915703e-08
is O 0 4.148786592050868e-10
easy O 0 2.148450528594026e-09
by O 0 1.9825009689444784e-10
urine O 0 5.8363185395649e-09
chromatography O 0 7.634783116827748e-08
. O 0 1.3169944246271825e-08
. O 0 1.816515435848487e-07

Detection O 0 2.9664848625543527e-05
of O 0 5.363847890293982e-07
heterozygous O 0 6.145609354746284e-09
carriers O 0 9.200887274296576e-10
of O 0 2.3872217980169808e-08
the O 0 1.017143290482636e-06
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 5.313352744451549e-07
ATM O 0 7.916415825093281e-07
) O 0 1.8439368087985741e-10
gene O 0 8.19482121050541e-11
by O 0 9.755601881877851e-11
G2 O 0 1.236680191141204e-06
phase O 0 2.5671999992482597e-07
chromosomal O 0 4.140329110668972e-07
radiosensitivity O 0 2.1487380763574038e-06
of O 0 1.3571043666615878e-07
peripheral O 0 0.00018994456331711262
blood O 0 5.747365889874345e-07
lymphocytes O 0 7.557976573480119e-07
. O 0 2.4942477239164873e-07

In O 0 3.153827856294811e-05
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9999892711639404
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 2.268810206373928e-08
patients O 0 1.0136049333198116e-08
, O 0 1.2050098419091881e-10
mutations O 0 5.994841428824671e-11
in O 0 8.250953392741067e-11
a O 0 3.8468198071406334e-10
single O 0 2.0204191097938917e-10
gene O 0 8.883829782924124e-11
, O 0 4.160734951019762e-11
ATM O 0 1.686905015674256e-08
, O 0 2.4710476720368746e-11
result O 0 3.3256800091585603e-10
in O 0 4.121247787480797e-09
an O 0 8.346680857584943e-08
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 1.1645579611752055e-08
embraces O 0 1.3689535727223756e-08
a O 0 3.0827870811656055e-10
variety O 0 8.99534668974411e-10
of O 0 3.603739529012273e-09
clinical O 0 3.53754572302023e-08
features O 0 2.8220398462508456e-08
and O 0 9.951212298631162e-09
manifests O 0 1.3543491661494045e-07
extreme O 0 2.3672116640227614e-06
radiosensitivity O 0 1.3588902220362797e-05
and O 0 1.355828338489573e-08
a O 0 1.3773632900893062e-08
strong O 0 3.3235906471418275e-08
pre O 0 3.1440926250070333e-05
- O 0 3.406444420761545e-06
disposition O 0 1.7020429368130863e-05
to O 0 2.142679846883766e-07
malignancy B-Disease 0 0.29165688157081604
. O 0 6.040475000190781e-07

Heterozygotes O 0 1.516448082838906e-05
for O 0 4.67931435821356e-08
the O 0 5.972070482584968e-08
ATM O 0 6.042128006811254e-07
gene O 0 1.6780056233400842e-09
have O 0 9.535140732541691e-11
no O 0 1.520129161436401e-10
clinical O 0 1.3685743649460846e-09
expression O 0 1.6844671213434026e-09
of O 0 1.376901650473883e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
but O 0 1.127417892377025e-08
may O 0 1.2915757352516266e-08
be O 0 4.475842363405036e-09
cancer B-Disease 0 2.0502491793195077e-07
prone O 0 1.9858257260807477e-08
with O 0 2.510738006389346e-10
a O 0 4.222023175515233e-09
moderate O 0 8.085591929329894e-08
increase O 0 7.209678409836329e-10
in O 0 2.028993195679618e-09
in O 0 4.341545789543488e-09
vitro O 0 6.887308359182498e-07
radiosensitivity O 0 1.185619203170063e-05
. O 0 1.4768082223781676e-07

We O 0 1.5953568208715296e-06
performed O 0 2.622608690217021e-07
a O 0 8.05425415251193e-08
blind O 0 2.487247456883779e-07
chromosomal O 0 8.548089169835293e-08
analysis O 0 1.592490761481713e-08
on O 0 4.9059373452564614e-08
G2 O 0 4.988453952137206e-07
- O 0 1.2653194048084515e-08
phase O 0 6.210800762573854e-08
lymphocytes O 0 1.0102909620002265e-08
from O 0 2.3526993686573405e-09
7 O 0 1.1554775802835593e-08
unrelated O 0 9.538970502376287e-09
A B-Disease 1 0.9999996423721313
- I-Disease 1 0.9999632835388184
T I-Disease 1 1.0
patients O 0 6.737131457157375e-07
, O 0 2.5199891062754887e-09
13 O 0 5.964464033780814e-09
obligate O 0 5.3981786152235145e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 8.850101949064992e-06
( O 0 3.4216560695909948e-09
parents O 0 4.0993258787480613e-10
of O 0 1.2728006426598881e-09
the O 0 6.241456795841316e-10
patients O 0 9.510620069264064e-11
) O 0 3.121159927732542e-11
, O 0 4.92148787001323e-11
and O 0 1.05958741780654e-09
14 O 0 5.804977831758151e-09
normal O 0 9.447927773464926e-09
controls O 0 2.1276985506801793e-08
following O 0 7.808814928011998e-09
X O 0 6.453162200159568e-07
- O 0 2.3815507788071955e-08
irradiation O 0 1.3838814538758015e-07
with O 0 1.4686523108764504e-09
1 O 0 6.735461965945433e-08
Gy O 0 7.677336725464556e-06
in O 0 1.6956680504165433e-10
order O 0 4.895183702835482e-10
to O 0 2.161297391056749e-10
evaluate O 0 1.4723714469866422e-09
this O 0 2.29626137548955e-10
cytogenetic O 0 1.287580460029858e-07
method O 0 1.4916274437837274e-08
as O 0 5.570432448642748e-10
a O 0 3.631842881990366e-10
tool O 0 6.361842608271218e-09
for O 0 1.032655627675183e-10
detection O 0 2.8058161660737824e-07
of O 0 1.381426244506656e-07
ATM O 0 5.417287866293918e-06
carriers O 0 9.631573760771062e-08
. O 0 1.2018921324852272e-07

Both O 0 4.94633823109325e-05
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
homozygotes O 1 0.9995328187942505
and O 0 2.5431538119846664e-07
heterozygotes O 0 1.084295490727527e-06
showed O 0 5.711068062907998e-09
significantly O 0 2.9534010792531262e-09
increased O 0 3.194324527111547e-10
levels O 0 6.212477199341038e-10
of O 0 1.9564661002391404e-09
radiation O 0 0.11299106478691101
- O 0 1.3525552731152857e-06
induced O 0 6.010294328007149e-06
chromatid O 0 2.9620074201375246e-05
damage O 0 1.108035121433204e-06
relative O 0 6.755944781389189e-08
to O 0 3.232613066117551e-10
that O 0 7.443332755707743e-11
of O 0 7.63882912480085e-09
normal O 0 6.401563013014311e-08
controls O 0 2.3862392595219717e-07
. O 0 7.495342657648507e-08

These O 0 1.1775084374221478e-07
results O 0 2.4928416664238284e-08
show O 0 7.483083486192754e-09
that O 0 4.368923001152325e-10
the O 0 2.0398708500124485e-08
G2 O 0 2.2626085410593078e-05
- O 0 4.509908251293382e-07
phase O 0 1.1575123153306777e-06
chromosomal O 0 5.908734692638973e-07
radiosensitivity O 0 1.1570698461582651e-06
assay O 0 2.5658236424419556e-08
can O 0 5.427014740377878e-11
be O 0 3.046567859099625e-11
used O 0 3.007402660237801e-10
for O 0 8.339571394566647e-11
the O 0 4.833504152479406e-10
detection O 0 1.32290665533219e-06
of O 0 1.0596686479402706e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 9.576247975928709e-05
. O 0 2.168355877074646e-06

In O 0 1.2688543904459948e-07
combination O 0 4.4036011104253703e-07
with O 0 1.7167796073636055e-09
molecular O 0 1.1807492938942232e-07
genetic O 0 2.21775433573157e-08
analyses O 0 5.379017675721798e-09
, O 0 1.5991152846339673e-10
this O 0 5.3438854036302885e-11
test O 0 3.915360480277741e-09
may O 0 5.862075824758506e-10
be O 0 1.0136020495155051e-10
of O 0 3.338352372317388e-10
value O 0 1.835018109686004e-10
in O 0 9.632602875064844e-12
studies O 0 2.6002821423842803e-11
of O 0 3.236876322532112e-10
familial B-Disease 0 1.6850592032824352e-08
and I-Disease 0 5.879143838427581e-09
sporadic I-Disease 0 4.0755759300736827e-07
cancers I-Disease 0 9.31316662899917e-06
aimed O 0 3.0897481906322355e-08
at O 0 3.2418088213859164e-09
determination O 0 3.84955223253769e-09
of O 0 2.5615680687707254e-09
the O 0 7.045891647905478e-10
potential O 0 1.4235427281406032e-09
involvement O 0 4.749447946039709e-09
of O 0 9.863305727719762e-09
ATM O 0 6.559161533914448e-07
mutations O 0 3.276889426473417e-09
in O 0 1.0456421284388284e-09
tumor B-Disease 0 4.882320467913814e-07
risk O 0 1.6569298821877965e-08
or O 0 9.388216426486906e-09
development O 0 3.598308495611491e-08
. O 0 5.454187324005488e-09
. O 0 5.158469917887487e-08

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
: O 0 7.206289609484884e-08
identification O 0 8.443426224857831e-08
and O 0 2.2528110488195807e-09
detection O 0 7.6041551437810995e-06
of O 0 1.2505277027230477e-06
founder O 0 0.00023069159942679107
- O 0 3.2705847274883126e-07
effect O 0 1.562490758999502e-08
mutations O 0 1.6758210374945293e-09
in O 0 6.701267873943095e-10
the O 0 5.345043074811429e-09
ATM O 0 1.8570337090295652e-07
gene O 0 1.9154033914503543e-09
in O 0 3.575154616797249e-10
ethnic O 0 9.335180406466748e-10
populations O 0 5.835372629547919e-09
. O 0 6.314950695696098e-08

To O 0 1.5531466601714783e-07
facilitate O 0 6.88735468656887e-08
the O 0 1.533520688212775e-08
evaluation O 0 3.595742725792661e-08
of O 0 9.501911790721351e-08
ATM O 0 7.41590338293463e-06
heterozygotes O 0 3.6214296983416716e-07
for O 0 1.0090348556701656e-09
susceptibility O 0 3.6500418332252593e-07
to O 0 1.3506550322617272e-09
other O 0 1.2793600623339785e-09
diseases O 0 0.0014359840424731374
, O 0 1.0345205248007971e-10
such O 0 1.407349792259538e-09
as O 0 4.594663209900318e-07
breast B-Disease 0 0.24147820472717285
cancer I-Disease 0 9.590411355020478e-05
, O 0 7.283847414107925e-10
we O 0 2.8362831527850574e-10
have O 0 1.0895331165050592e-10
attempted O 0 1.7862559431591762e-08
to O 0 2.756896100297723e-10
define O 0 2.0659789434773757e-09
the O 0 1.3299890078144472e-09
most O 0 8.985773236602768e-11
common O 0 3.4751995725557094e-10
mutations O 0 2.6832076491234425e-11
and O 0 3.462481343308177e-11
their O 0 6.04516853242032e-11
frequencies O 0 6.547909325860246e-09
in O 0 6.328464863258887e-09
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999457597732544
telangiectasia I-Disease 1 1.0
( O 0 0.0006353834760375321
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.1319730042202991e-08
homozygotes O 0 3.6999099961576576e-07
from O 0 3.2460283350133068e-09
10 O 0 1.2772802815419482e-09
ethnic O 0 4.95882279683002e-10
populations O 0 3.0363842551395237e-09
. O 0 5.2690076302042144e-08

Both O 0 1.3906577578381984e-07
genomic O 0 4.2207773276459193e-07
mutations O 0 7.669019197464877e-09
and O 0 7.93054066861032e-10
their O 0 7.037389559982898e-10
effects O 0 1.3278257426918572e-07
on O 0 8.33412912015774e-08
cDNA O 0 1.880250266594885e-07
were O 0 6.898290383361427e-09
characterized O 0 7.951526015403942e-08
. O 0 1.7978743471758207e-07

Protein O 0 1.8225555322715081e-06
- O 0 2.5934488689927093e-07
truncation O 0 9.765861932464759e-07
testing O 0 3.010751825627267e-08
of O 0 2.167103296812911e-08
the O 0 1.2886179234783413e-08
entire O 0 2.242437524557772e-08
ATM O 0 1.9367324455288326e-07
cDNA O 0 7.280159763922711e-08
detected O 0 1.5359034932771465e-08
92 O 0 3.334397291610003e-08
( O 0 9.45376332772696e-10
66 O 0 1.762535006832877e-08
% O 0 6.032340182926532e-10
) O 0 1.9493023861727465e-10
truncating O 0 5.87458437451005e-08
mutations O 0 2.2464947679878833e-09
in O 0 1.0425433849547971e-09
140 O 0 1.1057086801713467e-08
mutant O 0 3.179096097483125e-08
alleles O 0 6.97795510262722e-09
screened O 0 1.728062812844655e-07
. O 0 8.737008982961925e-08

The O 0 2.2316864942695247e-06
haplotyping O 0 0.0010305587202310562
of O 0 1.6536328075744677e-06
patients O 0 4.287343102760133e-08
with O 0 2.64577471043026e-10
identical O 0 2.3372473734184496e-08
mutations O 0 3.0068647571823703e-09
indicates O 0 3.5315641522259966e-09
that O 0 9.932202282847413e-11
almost O 0 1.753640288537639e-10
all O 0 2.2335640281756497e-11
of O 0 8.682904395485025e-11
these O 0 4.378378302277719e-12
represent O 0 3.7958256329795326e-12
common O 0 1.1115754844359671e-10
ancestry O 0 1.328325366367622e-10
and O 0 1.4162992827138066e-11
that O 0 3.4748577713156203e-12
very O 0 1.1243416614403756e-10
few O 0 1.2847323205278371e-09
spontaneously O 0 6.563702026340934e-09
recurring O 0 7.621731867857306e-08
ATM O 0 5.318144758348353e-06
mutations O 0 1.9562172326459404e-08
exist O 0 3.284900884636954e-08
. O 0 2.5684610704956867e-07

Assays O 0 1.3177894288673997e-05
requiring O 0 1.3906206675073918e-07
minimal O 0 2.6488987714401446e-07
amounts O 0 8.846032351073063e-09
of O 0 3.2933620275343856e-09
genomic O 0 5.170711414592688e-09
DNA O 0 6.535656460471273e-09
were O 0 4.841494427587634e-10
designed O 0 1.876823363389235e-09
to O 0 2.2365918839195587e-10
allow O 0 2.867806825346264e-10
rapid O 0 8.928958905585205e-09
screening O 0 1.0001103056822558e-08
for O 0 1.4080686616679827e-10
common O 0 2.5367616895977108e-09
ethnic O 0 6.110937311731846e-10
mutations O 0 1.850935738012538e-09
. O 0 1.3489514394393609e-08

These O 0 3.02733553780854e-08
rapid O 0 2.5439905471102975e-07
assays O 0 4.933045261168445e-07
detected O 0 7.438347182642246e-08
mutations O 0 8.077507551718099e-10
in O 0 5.233505850910092e-10
76 O 0 2.0974340486645815e-08
% O 0 5.595275354153273e-10
of O 0 4.609332027172286e-09
Costa O 0 1.0996141952546168e-07
Rican O 0 3.3621017792029306e-07
patients O 0 4.955563071007418e-09
( O 0 8.277976082382565e-10
3 O 0 5.2576010212135316e-09
) O 0 5.768922492488393e-11
, O 0 3.3398093318703914e-11
50 O 0 1.1194542515191586e-10
% O 0 8.202733631224035e-11
of O 0 1.6386001444601561e-09
Norwegian O 0 3.7390239526757796e-07
patients O 0 3.1866949079528695e-09
( O 0 3.6433464578600194e-10
1 O 0 6.012849773640028e-09
) O 0 5.742159178701023e-11
, O 0 4.513154086560611e-11
25 O 0 4.1042078069430943e-10
% O 0 1.5823189980501695e-10
of O 0 1.2658279979760323e-09
Polish O 0 3.2473728879267583e-06
patients O 0 2.5468178677101605e-08
( O 0 2.1279855655365054e-09
4 O 0 1.279697503520083e-08
) O 0 1.0914508880022211e-10
, O 0 6.184218415139497e-11
and O 0 2.468542870115442e-10
14 O 0 1.1840589619893649e-09
% O 0 3.836370943144374e-10
of O 0 4.169143696941546e-09
Italian O 0 1.0622773061186308e-06
patients O 0 9.69125757421807e-09
( O 0 6.326192347749782e-10
1 O 0 1.8072599416996127e-08
) O 0 1.2579307040461174e-10
, O 0 7.420707798244663e-11
as O 0 5.487827414718538e-10
well O 0 5.535005787038472e-10
as O 0 5.93227411638253e-10
in O 0 2.565693768552535e-10
patients O 0 1.4073336940256809e-09
of O 0 6.385599959912724e-08
Amish O 0 1.367194386148185e-06
/ O 0 2.0269383185222978e-06
Mennonite O 0 1.760695568009396e-06
and O 0 1.2456192521881349e-08
Irish O 0 9.797160771540803e-08
English O 0 6.026238708045639e-08
backgrounds O 0 5.7008300302641146e-08
. O 0 6.254833095908907e-08

Additional O 0 1.8730912643150077e-07
mutations O 0 9.881702567327011e-09
were O 0 3.6413476678376355e-09
observed O 0 2.7214182019008604e-09
in O 0 1.1142697875499152e-09
Japanese O 0 1.0010293181039742e-06
, O 0 3.046832341979666e-09
Utah O 0 2.011353217312717e-07
Mormon O 0 6.467702462487068e-08
, O 0 2.236498208851856e-10
and O 0 4.3954190287465167e-10
African O 0 6.478070524451596e-09
American O 0 1.6258741908359298e-08
patients O 0 3.064364761939942e-08
. O 0 1.7085901049540553e-07

These O 0 1.0330939659297655e-08
assays O 0 4.0527460498651635e-08
should O 0 5.637933453428445e-10
facilitate O 0 9.00241825529946e-10
screening O 0 7.871936880121666e-09
for O 0 1.334955146425898e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 8.755191629461478e-06
in O 0 4.937664943582831e-09
the O 0 1.7351655667852128e-09
populations O 0 1.520468334570424e-10
studied O 0 7.52345186150194e-10
. O 0 5.868542318765435e-10
. O 0 1.6489156706711583e-08

The O 0 1.1171558071509935e-05
von B-Disease 1 0.9999582767486572
Hippel I-Disease 1 1.0
- I-Disease 1 0.9999767541885376
Lindau I-Disease 1 0.9998189806938171
tumor I-Disease 0 4.4405009248293936e-05
suppressor O 0 9.601819783711107e-07
gene O 0 5.74547021070515e-10
is O 0 1.6596000615431983e-11
required O 0 4.5364299122718776e-11
for O 0 2.1424910456868673e-10
cell O 0 1.0382734672020888e-08
cycle O 0 1.9408707974122308e-09
exit O 0 6.827917342633327e-09
upon O 0 4.120807695073836e-09
serum O 0 7.986150052374796e-08
withdrawal O 0 1.0377195280852902e-07
. O 0 3.011803073604824e-07

The O 0 1.30049795643572e-06
inactivation O 0 2.118512747983914e-05
of O 0 4.007846143849747e-07
the O 0 1.0106767689421758e-07
von B-Disease 1 0.9990707039833069
Hippel I-Disease 1 1.0
- I-Disease 1 0.9999889135360718
Lindau I-Disease 1 1.0
( I-Disease 0 3.392685357539449e-06
VHL I-Disease 1 1.0
) I-Disease 0 9.926985740094096e-07
tumor I-Disease 0 0.005288530606776476
suppressor O 0 0.004018596839159727
gene O 0 9.138700818311918e-08
predisposes O 0 1.293967955007247e-07
affected O 0 4.823336730019889e-10
individuals O 0 3.879043353888223e-12
to O 0 8.203485113433828e-11
the O 0 1.8424621828216914e-08
human O 0 8.704029460204765e-05
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 9.057117833499717e-10
is O 0 1.8169278581670056e-11
associated O 0 5.656197732406554e-11
with O 0 1.984641444241486e-11
sporadic B-Disease 0 1.1340041055518668e-05
renal I-Disease 1 1.0
cell I-Disease 1 1.0
carcinomas I-Disease 1 1.0
( O 0 9.223649755085717e-08
RCC B-Disease 1 0.9997096657752991
) O 0 5.617941312152652e-08
and O 0 5.178452511245268e-07
brain B-Disease 1 0.9048436284065247
hemangioblastomas I-Disease 0 0.002419710624963045
. O 0 1.2311764976402628e-06

VHL O 1 0.7525602579116821
- O 0 6.443157326430082e-05
negative O 0 2.2616825390286976e-06
786 O 0 7.940511568449438e-05
- O 0 6.490611121989787e-05
0 O 0 9.026580300997011e-07
RCC B-Disease 0 0.016016487032175064
cells O 0 7.163956183831033e-08
are O 0 2.02202765642312e-09
tumorigenic O 0 0.00019466700905468315
in O 0 2.5075435061694407e-08
nude O 0 4.709326972829331e-08
mice O 0 6.6956622468694604e-09
which O 0 4.840956455143264e-11
is O 0 1.0798301836034696e-10
suppressed O 0 4.625696270466051e-09
by O 0 3.5157349254077985e-10
the O 0 5.337524644488667e-09
reintroduction O 0 1.0132243914995342e-06
of O 0 1.1115685794038654e-07
VHL B-Disease 0 0.34901508688926697
. O 0 1.554850996399182e-06

Remarkably O 0 4.803507908945903e-05
, O 0 1.1084833495544899e-08
this O 0 2.2793739118398548e-10
occurs O 0 1.0840013331403497e-09
without O 0 1.5338769143724562e-09
affecting O 0 1.575174324308648e-09
the O 0 6.885457204397483e-10
growth O 0 4.663147090688824e-10
rate O 0 1.4217355071011184e-09
and O 0 6.257835361012098e-10
cell O 0 2.600667947660895e-08
cycle O 0 1.3296441725429986e-09
profile O 0 1.9790329097713055e-10
of O 0 4.772965911392646e-10
these O 0 7.004590657500032e-11
cells O 0 9.689089530695583e-10
in O 0 6.999145152342123e-10
culture O 0 1.1949542688682868e-08
. O 0 1.730301590896488e-08

The O 0 5.882269761059433e-06
786 O 0 1.396901916450588e-05
- O 0 1.7961074263439514e-06
0 O 0 1.0925270998995984e-07
cell O 0 2.1114993842274998e-07
line O 0 7.573575544483901e-07
, O 0 1.1924401466245627e-09
like O 0 1.0754711565752473e-09
many O 0 5.949713499653342e-10
cancer B-Disease 0 9.486899443800212e-08
cells O 0 6.729372614699969e-09
, O 0 4.2586911774833425e-10
fails O 0 1.5456986801609673e-08
to O 0 3.101946255412713e-09
exit O 0 1.4860026453789033e-07
the O 0 1.4335978626434098e-08
cell O 0 3.466450948508282e-08
cycle O 0 1.309084840528385e-09
upon O 0 1.5105745543309013e-09
serum O 0 2.594836168157144e-08
withdrawal O 0 4.314570034580356e-08
. O 0 1.6979619488211029e-07

Here O 0 1.404290514983586e-06
, O 0 7.794900724888976e-09
it O 0 3.9042916122333793e-10
is O 0 1.8230904286209437e-10
shown O 0 1.712906205764142e-10
that O 0 2.8064533336147335e-11
reintroduction O 0 3.49672539812218e-08
of O 0 1.0774900083276862e-08
the O 0 1.1425060897352068e-08
wild O 0 3.6107248746475307e-08
- O 0 1.1378609166001752e-08
type O 0 5.162072369557791e-08
VHL B-Disease 0 0.1688898652791977
gene O 0 9.981173576534275e-08
restores O 0 1.3596917369795847e-06
the O 0 1.7467318258468367e-08
ability O 0 9.352507213122863e-09
of O 0 4.901195893580734e-07
VHL O 1 1.0
- O 0 0.0012290662853047252
negative O 0 3.2111273640111904e-07
RCC B-Disease 1 0.9846380352973938
cancer I-Disease 0 6.695402703371656e-07
cells O 0 3.900088696440207e-09
to O 0 1.5481615989187958e-09
exit O 0 2.3006430538430322e-08
the O 0 6.820992659584135e-09
cell O 0 2.2914509401061878e-08
cycle O 0 1.4173574536258116e-09
and O 0 7.696857595718143e-10
enter O 0 5.9063577140250345e-08
G0 O 0 0.00016582613170612603
/ O 0 1.2860288734373171e-05
quiescence O 0 8.672340300108772e-06
in O 0 1.609011590630871e-08
low O 0 3.8721734085811477e-07
serum O 0 8.246927905020129e-07
. O 0 1.0871723787886367e-07

Both O 0 8.502438504365273e-06
VHL O 1 0.999964714050293
- O 0 0.00015509634977206588
positive O 0 7.245472488648375e-08
and O 0 2.4229871087300126e-07
VHL O 1 1.0
- O 0 0.009181939996778965
negative O 0 2.9595275918836705e-07
RCC B-Disease 1 0.5363689661026001
cells O 0 1.224522492293545e-07
exit O 0 7.640289112487153e-08
the O 0 1.9743136014938045e-09
cell O 0 2.2169623914436443e-09
cycle O 0 9.111693344276972e-11
by O 0 7.637534701898652e-12
contact O 0 8.217289959588925e-09
inhibition O 0 2.7574020577958436e-07
. O 0 1.1588350901092781e-07

The O 0 8.112368050205987e-06
cyclin O 0 2.0559171389322728e-05
- O 0 1.8216345551991253e-06
dependent O 0 6.752260333087179e-07
kinase O 0 7.110551223377115e-07
inhibitor O 0 1.0508373549100725e-07
, O 0 7.430838722122246e-10
p27 O 0 5.963943863207533e-07
, O 0 5.212744680349601e-10
accumulates O 0 3.128816317143901e-09
upon O 0 8.749073687752684e-10
serum O 0 4.874873837934501e-09
withdrawal O 0 2.0330919170419293e-09
, O 0 5.2248656789988246e-11
only O 0 1.297316507692381e-11
in O 0 8.115151606258308e-11
the O 0 4.1152209417916197e-10
presence O 0 5.982645490121286e-10
of O 0 1.8381516753152027e-08
VHL B-Disease 1 0.9989481568336487
, O 0 3.967298489726545e-09
as O 0 7.719587191701294e-10
a O 0 5.996171337230294e-10
result O 0 6.702725041662916e-10
of O 0 4.578157852819231e-09
the O 0 2.7877036234968955e-09
stabilization O 0 2.1311025477643852e-07
of O 0 1.7382345163241553e-07
the O 0 8.218029989848219e-08
protein O 0 1.0949887752076393e-07
. O 0 8.552149921570162e-08

We O 0 1.1214646633561642e-07
propose O 0 3.3276247535241055e-08
that O 0 5.477056586045137e-10
the O 0 1.3126433273669136e-08
loss O 0 9.44447222650524e-08
of O 0 2.928140361291298e-07
wild O 0 2.547663768837083e-07
- O 0 7.019473002856103e-08
type O 0 1.8986186489655665e-07
VHL B-Disease 1 0.9997742772102356
gene O 0 2.3765501566685998e-08
results O 0 2.4793496145036897e-09
in O 0 6.616275860515941e-10
a O 0 3.5873835013688904e-09
specific O 0 1.010387329358764e-08
cellular O 0 1.244006966771849e-06
defect O 0 3.3738251659087837e-07
in O 0 5.190166518787009e-09
serum O 0 1.8162725154979853e-06
- O 0 3.008303337992402e-06
dependent O 0 1.5732510405541689e-07
growth O 0 5.624757548616799e-09
control O 0 4.539501219369413e-08
, O 0 1.6150884796228837e-10
which O 0 9.206184425902819e-11
may O 0 2.3272686000552767e-09
initiate O 0 3.7203992775403094e-08
tumor B-Disease 0 9.113033456742414e-07
formation O 0 2.974825008550397e-07
. O 0 3.899332341461559e-07

This O 0 4.675879239357528e-08
is O 0 3.169020379445442e-09
corrected O 0 2.4119826136370648e-08
by O 0 3.5954167421081706e-10
the O 0 4.628379013382755e-09
reintroduction O 0 3.825247461008985e-07
of O 0 2.5381227786169802e-08
wild O 0 8.196521150694025e-08
- O 0 2.7509791777902137e-08
type O 0 5.772657232228084e-07
VHL B-Disease 1 0.9999998807907104
, O 0 2.3570979834630634e-08
implicating O 0 5.652158051816514e-06
VHL B-Disease 1 0.9999998807907104
as O 0 7.841554747756163e-07
the O 0 1.0107423520366865e-07
first O 0 2.5559765859384243e-08
tumor B-Disease 0 6.77274343274803e-08
suppressor O 0 1.019252735545706e-07
involved O 0 7.546979152728284e-10
in O 0 5.097102184770108e-10
the O 0 3.1761973051658288e-09
regulation O 0 8.037767784685457e-09
of O 0 2.8652440420273706e-09
cell O 0 8.850352450906485e-09
cycle O 0 1.1150054213260319e-09
exit O 0 3.0564539788002776e-09
, O 0 2.3584387914832305e-11
which O 0 8.528529445162025e-12
is O 0 1.705127705697862e-11
consistent O 0 4.174799672629348e-10
with O 0 4.052677984867081e-11
its O 0 1.470485622157014e-09
gatekeeper O 0 4.4867425685879425e-07
function O 0 4.027466971034954e-10
in O 0 4.706179890234807e-10
the O 0 7.25426430037146e-09
kidney O 0 2.250269290016149e-06
. O 0 1.3963425082863523e-08
. O 0 9.434767633820229e-08

Piebaldism B-Disease 1 1.0
with O 0 0.004271901678293943
deafness B-Disease 1 1.0
: O 0 1.9890480373874198e-08
molecular O 0 2.0739314265938447e-08
evidence O 0 3.467264164669359e-08
for O 0 3.758255040509084e-09
an O 0 3.6317338025781964e-09
expanded O 0 3.648959818747244e-06
syndrome O 1 1.0
. O 0 3.2338089113181923e-06

In O 0 6.024894787515223e-07
a O 0 1.689657409542633e-07
South O 0 1.540482514883479e-07
African O 0 1.3861976455586955e-08
girl O 0 1.80136812133469e-08
of O 0 1.4143442861325184e-08
Xhosa O 0 0.00021758755610790104
stock O 0 3.040245388774565e-08
with O 0 1.745424776933291e-10
severe O 0 1.513302959210705e-05
piebaldism B-Disease 1 0.7591071724891663
and O 0 7.416671223836602e-07
profound O 1 0.999991774559021
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 7.101931487341062e-07
identified O 0 4.277449505707409e-09
a O 0 6.774752980831522e-10
novel O 0 3.202488718656582e-09
missense O 0 2.5583810625562364e-08
substitution O 0 8.44226661911307e-08
at O 0 3.57033371756188e-08
a O 0 1.6830894455921452e-09
highly O 0 1.6756835918840807e-09
conserved O 0 2.047033431651357e-09
residue O 0 2.257362652358097e-08
in O 0 2.5662860725361725e-10
the O 0 1.747424205333914e-09
intracellular O 0 6.333911173328488e-09
kinase O 0 1.8131224521766853e-08
domain O 0 2.745259131131661e-09
of O 0 3.2237792435552137e-09
the O 0 1.1099642982514979e-08
KIT O 0 2.0466111891437322e-05
proto O 0 3.970074249082245e-05
- O 0 3.3981834803853417e-06
oncogene O 0 1.3972762644698378e-05
, O 0 2.2238243246874845e-08
R796G O 0 3.221216502424795e-06
. O 0 3.027618902251561e-07

Though O 0 4.831803380511701e-06
auditory B-Disease 0 0.003807618049904704
anomalies I-Disease 0 0.0001368912635371089
have O 0 1.4027892625279037e-08
been O 0 1.4217959254381185e-08
observed O 0 1.1620839401871308e-08
in O 0 2.400365683996597e-09
mice O 0 8.363155501456276e-09
with O 0 6.23144091882466e-10
dominant O 0 8.691596303833649e-05
white O 0 2.915911863965448e-06
spotting O 0 6.05294758315722e-07
( O 0 5.067210651077403e-09
W O 0 6.123269713498303e-07
) O 0 8.210027796495822e-11
due O 0 9.61543555888511e-09
to O 0 3.2415119477491317e-09
KIT O 1 0.9911423921585083
mutations O 0 6.894977673255198e-07
, O 0 2.132655936293304e-07
deafness B-Disease 1 1.0
is O 0 1.80416970252395e-09
not O 0 1.224471773975111e-10
typical O 0 4.485328553016643e-09
in O 0 5.182824169835953e-10
human O 0 1.2204205646071387e-08
piebaldism B-Disease 0 1.0017226486525033e-05
. O 0 2.4328372205673077e-07

Thus O 0 1.7090448523049417e-07
, O 0 8.854451061246493e-10
the O 0 3.2394953386472025e-10
occurrence O 0 7.0402799146052075e-09
of O 0 1.0826679499587044e-06
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 0 2.275546194141498e-06
this O 0 9.232007158743727e-09
patient O 0 2.1560177287938131e-07
extends O 0 5.62943966997409e-08
considerably O 0 8.57419948374627e-08
the O 0 5.335611064083423e-09
phenotypic O 0 1.1123082899189285e-08
range O 0 1.3552594602117551e-08
of O 0 1.141347372168866e-08
piebaldism B-Disease 0 3.9094382486837276e-07
due O 0 2.715783331552757e-08
to O 0 2.9579674265534095e-09
KIT O 0 6.8299268605187535e-06
gene O 0 3.445836282978121e-09
mutation O 0 4.299122446926873e-10
in O 0 2.773127560917743e-11
humans O 0 6.296759225143944e-10
and O 0 1.1078444828171996e-09
tightens O 0 8.520839145376158e-08
the O 0 3.7781403006142966e-10
clinical O 0 2.260688081179296e-09
similarity O 0 1.1885306960834896e-08
between O 0 5.685711013114769e-09
piebaldism B-Disease 0 1.2254657804078306e-06
and O 0 5.529202096177244e-10
the O 0 1.3417933431014717e-10
various O 0 2.4493684858128972e-11
forms O 0 1.6493489907176695e-09
of O 0 1.6854279749622947e-07
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 2.887607486457e-08
. O 0 1.3274457444367727e-07

Cycloheximide O 0 5.50367112737149e-05
facilitates O 0 9.745312468112388e-08
the O 0 8.504404291898027e-09
identification O 0 5.279165105065431e-09
of O 0 1.4683505966672783e-08
aberrant O 0 4.9242558475270926e-08
transcripts O 0 5.2205308520569815e-08
resulting O 0 1.3990750780124017e-08
from O 0 6.781479378048516e-09
a O 0 9.846201187713177e-09
novel O 0 8.375833715490444e-08
splice O 0 1.0554475011304021e-05
- O 0 6.242474341888737e-07
site O 0 4.8959911680412915e-08
mutation O 0 6.997383228402043e-10
in O 0 2.3275692484503452e-10
COL17A1 O 0 1.8780272512231022e-05
in O 0 2.110322139259324e-09
a O 0 4.318907009803752e-09
patient O 0 3.0281036345058965e-08
with O 0 8.70715943790401e-09
generalized O 0 0.017105404287576675
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999988079071045
. O 0 1.137677190854447e-05

Patients O 0 4.850732693739701e-06
with O 0 1.5431807298682543e-07
generalized O 1 0.9876240491867065
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
often O 0 3.78336181938721e-07
show O 0 3.2733724619760096e-09
decreased O 0 9.31835164585948e-10
expression O 0 2.548856403716826e-10
of O 0 1.4702778994291066e-09
type O 0 4.010178145108512e-08
XVII O 0 0.004591444041579962
collagen O 0 4.755614554596832e-06
, O 0 1.2652856540285029e-08
a O 0 1.2392659343163359e-08
transmembrane O 0 8.92133122931682e-09
hemidesmosomal O 0 3.071913923236025e-08
protein O 0 3.8647055000673447e-10
encoded O 0 2.555184119845677e-10
by O 0 4.523834362668566e-10
COL17A1 O 0 0.00010737821867223829
. O 0 7.722222221673292e-07

This O 0 6.848240730050748e-08
report O 0 1.0106474768178941e-08
documents O 0 4.655473517800601e-08
a O 0 3.8774974342459245e-08
novel O 0 2.8675862040472566e-07
splice O 0 3.1521805794909596e-05
- O 0 9.243803447134269e-07
site O 0 2.6992784896151534e-08
mutation O 0 6.741625035999732e-10
in O 0 2.721162462027138e-10
COL17A1 O 0 0.001240900019183755
in O 0 2.5959139282605292e-09
a O 0 9.28418764090111e-09
patient O 0 1.1923798126645124e-07
with O 0 7.4038775110807364e-09
generalized O 0 0.17810757458209991
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9998934268951416
, O 0 1.0365480029861374e-08
and O 0 1.7715937605800036e-09
applies O 0 3.6570775296951297e-09
a O 0 6.26853902119251e-10
new O 0 6.187253487333066e-10
methodology O 0 3.01022762272396e-09
to O 0 2.0367664499421068e-10
define O 0 8.325843903200791e-10
and O 0 3.5298852729681585e-10
characterize O 0 1.712770725248447e-08
the O 0 2.5059740949018305e-09
resulting O 0 1.0733179678368288e-08
mRNA O 0 2.1148524709246885e-08
splice O 0 5.812165113638912e-07
variants O 0 6.492991388995506e-08
. O 0 4.5648018698329906e-08

Mutational O 0 0.0003421684668865055
analysis O 0 2.541441972425673e-07
of O 0 1.3297635632625315e-06
COL17A1 O 0 0.00624475535005331
identified O 0 4.4303365598352684e-07
a O 0 8.193754297280975e-08
maternally O 0 2.2905295793407277e-07
inherited O 0 1.4492931086351746e-06
G O 0 6.602367193409009e-06
- O 0 3.063046733586816e-06
to O 0 1.2449963548988308e-07
- O 0 7.885824743425474e-06
T O 0 1.1034196177206468e-05
transversion O 0 7.637267117388546e-06
at O 0 5.165851746369299e-09
the O 0 6.606616920201702e-10
- O 0 1.5828934829542618e-09
1 O 0 3.3834441914848412e-09
position O 0 6.527260065780638e-09
of O 0 2.4554905664331272e-08
exon O 0 2.1952561723992403e-07
32 O 0 5.979422468271878e-08
. O 0 7.326798368012533e-08

This O 0 7.339414054285953e-08
acceptor O 0 3.136292292538201e-08
splice O 0 6.720506462443154e-06
- O 0 5.314665258993045e-07
site O 0 5.1167841519372814e-08
mutation O 0 1.865616550134064e-09
led O 0 3.3387552722530245e-09
to O 0 7.90325527244562e-10
the O 0 7.2803509887364726e-09
formation O 0 3.989944374893639e-08
of O 0 1.920099776953066e-07
aberrant O 0 3.685200056224858e-08
transcripts O 0 2.08579304938894e-08
present O 0 6.9613115272204595e-09
at O 0 8.18445666794787e-09
extremely O 0 2.4309043666903563e-08
low O 0 4.2148201373493066e-07
levels O 0 8.434444964677823e-08
. O 0 9.530153732839608e-08

Based O 0 2.0051700175827136e-06
on O 0 7.807192901054805e-07
our O 0 3.968087369798923e-08
recent O 0 5.836106709011801e-09
finding O 0 1.2226947454507808e-08
that O 0 8.663537109931951e-10
cycloheximide O 0 4.522736162471119e-06
stabilized O 0 1.5120377611310687e-05
mutant O 0 1.0326170922780875e-06
COL17A1 O 0 1.6924321244005114e-05
transcripts O 0 4.433582390106494e-08
in O 0 9.096313147161084e-10
keratinocytes O 0 8.78374422086381e-08
homozygous O 0 6.213368930474417e-09
for O 0 3.5089015026912307e-10
a O 0 3.928676051145885e-09
frameshift O 0 2.181598546258101e-07
mutation O 0 2.8894462378303842e-09
, O 0 1.8276688495966198e-10
the O 0 1.1679697209387996e-09
effects O 0 3.298342932112064e-08
of O 0 1.568789258499237e-07
the O 0 1.1958873358253186e-07
splice O 0 4.278049800632289e-06
- O 0 7.002142865530914e-08
site O 0 4.941848263939619e-09
mutation O 0 8.361727282801823e-11
on O 0 4.333898795394475e-10
splicing O 0 6.164158072863302e-09
of O 0 5.243520284636816e-09
COL17A1 O 0 6.593073521798942e-06
transcripts O 0 5.501373223637529e-08
were O 0 1.342605471243985e-09
determined O 0 7.080163122452632e-10
using O 0 1.5607415360108234e-09
reverse O 0 1.2995101883461757e-08
transcriptase O 0 1.501085833410798e-08
polymerase O 0 1.0760651036889612e-07
chain O 0 3.840106455044179e-09
reaction O 0 7.656518752341412e-10
of O 0 3.408004101146389e-09
total O 0 8.928796590979005e-11
RNA O 0 1.757196943508177e-09
from O 0 2.3920779246289214e-10
keratinocytes O 0 3.3471607707724615e-08
incubated O 0 1.4050653085462272e-08
for O 0 3.4797759118632143e-10
2 O 0 3.849737595373881e-08
. O 0 3.098825374081571e-08

5 O 0 2.18051582123735e-06
h O 0 1.4293910055585002e-07
in O 0 1.4335314046931558e-09
the O 0 1.3262095865940182e-09
presence O 0 1.0767436942060726e-09
or O 0 5.219910281795137e-09
absence O 0 1.3698773670967057e-07
of O 0 2.5039690854100627e-07
10 O 0 4.868483216569075e-08
microg O 0 4.340030500316061e-06
cycloheximide O 0 3.261422989453422e-06
per O 0 5.944625769416234e-08
ml O 0 7.555338470410788e-07
. O 0 1.6431961569196574e-07

Using O 0 1.1577646574778555e-07
this O 0 2.584511493708419e-09
approach O 0 4.3601779964319576e-08
, O 0 5.152436810540451e-10
an O 0 1.3019277322889877e-10
abnormally O 0 9.552917568100838e-09
spliced O 0 7.142753588595951e-08
transcript O 0 1.4336229980926873e-07
was O 0 3.17948405381685e-08
identified O 0 1.0171467001995893e-09
that O 0 3.2734315258409197e-11
contains O 0 1.2120682235661207e-10
an O 0 4.962699001742621e-11
extra O 0 1.0566025832048354e-09
264 O 0 6.661103668648138e-09
bases O 0 1.1682844025528993e-08
upstream O 0 1.656481352085848e-08
from O 0 1.798250326423556e-09
exon O 0 2.2308000779958093e-08
32 O 0 3.4549838545672173e-09
, O 0 6.979238714732716e-11
resulting O 0 1.1533610733138744e-09
in O 0 1.380855874089093e-09
a O 0 1.2616731659420566e-08
premature O 0 1.6192318241792236e-07
termination O 0 3.165357384204981e-06
codon O 0 7.784851163705753e-07
27 O 0 1.139704750130477e-06
bp O 0 2.8484842005127575e-06
downstream O 0 1.0413857864932652e-07
from O 0 5.839358774295533e-09
the O 0 2.4410750754100263e-08
cryptic O 0 3.5793659662886057e-06
splice O 0 3.975852087023668e-05
site O 0 2.2917802198207937e-06
. O 0 3.3648089470261766e-07

Three O 0 2.040846425188647e-07
other O 0 3.9596024237198435e-09
splice O 0 3.6782273582502967e-07
variants O 0 2.052226300008897e-08
, O 0 1.524623899351596e-10
including O 0 3.097107292848733e-11
one O 0 4.9661649792476226e-11
derived O 0 1.8439096916011977e-09
from O 0 3.1121747401385846e-09
the O 0 5.733409746966345e-09
skipping O 0 8.63743920831439e-09
of O 0 8.790427052929317e-09
exon O 0 2.775333030058391e-08
32 O 0 2.737572835087576e-09
, O 0 3.8151783815498774e-11
were O 0 3.418138549982075e-10
also O 0 9.278623980257805e-10
identified O 0 1.532821869432155e-08
. O 0 7.885930841666777e-08

These O 0 6.825342069305407e-08
results O 0 2.3946871152702442e-08
indicate O 0 1.7149870856769667e-08
the O 0 1.2315465980350382e-08
usefulness O 0 2.6673711772673414e-07
of O 0 1.6761736887360712e-08
cycloheximide O 0 1.2202551715745358e-06
treatment O 0 1.509508820163319e-07
in O 0 1.1885118444965315e-09
evaluating O 0 2.209996408097936e-09
the O 0 6.233901728158742e-10
abnormal O 0 1.7616055836278122e-10
processing O 0 1.0663637972641027e-08
of O 0 5.262748015155694e-09
mRNA O 0 1.2053651410326438e-08
due O 0 4.6760845862081624e-08
to O 0 8.196282763606177e-09
splice O 0 5.050683284935076e-06
- O 0 2.4963512146314315e-07
site O 0 8.447610611028722e-09
mutations O 0 1.1832319846138972e-10
, O 0 5.412852110975308e-11
because O 0 2.570660906364708e-10
( O 0 1.4930697789239389e-09
i O 0 1.0196412603136196e-08
) O 0 6.616099335055026e-10
aberrant O 0 9.215733065559562e-09
splicing O 0 1.789464754153869e-08
often O 0 1.3751150218510588e-10
generates O 0 1.296456414445757e-10
a O 0 4.4118475539534074e-10
premature O 0 3.363131995115509e-09
termination O 0 9.071960249684707e-08
codon O 0 2.146166089289636e-08
, O 0 1.5966902244812786e-09
( O 0 4.999602953859039e-10
ii O 0 1.9125742255710065e-05
) O 0 7.057269768573349e-10
transcripts O 0 2.5584723228888606e-09
with O 0 6.291053789020395e-11
premature O 0 7.02021996090707e-09
termination O 0 2.7434006710791436e-07
codons O 0 7.570023541347837e-08
can O 0 4.042522760983047e-09
occur O 0 5.089401344804401e-09
at O 0 1.230886770287043e-08
low O 0 1.0161082286685996e-07
or O 0 4.844859180508365e-09
undetectable O 0 1.1509744979321113e-07
levels O 0 2.467569482078602e-09
due O 0 1.245165570651352e-08
to O 0 1.3189445091654761e-09
nonsense O 0 6.878428138179515e-08
- O 0 1.6902674815355567e-08
mediated O 0 6.41924344790823e-08
mRNA O 0 1.570600005607048e-08
decay O 0 3.199254550168007e-08
, O 0 9.284389923536196e-11
and O 0 1.7083319481248083e-10
( O 0 4.3995457277290484e-10
iii O 0 0.0005252655246295035
) O 0 2.091680162408238e-09
the O 0 2.429030754313999e-09
levels O 0 1.2760504874975709e-09
of O 0 1.0220668755778206e-09
these O 0 8.108080873370227e-11
transcripts O 0 3.3753868589059266e-09
can O 0 3.4752971334039984e-11
be O 0 4.120630572868045e-11
increased O 0 1.739907107278782e-10
by O 0 6.388408135826751e-10
cycloheximide O 0 6.042783297743881e-06
. O 0 3.4042872698591964e-07

A O 0 1.2197840078442823e-05
deletion O 0 2.715263008212787e-06
mutation O 0 4.010117038433236e-08
in O 0 6.528455109844344e-09
COL17A1 O 0 0.0003129327669739723
in O 0 5.503952404950496e-09
five O 0 2.915887753474067e-09
Austrian O 0 3.6989257523600827e-07
families O 0 1.8507769761200166e-09
with O 0 1.396205928649863e-09
generalized O 0 0.0003409844357520342
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999964237213135
represents O 0 9.470736728189877e-08
propagation O 0 3.4282987826372846e-07
of O 0 3.952835569975832e-08
an O 0 6.19726880923821e-10
ancestral O 0 2.906933218582708e-07
allele O 0 4.744488890651155e-08
. O 0 2.5431093675365446e-08

Patients O 0 2.9003751933487365e-06
with O 0 6.263118734750606e-08
generalized O 0 0.26822972297668457
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999998807907104
, O 0 5.347268583477671e-08
a O 0 4.3154901874231655e-09
usually O 0 2.0393369215554458e-09
nonlethal O 0 9.391315529683197e-07
form O 0 8.162136566625122e-08
of O 0 1.033236549119465e-05
junctional B-Disease 1 1.0
epidermolysis I-Disease 1 0.9999998807907104
bullosa I-Disease 1 0.9996942281723022
, O 0 5.9565516963289156e-09
have O 0 3.4363303869078266e-10
generalized O 0 1.1933762777971424e-07
blistering B-Disease 0 2.5499793991912156e-05
, O 0 2.626800643668048e-08
nail B-Disease 1 0.9999508857727051
dystrophy I-Disease 1 0.9999996423721313
, O 0 1.9364054537618358e-07
patchy B-Disease 1 1.0
alopecia I-Disease 1 1.0
, O 0 4.025102384730417e-07
and O 0 6.005555860610912e-06
dental B-Disease 1 1.0
abnormalities I-Disease 1 1.0
. O 0 9.938549919752404e-05

Skin B-Disease 1 1.0
fragility I-Disease 1 1.0
in O 0 3.333227382995574e-08
most O 0 8.226992975757241e-10
cases O 0 3.356279976163279e-10
is O 0 7.940905571990342e-11
due O 0 3.6122038693520153e-09
to O 0 4.451957968942821e-10
mutations O 0 3.0946817330956833e-10
in O 0 2.54242793484849e-10
the O 0 2.6631523653009026e-09
gene O 0 3.176813534455647e-10
encoding O 0 9.089102803727656e-09
type O 0 1.1021338508498957e-07
XVII O 0 0.0030366452410817146
collagen O 0 9.877145203063264e-06
( O 0 7.88432146237028e-08
COL17A1 O 0 0.0003242459788452834
) O 0 1.053007814277862e-08
. O 0 2.936809195830392e-08

Recently O 0 1.0445698535477277e-05
, O 0 3.1364180586024304e-08
we O 0 2.0096546649028824e-09
reported O 0 3.6849170381714202e-09
five O 0 9.830958269674284e-10
Austrian O 0 1.5173301903814718e-07
families O 0 1.894692180925972e-09
with O 0 6.902814431164472e-10
generalized O 0 5.674301428371109e-05
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
who O 0 3.8022137687221402e-06
share O 0 1.2018394102142338e-07
the O 0 4.975814960062053e-08
same O 0 1.0051459753412928e-07
COL17A1 O 0 0.004030260257422924
mutation O 0 3.937853705338057e-07
. O 0 3.2164726349037664e-07

Affected O 0 3.3478318073321134e-07
individuals O 0 5.433542504817979e-10
in O 0 1.2175856989316003e-09
three O 0 6.596681534354332e-10
families O 0 2.3815027727636107e-10
are O 0 1.3235321692783852e-11
homozygous O 0 4.854792123865082e-10
for O 0 1.1781021991286167e-10
4003delTC O 0 3.9328241996372526e-08
, O 0 9.450910193331552e-11
whereas O 0 3.8284037051639075e-10
those O 0 3.880127608102413e-10
in O 0 3.0625094127323393e-10
two O 0 1.9634222025999293e-10
others O 0 3.47572304271182e-10
are O 0 7.820030040184278e-11
compound O 0 3.9950930386112304e-07
heterozygotes O 0 2.4312005280080484e-06
. O 0 4.1778147874538263e-07

To O 0 1.2014304218155303e-07
determine O 0 2.3953997896342116e-08
if O 0 1.5921285401176988e-09
the O 0 1.7980377187143404e-09
occurrence O 0 3.578656482261522e-09
of O 0 4.861150593171715e-09
4003delTC O 0 3.5726358760257426e-08
in O 0 7.556020392707197e-11
these O 0 2.874634384697483e-11
unrelated O 0 1.692473272640882e-09
families O 0 4.82044681948679e-11
signifies O 0 1.1252684201101815e-10
propagation O 0 8.635511861143641e-09
of O 0 3.2745337552597675e-09
an O 0 1.5182687052028854e-10
ancestral O 0 2.6952758247489328e-08
allele O 0 1.9540755680225175e-09
or O 0 3.253292968352639e-09
a O 0 2.5397451253184045e-08
mutational O 0 2.025368121394422e-05
hot O 0 7.208143415482482e-06
spot O 0 3.33488145543015e-07
, O 0 3.0606292500401366e-10
haplotypes O 0 1.3894429606864378e-08
were O 0 1.2310668040527162e-09
determined O 0 3.8994416584614555e-09
for O 0 8.078709368142256e-10
polymorphisms O 0 2.129192466782115e-08
both O 0 1.2362032508761445e-09
within O 0 1.6833823224260414e-08
and O 0 4.9436795990231985e-08
flanking O 0 9.488115028943866e-05
COL17A1 O 1 0.9992210865020752
. O 0 1.820394459173258e-06

Five O 0 1.7357509705107077e-06
intragenic O 0 1.0874386134673841e-05
polymorphisms O 0 2.1849444920007954e-07
were O 0 6.0053193529086e-09
chosen O 0 8.920923555422178e-09
based O 0 1.4929709024613658e-08
on O 0 1.4772111001093435e-07
their O 0 2.7579403649724554e-08
informativeness O 0 0.00019448202510830015
. O 0 4.896617156191496e-07

One O 0 1.0587317689214615e-07
of O 0 4.28313384759349e-08
these O 0 2.5705823580857157e-10
, O 0 6.274133990125108e-11
not O 0 2.2377429770292778e-11
previously O 0 3.134227766210529e-09
reported O 0 1.2351734079985022e-09
, O 0 1.6939902258705786e-10
was O 0 2.0589268956427986e-08
2988 O 0 2.547360224980366e-07
A O 0 4.9480664898737814e-08
or O 0 2.8221407433193235e-09
C O 0 2.156027818500661e-07
that O 0 3.3896110918085753e-10
introduces O 0 3.880529231281571e-09
a O 0 8.118438699078467e-10
new O 0 1.033781393822153e-09
restriction O 0 4.891729799005873e-10
site O 0 1.7076355884881878e-09
for O 0 2.697150280894789e-10
Eco0109 O 0 3.696904968819581e-07
I O 0 1.8144427258448559e-06
. O 0 1.8625229358804063e-07

All O 0 1.7893133019697416e-07
the O 0 9.219938590376842e-08
4003delTC O 0 4.03487575795225e-07
alleles O 0 1.958979201077682e-09
showed O 0 7.826569392577198e-10
the O 0 2.159599721274219e-10
same O 0 3.8521724698981075e-10
haplotype O 0 6.952344477895167e-08
for O 0 6.150566167484328e-10
these O 0 5.944155168080556e-10
five O 0 3.752897104192243e-09
polymorphic O 0 2.94524681976327e-07
markers O 0 2.373185168380587e-07
. O 0 2.0473632389439445e-07

Fourteen O 0 6.970614322199253e-06
microsatellite O 0 1.7112877685576677e-05
polymorphisms O 0 2.8007551122755103e-07
were O 0 1.3574119606118984e-08
selected O 0 5.021145721428866e-09
based O 0 8.445000254653223e-09
on O 0 8.98047360919918e-08
their O 0 4.350298787869633e-09
high O 0 1.932623518996479e-07
heterozygosity O 0 2.192135616496671e-05
and O 0 4.82168349691392e-09
their O 0 8.509007942691937e-10
location O 0 5.918435164176117e-08
within O 0 1.018366191374298e-08
10q23 O 0 1.1616139090619981e-06
- O 0 3.5960962918579753e-07
q25 O 0 7.683635885769036e-06
near O 0 8.116469871310983e-06
COL17A1 O 0 0.001401628484018147
. O 0 1.5267985418176977e-06

Three O 0 6.505077294605144e-07
families O 0 4.745647075310444e-08
shared O 0 3.7891319948357705e-07
microsatellite O 0 1.0990005648636725e-05
polymorphisms O 0 9.949314971891e-07
covering O 0 4.410590292991401e-07
at O 0 1.1995105353435065e-07
most O 0 2.875075955088846e-09
19 O 0 9.958768920625971e-09
cM O 0 2.625879069739767e-08
, O 0 4.054419855403779e-10
whereas O 0 5.435628835925854e-09
the O 0 5.861858198841219e-08
others O 0 1.369713586996113e-08
shared O 0 1.3954025490647837e-08
smaller O 0 3.2287821305487796e-09
regions O 0 1.4112365720464481e-09
consistent O 0 7.49731299265477e-09
with O 0 4.1604353295809915e-10
cross O 0 2.1627016622005613e-08
- O 0 4.5330811104804525e-08
over O 0 1.0798637539721767e-09
events O 0 8.17942380493264e-11
during O 0 2.717770175575396e-10
passage O 0 1.1661843712928999e-09
of O 0 1.3068987558817469e-10
this O 0 1.1549536500787827e-11
mutation O 0 4.273799716902893e-11
through O 0 7.647962124712748e-11
several O 0 3.613105092892255e-10
generations O 0 1.1700097246603036e-07
. O 0 1.4135223125322227e-07

These O 0 2.8787319195089367e-08
results O 0 7.90660603655624e-09
indicate O 0 3.738337195358099e-09
that O 0 4.127649333440786e-10
4003delTC O 0 1.013212980183198e-07
occurs O 0 1.2225144230271212e-09
on O 0 2.944210875099884e-09
a O 0 8.706524390333925e-10
single O 0 1.93597182729377e-09
ancestral O 0 1.45963070963262e-07
allele O 0 9.441766479767466e-09
. O 0 5.080953435765423e-09
. O 0 3.89036536319054e-08

The O 0 8.777228686085436e-06
haptoglobin O 0 0.00020860183576587588
- O 0 4.590634034684626e-06
gene O 0 4.1662282512788806e-08
deletion O 0 1.2641500291010743e-07
responsible O 0 1.376732949864845e-08
for O 0 1.3892945460725059e-08
anhaptoglobinemia B-Disease 0 0.00041332771070301533
. O 0 1.2620999996215687e-06

We O 0 6.441443360927224e-07
have O 0 5.5776863128187415e-09
found O 0 2.1620323309434752e-09
an O 0 9.29785901049307e-11
allelic O 0 1.1739103911168058e-07
deletion O 0 9.286174673661662e-08
of O 0 1.0337172540175743e-07
the O 0 4.282268051269966e-08
haptoglobin O 0 1.2456853255571332e-05
( O 0 8.930167716414417e-09
Hp O 0 1.802652320748166e-07
) O 0 3.9004435792300285e-10
gene O 0 4.670838160691915e-10
from O 0 7.101464416514602e-10
an O 0 1.388638787291896e-10
individual O 0 3.5623969052434035e-11
with O 0 1.381978309566989e-09
anhaptoglobinemia B-Disease 0 2.4018929252633825e-05
. O 0 7.903350933702313e-07

The O 0 2.7169596705789445e-06
Hp O 0 2.0952822978870245e-06
gene O 0 1.5993672164427153e-08
cluster O 0 2.22735607735558e-08
consists O 0 4.085839222511822e-09
of O 0 1.0978638442793454e-08
coding O 0 1.247642131829707e-07
regions O 0 6.609821578962283e-09
of O 0 1.1839742342090176e-07
the O 0 1.150503621261123e-07
alpha O 0 5.4094957846473335e-08
chain O 0 3.209043475393969e-09
and O 0 2.0847845672022913e-10
beta O 0 2.9099651577269015e-09
chain O 0 1.58166213459765e-09
of O 0 2.612758231990142e-09
the O 0 5.7396243313689865e-09
haptoglobin O 0 1.8893797459895723e-07
gene O 0 9.38953803597542e-10
( O 0 1.0614296247490884e-10
Hp O 0 7.83738940413059e-09
) O 0 4.529254055141152e-11
and O 0 2.542912824754495e-10
of O 0 9.922062282896604e-09
the O 0 4.6961414312818306e-08
alpha O 0 3.813307358768725e-08
chain O 0 3.370317802620093e-09
and O 0 3.7586689316526645e-10
beta O 0 6.732260970920834e-09
chain O 0 4.703974099129482e-09
of O 0 2.899709805603834e-09
the O 0 2.6337174663382257e-09
haptoglobin O 0 3.1961809554559295e-07
- O 0 1.1594094573297298e-08
related O 0 2.024690415325381e-09
gene O 0 1.2426879525406775e-09
( O 0 2.7527555235273837e-10
Hpr O 0 2.4349262162104424e-07
) O 0 4.953850107902724e-10
, O 0 1.3017688316185883e-10
in O 0 7.306695248843198e-10
tandem O 0 9.996987415661351e-08
from O 0 1.7828927667551397e-08
the O 0 7.165856175106455e-08
5 O 0 1.455949387718647e-07
side O 0 2.973120274418761e-07
. O 0 2.3301707585687836e-07

Southern O 0 5.274740396998823e-05
blot O 0 9.432499064132571e-05
and O 0 5.4017835537933934e-08
PCR O 0 1.2034444125674781e-06
analyses O 0 5.532688973630684e-08
have O 0 4.1478373513648137e-10
indicated O 0 1.2198452248313174e-09
that O 0 4.665849651086518e-11
the O 0 3.100465717498224e-10
individual O 0 6.085330590127613e-12
with O 0 2.2417156672616123e-11
anhaptoglobinemia B-Disease 0 3.239196360027563e-07
was O 0 7.780330157913795e-09
homozygous O 0 7.563724646608705e-10
for O 0 1.4964246508597512e-10
the O 0 9.194238703713609e-10
gene O 0 4.072051307257851e-10
deletion O 0 3.0263296313393084e-09
and O 0 2.364818341149544e-10
that O 0 3.150923966188657e-11
the O 0 5.282869142142488e-10
gene O 0 3.1714497694679267e-10
deletion O 0 1.4301341222378028e-09
was O 0 2.590557102166713e-09
included O 0 1.6634799093750985e-10
at O 0 5.497864385972662e-10
least O 0 1.7672113772349007e-11
from O 0 1.6814873105008843e-10
the O 0 4.449532298167469e-09
promoter O 0 3.68791489790965e-07
region O 0 7.152856085212989e-08
of O 0 3.434840891713975e-07
Hp O 0 5.231737759459065e-06
to O 0 7.163178139535376e-08
Hpr O 0 5.957234861853067e-06
alpha O 0 7.055270856426432e-08
but O 0 4.886899218625729e-10
not O 0 1.663578302890656e-10
to O 0 2.4945001619869345e-09
Hpr O 0 4.543798695522128e-06
beta O 0 2.438267756588175e-07
( O 0 8.502198056703492e-09
Hpdel O 0 1.7476687617090647e-06
) O 0 5.720934836972447e-09
. O 0 2.4230258688362483e-08

In O 0 1.2928862247463258e-07
addition O 0 1.4405325821087445e-08
, O 0 2.595938575211676e-09
we O 0 7.988016914595164e-10
found O 0 1.2113384739720345e-09
seven O 0 4.186145874385261e-10
individuals O 0 5.8557672599768296e-12
with O 0 9.59278420586962e-11
hypohaptoglobinemia B-Disease 0 5.355155735742301e-06
in O 0 2.587431380263183e-09
three O 0 1.0037848330313182e-09
families O 0 2.515368191513545e-10
, O 0 4.830524868992825e-11
and O 0 1.187781678568811e-10
the O 0 9.034412662423108e-10
genotypes O 0 9.415654034228282e-09
of O 0 1.3121627340240138e-08
six O 0 2.2934567578403176e-09
of O 0 6.475501024283403e-09
the O 0 2.9403497414648427e-09
seven O 0 2.0325285898792345e-10
individuals O 0 1.0398251270443692e-12
were O 0 1.3890441574737622e-10
found O 0 3.793875213986553e-10
to O 0 8.368926662782883e-10
be O 0 1.8472476881470357e-08
Hp2 O 0 0.3670106828212738
/ O 1 0.8028305768966675
Hpdel O 0 0.028130529448390007
. O 0 7.87354451858846e-07

The O 0 1.2854337683165795e-06
phenotypes O 0 1.4628905091740307e-06
and O 0 1.568031748888643e-08
genotypes O 0 1.6926685475482373e-07
in O 0 1.1684755385488188e-09
one O 0 2.9749627761255226e-10
of O 0 1.0433869324089073e-09
these O 0 1.2458437059770233e-10
three O 0 2.0324045224562326e-10
families O 0 1.0830893126811958e-10
showed O 0 2.795321474291512e-10
the O 0 1.1151095602457417e-09
father O 0 6.164795252061595e-08
to O 0 7.289827852474673e-09
be O 0 1.7209442759735794e-08
hypohaptoglobinemic B-Disease 0 1.5032229384814855e-05
( O 0 2.0037385084492598e-08
Hp2 O 0 4.279441327526001e-06
) O 0 2.202598325951044e-09
and O 0 8.262820649918012e-09
Hp2 O 0 2.832296013366431e-05
/ O 0 4.361024366517086e-06
Hpdel O 0 2.47565967583796e-05
, O 0 2.1611747946792548e-09
the O 0 4.44455316994663e-09
mother O 0 8.587943689519761e-09
to O 0 7.519076472561892e-10
be O 0 1.304297003734689e-09
Hp2 O 0 5.3506628319155425e-06
- O 0 1.6876477104688092e-07
1 O 0 5.709328476655173e-08
and O 0 4.17935108742995e-09
Hp1 O 0 9.649586900195573e-06
/ O 0 7.507045438615023e-07
Hp2 O 0 2.471481366228545e-06
, O 0 2.030366569316655e-10
one O 0 6.084997783428747e-11
of O 0 7.201734764095136e-10
the O 0 1.1818659384488228e-09
two O 0 1.639806068709504e-10
children O 0 3.533049200421523e-11
to O 0 2.4138346876867445e-10
be O 0 4.232892258926313e-09
hypohaptoglobinemic B-Disease 0 1.1725229342118837e-05
( O 0 1.68838578673558e-08
Hp2 O 0 1.4702383850817569e-05
) O 0 6.999949953012674e-09
and O 0 8.549014829384305e-09
Hp2 O 0 0.00010272086365148425
/ O 0 1.0713600204326212e-05
Hpdel O 0 2.243907692900393e-05
, O 0 8.733335166155598e-10
and O 0 4.229549210865713e-10
the O 0 5.213440790186041e-10
other O 0 3.7451416967648754e-11
child O 0 1.418381662121604e-10
to O 0 1.1661549503827473e-10
be O 0 6.549067399497233e-10
Hp1 O 0 8.70249823492486e-06
and O 0 5.193457397467682e-08
Hp1 O 0 0.00038685646723024547
/ O 0 9.874775423668325e-05
Hpdel O 0 6.403166480595246e-05
, O 0 1.5709438194733139e-09
showing O 0 5.850615547586813e-10
an O 0 5.369356001483361e-11
anomalous O 0 3.364307943343192e-08
inheritance O 0 7.47553201563278e-07
of O 0 1.4541733435180504e-06
Hp O 0 2.1254661987768486e-05
phenotypes O 0 5.829356837239175e-07
in O 0 2.8608369007088186e-09
the O 0 7.157588743922361e-09
child O 0 5.223177446112004e-09
with O 0 2.4885313809619447e-09
Hp1 O 0 8.249196980614215e-05
. O 0 6.683236506432877e-07

The O 0 1.3066993233223911e-05
Hp2 O 0 0.0054936460219323635
/ O 0 0.0003286472347099334
Hpdel O 0 3.9479840779677033e-05
individuals O 0 3.6802233482902125e-10
had O 0 1.0453554466494097e-08
an O 0 1.2215278788474393e-10
extremely O 0 2.036868451682494e-09
low O 0 9.185202287653738e-08
level O 0 5.4376535274514026e-08
of O 0 3.946514937069878e-08
Hp O 0 3.8239198829614907e-07
( O 0 7.952019043244718e-10
mean O 0 2.4849742263910457e-09
+ O 0 4.3384829062631525e-09
/ O 0 7.251621969572852e-09
- O 0 5.75815528591761e-09
SD O 0 1.8675083879315935e-07
= O 0 3.61288621242295e-09
0 O 0 1.6806257496781996e-09
. O 0 1.8103528398594193e-10
049 O 0 8.58974971151838e-08
+ O 0 4.041289081158084e-09
/ O 0 1.5857075652547792e-08
- O 0 1.1016543233210996e-08
0 O 0 4.4467407533943515e-09
. O 0 5.819553172692338e-10
043 O 0 2.8181733568999334e-07
mg O 0 3.605508425152948e-08
/ O 0 9.94058879655313e-09
ml O 0 3.0282754082122665e-09
; O 0 2.0899883212965875e-10
n O 0 2.2036741320619058e-09
= O 0 2.1118200521641484e-09
6 O 0 2.170850388338863e-09
) O 0 1.2357164770604445e-11
, O 0 5.686764861095872e-12
compared O 0 2.798878490084533e-11
with O 0 9.680268739375997e-12
the O 0 1.1312925041195854e-09
level O 0 6.182738765403428e-09
( O 0 9.314135573923465e-11
1 O 0 1.6343301156851453e-09
. O 0 1.4311811458167512e-10
64 O 0 4.114963925161419e-09
+ O 0 2.9672233559097094e-09
/ O 0 1.131342663995838e-08
- O 0 1.0838530073442598e-08
1 O 0 7.440188909413337e-09
. O 0 2.5929139391145384e-10
07 O 0 2.965091994155955e-08
mg O 0 4.3139117167356744e-08
/ O 0 8.67380922642269e-09
ml O 0 1.8874171114902083e-09
) O 0 1.2450402687991247e-11
obtained O 0 2.172672042277668e-10
from O 0 2.230696738436677e-09
52 O 0 3.6188467333886365e-08
healthy O 0 1.8025220205331038e-09
volunteers O 0 4.0772424325652423e-10
having O 0 2.4668400655514233e-09
phenotype O 0 5.038906536469767e-08
Hp2 O 0 1.5230145891109714e-06
, O 0 3.3645866648335243e-10
whereas O 0 2.0484982599100476e-09
the O 0 3.316382723994593e-09
serum O 0 1.1408581457317268e-07
Hp O 0 2.2281342637597845e-07
level O 0 1.3822743838431961e-08
of O 0 1.4751037058502448e-09
an O 0 1.7209809966001188e-11
individual O 0 1.8298856353793358e-12
with O 0 2.5150312388255713e-11
Hp1 O 0 1.5670608490836457e-06
/ O 0 3.7514857353926345e-07
Hpdel O 0 1.3274272532726172e-05
was O 0 6.262867486839241e-07
0 O 0 1.2181710928871325e-07
. O 0 2.653034059107995e-08

50 O 0 2.1215485048742266e-06
mg O 0 3.13616010316764e-06
/ O 0 1.0592211765469983e-06
ml O 0 2.50109110311314e-07
, O 0 6.847620803718257e-10
which O 0 1.551140188515987e-10
was O 0 5.410741188427437e-09
approximately O 0 5.834810412608249e-11
half O 0 1.800435495136199e-10
the O 0 2.921408948086679e-10
level O 0 4.794391994522584e-09
of O 0 4.659487018443542e-09
Hp O 0 1.6924491319514345e-07
in O 0 4.378886142575311e-09
control O 0 1.003027847445992e-07
sera O 0 2.7039322958444245e-07
from O 0 3.0189097888211336e-09
the O 0 4.4555790168487874e-09
Hp1 O 0 1.9520544469742163e-07
phenotype O 0 3.300342221734809e-09
( O 0 7.862775708300518e-11
1 O 0 8.826931408023597e-10
. O 0 7.696736997742093e-11
26 O 0 1.7895013249003e-09
+ O 0 8.856089195319328e-10
/ O 0 5.550242487828427e-09
- O 0 3.6285350279996464e-09
0 O 0 1.7077788072583644e-09
. O 0 1.7175813549208385e-10
33 O 0 6.0273634971963475e-09
mg O 0 1.1237681896147933e-08
/ O 0 3.806968518205167e-09
ml O 0 1.471818333875774e-09
; O 0 2.9344432439515344e-10
n O 0 1.9293142639043026e-09
= O 0 1.807079708093795e-09
9 O 0 1.3059301418039126e-09
) O 0 3.4465295201124846e-11
, O 0 2.5339641843147298e-11
showing O 0 2.2742105421080794e-10
a O 0 2.3128867709942824e-09
gene O 0 4.448624135733326e-09
- O 0 3.4363473844223336e-08
dosage O 0 6.111001766839763e-07
effect O 0 3.084308275447256e-07
. O 0 3.033966322618653e-07

The O 0 1.6145193058036966e-06
other O 0 2.3878957478018492e-08
allele O 0 4.970380018676224e-08
( O 0 1.8825059289184765e-09
Hp2 O 0 1.1912766240129713e-06
) O 0 4.285924393165885e-10
of O 0 1.4882448606812204e-09
individuals O 0 5.05157270180856e-11
with O 0 1.1613078276795363e-09
Hp2 O 0 0.0010156724601984024
/ O 0 6.151717389002442e-05
Hpdel O 0 2.795570071612019e-05
was O 0 8.688980557280956e-08
found O 0 4.275424458910493e-10
to O 0 5.873646014009637e-11
have O 0 8.06592570512521e-11
, O 0 8.02339236716243e-11
in O 0 1.2201308019488266e-10
all O 0 3.375610901912296e-10
exons O 0 6.616471637244103e-08
, O 0 1.1068511385214919e-10
no O 0 1.4706783013629376e-10
mutation O 0 7.006888819161006e-11
, O 0 1.407249056867288e-11
by O 0 2.380793132084058e-11
DNA O 0 1.7037713462286774e-08
sequencing O 0 4.0135032008947746e-07
. O 0 1.3103749552101362e-07

On O 0 1.475151634622307e-06
the O 0 1.684265527046591e-08
basis O 0 7.015468206361675e-09
of O 0 5.340314412904945e-09
the O 0 6.773150929006988e-10
present O 0 7.357628950543926e-10
study O 0 1.8724137518244532e-10
, O 0 1.8115434499699212e-11
the O 0 1.276220240598036e-10
mechanism O 0 7.447230832013929e-09
of O 0 1.2317063813327422e-08
anhaptoglobinemia B-Disease 0 1.0519287343413453e-06
and O 0 1.4073310294904218e-09
the O 0 1.7658013939936268e-09
mechanism O 0 1.1725259874140193e-08
of O 0 2.4909818652218974e-09
anomalous O 0 3.315473406928504e-08
inheritance O 0 1.1196885907338583e-07
of O 0 3.211659560520275e-08
Hp O 0 3.797854333242867e-07
phenotypes O 0 5.955395820933518e-08
were O 0 7.121285339195538e-09
well O 0 8.310077959094997e-09
explained O 0 7.565029847000915e-08
. O 0 1.0584632548216177e-07

However O 0 3.9679136421000294e-07
, O 0 7.734034745965346e-09
the O 0 7.45611394847856e-09
mechanism O 0 1.262275475255592e-07
of O 0 2.695323075840861e-07
hypohaptoglobinemia B-Disease 0 0.0014022813411429524
remains O 0 3.7621157389367e-05
unknown O 0 1.5633080693078227e-05

ATM O 0 9.098718874156475e-05
mutations O 0 2.1981848874474963e-07
and O 0 2.7902210320007725e-08
phenotypes O 0 3.3542405617481563e-06
in O 0 1.1858788866447867e-06
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
families O 0 0.02104690857231617
in O 0 1.5197770153463352e-08
the O 0 2.793741238349412e-08
British O 0 1.3940172038928722e-07
Isles O 0 7.626180149600259e-07
: O 0 2.8658217465782343e-10
expression O 0 5.485901732882326e-10
of O 0 5.452897244850874e-09
mutant O 0 5.577717843152641e-09
ATM O 0 3.6592286534187224e-08
and O 0 1.707374103210313e-10
the O 0 3.2380126357978156e-10
risk O 0 6.62564669795529e-10
of O 0 1.5132801678419128e-08
leukemia B-Disease 1 1.0
, O 0 3.612480577430688e-05
lymphoma B-Disease 1 1.0
, O 0 2.8536339868878713e-06
and O 0 2.002963810809888e-05
breast B-Disease 1 0.9981915354728699
cancer I-Disease 0 0.00023603519366588444
. O 0 7.502879952880903e-07

We O 0 2.0055591676282347e-07
report O 0 5.59993296178618e-09
the O 0 8.152564845431698e-09
spectrum O 0 1.674451937105914e-07
of O 0 3.9079687041976285e-08
59 O 0 8.25428685402585e-08
ATM O 0 3.259294771851273e-07
mutations O 0 1.3216592265052896e-09
observed O 0 6.704365063114892e-09
in O 0 2.0320422677855277e-08
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.999998927116394
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.5869087377495816e-08
patients O 0 1.3846280566554015e-08
in O 0 3.187777153357274e-09
the O 0 2.0736388606223954e-08
British O 0 7.863106930017238e-07
Isles O 0 1.4080685105000157e-05
. O 0 3.8797472257101617e-07

Of O 0 3.6691781133413315e-05
51 O 0 5.914055236644344e-06
ATM O 0 8.620606422482524e-06
mutations O 0 1.4195956410389954e-08
identified O 0 9.11980535533985e-09
in O 0 1.059272225489849e-09
families O 0 1.0954055440492994e-09
native O 0 2.027755297007161e-09
to O 0 8.987252608783081e-10
the O 0 1.2054043097009526e-08
British O 0 2.2758364082164917e-07
Isles O 0 5.104169304104289e-06
, O 0 1.6325293339392033e-09
11 O 0 2.5423223526388483e-09
were O 0 1.0633125491210649e-09
founder O 0 1.0207936185224753e-07
mutations O 0 1.7987809852737513e-10
, O 0 5.1792049815535535e-11
and O 0 3.954913341264188e-10
2 O 0 1.160768103858345e-08
of O 0 3.0880265011745678e-09
these O 0 4.930604258213123e-10
11 O 0 5.1876725137844915e-09
conferred O 0 1.9443657350848298e-08
a O 0 2.1544497297298904e-09
milder O 0 5.1748583018707e-07
clinical O 0 3.4045495311829654e-08
phenotype O 0 4.636171446747994e-09
with O 0 1.555227648053492e-11
respect O 0 2.46103026846356e-10
to O 0 6.54222565010798e-10
both O 0 7.876983509902402e-09
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
and O 0 2.6181725843343884e-05
cellular O 0 1.022964397634496e-06
features O 0 3.5873714665513035e-08
. O 0 4.3515292702522856e-08

We O 0 2.1268915872951766e-07
report O 0 6.940920282971774e-09
, O 0 9.017025459634453e-10
in O 0 1.211148958901731e-09
two O 0 1.1108623354516567e-08
A B-Disease 1 1.0
- I-Disease 1 0.9999908208847046
T I-Disease 1 1.0
families O 0 8.868978795817384e-08
, O 0 8.297371678622767e-10
an O 0 2.7812441238950214e-10
ATM O 0 5.4033499452543765e-08
mutation O 0 1.2802119364607734e-09
( O 0 4.781330331660172e-10
7271T O 0 2.152328022475558e-07
- O 0 1.865142991164248e-07
- O 0 5.688544320037181e-07
> O 0 7.918220603642112e-07
G O 0 4.5283627514436375e-07
) O 0 4.843865933357172e-11
that O 0 9.984463342910255e-13
may O 0 2.8201524449045223e-11
be O 0 7.397119375363026e-12
associated O 0 1.899750079470408e-10
with O 0 3.3260443010885155e-12
an O 0 1.825152008694264e-12
increased O 0 6.77531850068469e-11
risk O 0 1.785086745087483e-09
of O 0 1.3581245639215922e-07
breast B-Disease 0 0.0001567681465530768
cancer I-Disease 0 2.853123248769407e-07
in O 0 1.0620883061918107e-09
both O 0 1.5095836802814233e-09
homozygotes O 0 2.0795827992969862e-07
and O 0 2.113153652061328e-09
heterozygotes O 0 1.4171607887192295e-08
( O 0 1.505321839401219e-10
relative O 0 7.0457475409568815e-09
risk O 0 3.664066827724355e-09
12 O 0 1.1479270867198466e-09
. O 0 2.134374482709589e-10
7 O 0 4.762456207174637e-09
; O 0 9.8871844045334e-10
P O 0 1.1141872846565093e-06
= O 0 2.012786026739377e-08
. O 0 1.2380462210970222e-09
0025 O 0 5.672119414157351e-07
) O 0 5.1830390673801574e-11
, O 0 1.0336600499150084e-11
although O 0 1.1224860624325927e-10
there O 0 6.274193664612682e-11
is O 0 8.266060058659264e-11
a O 0 5.868004970821517e-10
less O 0 2.693989697988286e-09
severe O 0 0.001252944115549326
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
phenotype O 0 6.401282348633686e-08
in O 0 3.82506595841825e-11
terms O 0 8.953883467999191e-11
of O 0 1.712112535079413e-10
the O 0 2.9530955458767494e-10
degree O 0 2.523838560364311e-08
of O 0 5.851793005717809e-08
cerebellar B-Disease 1 0.9999959468841553
degeneration I-Disease 1 1.0
. O 0 4.811824055650504e-06

This O 0 1.2051425812842353e-07
mutation O 0 3.0400251205264794e-08
( O 0 1.445326081039866e-09
7271T O 0 4.1041695908461406e-07
- O 0 9.467412809271991e-08
- O 0 1.1533126098584034e-07
> O 0 2.0273741085929942e-07
G O 0 2.4746179860812845e-07
) O 0 1.755728756824837e-10
also O 0 9.605601730688917e-11
allows O 0 2.6528175489648476e-11
expression O 0 9.043752552395645e-11
of O 0 6.549554787405043e-10
full O 0 9.31646759738669e-10
- O 0 2.742229110452854e-09
length O 0 7.509129984484275e-10
ATM O 0 3.109008162027749e-08
protein O 0 6.298933596937673e-10
at O 0 3.5394520647713534e-10
a O 0 9.627097730113832e-11
level O 0 4.818647147963873e-10
comparable O 0 3.1379721043833797e-09
with O 0 1.2257242443247662e-10
that O 0 7.410298069610022e-11
in O 0 1.4163628048180499e-09
unaffected O 0 2.0573729386796913e-07
individuals O 0 5.082055887228876e-10
. O 0 4.535442243991383e-08

In O 0 9.452472937709899e-08
addition O 0 1.9120024674634806e-08
, O 0 3.29318639025189e-09
we O 0 6.047950473764274e-10
have O 0 1.5649050111310459e-10
studied O 0 1.0159682872767917e-08
18 O 0 4.2812310141471244e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 3.849767836072715e-06
, O 0 8.705627330130028e-10
in O 0 4.215873206092624e-10
15 O 0 9.98813587393954e-10
families O 0 1.4281625881906734e-10
, O 0 7.200110646587987e-11
who O 0 3.231941103631897e-10
developed O 0 6.259052156565303e-07
leukemia B-Disease 1 1.0
, O 0 9.245661203749478e-06
lymphoma B-Disease 1 1.0
, O 0 2.063477268166025e-06
preleukemic O 0 0.0009856594260782003
T O 0 0.0003716886567417532
- O 0 1.4026950339030009e-06
cell O 0 5.128489419803373e-07
proliferation O 0 4.53775243158816e-07
, O 0 2.6507754324889277e-10
or O 0 1.3570630130743666e-07
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 1.1594280522331246e-06
mostly O 0 4.8416444187182606e-09
in O 0 3.9569902909875054e-09
childhood O 0 6.932725682418095e-07
. O 0 1.507039115722364e-07

A O 0 1.0059004125650972e-05
wide O 0 5.390121486925636e-07
variety O 0 2.074505189852971e-08
of O 0 3.1403690314846244e-08
ATM O 0 3.0393587735488836e-07
mutation O 0 2.0095780595141832e-09
types O 0 2.8189184320126515e-09
, O 0 2.0361644315070038e-10
including O 0 6.884537939733093e-10
missense O 0 3.040550211608206e-07
mutations O 0 6.652533635076452e-09
and O 0 3.6798459834841424e-09
in O 0 3.182910601751132e-09
- O 0 3.7970931288100473e-08
frame O 0 2.2198753413249506e-07
deletions O 0 3.6452341589665593e-08
, O 0 1.540323146809186e-10
were O 0 5.781681799987837e-10
seen O 0 3.1165585667736195e-09
in O 0 8.09819433733594e-10
these O 0 2.307387614308709e-09
patients O 0 7.127606949097753e-08
. O 0 1.945646062040396e-07

We O 0 8.066673444773187e-07
also O 0 2.1207254619071136e-08
show O 0 5.41042932677982e-10
that O 0 4.3644234060113973e-11
25 O 0 7.815352254247898e-10
% O 0 1.9110088511631318e-10
of O 0 3.5798237707496128e-09
all O 0 1.3025947431799523e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 1.0850219922531323e-07
carried O 0 2.2742074889947617e-09
in O 0 8.73866701223136e-10
- O 0 1.1044839709484222e-08
frame O 0 1.515929994866383e-07
deletions O 0 7.257589373921292e-08
or O 0 5.9202722724194246e-09
missense O 0 1.0311730136436381e-07
mutations O 0 5.250653245525427e-10
, O 0 3.3813053051945374e-11
many O 0 1.4482164599483038e-11
of O 0 8.82008133196166e-10
which O 0 6.31178651011588e-11
were O 0 2.3311502728162736e-10
also O 0 3.465685724513001e-11
associated O 0 1.041298922088707e-10
with O 0 3.7872361496882334e-11
expression O 0 1.324677589842338e-09
of O 0 2.6289558974212923e-08
mutant O 0 6.949149167212454e-08
ATM O 0 4.121938559364935e-07
protein O 0 3.760666089647202e-08
. O 0 2.1435560881855054e-08

The O 0 2.4458347525069257e-06
DMPK O 0 0.0024113089311867952
gene O 0 3.4737226428660506e-07
of O 0 3.7279258435773954e-07
severely O 0 0.09875623881816864
affected O 0 0.0002107445616275072
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9615792632102966
is O 0 1.3819052568919687e-08
hypermethylated O 0 1.0766055993371992e-06
proximal O 0 1.4940732398827095e-05
to O 0 5.4478690003634256e-08
the O 0 3.4690842198870087e-07
largely O 0 2.7044350758842484e-07
expanded O 0 3.793329597101547e-07
CTG O 0 2.7169284294359386e-05
repeat O 0 3.7117493434379867e-07
. O 0 2.531359939439426e-07

Using O 0 1.9224153220420703e-06
methylation O 0 9.040209079103079e-06
- O 0 3.0837543363304576e-06
sensitive O 0 8.141167882058653e-07
restriction O 0 2.1703463914946042e-08
enzymes O 0 2.1457229326671268e-09
, O 0 1.867701965307944e-10
we O 0 1.4204906695347574e-10
characterized O 0 8.430512399293377e-10
the O 0 2.0634232100746885e-09
methylation O 0 2.642024155008471e-09
pattern O 0 3.4483083055647512e-09
on O 0 8.258298933583319e-09
the O 0 2.6323465629474185e-09
5 O 0 2.9523197220271413e-09
side O 0 1.0628752100672045e-08
of O 0 2.811772503719112e-08
the O 0 8.508609994350991e-08
CTG O 0 4.822707069251919e-06
repeat O 0 1.7746383917938147e-08
in O 0 7.494849740830034e-10
the O 0 3.4137812576773285e-09
DMPK O 0 5.356166639103321e-06
gene O 0 1.637834645684677e-09
of O 0 5.579428030699773e-10
normal O 0 2.7695873372479696e-10
individuals O 0 1.4348314203438406e-12
and O 0 9.62482107902396e-11
of O 0 2.9104036958216284e-09
patients O 0 5.6441229467907306e-09
affected O 0 3.336342535575909e-09
with O 0 1.0062217725703704e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 5.137944736333111e-09
showing O 0 8.292989073233059e-10
expansions O 0 2.5444192530699183e-08
of O 0 2.035657686860759e-08
the O 0 1.1869267346753531e-08
repetitive O 0 8.804929052530497e-08
sequence O 0 2.0519131282981107e-08
. O 0 5.2425431107394616e-08

The O 0 1.3955936992715579e-06
gene O 0 6.805959174016607e-08
segment O 0 3.344665344684472e-08
analyzed O 0 4.269787634569866e-09
corresponds O 0 2.517183572692261e-09
to O 0 2.599287896032365e-09
the O 0 3.970661310859214e-08
genomic O 0 7.688661867177871e-07
SacI O 0 2.2352895030053332e-05
- O 0 1.3323972325451905e-07
HindIII O 0 1.4937903642930905e-06
fragment O 0 1.070699084948501e-07
carrying O 0 4.3319523967966234e-08
exons O 0 3.4086565392499324e-07
11 O 0 1.0312320597449798e-07
- O 0 2.6502101491132635e-07
15 O 0 1.1306916292141977e-07
. O 0 1.2364897372663108e-07

There O 0 8.738675205677282e-08
is O 0 1.2030109353133867e-08
constitutive O 0 7.717915195826208e-07
methylation O 0 3.3492881357233273e-07
in O 0 3.722124120031367e-08
intron O 0 2.2208452719496563e-05
12 O 0 3.1927081067806284e-07
at O 0 1.2338530197553155e-08
restriction O 0 6.835106369784683e-10
sites O 0 1.028606644304375e-09
of O 0 4.179494084155522e-09
SacII O 0 1.4470750784312258e-06
and O 0 1.0274522566078303e-08
HhaI O 0 1.560944042466872e-06
, O 0 4.608811388084888e-10
localized O 0 1.7783147399086374e-08
1 O 0 1.7954064901459788e-08
, O 0 2.2751434070045207e-10
159 O 0 5.916795497995508e-09
- O 0 1.8185533079417837e-08
1 O 0 3.8138747271432294e-08
, O 0 7.605953089573347e-10
232 O 0 2.2116335429700484e-08
bp O 0 3.4975832363670634e-07
upstream O 0 3.235744117091599e-08
of O 0 1.7094645698989552e-08
the O 0 3.462631781303571e-08
CTG O 0 8.574118510296103e-06
repeat O 0 3.4635959877959976e-08
, O 0 3.210529342378976e-10
whereas O 0 7.113624689303322e-10
most O 0 4.214208981778711e-10
, O 0 5.334038419291254e-11
if O 0 2.1295588556458078e-11
not O 0 2.816905389502189e-11
all O 0 5.5316046881914716e-11
, O 0 3.72589008257318e-11
of O 0 2.3188576059318677e-10
the O 0 3.841496842849068e-10
other O 0 4.244368051464775e-11
sites O 0 4.0082467900326435e-10
of O 0 2.2540058708386823e-09
SacII O 0 5.629873953694187e-07
, O 0 5.708309935847922e-10
HhaI O 0 1.7567406302987365e-06
, O 0 2.538416810082822e-09
and O 0 4.433410971671492e-09
HpaII O 0 7.178699434007285e-06
in O 0 1.9685906238464668e-09
this O 0 5.813572956370194e-10
region O 0 5.840360639552955e-09
are O 0 3.96930183166333e-10
unmethylated O 0 8.078206406025856e-07
, O 0 2.8565552701032004e-10
in O 0 8.84858783467557e-11
normal O 0 3.9577430221982013e-10
individuals O 0 2.867721685118063e-12
and O 0 9.663449901387011e-11
most O 0 2.0520636578869045e-10
of O 0 7.267864532423118e-09
the O 0 2.9413216751095206e-08
patients O 0 5.1656869004546024e-08
. O 0 2.4344151938748837e-07

In O 0 1.2815102934382594e-07
a O 0 2.7486555254085943e-08
number O 0 1.0607926759220732e-09
of O 0 2.0535576794600274e-08
young O 0 8.492603065235471e-09
and O 0 7.725114770096297e-09
severely O 0 2.1478372218552977e-05
affected O 0 1.1358876506051274e-08
patients O 0 6.718599454558216e-09
, O 0 9.810011830646559e-11
however O 0 3.0195185241055356e-10
, O 0 6.300660687630355e-11
complete O 0 1.5678605080893249e-09
methylation O 0 3.408205717647661e-09
of O 0 1.416570971635167e-09
these O 0 8.208962676281573e-11
restriction O 0 4.177085621837051e-10
sites O 0 3.404662940464931e-10
was O 0 2.6959223742295535e-09
found O 0 1.9067998568988997e-10
in O 0 1.4053667951596793e-10
the O 0 3.3777181052130345e-09
mutated O 0 5.268917391276773e-08
allele O 0 2.0576986514697637e-07
. O 0 1.503474749142697e-07

In O 0 7.392662126903815e-08
most O 0 2.3342390242930833e-09
of O 0 1.7442008948265197e-09
these O 0 6.40576827692918e-11
patients O 0 3.9367004101009684e-10
, O 0 9.654325082431026e-12
the O 0 1.8205503771184794e-10
onset O 0 0.0003477924328763038
of O 0 4.441704106739053e-07
the O 0 3.075153642839723e-07
disease O 1 0.5175775289535522
was O 0 0.000528601580299437
congenital O 1 1.0
. O 0 4.002157766080927e-06

Preliminary O 0 4.1819471334747504e-06
in O 0 5.469263442137162e-07
vivo O 0 1.0508506420592312e-05
footprinting O 0 6.857958214823157e-05
data O 0 4.304804690491437e-08
gave O 0 6.556832410353763e-09
evidence O 0 1.0679880979580503e-08
for O 0 1.4055256958300788e-09
protein O 0 3.359515998724305e-09
- O 0 5.822764936880276e-09
DNA O 0 3.018162786361245e-08
contact O 0 1.0712278175617485e-08
in O 0 1.1792223864048879e-09
normal O 0 1.3125005970948678e-08
genes O 0 2.00652161552739e-09
at O 0 2.957837974548738e-09
an O 0 1.4387874225363362e-10
Sp1 O 0 6.229022346815327e-07
consensus O 0 1.1768281638069311e-07
binding O 0 4.72410803808998e-08
site O 0 1.941716334386001e-07
upstream O 0 3.616328569933103e-08
of O 0 3.3134488486297187e-09
the O 0 4.235282791142936e-09
CTG O 0 1.9438728031673236e-06
repeat O 0 1.1568382696225399e-08
and O 0 5.102238076482024e-10
for O 0 6.223325327292528e-11
a O 0 4.940636788575148e-11
significant O 0 5.145912862491997e-11
reduction O 0 8.660282491135263e-10
of O 0 7.468763385531929e-10
this O 0 1.9206842713503924e-11
interaction O 0 7.501052556868615e-11
in O 0 2.2859906675942732e-11
cells O 0 5.257475357844932e-11
with O 0 6.963429138862054e-11
a O 0 1.0451760346086303e-08
hypermethylated O 0 3.3743217500159517e-06
DMPK O 0 3.295714486739598e-05
gene O 0 1.796776949447576e-08
. O 0 8.944742724281696e-09
. O 0 3.4209268306995e-08

The O 0 6.109065725468099e-05
hemochromatosis B-Disease 1 1.0
gene O 0 4.973016132225894e-08
product O 0 3.115078861526399e-09
complexes O 0 3.8626288834109346e-09
with O 0 1.7348503189573705e-10
the O 0 5.23758281190112e-09
transferrin O 0 1.4318948160507716e-05
receptor O 0 3.640946388827615e-08
and O 0 2.256311359971619e-09
lowers O 0 2.0343611240036807e-08
its O 0 2.0744833628683068e-10
affinity O 0 7.116746081337055e-10
for O 0 1.0746278866768932e-10
ligand O 0 2.6729242819101273e-08
binding O 0 7.230976706296133e-08
. O 0 1.1042232728186718e-07

We O 0 4.5845041540815146e-07
recently O 0 1.6548129622151464e-07
reported O 0 5.151446824669392e-09
the O 0 2.9181301819392047e-09
positional O 0 6.527922664645303e-07
cloning O 0 3.958033545359285e-08
of O 0 2.705833779259592e-09
a O 0 2.1329349397802844e-09
candidate O 0 1.0855266907583427e-08
gene O 0 2.5107453893724596e-08
for O 0 1.124961030996019e-07
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 1 0.9999908208847046
HFE O 1 0.9999961853027344
. O 0 2.908948545154999e-06

The O 0 3.361524534284399e-07
gene O 0 3.913837254287955e-09
product O 0 5.680985015743545e-09
, O 0 2.600308302014298e-10
a O 0 1.6162882143788693e-09
member O 0 3.1039937287147268e-09
of O 0 4.1872041833812546e-08
the O 0 1.0099869030000264e-07
major O 0 2.4003946919037844e-07
histocompatibility O 0 0.0009490533266216516
complex O 0 2.919520738942083e-06
class O 0 1.3198762083277416e-08
I O 0 6.176423283932309e-08
- O 0 8.228001391330508e-09
like O 0 2.0594077831948e-10
family O 0 6.883159597848021e-10
, O 0 2.7801819874051503e-11
was O 0 9.055010630198979e-10
found O 0 7.250715305939792e-11
to O 0 2.0369839148770552e-10
have O 0 5.146769677111251e-10
a O 0 1.194097620782486e-08
mutation O 0 4.4172052682256435e-09
, O 0 2.070882798577145e-09
Cys O 0 7.747790732537396e-06
- O 0 8.208182293856225e-07
282 O 0 5.898510266888479e-07
- O 0 5.495447226167016e-07
- O 0 5.360155910238973e-07
> O 0 4.812654310626385e-07
Tyr O 0 1.8642641634869506e-06
( O 0 7.825494696689361e-10
C282Y O 0 7.338571528237026e-09
) O 0 2.1496778315754916e-11
, O 0 6.3947536502184654e-12
in O 0 2.3726333397977584e-11
85 O 0 1.868166066287813e-09
% O 0 3.2037514308136394e-10
of O 0 4.446876644692566e-09
patient O 0 4.9537320023773646e-08
chromosomes O 0 2.573626645130389e-08
. O 0 1.2918988545607135e-07

This O 0 1.5801768427081697e-07
mutation O 0 8.206595225601632e-08
eliminates O 0 6.907772558406577e-07
the O 0 4.411448273344831e-08
ability O 0 3.204311127547044e-08
of O 0 2.4775224005679775e-07
HFE O 0 0.1371328979730606
to O 0 1.2666394866300834e-07
associate O 0 2.98176615842749e-07
with O 0 1.818309502965576e-09
beta2 O 0 1.1886509128089529e-05
- O 0 1.2206415931359516e-06
microglobulin O 0 2.0423432943061925e-05
( O 0 8.63346993895675e-09
beta2m O 0 2.766745183180319e-06
) O 0 1.6548192816046026e-09
and O 0 2.643395280443883e-09
prevents O 0 1.1443075820238846e-08
cell O 0 1.3914246892454685e-06
- O 0 1.059919867429926e-07
surface O 0 3.281084843820281e-07
expression O 0 1.7012798991800082e-07
. O 0 2.343520009162603e-07

A O 0 5.891662567591993e-06
second O 0 2.562858014698577e-07
mutation O 0 2.51674214801767e-09
that O 0 1.9715543086995524e-10
has O 0 1.6256243573486984e-10
no O 0 2.645260122058346e-10
effect O 0 5.844060790849426e-09
on O 0 5.829990712413746e-08
beta2m O 0 3.2507316518604057e-06
association O 0 3.692043781811094e-09
, O 0 1.081285838644419e-09
H63D O 0 6.415714597096667e-05
, O 0 1.6725448803711629e-09
was O 0 1.1267643706958097e-08
found O 0 2.597621562294705e-10
in O 0 1.4917539425951531e-10
eight O 0 6.317655287801927e-10
out O 0 2.461438830536622e-10
of O 0 4.737884751193633e-09
nine O 0 7.47349826468735e-09
patients O 0 1.1737022465041491e-09
heterozygous O 0 3.209874033238691e-10
for O 0 8.890412295237127e-10
the O 0 4.117415741689001e-08
C282Y O 0 7.3983214861073066e-06
mutant O 0 1.3656423334396095e-06
. O 0 4.411869269915769e-07

In O 0 8.436536091949165e-08
this O 0 3.6744456366477607e-09
report O 0 7.3541808198740455e-09
, O 0 1.169237928699829e-09
we O 0 8.850618016253975e-10
demonstrate O 0 1.1198546978619106e-08
in O 0 9.87776438421406e-09
cultured O 0 6.97310042596655e-07
293 O 0 1.2255435422048322e-07
cells O 0 3.095918899020944e-08
overexpressing O 0 4.299497959436849e-06
wild O 0 1.386128190006275e-07
- O 0 4.960918076335474e-08
type O 0 1.7571149157902255e-07
or O 0 1.6650582779220713e-07
mutant O 0 1.9061224065808346e-07
HFE O 0 3.018962843270856e-06
proteins O 0 1.1721938697473178e-10
that O 0 5.195252908429815e-11
both O 0 4.6441350765036304e-10
the O 0 8.264995798867858e-09
wild O 0 1.629776846812092e-08
- O 0 1.1479932560121142e-08
type O 0 5.147599324573093e-08
and O 0 5.998075636171052e-08
H63D O 0 0.00012555786815937608
HFE O 0 1.21642788144527e-05
proteins O 0 1.402718219356558e-10
form O 0 2.4405141796357555e-10
stable O 0 5.017144033558907e-09
complexes O 0 1.9748822577270175e-09
with O 0 8.019200581355079e-11
the O 0 5.497908794893647e-09
transferrin O 0 2.7602088721323526e-06
receptor O 0 3.2575538710943874e-08
( O 0 7.156602532809586e-10
TfR O 0 6.525059461637284e-07
) O 0 1.8155786873919055e-09
. O 0 1.6984762041261092e-08

The O 0 4.891393928119214e-06
C282Y O 0 2.4160028260666877e-05
mutation O 0 8.99123762110321e-08
nearly O 0 1.4596209796380322e-09
completely O 0 5.210470277461354e-09
prevents O 0 2.5228503730545526e-09
the O 0 2.630118123292391e-09
association O 0 5.689852478063528e-10
of O 0 7.542061197796102e-09
the O 0 1.275435579373152e-08
mutant O 0 9.843368786732754e-08
HFE O 0 9.851792128756642e-06
protein O 0 6.62378019100629e-09
with O 0 3.616897337188618e-10
the O 0 2.6456211443814937e-08
TfR O 0 9.120714821619913e-05
. O 0 5.212009455135558e-07

Studies O 0 2.885334708935261e-07
on O 0 1.4967037031965447e-07
cell O 0 1.9031635645205824e-07
- O 0 8.262004769221676e-08
associated O 0 5.081343701363039e-08
transferrin O 0 0.00014170940266922116
at O 0 4.781992402058677e-08
37 O 0 3.062219144922551e-09
degrees O 0 4.0471068274428035e-08
C O 0 7.047497518897217e-08
suggest O 0 5.733538088747991e-10
that O 0 1.444162567310059e-10
the O 0 1.3991337866059439e-08
overexpressed O 0 2.3388940917357104e-06
wild O 0 2.8094200388295576e-07
- O 0 6.357066695272806e-08
type O 0 1.2220469614021567e-07
HFE O 0 0.0001747786591295153
protein O 0 9.87057013901449e-09
decreases O 0 6.765094595628796e-10
the O 0 1.0609823436480426e-10
affinity O 0 2.234136209366966e-10
of O 0 2.972049051308545e-09
the O 0 4.371709216854924e-09
TfR O 0 1.2394571058393922e-06
for O 0 6.078809011711428e-09
transferrin O 0 1.29565914903651e-05
. O 0 2.042209246155835e-07

The O 0 5.3138075600145385e-05
overexpressed O 0 0.001038119662553072
H63D O 0 0.011879000812768936
protein O 0 1.507004583345406e-07
does O 0 1.1812573141867233e-09
not O 0 1.7668819185523432e-10
have O 0 3.599573070167672e-11
this O 0 3.6865725749901657e-11
effect O 0 3.3625016659932783e-10
, O 0 1.3729286804653462e-11
providing O 0 1.597195015135e-10
the O 0 9.533795281013724e-11
first O 0 3.3767873913737034e-11
direct O 0 4.4947101596193306e-11
evidence O 0 1.9681463403475874e-10
for O 0 6.161977178509304e-11
a O 0 3.113942714794149e-10
functional O 0 4.825455590662386e-09
consequence O 0 1.661620174786549e-08
of O 0 2.9054689321128535e-08
the O 0 5.517766865636986e-08
H63D O 0 8.959171827882528e-05
mutation O 0 1.4146039006845967e-07
. O 0 1.0102258585220625e-07

Addition O 0 4.868460337092984e-07
of O 0 1.4231301292966236e-06
soluble O 0 1.3959443094790913e-05
wild O 0 1.6416656762885395e-06
- O 0 2.656465198924707e-07
type O 0 3.2461218779644696e-06
HFE O 1 1.0
/ O 1 0.9986318945884705
beta2m O 0 3.38212339556776e-05
heterodimers O 0 5.387262262956938e-06
to O 0 1.5192494373650334e-08
cultured O 0 1.3852267954916897e-07
cells O 0 3.950745952607804e-09
also O 0 1.9399258588403967e-10
decreased O 0 2.7550248193897175e-10
the O 0 7.938653068251256e-10
apparent O 0 8.718077815217384e-09
affinity O 0 7.695907022764459e-09
of O 0 2.1967968777403257e-08
the O 0 8.037599030785714e-09
TfR O 0 1.0327633503948164e-07
for O 0 1.661346060721769e-10
its O 0 5.3621718176799504e-11
ligand O 0 6.063084256879847e-09
under O 0 1.8316489658332102e-08
steady O 0 3.9825771125379106e-08
- O 0 4.696264710446485e-09
state O 0 8.169788456857674e-11
conditions O 0 4.4652432862335445e-09
, O 0 8.690741876149488e-11
both O 0 4.305233600176983e-11
in O 0 1.2296347273732522e-10
293 O 0 6.456135070997959e-10
cells O 0 3.035942608420328e-10
and O 0 9.007296020158151e-10
in O 0 1.8534158652272481e-09
HeLa O 0 1.8647193428478204e-05
cells O 0 1.7272638785925665e-07
. O 0 3.3575389579709736e-07

Furthermore O 0 8.167663736458053e-07
, O 0 1.5307563216993003e-08
at O 0 1.4410272086706755e-08
4 O 0 5.118997226105648e-09
degrees O 0 4.79051855961643e-08
C O 0 2.5012175797201053e-07
, O 0 5.337073560873762e-10
the O 0 3.792821168246974e-09
added O 0 1.2536300886267782e-08
soluble O 0 1.676585128507213e-07
complex O 0 4.1134603634418454e-07
of O 0 2.325005397096902e-07
HFE O 1 0.571049690246582
/ O 0 1.9671162590384483e-05
beta2m O 0 2.8465806281019468e-06
inhibited O 0 1.4452441021717277e-08
binding O 0 3.930542558094885e-09
of O 0 1.0634733982328726e-08
transferrin O 0 4.087348770553945e-06
to O 0 4.0516948018876064e-08
HeLa O 0 3.651654697023332e-05
cell O 0 6.486851589215803e-07
TfR O 0 1.8402480463919346e-06
in O 0 1.5024226307502886e-09
a O 0 6.152505616086046e-09
concentration O 0 3.1375614639728155e-07
- O 0 6.491295323485247e-08
dependent O 0 4.857204771724355e-08
manner O 0 6.436812327592634e-08
. O 0 1.3240094176580897e-07

Scatchard O 0 0.0007739654392935336
plots O 0 5.180253538128454e-06
of O 0 3.6965380445508345e-07
these O 0 1.3816013888501288e-09
data O 0 4.258863928185974e-09
indicate O 0 1.3412949639857175e-09
that O 0 2.5552379656623714e-10
the O 0 1.0880556011727549e-08
added O 0 9.787781252157401e-09
heterodimer O 0 1.5562439159566566e-07
substantially O 0 1.373637825707874e-08
reduced O 0 3.968214201677256e-09
the O 0 8.46615666461048e-10
affinity O 0 2.0186290417001373e-09
of O 0 8.679220897533924e-09
TfR O 0 1.434866476301977e-06
for O 0 8.712508936525865e-09
transferrin O 0 1.9475228327792138e-05
. O 0 3.593706594529067e-07

These O 0 5.435434857758992e-08
results O 0 2.332989623710091e-08
establish O 0 3.1720396975742915e-08
a O 0 5.579654516196797e-09
molecular O 0 3.8569332616589236e-08
link O 0 5.872914954352382e-08
between O 0 3.08170839957711e-08
HFE O 1 0.9999959468841553
and O 0 6.235155751710408e-07
a O 0 7.963122072851547e-08
key O 0 3.692334757943172e-07
protein O 0 2.743981930564132e-09
involved O 0 2.4094143347141994e-10
in O 0 3.9158890019486137e-10
iron O 0 1.4025963537278585e-05
transport O 0 1.2502290758220624e-07
, O 0 5.378225087504518e-10
the O 0 1.7936087060022032e-09
TfR O 0 8.499034265696537e-06
, O 0 8.137228113547224e-10
and O 0 6.445848854674807e-10
raise O 0 9.69744728962496e-10
the O 0 1.2762841894442545e-09
possibility O 0 2.7928339640936883e-09
that O 0 8.85578069209636e-11
alterations O 0 2.7682380832061426e-08
in O 0 2.280809152654939e-10
this O 0 5.824802445930644e-11
regulatory O 0 2.909033014475426e-09
mechanism O 0 4.887777738105115e-09
may O 0 8.433616582870229e-10
play O 0 3.3267983923224165e-09
a O 0 1.2634111534737258e-09
role O 0 4.074422577104997e-09
in O 0 4.61114146865782e-10
the O 0 3.200107290268761e-09
pathogenesis O 1 0.9994681477546692
of O 0 0.09854047000408173
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 1.516926749900449e-05
. O 0 1.2682519923146174e-07

Genomic O 0 2.846113829946262e-06
organization O 0 5.93978661811434e-08
of O 0 4.098638726190984e-07
the O 0 6.245761028367269e-07
UBE3A O 1 0.9982849955558777
/ O 0 0.11054281890392303
E6 O 0 0.006725788582116365
- O 0 3.2376076433138223e-06
AP O 0 5.5711243476253e-06
gene O 0 8.047370769759254e-09
and O 0 8.503540649407171e-10
related O 0 3.484774069306695e-08
pseudogenes O 0 3.480490340734832e-05
. O 0 8.47576814066997e-07

The O 0 1.8157261365558952e-05
UBE3A O 0 0.00042245673830620944
gene O 0 2.485390950823785e-07
encodes O 0 1.7101110927342233e-07
the O 0 9.784592691630678e-08
E6 O 0 1.4799291420786176e-05
- O 0 8.822805739328032e-07
AP O 0 1.5040231119201053e-05
ubiquitin O 0 2.1868947897019098e-06
- O 0 1.303523475826296e-07
protein O 0 1.3531407105915605e-09
ligase O 0 6.868225543854578e-09
and O 0 1.2865886134250104e-09
has O 0 2.4718219138186726e-10
recently O 0 7.348596731127088e-10
been O 0 9.92928447796082e-11
shown O 0 4.277282000808569e-11
to O 0 3.29168844959149e-11
be O 0 9.416973451026323e-11
mutated O 0 1.2964804341208946e-07
in O 0 3.930323146050796e-06
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.7865720391273499
who O 0 4.479876025698104e-08
lack O 0 1.019073351926636e-06
15q11 O 0 5.567348125623539e-06
- O 0 3.307345366465597e-07
q13 O 0 4.919046432405594e-07
deletions O 0 5.3286168366639686e-08
or O 0 3.192571984556025e-09
chromosome O 0 2.1511084469238995e-08
15 O 0 3.770577805539688e-08
paternal O 0 1.3635753020935226e-05
uniparental B-Disease 1 0.9998788833618164
disomy I-Disease 1 0.5975872278213501
. O 0 1.0651079719536938e-05

Previous O 0 1.788243025657721e-05
UBE3A O 0 0.0004443288780748844
cDNA O 0 1.7570523596077692e-06
analysis O 0 9.789199673093663e-09
has O 0 3.787296032342624e-10
shown O 0 2.0781744380915512e-10
a O 0 1.2425409590122172e-09
coding O 0 9.108960341563943e-08
region O 0 3.961825356668669e-08
of O 0 4.308714807166325e-08
approximately O 0 7.654668010559362e-09
2 O 0 1.2312628427935124e-07
. O 0 5.409743408790746e-08

6 O 0 3.2269021176034585e-05
kb O 0 3.8749538362026215e-05
and O 0 1.3565609435772785e-07
a O 0 3.529580112626718e-07
3 O 0 2.1171424577914877e-06
- O 0 1.345056034551817e-06
untranslated O 1 0.9999997615814209
region O 0 2.478392389093642e-06
( O 0 1.4561376104893498e-08
UTR O 1 0.955305814743042
) O 0 4.5804022796858135e-09
of O 0 1.1347919048887434e-08
< O 0 2.0793784472061816e-07
50 O 0 7.1768231357793866e-09
bp O 0 2.886275041191766e-08
, O 0 6.08210842800716e-11
whereas O 0 7.024207882011524e-10
Northern O 0 6.876851088577496e-09
analysis O 0 6.484309200693872e-10
has O 0 7.190106149357334e-11
indicated O 0 1.1181397474580024e-10
mRNA O 0 6.020615672674978e-10
sizes O 0 1.0617561274628429e-09
of O 0 1.8382884547918366e-08
5 O 0 1.1272000932649462e-07
- O 0 3.02179785194312e-07
8 O 0 5.724757556890836e-07
kb O 0 2.341859544685576e-05
. O 0 9.70727910498681e-07

We O 0 6.421753937502217e-07
have O 0 8.080994540193842e-09
analyzed O 0 1.920262171495324e-08
additional O 0 6.332497637373535e-09
cDNA O 0 4.1277488094237924e-07
clones O 0 3.128866126189678e-07
and O 0 6.1220667424422e-10
provide O 0 1.4962248107153187e-10
evidence O 0 1.4870135123246087e-09
for O 0 6.90103391098873e-11
an O 0 3.122374581110421e-11
additional O 0 1.0880425449499853e-09
0 O 0 3.6571073280811106e-08
. O 0 4.1143696449807976e-08

5 O 0 1.0122186722583137e-05
kb O 0 2.3751312255626544e-05
of O 0 1.3918999002271448e-06
5 O 0 8.856171120896761e-07
- O 0 4.6466468006656214e-07
UTR O 1 0.9742628931999207
and O 0 1.8611416408020887e-07
> O 0 9.091062906918523e-07
2 O 0 2.5771197442736593e-07
kb O 0 6.232266969163902e-07
of O 0 2.5126047376033966e-07
3 O 0 4.42124655819498e-06
- O 0 4.916705620416906e-06
UTR O 1 0.9999996423721313
. O 0 3.7605263969453517e-06

We O 0 2.9294866976670164e-07
have O 0 2.3791930647831805e-09
established O 0 6.991890622032315e-09
the O 0 1.0391247862173714e-09
genomic O 0 2.849308788910321e-09
organization O 0 1.8361524800614148e-10
of O 0 4.790077223759681e-09
UBE3A O 0 1.8466103938408196e-05
and O 0 8.26635115913632e-09
the O 0 3.4340454924119967e-09
sequence O 0 8.282208252552437e-10
of O 0 4.779144635591592e-09
intron O 0 1.1826871286757523e-06
- O 0 7.099872618709924e-07
exon O 0 1.1653244200715562e-06
borders O 0 3.7546314501923916e-08
. O 0 8.634280135311201e-08

We O 0 1.5773538279972854e-06
have O 0 2.652153874294072e-08
also O 0 9.449910187697697e-09
mapped O 0 7.340253915799622e-08
two O 0 4.318519764012763e-09
highly O 0 1.7681514918876928e-08
homologous O 0 5.032432781604257e-08
processed O 0 1.911353990635689e-07
pseudogenes O 0 1.3838948689226527e-06
, O 0 1.0459019428310512e-08
UBE3AP1 O 0 7.018081669230014e-05
and O 0 4.7604878261608974e-08
UBE3AP2 O 0 0.0002234615240013227
, O 0 1.6676201530785306e-09
to O 0 4.0988096250416106e-10
chromosomes O 0 1.3673505661060403e-09
2 O 0 7.639324728359043e-09
and O 0 4.955475474410775e-10
21 O 0 4.086618599075109e-09
, O 0 1.3869738690885924e-10
respectively O 0 6.621098669334913e-10
, O 0 1.5548902443374146e-10
and O 0 3.12780051858752e-10
determined O 0 5.2692765706296996e-09
their O 0 2.0985055915190287e-09
genomic O 0 7.196784679308621e-08
organization O 0 5.102299027726076e-09
. O 0 4.9238707333643106e-08

These O 0 3.467158649073099e-08
results O 0 2.140988941690125e-09
will O 0 1.8644381871713023e-10
form O 0 1.8792331579753352e-10
the O 0 6.092282234249069e-10
basis O 0 2.5615179422011636e-10
for O 0 1.301182425694769e-11
studies O 0 2.498240329884549e-11
of O 0 1.313253117363189e-10
mutation O 0 1.1244317282832483e-10
and O 0 1.1118962417455691e-09
imprinting O 0 5.595557581727917e-07
of O 0 1.879041633401357e-06
UBE3A O 0 0.33922427892684937
. O 0 2.5050874228327302e-06

Mutation O 0 2.7625133043329697e-06
spectrum O 0 3.6732603803102393e-06
and O 0 3.2973989760876066e-08
genotype O 0 3.175979827574338e-06
- O 0 1.8291481751475658e-07
phenotype O 0 6.396241758466203e-08
analyses O 0 3.2814611028442187e-09
in O 0 6.062086388425314e-10
Cowden B-Disease 1 0.5746209025382996
disease I-Disease 0 4.2807147110579535e-05
and O 0 2.4087051997412345e-07
Bannayan B-Disease 1 1.0
- I-Disease 1 1.0
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 1.23692576181611e-08
two O 0 1.67557896446624e-08
hamartoma B-Disease 1 0.9998995065689087
syndromes I-Disease 1 0.9966462254524231
with O 0 9.074432227862417e-07
germline O 1 0.9983443021774292
PTEN O 1 0.9999978542327881
mutation O 0 5.888061878067674e-06
. O 0 5.942624170529598e-07

The O 0 4.8542166041443124e-05
tumour B-Disease 1 1.0
suppressor O 0 0.0005117957480251789
gene O 0 6.453974492615089e-07
PTEN O 0 0.0003961767361033708
, O 0 4.990154511830269e-09
which O 0 7.089934195292358e-10
maps O 0 2.1362582813821973e-08
to O 0 2.1647238668265345e-08
10q23 O 0 2.4098519133985974e-05
. O 0 1.036721982927702e-06

3 O 0 1.1360368716850644e-06
and O 0 7.033327698025005e-09
encodes O 0 2.6622635207473877e-09
a O 0 1.3872073489906711e-09
403 O 0 6.080347891845861e-10
amino O 0 1.645050207166321e-10
acid O 0 4.407844089726609e-10
dual O 0 8.678839868991872e-09
specificity O 0 8.974190279786853e-08
phosphatase O 0 4.979649474989856e-06
( O 0 2.2960477963351877e-09
protein O 0 6.230350901859083e-09
tyrosine O 0 1.2380231950714915e-08
phosphatase O 0 6.208289704545678e-08
; O 0 1.2482413713765794e-10
PTPase O 0 8.078993829485626e-08
) O 0 5.414751980126198e-11
, O 0 5.007884038010779e-11
was O 0 2.334559656702595e-09
shown O 0 5.66516222821889e-10
recently O 0 6.202735214344557e-09
to O 0 9.325819005923108e-10
play O 0 6.897711735120993e-09
a O 0 1.0164004748958178e-08
broad O 0 1.1184868498048672e-07
role O 0 2.5611688769799912e-08
in O 0 4.957642740777146e-09
human O 0 2.9747049268280534e-08
malignancy B-Disease 0 0.0013019144535064697
. O 0 3.835358484138851e-07

Somatic O 0 0.0011131977662444115
PTEN O 0 0.0019244782160967588
deletions O 0 2.4854552975739352e-06
and O 0 1.4262694136846221e-08
mutations O 0 1.207582922546635e-09
were O 0 5.122833268700333e-10
observed O 0 7.517269584589314e-10
in O 0 5.406921577133517e-10
sporadic B-Disease 0 9.596678864909336e-06
breast I-Disease 1 0.9999960660934448
, I-Disease 0 6.198149549163645e-08
brain I-Disease 1 0.7441540956497192
, I-Disease 0 6.545276676206413e-08
prostate I-Disease 1 1.0
and I-Disease 0 0.019922619685530663
kidney I-Disease 1 1.0
cancer I-Disease 1 0.9991783499717712
cell O 0 1.0515032954572234e-05
lines O 0 1.5985985868383068e-08
and O 0 9.997666028382923e-10
in O 0 2.1347326684129087e-10
several O 0 1.0305232223117855e-09
primary O 0 4.5647846036445117e-07
tumours B-Disease 1 0.999998927116394
such O 0 2.7915452172067035e-09
as O 0 6.312289428933582e-07
endometrial B-Disease 1 0.9999998807907104
carcinomas I-Disease 1 1.0
, O 0 0.05076594278216362
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 1.0
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 0 0.0002329409762751311

In O 0 8.370115978095782e-08
addition O 0 2.172885338325159e-08
, O 0 7.794098699775986e-09
PTEN O 0 0.00040022251778282225
was O 0 1.9804816986379592e-07
identified O 0 1.923362358269287e-09
as O 0 1.91359122991841e-10
the O 0 4.034786671436308e-10
susceptibility O 0 1.7117256945198278e-08
gene O 0 7.110640964924642e-10
for O 0 6.708378297304307e-10
two O 0 2.4609484228221845e-08
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
Cowden B-Disease 1 1.0
disease I-Disease 1 0.9992826581001282
( O 0 9.18348153078341e-09
CD B-Disease 0 7.796778845658991e-06
; O 0 1.8781302912884712e-07
MIM O 0 0.006877257488667965
158350 O 0 1.87616785751743e-06
) O 0 9.928191602170955e-10
and O 0 4.712990442357068e-09
Bannayan B-Disease 0 0.00011712455307133496
- I-Disease 0 2.459354800521396e-05
Zonana I-Disease 0 0.014511434361338615
( I-Disease 0 1.331960248762698e-07
BZS I-Disease 0 0.0007090687286108732
) I-Disease 0 1.2596798271147236e-08
or I-Disease 0 3.0811559526000565e-08
Ruvalcaba I-Disease 0 7.308786734938622e-05
- I-Disease 0 5.184582732908893e-06
Riley I-Disease 0 0.0001166743240901269
- I-Disease 0 0.4976188540458679
Smith I-Disease 1 0.9886553287506104
syndrome I-Disease 1 1.0
( O 0 4.651284655210475e-07
MIM O 1 0.9994708895683289
153480 O 0 5.405132833402604e-05
) O 0 2.6549578535650653e-08
. O 0 1.7040858324435249e-07

Constitutive O 0 1.1963614269916434e-05
DNA O 0 1.364067429676652e-06
from O 0 1.1940365141072107e-07
37 O 0 1.710810977328947e-07
CD B-Disease 0 1.105525257116824e-06
families O 0 1.9117399219226172e-08
and O 0 2.1873603373023798e-08
seven O 0 4.3204003929986357e-08
BZS B-Disease 0 0.0011171427322551608
families O 0 9.665154898641504e-09
was O 0 4.739089121130746e-08
screened O 0 4.4971180557240586e-08
for O 0 4.883416782064387e-09
germline O 0 1.5415760572068393e-05
PTEN O 0 0.003706115297973156
mutations O 0 1.297751168749528e-06
. O 0 6.443955840040871e-07

PTEN O 0 0.0010957259219139814
mutations O 0 2.1900429203469685e-07
were O 0 3.3643718921894106e-08
identified O 0 9.194839556414536e-09
in O 0 1.7484511616316922e-09
30 O 0 5.769325017723759e-09
of O 0 3.594631436953932e-08
37 O 0 3.5347806459640196e-08
( O 0 1.5622723115171766e-09
81 O 0 4.620152083134599e-08
% O 0 8.891564706736688e-10
) O 0 1.4217185761999929e-10
CD B-Disease 0 8.423464237239386e-08
families O 0 8.264046114092594e-10
, O 0 1.25367660697151e-10
including O 0 1.4366675904486925e-10
missense O 0 9.583744997598842e-08
and O 0 7.941656221532867e-09
nonsense O 0 1.403280833756071e-07
point O 0 2.4864025505166865e-08
mutations O 0 1.5629542104989014e-10
, O 0 5.7461580632578446e-11
deletions O 0 3.583560781450501e-09
, O 0 3.5740910231396583e-10
insertions O 0 2.679044008857545e-08
, O 0 5.523426160891631e-10
a O 0 8.489267067091077e-09
deletion O 0 3.2849831654857553e-07
/ O 0 1.1342854122631252e-06
insertion O 0 3.8484535025418154e-07
and O 0 8.50963246534775e-08
splice O 0 2.6800546038430184e-05
site O 0 5.662062108058308e-07
mutations O 0 2.3490775546974874e-08
. O 0 7.483386355033872e-08

These O 0 6.803688279433118e-08
mutations O 0 1.8283749625425116e-08
were O 0 5.83385917352075e-09
scattered O 0 7.594866957560953e-09
over O 0 1.819280948112123e-09
the O 0 2.5296782446559973e-09
entire O 0 3.186622077322454e-09
length O 0 8.509478677254378e-10
of O 0 4.317564528122375e-09
PTEN O 0 1.4916635109329945e-06
, O 0 1.7626541892745706e-10
with O 0 2.1800472885247224e-11
the O 0 7.573541238592441e-10
exception O 0 2.0043107173961516e-09
of O 0 4.921098195609375e-09
the O 0 3.028587380882186e-09
first O 0 2.603674387202659e-09
, O 0 2.2627531792718258e-10
fourth O 0 4.589525559595131e-08
and O 0 1.3782726071553952e-08
last O 0 3.147835343497718e-07
exons O 0 2.911599221988581e-05
. O 0 1.2775668665199191e-06

A O 0 6.32131050224416e-05
hot O 0 0.00010186569124925882
spot O 0 2.141677896361216e-06
for O 0 7.631314247191767e-09
PTEN O 0 5.952061655989382e-06
mutation O 0 7.602229956660267e-09
in O 0 1.4164358574930702e-09
CD B-Disease 0 5.394266509028967e-07
was O 0 1.3805122023313743e-07
identified O 0 6.12459283289013e-09
in O 0 1.4169654338758164e-09
exon O 0 4.9603695373434675e-08
5 O 0 1.436424423850724e-09
that O 0 3.536238316059759e-11
contains O 0 2.0663720734503954e-10
the O 0 3.7747782677399755e-09
PTPase O 0 9.066404800250893e-07
core O 0 1.2679677752203133e-07
motif O 0 7.466645080000944e-09
, O 0 5.846708533985279e-11
with O 0 5.973383593316228e-11
13 O 0 3.5895326710999598e-09
of O 0 8.978073395837782e-09
30 O 0 1.0548612650040923e-08
( O 0 5.240508027526403e-10
43 O 0 4.021788235775148e-09
% O 0 2.7186206064122587e-10
) O 0 1.5336888703476603e-10
CD B-Disease 0 5.937973668324048e-08
mutations O 0 6.177077183089352e-10
identified O 0 2.807842847118991e-09
in O 0 1.7565000565156197e-09
this O 0 4.277058263113531e-09
exon O 0 2.453693923598621e-06
. O 0 1.312003092834857e-07

Seven O 0 4.095245913049439e-06
of O 0 8.696978852640314e-07
30 O 0 1.1998490379028226e-07
( O 0 2.0587294091711783e-09
23 O 0 1.4026394268285003e-08
% O 0 1.0256249183271393e-09
) O 0 2.2722117243301199e-10
were O 0 8.485928071344517e-10
within O 0 2.4059025882650076e-09
the O 0 5.527454494114181e-09
core O 0 2.990280378867283e-08
motif O 0 4.326220270911563e-09
, O 0 3.835344888902803e-11
the O 0 4.0605724338504956e-10
majority O 0 7.378170296945541e-11
( O 0 7.41857061892226e-11
five O 0 4.442703149809546e-10
of O 0 2.9090772013518063e-09
seven O 0 8.702273901484148e-10
) O 0 3.8829685994334895e-11
of O 0 1.0958319807130579e-09
which O 0 3.5681652077457215e-10
were O 0 4.45489067857352e-09
missense O 0 1.3561016487528832e-07
mutations O 0 1.5878464099117195e-09
, O 0 1.908750379975288e-10
possibly O 0 4.092382432929753e-09
pointing O 0 2.9356890252074663e-08
to O 0 2.4059298997514134e-09
the O 0 8.930065575896151e-09
functional O 0 9.318483051856674e-08
significance O 0 5.144046255622925e-08
of O 0 1.1094796192878675e-08
this O 0 1.1461658289135812e-09
region O 0 3.5524276853493575e-08
. O 0 8.59233892924749e-08

Germline O 0 0.0021990991663187742
PTEN O 0 0.00046254292828962207
mutations O 0 5.703799388356856e-08
were O 0 6.548795727923107e-09
identified O 0 4.0394474432048355e-09
in O 0 8.982813382019117e-10
four O 0 1.09431541606142e-09
of O 0 2.501834650558976e-08
seven O 0 2.5730475528007446e-08
( O 0 2.6917912343549233e-09
57 O 0 2.3587445241446403e-07
% O 0 1.880321320868461e-08
) O 0 1.6954079029574132e-08
BZS B-Disease 1 0.9664224982261658
families O 0 1.369486852809132e-07
studied O 0 1.0244630175293423e-06
. O 0 4.251237442076672e-07

Interestingly O 0 1.4434899640036747e-06
, O 0 5.168640626607157e-09
none O 0 3.101449097542286e-09
of O 0 2.8737383583887777e-09
these O 0 2.64075317168988e-10
mutations O 0 7.557005021752161e-10
was O 0 5.280252679540354e-09
observed O 0 1.1763064966530123e-09
in O 0 8.876822610304202e-10
the O 0 2.199173998462811e-08
PTPase O 0 6.462473538704216e-05
core O 0 1.8760314560495317e-05
motif O 0 1.6400820186390774e-06
. O 0 1.4980831508637493e-07

It O 0 3.87204330820623e-08
is O 0 1.309209629596353e-09
also O 0 1.3988975255951885e-10
worthy O 0 9.077425922043858e-09
of O 0 3.8497871557297e-09
note O 0 1.230695878540189e-09
that O 0 9.373445769567113e-11
a O 0 3.656400959783923e-09
single O 0 6.959718579224727e-09
nonsense O 0 9.514371157592905e-08
point O 0 1.0712768450105159e-08
mutation O 0 1.6182244433338155e-10
, O 0 3.141394436245726e-11
R233X O 0 9.130038947091634e-09
, O 0 1.1443326147775323e-10
was O 0 2.6775561767777845e-09
observed O 0 5.128679703148009e-10
in O 0 1.724629189459037e-10
the O 0 8.124433348299931e-10
germline O 0 4.759014515798299e-09
DNA O 0 2.812720500955379e-09
from O 0 7.029474780040346e-10
two O 0 1.8356273445707671e-10
unrelated O 0 4.713206269713055e-09
CD B-Disease 0 1.631950112823688e-06
families O 0 7.623618181185066e-09
and O 0 2.2904153240688174e-08
one O 0 7.679429359086498e-08
BZS B-Disease 1 0.999767005443573
family O 0 2.696366436794051e-06
. O 0 6.333858664220315e-07

Genotype O 0 7.177062070695683e-05
- O 0 2.4265652882604627e-06
phenotype O 0 6.92230770482638e-08
studies O 0 4.862687474904703e-10
were O 0 1.9547828633559305e-10
not O 0 6.49326703516806e-11
performed O 0 1.4669614412099463e-09
on O 0 2.3335091636766947e-09
this O 0 1.4765667855076714e-10
small O 0 1.4257328651012813e-09
group O 0 3.2185185072641787e-10
of O 0 7.272859647855512e-08
BZS B-Disease 1 0.9999977350234985
families O 0 1.8982561869052006e-06
. O 0 1.3699548162549036e-06

However O 0 7.613448360643815e-07
, O 0 3.258206504597183e-08
genotype O 0 1.2842916703448282e-06
- O 0 1.5098096639576397e-07
phenotype O 0 4.852861934523389e-08
analysis O 0 2.642901231197925e-09
inthe O 0 9.359952457543841e-08
group O 0 1.8904172671696529e-10
of O 0 6.130670637816138e-09
CD B-Disease 0 1.3803537513012998e-05
families O 0 9.309402138057976e-09
revealed O 0 6.812827191282622e-09
two O 0 1.0140836087524363e-10
possible O 0 2.813040911320286e-10
associations O 0 8.685090840954146e-11
worthy O 0 3.741434895232487e-08
of O 0 1.1872210770036418e-08
follow O 0 6.306366095998328e-09
- O 0 1.0967026753405662e-07
up O 0 3.1750098106186897e-09
in O 0 5.997932706058862e-10
independent O 0 1.6772344624271796e-09
analyses O 0 2.6978836942248563e-08
. O 0 5.001610858812455e-08

The O 0 3.403736172913341e-06
first O 0 4.1539465200912673e-07
was O 0 2.91839967303531e-07
an O 0 4.4078271588254836e-10
association O 0 2.486850447791511e-10
noted O 0 6.500270877118908e-10
in O 0 3.3985511627143694e-10
the O 0 1.3887110350552234e-09
group O 0 1.1248049713863395e-10
of O 0 6.4548091316396494e-09
CD B-Disease 0 0.00528467632830143
families O 0 3.878770016285671e-08
with O 0 6.610933667161589e-08
breast B-Disease 1 0.9936435222625732
disease I-Disease 0 0.0009647121769376099
. O 0 9.476271429775807e-07

A O 0 3.5309976738062687e-06
correlation O 0 1.7307280586464913e-07
was O 0 8.807767670759858e-08
observed O 0 7.318173844694797e-10
between O 0 3.2033606323089714e-10
the O 0 6.179929346039614e-10
presence O 0 1.5615245763100916e-09
/ O 0 6.14181544733583e-07
absence O 0 1.65380484418165e-07
of O 0 9.81444259195996e-08
a O 0 2.3076529132026735e-08
PTEN O 0 2.2844176328362664e-06
mutation O 0 4.2290815294165895e-10
and O 0 1.717990749661169e-10
the O 0 3.0601970957278013e-10
type O 0 7.266339530076493e-09
of O 0 3.0705493259119976e-08
breast O 0 7.053588433336699e-07
involvement O 0 1.1422494594626187e-07
( O 0 1.2054157672025667e-08
unaffected O 0 5.277488980937051e-06
versus O 0 0.00015441108553204685
benign O 1 0.7069443464279175
versus O 0 0.015466623939573765
malignant O 1 0.572944164276123
) O 0 1.1821302159376046e-08
. O 0 4.782630824706757e-08

Specifically O 0 2.6012341436398856e-07
and O 0 1.2623158518465516e-08
more O 0 5.362028529520835e-11
directly O 0 3.4117356162433055e-10
, O 0 5.7457743424249585e-11
an O 0 2.0579303885992495e-11
association O 0 1.0370612008037128e-10
was O 0 7.950006875034887e-09
also O 0 1.7474999225441934e-10
observed O 0 8.047731231419775e-11
between O 0 7.382647271292342e-11
the O 0 3.118876268359827e-10
presence O 0 2.742191196336563e-10
of O 0 4.19262047302027e-09
a O 0 3.854888674936774e-08
PTEN O 0 0.45383286476135254
mutation O 0 4.6332482384059404e-07
and O 0 1.7718804201649618e-06
malignant B-Disease 1 1.0
breast I-Disease 1 0.9999996423721313
disease I-Disease 0 0.054060693830251694
. O 0 3.111123589860654e-07

Secondly O 0 0.00014420156367123127
, O 0 5.7786667895243227e-08
there O 0 5.129954239180279e-09
appeared O 0 2.1262257732246326e-08
to O 0 1.2991749898105809e-09
be O 0 9.874820960931174e-10
an O 0 5.022943727617246e-10
interdependent O 0 1.504330953139288e-07
association O 0 1.3440248913809683e-09
between O 0 6.0357154829659976e-09
mutations O 0 6.019436060711314e-09
upstream O 0 1.3857323288846146e-08
and O 0 7.969435666943525e-10
within O 0 3.019992478314748e-09
the O 0 1.3623244754512598e-08
PTPase O 0 2.802379412969458e-06
core O 0 2.5373637413395045e-07
motif O 0 9.992027649730062e-09
, O 0 8.427453179749023e-11
the O 0 2.106279733959937e-10
core O 0 9.955730462252177e-09
motif O 0 6.991739964767874e-10
containing O 0 4.016280363838831e-11
the O 0 2.432813117625443e-10
majority O 0 7.42716513291164e-11
of O 0 4.002961961901974e-09
missense O 0 8.473304546896543e-08
mutations O 0 5.092176125209846e-10
, O 0 5.833152710854606e-11
and O 0 1.749177330756524e-10
the O 0 4.736283032436006e-10
involvement O 0 3.386504632274523e-09
of O 0 2.4595063763399594e-09
all O 0 1.1602666050158916e-10
major O 0 2.87232415630001e-09
organ O 0 3.23872995977581e-07
systems O 0 0.3315151333808899
( O 0 6.251869422158052e-07
central O 0 0.06443404406309128
nervous O 0 0.00041694752871990204
system O 1 0.9946600794792175
, O 0 6.645610710620531e-07
thyroid O 1 1.0
, O 0 4.0383406485489104e-07
breast O 1 0.9999978542327881
, O 0 1.5268408048996207e-07
skin O 1 1.0
and O 0 0.0037593296729028225
gastrointestinal O 1 1.0
tract O 1 0.9476734399795532
) O 0 7.885525121764658e-08
. O 0 3.32683839587844e-07

However O 0 7.484270554414252e-07
, O 0 4.23352242151509e-09
these O 0 1.3581977209575768e-10
observations O 0 3.1415055001815517e-09
would O 0 1.5432137512316757e-10
need O 0 1.8996920703173714e-10
to O 0 1.6404380631662718e-10
be O 0 1.048013620330579e-10
confirmed O 0 2.3132031012895737e-10
by O 0 1.7344887678905074e-11
studying O 0 1.848698000239679e-10
a O 0 5.277971809602988e-11
larger O 0 5.379463541288487e-11
number O 0 2.0615368787058053e-11
of O 0 2.69886535342323e-09
CD B-Disease 0 2.8539989216369577e-06
families O 0 7.796867151910192e-08
. O 0 1.543208583143496e-07

Molecular O 0 0.000538409803994
defects O 1 0.9999469518661499
leading O 0 2.830147195709287e-06
to O 0 9.903307507386216e-09
human O 0 6.782671846394805e-08
complement B-Disease 0 0.004129824228584766
component I-Disease 1 1.0
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 2.9968351356046696e-08
an O 0 3.0760563540788155e-10
African O 0 7.935493151478568e-09
- O 0 2.86488468503876e-08
American O 0 2.935728105057933e-08
family O 0 7.56719416017404e-08
. O 0 6.128124141469016e-08

Complement B-Disease 0 0.00013039412442594767
component I-Disease 1 0.999998927116394
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 9.284492108463382e-08
C6D B-Disease 0 0.0018962755566462874
) O 0 8.7137053128572e-09
was O 0 3.230250342767249e-07
diagnosed O 0 5.209529945204849e-07
in O 0 8.597614176153456e-09
a O 0 3.4603143461708896e-08
16 O 0 4.826783595035522e-08
- O 0 9.365967557073418e-09
year O 0 3.960010097614486e-09
- O 0 5.763367028066568e-08
old O 0 6.019978400217951e-07
African O 0 5.895946131317942e-08
- O 0 2.4401954235031553e-08
American O 0 1.4156229521944397e-09
male O 0 3.225265887696338e-10
with O 0 3.2356914370090806e-10
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 3.849833319691243e-06

The O 0 8.444616241831682e-07
patients O 0 3.183010051088786e-07
father O 0 1.946072643477237e-06
and O 0 4.1958383434348434e-08
two O 0 1.6342188047246964e-08
brothers O 0 5.287206931825494e-06
also O 0 1.474429378589548e-08
had O 0 1.1870879035313919e-07
C6D B-Disease 1 0.9991194605827332
, O 0 1.820735340274382e-09
but O 0 3.018700844847899e-10
gave O 0 1.0242994230580393e-09
no O 0 2.4597632264367064e-10
history O 0 1.2088364753637393e-09
of O 0 3.991693198202029e-09
meningitis B-Disease 1 0.9999960660934448
or O 0 1.516999503792249e-08
other O 0 1.9224526415229093e-09
neisserial B-Disease 0 3.183747685397975e-05
infection I-Disease 0 0.00013685929297935218
. O 0 1.2386725529722753e-06

By O 0 6.681873543357142e-08
using O 0 7.682681513188072e-08
exon O 0 2.948470125829772e-07
- O 0 1.0138041517393503e-08
specific O 0 6.485014747426021e-10
polymerase O 0 9.847632043147314e-08
chain O 0 1.1856324810821661e-08
reaction O 0 2.1609112277332088e-09
( O 0 1.8326397344115009e-10
PCR O 0 3.4392321879295196e-08
) O 0 8.096356363118673e-10
/ O 0 1.880407474175172e-08
single O 0 8.199269707631629e-09
- O 0 1.1629664342649448e-08
strand O 0 7.319043149323079e-09
conformation O 0 1.3298311063447699e-10
polymorphism O 0 3.3452365877373325e-10
as O 0 2.548359440135428e-11
a O 0 5.800146821166585e-11
screening O 0 3.6472677655829955e-10
step O 0 7.899457199478377e-10
and O 0 6.139510427827233e-11
nucleotide O 0 2.531631848601279e-10
sequencing O 0 7.613602526213015e-10
of O 0 7.634455290173037e-10
target O 0 3.825733951856591e-09
exons O 0 7.36708614113013e-08
, O 0 4.178758727935161e-10
we O 0 8.312193988668781e-11
determined O 0 2.366912221773987e-10
that O 0 2.3021102385500924e-11
the O 0 8.183642097314703e-10
proband O 0 2.0281551371681417e-07
was O 0 1.4017943250621556e-08
a O 0 9.550452650941565e-10
compound O 0 9.815786405908966e-09
heterozygote O 0 1.7720752509831073e-07
for O 0 1.5658133678542185e-09
two O 0 4.907413586607845e-09
C6 O 0 6.760514224879444e-05
gene O 0 8.005091700624689e-08
mutations O 0 2.8026542864267867e-08
. O 0 8.372798987466012e-08

The O 0 2.107392674588482e-06
first O 0 1.2015621564387402e-07
, O 0 2.816822330942159e-09
1195delC O 0 5.473479518514068e-07
located O 0 3.77439164367388e-08
in O 0 1.4851370133683872e-09
exon O 0 9.919795473933846e-08
7 O 0 2.0620550600369825e-08
, O 0 8.827903685837413e-11
is O 0 8.022856684553048e-11
a O 0 3.046058127953444e-10
novel O 0 1.3004789467530031e-09
mutation O 0 1.6358606136357423e-10
, O 0 4.104393561132902e-11
while O 0 1.5315899937196065e-10
the O 0 1.877145772155586e-09
second O 0 1.6193315133250508e-08
, O 0 5.440044525961696e-10
1936delG O 0 1.0215726575779627e-07
in O 0 2.9579112492683635e-09
exon O 0 1.1920159437295297e-07
12 O 0 1.4383635615899948e-08
, O 0 2.449701552720285e-10
has O 0 1.5137521791608322e-10
been O 0 3.809029203161174e-10
described O 0 3.067995191230466e-09
before O 0 5.352378540379732e-09
to O 0 2.75411737860054e-09
cause O 0 3.151827741021407e-07
C6D B-Disease 1 0.999893307685852
in O 0 1.420310624666854e-08
an O 0 4.617724813638091e-10
unrelated O 0 8.887398372792177e-09
African O 0 9.734552719464773e-09
- O 0 5.231614963463471e-08
American O 0 1.7430243914873245e-08
individual O 0 1.2697285445284479e-09
. O 0 3.3180672431853964e-08

Both O 0 9.165636782881847e-08
mutations O 0 1.3307967172693225e-08
result O 0 8.063596013130336e-09
in O 0 6.556582388128618e-09
premature O 0 7.837527249421328e-08
termination O 0 2.9735076623182977e-06
codons O 0 5.111477889840899e-07
and O 0 1.9838350340251054e-07
C6 O 0 0.00017433607717975974
null O 0 6.9759930738655385e-06
alleles O 0 1.883795022195045e-07
. O 0 1.5138206777010055e-07

Allele O 0 1.1560638313312666e-06
- O 0 9.829916791659343e-08
specific O 0 1.0838668851320676e-09
PCR O 0 1.1094716256820902e-07
indicated O 0 8.30245738825397e-09
that O 0 1.1800227461833401e-10
the O 0 4.758524241310624e-09
probands O 0 2.837519787135534e-06
two O 0 8.221758385218436e-09
brothers O 0 4.433210563092871e-07
also O 0 2.6038828870866837e-09
inherited O 0 6.319378371699713e-07
the O 0 2.6623206750286954e-08
1195delC O 0 5.18797271809035e-08
mutation O 0 1.922547121502305e-10
from O 0 2.0095770880690367e-10
their O 0 4.444822288007799e-10
heterozygous O 0 7.687233072317667e-10
mother O 0 1.3851081392957099e-09
and O 0 2.429261236613911e-10
the O 0 1.7155423748249632e-09
1936delG O 0 2.345406358017499e-08
mutation O 0 4.235790052042887e-10
from O 0 3.996414588147701e-10
their O 0 7.374811317184538e-10
homozygous O 0 2.5465846320571472e-08
father O 0 2.5492826694062387e-07
. O 0 1.5798237384956337e-08
. O 0 1.982904507258354e-07

PAX6 O 0 0.12262727320194244
mutations O 0 1.2633953701879364e-05
reviewed O 0 9.560943908581976e-06
. O 0 2.7813798624265473e-06

Mutations O 0 1.435483909517643e-06
in O 0 7.768144172359825e-08
PAX6 O 0 0.001834325259551406
are O 0 4.1973251541094214e-09
responsible O 0 9.864114858260109e-09
for O 0 2.276034472004085e-09
human O 0 2.9192710826464463e-07
aniridia B-Disease 1 1.0
and O 0 1.0886150221267599e-06
have O 0 1.5920800233715227e-09
also O 0 3.072783971713733e-10
been O 0 1.471932714602886e-10
found O 0 7.825879527745272e-11
in O 0 2.221743448937996e-11
patients O 0 4.5146782146066045e-11
with O 0 5.7184413454480776e-11
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 4.603342418363354e-08
with O 0 2.5825029297266155e-06
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 0 0.00011173339589731768
with O 0 7.084937578838435e-07
autosomal B-Disease 1 0.9939242005348206
dominant I-Disease 1 0.9999991655349731
keratitis I-Disease 1 1.0
, O 0 7.793801160005387e-09
and O 0 3.842641760343213e-09
with O 0 1.5769336059179295e-08
isolated B-Disease 1 0.9999595880508423
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 0 0.0032387760002166033

No O 0 2.4642279186082305e-06
locus O 0 1.1063880265282933e-06
other O 0 2.818961508666007e-09
than O 0 9.264352618387761e-10
chromosome O 0 1.0672204453499035e-08
11p13 O 0 5.332439627636631e-07
has O 0 1.9699801789840876e-09
been O 0 1.7828409859532712e-09
implicated O 0 2.5130402647732808e-08
in O 0 1.1755354911713312e-08
aniridia B-Disease 1 1.0
, O 0 6.068637592449022e-09
and O 0 3.0307372167470703e-09
PAX6 O 1 0.7199292182922363
is O 0 3.2610458777782014e-09
clearly O 0 9.441005754950993e-10
the O 0 6.345092229409488e-10
major O 0 3.7028407007255737e-09
, O 0 2.4045604049560687e-11
if O 0 8.590813824205235e-12
not O 0 2.259534746806846e-11
only O 0 4.5375377066836364e-11
, O 0 5.114005399708965e-11
gene O 0 5.944233993915304e-10
responsible O 0 1.5121434771003806e-08
. O 0 1.2858760101153166e-07

Twenty O 0 9.688230420579202e-06
- O 0 3.4741208310151706e-06
eight O 0 5.19421021749622e-08
percent O 0 4.56980853158484e-09
of O 0 3.7099525673767175e-09
identified O 0 1.0554488838465659e-08
PAX6 O 0 4.639815415430348e-06
mutations O 0 9.612131091074616e-10
are O 0 3.302084716771958e-10
C O 0 3.162158918712521e-06
- O 0 6.6731186052493285e-06
T O 0 4.689393335866043e-06
changes O 0 3.771282663933562e-08
at O 0 2.8981020250284928e-08
CpG O 0 1.632410970842102e-07
dinucleotides O 0 9.294395653114407e-08
, O 0 1.2228916490553132e-10
20 O 0 2.1426668772583923e-10
% O 0 3.5845618140406543e-11
are O 0 3.3758904959685365e-12
splicing O 0 4.087351346271362e-09
errors O 0 2.624807393658557e-08
, O 0 2.19161772063714e-10
and O 0 2.715044855605697e-10
more O 0 1.4252936504643987e-11
than O 0 7.530267381872235e-11
30 O 0 9.34941790653454e-10
% O 0 2.1868992727824832e-10
are O 0 4.421761221062859e-11
deletion O 0 1.0534176198007117e-08
or O 0 2.5569892869725663e-09
insertion O 0 1.1728943860589425e-07
events O 0 6.917421746521768e-09
. O 0 4.9661249335031243e-08

There O 0 1.7191554491091665e-07
is O 0 1.0048312404364879e-08
a O 0 2.817586697290153e-08
noticeably O 0 3.438033672864549e-06
elevated O 0 1.6952588339336216e-05
level O 0 6.43934185973194e-08
of O 0 7.24632620574539e-09
mutation O 0 4.792725660784924e-10
in O 0 1.5256944319030907e-10
the O 0 1.6113815837215384e-09
paired O 0 9.295381131479985e-10
domain O 0 5.692783466848539e-10
compared O 0 1.0169017711225692e-10
with O 0 1.0441005698913486e-11
the O 0 8.299018139368286e-10
rest O 0 1.5647989570766185e-08
of O 0 1.0944789075040262e-08
the O 0 1.4207928167309092e-08
gene O 0 1.8805366153173964e-08
. O 0 3.5260736552800154e-08

Increased O 0 1.6611961939361208e-07
mutation O 0 2.4038303791940052e-08
in O 0 1.7958372566795333e-09
the O 0 9.893828867291177e-09
homeodomain O 0 2.5445610845054034e-06
is O 0 1.0487020141169978e-09
accounted O 0 1.6759488241646636e-09
for O 0 1.4082728039266357e-10
by O 0 6.02257965720554e-10
the O 0 4.967043665260462e-08
hypermutable O 0 4.4128260924480855e-05
CpG O 0 1.5271323718479834e-05
dinucleotide O 0 3.929483227693709e-06
in O 0 1.1072999406280815e-08
codon O 0 6.395497820221863e-08
240 O 0 9.558024061107062e-08
. O 0 6.122259321728052e-08

Very O 0 2.651823081123439e-07
nearly O 0 7.163448501046332e-09
all O 0 1.820036482635956e-10
mutations O 0 3.5657157781976423e-10
appear O 0 8.91705764782813e-10
to O 0 3.705912521301258e-10
cause O 0 2.3434728291249485e-07
loss O 0 2.426544369882322e-06
of O 0 5.334127877176797e-07
function O 0 5.1645314691484145e-09
of O 0 2.0686139023951e-08
the O 0 2.8934612483766387e-09
mutant O 0 9.060400762983534e-10
allele O 0 1.5656663465701826e-10
, O 0 2.2305924468613014e-11
and O 0 8.112753524525118e-11
more O 0 4.706327341730265e-12
than O 0 4.4071860744177016e-11
80 O 0 6.660592077878391e-10
% O 0 1.2015077821558862e-10
of O 0 1.867706433955618e-09
exonic O 0 1.5354984839177632e-07
substitutions O 0 7.03375713229093e-09
result O 0 2.3629620482523706e-09
in O 0 4.005681120133886e-09
nonsense O 0 2.9067282980577147e-07
codons O 0 3.110209831902466e-07
. O 0 2.544179835695104e-07

In O 0 7.077253627585378e-08
a O 0 7.2967836217685544e-09
gene O 0 7.010823033226643e-10
with O 0 2.542712741748776e-11
such O 0 4.566861055987914e-10
extraordinarily O 0 4.659227101910801e-07
high O 0 9.60385548864906e-08
sequence O 0 1.19894894012873e-09
conservation O 0 1.0845245812518556e-09
throughout O 0 3.082091873385373e-11
evolution O 0 1.4495271649650476e-10
, O 0 2.1562399435404167e-11
there O 0 1.5443497175526844e-11
are O 0 5.323539178925252e-11
presumed O 0 5.488382157636806e-07
undiscovered O 0 1.1520441148604732e-05
missense O 0 2.4850589852576377e-07
mutations O 0 2.955576228202972e-09
, O 0 7.352266018223474e-11
these O 0 7.077904928820544e-11
are O 0 4.055600993924102e-11
hypothesized O 0 2.4203654191978785e-08
to O 0 7.199537632729403e-10
exist O 0 3.0282987228957836e-09
in O 0 4.74728301114169e-09
as O 0 2.5652266089082332e-08
- O 0 3.449974173008741e-08
yet O 0 4.168221323652688e-09
unidentified O 0 1.1115998788113757e-08
phenotypes O 0 3.231180301099812e-08
. O 0 3.5610754345327678e-09
. O 0 7.01219349252824e-08

Genetic O 0 3.598704324758728e-06
heterogeneity O 0 3.436463430261938e-06
and O 0 1.1374985398049375e-08
penetrance O 0 5.200768669055833e-07
analysis O 0 4.304704148694327e-09
of O 0 4.183555901704494e-08
the O 0 2.364500595319896e-08
BRCA1 O 0 4.4224506723367085e-08
and O 0 8.782818028407746e-09
BRCA2 O 0 7.492597831060266e-08
genes O 0 6.856602396965172e-09
in O 0 6.189275314483211e-09
breast B-Disease 1 0.6820988655090332
cancer I-Disease 0 0.04798353463411331
families O 0 6.74283953117083e-08
. O 0 2.505660461338266e-07

The O 0 0.0011227946961298585
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 0.0002108000044245273
Consortium O 0 3.1590573144058e-06
. O 0 1.6326958984791418e-07

The O 0 1.3866146275631763e-07
contribution O 0 4.5989370534016416e-08
of O 0 6.578355993269724e-08
BRCA1 O 0 6.653259276845347e-08
and O 0 9.581858861906767e-09
BRCA2 O 0 1.6440252466054517e-06
to O 0 5.101718443256686e-07
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 0 4.791913670487702e-05
assessed O 0 1.488995238219104e-08
by O 0 1.8407743385129294e-10
linkage O 0 2.1090919233301975e-08
and O 0 3.1843055969815737e-10
mutation O 0 5.965015981157507e-11
analysis O 0 8.796573192082491e-11
in O 0 6.111284395204919e-11
237 O 0 5.026931093610187e-10
families O 0 1.0702422975628068e-10
, O 0 1.4457270450241033e-11
each O 0 3.2386272483253542e-12
with O 0 5.076812234494632e-11
at O 0 1.2275872540712385e-09
least O 0 2.1180260670328188e-11
four O 0 2.7517359918460826e-11
cases O 0 1.247622560818229e-10
of O 0 2.9640458976132322e-08
breast B-Disease 0 8.762407560425345e-06
cancer I-Disease 0 5.2230806346642566e-08
, O 0 1.9608389564829132e-11
collected O 0 4.897945590776054e-11
by O 0 3.9804676915666803e-11
the O 0 1.9743264090266166e-07
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 7.604228358104592e-06
Consortium O 0 4.781426810041012e-07
. O 0 7.666974966014095e-08

Families O 0 1.0511941894719712e-07
were O 0 4.4760302131408025e-09
included O 0 5.38077971068418e-10
without O 0 1.755213974163894e-09
regard O 0 1.25788393035009e-08
to O 0 3.2214664269503146e-10
the O 0 2.0775015041607503e-09
occurrence O 0 1.1580329584148785e-07
of O 0 3.463451866991818e-05
ovarian B-Disease 1 0.999998927116394
or I-Disease 0 1.0025818255599006e-06
other I-Disease 0 9.990353788680295e-08
cancers I-Disease 0 0.03861992433667183
. O 0 5.936535103501228e-07

Overall O 0 2.818893153744284e-05
, O 0 1.8839386939362157e-07
disease O 0 6.883228343212977e-05
was O 0 2.8987494715693174e-06
linked O 0 5.5881235994093e-07
to O 0 1.2115655145805704e-08
BRCA1 O 0 6.108378869384978e-08
in O 0 1.5384300500187464e-09
an O 0 9.086840307981348e-11
estimated O 0 3.8734779272964204e-11
52 O 0 6.303765287540841e-10
% O 0 1.0669282124453616e-10
of O 0 1.3021071998409184e-09
families O 0 4.4931525167157815e-10
, O 0 9.309873011398295e-11
to O 0 2.2448276570941061e-10
BRCA2 O 0 6.778724692679816e-09
in O 0 4.292125266314173e-10
32 O 0 1.2328573717468316e-09
% O 0 6.04428035400062e-11
of O 0 2.883653038576739e-10
families O 0 1.190432891151616e-10
, O 0 2.938451912348761e-11
and O 0 6.499474569654495e-11
to O 0 1.8372105226038826e-10
neither O 0 3.247180302423658e-09
gene O 0 1.0275870154785594e-09
in O 0 6.07359051940648e-10
16 O 0 1.9300394615839878e-09
% O 0 1.718862552291256e-10
( O 0 6.430336124685354e-11
95 O 0 1.9281898744338832e-08
% O 0 3.2795341997626792e-09
confidence O 0 4.725685442963368e-08
interval O 0 1.7957043851879462e-08
[ O 0 8.397060469178541e-08
CI O 0 3.6401904708327493e-06
] O 0 3.732283104795897e-08
6 O 0 3.0174202692023755e-08
% O 0 7.000359736331063e-10
- O 0 2.2541091215799725e-09
28 O 0 5.346021847429938e-09
% O 0 3.8196221185948787e-10
) O 0 1.531642590535398e-10
, O 0 6.62967597486741e-11
suggesting O 0 3.029650530450567e-09
other O 0 4.125573216384737e-09
predisposition O 0 2.37977656070143e-06
genes O 0 3.9127277773332025e-07
. O 0 3.51767084794119e-07

The O 0 2.695775037864223e-06
majority O 0 4.199930003778718e-08
( O 0 3.534252668302429e-09
81 O 0 4.812773468643172e-08
% O 0 1.12979814392844e-09
) O 0 2.08957365299689e-10
of O 0 9.211656326613138e-09
the O 0 5.553391474677483e-06
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 5.943622261028736e-10
were O 0 9.939782330548042e-11
due O 0 2.868601578498442e-09
to O 0 4.5890574673634887e-10
BRCA1 O 0 9.723580829401612e-10
, O 0 2.1706825573120092e-11
with O 0 1.1094588789339888e-11
most O 0 1.6032780658647994e-10
others O 0 4.54946441630355e-10
( O 0 1.1865181059889096e-10
14 O 0 1.3190702974341662e-09
% O 0 1.4664124081686936e-10
) O 0 7.199835866389392e-11
due O 0 3.7976583655563445e-08
to O 0 8.52646451221517e-08
BRCA2 O 0 8.769514352024999e-06
. O 0 1.169639858744631e-06

Conversely O 0 2.039997070824029e-06
, O 0 3.6698368788279367e-09
the O 0 2.8327056256216565e-09
majority O 0 4.1299802466809865e-10
of O 0 4.122851837706776e-09
families O 0 1.0696871860504942e-10
with O 0 2.3140184213232828e-11
male B-Disease 0 7.908683707924524e-10
and I-Disease 0 1.3318015579244502e-09
female I-Disease 0 3.5507596862771607e-09
breast I-Disease 0 6.868214654787153e-07
cancer I-Disease 0 2.56133546372439e-07
were O 0 6.0603788654134405e-09
due O 0 1.1814370282081654e-06
to O 0 7.89919312182974e-08
BRCA2 O 0 2.3264203719008947e-07
( O 0 5.330952124182886e-09
76 O 0 1.5302694578167575e-07
% O 0 3.3138281008149306e-09
) O 0 1.682213257581111e-09
. O 0 3.062255515828838e-08

The O 0 1.4161957551550586e-05
largest O 0 6.423223908313958e-07
proportion O 0 1.9557843344841785e-08
( O 0 2.2437285362997272e-09
67 O 0 3.344837651297894e-08
% O 0 9.087798291673721e-10
) O 0 1.5585720214428278e-10
of O 0 2.5804525183303895e-09
families O 0 1.746224720378109e-09
due O 0 5.5807639398608444e-08
to O 0 2.1136294936496824e-09
other O 0 4.0143524615565696e-10
genes O 0 4.216693660907822e-10
was O 0 3.785441737846895e-09
found O 0 1.5711587586508813e-10
in O 0 3.540111953581615e-11
families O 0 2.690916066361293e-11
with O 0 2.5953222210217675e-11
four O 0 2.891694106388343e-10
or O 0 5.75589020890277e-10
five O 0 4.6026532585230484e-10
cases O 0 5.102773759091406e-10
of O 0 2.8113660732742574e-07
female O 0 2.1893904431635747e-06
breast B-Disease 0 0.0002455075446050614
cancer I-Disease 0 1.6991814391076332e-06
only O 0 1.4114096558159872e-08
. O 0 1.8842837334887008e-07

These O 0 3.031264483865925e-08
estimates O 0 3.617797617039287e-08
were O 0 3.0151865448857507e-09
not O 0 2.33691510587164e-10
substantially O 0 1.594578868946428e-08
affected O 0 1.005118210883893e-09
either O 0 2.8975022381416693e-10
by O 0 2.6943877684537654e-11
changing O 0 3.581604457458809e-10
the O 0 4.676704024042522e-10
assumed O 0 3.888946498165069e-09
penetrance O 0 1.1737521177224153e-08
model O 0 2.6851545986694703e-10
for O 0 2.7985259942742147e-11
BRCA1 O 0 2.127262116458084e-10
or O 0 3.324016756289794e-11
by O 0 1.5897814314991265e-11
including O 0 1.894640694333205e-10
or O 0 3.595123754251972e-09
excluding O 0 6.183235967682776e-08
BRCA1 O 0 2.440800450642655e-08
mutation O 0 4.5717003516188015e-09
data O 0 1.8751997288291022e-08
. O 0 5.0555513553263154e-08

Among O 0 5.208158526670559e-08
those O 0 1.08608111393238e-09
families O 0 2.9590382921718117e-10
with O 0 4.422022470418341e-11
disease O 0 1.2739542398776393e-07
due O 0 7.466768465747009e-07
to O 0 1.0996179966582531e-08
BRCA1 O 0 1.3215237792962853e-08
that O 0 9.90514892329486e-11
were O 0 6.017034093197537e-10
tested O 0 2.1646762160543176e-10
by O 0 2.29637836524077e-11
one O 0 5.5817565847160466e-11
of O 0 3.5539152176689015e-10
the O 0 5.211521769687977e-10
standard O 0 1.1250199660750582e-09
screening O 0 1.873539101637789e-10
methods O 0 1.7166477961350068e-10
, O 0 1.1025270106601592e-11
mutations O 0 1.3582696599401256e-11
were O 0 8.149929342504691e-11
detected O 0 3.5666154474256473e-09
in O 0 4.1627296054613794e-10
the O 0 5.281723503003377e-09
coding O 0 2.936702614420028e-08
sequence O 0 1.5178294177076168e-09
or O 0 1.0859775301241825e-09
splice O 0 1.4119500235665328e-07
sites O 0 1.7973038612950631e-09
in O 0 1.6452698925473186e-10
an O 0 5.3002567612647766e-11
estimated O 0 9.74885033810935e-11
63 O 0 3.3266331911363523e-09
% O 0 3.898435740889994e-10
( O 0 3.890057165278904e-10
95 O 0 9.402771894428952e-08
% O 0 2.015259781273926e-08
CI O 0 1.2151328519394156e-05
51 O 0 9.2659341532908e-08
% O 0 4.375679818480194e-09
- O 0 5.92677196209479e-08
77 O 0 3.620738553422598e-08
% O 0 3.124963399159242e-09
) O 0 2.2947386213445498e-09
. O 0 3.441857288066785e-08

The O 0 8.395128361371462e-07
estimated O 0 1.2926108183819451e-08
sensitivity O 0 5.442281292289408e-08
was O 0 9.69543556550434e-09
identical O 0 3.9451114597355286e-10
for O 0 5.955545778757454e-11
direct O 0 5.481383680283614e-10
sequencing O 0 1.1986477588266098e-08
and O 0 2.614073124629357e-10
other O 0 1.80078923994742e-10
techniques O 0 1.6315721040882636e-07
. O 0 1.1927892273888574e-07

The O 0 2.9415878088911995e-06
penetrance O 0 0.00035639936686493456
of O 0 1.1870784874190576e-05
BRCA2 O 0 2.278573447256349e-06
was O 0 1.2071589594597754e-07
estimated O 0 1.1254702031449071e-10
by O 0 7.326717704758678e-11
maximizing O 0 4.013192622664974e-08
the O 0 3.500528933386704e-08
LOD O 0 0.18922695517539978
score O 0 3.281857914316788e-07
in O 0 1.0287425133981287e-08
BRCA2 O 0 7.463672346830208e-08
- O 0 1.7035374000329284e-08
mutation O 0 1.6158280269351621e-10
families O 0 5.031782629449921e-11
, O 0 1.5546819040479498e-11
over O 0 5.5572702689632436e-11
all O 0 3.6874444470091916e-11
possible O 0 3.437761408875417e-09
penetrance O 0 1.2669912621277035e-06
functions O 0 2.059920589658759e-08
. O 0 3.7481843406794724e-08

The O 0 1.8632869114298956e-07
estimated O 0 3.2273599348542348e-09
cumulative O 0 7.97976706934378e-09
risk O 0 1.4335158837752715e-08
of O 0 2.2188825710145466e-07
breast B-Disease 0 9.308111475547776e-05
cancer I-Disease 0 4.826617896469543e-06
reached O 0 2.1040840181285603e-07
28 O 0 2.6077310977257184e-08
% O 0 4.0722222816036435e-10
( O 0 1.537643068427741e-10
95 O 0 2.5914680179539573e-08
% O 0 4.394213881653286e-09
CI O 0 1.3767167956757476e-06
9 O 0 2.6385155393882087e-08
% O 0 5.516319623311006e-10
- O 0 1.530837234753335e-09
44 O 0 5.616156428800423e-10
% O 0 4.270825706975678e-11
) O 0 3.720413300351e-12
by O 0 6.2367858273681964e-12
age O 0 1.129000573585337e-10
50 O 0 2.281244221302714e-10
years O 0 2.1577797881811023e-10
and O 0 1.9105277082598349e-10
84 O 0 4.275173992596137e-09
% O 0 2.1485271894938762e-10
( O 0 2.1360850588347802e-10
95 O 0 1.8007051849622258e-08
% O 0 6.432612220663714e-09
CI O 0 1.7740650264386204e-06
43 O 0 2.779311181200228e-08
% O 0 1.4826181393701177e-09
- O 0 5.586096918364092e-09
95 O 0 1.1686699608048912e-08
% O 0 2.168283746994959e-10
) O 0 2.010181604505945e-11
by O 0 2.7230925847554488e-11
age O 0 2.812087451786738e-09
70 O 0 1.4086475985664038e-08
years O 0 1.2112836955679995e-08
. O 0 4.930815933334998e-08

The O 0 3.8496318666148e-06
corresponding O 1 0.9993970394134521
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 0 1.119246007874608e-06
were O 0 4.86645959085763e-08
0 O 0 1.9875885470810317e-07
. O 0 6.820097553372761e-08

4 O 0 3.2335221931134583e-06
% O 0 1.4073155973903795e-08
( O 0 1.0884079193473895e-09
95 O 0 5.848423256793467e-08
% O 0 6.718881895295681e-09
CI O 0 2.1483137970790267e-06
0 O 0 1.3720876879119714e-08
% O 0 4.797792718669314e-10
- O 0 2.6550779352874088e-09
1 O 0 3.6385703339192332e-09
% O 0 6.12243797326606e-11
) O 0 3.067908557405352e-12
by O 0 5.429766011810777e-12
age O 0 1.0740663913821891e-10
50 O 0 1.5643558670674906e-10
years O 0 6.500094906769505e-11
and O 0 1.3691896227907563e-10
27 O 0 1.261085458281741e-09
% O 0 7.27402860167814e-11
( O 0 5.838094591092968e-11
95 O 0 6.9814696246339736e-09
% O 0 9.754193008859602e-10
CI O 0 4.631843069091701e-07
0 O 0 7.726249862116674e-09
% O 0 6.397980478745069e-10
- O 0 3.554350813672613e-09
47 O 0 4.563319944139721e-09
% O 0 1.948324696021686e-10
) O 0 1.2013604520910715e-11
by O 0 1.738499795511661e-11
age O 0 9.946387047321537e-10
70 O 0 6.011312780884737e-09
years O 0 5.476829656458904e-09
. O 0 2.5873438502799218e-08

The O 0 1.4985489542596042e-06
lifetime O 0 2.6490906748222187e-06
risk O 0 1.5344534176620073e-06
of O 0 1.063349009200465e-05
breast B-Disease 1 0.9995015859603882
cancer I-Disease 0 9.631161447032355e-06
appears O 0 6.260703511173915e-09
similar O 0 1.0804735994796033e-09
to O 0 9.311813542467462e-10
the O 0 1.6967600657835646e-08
risk O 0 1.8119608924394015e-08
in O 0 1.1868740434906044e-09
BRCA1 O 0 6.409144326369187e-10
carriers O 0 4.5765316536439116e-10
, O 0 3.603426931841902e-11
but O 0 5.1590131472378786e-11
there O 0 6.557251269745379e-11
was O 0 1.7102169680427437e-09
some O 0 7.771997455330304e-12
suggestion O 0 1.4627926647747813e-09
of O 0 1.7431499577114096e-09
a O 0 2.5055917340921496e-09
lower O 0 5.8040949824089694e-08
risk O 0 5.113747203466801e-09
in O 0 2.117919173372229e-09
BRCA2 O 0 1.6434306360224582e-08
carriers O 0 6.925355844344949e-09
< O 0 7.048935657394395e-08
50 O 0 1.6275176761837429e-09
years O 0 5.395661695217768e-10
of O 0 4.759967975331847e-09
age O 0 3.218497113266494e-08
. O 0 1.4995424635344534e-07

Eye B-Disease 1 0.9999998807907104
movement I-Disease 0 5.5792163038859144e-05
abnormalities I-Disease 0 0.0002700928889680654
correlate O 0 1.3560719480665284e-07
with O 0 4.259798291883499e-09
genotype O 0 1.1950409316341393e-05
in O 0 3.6615325882394245e-08
autosomal O 0 0.013410604558885098
dominant O 1 0.999996542930603
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 1.0
I I-Disease 1 1.0
. O 0 1.6485375454067253e-05

We O 0 6.385234883055091e-07
compared O 0 4.4454372982727364e-07
horizontal O 0 2.466310888848966e-06
eye O 0 0.00018146703951060772
movements O 0 4.903131056721577e-08
( O 0 8.57568416279264e-09
visually O 0 4.6358028527038186e-08
guided O 0 4.4830855472355324e-07
saccades O 0 3.162393477396108e-05
, O 0 5.183627305171967e-09
antisaccades O 0 1.3268032716950984e-06
, O 0 6.616629466549284e-10
and O 0 1.0153168306104021e-09
smooth O 0 1.8140633883945156e-08
pursuit O 0 6.220236770104748e-08
) O 0 2.0290812086098953e-10
in O 0 2.3274450422494652e-10
control O 0 9.6098986546167e-09
subjects O 0 1.7429414356229245e-08
( O 0 4.914436635417019e-10
n O 0 2.4919799557210354e-09
= O 0 2.167234391947659e-09
14 O 0 6.273730424055657e-10
) O 0 4.0103247112011076e-11
and O 0 9.352855295796658e-11
patients O 0 2.107987950861201e-10
with O 0 4.925582164361231e-11
three O 0 1.8808503365885798e-10
forms O 0 1.1391051657483331e-08
of O 0 9.203718605022004e-07
autosomal O 0 3.2786526844574837e-06
dominant O 0 2.1570433091255836e-05
cerebellar B-Disease 1 0.9849067330360413
ataxias I-Disease 0 2.9735942007391714e-05
type I-Disease 0 3.094055955443764e-06
I I-Disease 0 2.5529869162710384e-05
spinocerebellar B-Disease 0 0.002200382063165307
ataxias I-Disease 0 1.985696508199908e-05
1 I-Disease 0 1.3649767538481683e-07
and I-Disease 0 5.360909494100952e-09
2 I-Disease 0 6.844219058166345e-08
( O 0 1.384696024508969e-09
SCA1 B-Disease 0 2.9521539545385167e-05
, O 0 4.698423872184776e-09
n O 0 1.0233665470593678e-08
= O 0 5.483477671930359e-09
11 O 0 2.9292888115151072e-09
; O 0 4.12050671361186e-10
SCA2 B-Disease 0 4.416653155203676e-06
, O 0 1.802336502265689e-09
n O 0 3.0289570851493863e-09
= O 0 3.123985958808362e-09
10 O 0 1.0122964688719094e-09
) O 0 2.691872280635721e-10
and O 0 4.716659951498059e-09
SCA3 B-Disease 1 1.0
/ O 0 2.7749056243919767e-05
Machado B-Disease 0 1.5795410490682116e-06
- I-Disease 0 3.1197993166642846e-07
Joseph I-Disease 0 5.419201625045389e-05
disease I-Disease 0 0.00024737761123105884
( O 0 2.352633288182915e-08
MJD B-Disease 1 1.0
) O 0 3.784323077127283e-09
( O 0 8.317542765645669e-10
n O 0 7.512571897905218e-09
= O 0 1.0497392288755236e-08
16 O 0 1.0164800556822229e-08
) O 0 4.3671088967300875e-09
. O 0 7.517592592876099e-08

In O 0 1.7302870674029691e-06
SCA1 B-Disease 0 0.0006506830686703324
, O 0 2.6423984778034537e-08
saccade O 0 3.517469849612098e-06
amplitude O 0 2.7936488322666264e-07
was O 0 1.783433667412737e-08
significantly O 0 1.765097623618317e-09
increased O 0 5.285005766353379e-10
, O 0 6.188666940021292e-11
resulting O 0 3.066146669894465e-09
in O 0 5.386851409383553e-09
hypermetria B-Disease 0 1.428756058885483e-05
. O 0 2.317719491884418e-07

The O 0 4.380849532026332e-06
smooth O 0 2.0300180949561764e-06
pursuit O 0 1.4619618013966829e-06
gain O 0 7.801685342201381e-07
was O 0 6.205152089933108e-07
decreased O 0 1.3001206866647408e-07
. O 0 1.3556918077028968e-07

In O 0 2.284923311890452e-06
SCA2 B-Disease 0 0.0006372817442752421
, O 0 3.347377841578236e-08
saccade O 0 3.0765104384045117e-06
velocity O 0 7.690010761507438e-07
was O 0 5.914445750931918e-07
markedly O 0 1.4504186083286186e-06
decreased O 0 3.472891023648117e-07
. O 0 9.19435194646212e-08

The O 0 1.2829415254600463e-06
percentage O 0 1.2730785670100886e-07
of O 0 4.283640464564087e-08
errors O 0 1.8275995898875408e-06
in O 0 4.8376225691981745e-08
antisaccades O 0 0.3427686393260956
was O 0 9.226268957718275e-07
greatly O 0 1.2147540751072938e-08
increased O 0 1.609974598082431e-09
and O 0 6.205217450983014e-10
was O 0 1.8099221010814404e-09
significantly O 0 3.6273914427731313e-10
correlated O 0 1.5358024574307905e-10
with O 0 2.713899244222162e-11
age O 0 1.4782667312474018e-09
at O 0 1.1490929985313869e-08
disease O 0 7.009612090769224e-08
onset O 0 0.0001441822969354689
. O 0 6.73641864068486e-07

In O 0 7.282132230557181e-08
addition O 0 2.0959463498115838e-08
, O 0 9.554370627995468e-10
a O 0 1.676332517241974e-09
correlation O 0 2.6927566842971373e-09
between O 0 8.0584907635739e-09
smooth O 0 1.0869732847140767e-07
pursuit O 0 1.0220736612609471e-07
gain O 0 1.4736140308002632e-08
and O 0 2.100863233378547e-10
the O 0 3.1874713979362923e-10
number O 0 4.431546796190844e-11
of O 0 3.3726712533876935e-09
trinucleotide O 0 2.817251015585498e-06
repeats O 0 7.701887483335668e-08
was O 0 9.14834501486439e-08
found O 0 6.447746336846194e-09
. O 0 4.809928810800557e-08

In O 0 2.4062945158220828e-05
SCA3 B-Disease 1 1.0
, O 0 2.6453692498762393e-06
gaze B-Disease 0 0.00027712059090845287
- I-Disease 0 2.0740122636198066e-05
evoked I-Disease 0 4.8058303946163505e-05
nystagmus I-Disease 0 0.00034177658380940557
was O 0 3.8267435797934013e-07
often O 0 3.170385065587311e-10
present O 0 9.215060936540453e-10
as O 0 1.3694360090354962e-09
was O 0 2.951544431084585e-08
saccade O 0 9.186321676679654e-07
hypometria O 0 1.847038447522209e-06
and O 0 1.2445719121956245e-08
smooth O 0 8.303268117515472e-08
pursuit O 0 1.7553145426063566e-07
gain O 0 1.2200021615171863e-07
was O 0 1.282048316397777e-07
markedly O 0 3.1968943403626326e-07
decreased O 0 1.8773995691390155e-07
. O 0 8.46403267473761e-08

Three O 0 7.064682563395763e-07
major O 0 3.1332555749941093e-07
criteria O 0 1.1352404527542603e-07
, O 0 3.1207580963865666e-09
saccade O 0 1.5792625163157936e-06
amplitude O 0 1.62232169031995e-07
, O 0 2.47815712395294e-10
saccade O 0 9.280137192035909e-08
velocity O 0 1.3745290239342012e-08
, O 0 1.3614606664269502e-10
and O 0 7.316202504936697e-11
presence O 0 8.783015426061525e-10
of O 0 9.262453204428311e-08
gaze B-Disease 0 3.210116483387537e-05
- I-Disease 0 1.095431230169197e-06
evoked I-Disease 0 1.4802673149461043e-06
nystagmus I-Disease 0 2.2943738713365747e-06
, O 0 6.236173244467125e-10
permitted O 0 6.15795026082111e-10
the O 0 5.889803644798519e-10
correct O 0 2.0533763578356456e-09
assignment O 0 6.3158753782488475e-09
of O 0 6.016864784186282e-09
90 O 0 2.9073798923917593e-09
% O 0 3.9270109386535523e-10
of O 0 2.161121281929468e-09
the O 0 5.294270355449271e-09
SCA1 B-Disease 0 8.51473305374384e-06
, O 0 8.140503271469868e-10
90 O 0 1.2397192161728299e-09
% O 0 1.9913652671288418e-10
of O 0 1.5686860699304361e-09
the O 0 5.676933589882083e-09
SCA2 B-Disease 0 8.673870979691856e-06
, O 0 9.622622698657324e-10
and O 0 6.410574848736417e-10
93 O 0 9.051527527503822e-09
% O 0 2.1353842305504855e-10
of O 0 9.879492779418797e-10
the O 0 2.510021079871194e-09
patients O 0 3.4655305292119465e-09
with O 0 2.4787871755194146e-09
SCA3 B-Disease 1 1.0
to O 0 2.407583821195658e-08
their O 0 1.9263948214387483e-09
genetically O 0 5.080817544467209e-09
confirmed O 0 2.8129887308381285e-09
patient O 0 1.3239861651470619e-08
group O 0 9.426336794460255e-11
and O 0 1.8901288867390065e-10
, O 0 4.945237969122829e-11
therefore O 0 1.4586135632654873e-09
, O 0 3.7671737951328055e-10
may O 0 4.4568966295344126e-09
help O 0 2.3626386180808367e-08
orient O 0 5.80402286232129e-07
diagnoses O 0 1.0914644690274145e-06
of O 0 1.0301031352355494e-06
SCA1 B-Disease 1 0.7217518091201782
, O 0 6.7502368139571445e-09
SCA2 B-Disease 0 9.468122152611613e-05
, O 0 2.5276574167065746e-09
and O 0 3.285120442342304e-08
SCA3 B-Disease 1 1.0
at O 0 5.7578510848088627e-08
early O 0 1.1808479527530835e-08
clinical O 0 5.066727037927876e-09
stages O 0 1.0317195098252796e-08
of O 0 8.916636318190285e-09
the O 0 1.9315834265398735e-08
diseases O 0 3.918846414308064e-05
. O 0 1.1155674606300181e-08
. O 0 9.445390958262578e-08

Genetic O 0 1.5359921690105693e-07
basis O 0 1.0841776365566602e-08
and O 0 3.7837002975216194e-10
molecular O 0 3.5700187250853332e-09
mechanism O 0 9.149305668643137e-08
for O 0 9.120260813233472e-08
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 1 0.9992985725402832

Ventricular B-Disease 1 1.0
fibrillation I-Disease 1 1.0
causes O 0 7.753408681310248e-06
more O 0 8.360200309809329e-10
than O 0 2.6049445933651327e-10
300 O 0 6.494521032074374e-10
, O 0 9.955056223809322e-11
000 O 0 2.035062784955244e-09
sudden O 0 6.4062879445714316e-09
deaths O 0 1.0036603770302577e-09
each O 0 3.190912811756874e-11
year O 0 3.868149411889732e-10
in O 0 5.906610756056807e-10
the O 0 1.5148627241501345e-08
USA O 0 7.976985472168963e-08
alone O 0 1.9132793127596415e-08
. O 0 3.727829422928153e-08

In O 0 6.183443019835977e-07
approximately O 0 1.3319877645301403e-08
5 O 0 6.521662498926162e-08
- O 0 2.726839021249816e-08
12 O 0 1.353662182346227e-09
% O 0 8.220746305909188e-11
of O 0 5.050608889445307e-11
these O 0 5.691496319376599e-12
cases O 0 2.159771667065158e-11
, O 0 8.0268786409321e-12
there O 0 7.339609822687443e-12
are O 0 4.510681758662649e-12
no O 0 6.302082189435509e-10
demonstrable O 0 0.0003959464083891362
cardiac O 1 0.9999995231628418
or O 0 3.920019662473351e-05
non O 1 0.9932779669761658
- O 1 0.9963470101356506
cardiac O 0 0.3958275616168976
causes O 0 9.200698869449297e-09
to O 0 1.3073175875177867e-10
account O 0 4.094478922578304e-11
for O 0 2.1026792806910777e-10
the O 0 4.0199705786392315e-09
episode O 0 1.088597390008772e-08
, O 0 8.474289846238658e-12
which O 0 1.7491255839552355e-12
is O 0 1.497850888459995e-12
therefore O 0 1.6499230801048093e-11
classified O 0 5.291077576075054e-10
as O 0 1.9024714248416785e-08
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 1 0.9984710812568665
IVF B-Disease 1 1.0
) O 0 6.412206943195997e-08
. O 0 5.62208946064402e-08

A O 0 2.2250030724535463e-06
distinct O 0 1.8730538897671067e-07
group O 0 7.509549426742979e-09
of O 0 9.88722831607447e-07
IVF B-Disease 1 1.0
patients O 0 5.0866124183812644e-06
has O 0 4.2713002579297665e-10
been O 0 3.91759055751173e-11
found O 0 2.4771113979471515e-11
to O 0 1.232207304940891e-11
present O 0 2.1239537906225792e-10
with O 0 2.6043087131277787e-10
a O 0 9.46894385123187e-09
characteristic O 0 2.0640625564283255e-07
electrocardiographic O 0 6.229549398995005e-06
pattern O 0 1.7575355570897955e-07
. O 0 2.456121421801072e-07

Because O 0 5.695894742530072e-07
of O 0 8.10098015335825e-07
the O 0 3.021808936409798e-08
small O 0 1.1839956792769613e-09
size O 0 9.669871570139321e-10
of O 0 1.5465088099020363e-09
most O 0 2.78989359392412e-10
pedigrees O 0 2.649372987661991e-08
and O 0 6.040226652181957e-10
the O 0 2.2391455356540746e-09
high O 0 1.2213660305349094e-08
incidence O 0 1.6005207825742218e-08
of O 0 4.948790266467995e-09
sudden B-Disease 0 2.145053201729752e-08
death I-Disease 0 3.215312815996185e-08
, O 0 9.12440609179832e-11
however O 0 9.101237125053174e-11
, O 0 7.80435091551901e-12
molecular O 0 1.1460669219198749e-10
genetic O 0 1.6098877786419052e-10
studies O 0 7.755091013805782e-11
of O 0 1.0369948455490885e-08
IVF B-Disease 1 1.0
have O 0 5.315883733203464e-09
not O 0 8.075381474625942e-10
yet O 0 5.691353166525914e-09
been O 0 7.775478039206973e-09
done O 0 2.7151099146749402e-08
. O 0 2.8126683204732217e-08

Because O 0 8.663221524329856e-05
IVF B-Disease 1 1.0
causes O 0 0.04775165766477585
cardiac O 1 1.0
rhythm O 1 0.9999982118606567
disturbance O 1 0.9999105930328369
, O 0 1.2322421305555054e-08
we O 0 9.173883319668619e-10
investigated O 0 5.73881431265022e-09
whether O 0 1.1271807931478861e-09
malfunction O 0 1.9406128558330238e-05
of O 0 2.1905000480160197e-08
ion O 0 1.7807707308747922e-06
channels O 0 9.890889884900389e-08
could O 0 1.3151663091903742e-09
cause O 0 2.353207761984777e-08
the O 0 3.4011986560500418e-09
disorder O 0 1.4372877332746725e-09
by O 0 2.717012032027455e-11
studying O 0 1.1040427599917635e-10
mutations O 0 1.3018129109421128e-11
in O 0 4.22822436785264e-11
the O 0 2.6327080515642365e-09
cardiac O 0 5.529293957806658e-06
sodium O 0 2.699551714613335e-06
channel O 0 8.089184575510444e-07
gene O 0 4.480012805174738e-08
SCN5A O 0 1.4403340173885226e-05
. O 0 1.4630005296112358e-07

We O 0 6.186456857903977e-07
have O 0 9.69125757421807e-09
now O 0 4.488075244779566e-09
identified O 0 3.88743348622711e-09
a O 0 3.2467220023590926e-09
missense O 0 1.4448615104356577e-07
mutation O 0 5.64368152211614e-09
, O 0 7.377864430502257e-10
a O 0 6.0756559783214925e-09
splice O 0 1.9158630948368227e-06
- O 0 1.3643013119235547e-07
donor O 0 1.1967608237739569e-08
mutation O 0 2.617287053752193e-09
, O 0 1.3999439107958978e-10
and O 0 2.6349872284114895e-10
a O 0 4.445706025535401e-09
frameshift O 0 1.158643883059085e-07
mutation O 0 1.0470750932967121e-09
in O 0 2.46532461112281e-10
the O 0 2.8250544126251498e-09
coding O 0 9.5278089418116e-08
region O 0 2.019065092895289e-08
of O 0 4.367352701706295e-08
SCN5A O 0 0.08719894289970398
in O 0 1.9627277580980262e-08
three O 0 2.0272883816119247e-08
IVF B-Disease 1 1.0
families O 0 3.868957421104824e-08
. O 0 9.910094433962513e-08

We O 0 2.364695177448084e-07
show O 0 3.365178802283708e-09
that O 0 4.206577794430011e-11
sodium O 0 3.5113203455949815e-09
channels O 0 1.2397949333831093e-09
with O 0 1.602222521324137e-11
the O 0 5.590155005563702e-10
missense O 0 1.2158741924395144e-07
mutation O 0 5.635495625710973e-09
recover O 0 1.6874142261258385e-07
from O 0 4.7914117118352806e-09
inactivation O 0 2.273359996252111e-06
more O 0 9.544711548903351e-11
rapidly O 0 8.02832578195023e-10
than O 0 8.140975740755785e-12
normal O 0 1.1048937459401387e-10
and O 0 4.150526103363639e-11
that O 0 1.8237191271031072e-11
the O 0 1.1729905935453644e-09
frameshift O 0 9.352046959065774e-08
mutation O 0 3.405156434599377e-10
causes O 0 2.8854907352382497e-10
the O 0 7.50981776764803e-10
sodium O 0 1.9915079363386212e-08
channel O 0 3.36890515484356e-08
to O 0 6.839358523968997e-10
be O 0 2.723012260119617e-09
non O 0 1.3237757912065717e-07
- O 0 3.3490834994154284e-07
functional O 0 2.5903786990966182e-06
. O 0 1.8056789485854097e-07

Our O 0 1.6155173625520547e-06
results O 0 5.44962208692823e-09
indicate O 0 3.68644270665186e-09
that O 0 2.1467860822355078e-10
mutations O 0 1.3558973943617048e-09
in O 0 1.9839394571619096e-09
cardiac O 0 1.7006566395139089e-06
ion O 0 7.950925464683678e-06
- O 0 2.2572421585209668e-05
channel O 0 1.56015374841445e-07
genes O 0 8.988172706114739e-11
contribute O 0 1.949881402174558e-11
to O 0 4.23343721189795e-11
the O 0 3.654704872069203e-10
risk O 0 2.519383590637858e-09
of O 0 1.6487584630908714e-08
developing O 0 2.1180471776460763e-06
IVF B-Disease 1 1.0
. O 0 2.1877191613839386e-08
. O 0 5.199334651706522e-08

Molecular O 0 6.572375696123345e-06
heterogeneity O 0 2.0091143596800976e-05
in O 0 1.8413734892419598e-07
mucopolysaccharidosis B-Disease 0 0.000710434396751225
IVA I-Disease 1 0.9999997615814209
in O 0 1.7574600974512578e-07
Australia O 0 3.948111171325763e-08
and O 0 3.6635636746495948e-09
Northern O 0 9.836087144776684e-08
Ireland O 0 7.931940615435451e-08
: O 0 6.13850692499085e-10
nine O 0 2.697614576163687e-09
novel O 0 2.0232313602264185e-09
mutations O 0 1.7442465527484075e-10
including O 0 1.9811137452752092e-10
T312S O 0 1.399598659190815e-07
, O 0 2.0264513678203144e-10
a O 0 7.62327978520716e-10
common O 0 9.066836170745773e-09
allele O 0 1.9203638679243795e-09
that O 0 8.055441036436406e-11
confers O 0 2.0642351827859784e-08
a O 0 1.5151055521300805e-08
mild O 0 3.4044373933284078e-06
phenotype O 0 2.486808989488054e-05
. O 0 4.594886604536441e-07

Mucopolysaccharidosis B-Disease 1 0.9991523027420044
IVA I-Disease 1 1.0
( O 0 0.0013919849880039692
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 2.486540893187339e-07
is O 0 6.9990422346677406e-09
an O 0 3.664206271736248e-09
autosomal B-Disease 1 0.9999902248382568
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 1 0.9999892711639404
by O 0 5.706584147446847e-07
a O 0 2.4145354473148473e-05
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 2.6734808216133388e-06
N O 0 4.252402959536994e-06
- O 0 8.625735290479497e-07
acetylgalactosamine O 0 4.344008630141616e-05
- O 0 6.858481924609805e-07
6 O 0 8.465556220471626e-07
- O 0 3.4721492170319834e-07
sulfate O 0 9.30141413846286e-06
sulfatase O 0 0.0002356520271860063
( O 0 6.143736186459137e-08
GALNS O 0 0.0004220332484692335
) O 0 1.6638370681221204e-08
. O 0 5.9049718004189344e-08

Previous O 0 5.601714292424731e-07
studies O 0 1.2450896313964677e-08
of O 0 9.868235117949098e-09
patients O 0 1.886934608563706e-09
from O 0 3.6779794765351426e-09
a O 0 7.808755420057878e-09
British O 0 5.191981813368329e-07
- O 0 9.845018666965188e-07
Irish O 0 4.865364076067635e-07
population O 0 3.443349425036324e-11
showed O 0 5.438547528990867e-11
that O 0 5.168761252338783e-12
the O 0 3.209745802479347e-10
I113F O 0 2.3951713501446648e-08
mutation O 0 1.8235390975007704e-10
is O 0 1.580110695065251e-11
the O 0 6.416749076532113e-11
most O 0 2.6162664049089734e-11
common O 0 7.92877152822058e-10
single O 0 7.596224760320069e-10
mutation O 0 6.905949145874501e-10
among O 0 3.4175013929882425e-09
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 0.00015997994341887534
and O 0 1.043367436892595e-08
produces O 0 1.6872453434402246e-09
a O 0 1.1751941642046404e-09
severe O 0 2.0344239715086587e-07
clinical O 0 6.691514613521576e-07
phenotype O 0 5.883335688849911e-06
. O 0 1.2487930689530913e-07

We O 0 1.9960299368904089e-07
studied O 0 1.8084604391788162e-07
mutations O 0 5.943319170143013e-09
in O 0 1.7223356074680396e-09
the O 0 9.24964993487265e-09
GALNS O 0 5.263686489342945e-06
gene O 0 3.439879936451007e-09
from O 0 1.939697513719807e-09
23 O 0 8.338211898717418e-09
additional O 0 1.2545630312388312e-08
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 4.642076874006307e-06
( O 0 1.3573258073051875e-09
15 O 0 8.344030466567176e-10
from O 0 5.035625250116027e-10
Australia O 0 8.017858599274064e-10
, O 0 5.0395718848017523e-11
8 O 0 5.898257438019527e-10
from O 0 1.8557813619146657e-10
Northern O 0 6.77403289017775e-09
Ireland O 0 2.7605175922928993e-09
) O 0 4.482501522740101e-11
, O 0 4.915537595018282e-12
with O 0 2.3476036652841925e-12
various O 0 4.061517511200208e-10
clinical O 0 1.528245121562577e-07
phenotypes O 0 1.7317942138106446e-06
( O 0 8.84441231363553e-09
severe O 0 0.0005601536249741912
, O 0 7.873618201870158e-09
16 O 0 4.4261114773291865e-09
cases O 0 2.2033956603717542e-10
; O 0 2.508392382694069e-10
intermediate O 0 1.1309979441875839e-07
, O 0 2.1633678182197968e-10
4 O 0 1.0133860417482765e-09
cases O 0 1.1248521558648861e-10
; O 0 6.85618117834963e-10
mild O 0 1.6168482034117915e-05
, O 0 3.768260814496216e-09
3 O 0 2.4060689440830174e-08
cases O 0 1.1379037712089257e-09
) O 0 3.24600368806216e-09
. O 0 6.896083704077682e-08

We O 0 2.1964163465781894e-07
found O 0 1.0911313630401764e-08
two O 0 7.805713297948103e-10
common O 0 1.447679420785164e-09
mutations O 0 7.773928029086719e-11
that O 0 9.077827899106605e-12
together O 0 3.2160499957578637e-11
accounted O 0 4.626117267036989e-10
for O 0 2.695612622005683e-10
32 O 0 4.018199994959559e-09
% O 0 5.609829267783084e-10
of O 0 4.587650703768986e-09
the O 0 6.531344798332839e-09
44 O 0 5.303285810498437e-09
unrelated O 0 1.3474464877205605e-09
alleles O 0 1.4644724322110392e-10
in O 0 5.101302019694387e-11
these O 0 3.646467849893753e-10
patients O 0 2.2917657105381295e-08
. O 0 1.064910861714452e-07

One O 0 2.7523446988197975e-07
is O 0 6.063188617844162e-09
the O 0 4.7231418776050305e-09
T312S O 0 1.611131210665917e-07
mutation O 0 1.3560087497310747e-09
, O 0 7.349686137470002e-11
a O 0 3.965563710739417e-10
novel O 0 6.306221767005127e-09
mutation O 0 8.64622040630536e-10
found O 0 4.856440249945138e-10
exclusively O 0 7.068154395106774e-10
in O 0 1.0056954158343956e-09
milder O 1 0.9054631590843201
patients O 0 0.0001663228904362768
. O 0 2.6646480364433955e-06

The O 0 6.38866993085685e-07
other O 0 2.8351054837116862e-09
is O 0 2.3783164326829365e-10
the O 0 5.627275867503556e-10
previously O 0 1.90497595475847e-09
described O 0 5.463704155772575e-09
I113F O 0 3.03212374319628e-07
that O 0 3.0314059595859533e-10
produces O 0 2.9827995629005954e-09
a O 0 2.195733017629209e-08
severe O 0 2.1127347281435505e-05
phenotype O 0 0.00015504888142459095
. O 0 8.082143949650344e-07

The O 0 3.095936108366004e-06
I113F O 0 1.4841241863905452e-05
and O 0 4.0918152421909326e-08
T312S O 0 7.702208790760778e-07
mutations O 0 2.6268793806849544e-09
accounted O 0 4.02889055450828e-09
for O 0 1.4072477627635749e-09
8 O 0 1.5929009222759305e-08
( O 0 5.603584263269568e-10
18 O 0 2.3022748152357053e-09
% O 0 1.6128383351077247e-10
) O 0 5.039206898982407e-11
and O 0 6.121599893660346e-10
6 O 0 2.12127577725596e-08
( O 0 3.671753456835347e-10
14 O 0 1.0504617176110287e-09
% O 0 1.7712245559131645e-10
) O 0 3.8308561184363654e-11
of O 0 1.0101863789913068e-09
44 O 0 5.132831493170897e-09
unrelated O 0 5.3431268298709256e-09
alleles O 0 5.682921910832306e-10
, O 0 5.288394167024535e-10
respectively O 0 2.65780517594294e-08
. O 0 2.460359951328428e-07

The O 0 2.3165493985288776e-06
relatively O 0 4.217880302803678e-07
high O 0 4.3777615132967185e-07
residual O 0 1.4449222362600267e-05
GALNS O 0 0.00024395027139689773
activity O 0 6.435730171006071e-09
seen O 0 4.395018571301534e-09
when O 0 1.5045074075459297e-09
the O 0 2.8277391539432983e-09
T312S O 0 1.093290009634984e-07
mutant O 0 2.0027679070722115e-08
cDNA O 0 5.290396742907433e-08
is O 0 1.2661927062396217e-09
overexpressed O 0 1.909991027559954e-07
in O 0 1.5663570440693775e-09
mutant O 0 6.127420792978455e-09
cells O 0 5.159310756397417e-10
provides O 0 8.137812645969689e-11
an O 0 3.019964703657174e-12
explanation O 0 2.63603278094493e-10
for O 0 8.435011716878549e-11
the O 0 1.7778221117481507e-09
mild O 0 6.338977414088731e-07
phenotype O 0 3.888711432864511e-07
in O 0 4.4771036877833126e-10
patients O 0 1.1423219314909971e-10
with O 0 5.59708442787743e-12
this O 0 3.616145438645191e-10
mutation O 0 5.984075013287793e-09
. O 0 4.923560581460151e-08

The O 0 2.8528674533845333e-07
distribution O 0 1.6144959147368354e-08
and O 0 1.7289316645019426e-09
relative O 0 5.504648115106647e-08
frequencies O 0 3.1363821761942745e-08
of O 0 4.4097299145562374e-09
the O 0 4.778816453665513e-09
I113F O 0 3.254750424730446e-07
and O 0 3.208664001164152e-09
T312S O 0 1.504395470419695e-07
mutations O 0 1.3091322470515365e-09
in O 0 2.571043100640935e-10
Australia O 0 3.0477609325174626e-10
corresponded O 0 1.689575979124669e-10
to O 0 1.1254637499735765e-10
those O 0 1.409175554023534e-10
observed O 0 5.363749444597943e-10
in O 0 3.192582309630154e-10
Northern O 0 5.420216098173114e-08
Ireland O 0 2.4301906265122852e-08
and O 0 7.685796443723802e-10
are O 0 6.453592434757516e-12
unique O 0 4.200220379835251e-11
to O 0 5.474401487681746e-11
these O 0 8.739228785081821e-11
two O 0 1.622396661460357e-10
populations O 0 1.516217013053378e-10
, O 0 1.9768209638670875e-11
suggesting O 0 1.2009097882792474e-10
that O 0 3.175527896193131e-11
both O 0 1.9667503736719993e-10
mutations O 0 2.8545293906390157e-10
were O 0 8.155126574038718e-10
probably O 0 1.7114831774023287e-09
introduced O 0 2.5003641379583996e-09
to O 0 4.892980465243113e-10
Australia O 0 3.2964148077851974e-10
by O 0 9.547188040137655e-11
Irish O 0 2.800473986042107e-08
migrants O 0 8.061730727426664e-10
during O 0 1.6251354706398047e-09
the O 0 2.572830171132523e-09
19th O 0 2.670838057383662e-07
century O 0 1.5192109685813193e-06
. O 0 1.6084629805845907e-07

Haplotype O 0 1.3921912795922253e-05
analysis O 0 1.294369127435857e-07
using O 0 1.2874147614638787e-07
6 O 0 2.1100822777953e-07
RFLPs O 0 7.555417482763005e-07
provides O 0 8.90116924612272e-10
additional O 0 1.1472894856368043e-10
data O 0 1.0772258779434551e-10
that O 0 1.493857294809775e-11
the O 0 1.4634680134406608e-09
I113F O 0 7.217693109851098e-08
mutation O 0 3.7023586973994327e-10
originated O 0 1.3516189278917068e-09
from O 0 2.4823582078781214e-10
a O 0 9.348115614926655e-10
common O 0 1.8778591126533684e-08
ancestor O 0 2.621920884848805e-06
. O 0 2.3164997742242122e-07

The O 0 7.299332764887367e-07
other O 0 7.427597648046458e-09
9 O 0 1.5338951442345206e-08
novel O 0 2.401849164002101e-09
mutations O 0 2.2977290903281045e-10
identified O 0 6.132258034696747e-10
in O 0 1.1930491317091452e-10
these O 0 3.469801390654226e-10
23 O 0 2.1889462686885963e-08
patients O 0 1.8302582782681043e-09
were O 0 8.232471371272254e-10
each O 0 2.3565501980349346e-11
limited O 0 7.394334033961059e-10
to O 0 1.5226138128099365e-09
a O 0 2.7356012566315258e-08
single O 0 9.161826852732702e-08
family O 0 1.7041621447333455e-07
. O 0 1.0539084627225748e-07

These O 0 5.253533430504831e-08
data O 0 3.6723875496136316e-08
provide O 0 1.3432662759882419e-09
further O 0 5.630722554883505e-10
evidence O 0 5.0377413352009626e-09
for O 0 8.890683189655135e-10
extensive O 0 3.2381272774273384e-08
allelic O 0 5.613891858047282e-07
heterogeneity O 0 1.2132522897445597e-06
in O 0 1.262776407884303e-07
MPS B-Disease 1 0.9999964237213135
IVA I-Disease 1 1.0
in O 0 1.2060037590799766e-07
British O 0 2.6718546450865688e-06
- O 0 1.9958752091042697e-06
Irish O 0 3.500082641494373e-07
patients O 0 2.0858474947260675e-09
and O 0 1.8338949803187177e-10
provide O 0 7.24998255874354e-11
evidence O 0 9.299885306290889e-10
for O 0 9.203814099745244e-11
their O 0 3.970854201007512e-10
transmission O 0 5.923706414279195e-09
to O 0 3.421471717057756e-10
Australia O 0 5.090690091691386e-10
by O 0 4.773476058872461e-10
British O 0 2.033549151292391e-07
- O 0 2.4281385435642733e-07
Irish O 0 1.7613898251056526e-07
migrants O 0 2.083215600023891e-09
. O 0 6.84946266371611e-10
. O 0 1.0470077249635779e-08

Identification O 0 6.404872578968934e-07
of O 0 2.0470658910198836e-06
constitutional O 0 1.646747659833636e-05
WT1 O 1 0.9970601201057434
mutations O 0 2.674327390650433e-07
, O 0 1.077057998344344e-09
in O 0 3.204368992371087e-10
patients O 0 1.3486445293864335e-09
with O 0 1.1468678229320517e-09
isolated O 0 0.0001224482257384807
diffuse B-Disease 1 1.0
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 3.950218374626502e-09
and O 0 1.7654704087544104e-10
analysis O 0 4.803506481465547e-10
of O 0 7.19668591386835e-09
genotype O 0 6.536145065183518e-07
/ O 0 1.950489405544431e-07
phenotype O 0 3.806489345947739e-09
correlations O 0 2.0109650056276962e-10
by O 0 8.047113322917632e-12
use O 0 6.499626392653113e-10
of O 0 1.0381823400962276e-08
a O 0 1.592001730443826e-08
computerized O 0 4.604374908012687e-07
mutation O 0 1.715288178161245e-08
database O 0 3.144540627886272e-08
. O 0 5.366702637843446e-08

Constitutional O 0 1.9119945136480965e-05
mutations O 0 2.1015431173054822e-07
of O 0 1.657629269402605e-07
the O 0 4.769048800312703e-08
WT1 O 0 6.453632522607222e-06
gene O 0 4.115953355920965e-09
, O 0 1.9496221304038386e-10
encoding O 0 7.650712952056438e-09
a O 0 3.449783747555557e-08
zinc O 0 0.00012111047544749454
- O 0 2.6060512027470395e-05
finger O 0 5.7157656556228176e-05
transcription O 0 6.423397735488834e-06
factor O 0 5.73789504798583e-09
involved O 0 4.034170775213397e-10
in O 0 2.225291284574382e-09
renal O 1 0.9995507597923279
and O 0 8.124548855903413e-08
gonadal O 0 8.708877430763096e-05
development O 0 1.4468776043941034e-07
, O 0 4.632649125424493e-11
are O 0 2.898162612674504e-12
found O 0 1.1167074903672969e-10
in O 0 4.004454406958402e-11
most O 0 5.170736061543835e-11
patients O 0 1.0805760453092006e-10
with O 0 8.787858218894939e-10
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 5.503374723048182e-06
DDS B-Disease 1 1.0
) O 0 1.0896797242310186e-08
, O 0 3.7417591247645987e-10
or O 0 8.141815044382383e-08
diffuse B-Disease 1 0.9999891519546509
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 0 1.5277220200005104e-06
DMS B-Disease 0 0.002476399065926671
) O 0 4.766579908555002e-10
associated O 0 1.4551179150501525e-09
with O 0 1.2410298344533999e-09
pseudohermaphroditism B-Disease 1 1.0
and O 0 5.876253908354556e-06
/ O 1 0.9898375272750854
or O 0 7.135119631129783e-06
Wilms B-Disease 1 1.0
tumor I-Disease 0 0.0002501901180949062
( O 0 7.417166614231974e-08
WT B-Disease 1 0.9999997615814209
) O 0 2.3920941671917717e-08
. O 0 7.020450709660508e-08

Most O 0 1.8991147499036742e-07
mutations O 0 2.7727702445190516e-07
in O 0 2.213400307482516e-07
DDS B-Disease 1 1.0
patients O 0 0.1322951763868332
lie O 0 9.792274795472622e-06
in O 0 1.9070347079264138e-08
exon O 0 2.1665833571660187e-07
8 O 0 1.5774570982785008e-08
or O 0 1.3102589013769261e-09
exon O 0 3.685762450800212e-08
9 O 0 8.978330079401076e-09
, O 0 1.6946689884722588e-10
encoding O 0 7.162753945522127e-08
zinc O 0 0.00018501057638786733
finger O 0 8.086262823780999e-05
2 O 0 2.5853244096651906e-06
or O 0 9.563257918898671e-08
zinc O 0 3.53092145815026e-05
finger O 0 6.069918526918627e-06
3 O 0 2.1111429759912426e-07
, O 0 2.6312507728221135e-10
respectively O 0 1.9754511360048355e-09
, O 0 1.2779521885164513e-10
with O 0 3.2153646412069747e-10
a O 0 8.419432617756684e-08
hot O 0 1.8150682080886327e-05
spot O 0 1.209724928230571e-06
( O 0 2.2228223706122208e-09
R394W O 0 1.0223192248304258e-07
) O 0 5.429398597378565e-10
in O 0 1.8633405929335822e-09
exon O 0 6.272921950767341e-07
9 O 0 5.721504408029432e-07
. O 0 1.7109562122641364e-07

We O 0 1.509445439751289e-07
analyzed O 0 4.760397231962088e-08
a O 0 1.0705230479857164e-08
series O 0 9.060647343517303e-09
of O 0 1.0289485707914992e-08
24 O 0 1.9767638193002313e-08
patients O 0 3.942239867882336e-09
, O 0 5.684298587382841e-10
10 O 0 2.2538595434440367e-09
with O 0 1.6620821385870954e-09
isolated B-Disease 0 6.204829696798697e-05
DMS I-Disease 1 1.0
( O 0 5.059202976553934e-07
IDMS B-Disease 1 0.8371263742446899
) O 0 3.11161096888668e-09
, O 0 3.204130294420793e-10
10 O 0 3.187495822842834e-10
with O 0 2.7524513224186364e-10
DDS B-Disease 1 1.0
, O 0 7.373310406677547e-09
and O 0 2.270800436576792e-09
4 O 0 2.409375454703877e-08
with O 0 5.811920944509552e-10
urogenital B-Disease 1 0.9975637197494507
abnormalities I-Disease 1 0.9984090924263
and O 0 4.52357289759675e-06
/ O 1 0.9999699592590332
or O 0 0.0006715167546644807
WT B-Disease 1 1.0
. O 0 1.7647049617153243e-06

We O 0 1.1460831501608482e-06
report O 0 3.1793086918696645e-07
WT1 O 0 0.00027683962252922356
heterozygous O 0 9.525029298629306e-08
mutations O 0 3.4250577929384463e-09
in O 0 2.760391248912697e-09
16 O 0 3.132089787527548e-08
patients O 0 8.418127528386776e-09
, O 0 1.3744181348585016e-09
4 O 0 5.616816167730576e-08
of O 0 2.2841986080379684e-08
whom O 0 5.135889580287767e-08
presented O 0 2.360051922778439e-07
with O 0 4.136354192496583e-08
IDMS B-Disease 1 0.9999998807907104
. O 0 1.175130091723986e-05

One O 0 6.704316319883219e-07
male O 0 7.254295297798308e-08
and O 0 4.236786033118278e-09
two O 0 2.2249473374813533e-09
female O 0 1.1323876059066151e-08
IDMS B-Disease 1 0.9999096393585205
patients O 0 4.1867011191243364e-07
with O 0 2.025827825491433e-07
WT1 O 1 1.0
mutations O 0 1.2263974895176943e-05
underwent O 0 0.0006620481144636869
normal O 0 7.039053571133991e-07
puberty O 0 2.7219443836656865e-06
. O 0 5.532573155164755e-08

Two O 0 3.9655722616771527e-07
mutations O 0 5.9053771650496856e-08
associated O 0 3.559922490126155e-08
with O 0 3.3245526331882047e-09
IDMS B-Disease 1 0.9999611377716064
are O 0 1.45284867469897e-10
different O 0 1.0957080381901463e-10
from O 0 3.2745195444050523e-10
those O 0 1.0799537653038982e-10
described O 0 9.847102688809173e-09
in O 0 2.3967295703641867e-08
DDS B-Disease 1 1.0
patients O 0 0.005827794782817364
. O 0 7.251070996971976e-07

No O 0 1.726539085211698e-05
WT1 O 0 0.0016208899905905128
mutations O 0 1.8185139083470858e-07
were O 0 1.603778265746314e-08
detected O 0 4.710387102591085e-08
in O 0 1.515856329348253e-09
the O 0 1.1609208705465335e-08
six O 0 9.79166525638675e-09
other O 0 8.776789961473241e-09
IDMS B-Disease 1 1.0
patients O 0 8.690443792147562e-05
, O 0 1.5122176844073465e-09
suggesting O 0 7.569963322850981e-09
genetic O 0 2.2033052715642043e-08
heterogeneity O 0 1.347352593938922e-07
of O 0 7.331173890179343e-08
this O 0 1.6326733742744182e-08
disease O 0 0.00029893414466641843
. O 0 1.8344256602631503e-07

We O 0 1.2872027355115279e-06
analyzed O 0 4.244682543230738e-07
genotype O 0 3.4135305213567335e-06
/ O 0 8.045377057896985e-07
phenotype O 0 8.395410588946106e-08
correlations O 0 1.5843893308442603e-08
, O 0 1.947433048155034e-10
on O 0 1.0262941607663834e-09
the O 0 2.8636251703240134e-10
basis O 0 5.325603291694847e-10
of O 0 1.025439066992817e-09
the O 0 1.658649217972652e-09
constitution O 0 4.4628487017028817e-10
of O 0 5.708661099390611e-09
a O 0 9.156895686146527e-09
WT1 O 0 2.6660793537303107e-06
mutation O 0 1.5256428342880213e-09
database O 0 1.866798271521475e-09
of O 0 1.3838570289692598e-08
84 O 0 1.7245791639197705e-07
germ O 1 0.7264556884765625
- O 0 0.0002549668133724481
line O 0 3.2678710795153165e-06
mutations O 0 2.8047544287090886e-09
, O 0 7.155506742684281e-11
to O 0 9.954315843829775e-11
compare O 0 1.8043933014411095e-09
the O 0 1.416041395252421e-09
distribution O 0 4.2388934029524705e-10
and O 0 6.447013756183395e-11
type O 0 1.6295056415316367e-09
of O 0 1.5727995572589748e-09
mutations O 0 3.092125513970423e-11
, O 0 4.157646883024002e-12
according O 0 5.979468222644391e-12
to O 0 4.533549924357061e-11
the O 0 7.362457865589533e-10
different O 0 1.4523700020419028e-09
symptoms O 0 2.204265229011071e-06
. O 0 4.191755067495251e-07

This O 0 1.1627871998598494e-07
demonstrated O 0 1.9516205895797611e-07
( O 0 4.0987493399313735e-09
1 O 0 2.099115015141706e-08
) O 0 1.2954774752937936e-10
the O 0 4.1307049447603106e-10
association O 0 1.432606949736126e-10
between O 0 7.01392610658047e-10
mutations O 0 6.123585527539888e-10
in O 0 2.0513368781394092e-09
exons O 0 1.2327349452334602e-07
8 O 0 1.801347515595353e-08
and O 0 1.5683301324287413e-09
9 O 0 2.616375205377608e-08
and O 0 5.364652722050778e-09
DMS B-Disease 0 0.0032852478325366974
; O 0 2.2202641503099585e-08
( O 0 1.4811321058516569e-08
2 O 0 1.6401322966430598e-07
) O 0 2.663740339414744e-10
among O 0 1.7819561104470694e-10
patients O 0 4.825582156087194e-10
with O 0 3.583579266663861e-10
DMS B-Disease 0 0.005064023192971945
, O 0 6.426379428603468e-10
a O 0 5.247359213811364e-10
higher O 0 2.6299176170141436e-09
frequency O 0 2.805176979592261e-09
of O 0 2.3167190388306835e-09
exon O 0 7.149484559931807e-09
8 O 0 1.6003123270991182e-09
mutations O 0 4.386321514338043e-11
among O 0 3.1781573900380167e-11
46 O 0 4.537819453531711e-09
, O 0 1.6317885931371734e-09
XY O 0 0.047088623046875
patients O 0 6.796476981207888e-08
with O 0 1.8621751918246332e-09
female O 0 6.472500313492446e-09
phenotype O 0 7.521546940836288e-09
than O 0 2.575518270875321e-11
among O 0 1.2711720565050655e-10
46 O 0 1.033992891308344e-08
, O 0 1.1928177334752377e-09
XY O 0 0.013292760588228703
patients O 0 1.0452677834393853e-08
with O 0 7.57238161064322e-11
sexual O 0 2.5428739669486333e-10
ambiguity O 0 4.3718508813128665e-09
or O 0 1.2282470873703488e-10
male O 0 3.744077617384711e-11
phenotype O 0 8.410833141070384e-11
; O 0 1.653151920910645e-11
and O 0 1.9457734035110974e-10
( O 0 4.758921590131138e-10
3 O 0 1.4512050228177031e-08
) O 0 1.1586567122412461e-10
statistically O 0 9.82974899393918e-12
significant O 0 5.6093987094163467e-11
evidence O 0 6.572455912845498e-10
that O 0 5.7030831446258645e-11
mutations O 0 1.5363883776320364e-10
in O 0 5.462877927797649e-10
exons O 0 1.0772109959589216e-07
8 O 0 2.6081192316951274e-08
and O 0 1.33885147413082e-09
9 O 0 7.3303736414231935e-09
preferentially O 0 5.924821744329734e-10
affect O 0 3.5024491640278654e-10
amino O 0 1.2329132159649703e-10
acids O 0 3.6811342168929784e-11
with O 0 3.026180651552468e-12
different O 0 3.953455618432855e-11
functions O 0 1.1050693693448466e-09
. O 0 8.453586719525674e-10
. O 0 1.0104797887322547e-08

The O 0 4.129754870518809e-06
185delAG O 0 8.649683877592906e-06
BRCA1 O 0 1.3637782103614882e-07
mutation O 0 1.4977675766303378e-09
originated O 0 1.3678618238088802e-09
before O 0 7.138443725018817e-10
the O 0 2.2143327449430927e-10
dispersion O 0 1.1386772413857216e-08
of O 0 9.551824220466187e-09
Jews O 0 1.312455655266831e-08
in O 0 1.1392111698427243e-09
the O 0 1.5408204712130669e-09
diaspora O 0 2.674116261758286e-09
and O 0 8.359912762045951e-10
is O 0 4.6939670900192354e-11
not O 0 3.864968761702059e-11
limited O 0 5.1312626370148e-10
to O 0 7.333394336228594e-09
Ashkenazim O 0 0.00011930173786822706
. O 0 1.4135063111098134e-06

The O 0 1.8067812561639585e-06
185delAG O 0 3.2589418879069854e-06
mutation O 0 3.524244718278169e-08
in O 0 3.684298643946704e-09
BRCA1 O 0 1.0915101711361785e-08
is O 0 1.4177649332314246e-10
detected O 0 1.5370280603832498e-09
in O 0 8.651494798339598e-11
Ashkenazi O 0 1.4507739365399175e-07
Jews O 0 7.743362395729037e-09
both O 0 4.0334169337796766e-10
in O 0 2.184865621757126e-09
familial B-Disease 1 0.9868011474609375
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.566124829821547e-08
in O 0 6.739876434735947e-10
the O 0 2.223220940678061e-09
general O 0 9.146422286221423e-09
population O 0 1.353697709483015e-10
. O 0 7.313740724157469e-09

All O 0 2.8094254389543494e-07
tested O 0 2.1846049946816493e-07
Ashkenazi O 0 5.9313970268704e-07
mutation O 0 3.760491917859099e-09
carriers O 0 1.4894432354140008e-09
share O 0 2.7800892699048063e-09
the O 0 1.516770153919822e-09
same O 0 1.3082436245426265e-09
allelic O 0 2.9882568242101115e-07
pattern O 0 8.170189147449491e-08
at O 0 4.543086973285426e-08
the O 0 1.4574796480815166e-08
BRCA1 O 0 9.541139434077195e-08
locus O 0 3.536028430062288e-07
. O 0 6.873339231106002e-08

Our O 0 3.714043941727141e-06
previous O 0 2.6614634407451376e-07
study O 0 2.2476434047291605e-09
showed O 0 5.848808104502723e-10
that O 0 1.7436203522680493e-11
this O 0 1.6515297462937895e-10
Ashkenazi O 0 9.218889545081765e-07
mutation O 0 2.3994042308572716e-09
also O 0 1.8041033944538043e-10
occurs O 0 3.0421203750519155e-11
in O 0 1.5181406479158888e-11
Iraqi O 0 2.8366091697762386e-09
Jews O 0 5.030069694100803e-09
with O 0 1.8478872598759466e-10
a O 0 6.807861496760381e-10
similar O 0 2.562496659308522e-09
allelic O 0 7.642794912499085e-07
pattern O 0 3.2556042128817353e-07
. O 0 1.817400772097244e-07

We O 0 4.648859146527684e-07
extended O 0 1.8714843008638127e-07
our O 0 2.2235953522908858e-08
analysis O 0 1.1485972173375103e-09
to O 0 4.0329706241237773e-10
other O 0 3.7770089833522036e-10
non O 0 8.114695582150944e-09
- O 0 1.9560904007676072e-08
Ashkenazi O 0 4.82441805615963e-07
subsets O 0 2.656735809125621e-08
354 O 0 3.77947539931256e-09
of O 0 3.317121299861725e-10
Moroccan O 0 6.6838086176801426e-09
origin O 0 8.468384882220903e-10
, O 0 1.6462743668288482e-10
200 O 0 1.1597445226385616e-10
Yemenites O 0 8.952358854230624e-08
and O 0 2.236857588044927e-09
150 O 0 2.445104563264522e-09
Iranian O 0 1.6330369589923066e-07
Jews O 0 3.8806240354460897e-07
. O 0 4.470520593713445e-07

Heteroduplex O 0 7.496521720895544e-05
analysis O 0 8.129463680006666e-08
complemented O 0 9.131435518838771e-08
by O 0 5.845216533018061e-10
direct O 0 2.1459398702461385e-09
DNA O 0 1.5327078273230654e-08
sequencing O 0 4.724099156305783e-08
of O 0 2.127734965995387e-08
abnormally O 0 2.3038134955299938e-08
migrating O 0 2.414609401313328e-09
bands O 0 5.9669451601962464e-09
were O 0 4.9935628965158685e-09
employed O 0 8.636668979988826e-08
. O 0 8.561681141827648e-08

Four O 0 4.4344031380205706e-07
of O 0 1.558543090141029e-07
Moroccan O 0 4.2998198068744387e-07
origin O 0 1.3267061227395516e-08
( O 0 4.907392270325772e-10
1 O 0 2.810596866353876e-09
. O 0 7.657113831882612e-11
1 O 0 3.7456455714846015e-09
% O 0 8.630514358731745e-11
) O 0 3.4492322192880565e-11
and O 0 9.981732107533503e-11
none O 0 2.7423285864358604e-09
of O 0 2.9305756044095688e-08
the O 0 1.977359609384166e-08
Yemenites O 0 3.6419402249521227e-07
or O 0 1.8256072209510421e-09
Iranians O 0 2.106907537324787e-09
was O 0 4.859555868819143e-09
a O 0 7.675394764206089e-10
carrier O 0 1.7757040282617709e-09
of O 0 6.0481615271612554e-09
the O 0 1.4586255758786137e-08
185delAG O 0 6.860175858491857e-07
mutation O 0 4.348990145786047e-08
. O 0 1.3708903168208053e-07

BRCA1 O 0 9.12638188310666e-06
allelic O 0 1.9512760900397552e-06
patterns O 0 1.834557927793412e-08
were O 0 2.716932012702955e-09
determined O 0 3.3354772277505162e-09
for O 0 3.717927077317995e-10
four O 0 2.1272297812124918e-10
of O 0 4.600107794683339e-10
these O 0 2.6335891800677302e-11
individuals O 0 3.580692166382793e-12
and O 0 1.602293714375591e-10
for O 0 1.210836569898177e-10
12 O 0 6.607196456620557e-10
additional O 0 4.551877486047573e-10
non O 0 9.167923309405523e-09
- O 0 1.529329196614526e-08
Ashkenazi O 0 1.755470151465488e-07
185delAG O 0 1.2186342601694378e-08
mutation O 0 1.5371036388156512e-10
carriers O 0 2.508287189062486e-10
who O 0 1.7213175329544583e-09
had O 0 1.2348687050689477e-06
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 4.846091087529203e-06

Six O 0 7.845131221984047e-06
non O 0 4.385355168778915e-06
- O 0 6.754527817065537e-07
Ashkenazi O 0 2.608806653370266e-06
individuals O 0 2.2940549460059856e-10
shared O 0 3.6738148079251687e-09
the O 0 1.0697489560840268e-09
common O 0 6.704416133374025e-09
Ashkenazi O 0 5.488256533681124e-07
haplotype O 0 8.33719639103947e-07
, O 0 1.921624193101934e-09
four O 0 1.3240941676428974e-09
had O 0 7.135751989295613e-09
a O 0 1.7148880093742491e-09
closely O 0 1.0407091854958139e-10
related O 0 6.196027579896679e-10
pattern O 0 2.2623282802669564e-08
, O 0 6.544934039176553e-10
and O 0 8.556644837121041e-10
the O 0 1.1698475077537296e-08
rest O 0 5.499148869603232e-08
( O 0 6.814071529248622e-10
n O 0 7.841845395262226e-09
= O 0 8.710780541321128e-09
6 O 0 6.040414390895421e-09
) O 0 1.63245389428468e-10
displayed O 0 2.7245605771497594e-09
a O 0 8.525939954040496e-09
distinct O 0 3.763701528214369e-08
BRCA1 O 0 1.7766221560577833e-07
allelic O 0 1.0966583658955642e-06
pattern O 0 4.6480565174533695e-07
. O 0 3.3224725370928354e-07

We O 0 3.0860471156302083e-07
conclude O 0 4.824813686354901e-07
that O 0 3.344523324955162e-09
the O 0 4.062420089212537e-08
185delAG O 0 1.2433404208422871e-06
BRCA1 O 0 3.24523767858409e-08
mutation O 0 1.0738866462745023e-09
occurs O 0 2.4355895078542744e-10
in O 0 8.751038782506271e-11
some O 0 5.4450766812097484e-11
non O 0 2.7584770023736382e-08
- O 0 1.350376805930864e-07
Ashkenazi O 0 9.183060683426447e-06
populations O 0 2.5950872561963934e-09
at O 0 8.618921132352853e-10
rates O 0 1.1274168404407092e-10
comparable O 0 7.670960533445736e-10
with O 0 6.749393405280912e-11
that O 0 4.726455338222024e-10
of O 0 2.4456804226247186e-07
Ashkenazim O 0 0.00015613160212524235
. O 0 6.646143901889445e-07

The O 0 4.0622967389936093e-07
majority O 0 8.237894810747548e-09
of O 0 1.1427589541312955e-08
Jewish O 0 1.233149671264755e-08
185delAG O 0 6.936621588238268e-08
mutation O 0 1.1130462107544759e-09
carriers O 0 3.659545999568081e-10
have O 0 1.3295216316766556e-10
a O 0 9.464660166713657e-10
common O 0 1.0220206014821542e-08
allelic O 0 1.2787488401500013e-07
pattern O 0 2.6373784933753086e-08
, O 0 2.730885517721049e-10
supporting O 0 2.639954033156755e-09
the O 0 2.09912691673253e-08
founder O 0 5.337914217307116e-07
effect O 0 1.045973796465205e-08
notion O 0 5.518734980114459e-08
, O 0 1.7381292238827228e-10
but O 0 3.825467373430591e-11
dating O 0 3.852091701173066e-10
the O 0 7.876389124250593e-11
mutations O 0 3.2031922687220105e-12
origin O 0 3.51574637458274e-11
to O 0 4.0372014759038066e-11
an O 0 2.138244442617676e-11
earlier O 0 2.5066528852590864e-09
date O 0 8.467859657912413e-08
than O 0 6.012456643667008e-10
currently O 0 1.148334316525279e-09
estimated O 0 9.61429491574961e-10
. O 0 2.5351569732379176e-08

However O 0 2.2124821441593667e-07
, O 0 2.1156580931602775e-09
the O 0 8.24348589389956e-10
different O 0 1.5023129962266069e-10
allelic O 0 6.84189558342041e-08
pattern O 0 3.394356795638487e-08
at O 0 1.2157832962600423e-08
the O 0 3.844122797858063e-09
BRCA1 O 0 4.888523807977663e-09
locus O 0 3.734168085856027e-09
even O 0 3.410603466313944e-10
in O 0 1.0151730844842888e-10
some O 0 3.434913464772649e-11
Jewish O 0 2.1209267675459387e-09
mutation O 0 9.045792448425516e-10
carriers O 0 9.619943730498903e-10
, O 0 1.324207132835653e-10
might O 0 4.5392711811587105e-10
suggest O 0 1.0959322338521815e-09
that O 0 1.751287170836946e-10
the O 0 2.898924655880819e-09
mutation O 0 4.768143657685187e-10
arose O 0 3.0728208866293016e-09
independently O 0 1.6267914793033356e-09
. O 0 2.310986069176124e-09
. O 0 6.089278770105011e-08

Crystal O 0 0.00026584576698951423
structure O 0 1.088880071620224e-05
of O 0 8.592580707045272e-05
the O 0 2.95946065307362e-05
hemochromatosis B-Disease 1 1.0
protein O 0 1.7286705542574055e-06
HFE O 0 0.000351564958691597
and O 0 3.221209965431626e-09
characterization O 0 7.622924158567912e-08
of O 0 2.1243652170710448e-08
its O 0 1.1275163025459278e-09
interaction O 0 1.1082079698354619e-09
with O 0 2.484797367863223e-10
transferrin O 0 3.047193786187563e-06
receptor O 0 9.526755917477203e-08
. O 0 5.1585779203833226e-08

HFE O 0 0.3311602771282196
is O 0 3.33377471406493e-07
an O 0 7.89644882814855e-09
MHC O 0 5.9731014516728465e-06
- O 0 2.739868023127201e-06
related O 0 2.279837758578651e-07
protein O 0 1.8167643389688237e-08
that O 0 1.2102524538093462e-10
is O 0 8.439291626638479e-11
mutated O 0 1.1350770323659276e-09
in O 0 7.794822565188042e-10
the O 0 4.065234406880336e-07
iron B-Disease 1 1.0
- I-Disease 1 1.0
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 0.00010207573359366506

HFE O 0 0.003557212883606553
binds O 0 2.0790939743164927e-06
to O 0 1.5006941112005734e-07
transferrin O 0 3.0314866307890043e-05
receptor O 0 1.1588582538024639e-07
( O 0 1.273568028814509e-09
TfR O 0 2.3236907509271987e-07
) O 0 1.95278557213463e-10
and O 0 2.7970228910767503e-10
reduces O 0 6.16277073817173e-09
its O 0 1.5760397431563433e-09
affinity O 0 9.828976743619933e-09
for O 0 5.742679665132755e-09
iron O 0 5.728195537813008e-05
- O 0 1.547548862390613e-07
loaded O 0 2.631495021887531e-07
transferrin O 0 5.968466211925261e-06
, O 0 8.681587893022424e-09
implicating O 0 5.909720584895695e-06
HFE O 1 0.9999973773956299
in O 0 2.7241933366894955e-06
iron O 1 0.9999998807907104
metabolism O 0 9.227142436429858e-05
. O 0 4.863495064455492e-07

The O 0 2.2228030502446927e-05
2 O 0 1.6902318748179823e-05
. O 0 1.9504780084389495e-06

6 O 0 0.00011786501272581518
A O 0 1.389613862556871e-05
crystal O 0 6.764911086065695e-05
structure O 0 1.0916873179667164e-05
of O 0 9.313211194239557e-06
HFE O 1 0.9999996423721313
reveals O 0 1.4252925666369265e-06
the O 0 9.60278967454542e-09
locations O 0 4.239170348085963e-09
of O 0 6.6594040504242e-08
hemochromatosis B-Disease 1 1.0
mutations O 0 9.378019427686013e-08
and O 0 1.3684418043169444e-08
a O 0 2.5865396935387253e-08
patch O 0 0.29575303196907043
of O 0 0.0008869348675943911
histidines O 0 0.008081011474132538
that O 0 1.789040693367383e-09
could O 0 2.229624707084099e-09
be O 0 7.893704023764769e-10
involved O 0 7.404565849356004e-10
in O 0 1.2939445070969668e-09
pH O 0 2.3392378807329806e-06
- O 0 6.529130018861906e-07
dependent O 0 8.401177353789535e-08
interactions O 0 3.4227412015752634e-08
. O 0 1.1665503052427084e-07

We O 0 1.1588078905333532e-06
also O 0 3.3772561636169485e-08
demonstrate O 0 1.7566282650705034e-08
that O 0 1.1845039393776347e-09
soluble O 0 1.2708844678854803e-06
TfR O 0 3.9698283217148855e-05
and O 0 2.611195171198233e-08
HFE O 0 0.00022564601385965943
bind O 0 1.22721374395951e-07
tightly O 0 1.4147225613214687e-07
at O 0 6.858642986884433e-09
the O 0 1.4791495805965837e-09
basic O 0 1.0845126574565711e-08
pH O 0 8.57230233464179e-08
of O 0 2.6691237664522305e-08
the O 0 5.036107975087134e-09
cell O 0 1.1445870029547223e-08
surface O 0 7.457123807341759e-09
, O 0 6.52940757017717e-11
but O 0 5.009202774797217e-11
not O 0 1.0456735477504253e-10
at O 0 3.2089881862873426e-09
the O 0 2.977711854867948e-09
acidic O 0 4.3844462993547495e-07
pH O 0 1.7319181324637611e-06
of O 0 4.6089658667369804e-07
intracellular O 0 4.3389363213464094e-07
vesicles O 0 8.631380410406564e-07
. O 0 1.6366649902010977e-07

TfR O 0 0.0017743294592946768
HFE O 0 0.0020065228454768658
stoichiometry O 0 3.270264278398827e-05
( O 0 1.9075955037806125e-07
2 O 0 4.2219852502967115e-07
1 O 0 2.9788779443151725e-08
) O 0 3.2971569918771593e-10
differs O 0 4.331512482025346e-09
from O 0 5.807680558689299e-09
TfR O 0 1.6792331507531344e-06
transferrin O 0 2.985475930472603e-06
stoichiometry O 0 1.1137821331885789e-07
( O 0 1.7902694882110382e-09
2 O 0 1.7986145905979356e-08
2 O 0 5.136954861484355e-09
) O 0 4.3638072322327304e-11
, O 0 1.8111012689558947e-11
implying O 0 5.344897857639808e-10
a O 0 4.999335390110105e-10
different O 0 4.560774327644346e-11
mode O 0 6.500733729097874e-09
of O 0 4.457999525087075e-10
binding O 0 6.376904004845585e-10
for O 0 5.358228305496482e-10
HFE O 0 4.4206768507137895e-05
and O 0 2.3622151346103237e-08
transferrin O 0 1.2456868034860236e-06
to O 0 4.241119455627995e-09
TfR O 0 1.0228960718450253e-06
, O 0 2.1147252005082606e-10
consistent O 0 9.321871052847541e-10
with O 0 2.952329769545514e-10
our O 0 9.22299481231903e-09
demonstration O 0 7.565618354021808e-09
that O 0 1.9439706788748623e-10
HFE O 0 2.35203406191431e-05
, O 0 2.0261894384532297e-09
transferrin O 0 9.359932278130145e-07
, O 0 9.632979969254052e-10
and O 0 6.998063795116138e-10
TfR O 0 4.3625325929497194e-07
form O 0 5.7162883315697854e-09
a O 0 2.6433964350758288e-08
ternary O 0 1.4893040543029201e-06
complex O 0 8.891368452168535e-06
. O 0 2.2442290514845809e-07

Identification O 0 9.814177701628068e-07
of O 0 7.497887395402358e-07
three O 0 8.612845547872894e-09
novel O 0 2.033181978333687e-08
mutations O 0 1.5295005262316863e-09
and O 0 8.427007980316148e-10
a O 0 1.9824490937736527e-09
high O 0 2.9432243309202022e-08
frequency O 0 1.1533440869015976e-08
of O 0 4.704387102094643e-09
the O 0 1.580100161824305e-09
Arg778Leu O 0 1.7351142389543384e-07
mutation O 0 4.2502357189277973e-10
in O 0 2.236532209431985e-10
Korean O 0 1.2116399261685729e-07
patients O 0 9.834221215143657e-10
with O 0 7.059262618902551e-10
Wilson B-Disease 0 3.336572035550489e-06
disease I-Disease 0 1.927123958012089e-05
. O 0 5.033901970818988e-07

Four O 0 2.0979498458473245e-06
mutations O 0 7.158875092727612e-08
- O 0 4.978601850780251e-07
- O 0 9.684983979241224e-07
R778L O 0 6.486068741651252e-06
, O 0 1.0217165780090909e-08
A874V O 0 1.1467303693279973e-06
, O 0 3.5890808103289373e-09
L1083F O 0 3.355851845299185e-07
, O 0 9.820819713013407e-10
and O 0 1.5392401797598154e-09
2304delC O 0 1.2558359685499454e-07
- O 0 4.509194440061037e-08
- O 0 3.934594872134767e-08
in O 0 3.5566429801292543e-09
the O 0 1.596557019922784e-08
copper O 0 5.323364575815503e-07
- O 0 3.709770268756074e-08
transporting O 0 3.6429330663168e-08
enzyme O 0 1.0244386672297878e-08
, O 0 2.1100161617937374e-09
P O 0 1.1810346904894686e-06
- O 0 1.521461285847181e-07
type O 0 3.608928125231614e-07
ATPase O 0 3.903894310042233e-07
( O 0 1.0356622226481704e-09
ATP7B O 0 7.808935151842888e-07
) O 0 7.720467321004065e-11
, O 0 1.1737682874268796e-11
were O 0 3.770600845443006e-11
identified O 0 1.8911168464530448e-10
in O 0 1.990131254236971e-10
Korean O 0 4.0236514564639947e-07
Patients O 0 5.457330143343597e-09
with O 0 6.892736381658437e-10
Wilson B-Disease 0 5.226596385909943e-06
disease I-Disease 0 3.440483851591125e-05
. O 0 4.606882555435732e-07

Arg778Leu O 0 0.008975405246019363
, O 0 7.67585603966836e-08
the O 0 1.8731194373344806e-08
most O 0 1.0235787772927551e-09
frequently O 0 8.4823520429822e-10
reported O 0 3.143098004088074e-10
mutation O 0 7.175898764089084e-11
of O 0 8.105008886261089e-10
this O 0 1.2713829988797443e-10
enzyme O 0 2.6205588810057634e-09
, O 0 2.0128762545645884e-10
was O 0 3.115286917321214e-09
found O 0 2.616576955105643e-10
in O 0 8.537730245006259e-11
six O 0 3.2151867279672786e-10
of O 0 1.3850895985711986e-09
eight O 0 6.461062795892758e-10
unrelated O 0 2.0431796254882784e-09
patients O 0 3.1795899246844783e-10
studied O 0 8.56797910397944e-10
, O 0 1.1969050750515464e-11
an O 0 5.581179182007068e-12
allele O 0 8.422311459366227e-11
frequency O 0 2.381249641913996e-09
of O 0 1.8461522088841775e-08
37 O 0 2.027627203915472e-07
. O 0 1.4823027072452533e-07

5 O 0 1.2993338032174506e-06
% O 0 1.1729688331740817e-08
, O 0 4.884196935783791e-10
which O 0 6.580768568964501e-11
is O 0 9.995563404752161e-11
considerably O 0 1.0581580944801772e-08
higher O 0 3.28619642608885e-09
than O 0 3.553039112924594e-11
those O 0 5.001469377541312e-11
in O 0 1.8295173709326207e-10
other O 0 3.4975888851818127e-10
Asian O 0 5.626098253941336e-09
populations O 0 2.6193947011421415e-09
. O 0 1.1758966245167812e-08

The O 0 1.0362970215282985e-06
novel O 0 1.5845259326852101e-07
single O 0 9.550949364722783e-09
nucleotide O 0 1.0593090848942666e-08
deletion O 0 1.7996372392303783e-08
, O 0 2.476163440956469e-10
2304delC O 0 7.664854706490587e-08
, O 0 7.506337773577343e-10
was O 0 1.736278854025386e-08
found O 0 2.3910071700328217e-09
in O 0 2.0752324303430214e-09
one O 0 9.277212775771204e-09
patient O 0 2.7185049589206756e-07
. O 0 4.255829537669342e-07

Since O 0 7.078069188537484e-07
a O 0 4.925495744600994e-08
mutation O 0 1.14006803997313e-08
at O 0 1.461008913850037e-08
cDNA O 0 6.96807518352216e-08
nucleotide O 0 1.1025880297665935e-07
2302 O 0 1.0782140634546522e-05
( O 0 5.134692226960169e-09
2302insC O 0 2.1921076154285402e-07
) O 0 1.2934288085020285e-09
had O 0 4.003939402252854e-09
been O 0 1.175720965029825e-09
previously O 0 3.795947112195108e-09
described O 0 1.4323070507415991e-09
, O 0 3.414650506794459e-11
this O 0 1.6714652231741844e-11
region O 0 2.6440811762284966e-09
of O 0 1.68809588529939e-08
the O 0 3.225023093023083e-08
ATP7B O 0 0.00022370688384398818
gene O 0 6.206345215531428e-09
may O 0 1.1910672448323112e-09
be O 0 7.083067465885051e-10
susceptible O 0 1.0599254665066837e-06
to O 0 2.2567858692923437e-08
gene O 0 9.429097076463222e-07
rearrangements O 0 0.0009634981979615986
causing O 0 7.264434680109844e-05
Wilson B-Disease 0 0.0007520806393586099
disease I-Disease 0 0.0003797534736804664
. O 0 5.714132385037374e-07

Disruption O 0 6.357231177389622e-05
of O 0 8.430823754679295e-07
splicing O 0 3.0391268523999315e-07
regulated O 0 1.0588566468072713e-08
by O 0 6.171448352354503e-10
a O 0 1.4934180114778428e-08
CUG O 0 0.00020800682250410318
- O 0 4.5928098302283615e-07
binding O 0 3.868249009997271e-08
protein O 0 2.7972291150035744e-07
in O 0 2.7310342431974277e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 2.0196397599647753e-05

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9240477681159973
DM B-Disease 1 1.0
) O 0 2.128784899468883e-07
is O 0 1.383481662564634e-09
caused O 0 1.1115235842851234e-08
by O 0 5.762701427158845e-10
a O 0 1.5136036424223676e-08
CTG O 0 2.804044697768404e-06
expansion O 0 6.638453697860314e-08
in O 0 9.391866173658059e-10
the O 0 3.5560530076139685e-09
3 O 0 2.8153143816211923e-08
untranslated O 0 5.851827881997451e-05
region O 0 2.3839412222059764e-08
of O 0 4.418142651729795e-08
the O 0 6.404158625628043e-07
DM B-Disease 1 1.0
gene O 0 2.6382824671600247e-06
. O 0 9.378588288200262e-07

One O 0 5.6575014895088316e-08
model O 0 5.047150253290056e-08
of O 0 5.338250161912583e-07
DM B-Disease 1 1.0
pathogenesis O 1 0.9987566471099854
suggests O 0 8.804542517282243e-08
that O 0 4.997467439871173e-10
RNAs O 0 4.91655072210051e-08
from O 0 1.1101288777126683e-09
the O 0 1.297176699388558e-09
expanded O 0 4.026055488992597e-09
allele O 0 1.1143675981983847e-09
create O 0 4.993294111521607e-10
a O 0 3.301991791104797e-09
gain O 0 3.6091822863681955e-08
- O 0 4.3470333110917636e-08
of O 0 2.999740189579825e-08
- O 0 2.8756367953519657e-08
function O 0 2.438341195620808e-10
mutation O 0 4.308683618226006e-11
by O 0 6.498677897898153e-12
the O 0 1.2497422541279946e-10
inappropriate O 0 2.989741232362064e-10
binding O 0 5.536104352721338e-10
of O 0 1.109115133068883e-09
proteins O 0 4.4102638208087797e-11
to O 0 8.363963965862808e-10
the O 0 4.187060653748631e-08
CUG O 0 0.0009896137053146958
repeats O 0 3.500834509395645e-06
. O 0 3.9514230820714147e-07

Data O 0 1.3000775425098254e-06
presented O 0 5.989261921968136e-07
here O 0 1.9899282222013426e-08
indicate O 0 4.913426554509215e-09
that O 0 1.5646430817639612e-09
the O 0 1.975580232738139e-08
conserved O 0 3.442960405664053e-08
heterogeneous O 0 5.972549956823059e-07
nuclear O 0 2.2510810595122166e-05
ribonucleoprotein O 0 3.766222289414145e-05
, O 0 1.3009882948722407e-08
CUG O 0 1.6551441149204038e-05
- O 0 1.2478800215376395e-07
binding O 0 1.2962647844005915e-08
protein O 0 1.0806019190567895e-08
( O 0 7.986417083216679e-10
CUG O 0 2.2830694433650933e-05
- O 0 7.15499766101857e-07
BP O 0 8.962094398157205e-06
) O 0 1.4136962711575052e-09
, O 0 5.063063857058125e-10
may O 0 5.4490301160114996e-09
mediate O 0 1.0796592277984018e-06
the O 0 1.0525710649744724e-06
trans O 0 1.4678153092972934e-06
- O 0 4.993723337065603e-07
dominant O 0 2.6479264647605305e-07
effect O 0 1.1515459696909147e-08
of O 0 3.494631783951263e-08
the O 0 3.207808774163823e-08
RNA O 0 6.309580840024864e-07
. O 0 6.403467978088884e-08

CUG O 1 0.9999712705612183
- O 0 0.1116708368062973
BP O 0 0.0007518771453760564
was O 0 3.483279726879118e-07
found O 0 9.37175337334395e-10
to O 0 1.1703440994104142e-10
bind O 0 6.293289223080478e-10
to O 0 2.00631511404481e-09
the O 0 6.138992603155202e-08
human O 0 6.163896273392311e-07
cardiac O 1 0.9915691018104553
troponin O 0 0.0010134855983778834
T O 0 1.795911339286249e-05
( O 0 7.172759275420049e-09
cTNT O 0 2.2077125549913035e-07
) O 0 2.1185887766339562e-10
pre O 0 1.6323534168805054e-07
- O 0 3.80729687776693e-08
messenger O 0 3.9559655107268554e-08
RNA O 0 2.6250377871406272e-08
and O 0 3.835844142319189e-10
regulate O 0 1.894546602931868e-10
its O 0 2.7864049956249914e-10
alternative O 0 3.25364197806266e-08
splicing O 0 6.943106996004644e-07
. O 0 9.237523102001433e-08

Splicing O 0 7.453481430275133e-06
of O 0 1.5242932249748264e-06
cTNT O 0 6.252365710679442e-05
was O 0 4.326092494011391e-06
disrupted O 0 9.974919521482661e-06
in O 0 2.171353088442629e-07
DM B-Disease 1 1.0
striated O 0 0.010195109993219376
muscle O 0 1.9599597180786077e-06
and O 0 5.0341899537897916e-08
in O 0 1.9219907887446652e-09
normal O 0 5.11685938064943e-09
cells O 0 2.1161021823701276e-09
expressing O 0 1.009485273151256e-09
transcripts O 0 1.0375884151869741e-08
that O 0 5.583484230520241e-10
contain O 0 3.481067167854235e-08
CUG O 0 0.003979488741606474
repeats O 0 7.404286407108884e-06
. O 0 5.870417112419091e-07

Altered O 0 6.697473509120755e-06
expression O 0 5.534899969461549e-07
of O 0 2.531727147925267e-07
genes O 0 2.702492984951732e-08
regulated O 0 1.473383548500351e-08
posttranscriptionally O 0 7.037945692900394e-07
by O 0 1.2327403986489571e-08
CUG O 1 0.9996423721313477
- O 0 0.0003313935885671526
BP O 0 5.330952990334481e-05
therefore O 0 1.1550391754155953e-08
may O 0 1.8328852879889723e-09
contribute O 0 8.345908963924842e-10
to O 0 1.249433534411537e-08
DM B-Disease 1 1.0
pathogenesis O 1 0.9999912977218628
. O 0 1.0497395663833231e-07
. O 0 1.4698964889703348e-07

Identification O 0 5.227121846473892e-07
of O 0 4.746923707443784e-07
a O 0 4.6368640482796764e-08
novel O 0 7.083627906467882e-08
nonsense O 0 9.006856771520688e-08
mutation O 0 3.2355262913341676e-09
and O 0 3.979991058944421e-10
a O 0 5.564793625900677e-10
missense O 0 7.86872433877761e-09
substitution O 0 7.723008010884769e-09
in O 0 2.1215944556729482e-09
the O 0 1.2049191866481124e-08
vasopressin O 0 1.5121354124403297e-07
- O 0 4.866570790795777e-08
neurophysin O 0 7.083998525558854e-07
II O 1 0.7868748903274536
gene O 0 3.1554918678011745e-09
in O 0 2.8730023915457537e-10
two O 0 1.20923257518335e-10
Spanish O 0 1.1708587877024002e-08
kindreds O 0 2.649133818977134e-07
with O 0 1.4486821742210054e-09
familial B-Disease 0 0.002935088472440839
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999998807907104
. O 0 6.283990387601079e-06

Familial B-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 7.995514170033857e-05
FNDI B-Disease 1 1.0
) O 0 3.4970856432892106e-08
is O 0 1.5948640186280727e-09
an O 0 1.7107912864133823e-09
autosomal B-Disease 1 0.9999997615814209
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 0.011251884512603283
by O 0 2.164360601852877e-08
deficiency O 1 0.9999691247940063
in O 0 8.63930438299576e-08
the O 0 2.582042498033843e-06
antidiuretic O 0 4.254617579135811e-06
hormone O 0 1.6306318073588955e-08
arginine O 0 5.5928271791572115e-08
vasopressin O 0 7.564164405948759e-08
( O 0 1.7151693398886891e-09
AVP O 0 1.0554654750194459e-07
) O 0 5.991526719206774e-11
encoded O 0 1.1930764709511266e-10
by O 0 1.1805044441981494e-10
the O 0 2.0162287839298187e-08
AVP O 0 9.343537385575473e-06
- O 0 8.066197096923133e-07
neurophysin O 0 2.9366492526605725e-05
II O 1 1.0
( O 0 3.2775602676338167e-07
AVP O 0 3.365393786225468e-05
- O 0 5.215887881604431e-07
NPII O 0 2.5333831217722036e-05
) O 0 1.8256768319346861e-09
gene O 0 3.290976158254466e-09
on O 0 1.7209803360174192e-08
chromosome O 0 5.0147548336099135e-08
20p13 O 0 3.181788542860886e-06
. O 0 3.3463027193647576e-07

In O 0 1.1002435940099531e-07
this O 0 9.176718829273511e-10
study O 0 4.958122801212994e-10
, O 0 6.176815309233419e-11
we O 0 4.938074255056435e-11
analyzed O 0 2.548020128223527e-10
two O 0 6.380209555123528e-11
families O 0 1.1481914030664342e-10
with O 0 3.375140444905611e-10
FNDI B-Disease 1 0.9999998807907104
using O 0 8.26318302671325e-09
direct O 0 5.262517088766572e-09
automated O 0 5.9487771153499125e-08
fluorescent O 0 7.912127841791516e-09
, O 0 1.218728312712969e-10
solid O 0 1.276172945097187e-08
phase O 0 4.8803464380853256e-08
, O 0 4.758948790595241e-10
single O 0 1.6729021501404873e-09
- O 0 5.004490155613439e-09
stranded O 0 5.625905519224261e-09
DNA O 0 7.581692496039238e-10
sequencing O 0 2.4398449927076626e-09
of O 0 2.6553210741298017e-09
PCR O 0 6.567886998709582e-07
- O 0 2.729644165810896e-06
amplified O 0 8.169507964339573e-06
AVP O 0 0.00011959345283685252
- O 0 2.7129310637974413e-06
NPII O 0 9.385994781041518e-05
DNA O 0 1.6975293419818627e-06
. O 0 2.4417090571660083e-07

In O 0 9.295654734842174e-08
one O 0 2.76245581964929e-09
of O 0 5.176612027923966e-09
the O 0 1.8445849292447747e-09
families O 0 2.638286256129163e-10
, O 0 4.003660597495795e-11
affected O 0 5.874295494479043e-11
individuals O 0 4.002680999148911e-12
presented O 0 2.4037376533669885e-09
a O 0 3.2791149795485808e-09
novel O 0 1.0764177993394242e-08
nonsense O 0 2.108657604082964e-08
mutation O 0 3.377626511813503e-10
in O 0 1.7494843074228328e-10
exon O 0 3.777010704197892e-09
3 O 0 1.800275040153565e-09
of O 0 5.661111579513545e-10
the O 0 4.783154983201143e-10
gene O 0 1.1905532115719097e-10
, O 0 1.7184816070159314e-11
consisting O 0 5.000048639014487e-11
in O 0 1.4448044149961703e-10
a O 0 3.0178965992888607e-09
G O 0 1.3692570632883871e-07
to O 0 1.3848922009174203e-08
T O 0 1.8040108216155204e-06
transition O 0 1.2899934063170804e-06
at O 0 3.1190342753006917e-08
nucleotide O 0 8.509742244200424e-09
2101 O 0 3.667292389764043e-07
, O 0 1.8697897397057517e-11
which O 0 9.658064278883494e-12
produces O 0 8.792480632457966e-11
a O 0 3.7558309240459664e-10
stop O 0 2.5454665042445868e-09
signal O 0 1.1455396276005558e-07
in O 0 5.037299466437162e-09
codon O 0 3.0687225205383584e-08
82 O 0 7.231251970551966e-07
( O 0 2.5461865504894376e-08
Glu O 0 2.182931530114729e-05
) O 0 1.375856228946759e-08
of O 0 2.84076435264069e-07
NPII O 1 0.7264580726623535
. O 0 2.0658007997553796e-06

The O 0 3.2769683002698002e-06
premature O 0 3.0356384286278626e-06
termination O 0 6.891427801747341e-06
eliminates O 0 6.129422445155797e-07
part O 0 2.548786071088216e-08
of O 0 3.046712038212718e-08
the O 0 1.0500355251963356e-08
C O 0 3.7012614484410733e-07
- O 0 5.004692837928815e-08
terminal O 0 8.266544426760447e-08
domain O 0 1.8156893766274607e-09
of O 0 2.4925597141844946e-09
NPII O 0 2.7069506813859334e-06
, O 0 1.2397470550151724e-10
including O 0 8.638155468698727e-11
a O 0 7.780073807417409e-10
cysteine O 0 2.0476507156530488e-09
residue O 0 9.402553402537706e-09
in O 0 2.562026146790686e-10
position O 0 2.0605648742844096e-08
85 O 0 2.595796644300208e-08
, O 0 2.991007441721649e-10
which O 0 8.573631388175684e-11
could O 0 5.762459398539477e-10
be O 0 2.544504051904539e-10
involved O 0 1.0467156030813385e-09
in O 0 6.847607481041962e-10
the O 0 3.4359655121107835e-09
correct O 0 2.5005752135598414e-08
folding O 0 3.0905445669304754e-07
of O 0 6.527374551978937e-08
the O 0 1.3758764794147282e-07
prohormone O 0 0.0005076774396002293
. O 0 7.554344847449102e-07

In O 0 2.3916842906146485e-07
the O 0 1.398887405912319e-07
second O 0 1.6926975376918563e-07
family O 0 1.9844931031798296e-08
, O 0 2.512625663086965e-10
a O 0 5.438664518742087e-10
G279A O 0 3.962006545066288e-08
substitution O 0 1.587393150259686e-08
at O 0 1.3601305859367585e-08
position O 0 6.433447108378232e-09
- O 0 9.329844452565794e-09
1 O 0 7.163488913164429e-09
of O 0 3.183754593294452e-09
the O 0 3.15901460545831e-09
signal O 0 4.213610438341675e-08
peptide O 0 4.604358672111175e-09
was O 0 4.577791035131895e-09
observed O 0 3.8426764548127323e-10
in O 0 1.6935768065717838e-10
all O 0 2.0165112635250892e-10
affected O 0 8.207119428504939e-10
individuals O 0 2.1049384457683118e-10
. O 0 7.152405601118517e-08

This O 0 1.5836543809655268e-07
missense O 0 2.891264330173726e-06
mutation O 0 3.8569183402614726e-08
, O 0 1.1596521520829128e-09
which O 0 9.772778142291827e-10
replaces O 0 3.50132686435245e-05
Ala O 0 0.001119408174417913
with O 0 5.824008830757066e-09
Thr O 0 0.48828235268592834
, O 0 1.3392243980447915e-09
is O 0 1.001269830935847e-10
frequent O 0 1.499373736280063e-09
among O 0 3.0337674594704822e-09
FNDI B-Disease 1 1.0
patients O 0 1.1376502015991719e-06
and O 0 5.934596813972348e-09
is O 0 1.8758060382761954e-10
thought O 0 3.885400334802114e-10
to O 0 1.6070222930153477e-10
reduce O 0 1.3723042702196153e-09
the O 0 1.3571963553005162e-09
efficiency O 0 2.4444066326623215e-08
of O 0 3.2356806123345905e-09
cleavage O 0 1.2999787912804095e-08
by O 0 7.67119423539242e-10
signal O 0 6.578619036190503e-07
peptidases O 0 3.622646090661874e-06
. O 0 1.2809405092184534e-08
. O 0 7.410422142584139e-08

Genetic O 0 7.191513304860564e-06
heterogeneity O 0 2.738683542702347e-05
of O 0 0.00021039802231825888
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 2.3532422677163822e-09
due O 0 4.735854588489019e-07
to O 0 2.0974260550588042e-08
TWIST O 1 0.5229355692863464
and O 0 1.6239142723861733e-06
FGFR O 1 0.999847412109375
mutations O 0 3.4380391866761784e-07
. O 0 2.1418728124444897e-07

Thirty O 0 0.00010297202243236825
- O 0 6.972928531467915e-06
two O 0 6.351197789911112e-09
unrelated O 0 2.3199261178774577e-08
patients O 0 5.592181162583643e-10
with O 0 3.711059931577054e-11
features O 0 5.01435071242895e-09
of O 0 1.129239535657689e-06
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 9.865521732876914e-10
a O 0 1.5173836631632298e-09
common O 0 3.8411604919019737e-07
autosomal B-Disease 0 3.799577461904846e-05
dominant I-Disease 0 0.0011559255653992295
condition I-Disease 0 0.01564919948577881
of O 0 0.00013255291560199112
craniosynostosis B-Disease 1 1.0
and O 0 3.397103137103841e-05
limb B-Disease 1 0.9999995231628418
anomalies I-Disease 0 0.0005594845279119909
, O 0 4.7022341576052895e-09
were O 0 7.681022928807124e-09
screened O 0 2.9354312758300694e-08
for O 0 7.943908864049831e-10
mutations O 0 8.213227320474914e-10
in O 0 2.677791099969795e-09
TWIST O 0 0.0002371983864577487
, O 0 1.3411012744768414e-08
FGFR2 O 0 0.4009515345096588
, O 0 6.331290158811953e-09
and O 0 2.6280735809791622e-08
FGFR3 O 0 0.2936164140701294
. O 0 1.2088921721442603e-06

Nine O 0 5.140221333022055e-07
novel O 0 1.4285446070516628e-07
and O 0 2.771998852679758e-09
three O 0 1.2094222290315315e-09
recurrent O 0 2.2408691791042656e-07
TWIST O 0 4.6889923396520317e-05
mutations O 0 1.3247009711392366e-08
were O 0 8.887398372792177e-09
found O 0 2.5801474290432225e-09
in O 0 2.5319084606678643e-09
12 O 0 7.398460155627617e-08
families O 0 4.861709257397706e-08
. O 0 1.7674810237622296e-07

Seven O 0 1.8904840999312e-06
families O 0 1.887767275832175e-08
were O 0 4.443866608028202e-09
found O 0 2.433807377855146e-09
to O 0 1.3596033188179035e-09
have O 0 1.5245374962447045e-09
the O 0 3.19791837455341e-08
FGFR3 O 0 0.000533253769390285
P250R O 0 6.748912824150466e-07
mutation O 0 3.171789941802672e-09
, O 0 1.999712340161608e-10
and O 0 2.5753624233182393e-10
one O 0 1.5297710320716362e-10
individual O 0 2.1156560878199393e-11
was O 0 4.286957011601089e-09
found O 0 3.4504774037991126e-10
to O 0 4.011505017054162e-10
have O 0 3.721417896063173e-10
an O 0 2.0743737838557763e-09
FGFR2 O 0 8.319727930938825e-05
VV269 O 0 6.7594255597214215e-06
- O 0 1.3055368981440552e-06
270 O 0 2.947261634744791e-07
deletion O 0 5.315349085321941e-07
. O 0 1.0717329246290319e-07

To O 0 1.2670079740928486e-07
date O 0 1.253852246918541e-06
, O 0 1.9874997203572775e-09
our O 0 2.8302968857474298e-09
detection O 0 1.667885811684755e-07
rate O 0 1.7662291629250149e-09
for O 0 1.8228922538110481e-10
TWIST O 0 1.7982482347633777e-07
or O 0 2.2795415333121127e-08
FGFR O 0 5.668525045621209e-05
mutations O 0 4.025533684171023e-09
is O 0 4.3991763010176044e-10
68 O 0 6.224863291492966e-09
% O 0 3.9684008856788466e-10
in O 0 5.66231062038014e-10
our O 0 5.615894949073663e-08
Saethre B-Disease 1 0.999976634979248
- I-Disease 1 0.9995467066764832
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 1.8541026491902812e-08
, O 0 7.284038650023916e-11
including O 0 1.615911293662009e-10
our O 0 5.244162792905627e-08
five O 0 2.496480133729051e-09
patients O 0 8.20787104949261e-10
elsewhere O 0 2.2612745009809032e-09
reported O 0 1.5084554716437992e-09
with O 0 7.85171871964252e-10
TWIST O 0 3.204455060767941e-05
mutations O 0 1.2986694741812244e-07
. O 0 1.4038992901532765e-07

More O 0 9.519595778328949e-09
than O 0 1.1484000417283369e-09
35 O 0 1.7364599758096233e-09
different O 0 1.571191787785864e-10
TWIST O 0 2.996444266045728e-07
mutations O 0 3.8176845018611516e-10
are O 0 1.7619608896901617e-11
now O 0 1.5091626559549098e-10
known O 0 7.113815092552045e-10
in O 0 2.3274981941767692e-10
the O 0 2.962100120740274e-09
literature O 0 2.2372171670781427e-08
. O 0 4.532268249590743e-08

The O 0 2.9108493890817044e-06
most O 0 2.5912900269986494e-08
common O 0 3.0110903992408566e-08
phenotypic O 0 3.145463978171392e-08
features O 0 4.434578038114978e-09
, O 0 6.527627050001428e-11
present O 0 2.9192198658378743e-10
in O 0 1.8331570983409762e-10
more O 0 9.488329393014805e-12
than O 0 1.063617770247216e-11
a O 0 1.523089432353686e-10
third O 0 5.765166566362723e-09
of O 0 2.7734001761814397e-09
our O 0 5.230175403880821e-09
patients O 0 5.903850741617589e-10
with O 0 4.003049627887556e-11
TWIST O 0 3.038361739982065e-07
mutations O 0 9.770690923005532e-10
, O 0 4.097158723403993e-11
are O 0 6.532534235770271e-11
coronal B-Disease 0 0.00010754423419712111
synostosis I-Disease 0 0.00023318652529269457
, O 0 1.315553355141219e-08
brachycephaly B-Disease 0 6.864062015665695e-05
, O 0 5.1578204818270024e-08
low B-Disease 0 0.017724184319376945
frontal I-Disease 1 1.0
hairline I-Disease 1 1.0
, O 0 1.1199726657196152e-07
facial B-Disease 0 2.7488462364999577e-05
asymmetry I-Disease 0 7.429554534610361e-05
, O 0 2.1596347821173367e-08
ptosis B-Disease 0 0.048403386026620865
, O 0 6.309641520374498e-08
hypertelorism B-Disease 1 0.9042385816574097
, O 0 1.698294056495797e-07
broad B-Disease 0 0.004802091978490353
great I-Disease 1 0.9999998807907104
toes I-Disease 1 0.9998805522918701
, O 0 1.980099462173257e-08
and O 0 6.934121188351128e-08
clinodactyly B-Disease 0 0.00306007475592196
. O 0 3.90003833672381e-06

Significant O 0 1.8679354980122298e-05
intra O 0 0.003306562313809991
- O 0 0.00019292192882858217
and O 0 7.841430260668858e-08
interfamilial O 0 3.107754309894517e-05
phenotypic O 0 7.859995321268798e-07
variability O 0 2.2257131604419556e-07
is O 0 1.174252500790729e-10
present O 0 3.9705816412549666e-10
for O 0 2.8650729011481246e-10
either O 0 3.4471048238060575e-09
TWIST O 0 2.9657609047717415e-05
mutations O 0 2.2019190026867363e-08
or O 0 3.948834148559399e-08
FGFR O 0 0.00027234305161982775
mutations O 0 5.0167447085414096e-08
. O 0 1.1305450442478104e-07

The O 0 8.863631819622242e-07
overlap O 0 9.350478080705216e-08
in O 0 1.7000116869780868e-09
clinical O 0 6.6623235817075965e-09
features O 0 1.0878059564234377e-09
and O 0 8.565135267701862e-10
the O 0 1.0437352093717323e-09
presence O 0 2.804758370000826e-10
, O 0 9.089336228118583e-11
in O 0 1.0934512323368395e-10
the O 0 4.1071204770481984e-10
same O 0 3.442582607871003e-10
genes O 0 1.3687563582553963e-10
, O 0 3.297583039962859e-11
of O 0 3.2297226004729396e-10
mutations O 0 1.157351298131104e-10
for O 0 2.3217251732265964e-10
more O 0 3.2677111017065386e-11
than O 0 1.427506307605242e-10
one O 0 5.584176454576095e-10
craniosynostotic B-Disease 0 1.6819437576032215e-07
condition I-Disease 0 1.734320136392853e-07
- O 0 5.515578038739477e-08
such O 0 5.826786608764678e-09
as O 0 4.544941845097128e-08
Saethre B-Disease 0 8.967866051534656e-06
- I-Disease 0 3.000335766500939e-07
Chotzen I-Disease 0 1.4323441973829176e-05
, I-Disease 0 4.008034792946091e-09
Crouzon I-Disease 0 2.2433107005781494e-05
, I-Disease 0 2.897675210888906e-09
and I-Disease 0 1.4386873914418175e-08
Pfeiffer I-Disease 0 0.00029497823561541736
syndromes I-Disease 1 0.9885359406471252
- O 0 5.486488589667715e-05
support O 0 4.0368308873439673e-07
the O 0 7.314203998021185e-08
hypothesis O 0 3.8122600187762146e-08
that O 0 1.220126083500972e-10
TWIST O 0 1.5276069120773172e-07
and O 0 1.7934275176045844e-09
FGFRs O 0 1.7782713257474825e-07
are O 0 2.137167873228485e-11
components O 0 2.44069697785676e-09
of O 0 4.008738230254494e-09
the O 0 5.502794886425022e-10
same O 0 2.560589795752577e-10
molecular O 0 1.4389279767712537e-09
pathway O 0 3.186821084799618e-10
involved O 0 5.884003353995304e-12
in O 0 4.261449266379502e-12
the O 0 1.18556345296561e-10
modulation O 0 3.478498555864462e-08
of O 0 1.3026172140939707e-08
craniofacial O 1 0.9986627101898193
and O 0 7.244601079037238e-07
limb O 1 0.9999896287918091
development O 0 2.4599428343208274e-06
in O 0 2.9132083412264365e-09
humans O 0 7.561679282730438e-09
. O 0 2.6391535623560003e-09
. O 0 2.8885661862432244e-08

Mutation O 0 4.507749551407869e-08
analysis O 0 1.0973593589369557e-08
of O 0 7.59246603365682e-08
UBE3A O 1 1.0
in O 0 0.047834962606430054
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9936107993125916
. O 0 6.180495688568044e-07

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9752470254898071
AS B-Disease 1 1.0
) O 0 2.1628130397743917e-08
is O 0 1.5334176151071688e-09
caused O 0 2.7149338777121557e-08
by O 0 2.8015678665838095e-09
chromosome O 0 1.100457609481964e-07
15q11 O 0 2.383669652772369e-06
- O 0 3.7316641510187765e-07
q13 O 0 6.892295232319157e-07
deletions O 0 2.4706366730242735e-08
of O 0 3.837090201130877e-09
maternal O 0 3.97528188145202e-09
origin O 0 4.3934744731188857e-10
, O 0 4.7915164891332296e-11
by O 0 1.6636735045150175e-10
paternal O 0 3.6118728985456983e-06
uniparental B-Disease 1 0.9998757839202881
disomy I-Disease 1 0.9407854080200195
( O 0 1.959856717803632e-06
UPD B-Disease 1 1.0
) O 0 7.0804637708477e-09
15 O 0 1.5774923589617629e-09
, O 0 6.11039829845339e-11
by O 0 3.6925981716784406e-10
imprinting O 0 4.085322143509984e-05
defects O 0 0.06571746617555618
, O 0 5.711566219979147e-10
and O 0 3.970944961739775e-10
by O 0 1.26481145001911e-10
mutations O 0 5.512932887974387e-10
in O 0 1.2158197781886315e-09
the O 0 7.454140416029986e-08
UBE3A O 0 0.00023537404194939882
gene O 0 3.514183788411174e-07
. O 0 1.4606082743284787e-07

UBE3A O 0 0.0024487399496138096
encodes O 0 2.8888914584968006e-06
a O 0 2.449524743042275e-07
ubiquitin O 0 2.467266085659503e-06
- O 0 4.11876328598737e-07
protein O 0 2.17535287561077e-08
ligase O 0 8.109113736054496e-08
and O 0 1.4030836048561923e-08
shows O 0 1.4864017572335797e-08
brain O 0 1.0099828386955778e-06
- O 0 5.2241961867594e-08
specific O 0 4.1519651716726e-08
imprinting O 0 1.2262898962944746e-05
. O 0 4.0630175135447644e-07

Here O 0 1.7463158883401775e-06
we O 0 2.0037996151245352e-08
describe O 0 1.487914147446645e-07
UBE3A O 0 0.0012738031800836325
coding O 0 2.822252645273693e-05
- O 0 2.398386413915432e-06
region O 0 3.103095735923489e-08
mutations O 0 2.7546374070652746e-09
detected O 0 3.2374216640818076e-09
by O 0 4.6863006530895035e-11
SSCP O 0 2.3190161755337613e-06
analysis O 0 3.996004860340463e-09
in O 0 1.9702093290163702e-09
13 O 0 3.164986850379137e-08
AS B-Disease 1 0.999944806098938
individuals O 0 8.027678521926873e-11
or O 0 5.8474944886199864e-09
families O 0 4.98144370197906e-09
. O 0 3.0293861641439435e-08

Two O 0 4.154291275426658e-07
identical O 0 7.523407816734107e-07
de O 0 8.225333658629097e-06
novo O 0 7.061650831019506e-05
5 O 0 5.438760126708075e-06
- O 0 2.6830869046534644e-06
bp O 0 2.981094439746812e-06
duplications O 0 1.0320962928744848e-06
in O 0 2.3786542513448694e-08
exon O 0 5.757108851867088e-07
16 O 0 2.8539441032648938e-08
were O 0 9.244500276395229e-09
found O 0 1.6959640802838294e-08
. O 0 1.3212445537647e-07

Among O 0 2.406149803846347e-07
the O 0 7.938614743352446e-08
other O 0 4.041874834825876e-09
11 O 0 3.2415243822470075e-09
unique O 0 8.055721090194368e-10
mutations O 0 8.310929722199489e-10
, O 0 2.57143556448014e-10
8 O 0 1.4646583501587429e-08
were O 0 7.915750721565473e-09
small O 0 6.581541089900611e-09
deletions O 0 8.031427256582901e-08
or O 0 1.007508387829148e-08
insertions O 0 2.647227006491448e-07
predicted O 0 6.643368521963566e-08
to O 0 2.679334087929419e-09
cause O 0 9.398815450367692e-07
frameshifts O 0 0.003754992736503482
, O 0 5.836485517107803e-09
1 O 0 1.7937464846795592e-08
was O 0 4.74435024599984e-09
a O 0 2.2018578627047702e-10
mutation O 0 1.4163263444000318e-11
to O 0 6.885532422007401e-11
a O 0 8.305479082260092e-10
stop O 0 1.8384032074436618e-09
codon O 0 2.780365049304123e-09
, O 0 1.184264464271223e-09
1 O 0 2.1013262241353914e-08
was O 0 2.207562310729827e-08
a O 0 2.5511337486960883e-09
missense O 0 1.2517568315217886e-08
mutation O 0 3.3897726292586583e-10
, O 0 7.675449859023686e-11
and O 0 8.73753402963473e-10
1 O 0 5.212262621512309e-08
was O 0 1.2069415333826328e-07
predicted O 0 1.8392599443473046e-08
to O 0 1.062420595943081e-09
cause O 0 1.6415789616530674e-08
insertion O 0 1.4079189725180186e-07
of O 0 5.274035075331085e-08
an O 0 5.81574677305241e-10
isoleucine O 0 5.2848296405727524e-08
in O 0 8.940849172134335e-10
the O 0 1.2869575627405538e-08
hect O 0 4.1499353642393544e-07
domain O 0 9.472629791673626e-09
of O 0 7.982918326376875e-09
the O 0 8.812081730980026e-09
UBE3A O 0 2.9873983748984756e-06
protein O 0 4.374661966011217e-09
, O 0 6.735452473538572e-11
which O 0 1.127605474271487e-11
functions O 0 1.2318225606211541e-10
in O 0 6.84656276117579e-10
E2 O 0 2.366513456308894e-07
binding O 0 4.837638289956203e-09
and O 0 4.106558648686587e-09
ubiquitin O 0 4.0398157352683484e-07
transfer O 0 9.800689895200776e-07
. O 0 3.2421169748886314e-07

Eight O 0 3.904530956333474e-07
of O 0 6.20989979438491e-08
the O 0 4.90002438624515e-09
cases O 0 7.932643986130472e-10
were O 0 1.861394038904507e-09
familial O 0 1.3097952944463032e-07
, O 0 1.328751775275805e-09
and O 0 1.490719325758505e-09
five O 0 1.0121535831686401e-09
were O 0 2.4841402268549473e-09
sporadic O 0 6.130100587142806e-07
. O 0 3.861906066049414e-07

In O 0 1.352150036382227e-07
two O 0 3.016699334779105e-09
familial O 0 2.217606862586763e-07
cases O 0 2.589173986322635e-09
and O 0 1.3728567171966688e-09
one O 0 2.0502483044637643e-10
sporadic O 0 1.642042413152467e-08
case O 0 3.911503654308035e-08
, O 0 2.1785031556476042e-09
mosaicism O 0 4.0659899241290987e-05
for O 0 2.5649233847957476e-08
UBE3A O 0 0.00041974266059696674
mutations O 0 1.006350291987701e-08
was O 0 2.4686583444122334e-08
detected O 0 3.341309673388082e-09
in O 0 9.215372215320983e-11
the O 0 6.836567423285089e-10
mother O 0 1.6980283845668964e-09
of O 0 4.432126221587396e-09
three O 0 4.813055731744953e-09
AS B-Disease 1 1.0
sons O 0 2.2982736481935717e-05
, O 0 2.658623599050003e-10
in O 0 1.1092267382384335e-10
the O 0 1.2595373632962037e-09
maternal O 0 2.7031321181425483e-08
grandfather O 0 1.0747642136266222e-06
of O 0 6.774965299882751e-08
two O 0 1.4829468319987882e-08
AS B-Disease 1 0.9999980926513672
first O 0 4.7930409863283785e-08
cousins O 0 3.745454932868597e-07
, O 0 4.106924800240108e-10
and O 0 6.075490666113126e-10
in O 0 6.356260517925705e-10
the O 0 9.161367664489717e-09
mother O 0 1.7817777475670482e-08
of O 0 3.7963111765293434e-08
an O 0 3.639341050742928e-09
AS B-Disease 1 1.0
daughter O 0 3.7708912714151666e-05
. O 0 1.3537837730837055e-06

The O 0 2.077107268405598e-07
frequencies O 0 2.0098321229511384e-08
with O 0 7.554435549339544e-11
which O 0 1.957311569766862e-11
we O 0 4.7391271462693396e-11
detected O 0 8.098333115214018e-10
mutations O 0 5.0140967766676425e-11
were O 0 5.456786134061531e-10
5 O 0 3.704649476077293e-09
( O 0 2.1583643206035674e-10
14 O 0 7.3614464524141e-10
% O 0 1.0303261716027023e-10
) O 0 4.122344132717615e-11
of O 0 2.5776438761226927e-09
35 O 0 4.1767846958862265e-09
in O 0 2.1743136457974543e-10
sporadic O 0 6.082230274984113e-09
cases O 0 7.936291068766366e-10
and O 0 1.9378632032385212e-09
8 O 0 7.14275127933206e-09
( O 0 1.161338178401472e-10
80 O 0 5.658251089890598e-10
% O 0 7.600569479349062e-11
) O 0 4.9368124172000094e-11
of O 0 1.220350154262917e-09
10 O 0 1.0057069621538517e-09
in O 0 2.477835714387311e-10
familial O 0 3.068359433200385e-08
cases O 0 4.017402854827878e-09
. O 0 7.021827119757518e-09
. O 0 6.478381919805543e-08

The O 0 6.935874262126163e-05
hemochromatosis B-Disease 1 1.0
845 O 0 3.680117879412137e-05
G O 0 1.0972610198223265e-06
- O 0 2.3052450615068665e-07
- O 0 7.853119399214847e-08
> O 0 9.738251094404404e-08
A O 0 3.571532047885739e-08
and O 0 8.587529576331576e-10
187 O 0 1.1018974621634925e-09
C O 0 3.836433393189509e-08
- O 0 3.9575205335040664e-08
- O 0 9.588042360064719e-08
> O 0 7.098809646777227e-07
G O 0 9.878679065877805e-07
mutations O 0 3.026854988874561e-09
: O 0 1.6523112045252475e-10
prevalence O 0 6.0483689168222554e-09
in O 0 7.418688441340748e-10
non O 0 5.460706375970403e-08
- O 0 2.7226170118410664e-07
Caucasian O 0 2.50157512482474e-07
populations O 0 2.1729849919438493e-08
. O 0 7.676427316027912e-08

Hemochromatosis B-Disease 1 1.0
, O 0 6.33921899861889e-07
the O 0 1.952971979335416e-05
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 1.0
iron I-Disease 1 1.0
metabolism I-Disease 1 0.9999992847442627
, O 0 2.424570055836739e-08
leads O 0 3.037602596123179e-07
, O 0 1.0534457750566162e-08
if O 0 2.7395128654461587e-07
untreated O 1 1.0
, O 0 7.594870510274632e-08
to O 0 6.59712782180577e-07
progressive O 1 1.0
iron B-Disease 1 1.0
overload I-Disease 1 0.9999926090240479
and O 0 1.1781082775996765e-07
premature B-Disease 0 5.207344315749651e-07
death I-Disease 0 1.3317104503585142e-06
. O 0 4.2132973021580256e-07

The O 0 7.456176535924897e-05
hemochromatosis B-Disease 1 1.0
gene O 0 1.182443497782515e-06
, O 0 2.8399778528864772e-08
HFE O 1 0.9999281167984009
, O 0 1.0007346418205998e-07
recently O 0 7.451212269415919e-08
has O 0 3.2906732894133484e-10
been O 0 1.333504001665986e-10
identified O 0 2.338489402120558e-10
, O 0 2.2922431314187364e-11
and O 0 3.101191872745268e-11
characterization O 0 1.2145362937587834e-08
of O 0 1.3088358841173431e-08
this O 0 3.8197528473560283e-10
gene O 0 8.989257671565554e-10
has O 0 3.6409687764749066e-11
shown O 0 1.2065962812224384e-11
that O 0 5.1034111832326534e-12
it O 0 1.572618077427812e-11
contains O 0 8.497877401758558e-11
two O 0 3.3080718719880053e-11
mutations O 0 9.61149822925611e-12
that O 0 8.488137276385643e-12
result O 0 2.7658078605163894e-10
in O 0 4.06161049237852e-10
amino O 0 3.274819304621701e-10
acid O 0 6.09233996584635e-10
substitutions O 0 3.3790394926569434e-09
- O 0 1.0801135097437964e-08
cDNA O 0 2.5480618504047925e-08
nucleotides O 0 1.5244095985522677e-09
845 O 0 5.876946040928033e-09
G O 0 7.244585376042778e-09
- O 0 1.4415330262806947e-08
- O 0 2.0134002909344417e-08
> O 0 5.922929702251167e-08
A O 0 5.232972100088773e-08
( O 0 2.9506858068018005e-10
C282Y O 0 8.452655464452619e-09
) O 0 2.2317160272566916e-11
and O 0 1.8550630476177332e-10
187 O 0 9.350006324737592e-10
C O 0 2.7007770242448714e-08
- O 0 2.928463516127522e-08
- O 0 8.584836308500599e-08
> O 0 5.960202429378114e-07
G O 0 2.236889940832043e-06
( O 0 2.353320027737027e-08
H63D O 0 4.3237443605903536e-05
) O 0 6.939199437283605e-09
. O 0 2.7741052122109977e-08

Although O 0 0.0001409549731761217
hemochromatosis B-Disease 1 1.0
is O 0 3.9803975226959665e-08
common O 0 4.115225138434653e-08
in O 0 1.6224965815325731e-09
Caucasians O 0 4.3646629421800753e-08
, O 0 5.278518178108982e-10
affecting O 0 2.7962452353591516e-09
> O 0 1.6353746445929573e-07
= O 0 3.7827010856972265e-08
1 O 0 3.130083214841761e-08
/ O 0 8.25776336199624e-09
300 O 0 8.113665989073482e-11
individuals O 0 8.253164319495243e-13
of O 0 7.861489237370733e-10
northern O 0 2.3019368633470094e-09
European O 0 8.036046827974985e-10
origin O 0 9.524566690899405e-10
, O 0 5.6097838180280135e-11
it O 0 9.190056701746663e-12
has O 0 4.968379440500881e-12
not O 0 3.4630870220098142e-12
been O 0 4.917509455193425e-11
recognized O 0 1.869673027510288e-10
in O 0 9.926785088376633e-11
other O 0 2.0632764941019843e-10
populations O 0 1.1933092292082392e-09
. O 0 3.07334424576311e-08

The O 0 4.644861633096298e-07
present O 0 2.4648944219052282e-08
study O 0 4.669271080892656e-10
used O 0 8.383065908112997e-10
PCR O 0 7.005722579833673e-08
and O 0 5.608677078328128e-09
restriction O 0 1.2356830225712656e-08
- O 0 8.956453356745442e-09
enzyme O 0 1.9346280133447635e-09
digestion O 0 9.267697720360957e-09
to O 0 1.2315359843029228e-10
analyze O 0 1.6742139896663844e-09
the O 0 4.75622652373886e-10
frequency O 0 1.9684289753740813e-09
of O 0 1.4747155718808358e-09
the O 0 2.4661439557149833e-09
845 O 0 1.2973778495961596e-08
G O 0 1.2315137354335093e-08
- O 0 9.452308269430887e-09
- O 0 1.2299315343966555e-08
> O 0 1.7593105638979978e-08
A O 0 1.804693638973731e-08
and O 0 4.737936709631185e-10
187 O 0 3.0707392184581295e-10
C O 0 1.3184420666334518e-08
- O 0 1.2881658406627139e-08
- O 0 4.4895244855069905e-08
> O 0 3.1067739314494247e-07
G O 0 3.415747471535724e-07
mutations O 0 1.0758589574777488e-09
in O 0 3.731638609227872e-10
HLA O 0 2.6787580154064017e-08
- O 0 7.730185380694365e-09
typed O 0 6.036498412242963e-09
samples O 0 6.103272887081346e-10
from O 0 1.4191238184579902e-09
non O 0 2.124571807371467e-08
- O 0 7.622313091815158e-08
Caucasian O 0 8.529083572739182e-08
populations O 0 2.6678297349036484e-09
, O 0 1.9648981053332903e-10
comprising O 0 1.0314685217061026e-10
Australian O 0 6.0367750798207e-09
Aboriginal O 0 2.9338849127924505e-09
, O 0 1.8606397672593644e-11
Chinese O 0 2.9485761054992565e-10
, O 0 1.227799806269303e-10
and O 0 3.0976419207462413e-09
Pacific O 0 7.680893077122164e-07
Islanders O 0 7.603597168781562e-06
. O 0 3.3750157513168233e-07

Results O 0 3.3440281299590424e-07
showed O 0 5.3340873051865856e-08
that O 0 1.1589843529336008e-09
the O 0 2.7345944175749537e-08
845 O 0 4.0227575937024085e-07
G O 0 4.1898488234437536e-07
- O 0 5.207612616686674e-07
- O 0 5.246023988547677e-07
> O 0 1.5718833878963778e-07
A O 0 1.649733682995702e-08
mutation O 0 3.012868288188031e-10
was O 0 3.1860247773352057e-10
present O 0 2.635921168836486e-11
in O 0 1.722547451898926e-11
these O 0 7.555987953378196e-12
populations O 0 5.565987341166201e-12
( O 0 2.810935728972397e-12
allele O 0 3.263282699617065e-11
frequency O 0 6.457415713256864e-10
0 O 0 5.495494614926599e-10
. O 0 6.920476691707478e-11
32 O 0 5.758394316934812e-10
% O 0 5.482227519171268e-11
) O 0 3.862050609870771e-11
, O 0 4.416046348043601e-11
and O 0 1.14426274011592e-10
, O 0 5.676624448280876e-11
furthermore O 0 5.75099579069871e-10
, O 0 1.4179055152219178e-10
it O 0 1.1487981399493918e-10
was O 0 9.407808754247071e-09
always O 0 1.0508464098890613e-09
seen O 0 9.315970217471659e-10
in O 0 9.514811161182024e-11
conjunction O 0 7.523782152851766e-10
with O 0 2.875047144801357e-10
HLA O 0 2.4504433895344846e-06
haplotypes O 0 1.7204494895395328e-07
common O 0 8.899666426032127e-08
in O 0 2.9188704786520248e-09
Caucasians O 0 4.607330339467808e-08
, O 0 1.8728245343435646e-10
suggesting O 0 8.278497332092627e-10
that O 0 1.8221206488089337e-10
845 O 0 7.810977820099652e-08
G O 0 3.2401942462456645e-07
- O 0 8.005478662198584e-07
- O 0 2.749610757746268e-06
> O 0 2.9672983146156184e-06
A O 0 3.313011802674737e-07
may O 0 4.6886925453293316e-09
have O 0 2.8733257440016757e-10
been O 0 2.2123400333917687e-10
introduced O 0 1.8469216434002789e-10
into O 0 7.105783322858272e-11
these O 0 3.929666921725916e-12
populations O 0 2.2692049628236788e-11
by O 0 7.488301645430795e-11
Caucasian O 0 3.79055187238464e-08
admixture O 0 1.4417139482247876e-06
. O 0 7.92222351719829e-07

187 O 0 8.629470471532841e-07
C O 0 6.736958653164038e-07
- O 0 2.522987188058323e-07
- O 0 1.2999916521039268e-07
> O 0 1.7551353437283979e-07
G O 0 1.1668908683759582e-07
was O 0 5.53092460719995e-09
present O 0 1.6223533627623965e-10
at O 0 1.1632492191715471e-10
an O 0 7.810303510706607e-13
allele O 0 5.176496384318163e-12
frequency O 0 5.491806454038795e-10
of O 0 5.627890597992291e-09
2 O 0 2.223922450639293e-07
. O 0 1.0138334971543372e-07

68 O 0 1.4580167771782726e-05
% O 0 6.49742659675212e-08
in O 0 3.963320338584708e-09
the O 0 1.0725219823370935e-08
two O 0 5.821274018380507e-10
populations O 0 5.305609840355885e-10
analyzed O 0 2.5295527894542147e-09
( O 0 2.897435902315948e-10
Australian O 0 2.2245583153335247e-08
Aboriginal O 0 5.841912198434329e-08
and O 0 1.2300903629025584e-09
Chinese O 0 6.5980816366106865e-09
) O 0 2.684613198411512e-09
. O 0 4.561877275932602e-08

In O 0 7.939839861137443e-07
the O 0 3.6938354242010973e-07
Australian O 0 1.8975417503952485e-07
Aboriginal O 0 3.572267814888619e-08
samples O 0 2.6633642513651523e-10
, O 0 1.11776442268674e-10
187 O 0 1.948976091625809e-09
C O 0 7.359825104913398e-08
- O 0 1.0867410793480303e-07
- O 0 2.2580761083190737e-07
> O 0 8.497134444951371e-07
G O 0 8.170733281076537e-07
was O 0 4.1778864812158645e-08
found O 0 3.1427985214271814e-10
to O 0 6.901231669464991e-11
be O 0 6.533929647334347e-11
associated O 0 1.7785750650034515e-09
with O 0 6.000335783795663e-10
HLA O 0 4.154618181928527e-06
haplotypes O 0 1.8327469319956435e-07
common O 0 8.673300300188203e-08
in O 0 1.330933030452286e-09
Caucasians O 0 2.6994122492851602e-08
, O 0 2.99501361211707e-11
suggesting O 0 1.0087534280112109e-10
that O 0 1.627376358670496e-11
it O 0 5.949914172465043e-11
was O 0 2.139348032059729e-09
introduced O 0 4.941497211419232e-10
by O 0 5.103500955172535e-11
recent O 0 2.1024957330695315e-09
admixture O 0 5.429905627352127e-07
. O 0 2.1040979447661812e-07

In O 0 8.613561135462078e-07
the O 0 1.2193520149139658e-07
Chinese O 0 2.6001670150321843e-08
samples O 0 3.4604558107886874e-10
analyzed O 0 4.281560939123352e-10
, O 0 5.940242048252387e-11
187 O 0 5.915156142677347e-10
C O 0 3.479055976640666e-08
- O 0 4.596148528435151e-08
- O 0 8.519133132267598e-08
> O 0 2.717815448249894e-07
G O 0 3.5533432196643844e-07
was O 0 1.0257154237081068e-08
present O 0 3.756203403870728e-10
in O 0 9.393115452116518e-11
association O 0 5.2527843186211953e-11
with O 0 1.5533539732270896e-11
a O 0 4.799952657563722e-10
wide O 0 4.900267747132148e-09
variety O 0 1.2188706710603014e-09
of O 0 9.478974050125544e-09
HLA O 0 1.0660199905032641e-06
haplotypes O 0 1.065705390601579e-07
, O 0 1.8455412198470356e-10
showing O 0 7.211408553642329e-11
this O 0 2.0694041966140553e-11
mutation O 0 9.373750387009494e-11
to O 0 1.3790180108941286e-10
be O 0 3.1126717869867093e-10
widespread O 0 1.1889932594044694e-08
and O 0 4.657718211120709e-09
likely O 0 7.199238982735778e-09
to O 0 2.083632821836545e-09
predate O 0 7.869145406402822e-07
the O 0 4.7351047527399714e-08
more O 0 1.84360637867087e-10
genetically O 0 1.8996930695180936e-09
restricted O 0 7.662289691623414e-10
845 O 0 2.8449765210325495e-08
G O 0 1.3321570691005036e-07
- O 0 5.016505610910826e-07
- O 0 5.929915118940698e-07
> O 0 9.776615570444847e-07
A O 0 2.1635376867834566e-07
mutation O 0 4.0188535166407746e-08
. O 0 2.4887036431664455e-08

Genotype O 0 0.0003292023029644042
- O 0 1.2412727301125415e-05
phenotype O 0 8.410947316406236e-07
correlations O 0 3.5127899877807067e-07
in O 0 1.206314408364051e-07
attenuated B-Disease 1 0.9999998807907104
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
. O 0 0.00022713688667863607

Germ O 0 0.10297399014234543
- O 0 4.217226160108112e-05
line O 0 7.770172487653326e-07
mutations O 0 5.565008454055942e-09
of O 0 1.552716533126386e-08
the O 0 1.4491416067130558e-08
tumor B-Disease 0 5.209281539464428e-07
suppressor O 0 1.3041183137829648e-06
APC O 0 4.179448254149065e-08
are O 0 9.683099461144096e-11
implicated O 0 1.8622827724357194e-08
in O 0 2.978838331557654e-08
attenuated B-Disease 1 0.999996542930603
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 3.8235511965467595e-06
AAPC B-Disease 1 1.0
) O 0 1.8787826849830935e-09
, O 0 5.558531759874974e-11
a O 0 4.658684549241343e-10
variant O 0 8.743959915591404e-05
of O 1 0.9691458940505981
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 7.853852366679348e-06
FAP B-Disease 0 3.20752733387053e-05
) O 0 4.137222120448314e-08
. O 0 3.062519056129531e-07

AAPC B-Disease 1 1.0
is O 0 1.5108093975868542e-07
recognized O 0 1.2549890016089194e-08
by O 0 4.286611066106616e-10
the O 0 1.3170942114726358e-09
occurrence O 0 4.6421089194836895e-09
of O 0 3.783848256944111e-08
< O 0 9.677791013018577e-07
100 O 0 7.974426452506123e-09
colonic B-Disease 0 5.276357114780694e-06
adenomas I-Disease 0 6.044035671948222e-07
and O 0 2.836488544044613e-10
a O 0 6.072107816557093e-10
later O 0 1.0304647801717692e-08
onset O 0 0.17233197391033173
of O 1 0.9952842593193054
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 3.8777156485814146e-10
age O 0 7.128334589268093e-10
> O 0 8.653484151466273e-09
40 O 0 1.7304095933923236e-09
years O 0 5.68542657397586e-10
) O 0 5.974662986574231e-10
. O 0 1.2349667954936194e-08

The O 0 3.9261766460185754e-07
aim O 0 9.493379593550344e-08
of O 0 1.1394376109308268e-08
this O 0 2.601707183025326e-10
study O 0 9.958075336546912e-11
was O 0 2.308004010131981e-09
to O 0 2.7857410822562656e-10
assess O 0 5.709382833174459e-08
genotype O 0 4.455880571185844e-06
- O 0 1.5187878261713195e-06
phenotype O 0 7.837068665139668e-07
correlations O 0 3.759504920708423e-07
in O 0 6.780136629913613e-08
AAPC B-Disease 1 1.0
families O 0 5.884463689653785e-07
. O 0 2.652157036209246e-07

By O 0 5.47775194092992e-08
protein O 0 3.594137965023947e-08
- O 0 6.699727350678586e-08
truncation O 0 1.7188419860758586e-06
test O 0 3.066879799007438e-07
( O 0 1.8238679899695853e-08
PTT O 0 6.242980248316599e-07
) O 0 1.5087943394664904e-10
assay O 0 1.961694628960231e-08
, O 0 1.5622655946678776e-10
the O 0 4.903051298299488e-10
entire O 0 1.3861387593294694e-09
coding O 0 1.5268488695596716e-08
region O 0 1.7034457178155549e-09
of O 0 3.3814893107830812e-09
the O 0 4.731183889106205e-09
APC B-Disease 0 7.978990801404962e-09
gene O 0 1.0060426935964983e-09
was O 0 8.15279754817766e-09
screened O 0 4.620599458604602e-09
in O 0 1.3327766668069785e-10
affected O 0 3.70888236789213e-10
individuals O 0 3.468608733570022e-11
from O 0 2.6040433809271235e-08
11 O 0 1.593010892975144e-06
AAPC B-Disease 1 1.0
kindreds O 0 0.27452319860458374
, O 0 8.247075911071988e-09
and O 0 2.04983874318998e-09
their O 0 1.1432902402574996e-09
phenotypic O 0 1.0912733472423497e-07
differences O 0 5.1352920138469926e-08
were O 0 2.504465435038128e-08
examined O 0 6.508304295493872e-07
. O 0 1.9687084318320558e-07

Five O 0 6.828219056842499e-07
novel O 0 2.521303485991666e-07
germ O 0 0.0002190551022067666
- O 0 5.395746029535076e-06
line O 0 8.524023087375099e-07
APC B-Disease 0 1.0792305005224989e-07
mutations O 0 6.624180648451272e-10
were O 0 5.036605021935259e-10
identified O 0 2.9647342358885e-09
in O 0 3.118354463538253e-09
seven O 0 1.2032616325541312e-07
kindreds O 0 6.86958956066519e-05
. O 0 1.1381852118574898e-06

Mutations O 0 4.062172820340493e-07
were O 0 8.868690315466665e-08
located O 0 1.706171381954391e-08
in O 0 5.204180975049155e-10
three O 0 7.514742994541024e-11
different O 0 2.0218557730822262e-11
regions O 0 5.346630915781247e-10
of O 0 1.1245229636358545e-08
the O 0 6.96957469514814e-09
APC B-Disease 0 4.74894079616206e-09
gene O 0 1.3660543529692148e-10
( O 0 7.83548295690828e-11
1 O 0 3.9790140071716e-09
) O 0 9.444188486806837e-11
at O 0 1.071288613374577e-09
the O 0 1.1875466165989224e-09
5 O 0 4.35306279911174e-09
end O 0 1.488853129671952e-08
spanning O 0 1.790803061396673e-08
exons O 0 2.8377254324141177e-08
4 O 0 8.780808080643965e-09
and O 0 3.1542143896778896e-10
5 O 0 1.2039308439071306e-09
, O 0 8.894325553843174e-11
( O 0 1.0823107687851774e-10
2 O 0 1.0857462484636926e-08
) O 0 2.3794777259666944e-10
within O 0 1.5713242929038529e-09
exon O 0 3.866714592959397e-08
9 O 0 7.508933030919707e-09
, O 0 5.955613779917712e-11
and O 0 2.3819024530524757e-10
( O 0 1.6749063247445406e-10
3 O 0 1.299909335727989e-08
) O 0 2.5403723569183967e-10
at O 0 1.934938209657844e-09
the O 0 4.46256143149526e-09
3 O 0 2.0254175225886684e-08
distal O 0 2.6563463961792877e-07
end O 0 3.2983621167659294e-07
of O 0 7.383967925989054e-08
the O 0 3.0972831410736035e-08
gene O 0 3.089394695621195e-08
. O 0 5.701308580796649e-08

Variability O 0 3.28467576764524e-05
in O 0 1.7977846766825678e-08
the O 0 1.0844837028400889e-08
number O 0 4.279546939045531e-09
of O 0 3.6505472962744534e-05
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 1 0.9994655251502991
most O 0 1.6742300879002414e-09
apparent O 0 2.2900090712596466e-08
in O 0 9.365851150189286e-11
individuals O 0 2.6185865541900055e-12
with O 0 1.9272050968965893e-11
mutations O 0 3.8615738384706333e-10
in O 0 1.3400650589190377e-09
region O 0 3.114679714144586e-07
1 O 0 6.131044938229024e-05
, O 0 1.0165459585209646e-08
and O 0 1.6355758702957246e-07
upper O 1 1.0
- O 1 0.9737780690193176
gastrointestinal O 1 0.943056046962738
manifestations O 0 0.04440392181277275
were O 0 4.295766231621201e-08
more O 0 9.01552443810516e-11
severe O 0 1.2455568310087983e-07
in O 0 1.931759419093737e-09
them O 0 3.732950393242618e-09
. O 0 6.584129863540511e-08

In O 0 2.5694870231518507e-08
individuals O 0 1.3654394281914506e-10
with O 0 1.808899696698063e-10
mutations O 0 5.841784278537432e-10
in O 0 6.252442452669982e-10
either O 0 1.1762240959001247e-08
region O 0 3.2384795645157283e-07
2 O 0 6.06684068316099e-07
or O 0 2.459259107467915e-08
region O 0 4.3672777394476725e-08
3 O 0 1.3013560362651333e-07
, O 0 3.7764760763003835e-10
the O 0 1.0502834157932739e-09
average O 0 6.170341459998951e-10
number O 0 9.297256020612821e-11
of O 0 1.780676939233672e-08
adenomas B-Disease 0 7.481724605895579e-05
tended O 0 1.3609509608158987e-07
to O 0 5.544201098217627e-09
be O 0 2.302086299366124e-09
lower O 0 1.2787403136371722e-07
than O 0 4.057442229421504e-11
those O 0 2.398921339352711e-11
in O 0 6.818107710360177e-12
individuals O 0 2.1053407769314886e-13
with O 0 1.7981480020246021e-12
mutations O 0 3.148965116439584e-11
in O 0 9.521546745494547e-11
region O 0 2.351272732070697e-09
1 O 0 2.0620040785956917e-08
, O 0 5.016411591673986e-11
although O 0 1.6233996091852276e-10
age O 0 1.0684438889185799e-09
at O 0 8.428486242273436e-10
diagnosis O 0 2.7082000642053572e-08
was O 0 5.090731391987902e-09
similar O 0 3.0844709009159033e-09
. O 0 4.4693440059973e-08

In O 0 2.59652006207034e-06
all O 0 8.43757220536645e-07
AAPC B-Disease 1 1.0
kindreds O 0 0.00034192262683063745
, O 0 1.211676448065191e-08
a O 0 1.3764914541525286e-08
predominance O 0 9.993266758101527e-06
of O 0 0.0008886469877324998
right O 1 1.0
- O 1 1.0
sided O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 1 0.9995121955871582
rectal B-Disease 1 1.0
polyp I-Disease 1 0.944098711013794
sparing O 0 2.144473683074466e-06
was O 0 5.15853912474995e-07
observed O 0 2.4787459196318196e-08
. O 0 7.238290322675311e-08

No O 0 0.00027434714138507843
desmoid B-Disease 1 0.9999998807907104
tumors I-Disease 1 1.0
were O 0 2.895859836371528e-07
found O 0 1.1526887000457009e-08
in O 0 3.702982143138911e-09
these O 0 1.2270681359893842e-08
kindreds O 0 0.00043971044942736626
. O 0 8.93679839464312e-07

Our O 0 4.2071201278304216e-06
data O 0 5.453794571508297e-08
suggest O 0 6.0540936708264326e-09
that O 0 5.277269732317791e-10
, O 0 2.83919665555743e-09
in O 0 2.369502993815331e-08
AAPC B-Disease 1 1.0
families O 0 3.905330814291119e-08
, O 0 1.4761865341217373e-10
the O 0 1.5752846249661445e-10
location O 0 4.543292408953903e-09
of O 0 4.717442880775025e-09
the O 0 6.221788861893174e-09
APC B-Disease 0 2.3681074878822983e-07
mutation O 0 1.6337201813598767e-08
may O 0 2.0386806909300503e-08
partially O 0 4.162067739343911e-07
predict O 0 3.4085388733728905e-08
specific O 0 1.9728238598304415e-08
phenotypic O 0 7.502908943024522e-07
expression O 0 3.0015235097380355e-07
. O 0 1.843752812646926e-07

This O 0 6.15363475731101e-08
should O 0 2.098978946207808e-08
help O 0 5.145358361602348e-09
in O 0 9.843904580364438e-10
the O 0 1.5851019385948462e-09
design O 0 1.06934558985472e-08
of O 0 3.2172555730625163e-09
tailored O 0 7.360046794246955e-09
clinical O 0 4.583070278840751e-08
- O 0 9.141054846395491e-08
management O 0 9.19133302801356e-09
protocols O 0 1.791753589941436e-07
in O 0 2.3680093996780727e-10
this O 0 5.2333436195706184e-11
subset O 0 1.4320994390359942e-09
of O 0 2.348234273696903e-09
FAP B-Disease 0 5.129174383000645e-07
patients O 0 1.7060216350728297e-08
. O 0 1.0405215356001918e-08
. O 0 9.09550550431959e-08

Wilms B-Disease 1 0.9999974966049194
' I-Disease 0 0.016734279692173004
tumor I-Disease 0 4.2814088374143466e-05
1 O 0 1.3641791838381323e-06
and O 0 2.9874527740503254e-08
Dax O 0 0.00013778620632365346
- O 0 6.657924132014159e-07
1 O 0 4.041399677134905e-07
modulate O 0 2.412712376553827e-07
the O 0 2.5652394697317504e-07
orphan O 0 1.0213657333224546e-06
nuclear O 0 2.705056431295816e-06
receptor O 0 1.1641807873274956e-07
SF O 0 8.134538074955344e-05
- O 0 1.928506634385485e-07
1 O 0 5.917348833150982e-09
in O 0 5.99539029533247e-11
sex O 0 5.589874743638923e-11
- O 0 1.6442910921732334e-10
specific O 0 2.2487732162512764e-11
gene O 0 4.907776407492292e-10
expression O 0 1.7345864744555684e-09
. O 0 1.1301306557243151e-08

Products O 0 3.4688866890064673e-06
of O 0 5.799994141852949e-06
steroidogenic O 0 0.005300405900925398
factor O 0 7.512223874073243e-07
1 O 0 2.2426607415582112e-07
( O 0 2.725423220439893e-09
SF O 0 0.000786061747930944
- O 0 4.675602838233317e-07
1 O 0 9.72536966514781e-08
) O 0 6.463750090723863e-10
and O 0 4.5848684848692756e-09
Wilms B-Disease 1 0.9936538934707642
tumor I-Disease 0 6.403275619959459e-06
1 O 0 3.7618468695654883e-07
( O 0 1.3633063566942383e-09
WT1 O 0 2.2135552626423305e-06
) O 0 1.764551421645777e-10
genes O 0 6.076437963908887e-11
are O 0 1.0528134787579635e-11
essential O 0 1.4807726156362833e-09
for O 0 5.125706525888063e-10
mammalian O 0 2.693182352686563e-07
gonadogenesis O 0 2.7567000415729126e-07
prior O 0 1.6783937795139536e-08
to O 0 8.487077152175004e-10
sexual O 0 1.4249227353602123e-09
differentiation O 0 2.7999719875992923e-08
. O 0 2.248738084631441e-08

In O 0 2.24702787932074e-07
males O 0 5.359334753762823e-09
, O 0 2.351866079663978e-08
SF O 1 0.999995231628418
- O 0 5.342128497431986e-05
1 O 0 2.633566396070819e-07
participates O 0 7.651920208573415e-10
in O 0 4.94436054598868e-11
sexual O 0 1.8013894195756386e-11
development O 0 4.9299436061245316e-11
by O 0 5.839906249555105e-12
regulating O 0 2.0105891951338606e-10
expression O 0 5.342329356672337e-10
of O 0 3.378684887422878e-09
the O 0 1.155845730238525e-08
polypeptide O 0 3.1070288741830154e-07
hormone O 0 1.7530235041363085e-08
Mullerian O 0 2.12606710192631e-06
inhibiting O 0 3.7698441701650154e-08
substance O 0 6.159646659398277e-08
( O 0 2.0276209156122604e-08
MIS O 0 6.998579920036718e-05
) O 0 9.150925350809302e-09
. O 0 7.254599410089213e-08

Here O 0 4.745782916870667e-06
, O 0 5.025871985253616e-08
we O 0 1.0169376452040524e-08
show O 0 4.613043724788213e-09
that O 0 2.8317601596938857e-09
WT1 O 0 0.00030372475157491863
- O 0 1.6751668226788752e-05
KTS O 0 0.0014351240824908018
isoforms O 0 5.456353733279684e-07
associate O 0 3.4084911249010474e-07
and O 0 6.768737570439498e-09
synergize O 0 8.338651582562306e-07
with O 0 8.249356753253778e-09
SF O 1 0.9999885559082031
- O 0 2.5925368390744552e-05
1 O 0 4.250264566962869e-07
to O 0 1.1208675765317366e-08
promote O 0 1.2734476229070424e-07
MIS O 0 0.0017097096424549818
expression O 0 3.279730265148828e-07
. O 0 1.7265836049773498e-07

In O 0 4.2364811747575004e-07
contrast O 0 1.4392411458175047e-06
, O 0 9.791145316739858e-08
WT1 O 0 0.001328430837020278
missense O 0 1.1070022083004005e-05
mutations O 0 2.090700057522099e-08
, O 0 2.7908464428350044e-10
associated O 0 3.330849152050064e-09
with O 0 9.726233152207442e-10
male B-Disease 0 9.304399384291173e-08
pseudohermaphroditism I-Disease 1 1.0
in O 0 1.7241055161321128e-07
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 6.027871535252416e-08
fail O 0 8.214486229007889e-07
to O 0 2.8680011254778037e-08
synergize O 0 5.260871330392547e-05
with O 0 6.476479370576271e-07
SF O 1 1.0
- O 0 0.3678276538848877
1 O 0 8.173404239641968e-06
. O 0 2.463353325765638e-07

Additionally O 0 1.6177775705727981e-06
, O 0 3.127839320882231e-08
the O 0 2.8476041080693903e-08
X O 0 1.9601613530539908e-05
- O 0 2.272293386340607e-06
linked O 0 1.2165113503215252e-06
, O 0 2.8056050815905564e-09
candidate O 0 1.1177314185317755e-08
dosage O 0 7.16094348263141e-07
- O 0 2.2096776319813216e-07
sensitive O 0 1.7599106172383472e-07
sex O 0 1.3499622530943611e-09
- O 0 2.436148172080266e-09
reversal O 0 1.9203489909358495e-09
gene O 0 4.399990372050411e-10
, O 0 2.2406269895025588e-10
Dax O 0 5.2593213695217855e-06
- O 0 1.0701927521949983e-07
1 O 0 1.3328916281807324e-07
, O 0 1.384342196431021e-09
antagonizes O 0 5.386355041991919e-07
synergy O 0 1.3033854884270113e-07
between O 0 4.3913843228438054e-08
SF O 0 0.14823505282402039
- O 0 5.766983690591587e-07
1 O 0 4.221904603696203e-08
and O 0 1.9414965191089095e-09
WT1 O 0 6.685992502752924e-06
, O 0 2.385312503072612e-10
most O 0 8.766357778577927e-11
likely O 0 5.024419214016973e-10
through O 0 3.5164257616848715e-10
a O 0 2.0037059511590627e-10
direct O 0 6.04874650367293e-10
interaction O 0 2.1741985989365276e-09
with O 0 1.2187219011750017e-09
SF O 1 0.9998847246170044
- O 0 1.2156380762462504e-05
1 O 0 9.902373676595744e-07
. O 0 1.5219590920878545e-07

We O 0 4.69687620352488e-07
propose O 0 3.914071271537978e-07
that O 0 8.078497870656065e-09
WT1 O 0 0.00017465921700932086
and O 0 6.625285209338472e-07
Dax O 0 0.2898213565349579
- O 0 3.843172180495458e-06
1 O 0 3.6101914702157956e-07
functionally O 0 6.899793447701086e-08
oppose O 0 1.1185269599423009e-08
each O 0 2.2916366027025958e-10
other O 0 3.877005660957167e-10
in O 0 1.1374154951226956e-09
testis O 0 8.408631657630394e-08
development O 0 1.568099872173434e-09
by O 0 2.9207514185003447e-10
modulating O 0 2.0496921138146718e-07
SF O 0 0.02499869279563427
- O 0 4.673053808801342e-06
1 O 0 6.880447926960187e-07
- O 0 1.1929097354368423e-07
mediated O 0 2.6797397367772646e-06
transactivation O 0 3.431126242503524e-05
. O 0 1.8050242189815435e-08
. O 0 3.6967666261489285e-08

A O 0 1.1231039025005884e-05
mouse O 0 1.5470767493752646e-06
model O 0 4.117258711744398e-08
for O 0 7.254931944089549e-08
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 1.0
- O 1 0.9999998807907104
centre O 0 0.00013613274495583028
mutations O 0 5.147589376974793e-08
. O 0 5.107111533675379e-08

Imprinting O 0 9.247913112631068e-05
in O 0 6.343863674374006e-07
the O 0 6.263620662139147e-07
15q11 O 0 1.840253571572248e-05
- O 0 8.657282819513057e-07
q13 O 0 3.1953964025888126e-06
region O 0 2.5206826848034325e-08
involves O 0 7.4464923116579484e-09
an O 0 8.445157351211208e-10
imprinting O 0 1.5359393046310288e-07
centre O 0 1.9142252938308957e-07
( O 0 7.871692742078551e-10
IC O 0 1.0641064136507339e-06
) O 0 6.150766007628761e-10
, O 0 1.0505973868646379e-10
mapping O 0 2.0399633093859393e-09
in O 0 2.5791524471685534e-10
part O 0 1.1969222279972769e-09
to O 0 6.234353588929764e-10
the O 0 1.1536476662854511e-08
promoter O 0 4.757438034630468e-07
and O 0 1.1836237767681723e-08
first O 0 1.909895708251952e-08
exon O 0 3.102551886513538e-07
of O 0 2.2545106048710295e-07
SNRPN O 0 0.0012292602332308888
. O 0 1.2213821491968702e-06

Deletion O 0 5.008421339880442e-06
of O 0 7.616425818923744e-07
this O 0 2.8262308049420426e-08
IC O 0 9.549948299536481e-05
abolishes O 0 1.0540031325945165e-05
local O 0 4.932349284558768e-08
paternally O 0 7.466748286333313e-08
derived O 0 2.639787721747666e-09
gene O 0 5.783755141486324e-10
expression O 0 4.214972815219653e-10
and O 0 1.2687691175461424e-10
results O 0 4.4857714764923173e-10
in O 0 5.2064205391388896e-08
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.999996542930603
PWS B-Disease 1 1.0
) O 0 8.860674256538914e-07
. O 0 5.101781539451622e-07

We O 0 2.3978117269507493e-07
have O 0 3.6264731217983126e-09
created O 0 8.60388027490444e-09
two O 0 2.9391835631997765e-09
deletion O 0 4.501271533285944e-08
mutations O 0 3.4090963385580153e-09
in O 0 2.1442256858961173e-09
mice O 0 2.4706226398052422e-08
to O 0 7.429751480714231e-09
understand O 0 4.871307282883208e-06
PWS B-Disease 1 1.0
and O 0 7.703377491452557e-07
the O 0 2.3837774421053837e-08
mechanism O 0 1.2220791489880867e-08
of O 0 3.204535525824781e-09
this O 0 9.963248004396519e-10
IC O 0 1.8761586034088396e-05
. O 0 2.240933127950484e-07

Mice O 0 9.202600631397218e-05
harbouring O 0 0.00010640339314704761
an O 0 9.998742456218679e-08
intragenic O 0 5.830638838233426e-05
deletion O 0 2.6808568236447172e-06
in O 0 3.316498364824838e-08
Snrpn O 0 0.0007707226905040443
are O 0 3.753412247675669e-09
phenotypically O 0 5.002717807656154e-05
normal O 0 1.9006404272658983e-07
, O 0 2.1393549431980574e-10
suggesting O 0 1.0888356882787775e-09
that O 0 7.719789391069654e-11
mutations O 0 1.0968251862308875e-09
of O 0 1.865307908133218e-08
SNRPN O 0 0.028718605637550354
are O 0 3.033106543703923e-10
not O 0 2.208646598944597e-10
sufficient O 0 1.546073136182713e-08
to O 0 1.4047169649700209e-08
induce O 0 1.0064683920063544e-05
PWS B-Disease 1 1.0
. O 0 9.164986113319173e-05

Mice O 0 3.3829603580670664e-06
with O 0 5.0854715993864374e-09
a O 0 1.2391878634332443e-08
larger O 0 2.3297388906939887e-08
deletion O 0 5.5302944446111724e-08
involving O 0 2.426252532217177e-09
both O 0 8.852880095666649e-10
Snrpn O 0 3.4461515951988986e-06
and O 0 9.844173476381002e-09
the O 0 4.702227585084984e-08
putative O 0 9.316226351074874e-05
PWS O 1 1.0
- O 0 0.00016345411131624132
IC O 0 0.00015630648704245687
lack O 0 3.5912503904000914e-07
expression O 0 4.301946354701158e-09
of O 0 3.4164000517478144e-09
the O 0 2.196846260460461e-09
imprinted O 0 8.15889578120732e-09
genes O 0 2.1362733804153322e-09
Zfp127 O 0 8.326834972649522e-07
( O 0 3.887300259464155e-09
mouse O 0 3.640315071606892e-07
homologue O 0 6.016804036335088e-06
of O 0 3.7669340713364363e-07
ZNF127 O 0 0.029946986585855484
) O 0 1.1040775405035674e-08
, O 0 3.482825583489557e-09
Ndn O 0 3.7862885164940963e-06
and O 0 1.4100104195335916e-08
Ipw O 0 9.253197390535206e-07
, O 0 1.3439120927216663e-09
and O 0 9.298963266068938e-10
manifest O 0 9.607003192968477e-09
several O 0 7.944257474079564e-10
phenotypes O 0 2.9102887211251982e-08
common O 0 1.5778309148117842e-07
to O 0 7.936319548207393e-07
PWS B-Disease 1 1.0
infants O 1 0.999998927116394
. O 0 1.0741559890448116e-05

These O 0 7.598247009354964e-08
data O 0 6.766042304207076e-08
demonstrate O 0 9.155604274724283e-09
that O 0 1.8741896923302193e-10
both O 0 2.1436273589525712e-10
the O 0 1.6175897288306373e-09
position O 0 8.13564859925009e-09
of O 0 2.7645010725052543e-09
the O 0 1.5632052319247691e-09
IC O 0 6.670641710115888e-07
and O 0 4.138086262539531e-10
its O 0 2.0664667199632447e-10
role O 0 5.422464699478269e-10
in O 0 5.583534676278923e-11
the O 0 1.3060015568999717e-10
coordinate O 0 2.411018606984783e-10
expression O 0 9.012520174600525e-10
of O 0 3.225046230070916e-09
genes O 0 4.071344372746921e-10
is O 0 7.399281881648179e-11
conserved O 0 8.84177620008586e-10
between O 0 9.086429386684358e-10
mouse O 0 7.150496372787529e-08
and O 0 9.450842330949172e-10
human O 0 8.518897254283786e-10
, O 0 8.08706018817773e-11
and O 0 1.1530305876750191e-10
indicate O 0 3.1453289972560583e-10
that O 0 3.459697250907112e-10
the O 0 1.1938881883111208e-08
mouse O 0 3.729337194613436e-08
is O 0 6.870970459260661e-11
a O 0 2.0487199436924897e-10
suitable O 0 1.129251536724496e-08
model O 0 3.02074143476716e-09
system O 0 7.673027546672984e-09
in O 0 1.4720842600457473e-10
which O 0 1.5073034834167665e-11
to O 0 6.052667395062272e-11
investigate O 0 1.1950448408626357e-09
the O 0 5.475176423352934e-10
molecular O 0 2.4390540698249197e-09
mechanisms O 0 1.1675849620473855e-08
of O 0 6.888902781554407e-09
imprinting O 0 1.4936637171558687e-07
in O 0 4.537730469156287e-10
this O 0 1.2121975645484895e-10
region O 0 2.0223747121406177e-09
of O 0 4.483703186508592e-09
the O 0 4.392135988240398e-09
genome O 0 3.6583962526037794e-09
. O 0 1.2833755169694427e-09
. O 0 3.55222447012693e-08

Mutations O 0 2.437409705180471e-07
of O 0 4.4829658918388304e-07
the O 0 1.8923930156233837e-07
ATM O 0 3.0842750220472226e-06
gene O 0 1.5669613162572205e-08
detected O 0 3.0713458443187847e-08
in O 0 6.794037776813866e-09
Japanese O 1 0.9969918727874756
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.9999966621398926
: O 0 3.2731599652890964e-09
possible O 0 4.612480619670123e-09
preponderance O 0 6.3883926486596465e-06
of O 0 8.195411282940768e-08
the O 0 1.2350703570973565e-08
two O 0 1.2815971617285982e-09
founder O 0 2.602956499231368e-07
mutations O 0 4.963025990178949e-09
4612del165 O 0 6.402845542652358e-07
and O 0 5.979092065899749e-08
7883del5 O 0 1.0590135389065836e-05
. O 0 4.4126858256277046e-07

The O 0 4.003680714959046e-06
ATM O 0 2.8479646061896347e-05
( O 0 3.9097213289096544e-07
A O 1 1.0
- O 1 0.9999966621398926
T O 1 1.0
, O 0 6.3917395820567435e-09
mutated O 0 7.776650434720978e-09
) O 0 4.690774435545109e-10
gene O 0 1.4004599702133191e-09
on O 0 5.2170241460203215e-09
human O 0 6.441354560848822e-09
chromosome O 0 1.3144428123723628e-07
11q22 O 0 5.0959156396857e-06
. O 0 4.632059642517561e-07

3 O 0 1.2509436601249035e-05
has O 0 1.7822706865899818e-08
recently O 0 6.032792043697555e-09
been O 0 3.486605448799196e-10
identified O 0 3.4836142304150997e-10
as O 0 7.124049267170918e-11
the O 0 2.266212911772314e-10
gene O 0 1.093720253253494e-10
responsible O 0 1.863737775220642e-10
for O 0 9.059808458999896e-11
the O 0 2.2787403075597013e-09
human O 0 6.68628459266074e-08
recessive B-Disease 0 0.0006796472007408738
disease I-Disease 1 0.9999998807907104
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9999552965164185
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 3.928805938357982e-07
. O 0 2.93009577490011e-07

In O 0 6.82336391832905e-08
order O 0 2.1601250566050112e-08
to O 0 1.5212290316313215e-09
define O 0 4.196012426405105e-09
the O 0 5.944222891685058e-10
types O 0 2.6941746611441886e-09
of O 0 1.0343617518060455e-08
disease O 0 2.1234106952761067e-06
- O 0 5.1010566437525995e-08
causing O 0 2.2272455879601694e-08
ATM O 0 2.2987227055182302e-07
mutations O 0 2.6456586921241865e-10
in O 0 2.643625873766098e-10
Japanese O 0 2.2471303964266554e-05
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 1.4738818663317943e-06
as O 0 3.5061136216540945e-09
well O 0 3.598908948632129e-10
as O 0 1.7287658804487904e-10
to O 0 9.44456735041399e-11
look O 0 6.136727237482376e-10
for O 0 2.7270857794192693e-10
possible O 0 4.6795108232799976e-08
mutational O 0 1.4520583135890774e-05
hotspots O 0 4.335180676662276e-07
, O 0 2.868063841976465e-10
reverse O 0 4.460774416514823e-09
- O 0 3.977276286093456e-09
transcribed O 0 8.427232800478635e-10
RNA O 0 3.6968705874329544e-09
derived O 0 2.0350966745130705e-10
from O 0 3.8343958563835656e-10
ten O 0 1.0391485449900983e-09
patients O 0 1.9345976209894644e-10
belonging O 0 3.1781728360158468e-09
to O 0 9.041652981878201e-10
eight O 0 3.922888236473909e-09
unrelated O 0 8.751385394134559e-08
Japanese O 0 0.0002038949605775997
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
families O 0 3.988863994663916e-08
was O 0 1.7322530965202532e-08
analyzed O 0 2.595254289250448e-10
for O 0 1.4053043451145442e-11
mutations O 0 1.912991813568521e-11
by O 0 1.947718202000015e-11
the O 0 1.2807419569327294e-09
restriction O 0 1.6962996562952526e-09
endonuclease O 0 6.073445746324069e-08
fingerprinting O 0 3.002396553597464e-08
method O 0 2.372781793269496e-08
. O 0 3.73915192142249e-08

As O 0 1.169044480775483e-06
has O 0 4.373227113774192e-09
been O 0 3.0623517610628426e-10
reported O 0 1.500480295568707e-10
by O 0 2.8175716967893116e-11
others O 0 5.017983251143221e-10
, O 0 9.302292963697667e-11
mutations O 0 5.151500406808118e-11
that O 0 3.979830007216911e-11
lead O 0 5.506976652469575e-09
to O 0 6.163428878380728e-09
exon O 0 1.0511575965210795e-06
skipping O 0 6.597215929105005e-08
or O 0 7.365621890187413e-09
premature O 0 2.177058711083646e-08
protein O 0 1.3046205227240648e-09
truncation O 0 2.247051469339567e-07
were O 0 3.828872774391812e-09
also O 0 9.441365467210971e-10
predominant O 0 5.049441824667156e-07
in O 0 8.69315375240376e-09
our O 0 9.322661043142944e-08
mutants O 0 6.371627137014002e-07
. O 0 8.517898208992847e-08

Six O 0 5.144674375401337e-08
different O 0 3.9242031846242753e-10
mutations O 0 3.170578799505108e-10
were O 0 3.3154828882331344e-10
identified O 0 2.0243546838827342e-09
on O 0 6.4298406599050395e-09
12 O 0 2.855413017144315e-09
of O 0 1.0142006345859045e-08
the O 0 4.124584052078717e-08
16 O 0 3.270228887686244e-08
alleles O 0 6.1440386112110446e-09
examined O 0 4.171540979314159e-07
. O 0 3.1139018119574757e-07

Four O 0 1.906344238022939e-07
were O 0 1.934119886470853e-08
deletions O 0 6.54563905300165e-08
involving O 0 9.543593471050826e-09
a O 0 9.877802575886108e-09
loss O 0 8.479545243744724e-08
of O 0 7.062379268063523e-07
a O 0 1.2055437537128455e-07
single O 0 2.5191157604353975e-08
exon O 0 1.6641629940750136e-07
exon O 0 7.052849326782962e-08
7 O 0 2.161621104335154e-08
, O 0 2.7834198834675306e-10
exon O 0 5.782415257726825e-08
16 O 0 4.3066606281172426e-08
, O 0 3.774216494889515e-09
exon O 0 6.536400860568392e-07
33 O 0 3.026539445727394e-07
or O 0 6.663304930043523e-08
exon O 0 5.98750784774893e-06
35 O 0 9.549202104608412e-07
. O 0 2.1588796528249077e-07

The O 0 2.537059344831505e-06
others O 0 1.5534681097051362e-07
were O 0 6.290559184662925e-08
minute O 0 3.317931884794234e-07
deletions O 0 2.3743126575936913e-07
, O 0 4.804241449107849e-09
4649delA O 0 3.76127644585722e-07
in O 0 7.694953119141701e-09
exon O 0 3.844561433652416e-07
33 O 0 8.728197542495764e-08
and O 0 7.344760799554706e-09
7883del5 O 0 5.381482424127171e-07
in O 0 1.8093777143235457e-08
exon O 0 3.776951871259371e-06
55 O 0 3.972608624280838e-07
. O 0 1.2018841744065867e-07

The O 0 2.4956948436738458e-06
mutations O 0 1.8000275758822681e-07
4612del165 O 0 1.2678785878961207e-06
and O 0 6.361940307897385e-09
7883del5 O 0 2.423444698251842e-07
were O 0 2.802043486127559e-09
found O 0 2.775118468356652e-10
in O 0 3.3757573125736684e-11
more O 0 1.837643318763904e-12
than O 0 5.8173275224726595e-12
two O 0 1.3859735407961704e-11
unrelated O 0 2.0174346915258212e-10
families O 0 2.3350472597161165e-11
; O 0 4.0478728008386256e-11
44 O 0 1.1171128466713753e-09
% O 0 2.1193527488527764e-10
( O 0 1.4138061554813675e-10
7 O 0 9.60447543718601e-09
of O 0 7.41177563767792e-09
16 O 0 7.085597886202777e-09
) O 0 1.5340632930627152e-10
of O 0 4.376005335871014e-09
the O 0 5.898417754224283e-09
mutant O 0 1.7649663952568062e-09
alleles O 0 1.2954576300572285e-10
had O 0 7.185462225223205e-10
one O 0 1.3821278843639817e-10
of O 0 1.92350180228118e-09
the O 0 7.62689111866166e-09
two O 0 4.292012967255232e-09
mutations O 0 1.2367723734030278e-08
. O 0 1.6413792991443188e-07

The O 0 7.193859346443787e-06
4612del165 O 0 6.314701295195846e-06
mutations O 0 1.2339731902955009e-08
in O 0 1.1666871913007526e-09
three O 0 2.3212116950777073e-10
different O 0 5.0298633313961005e-11
families O 0 2.3256521708425737e-10
were O 0 3.8179756578493595e-10
all O 0 8.763215153528847e-11
ascribed O 0 1.1581673398097792e-08
to O 0 1.0788548943096998e-09
the O 0 8.804522444449958e-09
same O 0 4.1856051957722684e-09
T O 0 1.1516255682408882e-07
- O 0 5.6398967274162715e-08
- O 0 2.1699490204696303e-08
> O 0 1.9693651154284453e-08
A O 0 9.016719815235774e-09
substitution O 0 4.103200001992491e-09
at O 0 2.530653242516223e-09
the O 0 8.156059716490915e-10
splice O 0 9.632621100763572e-08
donor O 0 5.094092259128047e-09
site O 0 1.7653915662663167e-08
in O 0 2.566683754423593e-09
intron O 0 5.254187726677628e-06
33 O 0 1.753851506691717e-06
. O 0 7.054180741761229e-07

Microsatellite O 0 0.0008720657788217068
genotyping O 0 8.77140264492482e-05
around O 0 1.1218540407753608e-07
the O 0 5.892978194310672e-08
ATM O 0 1.675558678471134e-06
locus O 0 3.717079977150206e-08
also O 0 2.351101258124544e-10
indicated O 0 1.0874383338244087e-10
that O 0 1.0112070035483978e-11
a O 0 3.1874472505855067e-10
common O 0 4.943318643313432e-09
haplotype O 0 3.190686754805938e-07
was O 0 5.117057355619181e-08
shared O 0 8.576137022764385e-10
by O 0 4.5097463957644024e-11
the O 0 1.2739932442329405e-09
mutant O 0 1.5906714834201807e-09
alleles O 0 1.524478598913248e-10
in O 0 3.6968686445426613e-10
both O 0 2.4035449186499136e-09
mutations O 0 2.7754495590670558e-08
. O 0 1.40647884450118e-07

This O 0 1.52657513297072e-08
suggests O 0 9.829538072381183e-09
that O 0 3.151164051917732e-11
these O 0 6.809962316278728e-11
two O 0 6.176441025296242e-10
founder O 0 2.3775096735789703e-07
mutations O 0 1.3712001534216256e-09
may O 0 1.5957919430320544e-09
be O 0 1.1240419706126659e-09
predominant O 0 6.820058047196653e-07
among O 0 2.2708437352747524e-09
Japanese O 0 1.519000960570338e-07
ATM O 0 9.69634243119799e-07
mutant O 0 7.37408782924831e-08
alleles O 0 6.833963173136226e-09
. O 0 3.283372507212334e-08

W474C O 0 2.7690688511938788e-05
amino O 0 9.222453201118697e-08
acid O 0 1.36592541721825e-08
substitution O 0 1.1082762263470158e-08
affects O 0 1.0670631045428536e-09
early O 0 2.2490413975617685e-09
processing O 0 1.6718048057029478e-09
of O 0 2.778085539389963e-09
the O 0 2.2237893748666693e-09
alpha O 0 1.6624087662009401e-09
- O 0 2.330447779197442e-10
subunit O 0 3.6054223495618487e-10
of O 0 7.274961189018825e-10
beta O 0 5.0414321606240264e-09
- O 0 3.940856529993653e-09
hexosaminidase O 0 2.302429891187785e-08
A O 0 3.471881893091222e-09
and O 0 6.136115920929441e-11
is O 0 1.4158725407387163e-11
associated O 0 1.5528482666393728e-10
with O 0 2.7882499087361623e-10
subacute O 0 0.0017409521387889981
G B-Disease 0 3.856988769257441e-05
( I-Disease 0 3.821870464548738e-08
M2 I-Disease 0 8.388627065869514e-06
) I-Disease 0 1.273401029067145e-08
gangliosidosis I-Disease 0 1.0034696060756687e-05
. O 0 3.639641761310486e-07

Mutations O 0 4.3859645870725217e-07
in O 0 4.8032088528771055e-08
the O 0 9.965309288872959e-08
HEXA O 0 9.14717293198919e-06
gene O 0 3.1717053428081954e-09
, O 0 1.1799979049431641e-10
encoding O 0 2.6918323126068344e-09
the O 0 6.3440066533360095e-09
alpha O 0 8.987479205302407e-09
- O 0 8.796762762663946e-10
subunit O 0 1.240807345759265e-09
of O 0 3.081648491942701e-09
beta O 0 2.6331512970045878e-08
- O 0 3.670440662517649e-08
hexosaminidase O 0 3.890755522206746e-07
A O 0 1.0833326058445891e-07
( O 0 1.324258258605937e-09
Hex O 0 1.1447445302792403e-07
A O 0 3.204262100098276e-08
) O 0 1.8578036331540204e-10
, O 0 1.1290458151735905e-10
that O 0 1.3934277343086166e-10
abolish O 0 1.5038705214465153e-07
Hex O 0 1.6819545862745144e-06
A O 0 1.3660940112458775e-07
enzyme O 0 2.6454141988097035e-08
activity O 0 1.199553434361178e-08
cause O 0 0.00016862235497683287
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 0.9999980926513672
( O 0 6.111665129537869e-08
TSD B-Disease 1 0.9931498169898987
) O 0 5.072644970738338e-09
, O 0 4.1470463174597683e-10
the O 0 6.527857809857096e-09
fatal O 0 1.950513563997447e-07
infantile B-Disease 0 5.8806492120311304e-08
form I-Disease 0 1.0736087574514386e-08
of I-Disease 0 1.4965081618356635e-06
G I-Disease 0 1.4642445194112952e-06
( I-Disease 0 3.7177871892168923e-09
M2 I-Disease 0 2.445559061925451e-07
) I-Disease 0 6.8192462787664e-10
gangliosidosis I-Disease 0 2.429711685181246e-07
, I-Disease 0 4.597266456407567e-10
Type I-Disease 0 1.7805419361138775e-07
1 I-Disease 0 1.7092465895984787e-06
. O 0 2.0154334379185457e-07

Less O 0 2.9749828627245734e-06
severe O 0 0.008006666786968708
, O 0 2.881556326883583e-07
subacute O 1 1.0
( O 0 3.519493475323543e-06
juvenile O 1 0.710344135761261
- O 0 5.338817118172301e-06
onset O 1 1.0
) O 0 1.3574474166944128e-07
and O 0 9.712059778621551e-08
chronic O 1 0.9999998807907104
( O 0 2.5751978327548386e-08
adult O 0 8.195176093295231e-08
- O 0 6.366457938611347e-08
onset O 0 5.628780400002142e-06
) O 0 8.986441452085714e-11
variants O 0 7.743491403644498e-10
are O 0 2.922921887166252e-12
characterized O 0 1.0871625127917284e-10
by O 0 1.3885507327282554e-11
a O 0 5.014137438585919e-10
broad O 0 1.679684480393462e-08
spectrum O 0 2.8433980503450584e-08
of O 0 3.6619898780010374e-10
clinical O 0 1.86626425424663e-09
manifestations O 0 2.0067906447707173e-08
and O 0 1.7222098747105008e-10
are O 0 1.9913216041389514e-12
associated O 0 1.1214181666607814e-10
with O 0 1.79660609306298e-11
residual O 0 1.0330648336775994e-07
levels O 0 8.373945092898794e-09
of O 0 3.878311360949738e-08
Hex O 0 5.367141966416966e-07
A O 0 8.104660054186752e-08
enzyme O 0 1.3481952443328282e-08
activity O 0 7.944307434115672e-09
. O 0 2.706186208456529e-08

We O 0 4.5167993789618777e-07
identified O 0 1.0233005554027841e-07
a O 0 3.8394496471028106e-08
1422 O 0 1.0435911462991498e-05
G O 0 1.4973903716963832e-06
- O 0 8.147475227815448e-07
- O 0 2.3827941220133653e-07
> O 0 1.4982475704528042e-07
C O 0 1.3653814789904573e-07
( O 0 2.1859235255217158e-10
amino O 0 6.100546456888623e-11
acid O 0 9.077001650314998e-11
W474C O 0 1.1512555353476728e-09
) O 0 1.3837646306580353e-12
substitution O 0 8.091643327601261e-11
in O 0 4.293981836767102e-11
the O 0 5.966486193997866e-10
first O 0 5.717484818923424e-10
position O 0 7.285768877096643e-09
of O 0 1.2151434525264904e-08
exon O 0 2.3530551729322724e-08
13 O 0 2.83373235987483e-09
of O 0 7.2923587168816084e-09
HEXA O 0 4.036619793623686e-05
of O 0 1.2037435226375237e-07
a O 0 4.784273244240467e-08
non O 0 1.528406841089236e-07
- O 0 2.991792769080348e-07
Jewish O 0 1.1671411925817665e-07
proband O 0 1.5806239389348775e-05
who O 0 7.0087273762453606e-09
manifested O 0 3.3783255304342674e-08
a O 0 1.188979581456806e-08
subacute O 0 3.285575076006353e-05
variant O 0 1.6333360690623522e-05
of O 0 0.0001177503218059428
G B-Disease 0 0.0003083756600972265
( I-Disease 0 3.8905358934471224e-08
M2 I-Disease 0 6.726719675498316e-06
) I-Disease 0 1.850237829614798e-08
gangliosidosis I-Disease 0 8.235506356868427e-06
. O 0 2.5503669576210086e-07

On O 0 1.2074348887836095e-05
the O 0 2.648835675245209e-07
second O 0 3.2409298000857234e-07
maternally O 0 7.741164722574467e-07
inherited O 0 1.3264818790048594e-06
allele O 0 3.070420362405457e-08
, O 0 6.707047139897782e-10
we O 0 2.500553653028703e-10
identified O 0 1.0036641517885414e-09
the O 0 3.176172880259287e-09
common O 0 1.4545229305440444e-06
infantile O 1 0.5502587556838989
disease O 0 0.28229185938835144
- O 0 5.922511263634078e-07
causing O 0 8.435577001364436e-07
4 O 0 1.2195176850582357e-06
- O 0 1.8372233512309322e-07
bp O 0 5.31870625763986e-07
insertion O 0 9.751391871759552e-08
, O 0 3.044874574698042e-09
+ O 0 2.5120721502958077e-08
TATC O 0 1.003445686365012e-05
1278 O 0 1.381656329613179e-05
, O 0 2.701749490796601e-09
in O 0 3.366334322407738e-09
exon O 0 1.1586499795157579e-06
11 O 0 2.087078883050708e-07
. O 0 1.6197832053421735e-07

Pulse O 0 0.0001250901259481907
- O 0 2.4804778604448074e-06
chase O 0 1.1153488088666563e-07
analysis O 0 3.361278810842805e-09
using O 0 7.61128315929227e-09
proband O 0 1.1826421086880146e-06
fibroblasts O 0 4.761205119052647e-08
revealed O 0 3.857389074823914e-08
that O 0 2.788941577680504e-10
the O 0 2.8391098361169043e-09
W474C O 0 4.091627658908692e-08
- O 0 3.692248062847625e-09
containing O 0 6.927135531853423e-10
alpha O 0 5.475869091497998e-09
- O 0 1.4346748233862172e-09
subunit O 0 1.744300592854131e-09
precursor O 0 6.105254968247209e-09
was O 0 1.792240911235865e-09
normally O 0 5.839453226519353e-11
synthesized O 0 3.3302374746746466e-10
, O 0 1.362067750254603e-11
but O 0 8.12583507425746e-12
not O 0 1.2936964867427125e-11
phosphorylated O 0 4.2686312262674164e-09
or O 0 5.960094640045099e-10
secreted O 0 3.3413719013886123e-10
, O 0 1.0148808182730562e-10
and O 0 6.148361819668935e-10
the O 0 1.1880636918704113e-08
mature O 0 1.1433519908621292e-08
lysosomal O 0 7.183844559222052e-07
alpha O 0 8.689394803695905e-08
- O 0 1.255395964960826e-08
subunit O 0 1.303564189925055e-08
was O 0 1.942756888695385e-08
not O 0 4.759638794205046e-10
detected O 0 7.249398237263449e-08
. O 0 4.363206329571767e-08

When O 0 2.2551137135451427e-06
the O 0 3.7577845546366007e-07
W474C O 0 1.7704531956042047e-06
- O 0 4.3501017898961436e-08
containing O 0 1.1102904373672118e-08
alpha O 0 3.4143170069000917e-08
- O 0 1.206519861796096e-08
subunit O 0 2.761614403823387e-08
was O 0 6.405276309351393e-08
transiently O 0 3.813467586155639e-08
co O 0 1.079827161021285e-08
- O 0 3.100230960839667e-09
expressed O 0 7.487533926209267e-10
with O 0 1.4820687732619575e-10
the O 0 2.4304118717566325e-09
beta O 0 3.2249847237153517e-09
- O 0 2.6828521626498514e-09
subunit O 0 2.474710214528386e-09
to O 0 7.507955368524222e-10
produce O 0 7.928292689030059e-09
Hex O 0 8.403883384744404e-07
A O 0 2.231249567330451e-07
( O 0 2.7543956004905112e-09
alphabeta O 0 6.615776442231436e-07
) O 0 9.03589425504947e-10
in O 0 2.790661479679102e-09
COS O 0 9.368448445457034e-06
- O 0 6.022614229550527e-07
7 O 0 5.1549882584822626e-08
cells O 0 2.0518808874214756e-09
, O 0 1.3948583954537241e-10
the O 0 1.2204246502278693e-09
mature O 0 6.386763895527281e-10
alpha O 0 3.906580392509795e-09
- O 0 9.898297737009898e-10
subunit O 0 1.5913756978847005e-09
was O 0 1.4188531460845866e-09
present O 0 1.6713545825108866e-10
, O 0 2.778188790131253e-11
but O 0 4.0069607354364933e-11
its O 0 1.7431824039793042e-10
level O 0 1.8407680935084159e-09
was O 0 2.0659474131434763e-09
much O 0 9.921031357551513e-11
lower O 0 8.423536868029657e-10
than O 0 4.9368287236006836e-12
that O 0 4.9795458555157435e-12
from O 0 2.53552678852742e-10
normal O 0 1.2625270828792168e-09
alpha O 0 9.543993151339691e-09
- O 0 4.230083838763221e-09
subunit O 0 5.092227084446677e-09
transfections O 0 4.942680220665352e-08
, O 0 4.49374981670303e-11
although O 0 4.8968246124658776e-11
higher O 0 1.2466383481068988e-09
than O 0 3.127727243867895e-11
in O 0 3.9270163509907974e-11
those O 0 5.3485455647761526e-11
cells O 0 5.706742300937151e-10
transfected O 0 3.109274970825027e-08
with O 0 5.928798424426063e-11
an O 0 1.8988662031649284e-10
alpha O 0 7.918288247310556e-09
- O 0 5.27875210210027e-09
subunit O 0 8.068949952644289e-09
associated O 0 5.840294470260687e-09
with O 0 5.756124021871756e-09
infantile O 0 5.379934736993164e-05
TSD B-Disease 0 0.002477830508723855
. O 0 1.5517061910941266e-06

Furthermore O 0 2.320914518350037e-06
, O 0 2.872928561714616e-08
the O 0 1.3961053646482924e-08
precursor O 0 2.0193390071199246e-07
level O 0 1.3692140043986e-07
of O 0 4.478543402797186e-08
the O 0 2.294486023401987e-08
W474C O 0 1.0406748884861372e-07
alpha O 0 5.593485674637577e-09
- O 0 1.7204510038837384e-09
subunit O 0 1.5842223088924356e-09
was O 0 2.136481214165542e-09
found O 0 1.7677415087291592e-10
to O 0 5.479457165780133e-11
accumulate O 0 1.7798544860170296e-09
in O 0 3.164929429644303e-10
comparison O 0 3.754085486917802e-09
to O 0 1.9329313705185314e-09
the O 0 8.301903164920077e-09
normal O 0 2.6060011037998265e-08
alpha O 0 8.487522507039102e-08
- O 0 1.2891145928506376e-08
subunit O 0 9.801193634473293e-09
precursor O 0 1.8771142862306078e-08
levels O 0 9.409549583949683e-09
. O 0 2.0329997241219644e-08

We O 0 3.25197987649517e-07
conclude O 0 1.6603314634267008e-07
that O 0 1.1969473190376334e-09
the O 0 1.2196340826164942e-08
1422 O 0 3.78394611288968e-06
G O 0 7.565533906017663e-07
- O 0 2.587085532468336e-07
- O 0 6.690035547762818e-08
> O 0 4.833444577911905e-08
C O 0 4.8253752993332455e-08
mutation O 0 7.043307603815663e-11
is O 0 4.168191399672727e-12
the O 0 4.896805877452337e-11
cause O 0 1.433094087843756e-09
of O 0 4.04204634207872e-08
Hex B-Disease 0 5.900529140490107e-05
A I-Disease 0 0.0002042954438365996
enzyme I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 1.2954838091161491e-08
the O 0 4.4503575935550543e-08
proband O 0 6.692346687486861e-06
. O 0 1.601263335260228e-07

The O 0 1.1938024044866324e-06
resulting O 0 7.235569796648633e-07
W474C O 0 2.9332040867302567e-06
substitution O 0 1.2538625071556453e-07
clearly O 0 6.407414332443295e-08
interferes O 0 3.700597517308779e-08
with O 0 6.180566058944237e-10
alpha O 0 1.0839253050676234e-08
- O 0 3.481570143293311e-09
subunit O 0 2.7359181586916748e-09
processing O 0 2.884435357231041e-09
, O 0 9.006032898606353e-12
but O 0 7.934027566880442e-12
because O 0 4.24648996522059e-11
the O 0 3.6554440030478474e-10
base O 0 1.026917395563487e-08
substitution O 0 3.9865668099992035e-08
falls O 0 2.2345351169406058e-07
at O 0 1.9448469501526233e-09
the O 0 1.039701769123269e-09
first O 0 2.2635358032374597e-09
position O 0 1.6308931094499712e-08
of O 0 2.9631866738100143e-08
exon O 0 1.3977660273667425e-07
13 O 0 9.381021293108915e-09
, O 0 6.15328552000527e-11
aberrant O 0 1.0822926999054516e-09
splicing O 0 3.540819548675245e-08
may O 0 2.1133352845481568e-09
also O 0 4.378884199685018e-10
contribute O 0 5.923375123728647e-10
to O 0 1.789730852408411e-08
Hex B-Disease 0 0.07881651818752289
A I-Disease 0 0.0029301666654646397
deficiency I-Disease 1 0.9999959468841553
in O 0 5.8751336240447927e-08
this O 0 9.47969702735918e-09
proband O 0 3.1926945212035207e-06
. O 0 8.825976394177815e-09
. O 0 3.230169554058193e-08

Two O 0 1.7397702833932271e-07
frequent O 0 2.5626820843172027e-07
missense O 0 7.277699751284672e-06
mutations O 0 4.7118876977947366e-07
in O 0 3.8847750261084e-07
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.00024491557269357145

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 6.678504632873228e-06
an O 0 3.842402293230407e-06
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 7.257586548803374e-05
by O 0 8.80757522470077e-10
early O 0 2.7404445063439198e-05
childhood O 1 1.0
deafness B-Disease 1 1.0
and O 1 1.0
goiter B-Disease 1 1.0
. O 1 0.9999399185180664

A O 0 2.1006103452236857e-06
century O 0 2.449618705213652e-06
after O 0 3.5891510208330146e-08
its O 0 4.7677339853891e-10
recognition O 0 3.0225626446167553e-09
as O 0 2.4189472647151433e-09
a O 0 3.574924578586547e-09
syndrome O 0 2.2621065909333993e-07
by O 0 3.6285124904722466e-10
Vaughan O 0 2.335096723982133e-06
Pendred O 0 0.00016459127073176205
, O 0 2.7415649750395232e-09
the O 0 6.2287588420417705e-09
disease O 0 4.381060847435947e-08
gene O 0 4.789218799317041e-09
( O 0 2.5505209055864952e-09
PDS O 0 9.439396308152936e-06
) O 0 3.1007865164411896e-09
was O 0 1.4934585124137811e-07
mapped O 0 1.435319347820041e-07
to O 0 2.1768636671026798e-08
chromosome O 0 3.425262775635929e-07
7q22 O 0 2.5794442990445532e-05
- O 0 8.368626367882825e-06
q31 O 0 2.493786632840056e-05
. O 0 5.940703431406291e-07

1 O 0 6.727425898134243e-06
and O 0 3.23961018011687e-08
, O 0 1.3994159164809616e-09
recently O 0 5.48711831527271e-09
, O 0 1.6845208561377945e-10
found O 0 2.8782787264702847e-10
to O 0 4.47417575211162e-10
encode O 0 7.380317690319771e-09
a O 0 4.287106136757757e-08
putative O 0 6.425872925319709e-06
sulfate O 0 0.00012774700007867068
transporter O 0 0.010538160800933838
. O 0 2.259813300042879e-06

We O 0 6.601835877972917e-08
performed O 0 1.3917815788744292e-09
mutation O 0 1.5058589097893815e-10
analysis O 0 1.7060004797730954e-10
of O 0 2.334101134593425e-09
the O 0 1.0419952012341582e-08
PDS B-Disease 0 2.6558560421108268e-05
gene O 0 4.695028366086262e-09
in O 0 7.147353819902946e-10
patients O 0 1.8335322149454214e-09
from O 0 1.1630728380396249e-08
14 O 0 1.8949894098341247e-08
Pendred B-Disease 0 1.8431883290759288e-06
families O 0 8.132867157506496e-10
originating O 0 1.201320487531632e-09
from O 0 2.843476287761604e-10
seven O 0 2.0637763720188218e-10
countries O 0 6.7112123150470104e-12
and O 0 4.584525536976969e-10
identified O 0 5.2833959429676725e-09
all O 0 4.526788721648245e-09
mutations O 0 1.7424527598564055e-08
. O 0 9.294892322486703e-08

The O 0 3.887495267917984e-07
mutations O 0 1.464865206912691e-08
include O 0 3.177736296322564e-09
three O 0 2.8141371455348008e-09
single O 0 5.192454466396157e-09
base O 0 2.371040608295516e-07
deletions O 0 2.518054884603771e-07
, O 0 2.901341833450033e-09
one O 0 1.8658370404267544e-09
splice O 0 1.5100415566848824e-06
site O 0 4.8148667275427215e-08
mutation O 0 8.936552609029036e-10
and O 0 2.178216496062646e-09
10 O 0 2.176282265509144e-08
missense O 0 3.286272203695262e-06
mutations O 0 3.716218941463012e-07
. O 0 9.454156497668009e-07

One O 0 1.5800021628820105e-06
missense O 0 5.314702320902143e-06
mutation O 0 9.311624893371118e-08
( O 0 6.510338046439301e-09
L236P O 0 8.693652944202768e-07
) O 0 1.8801340484486673e-09
was O 0 4.086480132059478e-08
found O 0 1.5307555223387226e-09
in O 0 6.704847788085999e-10
a O 0 2.144871835696449e-09
homozygous O 0 2.2480934891433435e-09
state O 0 5.326273866401721e-10
in O 0 3.0745664347797685e-10
two O 0 9.819227653196094e-10
consanguineous O 0 1.4286456462286878e-06
families O 0 2.228706330598129e-09
and O 0 2.164887824562811e-09
in O 0 1.1823303447400235e-09
a O 0 3.8909351296467776e-09
heterozygous O 0 3.460746411665383e-10
state O 0 9.753443885873736e-11
in O 0 2.283116057322232e-10
five O 0 7.212457298066965e-10
additional O 0 3.0089990499249097e-09
non O 0 5.724932066186739e-07
- O 0 2.0157074231974548e-06
consanguineous O 0 4.731322042061947e-05
families O 0 4.3028343554851745e-08
. O 0 7.872135654451995e-08

Another O 0 2.469201035637525e-06
missense O 0 8.741859346628189e-06
mutation O 0 1.0818066442652707e-07
( O 0 5.104382250209483e-09
T416P O 0 2.1759468893378653e-07
) O 0 4.996047464622677e-10
was O 0 8.204557033764104e-09
found O 0 8.536365503353238e-10
in O 0 6.590820667007335e-10
a O 0 1.678175265418247e-09
homozygous O 0 1.649547165527565e-09
state O 0 3.980818730209279e-10
in O 0 5.930373414564372e-10
one O 0 4.948721987751981e-10
family O 0 2.243386143518933e-09
and O 0 2.493890094434903e-10
in O 0 2.2505808328077137e-10
a O 0 1.634404944717005e-09
heterozygous O 0 2.8013152908457073e-10
state O 0 1.4640674783628072e-10
in O 0 8.440664833742062e-10
four O 0 2.7939741631399784e-09
families O 0 6.7619243537819784e-09
. O 0 7.891332387544026e-08

Pendred B-Disease 1 0.79864102602005
patients O 0 6.905177542648744e-06
in O 0 5.0454751487905014e-08
three O 0 2.517444208649522e-08
non O 0 5.961560987088887e-07
- O 0 2.4047260467341403e-06
consanguineous O 0 0.00012512852845247835
families O 0 1.0687073448423234e-08
were O 0 1.2007042027306625e-09
shown O 0 1.823156486890909e-10
to O 0 1.9838097831126333e-10
be O 0 8.318193356338099e-10
compound O 0 1.6413933678904868e-07
heterozygotes O 0 1.8689266312321706e-07
for O 0 3.9352681113768995e-09
L236P O 0 9.013961062009912e-07
and O 0 2.008467880898479e-08
T416P O 0 5.218846126808785e-06
. O 0 2.574751647443918e-07

In O 0 1.5150281740261562e-07
total O 0 4.274969711559606e-09
, O 0 4.5460729625190766e-10
one O 0 8.526663403118917e-11
or O 0 1.7255176454344934e-10
both O 0 1.1529974891510975e-10
of O 0 1.102032021194077e-09
these O 0 3.0013953128404935e-11
mutations O 0 9.402453815532397e-11
were O 0 6.078991199309769e-10
found O 0 3.0515592830404614e-10
in O 0 3.985620444790783e-10
nine O 0 2.38070474445351e-09
of O 0 6.641769800808106e-09
the O 0 2.335380244744556e-08
14 O 0 1.1260596899376196e-08
families O 0 2.4912385487851907e-09
analyzed O 0 4.138563625133429e-08
. O 0 7.03231037846308e-08

The O 0 1.5449801082922932e-07
identification O 0 1.355155347937398e-07
of O 0 1.7429853471639944e-07
two O 0 3.99041466536687e-09
frequent O 0 7.171873050992872e-08
PDS B-Disease 0 3.714010017574765e-05
mutations O 0 3.5658538344307544e-09
will O 0 1.567838914251496e-10
facilitate O 0 4.64738025840461e-09
the O 0 5.2765778413288444e-09
molecular O 0 3.980762812716421e-07
diagnosis O 1 0.8874792456626892
of O 0 0.09295249730348587
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 5.816262728330912e-06

Insertional O 0 9.223658707924187e-05
mutation O 0 9.535990841413877e-08
by O 0 3.067246012733449e-09
transposable O 0 5.180653715797234e-06
element O 0 3.298318063116312e-07
, O 0 5.279960912929482e-09
L1 O 0 3.6684361930383602e-06
, O 0 1.1935733512657976e-09
in O 0 9.251550636690808e-10
the O 0 2.8519364647650036e-08
DMD B-Disease 1 1.0
gene O 0 1.4880867205135928e-08
results O 0 2.1139074934950486e-09
in O 0 7.071744967390714e-09
X B-Disease 1 1.0
- I-Disease 1 0.9999905824661255
linked I-Disease 1 0.9999936819076538
dilated I-Disease 1 0.9999997615814209
cardiomyopathy I-Disease 1 1.0
. O 0 1.666432035563048e-05

X B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999873638153076
linked I-Disease 1 0.9997351765632629
dilated I-Disease 1 0.9999995231628418
cardiomyopathy I-Disease 1 1.0
( O 0 4.030448053526925e-06
XLDCM B-Disease 1 0.999982476234436
) O 0 2.923327580006685e-09
is O 0 2.5168273021236587e-10
a O 0 7.150803837951969e-10
clinical O 0 1.240334768226603e-08
phenotype O 0 4.709565075700084e-07
of O 0 2.788405026876717e-07
dystrophinopathy B-Disease 0 1.2172100468887947e-05
which O 0 2.0336027306555593e-10
is O 0 1.6426100063471338e-11
characterized O 0 5.6473582754623664e-11
by O 0 1.907620936214549e-11
preferential O 0 3.54487426079686e-08
myocardial B-Disease 0 0.0005397985223680735
involvement I-Disease 0 1.905609359198479e-08
without O 0 6.32653041066078e-10
any O 0 2.6020743892907205e-10
overt O 0 3.838224849062044e-09
clinical O 0 1.1956656109646246e-08
signs O 0 4.6946908582867763e-08
of O 0 2.6005820927821333e-06
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 0 0.014822560362517834

To O 0 4.554505039777723e-08
date O 0 5.104745355311024e-07
, O 0 1.699045570902058e-09
several O 0 2.6778970707574956e-10
mutations O 0 9.735011685663153e-10
in O 0 9.069772155534395e-10
the O 0 1.1189392523647257e-07
Duchenne B-Disease 1 0.9999990463256836
muscular I-Disease 1 0.9999991655349731
dystrophy I-Disease 1 1.0
gene O 0 9.722520189825445e-05
, O 0 1.4202136355834227e-07
DMD O 1 1.0
, O 0 1.6738477270905605e-08
have O 0 1.9283717678231227e-10
been O 0 2.63042782000511e-10
identified O 0 3.866902631433078e-10
in O 0 8.999271466914038e-11
patients O 0 1.8044887806212273e-10
with O 0 1.6397186386463147e-10
XLDCM B-Disease 1 0.9999994039535522
, O 0 3.0833768871474376e-09
but O 0 4.3810727268223104e-10
a O 0 2.9834637538250774e-10
pathogenic O 0 1.1877957506456482e-09
correlation O 0 1.5396035835113508e-10
of O 0 9.718963411842196e-10
these O 0 2.306699969922832e-10
cardiospecific O 0 1.0999539767908573e-07
mutations O 0 3.570806705877061e-10
in O 0 4.66024885348304e-10
DMD O 1 1.0
with O 0 3.3545537458934405e-09
the O 0 1.1493126805817155e-07
XLDCM B-Disease 0 0.009733355604112148
phenotype O 0 9.158076181847719e-07
has O 0 3.6473253306468223e-09
remained O 0 3.355656019721209e-08
to O 0 1.417944206494326e-09
be O 0 4.360649619172818e-09
elucidated O 0 1.243680435436545e-05
. O 0 4.937572839480708e-07

We O 0 1.604228714313649e-07
report O 0 6.58317356183602e-09
here O 0 9.148162782857128e-10
the O 0 1.934007398673998e-10
identification O 0 7.263592505246663e-10
of O 0 3.636100753823257e-09
a O 0 2.3243229563263412e-09
unique O 0 3.5024108058223646e-09
de O 0 1.750094185126727e-07
novo O 0 2.508034867787501e-06
L1 O 0 2.451691671012668e-06
insertion O 0 8.050936628478667e-08
in O 0 2.367030793593017e-09
the O 0 1.9812320672940587e-09
muscle O 0 1.5724755941803892e-09
exon O 0 2.7095950372313382e-08
1 O 0 6.113015871278549e-09
in O 0 5.335526465088947e-10
DMD O 1 1.0
in O 0 2.749609961938404e-08
three O 0 1.1062065041755886e-08
XLDCM B-Disease 0 0.02024764195084572
patients O 0 7.57277884844143e-09
from O 0 3.5479974513918933e-09
two O 0 6.273658259559056e-10
unrelated O 0 2.843642121774792e-08
Japanese O 0 1.2116807965867338e-06
families O 0 6.327958157470448e-09
. O 0 6.902978810785498e-08

The O 0 1.2925758028359269e-06
insertion O 0 1.4229632370188483e-06
was O 0 7.738397016510135e-07
a O 0 3.665864767299354e-08
5 O 0 2.08237427301583e-08
- O 0 3.152718308641056e-09
truncated O 0 1.394575210866833e-08
form O 0 8.466192191747268e-09
of O 0 6.62924222183392e-08
human O 0 1.636308510910567e-08
L1 O 0 1.5213205415420816e-06
inversely O 0 1.2932672177612403e-07
integrated O 0 2.841967159383785e-07
in O 0 2.6087445537115173e-09
the O 0 1.5598702773900186e-08
5 O 0 2.7696536619714607e-08
- O 0 6.330544266575089e-08
untranslated O 1 0.9993222951889038
region O 0 1.2762976098201761e-07
in O 0 4.557040078623231e-09
the O 0 6.478317438052272e-09
muscle O 0 4.2767642760566105e-09
exon O 0 7.259679080107162e-08
1 O 0 7.381021571717383e-09
, O 0 1.4492278904709721e-11
which O 0 1.9138749612901407e-11
affected O 0 4.377038453906579e-10
the O 0 4.1431587050055896e-09
transcription O 0 5.6622727839794607e-08
or O 0 3.970152206989042e-09
the O 0 1.0322430021858509e-08
stability O 0 4.119223149245954e-07
of O 0 1.046165678530997e-07
the O 0 1.3222448913552398e-08
muscle O 0 1.8528856227106871e-09
form O 0 2.5191433383753292e-09
of O 0 5.593776464252187e-08
dystrophin O 0 2.2399245835913462e-07
transcripts O 0 1.0264982641672304e-08
but O 0 8.245776977888752e-11
not O 0 1.523231020483795e-11
that O 0 2.023221347402515e-11
of O 0 8.798814121746545e-09
the O 0 2.901664331034226e-08
brain O 0 3.9610026192349324e-07
or O 0 7.53347872972654e-09
Purkinje O 0 5.7626206398708746e-05
cell O 0 7.563037911495485e-07
form O 0 2.084933825585722e-08
, O 0 1.5744322512389886e-09
probably O 0 1.4584335517042746e-08
due O 0 3.9111012029025005e-07
to O 0 3.5280629528955387e-09
its O 0 3.0505482584430865e-09
unique O 0 2.437435586699621e-09
site O 0 1.5796761232422796e-08
of O 0 7.308232241598489e-09
integration O 0 1.300376055723973e-07
. O 0 1.430992142559262e-07

We O 0 1.2904263257951243e-07
speculate O 0 5.951580561713854e-08
that O 0 9.896273384102372e-11
this O 0 7.0678275732039e-11
insertion O 0 6.452987033611635e-09
of O 0 3.222869304764231e-09
an O 0 7.664565510046017e-11
L1 O 0 6.878191527448507e-08
sequence O 0 1.1250457232492295e-09
in O 0 2.4181583402338447e-09
DMD O 1 1.0
is O 0 3.007208926320004e-09
responsible O 0 7.874425556053666e-10
for O 0 8.081694341521839e-11
some O 0 1.8411034849452612e-11
of O 0 5.83924408825709e-10
the O 0 2.3418816885723004e-10
population O 0 1.177860651895013e-12
of O 0 8.627173281317013e-11
Japanese O 0 1.6043717465663576e-08
patients O 0 3.5557051747403534e-10
with O 0 3.1747299233941817e-10
XLDCM B-Disease 0 0.0005209289956837893
. O 0 3.800832359956985e-08
. O 0 1.5334673264533194e-07

Severe O 1 0.999947190284729
early O 1 0.9999980926513672
- O 1 0.9999971389770508
onset O 1 1.0
obesity B-Disease 1 1.0
, O 0 5.336661956789612e-07
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 1.0077014849230181e-05
red O 0 0.00033155857818201184
hair O 0 2.517567736504134e-06
pigmentation O 0 0.0001558230142109096
caused O 0 5.518092507372785e-07
by O 0 1.1122361698312488e-08
POMC O 1 0.9999406337738037
mutations O 0 5.799624247515567e-08
in O 0 7.813508062781693e-09
humans O 0 1.249612751053064e-07
. O 0 1.3515337116132287e-07

Sequential O 0 5.0784692575689405e-06
cleavage O 0 6.046207545296056e-06
of O 0 2.942573019026895e-06
the O 0 1.7158501464109577e-07
precursor O 0 2.8925697392878646e-07
protein O 0 2.1387043247500515e-08
pre O 0 2.5044710127986036e-06
- O 0 1.2135647011746187e-06
pro O 0 3.7768079437228153e-06
- O 0 3.592970642785076e-06
opiomelanocortin O 0 4.492447988013737e-05
( O 0 2.8201567303653974e-08
POMC O 0 3.8651229260722175e-05
) O 0 1.4355013844280506e-09
generates O 0 5.135326053284928e-10
the O 0 3.6095939570657265e-09
melanocortin O 0 7.429594006680418e-06
peptides O 0 7.424597470162553e-08
adrenocorticotrophin O 0 2.4813011805235874e-06
( O 0 2.0164276914869106e-09
ACTH O 0 4.625980807304586e-07
) O 0 1.940852145665417e-09
, O 0 2.495390116763474e-09
melanocyte O 0 1.3399655472312588e-05
- O 0 2.7497783321450697e-06
stimulating O 0 2.158778045213694e-08
hormones O 0 2.1749866352394065e-09
( O 0 3.371505297167232e-10
MSH O 0 4.965737048223673e-07
) O 0 2.990813430248096e-10
alpha O 0 1.887442202530565e-09
, O 0 1.1642341604667372e-11
beta O 0 1.4257919844773426e-10
and O 0 4.0593930994425875e-11
gamma O 0 6.698430699003666e-10
as O 0 1.6708445738089495e-10
well O 0 2.481231609063883e-10
as O 0 4.674296505413622e-10
the O 0 7.612266372802878e-10
opioid O 0 3.101314760556306e-08
- O 0 1.2550201766714508e-08
receptor O 0 3.731512432381123e-09
ligand O 0 1.283630126636126e-07
beta O 0 1.8530903389546438e-07
- O 0 3.897495730598166e-07
endorphin O 0 1.0521774129301775e-05
. O 0 1.1939933131088765e-07

While O 0 2.1723928966821404e-07
a O 0 1.8553407699073432e-08
few O 0 3.905626932976247e-09
cases O 0 3.774375034737432e-09
of O 0 2.473138636105432e-07
isolated O 0 0.00023596275423187762
ACTH B-Disease 1 0.9999995231628418
deficiency I-Disease 1 1.0
have O 0 6.152754394861404e-08
been O 0 2.8934074691733258e-08
reported O 0 2.3192844977870664e-08
( O 0 1.1901980734307926e-08
OMIM O 0 0.0006503781769424677
201400 O 0 1.0089805073221214e-05
) O 0 2.7326689799878068e-09
, O 0 6.01675875788743e-10
an O 0 1.1711708269857013e-09
inherited O 1 0.9997650980949402
POMC O 1 1.0
defect O 1 1.0
has O 0 1.243941198936227e-07
not O 0 6.130105867363511e-10
been O 0 2.468176774073072e-09
described O 0 5.942400793657043e-09
so O 0 1.5187155977258726e-09
far O 0 1.4119320823624548e-08
. O 0 3.8809158553476664e-08

Recent O 0 3.498520584344078e-07
studies O 0 2.2543423128240647e-08
in O 0 1.8150523306559307e-09
animal O 0 1.982388697641113e-09
models O 0 1.6421669579713694e-09
elucidated O 0 9.693105766928056e-07
a O 0 3.2933826332737226e-08
central O 0 4.0867298878310976e-08
role O 0 5.532805147367981e-08
of O 0 9.969242000806844e-07
alpha O 0 2.0309050796640804e-06
- O 0 2.1346541245748085e-07
MSH O 0 2.4905590180424042e-05
in O 0 1.3972875079204528e-09
the O 0 3.2603992838886597e-09
regulation O 0 3.5006009202476207e-09
of O 0 3.630914735541779e-10
food O 0 1.6168638650171374e-10
intake O 0 3.845497531518305e-11
by O 0 3.1004625949959674e-12
activation O 0 2.0818571311309597e-09
of O 0 3.108118917793945e-08
the O 0 9.506534581760206e-08
brain O 0 1.2029602203256218e-06
melanocortin O 0 3.8983231206657365e-05
- O 0 8.802743991509487e-07
4 O 0 3.590024277855264e-07
- O 0 4.001956099841664e-08
receptor O 0 1.3733000514548621e-08
( O 0 1.7502062021890197e-09
MC4 O 0 2.5335666578030214e-05
- O 0 1.9825111507998372e-07
R O 0 1.0722584420364001e-07
; O 0 3.5149521071531353e-09
refs O 0 4.940064854963566e-07
3 O 0 2.5963659666672356e-08
- O 0 4.3984567099641936e-09
5 O 0 6.0625726661101e-10
) O 0 1.4263298007965997e-11
and O 0 3.604973611293083e-11
the O 0 3.3074359917506513e-10
linkage O 0 8.794455652605393e-08
of O 0 1.738200516854249e-08
human O 0 6.592524215420781e-08
obesity B-Disease 0 0.000863061985000968
to O 0 1.5216526927375185e-09
chromosome O 0 5.690191873242156e-09
2 O 0 2.7555321580052805e-08
in O 0 1.2910257307652273e-09
close O 0 2.9555778269241273e-08
proximity O 0 8.458737852379272e-07
to O 0 1.227009605031526e-08
the O 0 8.40241156652155e-08
POMC O 0 9.544785280013457e-05
locus O 0 5.20202299014727e-08
, O 0 1.3648926433518227e-10
led O 0 1.5206684522706126e-10
to O 0 7.250826328242255e-11
the O 0 1.2392298298635751e-09
proposal O 0 2.3587651831746825e-09
of O 0 1.9177393006941656e-09
an O 0 4.0177052657019985e-11
association O 0 1.331912635738064e-10
of O 0 5.824786430963513e-09
POMC O 1 0.807594895362854
with O 0 1.5757068538846397e-08
human O 0 9.299330486101098e-06
obesity B-Disease 1 1.0
. O 0 6.640466949647816e-07

The O 0 3.8771284494032443e-07
dual O 0 4.5751440325147996e-07
role O 0 6.580871740879957e-07
of O 0 6.081976607674733e-06
alpha O 0 9.29012821870856e-05
- O 0 3.1892814149614424e-05
MSH O 1 0.9383756518363953
in O 0 4.086340155140533e-08
regulating O 0 6.582409639577236e-08
food O 0 5.768447408627253e-08
intake O 0 9.066836170745773e-09
and O 0 8.422604835800485e-10
influencing O 0 4.354601657041712e-08
hair O 0 9.844964665717271e-08
pigmentation O 0 3.274903292549425e-06
predicts O 0 8.032404075208888e-09
that O 0 3.2549775375034784e-11
the O 0 6.160393306586798e-10
phenotype O 0 3.941894366477072e-09
associated O 0 5.411203152227984e-10
with O 0 4.0052489103103994e-11
a O 0 2.5853543750287145e-09
defect O 0 6.651590069850499e-07
in O 0 2.651860420144203e-08
POMC O 1 0.9912914037704468
function O 0 4.681061316347268e-09
would O 0 9.070775797148656e-10
include O 0 8.8363858452567e-09
obesity B-Disease 1 1.0
, O 0 4.744610260232207e-10
alteration O 0 9.741406756802462e-07
in O 0 1.4199367903700022e-08
pigmentation O 1 0.7697360515594482
and O 0 2.2621031803282676e-06
ACTH B-Disease 1 0.8441252112388611
deficiency I-Disease 1 0.9993189573287964
. O 0 2.8169636152597377e-06

The O 0 1.338357719760097e-06
observation O 0 6.807167210354237e-06
of O 0 1.8016230285411439e-07
these O 0 3.5989795588164952e-09
symptoms O 0 3.142909008602146e-06
in O 0 2.88651733626466e-08
two O 0 1.3454670266810353e-08
probands O 0 5.7271226978627965e-06
prompted O 0 3.529949665903587e-08
us O 0 4.535309905406848e-09
to O 0 6.857279744032496e-10
search O 0 1.5359972849182668e-08
for O 0 4.744556414415513e-10
mutations O 0 3.1020097601697216e-10
within O 0 3.1774149977792376e-09
their O 0 2.4331402670441094e-08
POMC O 0 0.0015618324978277087
genes O 0 1.3635961693125864e-07
. O 0 1.3516562091808737e-07

Patient O 0 4.4727756176143885e-05
1 O 0 1.3749337313129217e-06
was O 0 5.9275972574823754e-08
found O 0 4.920223117821365e-10
to O 0 2.2775313579526113e-10
be O 0 3.775525447835548e-10
a O 0 3.1996556515423435e-09
compound O 0 1.1353898798915907e-07
heterozygote O 0 4.512907025855384e-07
for O 0 1.6604535524322728e-09
two O 0 7.558431658338804e-10
mutations O 0 6.36676822374227e-10
in O 0 2.31378249893055e-09
exon O 0 2.1690578932975768e-07
3 O 0 5.9537377694596216e-08
( O 0 1.5730395874768988e-09
G7013T O 0 2.781730472634081e-07
, O 0 1.7252552719781988e-09
C7133delta O 0 8.074570700955519e-07
) O 0 4.999621827650458e-10
which O 0 9.259278066497956e-11
interfere O 0 1.339122257526526e-09
with O 0 3.247573390763314e-11
appropriate O 0 3.368852308227588e-09
synthesis O 0 1.5842051226400145e-08
of O 0 1.0386656867922284e-08
ACTH O 0 6.75119792958867e-07
and O 0 7.205396457266033e-08
alpha O 0 3.3174046620843e-06
- O 0 2.388612301729154e-06
MSH O 0 0.00020973944629076868
. O 0 2.651959789545799e-07

Patient O 0 2.8557728001032956e-05
2 O 0 1.7266936538362643e-06
was O 0 7.487341235901113e-08
homozygous O 0 2.986425773343626e-09
for O 0 4.290447164212452e-10
a O 0 1.5092498362179185e-09
mutation O 0 1.1470734362362123e-09
in O 0 4.435872558161691e-09
exon O 0 3.5705727441381896e-07
2 O 0 2.2247921549478633e-07
( O 0 3.376075863315009e-09
C3804A O 0 4.1354084601152863e-07
) O 0 1.4713131823995695e-09
which O 0 4.697115141283348e-09
abolishes O 0 6.4524697336310055e-06
POMC O 0 0.0007713545928709209
translation O 0 3.3243215966649586e-06
. O 0 5.922607329011953e-07

These O 0 1.1283407985729355e-08
findings O 0 8.828602737764868e-09
represent O 0 6.298693233652841e-10
the O 0 2.1059072263795997e-09
first O 0 5.954345350112078e-10
examples O 0 3.800323167268971e-09
of O 0 2.451232283817717e-08
a O 0 4.780341811283506e-08
genetic B-Disease 1 0.999998927116394
defect I-Disease 1 0.9999730587005615
within O 0 1.0050516863202574e-08
the O 0 1.7184317968599316e-08
POMC O 0 7.300736797333229e-06
gene O 0 1.6751403597581316e-09
and O 0 4.228161987196444e-10
define O 0 2.861241021889782e-09
a O 0 1.1126541465955597e-08
new O 0 8.406793767790077e-07
monogenic B-Disease 1 1.0
endocrine I-Disease 1 1.0
disorder I-Disease 0 0.0002202013711212203
resulting O 0 2.8968736387469107e-07
in O 0 6.991930590061202e-09
early O 0 0.0004613161727320403
- O 0 0.0010547266574576497
onset O 1 1.0
obesity B-Disease 1 1.0
, O 0 3.31946694132057e-07
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 2.296939555890276e-06
red O 0 2.2824253392172977e-05
hair O 0 9.436150207875471e-07
pigmentation O 0 1.536968193249777e-05
. O 0 2.6079202797291146e-08
. O 0 8.073894974813811e-08

A O 0 8.79453909874428e-06
European O 0 1.2234246469233767e-06
multicenter O 0 0.00013346096966415644
study O 0 4.0282898794430366e-07
of O 0 0.006607212591916323
phenylalanine B-Disease 1 1.0
hydroxylase I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 3.0169310605288047e-08
classification O 0 1.7748050140653504e-07
of O 0 3.550342171365628e-07
105 O 0 6.869931468145296e-08
mutations O 0 3.385508262621073e-10
and O 0 4.175890466751042e-10
a O 0 9.697502800776192e-10
general O 0 9.158852343205126e-09
system O 0 3.417653005044485e-08
for O 0 5.655834134365989e-10
genotype O 0 1.2055767051322164e-08
- O 0 4.072767456619886e-09
based O 0 1.029163976262737e-09
prediction O 0 1.9724934929854498e-07
of O 0 7.024723203130634e-08
metabolic O 0 0.0004523061215877533
phenotype O 0 2.1985317744110944e-06
. O 0 6.10148589430537e-08

Phenylketonuria B-Disease 0 0.03928878903388977
( O 0 1.2275654626137111e-06
PKU B-Disease 0 0.07945568114519119
) O 0 6.749235126335407e-08
and O 0 2.1815070283537352e-07
mild B-Disease 1 1.0
hyperphenylalaninemia I-Disease 1 1.0
( O 1 1.0
MHP B-Disease 1 1.0
) O 0 1.2881383781859768e-06
are O 0 6.352663728392827e-09
allelic B-Disease 0 0.0008383108070120215
disorders I-Disease 0 0.003866014303639531
caused O 0 1.3273161236782016e-08
by O 0 6.198992708039697e-11
mutations O 0 3.4638483054072466e-11
in O 0 5.6641441537053083e-11
the O 0 9.87749659842052e-10
gene O 0 2.101164797707611e-09
encoding O 0 1.5915045992187515e-07
phenylalanine O 0 7.3041564974118955e-06
hydroxylase O 0 0.0010635199723765254
( O 0 8.328073590746499e-07
PAH O 1 1.0
) O 0 2.432728081203095e-07
. O 0 3.9592237044416834e-07

Previous O 0 4.467610210667772e-07
studies O 0 2.704069412828858e-09
have O 0 4.727409089189116e-11
suggested O 0 2.700496215535253e-10
that O 0 1.9758410185755082e-11
the O 0 8.019694353045281e-10
highly O 0 3.920548863334261e-08
variable O 0 8.190830840248964e-07
metabolic O 1 0.9484553933143616
phenotypes O 0 0.00016421331383753568
of O 1 0.5288687348365784
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
correlate O 0 7.399871537927538e-05
with O 0 1.3452536222757772e-06
PAH O 1 1.0
genotypes O 1 0.9992750287055969
. O 0 2.545650886531803e-06

We O 0 7.425575176966959e-08
identified O 0 2.7357053511423146e-08
both O 0 9.160594505175368e-10
causative O 0 1.9466742173790408e-07
mutations O 0 1.1940817223887734e-08
in O 0 3.574767593050865e-09
686 O 0 3.0584726573579246e-06
patients O 0 2.84076435264069e-07
from O 0 2.1324871113392874e-07
seven O 0 1.394328279502588e-07
European O 0 1.913484339866045e-07
centers O 0 4.230182923947723e-07
. O 0 1.5887385984569846e-07

On O 0 5.944784220446309e-07
the O 0 4.84537698852705e-09
basis O 0 6.041485978158789e-09
of O 0 8.564290610024727e-09
the O 0 2.3105586333116435e-09
phenotypic O 0 2.189815084818747e-08
characteristics O 0 6.579859324062909e-09
of O 0 1.410462324713535e-08
297 O 0 1.774130709009114e-08
functionally O 0 1.3092459028030135e-07
hemizygous O 0 1.859702365436533e-06
patients O 0 7.703558679850175e-09
, O 0 2.017496308903688e-10
105 O 0 6.24392493264736e-09
of O 0 1.309394481729953e-09
the O 0 6.478091396644459e-10
mutations O 0 1.919805286965115e-11
were O 0 4.834810676812573e-11
assigned O 0 6.680848652074189e-10
to O 0 3.1182217918868105e-10
one O 0 5.394900082222875e-10
of O 0 4.367758599244098e-09
four O 0 9.52649292784713e-10
arbitrary O 0 2.4018769195777168e-09
phenotype O 0 7.940765556213591e-08
categories O 0 1.2781655733817843e-08
. O 0 4.338021497574118e-08

We O 0 2.7456749762677646e-07
proposed O 0 1.7919209938099812e-07
and O 0 7.358235798449186e-09
tested O 0 3.33015015563376e-09
a O 0 2.767348572518813e-10
simple O 0 3.271847792696292e-10
model O 0 2.3600599252660004e-10
for O 0 2.4997750397437457e-11
correlation O 0 1.7052392831118368e-10
between O 0 4.706933731668528e-10
genotype O 0 6.129995000492272e-08
and O 0 3.6517178170214493e-09
phenotypic O 0 4.46815917598542e-08
outcome O 0 2.0061521865955e-07
. O 0 1.3607771620627318e-07

The O 0 2.4226335426646983e-07
observed O 0 2.9006791635310947e-08
phenotype O 0 9.10343729287888e-08
matched O 0 2.6365283289919716e-08
the O 0 8.22524004462366e-09
predicted O 0 2.995098213887104e-08
phenotype O 0 6.089348403293116e-08
in O 0 1.5428790467453268e-09
79 O 0 1.1178678427370414e-08
% O 0 1.1078333389535899e-10
of O 0 2.2353124906615562e-10
the O 0 1.2555119444090934e-10
cases O 0 4.4938788801296425e-11
, O 0 2.202402843431983e-11
and O 0 4.68089594862775e-11
in O 0 3.532961770358334e-11
only O 0 2.0152261803740856e-11
5 O 0 3.516975322082061e-10
of O 0 7.638417121036412e-10
184 O 0 3.2756957146773402e-09
patients O 0 1.442610475521633e-09
was O 0 3.6300598083016666e-08
the O 0 3.4183813557575604e-09
observed O 0 1.5582993784235555e-09
phenotype O 0 3.310770546605113e-09
more O 0 1.8185158240369148e-11
than O 0 4.254548449655893e-11
one O 0 7.943238428120836e-11
category O 0 3.4273303639587027e-10
away O 0 1.757026080184687e-09
from O 0 2.9093089048970455e-10
that O 0 1.8461504547317986e-10
expected O 0 6.846268973959013e-08
. O 0 2.7203202535019955e-07

Among O 0 5.357069312594831e-07
the O 0 1.0608260225808408e-07
seven O 0 9.021191793578964e-09
contributing O 0 1.1130971699913061e-09
centers O 0 2.7257662793545023e-09
, O 0 2.914728527980692e-11
the O 0 8.495948389253272e-11
proportion O 0 1.9361591496735997e-10
of O 0 8.048932631510297e-10
patients O 0 5.953209036846374e-10
for O 0 4.260592156857257e-10
whom O 0 1.7201687851908787e-09
the O 0 3.6913041512320888e-09
observed O 0 1.2347729505535199e-09
phenotype O 0 2.3821218331221417e-09
did O 0 2.96777658004288e-10
not O 0 2.239101681844602e-10
match O 0 1.3044719970878305e-08
the O 0 1.725986820133585e-08
predicted O 0 3.1095005681436305e-08
phenotype O 0 2.138761701075964e-08
was O 0 5.109138356829135e-08
4 O 0 6.748112291177222e-09
% O 0 3.439950269079617e-10
- O 0 2.490126771448331e-09
23 O 0 4.847937606911046e-09
% O 0 1.3958837419281167e-09
( O 0 1.1242434760916353e-09
P O 0 3.555855755621451e-06
< O 0 1.0051763865703833e-06
. O 0 4.912452222782804e-09
0001 O 0 3.186679009559157e-07
) O 0 1.1308863567816019e-10
, O 0 1.780154842978554e-11
suggesting O 0 2.428019729716624e-10
that O 0 1.841110423839165e-11
differences O 0 6.143063280283911e-10
in O 0 4.6963134769928416e-11
methods O 0 4.019432009449986e-10
used O 0 2.5540733417095396e-10
for O 0 1.0028178981658087e-10
mutation O 0 1.1006161537707726e-09
detection O 0 3.8489781672979007e-07
or O 0 3.1026561320146584e-09
phenotype O 0 1.859641862722583e-08
classification O 0 1.6113508305437563e-09
may O 0 1.1261788723793131e-10
account O 0 1.956400839941974e-11
for O 0 4.271069956041096e-11
a O 0 3.4698147133305213e-10
considerable O 0 1.5670802433476183e-09
proportion O 0 3.9828693121357617e-10
of O 0 4.987880330986627e-09
genotype O 0 9.989494174078573e-07
- O 0 5.641278448820231e-07
phenotype O 0 2.2805467381203925e-07
inconsistencies O 0 3.5204362802687683e-07
. O 0 2.691398037768522e-07

Our O 0 5.812929884996265e-06
data O 0 1.0874543932004599e-07
indicate O 0 2.445255198324503e-08
that O 0 2.829810830107249e-09
the O 0 2.7604673391579126e-07
PAH O 1 1.0
- O 0 8.586826879763976e-06
mutation O 0 5.421288751250586e-09
genotype O 0 1.1354717166511819e-08
is O 0 1.3074191035356009e-11
the O 0 5.34176591848734e-11
main O 0 2.9928808320534017e-09
determinant O 0 1.905416802117088e-08
of O 0 7.069775875834239e-09
metabolic O 0 0.00029978377278894186
phenotype O 0 4.3025559648413036e-07
in O 0 4.134756981244436e-10
most O 0 1.2052656650496374e-09
patients O 0 3.7739162905836565e-08
with O 0 9.777724017112632e-07
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.00015816300583537668

In O 0 2.2085821171913267e-07
the O 0 2.3275360305774484e-08
present O 0 2.185807757015823e-09
study O 0 2.1237106517801863e-10
, O 0 3.773636958470661e-11
the O 0 2.5261573388668523e-10
classification O 0 1.040553332387617e-08
of O 0 3.387669664789428e-07
105 O 0 6.0651109379250556e-05
PAH O 1 1.0
mutations O 0 3.879036114540213e-08
may O 0 1.689937967341848e-09
allow O 0 1.4247650836907155e-09
the O 0 2.7913322764305804e-09
prediction O 0 2.1961858465147088e-07
of O 0 1.3399557019511121e-08
the O 0 6.0931335532643516e-09
biochemical O 0 6.980912559129138e-08
phenotype O 0 9.78929648454141e-08
in O 0 1.0714438225534195e-09
> O 0 3.328456443796313e-08
10 O 0 1.877682676010295e-09
, O 0 9.392182864775833e-11
000 O 0 1.9319656985317124e-09
genotypes O 0 2.856819847352199e-08
, O 0 1.498584034642647e-10
which O 0 2.9393713157910284e-11
may O 0 3.3890290573879156e-10
be O 0 5.899435107092899e-11
useful O 0 4.1957223806399213e-10
for O 0 1.724369536049153e-10
the O 0 6.69582500556487e-10
management O 0 1.6597196506040746e-08
of O 0 6.6200819048845e-08
hyperphenylalaninemia B-Disease 1 1.0
in O 0 4.1769144587533447e-08
newborns O 0 2.887525738515251e-07
. O 0 7.19168014029492e-08

Somatic O 0 0.0005814193282276392
instability O 0 0.0006822221912443638
of O 0 1.9684131984831765e-05
the O 0 4.952469680574723e-06
CTG O 0 0.006184590049088001
repeat O 0 1.0261517218168592e-06
in O 0 1.7803815310912796e-08
mice O 0 4.6901440953206475e-08
transgenic O 0 1.063952623781006e-07
for O 0 1.347862821354795e-09
the O 0 8.894616030374891e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 0 0.0004291389195714146
is O 0 1.4923665636601413e-09
age O 0 1.087739065486204e-10
dependent O 0 6.620918396871289e-11
but O 0 4.865865089326293e-12
not O 0 3.797346551787095e-12
correlated O 0 3.5268166165280945e-10
to O 0 2.555588796138153e-10
the O 0 3.680155069574198e-09
relative O 0 6.891664270369802e-07
intertissue O 0 1.944727591762785e-05
transcription O 0 3.839501232505427e-07
levels O 0 4.716158841233664e-08
and O 0 4.0059045858242825e-08
proliferative O 0 0.0009258977952413261
capacities O 0 6.926236437720945e-06
. O 0 8.624863312434172e-07

A O 0 0.00010386481153545901
( O 0 4.907018364974647e-07
CTG O 0 5.3938714700052515e-05
) O 0 1.4741398324247257e-08
nexpansion O 0 3.079810085182544e-06
in O 0 7.207551444565752e-09
the O 0 7.432348070324224e-08
3 O 0 3.1250368692781194e-07
- O 0 3.258859635479894e-07
untranslated O 1 0.9999786615371704
region O 0 7.632729079887213e-07
( O 0 7.269832735801174e-09
UTR O 1 0.8188974857330322
) O 0 1.2470782184692553e-09
of O 0 1.2368762014602908e-08
the O 0 8.340983725929618e-08
DM O 1 1.0
protein O 0 3.3468549531789904e-07
kinase O 0 6.741437630353175e-08
gene O 0 1.158184326222056e-09
( O 0 2.7130364621541503e-10
DMPK O 0 1.8526834537624381e-06
) O 0 1.4392018132802775e-10
is O 0 4.2916892262212514e-11
responsible O 0 5.494845134457194e-10
for O 0 6.061577351168523e-10
causing O 0 8.951313930083415e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.0001281492441194132
DM B-Disease 1 1.0
) O 0 8.486535563179132e-08
. O 0 9.982278470488382e-08

Major O 0 4.549442382995039e-05
instability O 0 0.0028619705699384212
, O 0 9.957477509203727e-09
with O 0 3.6770517186646146e-10
very O 0 5.688723936358997e-10
large O 0 7.8468531672371e-10
expansions O 0 8.52015258345773e-09
between O 0 1.5625792881834855e-09
generations O 0 1.1273490585494983e-08
and O 0 3.4080677169257e-10
high O 0 1.4058179065301601e-09
levels O 0 4.5320217023636644e-10
of O 0 9.862586303199805e-10
somatic O 0 4.828238431286991e-08
mosaicism O 0 1.1473736094558262e-06
, O 0 1.023150869583489e-10
is O 0 1.1634971631979685e-11
observed O 0 1.2339083921286687e-10
in O 0 6.915056860457014e-10
patients O 0 2.5618431820362275e-08
. O 0 1.6778183464793983e-07

There O 0 1.8603235218961345e-07
is O 0 1.3399250597956325e-08
a O 0 6.835709775998566e-09
good O 0 1.5192437530231473e-08
correlation O 0 3.2447533548918273e-09
between O 0 2.8477873392773745e-09
repeat O 0 1.865941356982148e-08
size O 0 1.1428025636917027e-08
( O 0 1.3914419616511964e-09
at O 0 1.4435462825090895e-09
least O 0 5.562795710178925e-11
in O 0 1.3937148657383602e-10
leucocytes O 0 6.596825841143072e-08
) O 0 8.220635977496116e-11
, O 0 2.067538154570947e-11
clinical O 0 1.4842818085725185e-09
severity O 0 9.032634125105687e-07
and O 0 8.697366382648397e-09
age O 0 8.163005382755273e-09
of O 0 4.286435739686567e-08
onset O 0 0.0004590660391841084
. O 0 5.347151841306186e-07

The O 0 6.883694732096046e-05
trinucleotide O 1 0.9581295251846313
repeat O 0 1.1719907888618764e-05
instability O 0 5.590092314378126e-06
mechanisms O 0 8.758512990425515e-07
involved O 0 1.8008458724239063e-08
in O 0 6.89858268287935e-08
DM B-Disease 1 1.0
and O 0 1.5155121673160465e-06
other O 0 1.2203880572769776e-08
human O 0 3.234886776226631e-07
genetic B-Disease 1 1.0
diseases I-Disease 1 1.0
are O 0 4.537911990620813e-10
unknown O 0 1.1564581825496134e-07
. O 0 5.1647710108682077e-08

We O 0 3.9875678226053424e-07
studied O 0 7.208873853414843e-07
somatic O 0 3.854767783195712e-06
instability O 0 1.446469354959845e-06
by O 0 3.5682077292875647e-09
measuring O 0 3.628862543791911e-07
the O 0 1.284873292206612e-07
CTG O 0 9.642226359574124e-06
repeat O 0 3.341967769188159e-08
length O 0 2.417111399921623e-09
at O 0 7.154105086115692e-10
several O 0 1.511339491055974e-11
ages O 0 1.433175383924734e-10
in O 0 2.3729816722717345e-11
various O 0 8.164584980319134e-11
tissues O 0 8.656042993493429e-09
of O 0 3.0105045567552224e-08
transgenic O 0 1.9564976128094713e-07
mice O 0 5.109564327199223e-09
carrying O 0 2.093164974681372e-09
a O 0 1.667143934014348e-08
( O 0 1.3424780398452185e-08
CTG O 0 1.692398109298665e-05
) O 0 5.5600217763185356e-09
55expansion O 0 6.66984021790995e-07
surrounded O 0 4.194174252347693e-08
by O 0 6.705870858603191e-10
45 O 0 1.0802144956301163e-08
kb O 0 3.983702185905713e-07
of O 0 2.7499403643105325e-08
the O 0 2.2904327323658435e-08
human O 0 1.6406828251547267e-07
DM B-Disease 1 1.0
region O 0 1.1416570799838155e-07
, O 0 9.39849642556112e-10
using O 0 2.216607342120369e-09
small O 0 1.2761217860202123e-08
- O 0 4.5387739788793624e-08
pool O 0 5.3446786552058256e-08
PCR O 0 1.1752013051591348e-06
. O 0 2.923137856214453e-07

These O 0 6.519709927488293e-07
mice O 0 4.4290399614510534e-07
have O 0 1.2209532274098933e-09
been O 0 1.7392444151553832e-09
shown O 0 6.461925439182892e-10
to O 0 1.1583302095274917e-09
reproduce O 0 2.02762855394667e-08
the O 0 1.8665678780394046e-08
intergenerational O 0 1.2481930866670155e-07
and O 0 6.469254465457652e-09
somatic O 0 3.4819944971786754e-07
instability O 0 1.1035811553483654e-07
of O 0 4.178619761319169e-08
the O 0 7.576235105943852e-08
55 O 0 1.0177258502608311e-07
CTG O 0 5.916171176068019e-06
repeat O 0 1.9144692942063557e-08
suggesting O 0 4.391817576276935e-09
that O 0 1.2866616105888795e-10
surrounding O 0 4.229002481537236e-09
sequences O 0 5.826583104884264e-10
and O 0 5.172040573597769e-10
the O 0 6.22807805328307e-10
chromatin O 0 1.2737363164205817e-08
environment O 0 4.276682563641998e-09
are O 0 8.433125725515467e-12
involved O 0 1.6272561076391412e-10
in O 0 7.722532613385624e-10
instability O 0 3.705920335050905e-07
mechanisms O 0 1.5560253814328462e-05
. O 0 6.772516485398228e-07

As O 0 2.5491851829428924e-07
observed O 0 1.8094468146045983e-08
in O 0 5.115510237629906e-10
some O 0 3.826211569801785e-11
of O 0 8.499648762594347e-10
the O 0 5.129970892525648e-10
tissues O 0 3.595920716747969e-08
of O 0 1.5442598169101984e-06
DM B-Disease 1 1.0
patients O 0 5.5886841437313706e-05
, O 0 5.883975529030749e-10
there O 0 9.402651574008658e-11
is O 0 7.36165364778607e-11
a O 0 1.1461411680846467e-10
tendency O 0 1.5502410466439187e-10
for O 0 7.952076497286242e-11
repeat O 0 8.692916941832607e-10
length O 0 9.346422524814102e-10
and O 0 7.229577492218198e-10
somatic O 0 5.442032247060524e-08
mosaicism O 0 3.2371272595810296e-07
to O 0 1.5692000476796863e-10
increase O 0 2.4804729450988994e-11
with O 0 1.7385658884760957e-11
the O 0 7.593849438158884e-10
age O 0 1.824716155951478e-09
of O 0 1.1411754208268121e-08
the O 0 2.1080342804680186e-08
mouse O 0 9.357593739878212e-07
. O 0 4.431544908811702e-08

Furthermore O 0 7.580180181321339e-07
, O 0 1.0739814371163448e-08
we O 0 2.7155938608913743e-10
observed O 0 6.390370455022776e-10
no O 0 1.4456341679291995e-10
correlation O 0 3.5715219670606757e-10
between O 0 2.8918376027142756e-10
the O 0 1.7241303940096486e-09
somatic O 0 1.1221023044072354e-07
mutation O 0 8.657379702015078e-09
rate O 0 4.007286058538284e-09
and O 0 8.044205856982956e-10
tissue O 0 5.485195941901111e-08
proliferation O 0 1.0704964097385528e-06
capacity O 0 1.3343479565719463e-07
. O 0 1.558917830379869e-07

The O 0 2.161272504963563e-06
somatic O 0 5.4898923735891e-06
mutation O 0 4.370844663981188e-08
rates O 0 3.731839726128783e-09
in O 0 6.379138883794155e-11
different O 0 2.8943965280081585e-11
tissues O 0 2.003539734118931e-08
were O 0 3.1890907692400106e-09
also O 0 1.9406586060366493e-10
not O 0 5.035411670961665e-11
correlated O 0 1.6555959936326303e-09
to O 0 6.700411336879597e-10
the O 0 2.1353701029624972e-08
relative O 0 1.0511423170100898e-05
inter O 0 0.0025039215106517076
- O 0 1.2475188668759074e-06
tissue O 0 6.750509129460625e-08
difference O 0 5.0667852136143665e-09
in O 0 8.586951982803015e-11
transcriptional O 0 3.2801472649168772e-09
levels O 0 4.724499680364147e-10
of O 0 5.419538706696869e-10
the O 0 7.265559820446299e-10
three O 0 2.0403592704276718e-10
genes O 0 1.3558736078334022e-10
( O 0 2.50046289229644e-10
DMAHP O 0 1.4207341337169055e-05
, O 0 6.1303433440684785e-09
DMPK O 0 0.0008985721506178379
and O 0 8.248746752315128e-08
59 O 0 1.298233627267109e-07
) O 0 7.148621694597068e-10
surrounding O 0 1.7800555696112497e-08
the O 0 7.308009308815144e-09
repeat O 0 2.549286826081243e-08
. O 0 3.9873104817900185e-09
. O 0 6.463324098149315e-08

A O 0 1.5006413605078706e-06
novel O 0 4.40603315610133e-07
missense O 0 6.480822776211426e-07
mutation O 0 7.500087662037913e-09
in O 0 5.547181047838023e-10
patients O 0 4.732700453757843e-09
from O 0 8.213356217368073e-09
a O 0 6.944843278233748e-08
retinoblastoma B-Disease 1 0.9476024508476257
pedigree O 0 9.952894288289826e-06
showing O 0 9.381342813696847e-09
only O 0 5.362215671489423e-10
mild O 0 6.037957973603625e-07
expression O 0 2.4201067816420618e-08
of O 0 7.956092673566673e-08
the O 0 5.7198572989136665e-08
tumor B-Disease 0 6.823050853199675e-07
phenotype O 0 5.209261644267826e-07
. O 0 3.372145229718626e-08

We O 0 3.146869005377084e-07
have O 0 3.974857332167403e-09
used O 0 9.627951769175525e-09
single O 0 1.1187850645910657e-08
strand O 0 1.4758080091326065e-08
conformation O 0 2.7140042990758673e-10
polymorphism O 0 2.568455170770534e-10
analysis O 0 2.050087009874968e-11
to O 0 3.381782354150431e-11
study O 0 1.3364881423783004e-10
the O 0 2.1272306138797603e-09
27 O 0 1.926241566252429e-08
exons O 0 1.9459058364645898e-07
of O 0 1.9440800969050542e-08
the O 0 1.0328220945154953e-08
RB1 O 0 1.1988178130195593e-06
gene O 0 4.4005188382101323e-10
in O 0 1.6099913069389515e-11
individuals O 0 1.139326697222054e-12
from O 0 3.6234157341219486e-10
a O 0 3.105118828727882e-09
family O 0 8.549764451970532e-09
showing O 0 2.345601934905517e-09
mild O 0 6.905704594828421e-07
expression O 0 7.098234533486902e-08
of O 0 5.249712557997555e-07
the O 0 2.4429832023997733e-07
retinoblastoma B-Disease 0 5.651700485032052e-05
phenotype O 0 3.470071078481851e-06
. O 0 1.3099526086080004e-07

In O 0 6.704085819819738e-08
this O 0 4.27021884519263e-09
family O 0 2.0769915565210795e-08
affected O 0 1.507632074737586e-10
individuals O 0 1.2186463643759637e-11
developed O 0 1.069480575210946e-07
unilateral B-Disease 0 0.00022249016910791397
tumors I-Disease 1 1.0
and O 0 5.673792657034937e-06
, O 0 1.056789988851392e-09
as O 0 4.291028088410087e-10
a O 0 2.7410196334898274e-10
result O 0 3.4845978880149175e-10
of O 0 1.956253603552227e-09
linkage O 0 1.1937469679423884e-08
analysis O 0 6.465031843205793e-10
, O 0 8.300390930138235e-11
unaffected O 0 2.7509199362896197e-09
mutation O 0 9.58046003640689e-11
carriers O 0 4.498923733553539e-10
were O 0 8.368448156659269e-10
also O 0 6.674199526379709e-10
identified O 0 3.2724110088366842e-09
within O 0 7.540680080353468e-09
the O 0 7.466149298807068e-08
pedigree O 0 1.1486797575344099e-06
. O 0 2.4193965941776696e-07

A O 0 5.266609605314443e-06
single O 0 2.807882424349373e-07
band O 0 9.361362884874325e-08
shift O 0 3.666900028065356e-08
using O 0 4.693148536460967e-09
SSCP O 0 9.771714758244343e-06
was O 0 6.818445541512119e-08
identified O 0 3.2480349521080143e-09
in O 0 1.0269325390055428e-09
exon O 0 9.254647892475987e-08
21 O 0 2.005002830429703e-09
which O 0 3.4891652067603474e-11
resulted O 0 4.814276977072041e-09
in O 0 2.5569355521781745e-09
a O 0 1.1972311142471881e-08
missense O 0 2.2051054315852525e-07
mutation O 0 5.209019882101984e-09
converting O 0 8.753004721029356e-08
a O 0 3.1221770058209586e-08
cys O 0 9.051027518580668e-06
- O 0 1.1913232356164372e-06
- O 0 8.73236672305211e-07
> O 0 9.21977800771856e-07
arg O 0 6.675064696537447e-07
at O 0 7.542550584105356e-09
nucleotide O 0 2.2104305053005646e-09
position O 0 1.7050327372203355e-08
28 O 0 1.679988770320051e-08
in O 0 3.3442426605745368e-09
the O 0 5.8199695729399537e-08
exon O 0 5.4303645811160095e-06
. O 0 4.677730203184183e-07

The O 0 2.2454159989138134e-06
mutation O 0 2.1195614863245282e-07
destroyed O 0 5.556204541790066e-06
an O 0 6.53450937804223e-09
NdeI O 0 2.4427624794043368e-06
restriction O 0 1.638882274335174e-08
enzyme O 0 3.5063294490100816e-08
site O 0 1.312892976557123e-07
. O 0 4.9839549376429204e-08

Analysis O 0 2.040941780023786e-07
of O 0 2.1906018901063362e-06
all O 0 1.740937882743765e-08
family O 0 2.3286462536020736e-08
members O 0 9.157445635121775e-11
demonstrated O 0 9.108848120220614e-10
that O 0 1.214627842749394e-10
the O 0 4.0499776865488e-09
missense O 0 9.279835211373211e-08
mutation O 0 1.9830212139027026e-08
co O 0 7.182755439316679e-07
- O 0 8.880367659003241e-07
segregated O 0 7.992699835313033e-09
with O 0 2.797983233993051e-10
patients O 0 1.546940353591708e-08
with O 0 9.702095127295252e-09
tumors B-Disease 1 1.0
or O 0 6.153724825708196e-05
who O 0 1.594424503537084e-07
, O 0 3.975947071577224e-10
as O 0 5.432775895819475e-10
a O 0 6.433664712091058e-10
result O 0 6.994314571961979e-10
of O 0 4.278787546496687e-09
linkage O 0 2.6017099585828873e-08
analysis O 0 1.0684928497539659e-09
had O 0 2.3031665463690842e-09
been O 0 4.6261791619706116e-10
predicted O 0 1.0425732499541596e-09
to O 0 1.4282905413942615e-10
carry O 0 2.03837635659454e-09
the O 0 2.8881695257609863e-08
predisposing O 0 5.3155081332079135e-06
mutation O 0 2.2965927826135157e-07
. O 0 3.757382955882349e-07

These O 0 7.838259818981896e-08
observations O 0 3.8752580167056294e-07
point O 0 4.917432505635588e-08
to O 0 4.924307073217449e-10
another O 0 7.847586469544865e-10
region O 0 4.7138177805550185e-09
of O 0 7.159762560604577e-08
the O 0 5.358621990581014e-08
RB1 O 0 1.765740307746455e-05
gene O 0 1.6232797328541437e-09
where O 0 1.7985579692236797e-10
mutations O 0 1.3764867717869222e-11
only O 0 6.943266274428428e-12
modify O 0 4.1169481712621803e-10
the O 0 5.268218639109534e-10
function O 0 2.0846216419734276e-10
of O 0 2.0662784816494195e-09
the O 0 1.6688164183875642e-09
gene O 0 9.379979015733397e-10
and O 0 4.224776084527093e-10
raise O 0 2.8275545793654544e-10
important O 0 2.539994603534268e-10
questions O 0 2.865078452263248e-10
for O 0 4.579524259806789e-11
genetic O 0 5.505188527266114e-10
counseling O 0 2.9207011809084804e-10
in O 0 3.1060459759757464e-11
families O 0 1.4096883382830327e-11
with O 0 4.1169988425349135e-12
these O 0 7.828118708808063e-11
distinctive O 0 1.8677109636655587e-08
phenotypes O 0 1.3417208322152874e-07
. O 0 1.2429683060588559e-08
. O 0 6.954943643222578e-08

Maternal B-Disease 0 0.0010468026157468557
disomy I-Disease 1 0.5638444423675537
and O 0 0.0002016231883317232
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 0 0.04882185533642769
with O 0 1.9151450203480636e-08
gamete O 0 3.3194606885444955e-07
complementation O 0 6.263214231694292e-07
in O 0 3.7935565799784854e-10
a O 0 8.682908281265611e-10
case O 0 6.785076056559092e-09
of O 0 2.9428480985416172e-08
familial O 0 1.750321274585076e-07
translocation O 0 4.3382282655102244e-08
( O 0 2.4048002478238573e-10
3 O 0 3.963274597396094e-09
; O 0 2.587434988488013e-10
15 O 0 4.193532188168092e-09
) O 0 1.3941960086416572e-10
( O 0 5.918846524011201e-10
p25 O 0 2.2994549908617046e-07
; O 0 1.9323120881153955e-09
q11 O 0 1.7353922032725677e-07
. O 0 1.3903064255416098e-09
2 O 0 4.567144529232792e-08
) O 0 1.4219524446801302e-09
. O 0 1.640827740345685e-08

Maternal B-Disease 0 0.16361118853092194
uniparental I-Disease 1 0.9999990463256836
disomy I-Disease 1 0.9997441172599792
( I-Disease 0 5.682954906660598e-06
UPD I-Disease 1 1.0
) I-Disease 0 1.8379623156761227e-08
for I-Disease 0 3.526273495424448e-09
chromosome I-Disease 0 8.107702953452645e-09
15 I-Disease 0 5.027815497271604e-09
is O 0 1.0808357681080238e-10
responsible O 0 5.36838629106029e-10
for O 0 1.5285549215260374e-10
an O 0 5.852264506334137e-11
estimated O 0 6.780799532979387e-11
30 O 0 2.4053550817804137e-10
% O 0 2.708144299090609e-11
of O 0 7.760032200154754e-11
cases O 0 2.884555094784247e-10
of O 0 3.674412880627642e-07
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.05405169725418091
PWS B-Disease 1 1.0
) O 0 4.0560254888077907e-07
. O 0 3.173298637193511e-07

We O 0 3.023559145276522e-07
report O 0 2.816490862755927e-08
on O 0 1.2800246196320586e-08
an O 0 4.994129415569759e-11
unusual O 0 5.709812622711752e-10
case O 0 5.03428321252386e-09
of O 0 9.420001667592715e-09
maternal B-Disease 0 2.5019357963174116e-06
disomy I-Disease 0 7.354973058681935e-05
15 I-Disease 0 3.412930027479888e-08
in O 0 7.4016321960357345e-09
PWS B-Disease 1 1.0
that O 0 1.2056663223347641e-08
is O 0 9.4175889309156e-10
most O 0 8.226392483878797e-11
consistent O 0 6.406150054871773e-10
with O 0 6.301838911815238e-11
adjacent O 0 3.196241493697016e-08
- O 0 3.56805962553608e-08
1 O 0 1.1356623197400495e-08
segregation O 0 1.2268381865965239e-09
of O 0 2.4343912996549477e-10
a O 0 2.3272761495718441e-10
paternal O 0 7.989011230336018e-09
t O 0 3.748833243832905e-09
( O 0 3.3197733451117983e-10
3 O 0 3.516588131802223e-09
; O 0 3.127943737357697e-10
15 O 0 1.4829404371141663e-09
) O 0 1.3416423527701227e-10
( O 0 1.995445059188583e-10
p25 O 0 7.132284451927262e-08
; O 0 3.0213159751824037e-10
q11 O 0 3.494071876275484e-08
. O 0 1.803085042384467e-10
2 O 0 1.8014223446272126e-09
) O 0 1.8303402196662155e-11
with O 0 1.3791121022954655e-11
simultaneous O 0 5.464694474710541e-09
maternal O 0 2.4161593614735466e-07
meiotic O 0 7.21226160749211e-06
nondisjunction O 0 3.858629042952089e-06
for O 0 6.2026295211126126e-09
chromosome O 0 3.097879641700274e-08
15 O 0 3.172826268382778e-08
. O 0 5.540398007042313e-08

The O 0 1.3449124480757746e-06
patient O 0 3.534494510404329e-07
( O 0 1.8710903937346757e-09
J O 0 1.6335089014773985e-07
. O 0 8.045724642080643e-10
B O 0 3.641675760945873e-08
. O 0 2.875842342042745e-10
) O 0 6.986364958772029e-11
, O 0 5.1008447465861195e-11
a O 0 8.913929039344737e-10
17 O 0 6.578277922386633e-09
- O 0 8.155597086556554e-09
year O 0 4.286743848780361e-09
- O 0 1.1014739698111953e-07
old O 0 3.6533782576952945e-07
white O 0 7.74160557881487e-09
male O 0 2.3367727197687316e-10
with O 0 8.784199756473043e-11
PWS B-Disease 1 1.0
, O 0 7.989437555977474e-09
was O 0 9.84485239996502e-08
found O 0 2.6590409873961107e-09
to O 0 1.4789744984256004e-09
have O 0 1.486531342465014e-09
47 O 0 2.771672491519439e-08
chromosomes O 0 4.731660063761467e-10
with O 0 3.9812741992051315e-10
a O 0 4.438193457190209e-08
supernumerary O 0 4.879985863226466e-05
, O 0 5.80874370825768e-09
paternal O 0 4.231615378103015e-07
der O 0 4.172935405222233e-06
( O 0 1.172876462618433e-09
15 O 0 1.9163499676011497e-09
) O 0 3.209799440129224e-11
consisting O 0 1.13176024107986e-10
of O 0 2.339248794669402e-09
the O 0 4.932920294464793e-09
short O 0 1.2381271119465964e-08
arm O 0 1.8395832057649386e-07
and O 0 4.8410164765755326e-09
the O 0 1.298226948165393e-08
proximal O 0 2.64278151007602e-05
long O 0 3.611386603097344e-07
arm O 0 6.245392114578863e-07
of O 0 3.869223164087998e-08
chromosome O 0 2.0735351213829745e-09
15 O 0 2.2392907528256956e-09
, O 0 2.6255056462254345e-10
and O 0 1.3642798002422296e-08
distal O 0 0.0015389753971248865
chromosome O 0 9.766296716406941e-05
arm O 0 0.15217162668704987
3p O 1 0.9998542070388794
. O 0 1.1499235370138194e-05

The O 0 6.170493179524783e-06
t O 0 3.9786294792065746e-07
( O 0 3.944338633488087e-09
3 O 0 1.0711868725366003e-08
; O 0 6.377877115326669e-10
15 O 0 2.765503159807281e-09
) O 0 2.0777146669814783e-10
was O 0 7.879553010070595e-09
present O 0 2.11057171739526e-09
in O 0 1.12055709156067e-09
the O 0 7.693423675902977e-10
balanced O 0 5.710868999919683e-10
state O 0 3.208776994112483e-11
in O 0 3.4783873698041035e-11
the O 0 4.204903369942059e-10
patients O 0 7.959135572832565e-10
father O 0 5.973677019710522e-08
and O 0 1.0347623202733303e-08
a O 0 2.1562067331615253e-07
sister O 0 9.138305358646903e-06
. O 0 3.962770733778598e-07

Fluorescent O 0 2.2749063646188006e-05
in O 0 7.294462989193562e-08
situ O 0 9.196954238177568e-07
hybridization O 0 1.796297155465254e-08
analysis O 0 1.736662036400105e-09
demonstrated O 0 2.912386110054399e-09
that O 0 1.8000956281127856e-10
the O 0 2.273250032658325e-08
PWS B-Disease 1 1.0
critical O 0 1.7960963305085897e-05
region O 0 1.4445666352003173e-07
resided O 0 1.3781193786144286e-07
on O 0 7.282101144312492e-09
the O 0 2.2778832986514175e-10
derivative O 0 8.634915005245603e-10
chromosome O 0 8.358749248316144e-10
3 O 0 1.5530828845200517e-09
and O 0 1.1927943355249937e-10
that O 0 2.178480139336525e-11
there O 0 2.0500176556303984e-10
was O 0 1.6739242880703387e-08
no O 0 6.5850030983583e-10
deletion O 0 6.6119016928212204e-09
of O 0 4.646493856341749e-09
the O 0 2.1132557037617516e-08
PWS B-Disease 1 1.0
region O 0 6.946544317543157e-07
on O 0 9.734574035746846e-08
the O 0 1.5436915079547475e-09
normal O 0 1.0727831956103273e-09
pair O 0 1.21911947204012e-09
of O 0 1.6229484423035956e-09
15s O 0 3.1551508072880097e-07
present O 0 2.491477424371169e-08
in O 0 3.178598717568093e-08
J O 0 5.2993447752669454e-05
. O 0 3.55465175516656e-07

B O 0 0.001194762997329235
. O 0 1.89257443707902e-05

Methylation O 0 1.1016016969733755e-06
analysis O 0 1.0700437513833094e-07
at O 0 9.305730941377988e-08
exon O 0 1.6079292208814877e-07
alpha O 0 3.903424783402443e-08
of O 0 6.773516414426695e-09
the O 0 8.137853058087785e-09
small O 0 2.7983368955375454e-09
nuclear O 0 1.7887366254853987e-07
ribonucleoprotein O 0 3.2814991755003575e-06
- O 0 6.491133319741493e-08
associated O 0 1.4693816829947082e-08
polypeptide O 0 1.4662941794085782e-07
N O 0 3.410125515301843e-08
( O 0 5.086458476633027e-10
SNRPN O 0 8.805901074993017e-07
) O 0 1.855632730807244e-10
gene O 0 1.958335715812609e-10
showed O 0 1.091292611832273e-10
a O 0 7.13465606039243e-11
pattern O 0 6.840218946813081e-10
characteristic O 0 1.8068661011838572e-09
of O 0 3.4606559840000273e-09
only O 0 2.710739965827713e-10
the O 0 1.4057294217550975e-09
maternal O 0 1.0001370398526888e-08
chromosome O 0 5.565964134035539e-09
15 O 0 7.83066500531504e-09
in O 0 4.3728931586883846e-09
J O 0 5.198690632823855e-05
. O 0 1.559286374686053e-06

B O 0 0.0006729043670929968
. O 0 9.282344763050787e-06

Maternal B-Disease 0 0.00031754569499753416
disomy I-Disease 0 0.0002837388892658055
was O 0 5.486398890752753e-07
confirmed O 0 8.503544535187757e-09
by O 0 1.81273357435785e-10
polymerase O 0 1.7171416288874752e-07
chain O 0 1.1343721517675931e-08
reaction O 0 2.1651644921405477e-09
analysis O 0 1.7597259205359705e-09
of O 0 6.378099826065409e-09
microsatellite O 0 3.883308181684697e-07
repeats O 0 1.481318534501952e-08
at O 0 2.6034159272825264e-09
the O 0 4.073651416192092e-10
gamma O 0 7.578400129659713e-09
- O 0 1.5212037851597415e-08
aminobutyric O 0 4.288684749553795e-07
acid O 0 1.3887248684341102e-08
receptor O 0 9.593526861806367e-09
beta3 O 0 1.9579591992169298e-07
subunit O 0 9.92980631053797e-09
( O 0 6.622462578320665e-10
GABRB3 O 0 2.162585815312923e-06
) O 0 3.3063149995626873e-09
locus O 0 1.2480097666411893e-07
. O 0 5.02221126907898e-08

A O 0 1.1823007298517041e-05
niece O 0 1.8337541405344382e-05
( O 0 2.415927013998953e-09
B O 0 3.9025312759122244e-08
. O 0 1.6705035965625115e-10
B O 0 3.757036459717256e-09
. O 0 2.8203567953299924e-11
) O 0 1.2057450524127766e-11
with O 0 1.4843029583211376e-11
45 O 0 3.823368566191476e-10
chromosomes O 0 9.335620471118133e-11
and O 0 2.348098659954445e-10
the O 0 1.2652245917621485e-09
derivative O 0 1.075274802531112e-08
3 O 0 7.63897478606168e-09
but O 0 1.7461838919263784e-10
without O 0 1.411990524502471e-09
the O 0 6.79079859011722e-09
der O 0 4.018662593807676e-07
( O 0 9.341342144253417e-10
15 O 0 2.3443587071625416e-09
) O 0 1.2883315247957938e-10
demonstrated O 0 2.7175435235449186e-09
a O 0 1.4458279018469966e-09
phenotype O 0 4.7133141833910486e-09
consistent O 0 8.365033110635522e-10
with O 0 3.5307253648531045e-11
that O 0 2.115591556106633e-11
reported O 0 3.1232816333215396e-10
for O 0 3.2309180331147047e-10
haploinsufficiency O 0 7.05033357917273e-07
of O 0 1.1354938322938324e-07
distal O 0 3.783364809351042e-05
3 O 0 1.2611058082256932e-05
p O 0 9.453350685362238e-06
. O 0 2.0146704571288865e-07

Uniparental B-Disease 1 1.0
disomy I-Disease 1 1.0
associated O 0 1.1011953574779909e-05
with O 0 5.195954244641143e-08
unbalanced O 0 6.627916263823863e-06
segregation O 0 1.3618187040265184e-06
of O 0 1.5739969683181698e-07
non O 0 6.237850129764411e-07
- O 0 1.5111363609321415e-06
Robertsonian O 0 0.0001238868135260418
translocations O 0 3.975522758992156e-06
has O 0 7.225486875483966e-09
been O 0 1.095865398426099e-09
reported O 0 7.847826832829696e-10
previously O 0 2.4979567303518024e-09
but O 0 9.962330960178178e-11
has O 0 4.4589325287613946e-11
not O 0 1.785984034274879e-11
, O 0 2.330499855596191e-11
to O 0 5.4285055617331324e-11
our O 0 2.5598294595141624e-09
knowledge O 0 2.733639981045144e-08
, O 0 8.380551808073733e-11
been O 0 4.363524472306146e-11
observed O 0 3.633580242246026e-11
in O 0 3.929054304130375e-11
a O 0 5.93604276843962e-10
case O 0 2.9756469288599874e-08
of O 0 1.043552515511692e-06
PWS B-Disease 1 1.0
. O 0 5.639662776957266e-05

Furthermore O 0 2.6030882054328686e-06
, O 0 2.260176223956023e-08
our O 0 1.1722933734858998e-08
findings O 0 1.7243637628894248e-09
are O 0 4.325143021510769e-11
best O 0 9.639302689379292e-10
interpreted O 0 1.919521652737899e-09
as O 0 2.1489667823004766e-09
true O 0 2.3094054668604258e-08
gamete O 0 3.847191010208917e-07
complementation O 0 1.0266734307151637e-06
resulting O 0 2.1531691984932877e-08
in O 0 9.106942755465752e-09
maternal B-Disease 0 5.239817255642265e-05
UPD I-Disease 1 1.0
15 I-Disease 0 8.386882655031513e-06
and O 0 4.632118361769244e-06
PWS B-Disease 1 1.0

Schwartz B-Disease 1 0.9999711513519287
- I-Disease 1 0.9999781847000122
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
type I-Disease 0 0.00015648752741981298
2 I-Disease 0 8.389042704948224e-06
and O 0 1.9225417702273262e-08
Stuve B-Disease 1 0.9999880790710449
- I-Disease 1 0.9980319142341614
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
: O 0 2.07328199053336e-09
a O 0 2.762650996857019e-09
case O 0 4.803838216105305e-09
for O 0 1.036464580828067e-09
" O 0 7.425997150534158e-09
lumping O 0 3.55570186627574e-08
" O 0 3.777617862965599e-08
. O 0 4.236109063526783e-08

Recent O 0 2.914489414251875e-07
studies O 0 1.4500927569827127e-08
demonstrated O 0 1.6109552802845428e-08
the O 0 2.2275590261244815e-09
existence O 0 1.2377682878650376e-08
of O 0 1.3507897023146143e-08
a O 0 1.6892868215379053e-09
genetically O 0 3.5754972316226485e-09
distinct O 0 9.036997261624435e-10
, O 0 3.805381704191646e-11
usually O 0 4.3269256233546827e-11
lethal O 0 2.671210586058237e-09
form O 0 8.101454507247752e-10
of O 0 9.287094826504472e-08
the O 0 8.111820903877742e-08
Schwartz B-Disease 0 0.01974211074411869
- I-Disease 0 0.05178061127662659
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 2.5555090132911573e-07
SJS B-Disease 1 0.9999988079071045
) O 0 5.628223664899679e-09
of O 0 2.867050170607399e-07
myotonia B-Disease 1 1.0
and O 0 7.785135494486894e-06
skeletal B-Disease 1 0.9997974038124084
dysplasia I-Disease 1 1.0
, O 0 1.1661271059892897e-08
which O 0 2.943610022398957e-09
we O 0 8.3823987750975e-09
called O 0 3.701159414504218e-07
SJS B-Disease 1 0.9041323661804199
type I-Disease 0 2.526155367377214e-05
2 I-Disease 0 6.105402007960947e-06
. O 0 1.3093581685552635e-07

This O 0 8.303543950205494e-07
disorder O 0 0.006072609685361385
is O 0 9.041087878358667e-09
reminiscent O 0 3.739605290320469e-06
of O 0 1.4430244732466235e-07
another O 0 3.1156435209567235e-09
rare O 0 7.825200043498626e-09
condition O 0 1.0487154895599815e-06
, O 0 1.8152116476599645e-09
the O 0 1.0726716936915182e-07
Stuve B-Disease 1 0.9999990463256836
- I-Disease 1 0.9999991655349731
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.1325795640004799e-05
SWS B-Disease 1 0.9554126262664795
) O 0 1.5170537048803112e-09
, O 0 9.942322659606262e-11
which O 0 1.4560166960997378e-10
comprises O 0 6.385252881990766e-10
campomelia B-Disease 0 3.980979101925186e-07
at O 0 3.3570117796699606e-09
birth O 0 3.675300730421327e-09
with O 0 4.4336539994915825e-10
skeletal B-Disease 0 0.2660607397556305
dysplasia I-Disease 1 1.0
, O 0 3.252996449987222e-08
contractures B-Disease 1 0.8191109895706177
, O 0 5.806838121458213e-09
and O 0 6.360047599685004e-09
early B-Disease 0 2.6073491881106747e-06
death I-Disease 0 5.914055236644344e-06
. O 0 6.534443741657014e-07

To O 0 1.1859790305379647e-07
test O 0 5.839338967916774e-08
for O 0 1.4370356016257801e-09
possible O 0 1.75019359005546e-08
nosologic O 0 0.00014269177336245775
identity O 0 7.130190482484977e-08
between O 0 7.389430400905894e-09
these O 0 1.8519173972109115e-09
disorders O 0 9.546743058308493e-07
, O 0 1.3400720810796685e-10
we O 0 7.23703735827641e-11
reviewed O 0 1.0365712732607335e-09
the O 0 6.7593419750267e-10
literature O 0 2.365738716036958e-10
and O 0 3.069525536525397e-11
obtained O 0 5.3752176321086864e-11
a O 0 1.7027365628585756e-10
follow O 0 2.5111401846800163e-10
- O 0 1.7733247092976967e-09
up O 0 3.545560234297085e-10
of O 0 4.937474318289503e-10
the O 0 4.124217911627426e-10
only O 0 3.7391176960221983e-11
two O 0 6.255636286756072e-11
surviving O 0 5.5871016257924566e-08
patients O 0 1.0524531246502988e-09
, O 0 2.4153085087519344e-10
one O 0 5.684298587382841e-10
with O 0 1.1132458288543035e-09
SJS B-Disease 0 0.002649386413395405
type I-Disease 0 6.544742518599378e-06
2 I-Disease 0 9.802429303817917e-07
at O 0 1.3606565874013654e-09
age O 0 1.1144222350489841e-10
10 O 0 5.868494579175376e-11
years O 0 5.834632083034919e-11
and O 0 1.201743843326497e-10
another O 0 7.569266879947634e-10
with O 0 1.1115441900244605e-09
SWS B-Disease 0 0.00010899103654082865
at O 0 5.099363775684651e-08
age O 0 1.014756012551743e-08
7 O 0 1.0539406503085047e-07
years O 0 1.5852691603868152e-08
. O 0 5.964261617918964e-08

Patients O 0 5.954679181741085e-06
reported O 0 1.6072439734671207e-07
as O 0 8.926199335235196e-09
having O 0 1.920262171495324e-08
either O 0 6.750741476935218e-07
neonatal O 1 1.0
SJS B-Disease 1 1.0
or O 0 0.00033861989504657686
SWS B-Disease 0 0.05044475570321083
presented O 0 1.6411751957434717e-08
a O 0 5.31120869506907e-10
combination O 0 3.838773743325419e-09
of O 0 8.471491064199199e-09
a O 0 5.1313437943179e-09
severe O 0 5.873570444236975e-06
, O 0 1.2322421305555054e-08
prenatal O 0 0.06661798059940338
- O 0 0.04970007762312889
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 0.9999997615814209
( O 0 1.3539134258166996e-08
with O 0 1.373365510204394e-08
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 1 1.0
respiratory O 1 1.0
and O 0 0.029610726982355118
feeding O 0 9.981075891118962e-06
difficulties O 0 8.106529207907442e-07
, O 0 4.818518362093016e-10
tendency O 0 2.531575171715872e-09
to O 0 1.0312867004813597e-08
hyperthermia B-Disease 1 0.9999997615814209
, O 0 4.0126932887574185e-09
and O 0 7.440071336795029e-10
frequent O 0 4.658464725082467e-09
death O 0 3.867855014050292e-07
in O 0 4.65872274091339e-09
infancy O 0 3.2176507147596567e-07
) O 0 8.766090631162626e-11
with O 0 2.1957087190105362e-11
a O 0 1.7929554507745138e-09
distinct O 0 8.879947444029312e-08
campomelic B-Disease 1 0.999736487865448
- I-Disease 1 0.6367322206497192
metaphyseal I-Disease 1 0.9999213218688965
skeletal I-Disease 1 0.9999998807907104
dysplasia I-Disease 1 1.0
. O 0 5.153383608558215e-05

The O 0 2.714349420784856e-07
similarity O 0 5.986412361380644e-07
of O 0 5.365923811950779e-07
the O 0 3.240240076252121e-08
clinical O 0 3.1411931900038326e-07
and O 0 8.264112949518676e-09
radiographic O 0 0.0001285389153053984
findings O 0 2.573688675511221e-07
is O 0 3.0630951108889803e-09
so O 0 2.6130958508119306e-10
extensive O 0 3.710292295622253e-09
that O 0 1.0075534850884083e-10
these O 0 4.787198415456828e-10
disorders O 0 1.4789365820888634e-07
appear O 0 8.40893310538604e-09
to O 0 1.3794395625765787e-09
be O 0 2.7131517033041064e-09
a O 0 8.366968451412049e-09
single O 0 1.7226586379592845e-08
entity O 0 8.150500718784315e-08
. O 0 3.041823219973594e-07

The O 0 2.081423190247733e-06
follow O 0 2.3188626130377088e-07
- O 0 5.050819709140342e-07
up O 0 7.71139418986877e-09
observation O 0 1.037343508869526e-07
of O 0 5.580027107043861e-09
an O 0 5.014134940584114e-11
identical O 0 6.006519170931313e-10
and O 0 3.2183955500642014e-10
unique O 0 1.067205546156913e-09
pattern O 0 4.814187448687335e-08
of O 0 4.007237293990329e-06
progressive O 1 0.9837019443511963
bone B-Disease 1 0.9997919201850891
dysplasia I-Disease 1 0.9999995231628418
in O 0 1.4458451325083388e-08
the O 0 4.081619309204143e-08
two O 0 7.497023002400738e-10
patients O 0 4.295450106717169e-10
( O 0 1.0606586442474253e-10
one O 0 4.1610387357948753e-10
with O 0 4.579203405352672e-10
SJS B-Disease 0 0.008197426795959473
type I-Disease 0 3.093740360782249e-06
2 I-Disease 0 1.0362623470427934e-06
, O 0 4.0554484770360943e-10
one O 0 4.1167125264252036e-10
with O 0 1.2036874830201327e-09
SWS B-Disease 0 2.4605113139841706e-05
) O 0 1.6755301590620775e-09
surviving O 0 6.791681244067149e-07
beyond O 0 4.792469781023101e-07
infancy O 0 1.1398352626201813e-06
adds O 0 3.4900671241899772e-09
to O 0 3.9030187415356465e-10
the O 0 3.149879801433997e-10
evidence O 0 2.8991955502988276e-09
in O 0 6.689863107922633e-10
favor O 0 1.0083581081232751e-08
of O 0 1.3033652379590421e-08
identity O 0 5.803829239425795e-08
. O 0 1.6679906877925532e-07

The O 0 1.4215106602932792e-06
hypothesis O 0 2.3188902105175657e-06
that O 0 3.305515861029562e-08
SWS B-Disease 1 0.7761595845222473
and O 0 4.5694582695432473e-07
SJS B-Disease 1 0.9999954700469971
type I-Disease 0 2.3853752281866036e-05
2 I-Disease 0 5.648411729453073e-07
are O 0 4.9449357802933136e-11
the O 0 7.647397159971092e-10
same O 0 1.2274607996687337e-09
disorder O 0 1.9631395176133992e-08
should O 0 2.4764656991749234e-10
be O 0 1.9129635375758625e-10
testable O 0 6.0152585135142544e-09
by O 0 1.4437816393819691e-11
molecular O 0 3.50131368342943e-10
methods O 0 3.837675954798669e-09
. O 0 2.394480391743059e-09
. O 0 2.813849064864371e-08

A O 0 5.091830189485336e-06
mouse O 0 5.145429895492271e-07
model O 0 5.30656407704555e-09
of O 0 8.18961076731739e-09
severe O 1 0.9995809197425842
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 1 0.9999748468399048
defects O 1 1.0
in O 0 5.655925860992284e-07
hemostasis O 1 0.9999959468841553
and O 0 1.4734258911630604e-05
thrombosis B-Disease 1 1.0
. O 0 0.00014293525600805879

von B-Disease 1 0.9999966621398926
Willebrand I-Disease 1 1.0
factor I-Disease 1 0.7412766218185425
( I-Disease 0 1.2095762940589339e-05
vWf I-Disease 1 0.999994158744812
) I-Disease 0 2.937349199783057e-05
deficiency I-Disease 1 1.0
causes O 1 0.9997476935386658
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 1 0.9954038858413696
humans O 0 0.00032977963564917445
. O 0 7.463970064236491e-07

We O 0 2.990015559589665e-07
generated O 0 3.16723358650961e-08
a O 0 1.0041013354111783e-08
mouse O 0 2.5924368429741662e-08
model O 0 6.659004458953177e-10
for O 0 4.7366510019797303e-11
this O 0 4.2116594933805374e-11
disease O 0 7.066995322269065e-10
by O 0 4.7458752205908894e-11
using O 0 7.145036784450554e-10
gene O 0 4.743545112262382e-09
targeting O 0 3.060293707335404e-08
. O 0 4.583175083894275e-08

vWf B-Disease 1 0.9706507921218872
- I-Disease 1 0.9999992847442627
deficient I-Disease 1 0.9999998807907104
mice O 0 1.1697843547153752e-05
appeared O 0 9.457703953330565e-08
normal O 0 2.166276935611222e-08
at O 0 4.426904620657979e-09
birth O 0 1.3365500928230745e-09
; O 0 3.0387695137967796e-10
they O 0 2.564773948776633e-10
were O 0 3.942623560959646e-09
viable O 0 1.508589093646151e-06
and O 0 3.2424658513718896e-08
fertile O 0 2.7994839911116287e-05
. O 0 3.4779421298480884e-07

Neither O 0 7.981954695424065e-05
vWf O 0 0.0010392764816060662
nor O 0 6.309145101113245e-05
vWf O 0 0.0003830702044069767
propolypeptide O 0 0.00031457949080504477
( O 0 1.0785287685166622e-07
von B-Disease 0 0.013347874395549297
Willebrand I-Disease 1 0.9999983310699463
antigen O 0 0.0009006414911709726
II O 1 1.0
) O 0 5.867160268735461e-08
were O 0 7.161221393658934e-09
detectable O 0 1.0068037425980947e-07
in O 0 6.392881779504478e-10
plasma O 0 1.4293603634030205e-08
, O 0 8.694637371187142e-11
platelets O 0 9.851423676821014e-09
, O 0 4.261031250063496e-10
or O 0 2.6397073416006833e-09
endothelial O 0 5.480343290287237e-08
cells O 0 7.765223131173116e-09
of O 0 9.982278470488382e-08
the O 0 3.237417445234314e-07
homozygous O 0 4.856186137658369e-07
mutant O 0 1.2047856898789178e-06
mice O 0 3.756035766855348e-07
. O 0 8.235353732288786e-08

The O 0 4.064462336828001e-05
mutant O 0 0.00015542797336820513
mice O 0 1.1593340332183288e-06
exhibited O 0 1.146861166034796e-07
defects O 0 0.000297303544357419
in O 0 3.26603988298757e-08
hemostasis O 0 0.004260452929884195
with O 0 1.5311739431922433e-08
a O 0 1.0322375487703539e-07
highly O 0 2.100562369378167e-06
prolonged O 1 0.9998063445091248
bleeding O 1 0.9943219423294067
time O 0 3.266688111125404e-07
and O 0 4.599077385591954e-08
spontaneous O 0 2.2815598299530393e-08
bleeding O 0 1.0094515090486311e-07
events O 0 1.0853144077893617e-10
in O 0 6.58694696009654e-11
approximately O 0 4.1818264129300786e-11
10 O 0 1.3560338962825824e-10
% O 0 1.3763377937348054e-10
of O 0 4.770684292054739e-09
neonates O 0 1.877651584436535e-06
. O 0 5.532139653041668e-07

As O 0 2.8051525191585824e-07
in O 0 6.899553817163451e-09
the O 0 4.844268097770055e-09
human O 0 6.12459283289013e-09
disease O 0 1.4077161836212326e-07
, O 0 1.5470213998725058e-10
the O 0 1.6710843819822685e-09
factor O 0 7.153767356271601e-09
VIII O 1 0.9999995231628418
level O 0 2.0267129002604634e-05
in O 0 1.40045730567806e-09
these O 0 1.21106527584125e-10
mice O 0 8.616093949420645e-10
was O 0 1.4816682325502484e-09
reduced O 0 2.678567589953218e-09
strongly O 0 2.2320374437612145e-09
as O 0 3.654370417383035e-10
a O 0 4.730649205697546e-10
result O 0 5.680472758839983e-10
of O 0 2.957110112333794e-09
the O 0 1.6413150838445745e-09
lack O 0 1.935514859496834e-08
of O 0 3.6668841296716437e-09
protection O 0 4.256535390823046e-08
provided O 0 7.778297117511102e-09
by O 0 3.0572178122412197e-09
vWf O 0 7.460094820999075e-06
. O 0 5.676129717357981e-07

Defective O 1 0.9830925464630127
thrombosis B-Disease 1 0.9999998807907104
in O 0 5.6372642575297505e-05
mutant O 0 2.9721426471951418e-05
mice O 0 2.748242309280613e-07
was O 0 7.046274674848974e-08
also O 0 5.4024168472111e-10
evident O 0 1.2357961765019354e-08
in O 0 5.572993733160558e-10
an O 0 6.64537452843561e-11
in O 0 1.2737204346802145e-10
vivo O 0 2.2152548684317708e-09
model O 0 3.6779657097696372e-09
of O 0 2.9149563829378167e-07
vascular B-Disease 1 1.0
injury I-Disease 1 0.9999997615814209
. O 0 4.6194785682018846e-05

In O 0 7.123488643401288e-08
this O 0 1.5202109571177402e-09
model O 0 1.3945459009789829e-08
, O 0 1.1132330612895203e-09
the O 0 9.001787759643776e-09
exteriorized O 0 3.1522204153588973e-06
mesentery O 0 1.186509234685218e-05
was O 0 1.3937885512405046e-07
superfused O 0 1.4774450107779558e-07
with O 0 1.4002909942689712e-10
ferric O 0 6.1613313846464735e-06
chloride O 0 2.713894104999781e-07
and O 0 2.2621168938030678e-08
the O 0 1.396968496436557e-08
accumulation O 0 7.911829413842497e-08
of O 0 4.3574178931748975e-08
fluorescently O 0 6.0827828747278545e-06
labeled O 0 6.298506605162402e-08
platelets O 0 6.540135188970453e-08
was O 0 2.817092514817432e-08
observed O 0 1.0560766705580704e-09
by O 0 4.798762498481324e-10
intravital O 0 7.928958325464919e-07
microscopy O 0 9.052857308233797e-07
. O 0 5.16214129220316e-07

We O 0 4.2613768869159685e-07
conclude O 0 3.9718585753689695e-07
that O 0 1.3256835629249508e-09
these O 0 2.794731113198168e-09
mice O 0 6.791306361719762e-08
very O 0 1.4087301325460544e-09
closely O 0 9.958522007025294e-09
mimic O 0 3.405658389965538e-06
severe O 1 0.9999963045120239
human O 1 0.9999997615814209
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 0.012159341014921665
will O 0 3.04803582373836e-09
be O 0 3.0937552519816336e-10
very O 0 8.00419452939849e-11
useful O 0 2.1145436790437344e-10
for O 0 1.0357539478866862e-11
investigating O 0 8.498833581338516e-11
the O 0 1.9879536905520467e-10
role O 0 2.74804623501268e-09
of O 0 1.0511336689944528e-08
vWf O 0 6.158684300316963e-07
in O 0 1.4898324796064344e-09
normal O 0 6.3819451945335e-09
physiology O 0 2.0014390145206562e-08
and O 0 2.707029878035172e-10
in O 0 2.173542318351096e-10
disease O 0 8.258802530747289e-09
models O 0 3.793674263619096e-09
. O 0 2.9693762115812206e-08
. O 0 4.046961237236246e-07

Oral O 0 0.0005864383419975638
contraceptives O 0 0.003840525634586811
and O 0 6.8025691746242956e-09
the O 0 3.150890881542523e-09
risk O 0 7.125078127501183e-08
of O 0 0.00018197039025835693
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 6.757710707461229e-06

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 0.9999982118606567
Clinical O 0 2.796834087348543e-05
Study O 0 3.0903493097866885e-08
Group O 0 7.649617828064947e-09
. O 0 3.566610473626497e-08

BACKGROUND O 0 7.013663889665622e-06
Women O 0 3.757273159266106e-09
with O 0 2.262843940004089e-10
mutations O 0 9.277172363653108e-10
in O 0 4.700438371862958e-10
either O 0 4.770192685299435e-09
the O 0 6.752802050868922e-08
BRCA1 O 0 1.689158857232087e-08
or O 0 2.7198665542016442e-09
the O 0 7.101075727433681e-09
BRCA2 O 0 5.0244990390524435e-09
gene O 0 2.5734325781456846e-10
have O 0 6.461577800598306e-11
a O 0 1.2644597591204843e-09
high O 0 2.0828112567983226e-08
lifetime O 0 4.7395683822060164e-08
risk O 0 7.669255523978791e-07
of O 1 0.9931307435035706
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.0048744343293947e-06

Oral O 1 0.9432015419006348
contraceptives O 1 1.0
protect O 1 0.9999806880950928
against O 1 1.0
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 1.3828385547753896e-08
general O 0 3.741948617630442e-08
, O 0 9.587553667644855e-11
but O 0 4.764831931791669e-11
it O 0 1.5802192887548472e-11
is O 0 4.200033550116888e-12
not O 0 1.6742082980386597e-12
known O 0 2.0310327031314301e-10
whether O 0 1.3789418218390637e-10
they O 0 1.5284791488046068e-10
also O 0 9.179887405785792e-10
protect O 0 8.540474993878888e-09
against O 0 4.059275582335431e-08
hereditary B-Disease 1 1.0
forms I-Disease 1 0.9956350922584534
of I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.076489238334034e-07

METHODS O 0 2.2579612050321884e-05
We O 0 2.034253157034982e-07
enrolled O 0 8.4110538978166e-08
207 O 0 1.9434608589108393e-08
women O 0 6.514367517640451e-11
with O 0 1.6530086188737414e-09
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.3376804552933663e-08
161 O 0 6.293484844377417e-09
of O 0 1.5126568442269672e-08
their O 0 2.0009160550671368e-08
sisters O 0 2.1230218862910988e-06
as O 0 6.945714225992106e-09
controls O 0 3.312635499241878e-08
in O 0 1.4781228463434104e-09
a O 0 1.0727141841471166e-08
case O 0 2.5268715830861765e-07
- O 0 2.9534007239817583e-07
control O 0 2.197229207467899e-07
study O 0 7.611762775638908e-09
. O 0 1.793086212842354e-08

All O 0 1.1386332232632412e-07
the O 0 2.8914985961137063e-08
patients O 0 5.021088433920795e-09
carried O 0 9.807641365711106e-10
a O 0 7.110586008884923e-10
pathogenic O 0 7.023461368049766e-09
mutation O 0 1.011848715926078e-09
in O 0 5.648277401348878e-10
either O 0 5.731059182778608e-09
BRCA1 O 0 1.3151469246963643e-08
( O 0 4.189916191776888e-10
179 O 0 2.354279438065987e-09
women O 0 3.284526470248572e-11
) O 0 8.485842584171621e-11
or O 0 4.6723376279089734e-09
BRCA2 O 0 2.083435788335919e-07
( O 0 4.79547113130252e-09
28 O 0 9.377643550578796e-08
women O 0 2.8209071190055113e-10
) O 0 6.7678596060716245e-09
. O 0 1.0581988618696414e-07

The O 0 1.1810881005658302e-05
control O 0 6.142310667200945e-06
women O 0 8.201330170543031e-10
were O 0 1.1492019558190236e-09
enrolled O 0 8.578116550417292e-10
regardless O 0 8.865925216205994e-10
of O 0 1.148229178404847e-09
whether O 0 1.4809244108793251e-10
or O 0 2.336866256058556e-10
not O 0 6.927515505683601e-11
they O 0 7.35415894848046e-11
had O 0 2.112698238576627e-09
either O 0 5.131196800789439e-09
mutation O 0 6.252090400948873e-08
. O 0 1.732532979303869e-07

Lifetime O 0 8.060129403020255e-06
histories O 0 1.950444357134984e-06
of O 0 5.159370743967884e-07
oral O 0 1.8181639461545274e-05
- O 0 1.945512480006073e-07
contraceptive O 0 1.4080168853070063e-07
use O 0 9.445435544819247e-10
were O 0 1.807071992043774e-10
obtained O 0 2.4856933178440954e-10
by O 0 4.496287717148384e-11
interview O 0 4.930011954229485e-10
or O 0 1.0586678061974553e-10
by O 0 1.2315869678258817e-11
written O 0 1.3096086715069788e-10
questionnaire O 0 4.8977211175582624e-11
and O 0 6.16640974393512e-11
were O 0 1.4319129215678572e-10
compared O 0 7.074142938101602e-10
between O 0 1.0910538028596761e-09
patients O 0 5.043855999531388e-09
and O 0 2.072147342602193e-09
control O 0 2.355763051298254e-08
women O 0 1.035301705476499e-11
, O 0 5.104199615052485e-12
after O 0 5.375032710586147e-11
adjustment O 0 8.241332061231788e-10
for O 0 2.3018731018509264e-11
year O 0 1.1183892700827869e-10
of O 0 1.897766388481159e-09
birth O 0 3.7530561769472115e-08
and O 0 2.3471248056239347e-08
parity O 0 5.599785595222784e-07
. O 0 1.1612601014121537e-07

RESULTS O 0 2.185708353863447e-06
The O 0 7.612722470184963e-07
adjusted O 0 5.63240860174119e-07
odds O 0 3.8335483623086475e-06
ratio O 0 4.724117275145545e-07
for O 0 3.0938581403461285e-06
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 4.859222357822546e-09
with O 0 1.260706643246845e-11
any O 0 9.071757234302424e-11
past O 0 1.1869027982669422e-10
use O 0 1.5100609651597097e-10
of O 0 1.0808610673151975e-09
oral O 0 1.1800356247704258e-07
contraceptives O 0 1.0556491361057851e-06
was O 0 1.1150149248351227e-07
0 O 0 2.194606807393029e-08
. O 0 8.11079647888846e-09

5 O 0 1.320875753663131e-06
( O 0 1.24219798891545e-08
95 O 0 2.9925317335255386e-07
percent O 0 3.3601008198047566e-08
confidence O 0 6.179062239652922e-08
interval O 0 1.2977341867781433e-08
, O 0 4.475660952962812e-10
0 O 0 9.096001174491164e-10
. O 0 9.581813120718152e-11
3 O 0 2.0507149312010142e-09
to O 0 2.9198934936580656e-10
0 O 0 6.6371597107206526e-09
. O 0 5.448715367784018e-10
8 O 0 3.146904248296778e-08
) O 0 2.6998023816560135e-09
. O 0 4.1291020380640475e-08

The O 0 1.8054222437058343e-06
risk O 0 1.1349590067766258e-07
decreased O 0 7.582476868606136e-09
with O 0 4.955680657503514e-11
increasing O 0 4.683908261249314e-10
duration O 0 6.22061424593312e-09
of O 0 2.098969886787927e-09
use O 0 9.326032168743836e-10
( O 0 1.987881526055446e-10
P O 0 6.694553889019517e-08
for O 0 1.5367400407750864e-10
trend O 0 7.311072858229295e-10
, O 0 4.960598251613213e-11
< O 0 2.599862991559121e-09
0 O 0 3.959117200746931e-10
. O 0 2.6388537188726247e-11
001 O 0 3.0864719668954876e-09
) O 0 2.703322808661479e-12
; O 0 5.412209309191285e-12
use O 0 1.192853454901055e-10
for O 0 2.051879777198451e-10
six O 0 4.5267689596784066e-10
or O 0 2.0170498604699105e-10
more O 0 1.2613152709783915e-11
years O 0 1.3332063231175084e-10
was O 0 5.091369548182456e-10
associated O 0 7.257273254568375e-11
with O 0 1.66759939190797e-11
a O 0 5.522162171978096e-10
60 O 0 2.491266970494621e-09
percent O 0 4.287895039034595e-10
reduction O 0 9.532532097011881e-09
in O 0 8.26217405602847e-09
risk O 0 3.111607043138065e-07
. O 0 3.175651102083066e-07

Oral O 0 0.00041694933315739036
- O 0 1.1397002708690707e-05
contraceptive O 0 4.017787432530895e-06
use O 0 5.724866980472143e-08
protected O 0 0.19647756218910217
against O 1 1.0
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 2.6542865128043047e-10
for O 0 4.161718886175336e-11
carriers O 0 7.727390949341384e-11
of O 0 3.116933156022128e-09
the O 0 6.466663204918177e-09
BRCA1 O 0 1.1078149508847446e-09
mutation O 0 5.923090490300709e-11
( O 0 1.6198016886126432e-11
odds O 0 2.8977749089165172e-09
ratio O 0 1.7888555914336024e-10
, O 0 1.8224395950672267e-11
0 O 0 1.4781673107755466e-10
. O 0 2.6484998222331413e-11
5 O 0 3.7291625343272017e-10
; O 0 1.3243156571363102e-10
95 O 0 3.2545234063263706e-08
percent O 0 4.901333117146578e-09
confidence O 0 4.3069214861191085e-09
interval O 0 2.014628686097808e-09
, O 0 1.4181976426552723e-10
0 O 0 2.891595018983395e-10
. O 0 5.331861688273598e-11
3 O 0 1.3657422970325683e-09
to O 0 3.0038138643107004e-10
0 O 0 1.0944031236803653e-09
. O 0 5.80669956562474e-11
9 O 0 9.44322064988512e-10
) O 0 6.6679071118735944e-12
and O 0 1.573938375465378e-11
for O 0 1.1990757345370362e-11
carriers O 0 2.520665620675544e-10
of O 0 1.0920516935186697e-08
the O 0 8.97307383951329e-09
BRCA2 O 0 8.394862582861151e-09
mutation O 0 3.155231353968446e-10
( O 0 6.200139707202013e-11
odds O 0 6.2359148955692945e-09
ratio O 0 5.208222741970303e-10
, O 0 6.326104917686592e-11
0 O 0 4.373458817319431e-10
. O 0 1.0569789488101833e-10
4 O 0 3.1822973145523292e-09
; O 0 4.973333411761871e-10
95 O 0 9.599587968978085e-08
percent O 0 9.74036584722171e-09
confidence O 0 1.354789080920682e-08
interval O 0 6.40878106139553e-09
, O 0 2.4665097742015973e-10
0 O 0 8.380268146090941e-10
. O 0 4.427119781880151e-11
2 O 0 1.1980391123600498e-09
to O 0 1.6855654372260886e-10
1 O 0 5.842923478383e-09
. O 0 4.590361701861667e-10
1 O 0 3.597004649691371e-08
) O 0 2.078793803761414e-09
. O 0 3.3706921698239967e-08

CONCLUSIONS O 0 8.999471901915967e-06
Oral O 0 0.0009405114105902612
- O 0 6.572839538421249e-06
contraceptive O 0 1.5321779756050091e-06
use O 0 1.7449529599034008e-09
may O 0 7.651759781346357e-10
reduce O 0 1.6473086228430134e-09
the O 0 2.9135693857540446e-09
risk O 0 3.0918297966309183e-07
of O 1 0.9999899864196777
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 4.4839407187247105e-10
women O 0 6.200522950985943e-13
with O 0 1.0427108395466567e-12
pathogenic O 0 6.259040508105329e-10
mutations O 0 1.3168624524162453e-10
in O 0 1.888600803523488e-10
the O 0 9.10920050500863e-09
BRCA1 O 0 2.6174133083145534e-08
or O 0 4.884071458377548e-08
BRCA2 O 0 1.6592533711445867e-06
gene O 0 6.295960588431626e-07

A O 0 1.5055900803417899e-05
Japanese O 0 3.33444113493897e-05
family O 0 1.6039503236697783e-07
with O 0 9.256391209078174e-09
adrenoleukodystrophy B-Disease 1 1.0
with O 0 1.2908861535265714e-08
a O 0 3.455249242279024e-08
codon O 0 5.179064643812126e-08
291 O 0 1.22780328126737e-08
deletion O 0 1.2931606008237395e-08
: O 0 1.5161534527852183e-10
a O 0 2.798170029016944e-10
clinical O 0 1.4094188927060713e-08
, O 0 2.520285924401122e-10
biochemical O 0 2.589647749573487e-07
, O 0 1.8525816436465448e-09
pathological O 0 3.5270131775178015e-06
, O 0 1.2753789135899751e-09
and O 0 1.7957070275187448e-09
genetic O 0 4.991985136371113e-08
report O 0 1.0035651420992053e-08
. O 0 1.7984231703849218e-07

We O 0 1.0745309708681816e-07
report O 0 6.009570618914495e-09
a O 0 4.874436854152009e-09
Japanese O 0 3.3369684615536244e-07
family O 0 1.0294962216050862e-08
with O 0 4.2301806502109685e-09
adrenoleukodystrophy B-Disease 1 1.0
( O 0 2.9182319849496707e-06
ALD B-Disease 1 1.0
) O 0 3.4328733189425975e-09
with O 0 3.7587261081384327e-10
a O 0 5.0187236588783435e-09
three O 0 2.953919553405626e-09
base O 0 1.186470015568375e-07
pair O 0 2.342509297648121e-08
deletion O 0 2.1242678727162456e-08
( O 0 4.729196478869824e-10
delGAG O 0 8.486308900046424e-08
291 O 0 2.2909689700867375e-09
) O 0 2.631818096787697e-10
in O 0 9.453312577178963e-10
the O 0 3.199679383669718e-07
ALD B-Disease 1 1.0
gene O 0 1.3438851965474896e-05
. O 0 1.398783524564351e-06

A O 0 2.0942036371707218e-06
variety O 0 4.808240561260391e-08
of O 0 4.08168183696489e-08
phenotypes O 0 4.571589684587707e-08
were O 0 1.7748947866991216e-09
observed O 0 1.180887831964128e-09
within O 0 1.2281891059728878e-09
this O 0 8.720218436231164e-10
family O 0 5.357824761631491e-08
. O 0 3.502051626469438e-08

While O 0 4.642952831090952e-07
the O 0 1.2941394800236594e-07
proband O 0 1.3409114217211027e-05
( O 0 6.533761975902053e-09
patient O 0 1.1842892888580536e-07
1 O 0 1.4403572379251273e-07
) O 0 4.1207739998050386e-10
was O 0 8.421934261093611e-09
classified O 0 2.828699274814994e-09
as O 0 6.86755430301389e-10
having O 0 5.450689899433314e-10
a O 0 8.981289045806307e-10
rare O 0 1.413434813635206e-09
intermediate O 0 1.627043566543307e-08
type O 0 1.7072521174554822e-08
of O 0 6.43683648604565e-08
adult O 0 5.641575029358137e-08
cerebral O 0 2.707155033476738e-07
and O 0 2.508108032373002e-08
cerebello O 0 0.00017497592489235103
- O 0 2.9254208584461594e-06
brain O 0 7.4253335924368e-08
stem O 0 2.796789466685823e-09
forms O 0 1.4521401858758054e-09
, O 0 1.8568045712097359e-10
his O 0 1.6838247463013545e-09
younger O 0 2.1568602903698775e-08
brother O 0 3.0267415240814444e-07
( O 0 4.548874332765962e-10
patient O 0 2.007648092217096e-08
2 O 0 3.16812176492931e-08
) O 0 1.4707260409529965e-10
and O 0 4.602427328137537e-09
nephew O 0 0.0008615559199824929
( O 0 1.5920564422344796e-08
patient O 0 1.9041035557165742e-06
3 O 0 8.263996846835653e-07
) O 0 1.5190747548743389e-09
had O 0 2.1334892963409402e-08
a O 0 1.0604293976257395e-07
childhood O 0 0.00016028975369408727
ALD B-Disease 1 1.0
type O 0 0.4733715057373047
. O 0 3.57712383447506e-06

Another O 0 1.8479383925296133e-06
nephew O 0 0.00032976645161397755
( O 0 1.6858885842907512e-08
patient O 0 2.563160990121105e-07
4 O 0 1.2632845880489185e-07
) O 0 2.0085767771238494e-10
of O 0 4.23689883177758e-09
patient O 0 8.545576406504551e-07
1 O 0 9.151693802778027e-07
was O 0 1.0031770614205016e-07
classified O 0 4.822143129246115e-09
as O 0 6.077948144778134e-10
having O 0 1.0337990463682445e-09
an O 0 1.7528846429915035e-10
adolescent O 0 2.0078885221153087e-09
form O 0 3.4736702403392883e-09
. O 0 1.5741231607080408e-07

The O 0 1.2633579899556935e-05
tau O 0 4.351465122454101e-06
level O 0 2.2906955621238012e-07
in O 0 6.0739528962017175e-09
the O 0 1.1534034172200336e-08
cerebrospinal O 0 1.1796642951367176e-07
fluid O 0 7.48034665321029e-08
( O 0 2.065542581419777e-08
CSF O 0 0.00031568302074447274
) O 0 9.34081345604909e-09
in O 0 1.0054178822826998e-08
patient O 0 7.547542736574542e-06
1 O 0 3.4471113394829445e-06
was O 0 2.9017979841228225e-07
as O 0 1.5657656282641597e-09
high O 0 8.839488252476713e-09
as O 0 9.99034049931069e-11
that O 0 6.8319976412323236e-12
of O 0 9.753672314261053e-10
patients O 0 2.5357556054927954e-09
with O 0 1.991028453218746e-09
Alzheimers B-Disease 1 1.0
disease I-Disease 0 0.0001599633105797693
( O 0 2.5820725557679225e-09
AD B-Disease 0 3.8790849998804333e-07
) O 0 1.186062181801617e-08
. O 0 2.6974770861443176e-08

His O 0 3.260433004470542e-05
brain O 0 3.255226692999713e-05
magnetic O 0 3.4808533655450447e-06
resonance O 0 1.1297037190161063e-06
image O 0 9.846850161920884e-07
( O 0 4.3769514235236784e-08
MRI O 0 0.0002627481007948518
) O 0 2.3745020172327713e-08
showed O 0 2.8798467610613443e-08
abnormalities B-Disease 0 3.1578167636325816e-06
in I-Disease 0 6.793467122179209e-09
the I-Disease 0 7.485713382493486e-08
bilateral I-Disease 0 0.00024671340361237526
cerebellar I-Disease 1 1.0
hemispheres I-Disease 1 0.9976546764373779
and O 0 2.292092858624528e-06
brain O 0 1.8070758187604952e-06
stem O 0 2.3130025894602113e-08
, O 0 1.6724929774447617e-10
but O 0 7.384999556325766e-11
not O 0 1.4742422560498625e-10
in O 0 1.473259292339435e-09
the O 0 1.0953539408831148e-08
cerebral O 0 1.7944945511771948e-06
white O 0 3.1624526997120483e-08
matter O 0 2.3756423495058243e-09
, O 0 2.4062028411431235e-11
where O 0 3.2549529044301195e-11
marked O 0 1.8317240779719413e-10
reductions O 0 1.3956900524192406e-08
of O 0 7.986272265725347e-08
the O 0 7.368885235337075e-08
cerebral O 0 1.3100604974169983e-06
blood O 0 3.436491624597693e-08
flow O 0 1.084717382582312e-08
and O 0 5.387046808635887e-09
oxygen O 0 1.1405339961356731e-07
metabolism O 0 2.1731052513018767e-08
were O 0 8.707769505456042e-10
clearly O 0 1.0650541559797944e-09
demonstrated O 0 1.4487705479737656e-09
by O 0 6.272389829753422e-10
positron O 0 4.988748258938358e-08
emission O 0 3.485591903995555e-08
tomography O 0 4.482209305933793e-07
( O 0 1.6244110057073158e-08
PET O 0 2.064038426397019e-06
) O 0 4.206469839118654e-09
. O 0 5.0991495470498194e-08

In O 0 2.855308878224605e-07
patients O 0 1.7900575244311767e-07
2 O 0 3.296242709893704e-07
and O 0 7.280101410600537e-09
3 O 0 6.886566694674912e-08
, O 0 5.112973933130149e-10
the O 0 3.5807523612874093e-09
autopsy O 0 1.4413080862141214e-07
findings O 0 1.3918194596840294e-08
showed O 0 1.8882426289223986e-08
massive O 0 2.2580986751563614e-06
demyelination B-Disease 1 1.0
of I-Disease 1 0.9183930158615112
the I-Disease 0 4.300563887227327e-06
cerebral I-Disease 0 1.7287899026996456e-05
white I-Disease 0 1.9694853747864727e-08
matter I-Disease 0 1.2569958407482318e-09
with O 0 2.2696117554787953e-11
sparing O 0 8.563735498512415e-09
of O 0 6.762714122032776e-08
the O 0 1.6353887133391254e-07
U O 0 0.00012609103578142822
- O 0 8.456285627289617e-07
fibers O 0 2.1725546162087994e-07
, O 0 8.453698852051161e-10
compatible O 0 3.706178404172533e-07
with O 0 5.741110364887447e-10
the O 0 5.066766117778343e-09
findings O 0 3.934938153093981e-09
of O 0 1.1277119682517878e-07
childhood O 0 0.00028793339151889086
ALD B-Disease 1 1.0
. O 0 8.978408914117608e-06

Oleic O 0 0.04729786142706871
and O 0 7.128950528567657e-06
erucic O 1 0.839763879776001
acids O 0 9.433342711417936e-07
( O 0 1.2026370121986929e-08
Lorenzos O 0 7.787006325088441e-06
Oil O 0 3.7052981838314736e-07
) O 0 1.515572251031827e-10
were O 0 2.161128498379128e-10
administered O 0 8.138469342888754e-10
to O 0 5.611220377232939e-10
patients O 0 3.4245026814261337e-09
1 O 0 5.630954191815363e-08
and O 0 2.120570830044244e-09
4 O 0 9.811668810755236e-09
, O 0 3.3653614617268346e-11
but O 0 2.568640092293073e-11
sufficient O 0 3.067761156216875e-09
effectiveness O 0 1.6630215426971517e-08
was O 0 9.27657595184428e-09
not O 0 1.0815905115979518e-10
obtained O 0 8.197925005504203e-09
. O 0 5.606369768429431e-08

The O 0 1.394478772454022e-06
findings O 0 3.744847276720975e-08
in O 0 1.9576569254553533e-09
this O 0 6.58902377104198e-10
family O 0 1.6668633140426437e-09
suggest O 0 1.4227656552900925e-10
that O 0 1.6201106428637146e-11
delGAG291 O 0 2.7304716709863897e-08
is O 0 1.0936180433462894e-10
part O 0 4.925077567996539e-10
of O 0 5.7584852442005285e-09
the O 0 3.668633175024638e-09
cause O 0 4.501220018937602e-08
of O 0 5.254796633380465e-07
Japanese O 0 0.00027729684370569885
ALD B-Disease 1 1.0
with O 0 7.607570751133608e-08
phenotypic O 0 1.6375767017962062e-06
variations O 0 6.506392651317583e-07
. O 0 4.2461482507860637e-07

Moreover O 0 1.1289014310023049e-06
, O 0 7.562098502944536e-09
although O 0 2.3048012387505423e-09
the O 0 2.6802335906239705e-09
scale O 0 1.5155968924318586e-08
of O 0 3.4319174169183952e-09
the O 0 9.5420593648754e-10
study O 0 4.311388399069749e-11
is O 0 2.210466358565366e-11
limited O 0 2.0066354133874142e-10
, O 0 5.6823226679547645e-11
there O 0 4.774566159104765e-11
is O 0 1.6493607868373061e-10
a O 0 1.1989054193861648e-09
possibility O 0 1.8345721386481273e-08
that O 0 3.15991854904496e-09
PET O 0 5.413668077380862e-06
can O 0 4.684928889275852e-09
detect O 0 2.9747002372459974e-07
an O 0 2.4676118925981427e-09
insidious B-Disease 0 6.376305009325733e-06
lesion I-Disease 0 5.943635187577456e-05
which O 0 2.0100074937801082e-09
is O 0 1.209117250766667e-10
undetectable O 0 2.690323297471764e-09
by O 0 1.0082110146747425e-10
computed O 0 5.754027476712054e-09
tomogram O 0 5.765432433690876e-07
( O 0 1.878757593942737e-09
CT O 0 3.608395672927145e-06
) O 0 7.272048518913721e-10
or O 0 8.214965929731477e-10
MRI O 0 8.717898225540921e-08
analysis O 0 1.1991502235630946e-09
, O 0 6.895126830608334e-11
and O 0 5.078332546148978e-11
that O 0 8.29976885829975e-12
the O 0 2.789765918276288e-10
higher O 0 2.1274173533925023e-09
level O 0 1.7478509750645799e-09
of O 0 1.2381218272849992e-09
tau O 0 1.222780321441519e-09
reflects O 0 8.063264639313061e-11
the O 0 3.918726107499104e-11
process O 0 1.5971463040997946e-10
of O 0 1.8404452406528549e-09
neuronal B-Disease 0 2.8397341793606756e-06
degeneration I-Disease 1 0.9999740123748779
in O 0 4.4920261643710546e-07
ALD B-Disease 1 1.0
. O 0 2.9321769034140743e-05

Lorenzos O 0 0.0007492193253710866
Oil O 0 4.371563136373879e-06
should O 0 4.732122693695828e-09
be O 0 1.5071575931724368e-10
given O 0 1.3388763708821472e-10
in O 0 1.8175352889393537e-10
the O 0 8.500588566384693e-10
early O 0 1.331162291506871e-08
stage O 0 7.871471474629743e-09
. O 0 1.5858306889882101e-09
. O 0 3.405160242664351e-08

Nonsense O 0 2.013182529481128e-05
mutation O 0 1.8459397210790485e-07
in O 0 1.5129021591064884e-08
exon O 0 5.046736077929381e-07
4 O 0 7.636064225380323e-08
of O 0 8.058245626330063e-09
human O 0 3.2249476422663292e-09
complement O 0 3.523774338987096e-08
C9 O 0 0.013766053132712841
gene O 0 1.3251938213443282e-08
is O 0 2.5538490766585653e-10
the O 0 5.433314353986418e-10
major O 0 2.431065571073532e-09
cause O 0 1.1566000601703763e-08
of O 0 1.006513770107631e-07
Japanese O 0 4.804766831512097e-06
complement B-Disease 0 1.1791905308200512e-05
C9 I-Disease 1 1.0
deficiency I-Disease 1 0.9999741315841675
. O 0 1.7261537550439243e-06

Deficiency B-Disease 1 0.999982476234436
of I-Disease 0 0.0012164510553702712
the I-Disease 0 1.6870497347554192e-05
ninth I-Disease 0 0.0004313729587011039
component I-Disease 0 8.931932029554446e-07
of I-Disease 0 3.5026928912884614e-08
human I-Disease 0 1.954299166939677e-09
complement I-Disease 0 2.870556770062649e-08
( O 0 2.184483527400971e-08
C9 O 1 0.9999958276748657
) O 0 3.5357428096460808e-09
is O 0 1.8172476023980977e-10
the O 0 2.225706147163109e-10
most O 0 7.808196450520555e-11
common O 0 1.0342493084181115e-08
complement B-Disease 1 0.9999802112579346
deficiency I-Disease 1 1.0
in O 0 3.1946063572263483e-09
Japan O 0 9.793196475982313e-09
but O 0 9.157375552293345e-11
is O 0 5.119851417823007e-11
rare O 0 3.168825479793469e-10
in O 0 7.132437696011351e-11
other O 0 1.0780686066080847e-10
countries O 0 5.438384742539881e-10
. O 0 7.56050084760318e-08

We O 0 1.5455989910151402e-07
studied O 0 3.9950467822791325e-08
the O 0 1.8700270221216897e-09
molecular O 0 6.605133329173896e-09
basis O 0 1.4694545136251236e-08
of O 0 3.2320744480784924e-07
C9 B-Disease 1 1.0
deficiency I-Disease 1 0.9999977350234985
in O 0 5.7021782851052194e-08
four O 0 2.4835065559614122e-08
Japanese O 0 4.41262818640098e-06
C9 B-Disease 1 1.0
- I-Disease 1 0.9999816417694092
deficient I-Disease 1 0.9999998807907104
patients O 0 0.00013475508603733033
who O 0 1.3727348857628385e-07
had O 0 4.52520708904558e-07
suffered O 0 0.004242610651999712
from O 0 2.7070952910435153e-06
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 3.5340094655111898e-06

Direct O 0 1.2629067214220413e-06
sequencing O 0 1.4573304270015797e-06
of O 0 4.69299862970729e-07
amplified O 0 3.5294995086587733e-06
C9 O 0 0.000333335978211835
cDNA O 0 1.1661092003123485e-06
and O 0 6.507693495194644e-09
DNA O 0 5.959565996249694e-08
revealed O 0 5.985504003547248e-08
a O 0 4.887069415815404e-09
nonsense O 0 3.751896571202451e-08
substitution O 0 4.311164758519226e-08
( O 0 3.3492344453378564e-09
CGA O 0 8.423574513471976e-07
- O 0 9.689190960671112e-08
- O 0 1.4360080058395397e-07
> O 0 4.2635232944121526e-07
TGA O 0 3.784213276958326e-06
) O 0 4.386625229724217e-10
at O 0 7.178804217744528e-10
codon O 0 1.823817347146317e-10
95 O 0 6.858511980567528e-09
in O 0 5.996617646886193e-10
exon O 0 2.3881280952764428e-08
4 O 0 1.4961464955831616e-08
in O 0 1.93864604924876e-10
the O 0 7.313726513302754e-09
four O 0 2.250029496053685e-08
C9 B-Disease 1 0.9999991655349731
- I-Disease 0 0.0011542850406840444
deficient I-Disease 0 0.0002169565559597686
individuals O 0 1.0573893760579267e-08
. O 0 2.833242831457028e-07

An O 0 6.748140890522336e-08
allele O 0 9.715468252124992e-08
- O 0 4.0501340947685094e-08
specific O 0 7.517962252734378e-09
polymerase O 0 9.015903970066574e-07
chain O 0 9.111167287301214e-08
reaction O 0 3.986732277638794e-09
system O 0 2.159115730648864e-08
designed O 0 9.829594027621624e-09
to O 0 1.2033477547745974e-09
detect O 0 4.468037495541921e-09
exclusively O 0 7.715554306564343e-10
only O 0 3.080728380733255e-11
one O 0 2.7538886102074223e-11
of O 0 3.2921798620577647e-10
the O 0 7.025842130303772e-10
normal O 0 8.118593575190403e-10
and O 0 1.5551156196114135e-10
mutant O 0 5.374564127080816e-10
alleles O 0 2.1406518918576367e-11
indicated O 0 1.2625962775292265e-10
that O 0 1.1755382257894187e-11
all O 0 6.166691463027618e-11
the O 0 8.450249389113651e-10
four O 0 1.7655614470424297e-10
patients O 0 1.6136260383436962e-10
were O 0 4.0517836308318067e-10
homozygous O 0 5.016873583230108e-10
for O 0 1.1662260046563233e-10
the O 0 1.5378784912201127e-09
mutation O 0 7.130061541182897e-10
in O 0 1.3277940968947632e-09
exon O 0 3.38905223884467e-08
4 O 0 5.1240669485252965e-09
and O 0 8.525492117827937e-11
that O 0 9.382796622992018e-12
the O 0 7.601239637722301e-10
parents O 0 3.448779872794461e-10
of O 0 3.16912940334646e-09
patient O 0 7.039410121478795e-08
2 O 0 1.9220692593080457e-07
were O 0 2.1698207675058256e-08
heterozygous O 0 3.085778743638912e-08
. O 0 9.39302040592338e-08

The O 0 4.843536203225085e-07
common O 0 9.764308828152934e-08
mutation O 0 7.200598783896339e-09
at O 0 2.410734722957386e-09
codon O 0 9.098620745717767e-10
95 O 0 2.916790542428771e-08
in O 0 2.4531581210851527e-09
exon O 0 1.3767768791694834e-07
4 O 0 1.7306051702803416e-08
might O 0 1.0547319684306444e-09
be O 0 2.0407406320366306e-10
responsible O 0 2.283953470794131e-09
for O 0 3.8145109293452606e-10
most O 0 1.9987065336124488e-09
Japanese O 0 5.22894424648257e-06
C9 B-Disease 1 1.0
deficiency I-Disease 1 0.9923092126846313
. O 0 6.27171345968236e-08
. O 0 1.8434909065945249e-07

BRCA1 O 0 2.8454442713155004e-07
required O 0 1.7282005160268454e-08
for O 0 1.297788720933113e-08
transcription O 0 1.446568603569176e-06
- O 0 3.0958356092014583e-06
coupled O 0 8.264428288384806e-06
repair O 0 0.10042708367109299
of O 0 1.0601498843243462e-06
oxidative O 0 3.851269411825342e-06
DNA O 0 1.8919251942861592e-06
damage O 0 5.290321496431716e-05
. O 0 3.403173707283713e-07

The O 0 3.063349504373036e-05
breast B-Disease 1 1.0
and I-Disease 1 0.9999973773956299
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 0 3.0143626190692885e-06
gene O 0 5.542911019063013e-09
BRCA1 O 0 3.399071690779465e-09
encodes O 0 1.1307769165469495e-09
a O 0 2.4192932102096165e-09
zinc O 0 5.848400519425923e-07
finger O 0 1.0469761946296785e-07
protein O 0 1.5139441700284806e-08
of O 0 1.9338580514727255e-08
unknown O 0 7.787340905451856e-08
function O 0 1.537497951176192e-08
. O 0 4.1580275222941054e-08

Association O 0 5.441548864837387e-07
of O 0 6.930127369741967e-07
the O 0 9.694921487835018e-08
BRCA1 O 0 1.065587085236075e-08
protein O 0 5.001510317015345e-10
with O 0 2.9807094292788605e-11
the O 0 1.7693582154976184e-09
DNA O 0 3.4780151736413245e-07
repair O 0 4.548301512841135e-05
protein O 0 1.4196191955306858e-07
Rad51 O 0 6.929520282028534e-07
and O 0 1.6918785816777415e-10
changes O 0 1.3316281410880038e-10
in O 0 7.451912004130534e-11
the O 0 2.890690742329838e-10
phosphorylation O 0 1.6036734162838684e-09
and O 0 7.322208950277798e-10
cellular O 0 1.3279669808241579e-08
localization O 0 3.236229133563029e-07
of O 0 8.92521256901091e-09
the O 0 5.307151162980972e-09
protein O 0 2.7383246781198523e-09
after O 0 2.8874573843040707e-09
exposure O 0 1.0454392018743874e-08
to O 0 9.041617454741413e-10
DNA O 0 2.1049169163234183e-07
- O 0 1.617941336462536e-07
damaging O 0 2.7508880862114893e-07
agents O 0 4.10243305992708e-09
are O 0 3.407454873816107e-11
consistent O 0 8.396395800858159e-10
with O 0 5.7266386077614584e-11
a O 0 1.3782772700920987e-09
role O 0 7.218709185963235e-09
for O 0 2.231573370536921e-09
BRCA1 O 0 2.2050794967753973e-08
in O 0 5.202436703655167e-09
DNA O 0 1.1284870424788096e-06
repair O 0 0.0004583155387081206
. O 0 1.5872423091423116e-06

Here O 0 5.555858137995529e-07
, O 0 3.7115166495738094e-09
it O 0 1.8612901497849776e-10
is O 0 7.444383304244795e-11
shown O 0 3.035971474218968e-10
that O 0 4.867568570432468e-10
mouse O 0 3.709417342179222e-07
embryonic O 0 3.138563897664426e-07
stem O 0 1.0771472602755239e-07
cells O 0 3.8205664054657973e-07
deficient B-Disease 0 7.400245522148907e-05
in I-Disease 0 9.571886394610374e-09
BRCA1 I-Disease 0 5.456850971086169e-09
are O 0 6.702491339716232e-11
defective O 0 9.526537780857325e-08
in O 0 2.0640216202849615e-09
the O 0 3.871436060620681e-09
ability O 0 1.0214841195121949e-09
to O 0 5.314158002533986e-10
carry O 0 1.8438814919363722e-09
out O 0 8.662632389189184e-09
transcription O 0 4.102964226149197e-07
- O 0 4.469813745799911e-07
coupled O 0 9.333173807135609e-07
repair O 0 7.26820362615399e-05
of O 0 1.6334482211277646e-07
oxidative O 0 4.759725413805427e-07
DNA O 0 3.1930065347296477e-07
damage O 0 5.050427716923878e-06
, O 0 5.951699133532884e-10
and O 0 6.427678944653792e-10
are O 0 3.744700938224099e-10
hypersensitive O 0 1.4108653658695403e-06
to O 0 6.1055347444494146e-09
ionizing O 0 0.00013777280400972813
radiation O 0 0.0011503146961331367
and O 0 1.3375402119208957e-08
hydrogen O 0 1.3741704663061682e-07
peroxide O 0 1.3288672562339343e-06
. O 0 2.683013065052364e-07

These O 0 1.4238563039725705e-07
results O 0 3.801803671876769e-08
suggest O 0 2.13919388869499e-08
that O 0 2.410592392365629e-09
BRCA1 O 0 3.384769087233508e-08
participates O 0 2.5182689267211344e-09
, O 0 7.238666610565048e-11
directly O 0 1.7198102664206516e-10
or O 0 3.534810499861152e-10
indirectly O 0 1.2067976618013176e-09
, O 0 1.4341788867611172e-10
in O 0 1.6517793799408764e-09
transcription O 0 5.605782916973112e-06
- O 0 8.373407581530046e-06
coupled O 0 2.0342647985671647e-05
repair O 0 0.002280677668750286
of O 0 2.404603662853333e-07
oxidative O 0 3.411472846437391e-07
DNA O 0 2.317967187082104e-07
damage O 0 1.2499351669248426e-06
. O 0 1.1451897208303308e-08
. O 0 5.985938145158798e-08

Truncation O 0 8.275749132735655e-05
mutations O 0 3.436695408254309e-07
in O 0 3.1307877179642674e-08
the O 0 4.3363090895809364e-08
transactivation O 0 3.01231393677881e-05
region O 0 2.7982349593003164e-07
of O 0 8.164283258338401e-07
PAX6 O 1 0.9991301894187927
result O 0 7.05502145592618e-07
in O 0 3.7809773090202725e-08
dominant O 0 1.120241176977288e-05
- O 0 4.7160642679955345e-07
negative O 0 1.3253758979203667e-08
mutants O 0 4.1679183482301596e-07
. O 0 7.431228254972666e-08

PAX6 O 0 0.006489668041467667
is O 0 1.5837571254451177e-07
a O 0 3.980336771292059e-08
transcription O 0 5.018716109361776e-08
factor O 0 2.1765593771760905e-09
with O 0 9.320622051944838e-11
two O 0 3.6390471191971585e-10
DNA O 0 2.9452907668314765e-08
- O 0 2.093321604945686e-08
binding O 0 1.1289241541589945e-08
domains O 0 1.0570203379245413e-08
( O 0 3.4074629229330355e-10
paired O 0 1.315956676961605e-09
box O 0 2.771059115502794e-08
and O 0 1.4865936259766954e-09
homeobox O 0 2.815626771734969e-07
) O 0 4.017354782170912e-10
and O 0 2.3010413574553468e-09
a O 0 2.0561522262596554e-08
proline O 0 2.6227661464872654e-07
- O 0 3.0171963771863375e-07
serine O 0 4.369477721866133e-07
- O 0 4.0492236053069064e-07
threonine O 0 3.938259567348723e-07
( O 0 7.777407162734562e-09
PST O 0 0.0003079928574152291
) O 0 2.1163332419860126e-08
- O 0 1.635523005916184e-07
rich O 0 4.0387641320194234e-07
transactivation O 0 8.022160909604281e-05
domain O 0 1.5976421536834096e-06
. O 0 7.615599884047697e-08

PAX6 O 1 0.9999995231628418
regulates O 0 5.8652698498917744e-05
eye O 0 0.006367587484419346
development O 0 6.748526288902212e-07
in O 0 3.4957234884558375e-09
animals O 0 1.3433610890345449e-09
ranging O 0 1.9436612319623237e-08
from O 0 9.332193684485901e-09
jellyfish O 0 2.9015534863674475e-08
to O 0 2.88103185752675e-09
Drosophila O 0 9.715747495420146e-08
to O 0 7.350843045372812e-09
humans O 0 2.71731266821007e-07
. O 0 2.6034777533823217e-07

Heterozygous O 0 9.569932899466949e-07
mutations O 0 3.395314962517659e-08
in O 0 1.7006213104409085e-09
the O 0 6.688220643980003e-09
human O 0 1.2691528716857192e-08
PAX6 O 0 0.0003015135880559683
gene O 0 6.8445031864428074e-09
result O 0 1.490830237038665e-09
in O 0 9.756606633715137e-11
various O 0 2.7566177118742985e-10
phenotypes O 0 1.8667636325631065e-08
, O 0 1.281276335030057e-10
including O 0 1.1680878486686197e-09
aniridia B-Disease 1 1.0
, O 0 6.546962794118372e-08
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 3.7377255068804516e-08
autosomal B-Disease 0 4.207698111713398e-06
dominant I-Disease 0 0.001192527706734836
keratitis I-Disease 1 1.0
, O 0 7.333593288194606e-08
and O 0 1.9165415210409265e-07
familial B-Disease 1 0.9999995231628418
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 0 0.46419787406921387

It O 0 6.401538854561295e-08
is O 0 1.3154222155975503e-09
believed O 0 2.498194984212887e-09
that O 0 4.447194695833545e-11
the O 0 4.260015395995964e-10
mutated O 0 4.620088311924064e-09
allele O 0 1.3205939453087012e-08
of O 0 3.2734675414758385e-08
PAX6 O 0 4.698391421698034e-05
produces O 0 3.2064979560431084e-09
an O 0 5.945943737373227e-11
inactive O 0 2.0153740898365413e-09
protein O 0 5.49890533108055e-09
and O 0 5.81641534935784e-09
aniridia B-Disease 1 1.0
is O 0 7.193145190598216e-09
caused O 0 7.222278952667693e-08
due O 0 4.845111334361718e-07
to O 0 2.7850370898363508e-08
genetic O 0 5.172973374101275e-07
haploinsufficiency O 0 2.290724660269916e-05
. O 0 3.792143274949922e-07

However O 0 7.749067663098685e-07
, O 0 1.1109005271237038e-08
several O 0 1.5632173333557375e-09
truncation O 0 4.544846490261989e-07
mutations O 0 4.424397737068375e-09
have O 0 4.2420558732381153e-10
been O 0 8.086787905980941e-10
found O 0 1.727767096060262e-10
to O 0 6.624101267505011e-11
occur O 0 1.542713456981204e-10
in O 0 6.008192277029423e-10
the O 0 8.405981688497377e-09
C O 0 1.7496282680440345e-06
- O 0 2.0591041050010972e-07
terminal O 0 5.568976462200226e-07
half O 0 5.54540680042237e-09
of O 0 5.250816226265442e-09
PAX6 O 0 7.269077468663454e-05
in O 0 2.0748642803880557e-09
patients O 0 3.313904040069815e-09
with O 0 1.6106502798152178e-09
Aniridia B-Disease 1 1.0
resulting O 0 5.914034204579366e-07
in O 0 8.269537055127785e-09
mutant O 0 4.1134340378334855e-09
proteins O 0 2.0102124825838175e-11
that O 0 1.0402065493686496e-11
retain O 0 1.896152790337169e-09
the O 0 2.92849544614171e-09
DNA O 0 6.876142766287785e-09
- O 0 2.2727590920368357e-09
binding O 0 8.667652706684237e-10
domains O 0 1.7168975130488207e-09
but O 0 7.024113513054431e-10
have O 0 5.040468598060954e-10
lost O 0 5.565924254824495e-08
most O 0 7.157968107129875e-10
of O 0 5.425819793458686e-09
the O 0 1.4570850304096439e-08
transactivation O 0 8.16466399555793e-06
domain O 0 3.2580797437731235e-07
. O 0 8.949899665822159e-08

It O 0 5.243402867449731e-08
is O 0 2.7252673451272358e-09
not O 0 4.489434657362068e-10
clear O 0 5.53655032931033e-09
whether O 0 1.2046382780184217e-09
such O 0 6.104929450856389e-09
mutants O 0 4.2452270463400055e-06
really O 0 4.381896445693201e-08
behave O 0 1.6317013296074379e-09
as O 0 2.484775274425033e-09
loss O 0 2.556732248137905e-08
- O 0 9.676115553247655e-08
of O 0 4.368419581624039e-07
- O 0 1.2633628898583993e-07
function O 0 1.343637867634584e-09
mutants O 0 6.943939645509545e-09
as O 0 4.0145514690337336e-10
predicted O 0 4.42541914225103e-09
by O 0 1.244371938824429e-09
haploinsufficiency O 0 1.888386395876296e-05
. O 0 5.068465611657302e-07

Contrary O 0 1.4123219216344296e-06
to O 0 7.0338912472323045e-09
this O 0 4.836824274434548e-10
theory O 0 2.3917657188121666e-08
, O 0 5.706002337291238e-10
our O 0 5.220846421849501e-09
data O 0 3.1213773787897026e-09
showed O 0 5.566152538882818e-10
that O 0 3.376349547168367e-11
these O 0 4.285703458783985e-10
mutants O 0 4.307465673036859e-08
are O 0 3.2136845962149607e-10
dominant O 0 1.7176493827264494e-07
- O 0 2.9816234814461495e-08
negative O 0 2.1251946868972027e-09
in O 0 6.063844426584808e-10
transient O 0 2.6502423366991934e-08
transfection O 0 2.3639285018361988e-07
assays O 0 4.32542801576119e-09
when O 0 5.538871028498704e-10
they O 0 9.149833668509189e-11
are O 0 7.342610547356188e-11
coexpressed O 0 1.6402776736867963e-07
with O 0 7.233811882834118e-10
wild O 0 1.946273329167525e-07
- O 0 1.353338205944965e-07
type O 0 4.9979144023382105e-06
PAX6 O 1 0.9999016523361206
. O 0 1.7355755517201032e-06

We O 0 3.601965659072448e-07
found O 0 2.444630453624086e-08
that O 0 7.74589947738491e-10
the O 0 1.9940962658893113e-08
dominant O 0 1.3474335901264567e-05
- O 0 1.7095696591695742e-07
negative O 0 1.4639929268867036e-09
effects O 0 8.389692496280077e-09
result O 0 1.2292343809505724e-09
from O 0 1.2327679987933493e-09
the O 0 5.26635013375909e-10
enhanced O 0 2.375560859135817e-09
DNA O 0 1.8524261014007948e-09
binding O 0 2.4403790099825073e-10
ability O 0 3.1955860180232776e-10
of O 0 2.759807049557139e-09
these O 0 1.172104968638621e-09
mutants O 0 1.7498723536846228e-07
. O 0 3.855285513054696e-08

Kinetic O 0 2.3411928395944415e-06
studies O 0 7.433720305982661e-09
of O 0 4.751894433496773e-09
binding O 0 9.700393377443106e-09
and O 0 1.5384300500187464e-09
dissociation O 0 3.5817581789387987e-08
revealed O 0 4.701175448929007e-09
that O 0 3.269325782317978e-11
various O 0 3.904202516835653e-10
truncation O 0 2.4650501018186333e-07
mutants O 0 8.14212555155791e-08
have O 0 1.7309114141994542e-09
3 O 0 2.6885704329515647e-08
- O 0 2.5662837188633603e-08
5 O 0 3.542252002830537e-08
- O 0 3.727751263227219e-08
fold O 0 2.3784412661598253e-08
higher O 0 4.1475067824592315e-09
affinity O 0 1.0198819566653583e-09
to O 0 1.395225601719119e-10
various O 0 5.795424556920281e-11
DNA O 0 1.3717208480201748e-09
- O 0 9.695542146914704e-10
binding O 0 4.80788797663223e-10
sites O 0 7.812192559519815e-10
when O 0 1.7634510518504953e-10
compared O 0 3.6788899704376377e-10
with O 0 6.900783416918799e-11
the O 0 1.088312995278784e-08
wild O 0 1.8591795480915607e-07
- O 0 9.448652349419717e-08
type O 0 1.0560218015598366e-06
PAX6 O 1 0.8146939873695374
. O 0 1.3034033372605336e-06

These O 0 3.3000794985582615e-08
results O 0 1.5290696708802898e-08
provide O 0 7.732825046957714e-09
a O 0 6.390251883203746e-09
new O 0 4.841108847131181e-09
insight O 0 6.009386765981617e-09
into O 0 6.148127007499227e-10
the O 0 5.009625492213843e-10
role O 0 1.7595714885132452e-09
of O 0 1.4971769601856977e-08
mutant O 0 2.15814054627117e-07
PAX6 O 0 0.0008601675508543849
in O 0 2.937470000574649e-08
causing O 0 1.0737447837527725e-06
aniridia B-Disease 1 1.0
. O 0 1.1036063796154849e-07
. O 0 2.1297209684689733e-07

Reversal O 0 3.4033968404401094e-05
of O 0 1.682570291450247e-05
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 1 0.999809205532074
excellent O 0 0.006757994182407856
neuropsychologic O 0 0.0008967077010311186
outcome O 0 3.085796151935938e-06
in O 0 2.775200691473856e-08
very B-Disease 0 2.4394228859137e-08
- I-Disease 0 1.2595818077443255e-07
long I-Disease 0 1.0492371416148671e-07
- I-Disease 0 1.0496734859088974e-07
chain I-Disease 0 4.709308853989569e-08
acyl I-Disease 0 8.855337796376261e-08
- I-Disease 0 9.488383767575215e-08
coenzyme I-Disease 0 7.510125499265996e-08
A I-Disease 0 3.885285423166351e-06
dehydrogenase I-Disease 0 3.0172303013387136e-05
deficiency I-Disease 0 3.4652326576178893e-05
. O 0 3.2921462889135e-07

Very B-Disease 0 1.647327280807076e-06
- I-Disease 0 1.4583885104002547e-06
long I-Disease 0 1.1264661736731796e-07
- I-Disease 0 5.779945766448691e-08
chain I-Disease 0 1.9923513505659685e-08
acyl I-Disease 0 7.974822580081309e-09
- I-Disease 0 6.5469722976274625e-09
coenzyme I-Disease 0 2.9459861217162597e-09
A I-Disease 0 1.0527110561042718e-07
dehydrogenase I-Disease 0 8.20800494238938e-08
( I-Disease 0 1.6162450267032114e-09
VLCAD I-Disease 0 0.026570167392492294
) I-Disease 0 1.128093352065207e-08
deficiency I-Disease 0 8.095288649201393e-05
is O 0 2.3729525011617625e-09
a O 0 1.9585915111974828e-08
disorder O 0 1.1306909073027782e-05
of O 0 7.082302545313723e-06
fatty O 0 5.773862312707934e-07
acid O 0 1.3066758342006324e-08
beta O 0 1.7086912995623038e-09
oxidation O 0 5.956366511128408e-10
that O 0 7.304100380078893e-11
reportedly O 0 8.491988445769039e-09
has O 0 1.4714555962580533e-10
high O 0 6.586966527777349e-09
rates O 0 7.278583846748177e-10
of O 0 1.8241836929888677e-09
morbidity O 0 8.716467050362553e-07
and O 0 1.3494609873987429e-08
mortality O 0 2.964075065392535e-07
. O 0 7.698744042272665e-08

We O 0 8.580776267308465e-08
describe O 0 2.1840920183535673e-08
the O 0 1.1268718402845934e-08
outcome O 0 2.9487027930485965e-08
of O 0 2.992711145566318e-08
a O 0 6.206581915080278e-09
5 O 0 5.448717921296975e-09
- O 0 1.6796675161856456e-09
year O 0 2.3597102050132435e-09
- O 0 3.899123868222887e-08
old O 0 4.045510308969824e-07
girl O 0 3.3253531483978804e-08
with O 0 2.7571078753396705e-09
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 9.478214906266658e-07
was O 0 1.7044418143541407e-07
first O 0 3.3242104624520152e-09
seen O 0 3.2227340795998316e-09
at O 0 2.0209711681928866e-09
5 O 0 2.9414029545371534e-10
months O 0 8.905342435694408e-11
of O 0 2.342466776106278e-10
age O 0 2.8853200384482136e-10
with O 0 5.7625442612119215e-11
severe O 0 4.8978930863086134e-05
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 1 0.9889307618141174
hepatomegaly B-Disease 1 1.0
, O 0 0.001451629912480712
encephalopathy B-Disease 1 0.9999988079071045
, O 0 6.47815951992925e-08
and O 0 1.1055664117520791e-06
hypotonia B-Disease 1 0.9999947547912598
. O 0 7.775408448651433e-05

Biochemical O 0 2.8129905331297778e-05
studies O 0 8.996998985821847e-07
indicated O 0 0.00036354258190840483
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 0 0.05025913566350937
by O 0 9.097306907790426e-09
a O 0 2.2901225804616843e-08
stable O 0 1.3272128285279905e-07
yet O 0 3.1618011320233563e-08
inactive O 0 4.273093452411558e-07
enzyme O 0 6.357406050483405e-07
. O 0 1.214057334664176e-07

Molecular O 0 3.028363835255732e-07
genetic O 0 2.598565629341465e-08
analysis O 0 5.301101335675185e-09
of O 0 1.1545660782985578e-07
her O 0 3.331091846803247e-08
VLCAD O 0 0.0016061555361375213
gene O 0 5.459623153569737e-08
revealed O 0 7.525338929781356e-08
a O 0 1.6673665115263248e-08
T1372C O 0 4.7110520995374827e-07
( O 0 2.6818034459807905e-09
F458L O 0 2.8821528985645273e-07
) O 0 9.767485709133439e-10
missense O 0 6.118442286151549e-08
mutation O 0 2.16598650126798e-09
and O 0 2.5371922340866604e-09
a O 0 6.105304350967344e-08
1668 O 0 0.00018865548190660775
ACAG O 1 0.9441729784011841
1669 O 0 0.000513052218593657
splice O 0 0.00011462406837381423
site O 0 1.910440460051177e-06
mutation O 0 1.4297154393716482e-07
. O 0 9.930094080345953e-08

After O 0 5.59678539957531e-07
initial O 0 1.6624467491510586e-07
treatment O 0 5.006650667382928e-07
with O 0 1.7612638014696813e-09
intravenous O 0 2.9109224897183594e-07
glucose O 0 2.10178473025735e-06
and O 0 6.9252630297000906e-09
carnitine O 0 3.772412640046241e-07
, O 0 1.2026685203281318e-09
the O 0 4.3732604204649306e-09
patient O 0 7.31815319454654e-08
has O 0 2.1043733422487776e-09
thrived O 0 1.8629968678851583e-08
on O 0 4.3546988237608275e-09
a O 0 2.8218232195342807e-09
low O 0 2.5902602374117123e-07
- O 0 1.1631576768422747e-07
fat O 0 1.565414606830018e-07
diet O 0 1.823394946143253e-08
supplemented O 0 6.4272165367640355e-09
with O 0 6.866650581471845e-10
medium O 0 1.9486856217554305e-06
- O 0 8.006463758647442e-07
chain O 0 1.7282242481542198e-07
triglyceride O 0 1.5754733340145322e-07
oil O 0 4.0826780178804256e-08
and O 0 8.883377367041589e-10
carnitine O 0 5.48400294064777e-08
and O 0 1.0804488415061542e-09
avoidance O 0 2.1379271402111044e-06
of O 0 1.0777144865414812e-07
fasting O 0 1.0596728543532663e-06
. O 0 1.7372204297316785e-07

Her O 0 2.476932422723621e-05
ventricular O 1 0.9993225336074829
hypertrophy O 1 0.996393620967865
resolved O 0 0.00014081488188821822
significantly O 0 8.471775458929187e-07
over O 0 1.4489398125761e-08
1 O 0 5.5356315087351504e-09
year O 0 1.502780261342096e-10
, O 0 1.4657412783503077e-10
and O 0 7.872187901547534e-10
cognitively O 0 1.2998258398511098e-06
, O 0 6.055430046281174e-10
she O 0 1.40191580566551e-10
is O 0 2.3621306299848044e-11
in O 0 7.148576869342449e-11
the O 0 5.238679490204845e-10
superior O 0 2.8757665404555155e-07
range O 0 9.623053642826562e-08
for O 0 2.579512603517742e-09
age O 0 3.42278028142573e-08
. O 0 1.1147979250836215e-07

Clinical O 0 1.3078848496661521e-05
recognition O 0 0.0001279494899790734
of O 1 0.9999997615814209
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 1.5987015444807184e-07
important O 0 3.689277328078333e-09
because O 0 1.0636934388852382e-10
it O 0 1.8221197120582566e-11
is O 0 1.8535057169644098e-11
one O 0 1.67571078540929e-11
of O 0 7.52788775759683e-10
the O 0 1.5954846332988382e-09
few O 0 1.1595104876249707e-09
directly O 0 2.91598256652037e-09
treatable O 0 0.09042780846357346
causes O 0 9.791799016056757e-08
of O 0 1.0283735718985554e-05
cardiomyopathy B-Disease 1 1.0
in O 0 7.26109078641457e-07
children O 0 3.377653934322211e-09
. O 0 2.650604846721194e-09
. O 0 2.3317438646586197e-08

Cloning O 0 4.876327238889644e-06
of O 0 2.6824270094039093e-07
a O 0 1.702471941200656e-08
novel O 0 2.14967297296198e-08
member O 0 2.2963149159949126e-09
of O 0 7.686430159026258e-09
the O 0 2.0002179468292525e-08
low O 0 9.037580639414955e-07
- O 0 5.080781662059053e-08
density O 0 4.436405465213511e-09
lipoprotein O 0 1.3096644124743761e-06
receptor O 0 8.366349391053518e-08
family O 0 4.195214131641478e-08
. O 0 2.115893238396893e-08

A O 0 1.8222461903860676e-06
gene O 0 2.3872081200693174e-08
encoding O 0 1.648520395747255e-07
a O 0 3.2112247083659895e-08
novel O 0 5.124060109551465e-08
transmembrane O 0 5.3148800915892025e-09
protein O 0 8.916360427768666e-10
was O 0 6.509353056571854e-10
identified O 0 4.2942521066846595e-11
by O 0 1.9375278291489106e-12
DNA O 0 7.003187613152662e-11
sequence O 0 1.6732611823888632e-11
analysis O 0 1.691348450183483e-11
within O 0 1.0290691909720096e-10
the O 0 1.4132029990676642e-09
insulin B-Disease 0 0.0003774608194362372
- I-Disease 0 0.00012048315693391487
dependent I-Disease 1 0.5584748983383179
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 1.6693259397015936e-07
IDDM B-Disease 0 6.80526063661091e-05
) O 0 4.421588428726864e-09
locus O 0 1.1844802116911524e-07
IDDM4 O 0 9.16759017854929e-06
on O 0 1.3813287580433098e-07
chromosome O 0 6.42007620399454e-08
11q13 O 0 2.352387582504889e-06
. O 0 1.6231945210165577e-07

Based O 0 1.142120254371548e-06
on O 0 4.671306612635817e-07
its O 0 4.631885097694521e-09
chromosomal O 0 1.0835578478918251e-07
position O 0 1.5005969089543214e-07
, O 0 2.0596786776128084e-10
this O 0 6.811391034533543e-11
gene O 0 1.5305152978317693e-10
is O 0 3.956563549012415e-11
a O 0 1.0931550803450207e-10
candidate O 0 7.325128836832562e-10
for O 0 3.836458650763319e-10
conferring O 0 1.2756427736348996e-07
susceptibility O 0 2.0748371753143147e-05
to O 0 4.964316531186341e-07
diabetes B-Disease 1 1.0
. O 0 1.6272741049760953e-05

The O 0 9.333083994533808e-07
gene O 0 4.053256219549439e-08
, O 0 3.106137791419883e-09
termed O 0 2.020302218852521e-07
low O 0 3.04864147437911e-06
- O 0 1.0491370971976721e-07
density O 0 3.5066354264756683e-09
lipoprotein O 0 8.066245271720618e-08
receptor O 0 1.1862379967197967e-09
related O 0 3.3435779145385425e-10
protein O 0 5.15512021959097e-10
5 O 0 5.183615203740999e-10
( O 0 5.325549723433909e-11
LRP5 O 0 1.62730501074293e-07
) O 0 6.398636481774744e-11
, O 0 2.0756776505925778e-11
encodes O 0 7.485445596699947e-11
a O 0 1.7821533138118184e-10
protein O 0 3.443915708167822e-10
of O 0 2.362241069420179e-09
1615 O 0 6.192406232230496e-08
amino O 0 1.402307048259388e-09
acids O 0 5.003647496337749e-10
that O 0 4.151761226478534e-11
contains O 0 2.3100285573285362e-10
conserved O 0 5.629884891611425e-10
modules O 0 2.207662497255569e-09
which O 0 8.601635029248378e-12
are O 0 1.0934168067494587e-12
characteristic O 0 2.400272758329436e-10
of O 0 2.315897029703251e-09
the O 0 5.25855359256866e-09
low O 0 6.967517407474588e-08
- O 0 3.3544003130714373e-09
density O 0 1.7506592009386424e-10
lipoprotein O 0 2.862579684403954e-08
( O 0 3.1096811237141253e-10
LDL O 0 8.723787203734901e-08
) O 0 1.040340480429336e-09
receptor O 0 9.942977996502123e-09
family O 0 1.552953499128762e-08
. O 0 1.5480116744015504e-08

These O 0 3.23988160744193e-08
modules O 0 3.118891811482172e-07
include O 0 2.329986648064164e-09
a O 0 6.720881184918426e-09
putative O 0 1.2559438289372338e-07
signal O 0 9.990411342641892e-08
peptide O 0 7.641943744474133e-10
for O 0 1.0058830157699816e-10
protein O 0 1.475694011432438e-10
export O 0 3.923277258621738e-09
, O 0 2.0268224598662954e-10
four O 0 8.625696268360628e-10
epidermal O 0 4.5509793267228815e-08
growth O 0 9.269531253686125e-10
factor O 0 1.0804426242572163e-09
( O 0 6.029314825184429e-10
EGF O 0 5.1947456114476154e-08
) O 0 1.1515623871138914e-10
repeats O 0 9.329288452875062e-10
with O 0 7.47953712854077e-11
associated O 0 4.509019824183724e-09
spacer O 0 1.4193443576004938e-07
domains O 0 7.042294747350297e-09
, O 0 5.476429865147736e-10
three O 0 4.885454818470691e-10
LDL O 0 1.1271130517798156e-07
- O 0 8.875950641140662e-08
receptor O 0 7.447856109621398e-09
( O 0 1.147104078391692e-09
LDLR O 0 3.294587941127247e-06
) O 0 8.854636468491606e-10
repeats O 0 4.0063077300089844e-09
, O 0 2.0003645961885752e-10
a O 0 1.6900731925062473e-09
single O 0 6.489497383910248e-09
transmembrane O 0 7.701002502358278e-09
spanning O 0 4.419860033522127e-09
domain O 0 1.9942019147123347e-09
, O 0 1.2391418446888736e-10
and O 0 3.9971309595543403e-10
a O 0 8.655332450757669e-09
cytoplasmic O 0 1.625121370807392e-07
domain O 0 1.4209045673396759e-07
. O 0 6.62504575643652e-08

The O 0 1.276527996196819e-06
encoded O 0 9.567417436073811e-08
protein O 0 2.5394012226342966e-08
has O 0 4.820945309624847e-10
a O 0 3.9372333171527885e-10
unique O 0 2.956273836840495e-10
organization O 0 2.3755053479845856e-10
of O 0 1.2845100982872282e-08
EGF O 0 1.8300119336345233e-05
and O 0 3.071099641260844e-08
LDLR O 0 4.3849922803929076e-05
repeats O 0 2.1878443945411163e-08
; O 0 2.460805170745317e-10
therefore O 0 1.3904178919332821e-09
, O 0 8.812144902670127e-10
LRP5 O 0 2.1082301827846095e-05
likely O 0 1.185058184915988e-08
represents O 0 9.895485542088522e-10
a O 0 5.00521291080247e-10
new O 0 4.0589773209198654e-10
category O 0 5.893758814323746e-10
of O 0 2.9915394605950496e-09
the O 0 2.6261744778821594e-08
LDLR O 0 0.001429514610208571
family O 0 4.230086005918565e-07
. O 0 1.2006846361600765e-07

Both O 0 5.60739522370568e-07
human O 0 5.47686852314655e-07
and O 0 1.893223355864393e-07
mouse O 0 2.298997060279362e-05
LRP5 O 1 0.9027820229530334
cDNAs O 0 0.00010817532893270254
have O 0 8.062673195752268e-09
been O 0 1.0419813456508109e-08
isolated O 0 3.7234023864129995e-08
and O 0 1.363428481226947e-09
the O 0 2.2412820488426632e-09
encoded O 0 7.320449801895279e-10
mature O 0 4.024019450987737e-10
proteins O 0 9.540193288137822e-12
are O 0 5.400855544041017e-12
95 O 0 2.9738183027205878e-09
% O 0 6.334182484080131e-11
identical O 0 3.378889390504014e-10
, O 0 3.847346052854306e-11
indicating O 0 1.490764955924817e-09
a O 0 4.098155148568594e-09
high O 0 1.3421453282091989e-08
degree O 0 2.4658065811422603e-08
of O 0 2.358666373325491e-09
evolutionary O 0 6.16493389671291e-09
conservation O 0 1.5549651566360012e-09
. O 0 4.212417081816966e-10
. O 0 1.3190557979214645e-08

The O 0 3.6375286072143354e-06
APC B-Disease 0 1.4416397107197554e-06
variants O 0 4.5572855356112996e-07
I1307K O 0 2.7612095436779782e-06
and O 0 7.697390280725358e-09
E1317Q O 0 1.1669197874653037e-07
are O 0 6.644626515672769e-11
associated O 0 1.7824618225859012e-07
with O 0 0.005045086145401001
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 9.056589789224745e-08
but O 0 2.0242338361065038e-10
not O 0 9.813604789910002e-11
always O 0 3.2765939961265644e-10
with O 0 3.6725920915525734e-11
a O 0 2.4947428567401175e-09
family O 0 1.3119651143256306e-08
history O 0 2.0316313964485744e-08
. O 0 4.9327915974117786e-08

Classical O 0 0.013659121468663216
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 1.9504164811223745e-05
FAP B-Disease 0 0.00021777459187433124
) O 0 5.593869367714888e-09
is O 0 2.1044779252576973e-09
a O 0 5.853199880334614e-08
high O 1 0.9992582201957703
- O 1 0.9999997615814209
penetrance O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 0 0.4752059280872345
that O 0 3.8355371656528803e-10
predisposes O 0 5.723928353518204e-08
to O 0 1.406694982719614e-09
hundreds O 0 1.2793283099554742e-09
or O 0 5.7525348928777476e-09
thousands O 0 1.3733549408811996e-08
of O 0 0.29592686891555786
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 1.0
carcinoma I-Disease 1 1.0
and O 0 2.1803623795335625e-08
that O 0 9.624619157211356e-11
results O 0 2.3883944821889713e-10
from O 0 1.1912761888055456e-09
truncating O 0 5.057904672867153e-08
mutations O 0 8.899131986872533e-10
in O 0 1.3352149386136603e-09
the O 0 4.031836198237215e-08
APC B-Disease 0 4.606851859989547e-07
gene O 0 1.5491835370085028e-07
. O 0 4.1409649043089303e-07

A O 0 1.0715505140979076e-06
variant O 0 6.59957186144311e-06
of O 0 8.723351925254974e-07
FAP B-Disease 0 6.277421925915405e-05
is O 0 2.8315952249613474e-07
attenuated B-Disease 1 0.99992835521698
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
, O 0 3.518414715131257e-08
which O 0 1.52122828223078e-10
results O 0 7.709313049053534e-11
from O 0 9.793528210622071e-10
germ O 0 0.0004410718393046409
- O 0 9.248026913155627e-07
line O 0 2.2460039872385096e-07
mutations O 0 6.949579800519246e-10
in O 0 3.1277763712367346e-10
the O 0 3.2411779926633244e-09
5 O 0 1.585930498038124e-09
and O 0 2.6824414911530425e-10
3 O 0 2.4033890433372562e-09
regions O 0 3.7313965806085037e-10
of O 0 8.255290673275795e-09
the O 0 4.399826991630107e-08
APC B-Disease 0 2.9833248049726535e-07
gene O 0 4.752658355755557e-08
. O 0 5.434387517766481e-08

Attenuated B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 1 0.9987665414810181
have O 0 6.435560351292224e-08
" O 0 7.423252412763759e-08
multiple O 0 2.985040282510454e-06
" O 1 0.9999992847442627
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 2.440940249925916e-08
typically O 0 9.835572356564626e-10
fewer O 0 1.3960135825108466e-10
than O 0 2.183817709999758e-11
100 O 0 9.273169732093578e-11
) O 0 3.937304475509773e-12
without O 0 4.031076861199523e-11
the O 0 1.355088263821358e-09
florid O 0 2.1186117749039113e-07
phenotype O 0 3.504925061292852e-08
of O 0 7.855348371776927e-09
classical O 0 4.249899632213783e-08
FAP B-Disease 0 1.3169701560400426e-06
. O 0 8.052855804407955e-08

Another O 0 1.6709536510006728e-07
group O 0 2.6439750389073424e-09
of O 0 1.4689865324157836e-08
patients O 0 4.978574885683429e-09
with O 0 4.5236789314451187e-10
multiple O 0 4.411280372096371e-07
adenomas B-Disease 1 0.9999939203262329
has O 0 9.253672494935472e-09
no O 0 1.8653889544140156e-09
mutations O 0 2.301180634933786e-10
in O 0 2.662328135727421e-10
the O 0 3.5048364210865657e-09
APC B-Disease 0 6.9543837355467986e-09
gene O 0 3.7053257684327434e-10
, O 0 4.7671044195451984e-11
and O 0 7.306636545800771e-11
their O 0 2.774081242495896e-10
phenotype O 0 1.8190666750683704e-08
probably O 0 1.7377589367484347e-09
results O 0 7.45080316888469e-11
from O 0 4.913892626134952e-10
variation O 0 2.300616941397493e-08
at O 0 5.435432104405891e-09
a O 0 1.0645261339092826e-09
locus O 0 2.5167612438536935e-09
, O 0 3.5145060472974166e-11
or O 0 2.0218800245164203e-10
loci O 0 4.06863742696828e-09
, O 0 1.7542224617361768e-10
elsewhere O 0 1.431668006368625e-09
in O 0 1.225937573678948e-09
the O 0 2.473484705944884e-08
genome O 0 6.59339249864388e-08
. O 0 5.699677529946712e-08

Recently O 0 1.6664212125760969e-06
, O 0 4.2065981809003006e-09
however O 0 5.5354623107461975e-09
, O 0 4.929814334531102e-10
a O 0 1.8989105843303378e-09
missense O 0 1.2692271411651745e-07
variant O 0 1.6406311260652728e-06
of O 0 8.55722464621067e-06
APC B-Disease 0 3.454344323472469e-06
( O 0 5.250846424331712e-09
I1307K O 0 1.682648047562907e-07
) O 0 3.1212032958194413e-10
was O 0 2.2975854552242936e-09
described O 0 3.222166977678853e-10
that O 0 1.2080147646087447e-11
confers O 0 1.1573054736757626e-09
an O 0 3.93997898542886e-12
increased O 0 1.2460006637571297e-10
risk O 0 6.514473849250635e-09
of O 0 0.395724356174469
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 3.4254060921057317e-08
including O 0 7.958346759373569e-10
multiple O 0 7.411721725247844e-08
adenomas B-Disease 0 0.04435150325298309
, O 0 2.7322311080268946e-09
in O 0 1.1033954194772377e-08
Ashkenazim O 0 0.004647048655897379
. O 0 1.7869870134745724e-06

We O 0 1.8622192499151424e-07
have O 0 2.8356788028816027e-09
studied O 0 8.848545896000815e-09
a O 0 1.3140103449771345e-09
set O 0 1.864499443726686e-09
of O 0 2.4065451853516606e-09
164 O 0 2.2961671675147954e-08
patients O 0 1.748641231813508e-09
with O 0 2.9766558107269248e-09
multiple O 1 0.9999990463256836
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999867677688599
/ I-Disease 1 1.0
or I-Disease 0 0.0004451106069609523
carcinoma I-Disease 1 1.0
and O 0 1.448116471181038e-08
analyzed O 0 3.3676443855767957e-09
codons O 0 2.628483430910933e-09
1263 O 0 1.0110101129612303e-06
- O 0 1.2415057426551357e-07
1377 O 0 4.522831204667455e-06
( O 0 7.428107462459366e-09
exon O 0 1.3864480763459142e-07
15G O 0 1.6108700151562516e-07
) O 0 1.037290670025115e-10
of O 0 2.8082711711618913e-09
the O 0 1.2783508474001337e-08
APC B-Disease 0 5.149445669871966e-08
gene O 0 2.4942719001330715e-09
for O 0 3.107198276453005e-09
germ O 0 0.002038840437307954
- O 0 1.0820375791809056e-05
line O 0 2.9485140657925513e-06
variants O 0 2.4961734652606538e-06
. O 0 5.238645144345355e-07

Three O 0 1.5695076172050904e-07
patients O 0 1.2102352009435435e-08
with O 0 3.03829433834224e-10
the O 0 5.4008948424666414e-09
I1307K O 0 1.3922263519816624e-07
allele O 0 1.1348367801033987e-09
were O 0 2.1541363137700387e-10
detected O 0 2.173435653674005e-09
, O 0 2.3880153063315923e-11
each O 0 2.7944190364448396e-11
of O 0 7.3455175275682905e-09
Ashkenazi O 0 1.99398746190127e-05
descent O 0 1.8524682673159987e-05
. O 0 9.733792012411868e-07

Four O 0 5.399086603574688e-06
patients O 0 6.752389367647993e-07
had O 0 1.5270722997229313e-07
a O 0 2.6854646506535573e-08
germ O 0 0.0032895784825086594
- O 0 6.38426990917651e-06
line O 0 1.6884442857190152e-06
E1317Q O 0 8.483879128107219e-07
missense O 0 1.0406908046434182e-07
variant O 0 1.3475747095981205e-07
of O 0 1.0236811931463308e-07
APC O 0 3.957293870371359e-08
that O 0 8.675141160985333e-11
was O 0 4.323761793045833e-09
not O 0 1.4922426141983358e-11
present O 0 1.6462931018423888e-10
in O 0 8.044814814311962e-11
controls O 0 1.4669305770098617e-09
; O 0 1.1583871362130793e-10
one O 0 7.151140790639943e-11
of O 0 2.084060979345992e-10
these O 0 1.223308607189999e-11
individuals O 0 3.789835632816985e-12
had O 0 9.475353834886846e-10
an O 0 2.8978324947970258e-11
unusually O 0 1.7848961197941549e-09
large O 0 6.946664909968092e-10
number O 0 1.9164694831097506e-10
of O 0 1.9459534428278857e-08
metaplastic B-Disease 0 1.6184927517315373e-05
polyps I-Disease 0 3.6949593322788132e-06
of I-Disease 0 5.103489684188389e-07
the I-Disease 0 5.447223543342261e-07
colorectum I-Disease 0 4.23116835008841e-05
. O 0 6.36603317616391e-07

There O 0 3.1915209319777205e-07
is O 0 5.309641615269811e-09
increasing O 0 7.21749437992969e-10
evidence O 0 1.9538446416333954e-09
that O 0 4.26677096432293e-11
there O 0 3.1423651875028824e-11
exist O 0 2.9700020220957413e-10
germ O 0 5.109073299536249e-06
- O 0 4.639305473119748e-08
line O 0 1.1691581924822003e-08
variants O 0 7.528838885662026e-09
of O 0 1.5491666616185285e-08
the O 0 5.637280420245361e-09
APC B-Disease 0 3.863690256622476e-09
gene O 0 8.002042084509497e-11
that O 0 1.7531578619389698e-11
predispose O 0 5.61154456235613e-09
to O 0 3.0801070027841604e-10
the O 0 1.697801677025268e-09
development O 0 1.840466978819677e-08
of O 0 3.3637174823297755e-08
multiple O 1 0.9747301936149597
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999655485153198
carcinoma I-Disease 1 1.0
, O 0 8.18757561749095e-10
but O 0 1.0882620499197415e-10
without O 0 5.790996571164442e-10
the O 0 2.0030190839293027e-09
florid O 0 1.9798905270818068e-07
phenotype O 0 2.019091915883564e-08
of O 0 2.8736504287252274e-09
classical O 0 1.5876443271167773e-08
FAP B-Disease 0 8.552753882895558e-08
, O 0 6.92314330863475e-11
and O 0 7.046183775338832e-11
possibly O 0 3.0442692811050165e-10
with O 0 5.3040995207087605e-11
importance O 0 4.715996482218543e-08
for O 0 2.106124156853184e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 0 2.3389834495901596e-06
in O 0 4.5136125392808424e-10
the O 0 6.321561052402558e-10
general O 0 9.916155674360994e-10
population O 0 1.3124435566114201e-11
. O 0 2.2852682246554679e-10
. O 0 1.274810568219209e-08

Genomic O 0 1.6058450000855373e-06
structure O 0 2.2803337174082117e-07
of O 0 9.636884357178133e-08
the O 0 6.062554547270338e-08
human O 0 0.0001657579850871116
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 0.6985543370246887
CLD B-Disease 1 1.0
) O 0 6.728245693921053e-08
gene O 0 3.505640577827762e-08
. O 0 4.489558946829675e-08

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 0.8773691654205322
CLD B-Disease 1 1.0
) O 0 1.9670000739324678e-08
is O 0 2.1835315500151609e-10
caused O 0 9.816680801577604e-10
by O 0 5.009078568596337e-11
mutations O 0 1.0986273002444591e-10
in O 0 2.2502934238222139e-10
a O 0 1.3893441952461671e-09
gene O 0 4.215278126551425e-10
which O 0 1.3843705348737245e-10
encodes O 0 1.2829081130760756e-09
an O 0 6.478038938606545e-11
intestinal O 0 2.880391605231125e-07
anion O 0 3.999973046120431e-07
transporter O 0 2.0277568182791583e-05
. O 0 3.0084157742749085e-07

We O 0 3.277410201008024e-07
report O 0 1.958345130503858e-08
here O 0 3.822131056097078e-09
the O 0 1.6488364007472e-09
complete O 0 1.8878489882467875e-09
genomic O 0 5.162482885623376e-09
organization O 0 4.4679079880260986e-10
of O 0 2.727118308953891e-09
the O 0 6.6525971398334605e-09
human O 0 3.202044140948601e-08
CLD B-Disease 1 0.9555259346961975
gene O 0 3.0834840458737744e-08
which O 0 6.148772047076534e-10
spans O 0 2.049948211180208e-09
approximately O 0 4.8635387384088347e-11
39kb O 0 3.0707365539228704e-08
, O 0 1.6195923768780318e-10
and O 0 5.406209924174732e-10
comprises O 0 1.8818777647311435e-09
21 O 0 6.686106246434065e-08
exons O 0 6.6760785557562485e-06
. O 0 4.583673671731958e-07

All O 0 2.9651935165020404e-06
exon O 0 2.0091660189791583e-05
/ O 0 1.8913480062110466e-06
intron O 0 1.4961372016841779e-06
boundaries O 0 2.10801811562078e-08
conform O 0 1.7192579804259367e-08
to O 0 6.907217464657833e-09
the O 0 1.1097890251221543e-07
GT O 0 0.00046538759488612413
/ O 0 0.0009407080360688269
AG O 0 0.006108194123953581
rule O 0 4.46716421720339e-06
. O 0 8.162625135810231e-07

An O 0 1.6817232051380415e-08
analysis O 0 1.2840494889587717e-08
of O 0 4.32064766187068e-08
the O 0 6.032126265154147e-08
putative O 0 4.337444806878921e-06
promoter O 0 4.4963003347220365e-06
region O 0 4.280079579643825e-08
sequence O 0 4.419919097387037e-09
shows O 0 2.4283453026185953e-09
a O 0 5.815483650195574e-09
putative O 0 4.6265290620794985e-06
TATA O 0 0.0005287144449539483
box O 0 5.209788014326477e-07
and O 0 3.7280050158017275e-09
predicts O 0 2.0632155539601627e-08
multiple O 0 6.985172440465703e-09
transcription O 0 6.311687172910752e-08
factor O 0 3.4434444184938684e-09
binding O 0 3.754959010393577e-09
sites O 0 4.603079162279755e-08
. O 0 8.065829604220198e-08

The O 0 5.673970235875458e-07
genomic O 0 4.635281243281497e-07
structure O 0 1.430517357903227e-07
was O 0 5.133715674787709e-08
determined O 0 6.781851191739463e-10
using O 0 1.5279194576223176e-10
DNA O 0 4.437116452038481e-09
from O 0 3.1770561181865276e-10
several O 0 1.1249680353930813e-10
sources O 0 2.7475848263236458e-09
including O 0 3.370341505881669e-10
multiple O 0 6.869902868800182e-09
large O 0 5.273773595604325e-08
- O 0 2.1570232888734608e-07
insert O 0 2.3690425621225586e-07
libaries O 0 1.680750415289367e-06
and O 0 1.5421494081735432e-09
genomic O 0 4.734018510532678e-09
DNA O 0 1.1059069215946238e-08
from O 0 7.40899119833216e-09
Finnish O 0 0.0002789679856505245
CLD B-Disease 1 1.0
patients O 0 0.0004300314176362008
and O 0 5.998956567054847e-07
controls O 0 7.5380189628049266e-06
. O 0 4.598192049343197e-07

Exon O 0 4.067486952408217e-05
- O 0 8.361521395272575e-07
specific O 0 7.389416190051179e-09
primers O 0 3.469428691005305e-07
developed O 0 3.932569114795115e-08
in O 0 1.9478975377129615e-10
this O 0 2.3829009945797175e-11
study O 0 1.9644326096357467e-11
will O 0 8.975559011303869e-12
facilitate O 0 4.903909223141767e-11
mutation O 0 2.1223370283429688e-11
screening O 0 8.527053368956317e-11
studies O 0 5.6642923858263305e-12
of O 0 6.988709611022159e-11
patients O 0 1.4487754051994983e-10
with O 0 1.7806175978130057e-10
the O 0 5.711888206860749e-08
disease O 0 6.377231329679489e-05
. O 0 2.5835524297690426e-07

Genomic O 0 1.1048780379496748e-06
sequencing O 0 6.311126981017878e-07
of O 0 7.19327090337174e-07
a O 0 1.355720542051131e-06
BAC O 1 0.9999949932098389
clone O 1 0.9987096786499023
H O 1 1.0
_ O 0 3.4104579071936314e-07
RG364P16 O 0 1.2090144991816487e-06
revealed O 0 2.3139909544056536e-08
the O 0 9.896655717156477e-10
presence O 0 3.195421427459877e-10
of O 0 2.3996467035658497e-09
another O 0 6.89978685297632e-10
, O 0 7.293381176776137e-11
highly O 0 3.254048142053989e-10
homologous O 0 3.5101868633979905e-10
gene O 0 9.083621632655081e-10
3 O 0 3.0088498359504e-09
of O 0 3.799489611822082e-09
the O 0 2.4724375435880575e-08
CLD B-Disease 0 0.0007087687263265252
gene O 0 8.750279612002032e-09
, O 0 1.319472309191383e-10
with O 0 2.2661166346193973e-11
a O 0 1.527461906958294e-10
similar O 0 1.9911981785636357e-10
genomic O 0 4.900417405195867e-09
structure O 0 4.303045919584747e-09
, O 0 8.599769507622312e-11
recently O 0 4.4971479318256513e-10
identified O 0 2.635057727573553e-10
as O 0 6.637891347693881e-10
the O 0 1.2075125255250896e-07
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 8.986557276102758e-08
( O 0 4.000824560534966e-09
PDS B-Disease 0 6.6195275394420605e-06
) O 0 7.708523264149392e-10
. O 0 3.0499023306873596e-09
. O 0 1.369371886994486e-07

The O 0 1.7598092654225184e-06
APCI1307K O 0 0.0015594437718391418
allele O 0 1.1288594805591856e-06
and O 0 7.676808166934279e-08
cancer B-Disease 0 2.8318638214841485e-05
risk O 0 1.1823978240954602e-07
in O 0 6.117331086130662e-09
a O 0 1.5793537144759284e-08
community O 0 1.5577584777659581e-09
- O 0 1.1228783458605562e-09
based O 0 1.1339166411383772e-10
study O 0 2.9747797974932766e-11
of O 0 9.897372921230385e-10
Ashkenazi O 0 6.204199394233001e-07
Jews O 0 8.822008368269962e-08
. O 0 1.589212814678831e-07

Mutations O 0 9.681068604550092e-07
in O 0 4.337690739930622e-08
APC O 0 2.362585291848518e-07
are O 0 3.3003216826088533e-10
classically O 0 3.8704010307810677e-07
associated O 0 6.143502417899072e-08
with O 0 1.7522052075946704e-07
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 1.1623492355283815e-05
FAP B-Disease 0 1.2640316526812967e-05
) O 0 8.478081570117979e-10
, O 0 1.33107455613235e-10
a O 0 8.728809675062621e-09
highly O 1 0.9524824023246765
penetrant O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 5.4093812650535256e-05
by O 0 9.355754393425286e-09
multiple O 0 6.989052394601458e-07
intestinal O 1 0.999150276184082
polyps B-Disease 0 4.3506188376341015e-06
and O 0 3.199924103469698e-09
, O 0 1.4336345999232947e-10
without O 0 2.4404176457437643e-09
surgical O 0 0.004781036172062159
intervention O 0 0.00022049910330679268
, O 0 1.5784855644795925e-09
the O 0 4.480062099077031e-09
development O 0 2.569977652910893e-07
of O 0 0.12861911952495575
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 4.128614818910137e-07
CRC B-Disease 0 4.746416834677802e-06
) O 0 2.8720175127006087e-09
. O 0 4.0986421367961157e-08

APC B-Disease 0 3.983533679274842e-05
is O 0 2.64069626609853e-07
a O 0 4.3601451693575655e-07
tumour O 1 0.9999834299087524
- O 0 6.908602472321945e-07
suppressor O 0 3.1446910497834324e-07
gene O 0 1.2048864128644254e-09
, O 0 1.0632269370480785e-10
and O 0 5.568764338548249e-10
somatic O 0 1.3513331396097783e-06
loss O 0 3.556333467713557e-07
occurs O 0 1.1279711031875195e-07
in O 0 1.0710810727232456e-07
tumours B-Disease 1 1.0
. O 0 2.2891961179993814e-06

The O 0 1.466937374061672e-05
germline O 0 1.771846473275218e-05
T O 0 2.8141712391516194e-06
- O 0 3.933274967948819e-07
to O 0 1.582414199674531e-08
- O 0 1.0907240266533336e-07
A O 0 1.3761219008756598e-07
transversion O 0 9.61358409767854e-07
responsible O 0 7.749184405270171e-09
for O 0 8.197826861788826e-10
the O 0 7.364146625832291e-09
APC O 0 6.810451935734818e-08
I1307K O 0 1.7599390389477776e-07
allele O 0 3.348723520701924e-09
converts O 0 4.942828368825758e-09
the O 0 1.2494638657045698e-09
wild O 0 2.6926436635932305e-09
- O 0 5.889309040441049e-10
type O 0 9.082201657406586e-10
sequence O 0 6.305881372625777e-10
to O 0 6.598506185895303e-10
a O 0 1.2250710668126885e-08
homopolymer O 0 2.3598886400577612e-05
tract O 0 2.8380125058902195e-06
( O 0 7.567018123211255e-09
A8 O 0 6.350728085635637e-07
) O 0 2.389328457308437e-10
that O 0 4.282016408119205e-11
is O 0 4.967758981955228e-10
genetically O 0 4.864603297960457e-08
unstable O 0 0.00011577639816096053
and O 0 2.3790587988514744e-07
prone O 0 5.147941919858567e-06
to O 0 4.315788260100817e-08
somatic O 0 5.649172635457944e-06
mutation O 0 2.369056062434538e-07
. O 0 1.0400538030808093e-07

The O 0 4.3014292714360636e-06
I1307K O 0 1.252009406016441e-05
allele O 0 1.6872806440915156e-07
was O 0 1.1695824753132911e-07
found O 0 6.1716520782795214e-09
in O 0 4.464962177763709e-09
6 O 0 6.558573204529239e-07
. O 0 4.811204235011246e-07

1 O 0 7.604068741784431e-06
% O 0 2.295961287757109e-08
of O 0 1.7224285997485822e-08
unselected O 0 3.161018685204908e-05
Ashkenazi O 0 1.310511834162753e-05
Jews O 0 1.1828524293377995e-07
and O 0 2.1088253365775245e-09
higher O 0 4.322656899091726e-09
proportions O 0 9.519486532383326e-09
of O 0 1.320843345808953e-08
Ashkenazim O 0 4.401066689752042e-06
with O 0 4.018902988178752e-10
family O 0 5.136612024614351e-09
or O 0 7.953672165328385e-10
personal O 0 2.8679682628762748e-08
histories O 0 1.568231340343118e-07
of O 0 6.953656793484697e-06
CRC B-Disease 0 0.00972377322614193
( O 0 7.715075867054111e-08
ref O 0 0.00027030642377212644
. O 0 2.2987702408272526e-08
2 O 0 2.629357993555459e-07
) O 0 6.500052052160754e-09
. O 0 8.280684227202073e-08

To O 0 2.836119392668479e-07
evaluate O 0 2.4418861244157597e-07
the O 0 3.447047447480145e-08
role O 0 3.596812803152716e-08
of O 0 4.682778609321758e-08
I1307K O 0 1.170101768366294e-06
in O 0 3.2445304221084825e-09
cancer B-Disease 0 1.8461774686784338e-07
, O 0 1.0236900216398226e-09
we O 0 1.2190752851637399e-09
genotyped O 0 2.7245077944826335e-06
5 O 0 6.282525077949686e-08
, O 0 2.818902222756492e-09
081 O 0 9.180888810078613e-06
Ashkenazi O 0 5.933619831921533e-06
volunteers O 0 3.229578027230673e-08
in O 0 3.4532183779134584e-09
a O 0 9.642525888864384e-09
community O 0 3.8977683303187405e-09
survey O 0 1.3037623203260296e-09
. O 0 1.1716719150456356e-08

Risk O 0 1.2874314961663913e-05
of O 0 6.164658316265559e-06
developing O 1 0.9999942779541016
colorectal B-Disease 1 1.0
, I-Disease 0 0.0018952047685161233
breast I-Disease 1 0.9999996423721313
and I-Disease 0 3.1178408335108543e-06
other I-Disease 0 4.921983176586764e-08
cancers I-Disease 1 0.8711097240447998
were O 0 2.4687524913247216e-08
compared O 0 1.1029809066087637e-08
between O 0 7.975811122662435e-09
genotyped O 0 5.223426796874264e-06
I1307K O 0 1.2573507035540388e-07
carriers O 0 4.454820401456061e-10
and O 0 7.938895096870624e-10
non O 0 3.512847568387656e-09
- O 0 4.288183585998695e-09
carriers O 0 5.192798413489186e-10
and O 0 2.8450386491130075e-10
their O 0 1.9625236158393733e-10
first O 0 2.436863821841939e-09
- O 0 5.4324678089301415e-09
degree O 0 9.150090818366152e-08
relatives O 0 1.2366230350835394e-07
. O 0 5.313139794793642e-08

Sperm O 0 1.140280616596101e-07
DNA O 0 3.068359433200385e-08
analysis O 0 7.608874419418044e-09
in O 0 3.015819372009787e-09
a O 0 6.046848710639097e-08
Friedreich B-Disease 1 0.9998724460601807
ataxia I-Disease 1 1.0
premutation O 1 0.9999998807907104
carrier O 0 0.00011573886149562895
suggests O 0 1.2417899597494397e-07
both O 0 4.980930334852474e-09
meiotic O 0 3.369199703229242e-06
and O 0 4.466361502863947e-08
mitotic O 0 4.735605898531503e-07
expansion O 0 4.036353686842631e-07
in O 0 6.116048112403405e-09
the O 0 6.654681072859603e-08
FRDA B-Disease 0 6.891115481266752e-05
gene O 0 1.1933103394312639e-07
. O 0 8.283732455538484e-08

Friedreich B-Disease 1 1.0
ataxia I-Disease 1 1.0
is O 0 2.8629565349547192e-06
usually O 0 6.793793261294923e-08
caused O 0 3.4069984167217626e-08
by O 0 1.4611412080256514e-10
an O 0 5.4711651875649636e-11
expansion O 0 2.489021788676382e-08
of O 0 1.7025442389240197e-07
a O 0 5.64495394428377e-07
GAA O 0 3.173021104885265e-05
trinucleotide O 0 4.798589725396596e-05
repeat O 0 9.928237432177411e-08
in O 0 4.70676519981339e-09
intron O 0 5.585811209130043e-07
1 O 0 5.4068241439608755e-08
of O 0 1.1243921349546326e-08
the O 0 2.199698379001802e-08
FRDA B-Disease 0 7.407814700854942e-05
gene O 0 2.0179606963210972e-07
. O 0 1.191854508419965e-07

Occasionally O 0 1.110635707846086e-06
, O 0 2.212055427719406e-08
a O 0 1.624875700656503e-08
fully O 0 3.998172104502373e-08
expanded O 0 1.5652588558623393e-08
allele O 0 5.458995477880535e-09
has O 0 9.212806212355318e-11
been O 0 1.0104517916831313e-10
found O 0 7.593164985664203e-11
to O 0 6.980716699134248e-11
arise O 0 2.034725055111153e-09
from O 0 1.876494293284736e-09
a O 0 1.2383821967887343e-08
premutation O 0 2.139640400855569e-06
of O 0 7.495099652032877e-08
100 O 0 3.727244290985254e-09
or O 0 1.9379964300014763e-09
less O 0 3.079141208672809e-08
triplet O 0 3.1095592021301854e-06
repeats O 0 8.870600822774577e-07
. O 0 1.8636441723174357e-07

We O 0 5.409040682025079e-07
have O 0 8.114680483117809e-09
examined O 0 6.558711618254165e-08
the O 0 4.117711949191971e-09
sperm O 0 1.1011075384814717e-09
DNA O 0 3.5453726621170745e-09
of O 0 4.522697771847106e-09
a O 0 1.9279616125800203e-08
premutation O 0 4.7379326133523136e-05
carrier O 0 4.1452581172052305e-06
. O 0 1.1067730838476564e-06

This O 0 6.794130058551673e-07
mans O 0 2.2820117010269314e-05
leucocyte O 0 5.220040748099564e-06
DNA O 0 1.0982056863895195e-07
showed O 0 7.64054863822139e-09
one O 0 5.108704015377441e-10
normal O 0 1.267410509875333e-09
allele O 0 1.4394166969466937e-09
and O 0 1.938919580446452e-10
one O 0 4.4679395599933613e-11
allele O 0 1.851139658226586e-10
of O 0 6.864555590624377e-10
approximately O 0 3.422711558620506e-10
100 O 0 2.2909951713501187e-09
repeats O 0 2.1824511975410132e-08
. O 0 3.152407046513872e-08

His O 0 3.7014415283920243e-06
sperm O 0 1.6987685569347377e-07
showed O 0 8.360268033413831e-09
an O 0 8.324219785693643e-11
expanded O 0 1.3636755058499261e-09
allele O 0 2.9190430073100515e-09
in O 0 9.972982439876432e-10
a O 0 1.2063932963712887e-08
tight O 0 2.13325790809904e-07
range O 0 1.9701923292814172e-07
centering O 0 7.80457298787951e-07
on O 0 2.9214898944474044e-08
a O 0 1.4427865568933385e-09
size O 0 1.9564623254808566e-09
of O 0 4.514923546139471e-09
approximately O 0 1.0093159641400007e-09
320 O 0 1.0713095299763609e-08
trinucleotide O 0 2.464528733980842e-06
repeats O 0 1.0014771305577597e-06
. O 0 3.732468485395657e-07

His O 0 1.5108284969755914e-05
affected O 0 4.347188678366365e-06
son O 0 0.28003227710723877
has O 0 1.8672693613552838e-08
repeat O 0 9.810882772853802e-09
sizes O 0 7.497985343718483e-09
of O 0 3.103723145159165e-08
1040 O 0 1.810933440538065e-06
and O 0 3.995221931063497e-08
540 O 0 2.3143601879382913e-07
. O 0 6.599292845521632e-08

These O 0 5.6838707962469925e-08
data O 0 3.679328486327904e-08
suggest O 0 3.365872025540284e-09
that O 0 1.383304165658572e-10
expansion O 0 1.0453435450585857e-08
occurs O 0 7.575491345335195e-10
in O 0 8.92607168734294e-11
two O 0 3.2442423747447435e-11
stages O 0 7.102182730811535e-10
, O 0 3.820290264688886e-11
the O 0 5.295338056932053e-10
first O 0 5.011001613652866e-10
during O 0 1.261501680893673e-09
meiosis O 0 1.1188400206307847e-09
followed O 0 5.932477287196036e-10
by O 0 6.021864257244047e-11
a O 0 1.8309145310979602e-09
second O 0 3.590958641552788e-08
mitotic O 0 1.153680031507065e-07
expansion O 0 6.63032949432818e-07
. O 0 1.4109554058450158e-07

We O 0 1.9061619696003618e-06
also O 0 4.292964561614099e-08
show O 0 9.616127893963267e-10
that O 0 3.433439643707459e-11
in O 0 1.31669675162982e-10
all O 0 3.774083129348682e-11
informative O 0 5.890679610764948e-10
carrier O 0 2.365126317016575e-09
father O 0 5.3122146681516824e-09
to O 0 3.851915453267907e-10
affected O 0 1.3901049200626403e-09
child O 0 3.4811253879496462e-09
transmissions O 0 6.181807066241163e-09
, O 0 1.5884142959277092e-11
with O 0 2.615197338198816e-12
the O 0 2.381007890850384e-10
notable O 0 6.350019954304287e-10
exception O 0 8.213978941462585e-10
of O 0 3.341360743647215e-09
the O 0 3.763821698754555e-09
premutation O 0 4.936626964990865e-07
carrier O 0 1.3675311549832259e-08
, O 0 4.517204110765505e-10
the O 0 2.944626320555699e-09
expansion O 0 2.089328710042082e-08
size O 0 6.953296161071876e-09
decreases O 0 4.7714756590266916e-09
. O 0 2.6284481258187498e-09
. O 0 3.161342831958791e-08

The O 0 1.7457497278883238e-06
R496H O 0 4.7550161070830654e-06
mutation O 0 4.1694956820492735e-08
of O 0 8.778936688713657e-08
arylsulfatase O 0 6.458604184444994e-05
A O 0 1.2116449852328515e-06
does O 0 6.812463926308965e-09
not O 0 5.763385768631224e-09
cause O 0 7.330410153372213e-05
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
. O 0 6.15132103121141e-06

Deficiency B-Disease 1 0.9998791217803955
of I-Disease 0 0.000750431208871305
arylsulfatase I-Disease 1 0.9967365860939026
A I-Disease 0 0.0012944306945428252
( O 0 8.296277655972517e-07
ARSA O 1 0.965180516242981
) O 0 1.2796926185387747e-08
enzyme O 0 6.321590717561776e-08
activity O 0 2.1088103707711525e-08
causes O 0 8.887366220733384e-07
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 2.2077954326960025e-06
MLD B-Disease 1 1.0
) O 0 2.0758119489983073e-07
. O 0 1.4185594920945732e-07

A O 0 3.327858394186478e-06
number O 0 4.150864540974908e-08
of O 0 2.5808535042415315e-07
ARSA O 0 0.00023240104201249778
gene O 0 1.4603290132697566e-08
mutations O 0 3.6616003562528476e-09
responsible O 0 5.957256021815738e-09
for O 0 1.2336812460489455e-08
MLD B-Disease 1 1.0
have O 0 1.5686038068452035e-07
been O 0 2.4245977670034335e-08
identified O 0 2.3068167820383678e-08
. O 0 3.7285118992258504e-08

Recently O 0 4.027343038615072e-06
, O 0 1.3379994889817226e-08
the O 0 1.9759344382919153e-08
R496H O 0 4.4902441231897683e-07
mutation O 0 1.5464211244875514e-08
of O 0 7.897671849832477e-08
ARSA O 0 0.000652266142424196
was O 0 2.5701319827931e-07
proposed O 0 9.190876504305834e-09
to O 0 8.864572964562001e-10
be O 0 5.109941914049898e-10
a O 0 3.334885478878391e-09
cause O 0 8.373501714231679e-08
of O 0 3.1537717859464465e-06
MLD B-Disease 1 1.0
( O 0 1.385374872597822e-07
Draghia O 0 5.57913699594792e-06
et O 0 1.6592582596786087e-07
al O 0 1.339866884109142e-07
. O 0 8.803107132138166e-10
, O 0 3.3126004717054514e-10
1997 O 0 4.806184783490153e-09
) O 0 4.726151470180184e-09
. O 0 9.414095103466025e-08

We O 0 8.755523026593437e-07
have O 0 1.847818609235219e-08
investigated O 0 5.639122235834293e-08
the O 0 1.2184063535869427e-08
R496H O 0 8.445422849945317e-08
mutation O 0 8.814481922136963e-10
and O 0 1.169168234449458e-10
found O 0 7.013226804852835e-11
this O 0 2.599582875351114e-11
mutation O 0 3.7395761487424295e-10
at O 0 6.908425498330928e-10
a O 0 2.846965996283757e-10
relatively O 0 1.2279642858104012e-09
high O 0 3.571871021179618e-09
frequency O 0 3.6834555405818037e-09
in O 0 1.2453542364010417e-10
an O 0 5.416032552996164e-11
African O 0 2.1412818740351725e-10
American O 0 1.8006313107221672e-10
population O 0 7.333715340736291e-13
( O 0 5.349614414645876e-12
f O 0 1.1418912482241694e-09
= O 0 2.082353400822967e-09
0 O 0 1.242830172110132e-09
. O 0 1.558197598727773e-10
09 O 0 7.807488877631386e-09
, O 0 4.5021170125281174e-10
n O 0 1.2348277955709364e-08
= O 0 3.368339918097263e-08
61 O 0 3.778151125288787e-08
subjects O 0 2.0362634245429945e-08
) O 0 6.270623131854336e-09
. O 0 7.401946078289257e-08

The O 0 5.7673754781717435e-05
ARSA O 0 0.01921653375029564
enzyme O 0 3.572950220132043e-07
activity O 0 3.5016025634604375e-09
in O 0 9.587334398597491e-11
subjects O 0 5.766395694273285e-10
with O 0 2.06574063410514e-11
and O 0 1.2652144609770488e-10
without O 0 7.219283504333873e-10
the O 0 2.4432773582105938e-09
R496H O 0 2.6209551862166336e-08
mutation O 0 2.9576274762632693e-10
was O 0 2.1664947613686536e-09
determined O 0 5.480275122593525e-10
and O 0 3.6009825676863727e-10
found O 0 5.169495942425328e-10
to O 0 1.032959495717023e-09
be O 0 4.174411483148788e-09
normal O 0 2.037971711388309e-07
. O 0 2.4011549726310477e-07

It O 0 8.364562376073081e-08
is O 0 2.3225679157690138e-09
therefore O 0 2.1026080876396236e-09
concluded O 0 3.335108189617131e-09
that O 0 6.95504001613223e-11
the O 0 2.2299735391584363e-09
R496H O 0 1.417077584164872e-07
mutation O 0 1.0716773246599587e-08
of O 0 1.4454499819294142e-07
ARSA O 0 0.02390119805932045
does O 0 6.305572064491116e-09
not O 0 9.47143252716387e-10
negatively O 0 2.637442486630448e-09
influence O 0 1.043944841683242e-08
the O 0 3.153331817884464e-09
activity O 0 1.140541661115435e-09
of O 0 4.769819650363161e-09
ARSA O 0 0.0001811284018913284
and O 0 6.346932424072804e-10
is O 0 8.931214795504516e-11
not O 0 6.560779697295516e-11
a O 0 6.660977103223331e-09
cause O 0 7.556981813650054e-07
of O 0 2.5989433197537437e-05
MLD B-Disease 1 1.0

Down O 0 0.0001849980471888557
- O 0 3.581551027309615e-06
regulation O 0 3.649241477887699e-07
of O 0 1.249126597713257e-07
transmembrane O 0 3.72398517356487e-07
carbonic O 0 0.00042596313869580626
anhydrases O 0 0.002512840088456869
in O 0 1.0441060567245586e-06
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 0 0.00017424651014152914
lines O 0 2.3298545315242336e-08
by O 0 5.823361237666802e-10
wild O 0 2.975090751533571e-08
- O 0 2.2728208648459258e-08
type O 0 9.312173574471672e-07
von B-Disease 1 1.0
Hippel I-Disease 1 1.0
- I-Disease 1 0.8829894065856934
Lindau I-Disease 1 0.9768333435058594
transgenes O 0 0.00036254359292797744
. O 0 1.6707065242371755e-06

To O 0 4.77557534850348e-07
discover O 0 6.537416652463435e-08
genes O 0 4.724925783960998e-09
involved O 0 1.4413370497123879e-09
in O 0 4.023568145328227e-09
von B-Disease 1 0.9997177720069885
Hippel I-Disease 1 1.0
- I-Disease 1 0.9999991655349731
Lindau I-Disease 1 1.0
( O 0 1.6959662616500282e-06
VHL B-Disease 1 0.9999995231628418
) O 0 2.2113789555078256e-07
- O 0 1.8852934999813442e-06
mediated O 0 0.0006127350497990847
carcinogenesis O 1 0.9999958276748657
, O 0 4.008004150790612e-09
we O 0 9.623539742875664e-10
used O 0 2.0596540650785755e-07
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 0 0.0033108156640082598
lines O 0 1.6207133057832834e-07
stably O 0 3.669898660518811e-07
transfected O 0 2.2269234989380493e-07
with O 0 1.1869124572072565e-09
wild O 0 1.0787983484306096e-07
- O 0 1.4861628017115436e-07
type O 0 1.4829413885308895e-05
VHL O 1 1.0
- O 0 0.0007697028922848403
expressing O 0 8.358659329132934e-07
transgenes O 0 0.00010840932372957468
. O 0 8.215630487029557e-07

Large O 0 2.8358128929539816e-06
- O 0 2.3500510906160343e-06
scale O 0 9.75913962975028e-07
RNA O 0 3.8573455185542116e-07
differential O 0 8.684705932182624e-08
display O 0 7.124382861434242e-09
technology O 0 3.8610622254964255e-08
applied O 0 5.71079583622236e-09
to O 0 3.07595060533572e-10
these O 0 1.0408063993994077e-10
cell O 0 6.709711897201487e-09
lines O 0 1.3620431449368198e-09
identified O 0 3.419305671936712e-10
several O 0 1.537490690317611e-10
differentially O 0 3.143545157513472e-08
expressed O 0 8.875570278732425e-10
genes O 0 2.9452654204398243e-10
, O 0 4.4084805250754755e-11
including O 0 8.587312805286018e-11
an O 0 2.582652425253684e-10
alpha O 0 1.931664606047434e-08
carbonic O 0 1.1180745786987245e-06
anhydrase O 0 9.900060831569135e-06
gene O 0 1.4416814408946266e-08
, O 0 1.2032536078621092e-09
termed O 0 6.739702484992449e-07
CA12 O 0 0.0037669558078050613
. O 0 1.1524916772032157e-06

The O 0 5.615176519313536e-07
deduced O 0 8.776894588891082e-08
protein O 0 1.0734115818422652e-09
sequence O 0 4.0877545792739056e-10
was O 0 2.844264379575634e-09
classified O 0 1.4569341288961368e-09
as O 0 5.578183470689169e-10
a O 0 3.790766811562207e-09
one O 0 1.0261107519227153e-08
- O 0 4.92743595259526e-07
pass O 0 2.2543933937413385e-06
transmembrane O 0 7.826993737580779e-07
CA O 0 5.37320090643334e-07
possessing O 0 1.4361814848484755e-08
an O 0 3.418042515690445e-09
apparently O 0 6.580965816738171e-08
intact O 0 1.8251159872306744e-07
catalytic O 0 2.2300937985164637e-08
domain O 0 1.0967064589806341e-08
in O 0 1.04994690719451e-09
the O 0 1.4417310012504458e-08
extracellular O 0 2.347738785601905e-07
CA O 0 2.3333168428507634e-05
module O 0 7.122456008801237e-05
. O 0 7.136706585697539e-07

Reintroduced O 0 3.672377351904288e-05
wild O 0 2.8716165161313256e-06
- O 0 5.631769113279006e-07
type O 0 1.1314646144455764e-06
VHL B-Disease 1 0.9999946355819702
strongly O 0 3.739437488547992e-07
inhibited O 0 2.519438453418843e-07
the O 0 2.5543535286942642e-08
overexpression O 0 1.0668809125036205e-07
of O 0 1.428559048832767e-08
the O 0 1.0317942944482184e-08
CA12 O 0 1.3445508102449821e-06
gene O 0 5.335037966958112e-10
in O 0 1.2417207539971997e-10
the O 0 2.0475099393735263e-09
parental O 0 3.3415365123801166e-06
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9773305654525757
lines O 0 1.743641632856452e-06
. O 0 1.5923046703392174e-07

Similar O 0 1.6346464803973504e-07
results O 0 1.6042678296912527e-08
were O 0 3.576697826801478e-09
obtained O 0 2.1255071036563322e-09
with O 0 3.2095193169823233e-10
CA9 O 0 4.721955338027328e-05
, O 0 2.2302626412340487e-09
encoding O 0 5.1776321896568334e-08
another O 0 5.557109261644655e-08
transmembrane O 0 7.417025216227557e-08
CA O 0 9.568713466023837e-08
with O 0 8.176527233061393e-10
an O 0 2.3581085972779192e-09
intact O 0 5.509699576577987e-07
catalytic O 0 1.7768338977930398e-07
domain O 0 2.3602432008829055e-07
. O 0 5.7660496821654306e-08

Although O 0 1.8970548865127057e-07
both O 0 1.9219109859136552e-08
domains O 0 3.364667122696119e-08
of O 0 8.071292967315458e-08
the O 0 1.2857152853484877e-07
VHL B-Disease 0 0.002211904153227806
protein O 0 4.647453621942077e-08
contribute O 0 2.6728821378441125e-09
to O 0 2.612678517976974e-09
regulation O 0 1.2473553567815543e-07
of O 0 1.6393768476063997e-07
CA12 O 0 0.012610393576323986
expression O 0 4.031590350450642e-08
, O 0 5.645379719254606e-10
the O 0 2.0637971331893823e-09
elongin O 0 1.3148026312137517e-07
binding O 0 4.127974406742396e-09
domain O 0 1.4016045213338657e-08
alone O 0 3.164381645603953e-09
could O 0 3.3543103850064426e-09
effectively O 0 6.648375716622468e-08
regulate O 0 1.1127330878935027e-07
CA9 O 0 0.003574491012841463
expression O 0 6.814116204623133e-07
. O 0 3.5299368050800695e-07

We O 0 4.3991194615955465e-06
mapped O 0 1.620205512153916e-05
CA12 O 0 0.027759859338402748
and O 0 6.612086735913181e-07
CA9 O 0 0.021827848628163338
loci O 0 6.702468340336054e-07
to O 0 2.0385252597066028e-08
chromosome O 0 4.0565197423347854e-08
bands O 0 2.718624045883189e-07
15q22 O 0 3.4605368455231655e-06
and O 0 5.654674950505978e-08
17q21 O 0 1.9727280232473277e-05
. O 0 2.8077596425646334e-07

2 O 0 5.179389063414419e-06
respectively O 0 1.2478884059419215e-07
, O 0 5.2959063800983586e-09
regions O 0 2.6405041708699173e-08
prone O 0 1.8705488855630392e-06
to O 0 8.018627539740919e-09
amplification O 0 0.0004977516946382821
in O 0 1.4380646007339237e-08
some O 0 1.703188923229959e-09
human O 0 8.722921762682745e-08
cancers B-Disease 0 0.00023323390632867813
. O 0 2.9346486485337664e-07

Additional O 0 2.2588385206745443e-07
experiments O 0 7.13344121550108e-08
are O 0 3.7035946531815966e-10
needed O 0 1.8478219843132138e-08
to O 0 1.540520710996418e-09
define O 0 1.0169046937846815e-08
the O 0 7.06710689968304e-09
role O 0 5.54022925314257e-08
of O 0 3.4598662068674457e-07
CA O 0 2.8282504445087397e-06
IX O 1 0.9999984502792358
and O 0 1.6689881476850132e-06
CA O 0 1.5264287185345893e-06
XII O 0 0.0006196832400746644
enzymes O 0 7.942746904632259e-09
in O 0 6.28024354742962e-10
the O 0 6.640322181006297e-10
regulation O 0 1.0866365585116e-09
of O 0 5.585337192748341e-10
pH O 0 1.9362165204483972e-08
in O 0 3.12184028627982e-10
the O 0 1.7724725021039944e-09
extracellular O 0 3.0560225461329082e-09
microenvironment O 0 1.2394023940487386e-07
and O 0 2.8567895271613963e-10
its O 0 2.437550716827275e-10
potential O 0 1.893933454510943e-09
impact O 0 3.012067040231159e-08
on O 0 4.4071677507417917e-07
cancer B-Disease 0 5.2659461289294995e-06
cell O 0 1.7652317865213263e-06
growth O 0 4.046906454391319e-08
. O 0 1.1679707512257664e-07

A O 0 1.0516749853195506e-06
gene O 0 9.146772228518785e-09
encoding O 0 5.491811805313773e-08
a O 0 2.5660487068535076e-08
transmembrane O 0 1.1039047898009358e-08
protein O 0 8.006427187901011e-10
is O 0 2.13401119691925e-11
mutated O 0 4.880453263744755e-10
in O 0 1.0171617020882096e-10
patients O 0 4.51006965107581e-09
with O 0 1.8705987869793717e-08
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 0 6.808857142459601e-05
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 2.3470565491123807e-09
. O 0 1.4935576331254197e-08

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 4.794148844666779e-05
WFS B-Disease 1 0.9999990463256836
; O 0 2.3356335532298544e-06
OMIM O 1 0.9999122619628906
222300 O 0 6.394135562004521e-05
) O 0 3.088762801084499e-09
is O 0 1.2446426111978326e-09
an O 0 4.9819188774336e-09
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 0.9999991655349731
defined O 0 1.4866603237351228e-07
by O 0 6.914071093433449e-09
young O 0 5.646225531563687e-08
- O 0 4.799976068170508e-06
onset O 1 1.0
non O 1 1.0
- O 1 1.0
immune O 1 1.0
insulin B-Disease 1 1.0
- I-Disease 1 0.9999057054519653
dependent I-Disease 1 0.9997698664665222
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 0.02196909300982952
progressive O 1 0.9999996423721313
optic B-Disease 1 1.0
atrophy I-Disease 0 0.0001985053240787238
. O 0 4.884574877905834e-07

Linkage O 0 6.583752110600471e-05
to O 0 3.081900104007218e-07
markers O 0 1.3534404388337862e-06
on O 0 4.633968444522907e-07
chromosome O 0 3.613398291690828e-07
4p O 0 0.009324396029114723
was O 0 1.1340019909766852e-06
confirmed O 0 4.4946482091745565e-08
in O 0 3.2991589460351634e-09
five O 0 6.058783696971659e-09
families O 0 1.2459899778605177e-08
. O 0 1.1608105410232383e-07

On O 0 1.2927681609653519e-06
the O 0 1.2556378159445103e-08
basis O 0 1.41773384143562e-08
of O 0 5.1886850371829496e-08
meiotic O 0 0.00039367593126371503
recombinants O 1 0.9647272229194641
and O 0 9.556383417930192e-08
disease O 0 7.4293111538281664e-06
- O 0 4.279205967350208e-08
associated O 0 2.692121192637842e-08
haplotypes O 0 3.5613769000519824e-07
, O 0 5.613811082660902e-10
the O 0 6.171522404230245e-09
WFS B-Disease 0 0.00024957541609182954
gene O 0 1.9497655046052387e-08
was O 0 4.4927968900765336e-08
localized O 0 3.125632730416328e-08
to O 0 7.222427544917309e-09
a O 0 1.0905783653925027e-07
BAC O 0 0.017007991671562195
/ O 0 1.9096474716207013e-05
P1 O 0 1.625438017072156e-05
contig O 0 1.0223402568954043e-06
of O 0 5.809474679097093e-09
less O 0 1.2467239463020974e-09
than O 0 2.830576051326972e-10
250 O 0 6.448090505983828e-09
kb O 0 8.385894147977524e-07
. O 0 7.653547839936437e-08

Mutations O 0 3.189749975263112e-07
in O 0 1.494044887806467e-08
a O 0 1.6692057513978398e-08
novel O 0 5.074834774632109e-08
gene O 0 3.2622156087569465e-09
( O 0 8.357697312000312e-10
WFS1 O 0 8.395140866923612e-06
) O 0 1.7498722471032124e-09
encoding O 0 7.987658534602815e-08
a O 0 6.700826560290807e-08
putative O 0 1.1695483408402652e-06
transmembrane O 0 1.1432865321125973e-08
protein O 0 6.458081291960127e-10
were O 0 1.5689696764020766e-10
found O 0 1.7809097252463602e-10
in O 0 2.0346929696657412e-10
all O 0 3.2533281624225197e-10
affected O 0 1.3783245655929477e-09
individuals O 0 4.981410076099202e-11
in O 0 1.8935000234421295e-09
six O 0 2.233597129475129e-08
WFS B-Disease 1 0.956092119216919
families O 0 3.5847704804581326e-09
, O 0 7.790746520131009e-11
and O 0 3.521424124519612e-11
these O 0 7.71766591606271e-12
mutations O 0 4.9146773456465453e-11
were O 0 5.036554506787638e-11
associated O 0 6.145453590455929e-10
with O 0 2.896783923844737e-10
the O 0 6.331425339567431e-08
disease O 0 1.8696304323384538e-05
phenotype O 0 5.409503046394093e-06
. O 0 1.9895077230103198e-07

WFS1 O 0 0.010177797637879848
appears O 0 1.040858023770852e-06
to O 0 1.0968361330299103e-08
function O 0 1.9884627278088374e-09
in O 0 2.100187357356731e-09
survival O 0 2.547718759160489e-05
of O 0 8.591139248892432e-07
islet O 0 4.6704630221938714e-05
beta O 0 8.983623729363899e-07
- O 0 6.274310067055922e-07
cells O 0 6.96776725206405e-09
and O 0 3.877887788661383e-09
neurons O 0 2.7520076884002265e-08
. O 0 6.618021686222164e-09
. O 0 7.176757321758487e-08

Stable O 0 1.363412866339786e-05
interaction O 0 3.828085937129799e-08
between O 0 5.789585699744748e-09
the O 0 1.5920678109182518e-09
products O 0 7.929381595772611e-09
of O 0 1.680027317263466e-08
the O 0 1.518936620925615e-08
BRCA1 O 0 9.573967396647731e-09
and O 0 3.807230086749769e-09
BRCA2 O 0 2.628966022655277e-08
tumor B-Disease 0 4.879397508261718e-08
suppressor O 0 1.0128343319593114e-07
genes O 0 4.663983643737879e-10
in O 0 2.0585907978265539e-10
mitotic O 0 3.26509308479217e-08
and O 0 2.0806433909115185e-08
meiotic O 0 1.7235450286534615e-05
cells O 0 2.152427668988821e-06
. O 0 4.076255777363258e-07

BRCA1 O 0 1.7669413864496164e-05
and O 0 5.742759157101318e-08
BRCA2 O 0 5.7285920007643654e-08
account O 0 3.6433878136676867e-10
for O 0 4.81704572063979e-11
most O 0 4.8373381689170714e-11
cases O 0 5.002022754330149e-11
of O 0 1.935908988670576e-09
familial O 0 1.8332293905132246e-07
, O 0 4.0174161219930227e-10
early O 0 8.582347277297231e-08
onset O 1 0.9999724626541138
breast B-Disease 1 0.9914257526397705
and I-Disease 0 0.0005201445310376585
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.896691692593322e-09
encode O 0 2.2338207672500943e-10
products O 0 1.027434026745766e-09
that O 0 1.8351081071399378e-11
each O 0 1.0698866272085272e-11
interact O 0 9.393760075360191e-11
with O 0 1.0444775599971479e-10
hRAD51 O 0 5.222577215135971e-07
. O 0 7.283326652895994e-08

Results O 0 4.085335376657895e-07
presented O 0 8.623818530395511e-07
here O 0 5.8177278106086305e-08
show O 0 2.275630572867726e-09
that O 0 1.9932540340494853e-10
BRCA1 O 0 3.002041282229584e-08
and O 0 9.172873127738512e-09
BRCA2 O 0 2.4781863317002717e-07
coexist O 0 4.346502535668151e-08
in O 0 7.021930814588018e-10
a O 0 1.4754638621994332e-09
biochemical O 0 1.41008897003303e-07
complex O 0 8.34388572457101e-07
and O 0 1.199452714928384e-08
colocalize O 0 4.769635779666714e-06
in O 0 5.274213510375603e-09
subnuclear O 0 2.3234126729221316e-06
foci O 0 2.934178269242693e-07
in O 0 5.084421772494352e-10
somatic O 0 1.0696923347097709e-08
cells O 0 5.866885866012694e-10
and O 0 2.800652765255762e-10
on O 0 1.7633680071682534e-09
the O 0 3.225462952283209e-10
axial O 0 1.4398834347062461e-09
elements O 0 1.2540653848702732e-08
of O 0 4.7309701045605834e-08
developing O 0 8.944103910835111e-07
synaptonemal O 0 2.0026584024890326e-05
complexes O 0 8.699375939613674e-07
. O 0 2.7354062126505596e-07

Like O 0 3.926175850210711e-06
BRCA1 O 0 5.042424163548276e-06
and O 0 4.7311237949543283e-07
RAD51 O 0 0.04026583209633827
, O 0 1.3091859329961153e-07
BRCA2 O 0 8.418875836468942e-07
relocates O 0 1.5210375750029925e-06
to O 0 4.171882039827324e-08
PCNA O 0 3.21403713314794e-05
+ O 0 7.887811648288334e-08
replication O 0 2.6003788011763618e-09
sites O 0 2.1501136981960656e-10
following O 0 1.6594649265844197e-10
exposure O 0 1.1134162924975044e-08
of O 0 7.77995889933436e-09
S O 0 4.4502181140160246e-07
phase O 0 1.0490770563365004e-07
cells O 0 7.504351806630893e-09
to O 0 1.378753111680453e-09
hydroxyurea O 0 4.818555794372514e-07
or O 0 2.028649781493641e-08
UV O 0 0.010946812108159065
irradiation O 0 5.973073348286562e-05
. O 0 2.67867164893687e-07

Thus O 0 2.963384531540214e-06
, O 0 8.784832772334994e-08
BRCA1 O 0 1.102773126149259e-07
and O 0 1.0740838440881362e-08
BRCA2 O 0 1.544817429532941e-08
participate O 0 5.091350119279525e-10
, O 0 2.5602872599783666e-10
together O 0 2.0953568047321625e-10
, O 0 1.3450449087848426e-10
in O 0 3.530255809902627e-10
a O 0 3.6623968302507137e-09
pathway O 0 5.4373838764831817e-08
( O 0 5.801775726510527e-10
s O 0 1.2194596443748651e-08
) O 0 3.118160937787273e-11
associated O 0 2.3586199660030616e-10
with O 0 6.493378751359913e-11
the O 0 2.958181921641767e-09
activation O 0 3.0674815576503534e-08
of O 0 1.0572143338549722e-07
double O 0 2.219866246377933e-08
- O 0 1.4802685655013192e-07
strand O 0 7.243952637736584e-08
break O 0 5.295727589782473e-08
repair O 0 2.0699303604487795e-06
and O 0 5.3691291412860664e-08
/ O 0 9.222117114404682e-07
or O 0 2.0469174799586654e-08
homologous O 0 1.249360224164775e-07
recombination O 0 1.730026752966296e-07
. O 0 1.0774616754360977e-07

Dysfunction O 0 0.33868423104286194
of O 0 9.349259926239029e-06
this O 0 1.300581420338176e-08
pathway O 0 1.833551266372524e-07
may O 0 1.6964292193222263e-09
be O 0 1.7145798669737644e-10
a O 0 7.579726291062627e-10
general O 0 4.369316908281462e-09
phenomenon O 0 3.3506208918510083e-09
in O 0 9.557719199415615e-11
the O 0 2.668281151585461e-10
majority O 0 1.7169841937114683e-11
of O 0 9.957278057637353e-11
cases O 0 1.5792858687468936e-10
of O 0 1.0344504808301735e-08
hereditary B-Disease 1 0.9999939203262329
breast I-Disease 0 0.01281364168971777
and I-Disease 0 0.00015948600776027888
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.737166937549773e-08
. O 0 5.485091136847586e-08

A O 0 6.35146443528356e-06
novel O 0 9.167303574031394e-07
Arg362Ser O 0 3.2431978524982696e-06
mutation O 0 5.688444382201396e-09
in O 0 1.0284614271327541e-09
the O 0 5.181423290423481e-09
sterol O 0 2.1834644030604977e-06
27 O 0 6.243926691240631e-07
- O 0 8.905674917514261e-07
hydroxylase O 0 6.1851525970269e-05
gene O 0 9.359970221112235e-08
( O 0 8.779033500161404e-09
CYP27 O 0 0.00010517973714740947
) O 0 2.7946724934224676e-09
: O 0 1.6293928706279104e-10
its O 0 1.0911287429138383e-09
effects O 0 5.54071526437383e-08
on O 0 3.891070221584414e-08
pre O 0 4.7545353254463407e-07
- O 0 1.8618742103626573e-08
mRNA O 0 6.323831236443311e-09
splicing O 0 2.531533205285541e-08
and O 0 2.8538704732739006e-10
enzyme O 0 9.895712027585546e-10
activity O 0 8.661504846685375e-10
. O 0 7.649939348652879e-09

A O 0 1.9846179384330753e-06
novel O 0 1.6670969671395142e-07
C O 0 8.991235063149361e-07
to O 0 4.191428981670242e-09
A O 0 2.1263881322397538e-08
mutation O 0 8.102953308330996e-10
in O 0 3.938044335072277e-10
the O 0 3.3643061669863528e-09
sterol O 0 9.119223705056356e-07
27 O 0 2.6687527565627533e-07
- O 0 1.7458783929669153e-07
hydroxylase O 0 9.486512681178283e-06
gene O 0 1.919873859890231e-08
( O 0 1.9903905190687965e-09
CYP27 O 0 6.561453119502403e-06
) O 0 3.600350573229605e-10
was O 0 2.4842254919832385e-09
identified O 0 3.0630353808902555e-10
by O 0 5.039187470079476e-11
sequencing O 0 1.0952870610481114e-08
amplified O 0 4.328268943254443e-08
CYP27 O 0 1.3062093557891785e-06
gene O 0 1.0344914924687032e-09
products O 0 2.915431673855551e-09
from O 0 1.351794232107295e-09
a O 0 3.0377049764496178e-09
patient O 0 2.7067025953897428e-08
with O 0 1.1300530289304334e-08
cerebrotendinous B-Disease 1 1.0
xanthomatosis I-Disease 1 1.0
( O 0 2.436480315282097e-07
CTX B-Disease 0 0.02722172811627388
) O 0 3.7418843135128554e-08
. O 0 1.3582062763362046e-07

The O 0 1.8591791786093381e-06
mutation O 0 2.6367376904090634e-07
changed O 0 8.624684966207496e-08
the O 0 1.672555072218529e-08
adrenodoxin O 0 7.411693445646961e-07
cofactor O 0 4.721594848433597e-08
binding O 0 4.0388847821759555e-09
residue O 0 8.053101652194528e-08
362Arg O 0 8.371457482780897e-08
to O 0 3.432388817614651e-09
362Ser O 0 7.052498744997138e-07
( O 0 1.4936828662825974e-08
CGT O 0 2.5803914468269795e-05
362Arg O 0 5.017413968744222e-06
to O 0 1.0494213142919762e-07
AGT O 0 0.001438342034816742
362Ser O 0 1.6371753872590489e-06
) O 0 8.523740602228713e-10
, O 0 8.485163266458429e-11
and O 0 1.6359635868212763e-10
was O 0 9.970096748190826e-09
responsible O 0 1.8930088607760354e-09
for O 0 6.328364499097461e-10
deficiency O 0 4.871715646004304e-06
in O 0 1.6365707011800623e-08
the O 0 1.0559890029071539e-07
sterol O 0 5.315042017173255e-06
27 O 0 5.453263725030411e-07
- O 0 1.8537072321578307e-07
hydroxylase O 0 4.393250037537655e-06
activity O 0 3.1497491281839984e-09
, O 0 5.693236507231525e-11
as O 0 8.17763010085848e-11
confirmed O 0 3.495241596151999e-10
by O 0 1.1177687248009605e-10
expression O 0 1.3626225703333716e-09
of O 0 1.5099759664849444e-08
mutant O 0 2.5872697761997188e-08
cDNA O 0 4.5254097358338186e-08
into O 0 4.58544846537734e-08
COS O 0 2.6702406103140675e-05
- O 0 1.995578259084141e-06
1 O 0 2.0474082873533916e-07
cells O 0 5.390585045006446e-08
. O 0 9.848402271472878e-08

Quantitative O 0 7.095066507645242e-07
analysis O 0 2.276300392622943e-08
showed O 0 4.2269463484956304e-09
that O 0 3.9410481822432786e-11
the O 0 4.365782735327173e-10
expression O 0 8.521058303401219e-10
of O 0 4.577720869036739e-09
CYP27 O 0 1.090995056074462e-06
gene O 0 3.889255861810881e-10
mRNA O 0 2.345154515026593e-09
in O 0 3.1280031342895143e-10
the O 0 1.3217197336601316e-09
patient O 0 2.3925505132638136e-08
represented O 0 1.2405903859757927e-08
52 O 0 5.164308163330134e-07
. O 0 2.565574845903029e-07

5 O 0 1.4273192618929897e-06
% O 0 1.3101170814877605e-08
of O 0 2.0246528009693066e-08
the O 0 1.6300162997140433e-08
normal O 0 3.800324677172284e-08
level O 0 3.791673179875943e-07
. O 0 7.775629740081058e-08

As O 0 1.5914757511836797e-07
the O 0 3.679539162249057e-08
mutation O 0 1.7243614536255336e-08
occurred O 0 4.274849985108631e-08
at O 0 2.0024155666931165e-09
the O 0 8.026320164056244e-10
penultimate O 0 7.230548959569205e-08
nucleotide O 0 7.1337109552871425e-09
of O 0 2.3723245590190345e-08
exon O 0 8.93864111617404e-08
6 O 0 4.0331595840825685e-08
( O 0 7.994860329318954e-10
- O 0 2.4781691365660663e-08
2 O 0 5.9594409407282e-08
position O 0 1.21970558097928e-07
of O 0 1.8936026435767417e-07
exon O 0 3.806731285749265e-07
6 O 0 3.117434630439675e-07
- O 0 1.1048237524846627e-07
intron O 0 1.7439742805436254e-06
6 O 0 2.023794536398782e-07
splice O 0 1.2132418305554893e-06
site O 0 1.1053206350197797e-08
) O 0 5.893058957484598e-11
of O 0 6.343470748682023e-10
the O 0 1.876479860385416e-09
gene O 0 2.0527224364741414e-09
, O 0 7.486192221684007e-10
we O 0 3.021321803853283e-10
hypothesized O 0 2.0125748179111724e-08
that O 0 4.051652346959145e-10
the O 0 6.816973652234992e-09
mutation O 0 2.479094485252631e-09
may O 0 4.168714706764831e-09
partially O 0 3.061245479329955e-08
affect O 0 1.3302250412294825e-09
the O 0 2.8534092866294714e-09
normal O 0 2.4215647265179996e-09
splicing O 0 1.12001066199241e-08
efficiency O 0 7.74690800398048e-09
in O 0 1.8646693911161805e-10
exon O 0 1.914133385128025e-08
6 O 0 2.876710647470304e-09
and O 0 5.363604005381717e-11
cause O 0 3.4224637013302583e-10
alternative O 0 1.258858350894343e-08
splicing O 0 1.3960894662545797e-08
elsewhere O 0 6.308528144316483e-10
, O 0 1.0375592746081352e-11
which O 0 4.589884462086191e-12
resulted O 0 9.195150196816826e-10
in O 0 1.1219829926245595e-10
decreased O 0 1.5779828554940423e-09
transcript O 0 2.3253617698060225e-08
in O 0 7.440894567167788e-10
the O 0 1.060113508088989e-08
patient O 0 2.5767317879399343e-07
. O 0 2.6679029474507843e-07

Transfection O 0 0.0006109153619036078
of O 0 4.567511950881453e-06
constructed O 0 2.7752337700803764e-05
minigenes O 0 1.9752425941987894e-05
, O 0 1.0485260437675947e-09
with O 0 3.170794876661276e-11
or O 0 8.440873555670692e-10
without O 0 3.0050071320175675e-09
the O 0 2.72103406473434e-09
mutation O 0 3.8297037763257435e-10
, O 0 1.1778863995282052e-10
into O 0 3.87810228374974e-09
COS O 0 1.661378155404236e-05
- O 0 6.19641184584907e-07
1 O 0 2.5502302491986484e-08
cells O 0 5.828362237281226e-10
confirmed O 0 6.944478880832605e-10
that O 0 3.488200353563009e-11
the O 0 1.8149519664945046e-09
mutant O 0 1.1159548840566913e-08
minigene O 0 1.386852801488203e-07
was O 0 6.370391325560831e-09
responsible O 0 3.749353605364547e-10
for O 0 2.327647970201685e-11
a O 0 2.755744799021187e-10
mRNA O 0 6.689365728007601e-10
species O 0 3.68536347272741e-11
alternatively O 0 1.0699774399824946e-09
spliced O 0 3.6667039182702865e-08
at O 0 4.6437471645788264e-09
an O 0 1.557805273666446e-10
activated O 0 2.1144293782526802e-07
cryptic O 0 7.720094572505332e-07
5 O 0 1.2129335402732977e-07
splice O 0 3.2859995826584054e-06
site O 0 3.267112163030106e-07
88 O 0 1.2707558028068888e-07
bp O 0 1.478885707228983e-07
upstream O 0 7.097054055549279e-09
from O 0 6.161215981848045e-10
the O 0 2.6496342897530667e-09
3 O 0 2.314600244801568e-08
end O 0 3.8127108581420543e-08
of O 0 9.268514844507081e-08
exon O 0 1.4842040627627284e-06
6 O 0 8.029326181713259e-07
. O 0 7.426764625506621e-08

Our O 0 2.79885102827393e-06
data O 0 5.079318654566123e-08
suggest O 0 5.66855939965194e-09
that O 0 1.692259388175188e-10
the O 0 1.1126748411527387e-09
C O 0 1.1391751542078055e-07
to O 0 3.018230332330063e-09
A O 0 6.099833882444727e-08
mutation O 0 2.304748614179175e-09
at O 0 2.8866589119047603e-09
the O 0 7.370888344127025e-10
penultimate O 0 1.856253994958479e-08
nucleotide O 0 3.712578910963771e-09
of O 0 5.3379114461904464e-09
exon O 0 2.6627271054735502e-08
6 O 0 7.57100249160203e-09
of O 0 2.7711528627349935e-09
the O 0 5.417102322269329e-09
CYP27 O 0 1.2026404874632135e-05
gene O 0 3.3627280959791506e-09
not O 0 2.4898405559525827e-10
only O 0 3.9853390032540403e-10
causes O 0 4.187425961532654e-09
the O 0 1.0543101502946683e-08
deficiency B-Disease 0 3.502307208691491e-06
in I-Disease 0 1.1736625893377095e-08
the I-Disease 0 3.958584926522235e-08
sterol I-Disease 0 3.5306914014654467e-06
27 I-Disease 0 4.060042613218684e-07
- I-Disease 0 2.6001927722063556e-07
hydroxylase I-Disease 0 1.5055571566335857e-05
activity I-Disease 0 9.971009795606278e-09
, O 0 3.011937643737639e-10
but O 0 2.635600626632595e-10
also O 0 7.796621681599447e-10
partially O 0 1.3055771574954633e-08
leads O 0 9.797526123733746e-10
to O 0 1.7633267068717373e-10
alternative O 0 1.3706150880921086e-08
pre O 0 2.3038538188302482e-07
- O 0 9.851085280843108e-09
mRNA O 0 4.21581081155864e-09
splicing O 0 8.016517227815712e-09
of O 0 4.858886071268387e-10
the O 0 9.88152892844596e-10
gene O 0 3.5263005848662488e-09
. O 0 1.889150347267332e-08

To O 0 6.730350605721469e-07
our O 0 1.598966719029704e-07
knowledge O 0 1.259723489965836e-07
, O 0 2.6923549500956767e-10
this O 0 2.685941920266277e-11
is O 0 4.1391653993194666e-11
the O 0 2.1931817473230808e-10
first O 0 4.253666030518133e-10
report O 0 2.469305870889116e-10
regarding O 0 2.62323451849511e-09
effects O 0 4.1233885639258006e-08
on O 0 6.609357683373673e-08
pre O 0 1.2256090542450693e-07
- O 0 4.241944573379897e-09
mRNA O 0 1.1654839315866639e-09
splicing O 0 2.0909063369600744e-09
of O 0 4.5396264525265906e-10
a O 0 2.5497509659189177e-10
mutation O 0 1.8854695582604108e-10
at O 0 1.003557015266665e-09
the O 0 1.209094713239267e-09
- O 0 1.0475471157178617e-08
2 O 0 3.569488882249061e-08
position O 0 4.0349750207724355e-08
of O 0 2.7089077647701743e-08
a O 0 4.7227658228621294e-08
5 O 0 1.2483728539791628e-07
splice O 0 4.1188673094438855e-06
site O 0 3.9376962490678125e-07
. O 0 6.050286316394704e-08

ATM O 0 0.0001588364684721455
germline O 0 1.5328065273934044e-05
mutations O 0 9.779200382808995e-08
in O 0 2.3656328451693298e-08
classical O 0 0.002482379088178277
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 1.0
in O 0 1.1552148038163068e-07
the O 0 1.994313691966454e-07
Dutch O 0 6.953424417588394e-06
population O 0 6.593298129686787e-10
. O 0 2.412272337437571e-08

Germline O 0 3.054082844755612e-05
mutations O 0 3.435967244058702e-08
in O 0 3.0510372006631314e-09
the O 0 4.350166005195888e-09
ATM O 0 9.803852663026191e-08
gene O 0 3.1150002022251044e-10
are O 0 1.3725927946323102e-12
responsible O 0 3.0024947805795676e-11
for O 0 5.1855308241810505e-11
the O 0 4.206306130072335e-06
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9765441417694092
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.7017802747432142e-05
. O 0 8.866591997502837e-06

In O 0 3.0376403969967214e-07
our O 0 3.703068784943753e-08
study O 0 7.482651720458477e-10
, O 0 1.4734270747940315e-10
we O 0 4.951249479856479e-11
have O 0 3.1883027468149194e-11
determined O 0 1.6693959548064186e-09
the O 0 3.116796598590099e-09
ATM O 0 4.2537596556257995e-08
mutation O 0 6.864228074832113e-10
spectrum O 0 7.576160143685229e-09
in O 0 5.078780729306231e-10
19 O 0 5.951645842827702e-09
classical O 0 3.1160851676759194e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 1.049437742040027e-06
, O 0 1.4231131550968001e-10
including O 0 2.397809728549305e-11
some O 0 6.728053010551793e-12
immigrant O 0 1.7504689364677972e-10
populations O 0 1.1869588645296858e-11
, O 0 8.051626206040385e-12
as O 0 5.094874522271198e-11
well O 0 2.355868278236528e-10
as O 0 6.918077777307019e-10
12 O 0 1.0560807783832615e-09
of O 0 4.909108231032633e-09
Dutch O 0 3.3323189541079046e-07
ethnic O 0 1.2845903230029876e-09
origin O 0 1.6898484389571422e-08
. O 0 5.5713837099347074e-08

Both O 0 2.1876070377402357e-07
the O 0 6.601218416335541e-08
protein O 0 1.8203785145942675e-08
truncation O 0 4.860541480411484e-07
test O 0 8.661199046855472e-08
( O 0 8.034456655536815e-09
PTT O 0 5.477427293953951e-07
) O 0 1.5695622579414703e-10
and O 0 4.184038393528766e-10
the O 0 3.604131437739966e-09
restriction O 0 7.796001177950984e-09
endonuclease O 0 2.8489358783190255e-07
fingerprinting O 0 9.06869033201474e-08
( O 0 1.6811291247975646e-09
REF O 0 1.3870170505470014e-06
) O 0 3.114285565541941e-11
method O 0 1.9718739141527664e-10
were O 0 4.0312305576994945e-11
used O 0 9.386273702727266e-11
and O 0 1.392439358260944e-10
compared O 0 2.6622673510168227e-10
for O 0 3.149860233753188e-11
their O 0 1.0701994151984806e-10
detection O 0 1.2577152119774837e-07
efficiency O 0 7.453028416648522e-09
, O 0 2.095551510095106e-11
identifying O 0 2.3978977137240065e-10
76 O 0 3.948049442925594e-09
% O 0 1.1501005009462162e-10
and O 0 8.480374041885952e-11
60 O 0 3.532242554005194e-10
% O 0 6.011489916968316e-11
of O 0 2.8617250236173675e-10
the O 0 1.3334944259923986e-09
mutations O 0 6.578563249703961e-10
, O 0 6.031845578569062e-10
respectively O 0 9.927514810215143e-09
. O 0 4.698883415699129e-08

Most O 0 2.0523384591797367e-07
patients O 0 6.310989419944235e-08
were O 0 2.8554620890020033e-09
found O 0 8.745419943778643e-10
to O 0 5.941763192574001e-10
be O 0 3.8107317301694366e-09
compound O 0 8.340755812241696e-06
heterozygote O 0 0.0007940993527881801
. O 0 6.928713673914899e-07

Seventeen O 0 2.214657342847204e-06
mutations O 0 1.800138527130457e-08
were O 0 2.982998736911213e-09
distinct O 0 1.5412584541962815e-09
, O 0 4.3287104456446457e-10
of O 0 1.8740295981700683e-09
which O 0 1.4227005684652738e-10
10 O 0 4.726455338222024e-10
were O 0 3.560659267431987e-10
not O 0 1.768183238715082e-10
reported O 0 1.316308839705016e-08
previously O 0 2.4901740403038275e-07
. O 0 2.8677666819021397e-07

Mutations O 0 5.824244340146834e-07
are O 0 4.419362653607095e-09
small O 0 7.706674409746483e-09
deletions O 0 6.26096891664929e-07
or O 0 2.1994262056068692e-07
point O 0 2.0876791495538782e-06
mutations O 0 8.9598373165245e-09
frequently O 0 1.66691815906006e-08
affecting O 0 3.0556158492345276e-08
splice O 0 3.435160033404827e-05
sites O 0 1.2330576737440424e-06
. O 0 3.526662908370781e-07

Moreover O 0 6.913941433595028e-06
, O 0 1.4652877666776476e-07
a O 0 2.0276658574402973e-07
16 O 0 5.917170824432105e-07
. O 0 4.1956704421863833e-07

7 O 0 6.312430195976049e-05
- O 0 6.173901056172326e-06
kb O 0 9.539968232274987e-06
genomic O 0 3.690771848141594e-07
deletion O 0 8.373118731697105e-08
of O 0 5.4777100189085104e-08
the O 0 1.1525918885979536e-08
3 O 0 1.3364385154090996e-08
end O 0 1.1025875323866785e-08
of O 0 3.456223085507304e-09
the O 0 1.4264809333752737e-09
gene O 0 6.633992799542909e-10
, O 0 5.819028245368507e-11
most O 0 7.704903381977601e-11
likely O 0 1.0733890443148653e-09
a O 0 5.868251440332983e-10
result O 0 7.049440475803692e-10
of O 0 3.8162304427658e-09
recombination O 0 9.554297353275842e-10
between O 0 5.557008186940493e-10
two O 0 1.4791487479293153e-10
LINE O 0 5.3860325976984313e-08
elements O 0 5.392227997447208e-09
, O 0 4.046207813246383e-10
was O 0 1.3150716959842157e-08
identified O 0 1.4657091540470901e-08
. O 0 5.524274726553813e-08

The O 0 1.998471134356805e-06
most O 0 1.4628659172899461e-08
frequently O 0 1.638090774136458e-09
found O 0 1.3994899683567041e-10
mutation O 0 9.414405366392486e-11
, O 0 2.0092004449079326e-11
identified O 0 2.752933991878592e-10
in O 0 2.875299165427947e-10
three O 0 7.155455672425148e-10
unrelated O 0 4.27890398668751e-08
Turkish O 0 2.4364400815102272e-05
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
individuals O 0 1.7016985598417023e-09
, O 0 1.0545669892891851e-09
was O 0 1.1029913871141162e-08
previously O 0 1.1837043567552996e-09
described O 0 6.062618740365622e-10
to O 0 2.023415462959477e-10
be O 0 2.321424302786923e-10
a O 0 5.419923621019507e-09
Turkish O 0 1.4150588185657398e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
founder O 0 0.00042152844252996147
mutation O 0 3.8825785964036186e-07
. O 0 1.0745555556468389e-07

The O 0 4.528665158431977e-07
presence O 0 7.49276978240232e-08
of O 0 2.572209041318274e-07
a O 0 8.467456069638502e-08
founder O 0 1.292672550334828e-05
mutation O 0 2.5949301374339484e-08
among O 0 1.6048821160907778e-09
relatively O 0 3.6088778632148433e-09
small O 0 2.656332653838689e-10
ethnic O 0 4.0933076372873245e-11
population O 0 1.0182205556139023e-12
groups O 0 5.944689727456487e-13
in O 0 2.2350642170376744e-11
Western O 0 1.0361210556197875e-08
Europe O 0 7.290105852320039e-09
could O 0 2.906130891489056e-10
indicate O 0 2.477391625177461e-10
a O 0 1.2943320859548635e-09
high O 0 5.932253799301179e-09
carrier O 0 5.916035994424362e-10
frequency O 0 1.174638386558513e-09
in O 0 1.382009368056103e-10
such O 0 4.4504044893756145e-10
communities O 0 1.2044091945995206e-08
. O 0 7.897822484892458e-08

In O 0 3.1033505365485325e-07
patients O 0 2.720616123497166e-07
of O 0 1.3811390431328618e-07
Dutch O 0 7.601826155223534e-07
ethnic O 0 3.7056863133599904e-10
origin O 0 7.943515289987602e-10
, O 0 4.3938238464269475e-11
however O 0 9.303925685433256e-11
, O 0 2.0073541787124505e-11
no O 0 8.906599069380405e-11
significant O 0 1.2316868636119693e-09
founder O 0 4.424349526743754e-07
effect O 0 9.162172354137965e-09
could O 0 5.918251222425397e-09
be O 0 4.3980539210508596e-09
identified O 0 1.051942319918453e-07
. O 0 1.3934138110016647e-07

The O 0 5.376680860535998e-07
observed O 0 4.754870630563346e-08
genetic O 0 3.455394192997119e-08
heterogeneity O 0 1.2870734167336195e-07
including O 0 5.108053979796523e-09
the O 0 2.5045322260552894e-08
relative O 0 2.074198164336849e-05
high O 0 8.26484574645292e-06
percentage O 0 2.992186054484591e-08
of O 0 3.0338615175651285e-08
splice O 0 1.7811305951909162e-05
- O 0 6.335979492178012e-07
site O 0 2.2627901330452005e-08
mutations O 0 3.6328542951657994e-10
had O 0 2.1430972552138883e-09
no O 0 5.925793744587793e-10
reflection O 0 4.69648178125226e-08
on O 0 3.545902060864137e-08
the O 0 1.8962186487669896e-08
phenotype O 0 6.463798740696802e-07
. O 0 1.4925343805316515e-07

All O 0 2.1799014859880117e-07
patients O 0 5.362630162153437e-08
manifested O 0 8.491473124649929e-08
classical O 0 1.3734069170823204e-06
A B-Disease 1 1.0
- I-Disease 1 0.9999984502792358
T I-Disease 1 1.0
and O 0 5.328230301415715e-08
increased O 0 2.612749661068392e-08
cellular O 0 8.381906724252985e-08
radioresistant O 0 2.365859046449259e-07
DNA O 0 2.4826825040236145e-08
synthesis O 0 1.358774994741907e-07
. O 0 3.495645017892457e-08

Determination O 0 7.993158760655206e-06
of O 0 5.597938184109807e-07
the O 0 2.6743927961092595e-08
genomic O 0 1.618139755521497e-08
structure O 0 5.950476555938167e-09
of O 0 4.089947935881355e-09
the O 0 1.3302834389605778e-09
COL4A4 O 0 2.686505240490078e-06
gene O 0 9.539511403033885e-10
and O 0 2.3208973631838603e-10
of O 0 3.3545153321767884e-09
novel O 0 3.0849406584820827e-07
mutations O 0 2.0664300848238781e-07
causing O 0 9.49024467900017e-07
autosomal B-Disease 1 0.9999996423721313
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 5.006674837204628e-05

Autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 1.5259194015015964e-06
a O 0 1.0884416496992344e-06
progressive O 1 0.9999144077301025
hematuric B-Disease 1 1.0
glomerulonephritis I-Disease 1 1.0
characterized O 0 0.24645841121673584
by O 0 1.2992653353194328e-07
glomerular B-Disease 1 1.0
basement I-Disease 1 1.0
membrane I-Disease 0 1.8974265913129784e-05
abnormalities I-Disease 0 7.866211717555416e-07
and O 0 6.666617258233032e-10
associated O 0 8.955292507550894e-09
with O 0 1.3585768066093351e-09
mutations O 0 7.774232813062554e-09
in O 0 2.98789570862823e-09
either O 0 3.602277587333447e-08
the O 0 2.3923388425828307e-07
COL4A3 O 0 0.001298345043323934
or O 0 1.6779136302602637e-08
the O 0 1.295884111129908e-08
COL4A4 O 0 3.349400913066347e-06
gene O 0 1.2208762889542868e-09
, O 0 7.036245891489656e-11
which O 0 2.3089263140319005e-11
encode O 0 1.4405345805101888e-09
the O 0 9.978847970160132e-09
alpha3 O 0 1.352018898614915e-06
and O 0 1.1272373257043e-08
alpha4 O 0 8.29619068554166e-07
type O 0 2.968281478388235e-07
IV O 1 1.0
collagen O 0 0.00899194460362196
chains O 0 4.301737135392614e-06
, O 0 1.1606861249902067e-08
respectively O 0 1.3576967994310962e-08
. O 0 5.996165697297329e-08

To O 0 6.196175661443704e-08
date O 0 2.5641756451477704e-07
, O 0 5.555757520703253e-10
mutation O 0 1.1430738994233636e-10
screening O 0 7.80458198068601e-10
in O 0 1.2802967019887035e-10
the O 0 1.4717200791380947e-09
two O 0 1.0398742977812958e-09
genes O 0 1.6567837102243743e-09
has O 0 3.7541547648345386e-10
been O 0 1.0068854638944913e-09
hampered O 0 1.8723069388215663e-06
by O 0 8.006977303409712e-10
the O 0 5.218696141895407e-09
lack O 0 3.404023374287135e-08
of O 0 4.37897806904175e-09
genomic O 0 6.975107158524452e-09
structure O 0 7.68266428252673e-09
information O 0 4.81993644996237e-09
. O 0 3.1836712821586843e-08

We O 0 2.2786575470945536e-07
report O 0 1.4867873154855715e-08
here O 0 2.338655491485042e-09
the O 0 8.906875792469293e-10
complete O 0 1.0627976276822437e-09
characterization O 0 2.6103787575948445e-08
of O 0 1.627739010245932e-08
the O 0 1.2983532471366743e-08
48 O 0 2.194255088738828e-08
exons O 0 1.2382764680296532e-07
of O 0 1.7308064315102456e-08
the O 0 1.2609370436678091e-08
COL4A4 O 0 7.001353878877126e-06
gene O 0 4.426127908629951e-09
, O 0 2.351271677358824e-10
a O 0 4.743036519094801e-10
comprehensive O 0 2.275938770779362e-09
gene O 0 8.428100439772379e-10
screen O 0 1.7009984532023736e-08
, O 0 6.759080795060157e-11
and O 0 6.379358152841519e-11
the O 0 1.2464712595416927e-10
subsequent O 0 7.332383589186975e-10
detection O 0 3.471552645351039e-08
of O 0 1.7834735910327026e-09
10 O 0 1.5932760666359513e-10
novel O 0 2.8477098457102556e-10
mutations O 0 9.279238488701935e-11
in O 0 5.819916423788207e-11
eight O 0 2.148565103610167e-09
patients O 0 2.1733786326194604e-08
diagnosed O 0 2.4672331164765637e-06
with O 0 9.232661568603362e-08
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 2.4097806090139784e-05

Furthermore O 0 1.043584347826254e-06
, O 0 8.7980591700898e-09
we O 0 6.669364505107467e-10
identified O 0 1.4283294547112746e-09
a O 0 6.892210691056277e-10
glycine O 0 2.849107394453654e-09
to O 0 6.168530131134276e-10
alanine O 0 9.944780110515694e-09
substitution O 0 1.6056490892424335e-07
in O 0 1.3400783593908727e-08
the O 0 2.8112740579899764e-08
collagenous O 0 2.3700013116467744e-06
domain O 0 2.284511024797098e-09
that O 0 2.4250334379471994e-11
is O 0 3.1686667179009476e-11
apparently O 0 1.759675627432955e-09
silent O 0 9.146910784352258e-09
in O 0 2.5837559869401616e-10
the O 0 1.314043096556361e-09
heterozygous O 0 4.586265811568069e-10
carriers O 0 9.068180095717082e-10
, O 0 1.8973600468541463e-10
in O 0 2.51317322508271e-09
11 O 0 1.9596740230554133e-07
. O 0 4.1916470649994153e-07

5 O 0 5.645680971611e-07
% O 0 3.179433827327216e-09
of O 0 5.242080103329272e-09
all O 0 2.1618003220869042e-10
control O 0 2.8803561757939633e-09
individuals O 0 1.3902440830493301e-11
, O 0 5.5872317189509246e-11
and O 0 9.628896985303115e-11
in O 0 2.372715912635215e-10
one O 0 1.9948133422875713e-10
control O 0 1.7177328448525486e-09
individual O 0 1.5010404377790998e-11
homozygous O 0 2.6921187501471877e-10
for O 0 6.570020916196739e-11
this O 0 9.341908496773854e-11
glycine O 0 2.3692090067584104e-08
substitution O 0 3.2400305371993454e-07
. O 0 2.5855959506770887e-07

There O 0 3.3325574122500257e-07
has O 0 5.7571671874256936e-09
been O 0 8.395819039996866e-10
no O 0 1.2393262804888394e-10
previous O 0 5.91416304818182e-10
finding O 0 1.366941226876861e-09
of O 0 8.620959501826064e-10
a O 0 3.0085844926475147e-10
glycine O 0 5.572186045910144e-10
substitution O 0 2.185532421705716e-09
that O 0 3.1800735655895807e-11
is O 0 1.2485454510546834e-11
not O 0 4.463099594759212e-12
associated O 0 6.468704738527009e-11
with O 0 5.126718494175009e-12
any O 0 1.1233813185240749e-10
obvious O 0 1.105257485534139e-08
phenotype O 0 4.79401940367552e-08
in O 0 6.549479847350881e-10
homozygous O 0 3.8609497821084915e-09
individuals O 0 1.8545427693528183e-10
. O 0 7.447575001151563e-08

Founder O 0 0.002618958707898855
BRCA1 O 0 5.547706678044051e-06
and O 0 1.5071627501583862e-07
BRCA2 O 0 9.542158352360275e-08
mutations O 0 1.8486917552351656e-09
in O 0 1.0150554841104054e-09
French O 0 5.451028073366615e-07
Canadian O 0 0.01207694597542286
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.5611404080573266e-07
. O 0 1.0029933861233076e-07

We O 0 2.4397749598392693e-07
have O 0 1.920356540452417e-09
identified O 0 6.032032651148711e-09
four O 0 2.846591296012946e-10
mutations O 0 6.278515207736035e-11
in O 0 7.93251922481808e-11
each O 0 3.705218076799355e-11
of O 0 5.176170958520743e-08
the O 0 5.250175490800757e-06
breast B-Disease 1 0.9063217639923096
cancer I-Disease 0 0.001204557018354535
- O 0 7.530069296990405e-07
susceptibility O 0 5.32978560841002e-07
genes O 0 6.891478054882327e-09
, O 0 5.291854732192292e-10
BRCA1 O 0 1.9837389508836623e-09
and O 0 1.772100577390745e-09
BRCA2 O 0 7.2209398460643115e-09
, O 0 1.2402673332800873e-10
in O 0 2.3453147757201975e-10
French O 0 3.293195049991482e-07
Canadian O 0 2.1973808543407358e-05
breast B-Disease 0 0.0001447568938601762
cancer I-Disease 0 4.477725815377198e-05
and O 0 1.1217849532840773e-05
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 5.348724574361086e-09
from O 0 7.692604775400014e-09
Quebec O 0 2.486984271854453e-07
. O 0 6.588024348275212e-08

To O 0 7.378138207059237e-07
identify O 0 1.6745315178923192e-06
founder O 0 0.00018663548689801246
effects O 0 0.00012963627523276955
, O 0 1.2033069651806727e-08
we O 0 1.3428103073920283e-09
examined O 0 8.103961945948868e-09
independently O 0 1.308251174059194e-09
ascertained O 0 4.530703989757967e-08
French O 0 3.842629325845337e-08
Canadian O 0 1.1175123404427723e-07
cancer B-Disease 0 5.070790365380162e-08
families O 0 1.0277745321474185e-10
for O 0 1.2050667755336697e-11
the O 0 6.483799608325569e-11
distribution O 0 9.991808769260757e-11
of O 0 7.6358241951624e-10
these O 0 3.2131514116073845e-10
eight O 0 1.0236046676936894e-08
mutations O 0 5.980594686150198e-09
. O 0 3.610945498166984e-08

Mutations O 0 2.4929232722570305e-07
were O 0 1.3320512692871489e-08
found O 0 1.9456631861203277e-09
in O 0 1.4473122700309204e-09
41 O 0 7.215160735540849e-08
of O 0 1.2196544219023053e-07
97 O 0 1.2182087630208116e-05
families O 0 3.1902732189337257e-07
. O 0 7.315779839700554e-07

Six O 0 1.0101609859702876e-06
of O 0 2.366109441709341e-07
eight O 0 1.7697372456382254e-08
mutations O 0 1.149600969974074e-09
were O 0 1.5451762092055787e-09
observed O 0 5.3133901722901555e-09
at O 0 6.085073334105573e-09
least O 0 1.3622041272753904e-09
twice O 0 4.830633670849238e-08
. O 0 1.1036547675757902e-07

The O 0 6.327975825115573e-06
BRCA1 O 0 2.9100917799951276e-06
C4446T O 0 1.252629544978845e-06
mutation O 0 5.611555220497166e-09
was O 0 1.2912554581134827e-08
the O 0 9.250386012737977e-10
most O 0 9.897065805786198e-11
common O 0 5.101498667947624e-10
mutation O 0 1.0758460095017242e-10
found O 0 4.702480418949939e-11
, O 0 9.519290737614039e-12
followed O 0 2.2729486348627148e-10
by O 0 1.466750748635448e-10
the O 0 1.5780168283185958e-08
BRCA2 O 0 1.6520030499123095e-07
8765delAG O 0 4.998349254492496e-07
mutation O 0 1.9890480373874198e-08
. O 0 3.5007495569061575e-08

Together O 0 1.5376629391994356e-07
, O 0 1.4087462307799115e-09
these O 0 7.582035693731726e-11
mutations O 0 1.7977828947746133e-10
were O 0 2.6758495419443307e-10
found O 0 1.7257348328136857e-10
in O 0 2.3175088237348263e-10
28 O 0 1.1753427564542562e-08
of O 0 1.577613595316052e-08
41 O 0 3.309408569407424e-08
families O 0 6.404439201190826e-10
identified O 0 2.78807577025475e-09
to O 0 1.516964109882224e-09
have O 0 2.997897041723263e-09
a O 0 9.458027960818072e-08
mutation O 0 1.6318803375270363e-07
. O 0 2.0404766587489576e-07

The O 0 7.976162237355311e-07
odds O 0 1.097170979846851e-06
of O 0 1.9875082912790276e-08
detection O 0 5.654426331602735e-07
of O 0 1.5547199083698615e-08
any O 0 2.595215820022645e-09
of O 0 1.5253467822162747e-08
the O 0 1.3339631621533954e-08
four O 0 1.9749086810350036e-09
BRCA1 O 0 4.237852291311128e-09
mutations O 0 9.41907996043767e-10
was O 0 6.182481371297399e-08
18 O 0 3.043877683239771e-08
. O 0 1.1663500032454976e-07

7x O 0 0.38318517804145813
greater O 0 2.065785110971774e-06
if O 0 1.8958642655775293e-08
one O 0 9.847586079914095e-10
or O 0 6.037229050015469e-11
more O 0 1.4476026714144163e-12
cases O 0 7.583062650029504e-11
of O 0 5.357913778425427e-06
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 9.397497002794353e-09
also O 0 1.1658302101480444e-10
present O 0 1.6435573735318343e-10
in O 0 5.580896855761353e-10
the O 0 8.36548430527273e-09
family O 0 3.808473891808717e-08
. O 0 3.944287740864638e-08

The O 0 1.0933782732536201e-06
odds O 0 2.2006443032296374e-06
of O 0 3.3744100846888614e-08
detection O 0 7.488932851629215e-07
of O 0 1.3307255741779045e-08
any O 0 3.8070413488355825e-09
of O 0 1.4859651287224551e-08
the O 0 1.174327657338381e-08
four O 0 3.235335332973932e-09
BRCA2 O 0 9.13644981892503e-09
mutations O 0 8.635145376523212e-10
was O 0 1.287662740878659e-07
5 O 0 1.0939679384591727e-07
. O 0 5.958668225503061e-08

3x O 0 9.205014794133604e-05
greater O 0 2.4261177600237716e-07
if O 0 2.7646696043603924e-09
there O 0 2.2812049471632179e-10
were O 0 1.4597879571809358e-09
at O 0 2.1700710672867274e-10
least O 0 5.328585229308347e-12
five O 0 3.4857045635300343e-12
cases O 0 1.471510933936937e-11
of O 0 8.644773785704274e-09
breast B-Disease 0 0.0001521155354566872
cancer I-Disease 0 3.179673967679264e-06
in O 0 4.266831776789104e-09
the O 0 1.2859592857239477e-07
family O 0 2.4336699766536185e-07
. O 0 8.053915934169709e-08

Interestingly O 0 2.3065101686370326e-06
, O 0 7.682986691293081e-09
the O 0 2.0478301276938282e-09
presence O 0 1.5186720769833073e-09
of O 0 6.305586452981515e-08
a O 0 4.8426816334767864e-08
breast B-Disease 0 2.5956487661460415e-06
cancer I-Disease 0 1.1672068467305508e-07
case O 0 2.3751182354203593e-08
< O 0 6.838556032562337e-08
36 O 0 3.959496730487899e-09
years O 0 5.001128955406386e-10
of O 0 1.773994506848453e-09
age O 0 1.3536364251720556e-09
was O 0 2.1040202913269468e-09
strongly O 0 2.1079546094759927e-11
predictive O 0 3.4138511462167287e-10
of O 0 5.131957636628215e-10
the O 0 1.5526260832565697e-10
presence O 0 4.184196392142958e-11
of O 0 4.3331216392772376e-10
any O 0 4.077351511977412e-10
of O 0 3.184617014539981e-09
the O 0 3.9694176834359496e-09
eight O 0 2.030948520470588e-09
mutations O 0 2.0413097878702047e-09
screened O 0 8.765552195200144e-08
. O 0 7.61744445298973e-08

Carriers O 0 3.683633451601054e-07
of O 0 3.0608197221226874e-07
the O 0 1.2433713614257158e-08
same O 0 1.1511368525063403e-09
mutation O 0 5.364466093560338e-10
, O 0 2.1204149547315865e-11
from O 0 2.6944597594780184e-11
different O 0 4.2699538349566524e-11
families O 0 2.3330895548845376e-10
, O 0 1.7598986504219205e-11
shared O 0 1.6325286955609641e-10
similar O 0 1.5707422862387688e-10
haplotypes O 0 1.2227809875753337e-08
, O 0 1.0429605790118757e-10
indicating O 0 1.3292156264554933e-09
that O 0 3.145593230335919e-10
the O 0 7.176235161665545e-09
mutant O 0 3.726917441326805e-09
alleles O 0 1.0973331271424414e-10
were O 0 2.0252610699600382e-10
likely O 0 2.5505778045165073e-10
to O 0 7.757102599148524e-11
be O 0 3.5270501796969e-11
identical O 0 1.478657890574553e-10
by O 0 5.600333391475587e-11
descent O 0 8.837194975797047e-09
for O 0 2.0951129720003792e-10
a O 0 6.668702257073278e-10
mutation O 0 2.718578973048835e-10
in O 0 3.8965025650483653e-10
the O 0 1.2326322185174377e-08
founder O 0 6.087705628488038e-07
population O 0 3.2074631839407175e-10
. O 0 3.052750230381207e-08

The O 0 6.61541150748235e-08
identification O 0 2.5614522058958755e-08
of O 0 9.320100957666e-08
common O 0 8.258702450802957e-07
BRCA1 O 0 2.1397106308995717e-07
and O 0 1.5615372106481118e-08
BRCA2 O 0 2.3787631420191246e-08
mutations O 0 4.4563164269817435e-10
will O 0 2.6708626976734706e-10
facilitate O 0 2.1431461050269718e-09
carrier O 0 3.3273579447268276e-08
detection O 0 3.292605697424733e-06
in O 0 9.997975780606794e-09
French O 0 1.6135803662109538e-06
Canadian O 0 1.4465313142864034e-05
breast B-Disease 0 0.0003259829827584326
cancer I-Disease 0 7.192820339696482e-05
and O 0 6.530489827127894e-06
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 3.3253407139000046e-08
. O 0 3.46644455362366e-08

Are O 0 1.0956092921787786e-07
Dp71 O 0 0.000357289332896471
and O 0 6.587904977095604e-07
Dp140 O 0 7.061899668769911e-05
brain O 0 1.4163051673676819e-05
dystrophin O 0 4.9924792620004155e-06
isoforms O 0 1.7383356976097275e-07
related O 0 3.381039448413503e-08
to O 0 7.105939836549169e-09
cognitive B-Disease 0 0.0024232850410044193
impairment I-Disease 1 0.9999991655349731
in O 0 0.0006075460696592927
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 1 0.9999904632568359

Molecular O 0 3.969889519339631e-07
study O 0 8.159596553980464e-09
and O 0 8.052080113785109e-10
neuropsychological O 0 3.112117141768067e-08
analysis O 0 1.5136374376112371e-09
were O 0 1.2017604689162908e-09
performed O 0 3.837424822350499e-10
concurrently O 0 1.2528598158922932e-09
on O 0 1.0727776889041252e-08
49 O 0 1.7837940902154514e-08
patients O 0 4.939435971351713e-09
with O 0 2.1986833687037688e-08
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.00020087120356038213
DMD B-Disease 1 1.0
) O 0 1.7158172660458604e-09
in O 0 6.49392345453137e-11
order O 0 1.8690776704133327e-10
to O 0 1.1934087051912456e-10
find O 0 5.808607483892558e-10
a O 0 1.627616097454876e-10
molecular O 0 4.357322280768017e-10
explanation O 0 5.929050028719018e-10
for O 0 1.450719266937739e-10
the O 0 4.476081283399935e-09
cognitive B-Disease 0 6.189147825352848e-07
impairment I-Disease 0 1.0444157396705123e-06
observed O 0 8.447449850734756e-09
in O 0 2.3937360982273503e-09
most O 0 5.251008872164675e-08
DMD B-Disease 1 1.0
patients O 0 3.2669446227373555e-05
. O 0 5.170433610146574e-07

Complete O 0 3.3692660394990526e-07
analysis O 0 1.9735464817927095e-08
of O 0 2.6932513108590683e-08
the O 0 1.3457390757309895e-08
dystrophin O 0 7.967229294081335e-07
gene O 0 1.117590731070095e-08
was O 0 3.1703038416708296e-08
performed O 0 7.936669654817763e-10
to O 0 3.2637326174977943e-10
define O 0 6.4221428175414985e-09
the O 0 1.6102426059205754e-08
localization O 0 1.1628237189142965e-05
of O 0 5.3441077341176424e-08
deletions O 0 3.356693056844051e-08
and O 0 1.3867734738326476e-09
duplications O 0 1.423722650883974e-08
in O 0 9.615205853741315e-11
relation O 0 9.694431923890079e-10
to O 0 4.407844089726609e-10
the O 0 4.6148040944160584e-09
different O 0 4.5395527337177555e-08
DMD B-Disease 1 1.0
promoters O 0 0.0001926632976392284
. O 0 8.031547054088151e-07

Qualitative O 0 1.9263941339886514e-06
analysis O 0 5.368504574221333e-08
of O 0 3.006241797720577e-07
the O 0 8.935828077483166e-08
Dp71 O 0 1.0414139069325756e-05
transcript O 0 5.662391231453512e-07
and O 0 1.6449317463695934e-09
testing O 0 6.434719979075965e-10
for O 0 5.361517479984812e-11
the O 0 2.0195674299561261e-10
specific O 0 9.806775530529777e-11
first O 0 1.457845844043959e-09
exon O 0 1.4170418616288316e-08
of O 0 7.1746200092093204e-09
Dp140 O 0 7.236108956476528e-08
were O 0 3.1606659511851376e-09
also O 0 1.2137252314303737e-09
carried O 0 1.8970063297985007e-09
out O 0 7.348039954280239e-09
. O 0 3.275903281974024e-08

Neuropsychological O 0 6.165613740449771e-05
analysis O 0 2.8308903665674734e-07
assessed O 0 5.284386475068459e-07
verbal O 0 8.200287311410648e-07
and O 0 8.486340874469533e-08
visuospatial O 0 1.373274062643759e-05
intelligence O 0 3.724304917795962e-07
, O 0 1.1142017308785057e-09
verbal O 0 8.148666097440582e-08
memory O 1 0.9999995231628418
, O 0 4.753274751578829e-08
and O 0 2.370569696097391e-08
reading O 0 4.7456742890972237e-07
skills O 0 4.851986886933446e-06
. O 0 3.03693042269515e-07

Comparison O 0 3.851967449008953e-06
of O 0 1.3128358204994584e-06
molecular O 0 1.8640686221260694e-06
and O 0 6.951694331291947e-08
psychometric O 0 2.9873681341996416e-05
findings O 0 7.113604283404129e-08
demonstrated O 0 3.699129536016699e-08
that O 0 8.041644017353633e-10
deletions O 0 5.7634107264448176e-08
and O 0 3.4930576209291075e-09
duplications O 0 8.284870745001172e-08
that O 0 3.592160735532701e-10
were O 0 1.4136720682955684e-09
localized O 0 9.768141850940992e-09
in O 0 6.204992630820527e-10
the O 0 3.017510907810106e-09
distal O 0 2.9098566756147193e-07
part O 0 4.1888479351825936e-09
of O 0 1.4576464479887363e-08
the O 0 3.9347054503480194e-09
gene O 0 6.000106522741078e-10
seemed O 0 2.4617452520914185e-09
to O 0 4.112794133037667e-11
be O 0 7.452281847175612e-11
preferentially O 0 2.441949309428537e-09
associated O 0 7.500903009827198e-09
with O 0 3.640715506847414e-09
cognitive B-Disease 0 0.0005628992221318185
impairment I-Disease 1 0.7405809760093689
. O 0 1.0315215149603318e-05

Two O 0 1.7908871541294502e-06
altered O 0 3.9440351429220755e-06
Dp71 O 0 4.67331446998287e-05
transcripts O 0 5.954844368716294e-07
and O 0 1.6159315663344387e-08
two O 0 2.1431503238744654e-09
deleted O 0 1.3773687079776664e-08
Dp140 O 0 4.9169162963380586e-08
DNA O 0 2.2211907868552316e-09
sequences O 0 1.5218755422541363e-10
were O 0 1.4315525154184883e-10
found O 0 1.3439113710767003e-10
in O 0 1.978595065565969e-10
four O 0 7.74931285807412e-10
patients O 0 6.542379082929983e-09
with O 0 1.4294148975579901e-08
severe O 1 1.0
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 1.0
. O 0 1.3959988791611977e-05

These O 0 9.457630767428782e-08
findings O 0 3.211347276987908e-08
suggest O 0 5.213125042757838e-09
that O 0 9.466064043728295e-11
some O 0 4.352643245830734e-11
sequences O 0 1.1586124420981392e-10
located O 0 2.3204016486033652e-10
in O 0 4.06593300694702e-11
the O 0 3.653088109789593e-10
distal O 0 7.665102685905367e-08
part O 0 3.863189323993765e-09
of O 0 5.4038209462703435e-09
the O 0 7.447255034875866e-10
gene O 0 8.672444012924885e-11
and O 0 6.418315878775616e-11
, O 0 5.090345246011596e-12
in O 0 5.6151546086458115e-12
particular O 0 1.304473057350819e-10
, O 0 3.6299366290570845e-11
some O 0 1.0277510092970843e-10
DMD B-Disease 1 1.0
isoforms O 0 1.944928129660184e-07
expressed O 0 5.757419874186098e-09
in O 0 1.1460302706822745e-09
the O 0 1.6730689722521674e-08
brain O 0 3.267514046001452e-07
may O 0 3.409387216990467e-10
be O 0 5.953933179814186e-11
related O 0 1.4503908074559035e-09
to O 0 6.853618228497282e-10
the O 0 3.176065632715108e-08
cognitive B-Disease 0 2.44372604356613e-05
impairment I-Disease 0 2.6550886104814708e-05
associated O 0 1.212302663589071e-06
with O 0 6.638453697860314e-08
DMD B-Disease 1 1.0
. O 0 2.2820304934612068e-07
. O 0 1.6809751457458333e-07

I1307K O 0 0.0002142841403838247
APC O 0 9.35355910769431e-06
and O 0 8.133231688134401e-08
hMLH1 O 0 1.38678160510608e-06
mutations O 0 7.686533187722944e-09
in O 0 2.4868993531157457e-09
a O 0 1.031475527213388e-08
non O 0 1.4965952743750677e-07
- O 0 1.9288157204755407e-07
Jewish O 0 6.375802996672064e-08
family O 0 6.61975096960532e-09
with O 0 1.5992129842601344e-10
hereditary B-Disease 1 0.9999998807907104
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.051451172679662704

We O 0 2.1864119048586872e-07
describe O 0 1.473974435839409e-07
a O 0 6.307643474201541e-08
French O 0 1.2524993735496537e-06
Canadian O 0 8.932060154620558e-06
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 1.395768686052179e-05
HNPCC B-Disease 1 0.9999997615814209
) O 0 7.59718599141479e-09
kindred O 0 1.006763113764464e-06
which O 0 6.264355700835722e-10
carries O 0 2.0434369751853865e-09
a O 0 1.6029578775444975e-09
novel O 0 1.2385003245185544e-08
truncating O 0 2.556530489528086e-07
mutation O 0 1.1979163438979867e-08
in O 0 6.40878106139553e-09
hMLH1 O 0 2.6251586859871168e-06
. O 0 3.569095099464903e-07

Interestingly O 0 9.553060408507008e-06
, O 0 5.528891477979414e-08
the O 0 5.74558605137554e-08
I1307K O 0 1.69932081917068e-06
APC O 0 1.365682322784778e-07
polymorphism O 0 5.527911284275433e-08
, O 0 9.06146754853232e-11
associated O 0 4.814540432995784e-10
with O 0 2.1296563471051577e-11
an O 0 1.5903363695390915e-11
increased O 0 6.566741594937753e-10
risk O 0 1.3191367997933412e-07
of O 1 0.9996374845504761
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 5.0288710973234174e-09
is O 0 2.9058413661409155e-11
also O 0 1.2306335638034849e-11
present O 0 3.068864259936355e-11
in O 0 1.1876184757841912e-10
this O 0 4.3629938550893144e-10
family O 0 3.1434968406074404e-08
. O 0 4.5649063196151474e-08

The O 0 2.988535470649367e-06
I1307K O 0 7.3431565397186205e-06
polymorphism O 0 1.020597437673132e-06
has O 0 3.2336693323031795e-09
previously O 0 1.6465577790114594e-09
only O 0 3.686193017493622e-11
been O 0 1.060086185500353e-10
identified O 0 2.9058153105943063e-10
in O 0 3.9723217770681885e-11
individuals O 0 8.625819676588709e-12
of O 0 1.3854416280878468e-08
self O 0 1.3839394341630396e-07
- O 0 2.4593910552539455e-07
reported O 0 5.115337042838064e-09
Ashkenazi O 0 4.2385462961647136e-07
Jewish O 0 2.219806916059497e-08
origins O 0 1.7441476529711508e-07
. O 0 5.1658350486150084e-08

In O 0 1.1156956247759808e-07
addition O 0 1.8684735536567132e-08
, O 0 1.8071073526471082e-09
in O 0 3.190810948794365e-10
this O 0 4.0083997232542856e-10
family O 0 1.2167018503816962e-08
, O 0 1.3698402134831866e-10
there O 0 4.665013167426402e-11
appears O 0 2.0812216394716643e-09
to O 0 3.11473263847617e-10
be O 0 6.104657890304566e-10
no O 0 1.8764512166313807e-09
relationship O 0 2.883467242753568e-09
between O 0 3.1340483541697495e-09
the O 0 5.193375063328176e-09
I1307K O 0 2.049237934897974e-08
polymorphism O 0 2.208900617972631e-09
and O 0 4.305849427010955e-11
the O 0 4.992110544388417e-11
presence O 0 4.105567968926138e-11
or O 0 6.043291977952947e-10
absence O 0 3.788253621905824e-08
of O 0 1.3439748158816656e-07
cancer B-Disease 0 1.0301562269887654e-06
. O 0 1.1995282989119005e-08
. O 0 6.076979275349004e-08

Identification O 0 4.872984504800115e-07
of O 0 3.7621734350068436e-07
a O 0 9.14930176065809e-09
novel O 0 1.7847948896587695e-08
mutation O 0 2.0168009484677896e-09
of O 0 2.317215219704849e-08
the O 0 3.2449776199428015e-08
CPO O 0 1.865528702182928e-06
gene O 0 3.919193414247957e-09
in O 0 1.152103412671579e-09
a O 0 2.675030685850288e-08
Japanese O 0 2.373197457927745e-05
hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 0.999880313873291
family O 0 4.866923518420663e-06
. O 0 3.586940806599159e-07

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
( O 0 1.2556000910990406e-05
HCP B-Disease 1 1.0
) O 0 6.397461760343504e-08
is O 0 6.155146614617024e-09
an O 0 7.524704415118322e-09
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
characterized O 0 1.0114276847161818e-06
by O 0 1.402349791845836e-09
a O 0 4.6906627915177523e-08
deficiency B-Disease 0 0.2727885842323303
of I-Disease 1 0.8322811126708984
coproporphyrinogen I-Disease 1 0.7783827781677246
oxidase I-Disease 0 3.0932423555896094e-07
( O 0 1.22149590442433e-09
CPO O 0 2.7016588433070865e-07
) O 0 1.0824243584783844e-10
caused O 0 5.47507206238862e-10
by O 0 7.670532958803378e-11
a O 0 1.4286891669712531e-09
mutation O 0 1.083339862262278e-09
in O 0 5.91416304818182e-10
the O 0 1.2357042500354964e-08
CPO O 0 1.8213305565950577e-06
gene O 0 8.457707423303873e-08
. O 0 8.576832755124997e-08

Only O 0 1.2653657677219599e-07
11 O 0 4.2352123585942536e-08
mutations O 0 5.60798962823128e-10
of O 0 5.363793409429718e-09
the O 0 3.86039022970408e-09
gene O 0 2.2945285671482907e-09
have O 0 2.025632023228141e-10
been O 0 1.4236078982321487e-09
reported O 0 3.419046601393916e-09
in O 0 7.911917343506047e-09
HCP B-Disease 1 1.0
patients O 0 0.0009004843304865062
. O 0 4.584251655614935e-06

We O 0 7.167442106492672e-08
report O 0 3.854621954957338e-09
another O 0 1.0029600483463241e-09
mutation O 0 7.354177267160367e-10
in O 0 2.8879573732432107e-10
a O 0 1.0148024642830933e-08
Japanese O 0 9.532928743283264e-06
family O 0 5.379820322559681e-07
. O 0 2.625639297093585e-07

Polymerase O 0 1.4829470273980405e-05
chain O 0 2.9813114110766037e-07
reaction O 0 2.3734651577456134e-08
- O 0 9.03771208982107e-08
single O 0 2.587959402333695e-09
strand O 0 6.58921583962524e-09
conformational O 0 4.4829656653533334e-10
polymorphism O 0 8.953273122891403e-10
and O 0 2.2798422871783686e-11
direct O 0 1.2502905655242813e-10
sequence O 0 5.546172895942725e-11
analyses O 0 1.187065862273684e-10
demonstrated O 0 2.4487673000450627e-10
a O 0 4.5461509556865565e-10
C O 0 1.3122103403873098e-08
to O 0 6.721339040893781e-10
T O 0 7.391728562566868e-09
substitution O 0 9.431975200868692e-09
in O 0 1.068264587900103e-09
exon O 0 1.1834251800735274e-08
1 O 0 3.0530804551176516e-09
of O 0 8.790825845039762e-10
the O 0 3.16359116681042e-09
CPO O 0 1.1548291922736098e-07
gene O 0 7.71676111899211e-10
at O 0 9.688960744824726e-10
nucleotide O 0 9.460364713831382e-10
position O 0 6.842532318529493e-09
85 O 0 7.953008918093474e-09
, O 0 1.2622375367143945e-10
which O 0 2.0202764461352274e-10
lies O 0 3.782448487754664e-08
in O 0 1.7877443969638307e-09
the O 0 9.096439157474379e-09
putative O 0 2.9305709858817863e-07
presequence O 0 4.621205675903184e-07
for O 0 8.014892638463778e-10
targeting O 0 5.0873731893830154e-09
to O 0 6.07776584615749e-09
mitochondria O 0 8.946893785832799e-07
. O 0 2.756821118055086e-07

This O 0 3.326888631249858e-08
mutation O 0 7.523212275373226e-09
changes O 0 1.1425360657568717e-09
the O 0 1.7120120876512601e-09
codon O 0 7.481866237668555e-10
for O 0 2.1963214580367207e-10
glutamine O 0 2.4431840994765253e-09
to O 0 4.5539788606774323e-10
a O 0 1.66796998435359e-09
termination O 0 1.1428421942127898e-07
codon O 0 1.3774711149494578e-08
at O 0 3.0095155256759654e-09
amino O 0 4.0710107507280213e-10
acid O 0 1.3010396093804388e-09
position O 0 2.5592935770646363e-08
29 O 0 3.3773341101550614e-07
. O 0 1.7432945753625972e-07

MaeI O 0 0.00019615385099314153
restriction O 0 7.982922056726238e-08
analysis O 0 6.535170626875697e-09
showed O 0 5.120081247866892e-09
two O 0 2.7889837661554395e-10
other O 0 1.0263288829914785e-10
carriers O 0 1.485615852558908e-09
in O 0 2.7287105908158082e-09
the O 0 8.029344655824389e-08
family O 0 1.788850880757309e-07
. O 0 7.439524551955401e-08

The O 0 3.0279245493147755e-06
C O 0 7.696533430134878e-05
- O 0 1.7839931388152763e-05
T O 0 1.1223736464671674e-06
mutation O 0 5.144259684897179e-09
is O 0 5.259022106685052e-10
located O 0 1.3705464541047263e-09
within O 0 3.768014789073959e-10
a O 0 8.479408286632406e-10
recently O 0 2.0482404661237297e-09
proposed O 0 3.2964981855343467e-09
putative O 0 6.662224194542432e-08
alternative O 0 3.840943918476114e-08
translation O 0 1.6067236430217235e-08
initiation O 0 6.4179550562926124e-09
codon O 0 6.12959183410311e-10
( O 0 8.710921567400831e-11
TIC O 0 7.327633610998419e-09
- O 0 1.6069932939899445e-08
1 O 0 1.1200789629128849e-08
) O 0 1.1807768651728168e-10
, O 0 5.258498150806368e-11
supporting O 0 1.29144694938077e-09
that O 0 4.2399039834606356e-10
TIC O 0 2.990731502450217e-07
- O 0 4.891035132459365e-07
1 O 0 1.3241495366855816e-07
is O 0 1.0248114579169965e-09
the O 0 7.4142643136099196e-09
real O 0 6.3920829518338e-08
TIC O 0 7.271125923580257e-08
rather O 0 1.348050560068259e-09
than O 0 6.114015405067619e-10
TIC O 0 7.790044520561423e-08
- O 0 1.4144717397357454e-07
2 O 0 3.759884492637866e-08
. O 0 2.0862296334911434e-09
. O 0 2.7018126402822418e-08

Human B-Disease 0 2.9221149588920525e-07
complement I-Disease 0 1.429594249202637e-06
factor I-Disease 0 2.2271357011049986e-05
H I-Disease 1 1.0
deficiency I-Disease 1 0.9999945163726807
associated O 0 1.530237750557717e-05
with O 0 3.350173938088119e-05
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9999892711639404

This O 0 1.2550320782622748e-08
study O 0 1.9124208883170013e-09
reports O 0 3.586822394652245e-09
on O 0 2.4082074112641294e-09
six O 0 1.810625677167721e-10
cases O 0 5.271957870256472e-10
of O 0 4.161399758118023e-08
deficiency B-Disease 1 0.997556209564209
in I-Disease 0 2.9536053602896573e-08
the I-Disease 0 3.027006556521883e-08
human I-Disease 0 2.429373591184003e-09
complement I-Disease 0 2.9730755635171136e-09
regulatory I-Disease 0 6.940711472225303e-08
protein I-Disease 0 1.0711051601219879e-08
Factor I-Disease 0 7.231056198264696e-09
H I-Disease 0 0.0068534198217093945
( O 0 1.053031439823826e-09
FH O 0 5.304056927002421e-08
) O 0 1.4512637619423785e-11
in O 0 4.433268856185446e-12
the O 0 3.0819860552533385e-11
context O 0 6.688625764361689e-10
of O 0 5.173244055356463e-10
an O 0 4.3016484818636513e-10
acute B-Disease 1 0.9999973773956299
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 4.297374289308209e-06

Five O 0 3.3755404160729086e-07
of O 0 3.391839342725689e-08
the O 0 1.712394226416336e-09
cases O 0 1.1997466908830745e-10
were O 0 1.0183924536999456e-10
observed O 0 1.069258848129806e-10
in O 0 1.2873975323290932e-11
children O 0 7.135631929083841e-12
presenting O 0 2.1618251633270802e-10
with O 0 1.7434891308454326e-09
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 1.0
HUS B-Disease 1 1.0
) O 0 2.5800436560530216e-06
. O 0 1.372673636979016e-06

Two O 0 1.3832296019700152e-07
of O 0 2.049207239451789e-07
the O 0 7.871820173477317e-08
children O 0 2.4371800133593524e-09
exhibited O 0 5.283053106097668e-09
a O 0 4.4875640980990283e-08
homozygous O 0 2.5323115551145747e-06
deficiency O 0 0.027175361290574074
characterized O 0 1.083522676026405e-07
by O 0 5.132713809530287e-09
the O 0 3.933889658469525e-08
absence O 0 1.5111825746316754e-07
of O 0 9.59825143809212e-08
the O 0 1.2845100982872282e-08
150 O 0 1.4126801950453682e-09
- O 0 7.812192559519815e-10
kD O 0 1.1467021110433961e-08
form O 0 4.84911000242505e-10
of O 0 2.5241323697855478e-08
Factor O 0 5.4085980139007006e-08
H O 1 0.9999498128890991
and O 0 3.384748037404961e-09
the O 0 8.52149795171897e-10
presence O 0 1.805060267923153e-10
, O 0 4.362708805327742e-11
upon O 0 8.748640145661568e-10
immunoblotting O 0 8.786391703097252e-08
, O 0 1.6544461634016017e-10
of O 0 2.3619075584235816e-09
the O 0 1.2853850428484748e-08
42 O 0 2.319089809077468e-08
- O 0 9.824590030405034e-09
kD O 0 2.9931936751381727e-07
Factor O 0 9.834418079890384e-08
H O 0 0.040473222732543945
- O 0 1.6979814176920627e-07
like O 0 4.078753335079455e-09
protein O 0 8.746658508584915e-09
1 O 0 1.8555034841938323e-08
( O 0 5.954594595181106e-10
FHL O 0 7.481389729946386e-06
- O 0 2.6373538730695145e-07
1 O 0 6.435769250856538e-08
) O 0 3.928771752370608e-10
and O 0 6.300254762336976e-10
other O 0 1.2606983235130542e-09
FH O 0 9.397120948051452e-07
- O 0 1.4590428421001889e-08
related O 0 5.474991571219334e-09
protein O 0 5.190701646284879e-09
( O 0 4.792433117017936e-10
FHR O 0 4.325712779973401e-06
) O 0 1.6010084369355582e-09
bands O 0 1.7461681522945582e-07
. O 0 1.7246975403395481e-07

Southern O 0 1.4040403584658634e-05
blot O 0 1.527490712760482e-05
and O 0 4.6496855254929415e-09
PCR O 0 2.3593782927378015e-08
analysis O 0 4.88272533516465e-10
of O 0 5.899629673677964e-10
DNA O 0 8.079623192713825e-09
of O 0 6.701475374626398e-09
one O 0 1.0111328441197998e-09
patient O 0 7.0960659570573625e-09
with O 0 1.3041950852610285e-09
homozygous O 0 4.153574195697729e-07
deficiency O 0 0.0034299883991479874
ruled O 0 6.780923285987228e-05
out O 0 1.6929840640500515e-08
the O 0 4.048711144122308e-09
presence O 0 1.2967883433745442e-09
of O 0 6.121323004038004e-09
a O 0 1.011123296201788e-09
large O 0 6.566867050139535e-10
deletion O 0 1.2395584558788642e-09
of O 0 1.4905913170437657e-09
the O 0 5.2803330596873366e-09
FH O 0 3.4991614938917337e-07
gene O 0 1.1115823816965076e-09
as O 0 5.720026119426791e-10
the O 0 2.7524575951787256e-09
underlying O 0 3.038442173419753e-06
defect O 0 7.546779215772403e-06
for O 0 3.358588784863059e-08
the O 0 2.7715566375263734e-06
deficiency O 1 0.999997615814209
. O 0 5.710052846552571e-06

The O 0 5.166101004761003e-07
other O 0 4.630798411398018e-09
four O 0 8.982350974129361e-10
children O 0 5.042562201129641e-11
presented O 0 2.6743305348020385e-09
with O 0 1.1793888088362792e-09
heterozygous O 0 5.5789655561966356e-08
deficiency O 0 0.0005990591598674655
and O 0 3.558178107709864e-08
exhibited O 0 7.3620682883301924e-09
a O 0 1.1413866296550168e-08
normal O 0 1.9189000610708717e-08
immunoblotting O 0 1.2640583690881613e-07
pattern O 0 1.6131098679039724e-09
of O 0 1.2478944544369597e-09
proteins O 0 3.596436690123106e-11
of O 0 2.3143165162053947e-09
the O 0 2.9162231740542666e-08
FH O 0 4.95588501507882e-05
family O 0 8.673200824205196e-08
. O 0 3.9722671374420315e-08

Factor B-Disease 1 0.9997908473014832
H I-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 8.894384784241538e-09
the O 0 5.657757817800757e-09
only O 0 9.428084979390405e-10
complement B-Disease 1 0.9905704259872437
deficiency I-Disease 1 1.0
associated O 0 3.2914035728026647e-06
with O 0 1.6529659774278116e-07
HUS B-Disease 1 1.0
. O 0 7.825499051250517e-05

These O 0 3.937605441706182e-08
observations O 0 9.62288808636913e-08
suggest O 0 1.3010950539182886e-08
a O 0 5.243680156752362e-09
role O 0 1.4096769973548362e-08
for O 0 3.3717257874599227e-09
FH O 0 1.4574189663107973e-05
and O 0 6.855010070694334e-08
/ O 0 3.927460511476966e-06
or O 0 3.580337804010014e-08
FH O 0 3.278171561760246e-06
receptors O 0 1.5238804662587313e-09
in O 0 6.629031351623738e-11
the O 0 4.840765011060455e-10
pathogenesis O 0 2.7520241019374225e-06
of O 0 1.5741665038149222e-07
idiopathic O 1 0.9999954700469971
HUS B-Disease 1 1.0
. O 0 1.655962137192546e-06
. O 0 4.908109190182586e-07

Further O 0 2.09311394883116e-08
evidence O 0 2.5111811297051645e-08
for O 0 1.139293659413454e-09
a O 0 2.3756423495058243e-09
major O 0 2.0423819080406247e-08
ancient O 0 1.6500002857355867e-06
mutation O 0 1.8533586398916668e-06
underlying O 1 0.9262735843658447
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 0 7.548123335254786e-07
linkage O 0 1.2200597439004923e-06
disequilibrium O 0 6.152133096293255e-07
studies O 0 9.18834841545646e-10
in O 0 2.5203819586927523e-10
the O 0 3.604922138578104e-09
Japanese O 0 1.4891605815137154e-07
population O 0 3.7120670426382674e-10
. O 0 1.4053279429049326e-08

The O 0 4.9788974138209596e-05
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.0007590099121443927
DM B-Disease 1 1.0
) O 0 2.8407905361405028e-08
mutation O 0 6.495069371226236e-09
is O 0 4.045806467622981e-10
an O 0 2.717303881905053e-10
unstable O 0 1.6108605223053019e-06
( O 0 3.7145991171883e-08
CTG O 0 1.5959632946760394e-05
) O 0 1.1617153905518762e-09
n O 0 4.626472538404869e-09
repeat O 0 2.3685120531524717e-09
, O 0 5.1816950036309706e-11
present O 0 2.2670516852674183e-10
at O 0 6.618535164371053e-10
a O 0 8.713430671436484e-11
copy O 0 6.416605580206181e-10
number O 0 3.498040745952835e-11
of O 0 1.640451330331416e-09
5 O 0 1.60739794807796e-08
- O 0 3.450731256293693e-08
37 O 0 4.049392643423744e-08
repeats O 0 2.0559834723599124e-08
on O 0 8.014590768823382e-09
normal O 0 7.907839383314297e-10
chromosomes O 0 5.274190528758993e-10
but O 0 2.2550367129170468e-10
amplified O 0 5.4082134326449705e-09
to O 0 9.985640092580184e-10
50 O 0 5.4319908571187625e-09
- O 0 1.2253631886949279e-08
3000 O 0 6.5189738052140456e-09
copies O 0 4.807284792462951e-09
on O 0 1.3081249505830783e-07
DM B-Disease 1 0.9999997615814209
chromosomes O 0 2.4677314058862976e-07
. O 0 1.5085633719991165e-07

Previous O 0 1.2055867273375043e-06
findings O 0 6.364150806348334e-08
in O 0 7.636367094221441e-09
Caucasian O 0 1.4256430347359128e-07
populations O 0 5.777143208263169e-09
of O 0 6.440226485437961e-08
a O 0 1.7522130519864731e-06
DM B-Disease 1 1.0
founder O 1 0.995528519153595
chromosome O 0 1.7120660800173937e-07
raise O 0 4.918489615590715e-09
a O 0 1.1542370392803036e-09
question O 0 1.7269080609949583e-09
about O 0 1.793247668413489e-11
the O 0 8.685753505321969e-11
molecular O 0 1.220561429704503e-10
events O 0 5.8791795216894815e-12
involved O 0 3.121719549525892e-11
in O 0 6.337142616219538e-11
the O 0 1.3636677342887538e-09
expansion O 0 6.125961959924098e-08
mutation O 0 4.482918924963997e-08
. O 0 5.831303084846695e-08

To O 0 2.4153806066351535e-07
investigate O 0 1.0836880193210163e-07
whether O 0 2.5162345096418903e-08
a O 0 4.537838904639102e-08
founder O 0 9.490878483120468e-07
chromosome O 0 8.79530759334557e-09
for O 0 1.874119082145853e-09
the O 0 6.399218932529038e-08
DM B-Disease 1 1.0
mutation O 0 1.764714774310505e-08
exists O 0 1.4387578906038812e-09
in O 0 1.3665416020991472e-10
the O 0 3.672762094453219e-10
Japanese O 0 1.0865872646093067e-08
population O 0 5.164257476514278e-12
, O 0 1.4142153594021156e-11
we O 0 5.6497504591357384e-11
genotyped O 0 7.766129783703946e-08
families O 0 6.100988464430301e-11
using O 0 4.456571223165895e-10
polymorphic O 0 2.5027510730524227e-08
markers O 0 3.327218323079251e-08
near O 0 3.793387577388785e-07
the O 0 6.791707818365467e-08
( O 0 1.0330782451717369e-08
CTG O 0 6.009526259731501e-06
) O 0 3.171191087503189e-09
n O 0 1.0562242636069641e-08
repeat O 0 8.51458104023095e-09
region O 0 3.6157816740711723e-09
and O 0 5.1067581274821805e-09
constructed O 0 2.4954424588941038e-06
haplotypes O 0 1.5656462437618757e-06
. O 0 1.372814750766338e-07

Six O 0 2.204907758596164e-07
different O 0 3.237335066685887e-09
haplotypes O 0 2.61871718976181e-07
were O 0 5.205017306053605e-09
found O 0 2.424226597241841e-09
and O 0 1.1204978278556155e-08
DM B-Disease 1 1.0
alleles O 0 6.938778795984035e-08
were O 0 3.454676189562633e-08
always O 0 5.157859916948837e-08
haplotype O 0 6.657398898823885e-06
A O 0 2.844841219484806e-06
. O 0 6.079554282223398e-07

To O 0 1.6747665654293087e-07
find O 0 1.7444811817313166e-08
an O 0 1.0733863797796062e-10
origin O 0 2.2200512539427564e-09
of O 0 2.805638565916979e-08
the O 0 2.3899051626585788e-08
( O 0 1.0954019913356206e-08
CTG O 0 6.151843081170227e-06
) O 0 1.9229993153402347e-09
n O 0 7.813418356761304e-09
repeat O 0 2.7858857443163743e-09
mutation O 0 1.4158624273008513e-10
and O 0 1.6741143193943486e-10
to O 0 2.54837012603204e-10
investigate O 0 2.099426410495653e-09
the O 0 1.482360678650707e-09
mechanism O 0 1.444031649810995e-08
of O 0 5.225299748445877e-09
the O 0 1.5909326078755726e-09
expansion O 0 5.088284904530838e-09
mutation O 0 7.609475549674727e-11
in O 0 2.1150066073505336e-11
the O 0 3.907741352726646e-10
Japanese O 0 2.0392640465161094e-08
population O 0 9.222894149785166e-12
we O 0 1.720770921587178e-11
have O 0 2.8015062492059428e-11
studied O 0 1.5468097913640122e-09
90 O 0 5.644607448118677e-09
Japanese O 0 8.543823923901073e-07
DM B-Disease 1 1.0
families O 0 1.6023044224766636e-08
comprising O 0 1.3328332881812344e-09
190 O 0 1.0517067217108433e-09
affected O 0 8.007496332673725e-10
and O 0 1.737573196436415e-09
130 O 0 2.556015665788891e-08
unaffected O 0 6.534885983455752e-07
members O 0 5.972387473462959e-09
. O 0 9.723978422471191e-08

The O 0 1.9572139535739552e-06
results O 0 2.7941728930613863e-08
suggest O 0 9.376781129333267e-09
that O 0 3.913895041396387e-10
a O 0 2.4299113832171315e-09
few O 0 1.6642963673874078e-09
common O 0 1.7008328967449415e-08
ancestral O 0 7.917352036201919e-07
mutations O 0 5.189154661522366e-10
in O 0 2.084979411343113e-10
both O 0 1.5427781274723884e-10
Caucasian O 0 6.581493749990841e-08
and O 0 8.191484823782957e-09
Japanese O 0 4.680662186729023e-07
populations O 0 1.5869948410962564e-10
have O 0 1.6579137368522012e-11
originated O 0 1.9773048476334765e-10
by O 0 1.5032926292679605e-11
expansion O 0 2.4157058575724477e-09
of O 0 1.2623007084044957e-09
an O 0 1.0853538207067359e-10
ancestral O 0 1.0221063106996553e-08
n O 0 1.8868591133980317e-09
= O 0 1.7016400510883045e-09
5 O 0 1.3069043625080212e-09
repeat O 0 1.0881919809690999e-09
to O 0 8.654783556494294e-10
n O 0 1.7324447654232245e-08
= O 0 5.5458642123085156e-08
19 O 0 7.653328282231087e-08
- O 0 9.787374466441179e-08
37 O 0 3.789763880490682e-08
copies O 0 2.7086443310508912e-08
. O 0 1.9968982201135077e-07

These O 0 3.195144060441635e-08
data O 0 2.2505659558191837e-08
support O 0 8.26978929779898e-09
multistep O 0 4.689486559072975e-07
models O 0 3.291580341624467e-08
of O 0 2.0204063844175835e-07
triplet O 0 1.4996398931543808e-06
repeat O 0 4.507921858021291e-08
expansion O 0 1.860841081224862e-08
that O 0 6.932009133375772e-11
have O 0 2.4672895670985184e-11
been O 0 4.1633071989899406e-11
proposed O 0 1.4583820262537017e-10
for O 0 3.494786751656598e-11
both O 0 1.588906783922539e-09
DM B-Disease 1 1.0
and O 0 2.2794139908910438e-07
Friedreichs B-Disease 0 0.0011813571909442544
ataxia I-Disease 0 0.1532827615737915
. O 0 7.91522580811943e-08
. O 0 1.835951906059563e-07

The O 0 1.4144407600724662e-07
molecular O 0 1.4644719215084478e-07
basis O 0 2.5100516154452635e-07
of O 0 0.0006010694778524339
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 4.596586578031747e-08
the O 0 2.3510947855243103e-08
western O 0 1.198417294290266e-07
Cape O 0 1.581483957124874e-06
, O 0 6.589375711740786e-10
South O 0 7.863563133980733e-09
Africa O 0 1.2281193839669413e-08
. O 0 4.237014294972141e-08

Deficiency B-Disease 1 0.9998902082443237
of I-Disease 0 0.00039705695235170424
the I-Disease 0 7.520082363043912e-06
sixth I-Disease 0 1.637103923712857e-05
component I-Disease 0 3.0097069725343317e-07
of I-Disease 0 4.912304518711608e-08
human I-Disease 0 4.1004848405634675e-09
complement I-Disease 0 4.9889390396629096e-08
( O 0 3.4026150785848586e-08
C6 O 1 0.9971991777420044
) O 0 2.7277895497945792e-09
has O 0 4.090850991289585e-10
been O 0 2.7177338157713393e-10
reported O 0 1.990104747662258e-10
in O 0 4.967149955237282e-11
a O 0 9.387992466747264e-11
number O 0 7.557660226809038e-12
of O 0 1.9213300395115596e-10
families O 0 9.705657805225698e-11
from O 0 2.4891000371951577e-10
the O 0 2.3043704722169878e-09
western O 0 1.0734452615679402e-07
Cape O 0 1.7524803297419567e-06
, O 0 1.7519061756843257e-09
South O 0 1.6343934206020094e-08
Africa O 0 1.695446627536512e-08
. O 0 7.053616002394847e-08

Meningococcal B-Disease 1 1.0
disease I-Disease 1 0.9999982118606567
is O 0 3.901102374470611e-08
endemic O 0 3.121503766578826e-08
in O 0 1.1878819039523592e-09
the O 0 1.2359469891976005e-08
Cape O 0 1.7620932339923456e-06
and O 0 1.5281883536388818e-09
almost O 0 1.8357149134118345e-10
all O 0 1.3728193581918902e-10
pedigrees O 0 1.6690592019585893e-08
of O 0 2.7816501102506663e-08
total O 0 8.965429998397667e-08
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 6.678127562054215e-08
C6Q0 O 0 0.0001556321803946048
) O 0 2.697402301521379e-10
have O 0 2.916663785490492e-11
been O 0 2.6521460028128274e-10
ascertained O 0 1.1384187814655888e-08
because O 0 4.247107665555916e-10
of O 0 7.5092483342587e-09
recurrent O 0 0.0002575581311248243
disease O 0 0.030263472348451614
. O 0 1.0266940080327913e-06

We O 0 1.4719347518621362e-07
have O 0 2.757844175249602e-09
sequenced O 0 8.832055975460662e-09
the O 0 3.1979594528053212e-09
expressed O 0 5.5562692224953025e-09
exons O 0 5.393279138843354e-07
of O 0 1.4413863880236022e-07
the O 0 7.500591436837567e-08
C6 O 0 6.8039284997212235e-06
gene O 0 8.773538562323324e-10
from O 0 1.766794349711276e-10
selected O 0 9.970695102889948e-11
cases O 0 5.59185857340605e-11
and O 0 1.0161436275746283e-10
have O 0 3.5949212356944926e-11
found O 0 5.683279402646235e-10
three O 0 6.182228062812101e-10
molecular O 0 5.142957206771825e-07
defects O 0 0.4711639881134033
leading O 0 5.937378659837123e-07
to O 0 3.306934814872875e-08
total O 0 5.255718349417293e-08
deficiency O 1 0.999434769153595
879delG O 0 9.269668225897476e-05
, O 0 1.0667619010362728e-09
which O 0 9.54460260826906e-11
is O 0 9.988283117268182e-11
the O 0 2.386122410769076e-10
common O 0 5.004509251449463e-09
defect O 0 1.5252196305937105e-07
in O 0 1.6105704547797473e-09
the O 0 1.932512105895512e-08
Cape O 0 1.108401875171694e-06
and O 0 2.6034754352366463e-09
hitherto O 0 5.3420489365407775e-08
unreported O 0 9.175672666117407e-09
, O 0 4.2943339856327256e-11
and O 0 1.5185874779888309e-10
1195delC O 0 2.3206563781741352e-08
and O 0 1.397692739324441e-09
1936delG O 0 9.03407553209945e-08
, O 0 1.7796872309183698e-10
which O 0 5.138204098309451e-11
have O 0 1.371845692599294e-10
been O 0 1.3604437576475448e-09
previously O 0 4.325609648248019e-09
reported O 0 6.819662612400634e-10
in O 0 4.4364031892563105e-10
African O 0 1.386578407647221e-08
- O 0 1.3778816310150432e-07
Americans O 0 1.0517513082675123e-08
. O 0 9.661398792104592e-08

We O 0 1.4262307104218053e-06
also O 0 6.587044509842599e-08
show O 0 2.2041490854718404e-09
that O 0 8.696064701663175e-11
the O 0 2.4115396346502393e-09
879delG O 0 3.671424906315224e-07
and O 0 4.944044729171537e-09
1195delC O 0 2.3715817860647803e-06
defects O 0 1.4678291790914955e-06
are O 0 6.474482061591402e-11
associated O 0 5.1855755245355795e-09
with O 0 2.156571143885344e-09
characteristic O 0 0.0003727719886228442
C6 O 1 1.0
/ O 1 0.8231108784675598
C7 O 0 1.543074904475361e-05
region O 0 8.122778893948635e-09
DNA O 0 1.1820219469882431e-08
marker O 0 1.298635599056297e-08
haplotypes O 0 5.356279419999055e-09
, O 0 3.383286012459408e-11
although O 0 1.622563750025563e-10
small O 0 1.7711604405334924e-10
variations O 0 1.769391966277567e-09
were O 0 5.371861178105064e-09
observed O 0 6.256109941205068e-08
. O 0 1.4357560473854392e-07

The O 0 4.502792307903292e-06
1936delG O 0 5.3118725190870464e-05
defect O 0 6.758902600267902e-05
was O 0 8.314780757245899e-07
observed O 0 5.891076071407042e-09
only O 0 4.942826148379709e-10
once O 0 4.007393084037858e-09
in O 0 3.334152676170987e-10
the O 0 2.146533395475103e-09
Cape O 0 3.367916576735297e-07
, O 0 6.06120501012164e-11
but O 0 3.432981329765106e-11
its O 0 1.7680888697579888e-10
associated O 0 3.774994095095963e-09
haplotype O 0 7.105298323040188e-07
could O 0 3.341821397384592e-08
be O 0 9.500549680296899e-09
deduced O 0 8.557613000448328e-07
. O 0 2.1390822269040655e-07

The O 0 1.2079541420462192e-06
data O 0 1.0488910362482784e-07
from O 0 1.2356783152256412e-08
the O 0 1.2153937412051619e-08
haplotypes O 0 1.447956918809723e-07
indicate O 0 1.3063311543604073e-09
that O 0 1.23947282992809e-10
these O 0 3.9631364856518303e-10
three O 0 9.625522601197645e-10
molecular O 0 7.640624488658432e-08
defects O 0 2.299856447507409e-07
account O 0 6.046612655019601e-10
for O 0 2.5294757399763057e-09
the O 0 6.859999643893389e-07
defects O 1 0.9966727495193481
in O 0 9.461343708494496e-09
all O 0 1.7116267292394127e-09
the O 0 7.928442791182988e-09
38 O 0 8.214234625825156e-09
unrelated O 0 4.377116002984849e-09
C6Q0 O 0 4.293216534279054e-06
individuals O 0 3.655860336682082e-11
we O 0 2.261881515419617e-10
have O 0 1.3598774883938347e-10
studied O 0 1.889668421739543e-09
from O 0 8.446864874223081e-10
the O 0 1.1003690403299515e-08
Cape O 0 1.8313297687200247e-06
. O 0 6.30810106372337e-08

We O 0 6.197015522957372e-07
have O 0 1.1327915494518948e-08
also O 0 1.486140099871136e-09
observed O 0 1.1616024808702718e-09
the O 0 2.999303916340068e-09
879delG O 0 2.2582570124995982e-07
defect O 0 1.2970863849659509e-07
in O 0 5.9099267701867575e-09
two O 0 4.9629907294956865e-08
Dutch O 1 1.0
C6 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
kindreds O 0 0.014141414314508438
, O 0 1.7134462737544709e-09
but O 0 3.2525834803287523e-10
the O 0 2.3340431809515394e-09
879delG O 0 2.593194210476213e-07
defect O 0 1.2399378590544075e-07
in O 0 2.4827095934654153e-09
the O 0 6.0350501485118e-08
Cape O 0 5.4439028644992504e-06
probably O 0 2.7896463805632266e-08
did O 0 1.2789257430867451e-09
not O 0 1.8399774759370047e-10
come O 0 5.362972288480705e-10
from O 0 1.3043145452584781e-09
The O 0 6.427363530292496e-09
Netherlands O 0 5.98173812704772e-08
. O 0 9.357111530050588e-09
. O 0 1.5025186428374582e-07

Complement B-Disease 1 0.9999988079071045
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 4.857835023130974e-08
seven O 0 7.1044627958372075e-09
further O 0 3.2134042093900916e-09
molecular O 0 3.1598602845406276e-07
defects O 0 4.043123044539243e-05
and O 0 2.6070086089902134e-09
their O 0 2.5814324011719236e-09
associated O 0 1.0069148856928223e-06
marker O 0 1.3310653230291791e-05
haplotypes O 0 2.7336112907505594e-05
. O 0 2.2497692953038495e-06

Seven O 0 4.5984810981281043e-07
further O 0 1.4792575164790378e-08
molecular O 0 4.900933703311239e-08
bases O 0 3.703277684508066e-07
of O 0 0.0004208729660604149
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 5.101815503394391e-08
described O 0 5.899652251173393e-07
. O 0 1.7385461603680596e-07

All O 0 3.144270621646683e-08
these O 0 5.344900522175067e-09
new O 0 1.1273577626980114e-08
molecular O 0 3.90318689369451e-07
defects O 0 3.933792243060452e-07
involve O 0 8.575340437744217e-09
single O 0 1.0300367847548841e-07
- O 0 8.789978522827369e-08
nucleotide O 0 4.082234639213311e-08
events O 0 4.80615491849079e-10
, O 0 6.983566502860583e-11
deletions O 0 2.3128339243783103e-09
and O 0 3.1867419814091136e-10
substitutions O 0 9.409729884168883e-09
, O 0 2.348053973477704e-10
some O 0 3.6887107951466547e-11
of O 0 2.13192619114011e-09
which O 0 2.762602091532784e-10
alter O 0 9.883795115683824e-09
splice O 0 5.712622623832431e-07
sites O 0 2.23634555318597e-09
, O 0 1.0375954262453746e-10
and O 0 3.465832898452703e-10
others O 0 5.486490373129982e-09
codons O 0 4.3032122221120517e-07
. O 0 6.594215733457531e-07

They O 0 4.073531201242986e-08
are O 0 8.136296636429563e-10
distributed O 0 7.50934481263954e-10
along O 0 3.7946876751959735e-09
the O 0 8.01578359244104e-09
C7 O 0 2.465445504640229e-06
gene O 0 3.333899822877129e-09
, O 0 1.0682477125101286e-10
but O 0 1.0137915507080208e-10
predominantly O 0 1.40021091943332e-10
towards O 0 9.514693921630624e-09
the O 0 1.1185461445961664e-08
3 O 0 4.8811379826929624e-08
end O 0 1.0373118897177847e-07
. O 0 1.2848290964484477e-07

All O 0 6.277314668068357e-08
were O 0 1.1693233048504226e-08
found O 0 2.022868539341971e-09
in O 0 9.896523600616547e-10
compound O 0 2.502789868685795e-07
heterozygous O 0 7.675662772044234e-09
individuals O 0 3.546398730236433e-10
. O 0 6.450959233461617e-08

The O 0 8.14324666862376e-05
C6 O 1 0.9999974966049194
/ O 0 0.2948005497455597
C7 O 0 0.0007084230310283601
marker O 0 1.528131406303146e-06
haplotypes O 0 9.989761338147218e-07
associated O 0 4.110745521757053e-08
with O 0 1.0316703047408282e-08
most O 0 9.352773304271977e-06
C7 B-Disease 1 1.0
defects I-Disease 1 1.0
are O 0 5.614071429960177e-09
tabulated O 0 6.895425741504368e-08
. O 0 1.135512928129856e-08
. O 0 8.320707678421968e-08

A O 0 1.6802179743535817e-05
genome O 0 8.428974638263753e-07
- O 0 3.931448588900821e-07
wide O 0 8.330108158816074e-08
search O 0 4.464249059310532e-08
for O 0 1.7549729447452478e-09
chromosomal O 0 1.3885642147215549e-06
loci O 0 1.20798404168454e-06
linked O 0 1.1767662726924755e-05
to O 0 2.0742585604693886e-07
mental O 1 0.9999998807907104
health O 0 0.005345826502889395
wellness O 0 4.924974291498074e-06
in O 0 1.4343684018314207e-09
relatives O 0 6.577525191175937e-09
at O 0 6.665523688553776e-10
high O 0 1.5852349433131963e-09
risk O 0 4.747183535158683e-09
for O 0 7.901181930947132e-08
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
among O 0 1.6791334928711876e-05
the O 0 6.828923687862698e-06
Old O 0 7.672600622754544e-05
Order O 0 2.067150717266486e-06
Amish O 0 1.2331810467003379e-05
. O 0 3.378487463123747e-07

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 1.0
BPAD B-Disease 1 1.0
; O 1 1.0
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 1.3108612506584905e-07
is O 0 2.921052288940018e-10
characterized O 0 1.3406300514162695e-09
by O 0 2.449014602223798e-10
episodes O 0 7.124901912902715e-08
of O 0 4.0984551219480636e-07
mania B-Disease 0 0.0026260865852236748
and O 0 2.191825245745349e-07
/ O 0 0.0001515561161795631
or O 0 2.815158772762061e-08
hypomania B-Disease 0 2.5188017389154993e-05
interspersed O 0 2.1900059543611405e-09
with O 0 5.7059634794853764e-12
periods O 0 1.3855791181072163e-08
of O 0 3.510558599373326e-08
depression B-Disease 0 2.7791324100689963e-05
. O 0 8.894440384210611e-08

Compelling O 0 1.3531953300116584e-06
evidence O 0 3.161840709253738e-07
supports O 0 8.614048141453168e-08
a O 0 5.087819499038915e-09
significant O 0 3.270963278012573e-09
genetic O 0 1.8036441673530135e-08
component O 0 5.544055881046006e-08
in O 0 2.2539456967507476e-09
the O 0 1.2039245156358902e-08
susceptibility O 0 1.3761903119302588e-06
to O 0 4.100174422205782e-08
develop O 0 0.002176059177145362
BPAD B-Disease 1 1.0
. O 0 3.453682438703254e-05

To O 0 1.5255527330282348e-07
date O 0 8.699699378666992e-07
, O 0 2.351788763732543e-09
however O 0 1.3549900090836786e-09
, O 0 1.1279480127690533e-10
linkage O 0 1.5552567234067283e-08
studies O 0 5.95995808261307e-10
have O 0 1.0918006776439171e-10
attempted O 0 1.5516240736701548e-08
only O 0 2.4666838016607073e-10
to O 0 4.4949355348933295e-10
identify O 0 1.2933210058463374e-08
chromosomal O 0 1.2651174756683758e-06
loci O 0 2.08941102641802e-07
that O 0 1.2163068330295346e-09
cause O 0 1.052990228345152e-07
or O 0 2.797226894557525e-09
increase O 0 4.158151045707825e-10
the O 0 2.0214800944273748e-09
risk O 0 3.6762262123346545e-09
of O 0 3.3989692838076735e-08
developing O 0 1.038080154103227e-05
BPAD B-Disease 1 1.0
. O 0 3.4605895962158684e-06

To O 0 1.5072704684371274e-07
determine O 0 2.9869344331245884e-08
whether O 0 1.070047428441967e-08
there O 0 1.7418936293367437e-09
could O 0 1.2203826837975384e-09
be O 0 7.521457345838201e-10
protective O 0 2.0855787852269714e-07
alleles O 0 8.258531081217768e-10
that O 0 5.682192563694066e-11
prevent O 0 1.5278969200949177e-09
or O 0 3.2520954817982783e-09
reduce O 0 9.897113351087228e-09
the O 0 4.981120849123499e-09
risk O 0 4.504120632020658e-09
of O 0 2.0918808019132484e-08
developing O 0 3.5541806937544607e-06
BPAD B-Disease 1 1.0
, O 0 2.970358958798158e-10
similar O 0 7.488216297035777e-11
to O 0 1.494023377235365e-10
what O 0 7.703521848201333e-11
is O 0 1.808977967421299e-11
observed O 0 1.1560871010507512e-10
in O 0 4.455548777149154e-11
other O 0 2.7675135516602722e-09
genetic B-Disease 1 1.0
disorders I-Disease 1 1.0
, O 0 4.43208358902325e-09
we O 0 8.697561559856126e-10
used O 0 1.2125292414566502e-06
mental O 1 0.9999997615814209
health O 0 0.00011688756057992578
wellness O 0 2.328221171410405e-06
( O 0 2.2304064151157377e-10
absence O 0 3.1898572672162118e-09
of O 0 9.475394691094152e-09
any O 0 6.900530991060805e-08
psychiatric B-Disease 1 0.9651365876197815
disorder I-Disease 0 3.856933687984565e-07
) O 0 3.218199040588843e-10
as O 0 6.832956422897496e-10
the O 0 4.834004307952e-09
phenotype O 0 2.1407654315908076e-08
in O 0 1.1342028427563378e-09
our O 0 2.2443590097509514e-08
genome O 0 1.1368695318481059e-08
- O 0 3.194266895434339e-08
wide O 0 4.086121663249287e-08
linkage O 0 2.4735936676734127e-07
scan O 0 1.7132730079083558e-07
of O 0 3.249089886026013e-08
several O 0 2.1636907820976603e-09
large O 0 2.0774619802210736e-09
multigeneration O 0 6.168830282149429e-07
Old O 0 1.870734820386133e-07
Order O 0 1.522275567822362e-07
Amish O 0 8.236042390308285e-07
pedigrees O 0 5.343211029185113e-08
exhibiting O 0 1.5517623852545626e-09
an O 0 2.045760227886717e-10
extremely O 0 1.21416103837646e-08
high O 0 1.442395785034023e-07
incidence O 0 2.7756673262047116e-06
of O 0 2.554092679929454e-05
BPAD B-Disease 1 1.0
. O 0 4.9642334488453344e-05

We O 0 5.777079081781267e-07
have O 0 6.127537588440646e-09
found O 0 2.853333125329982e-09
strong O 0 2.1231365554541526e-09
evidence O 0 1.5506330441894534e-08
for O 0 1.8487552599921742e-09
a O 0 1.2420867001594615e-08
locus O 0 8.984602573036682e-08
on O 0 6.329553770001439e-08
chromosome O 0 7.566660542579484e-08
4p O 0 0.00036621122853830457
at O 0 2.698679395507497e-07
D4S2949 O 0 2.682997717329272e-07
( O 0 8.200203849284549e-10
maximum O 0 1.4023773253768468e-08
GENEHUNTER O 0 3.5947837204730604e-06
- O 0 9.81725136739442e-08
PLUS O 0 8.062553291665608e-08
nonparametric O 0 1.0704030017905097e-07
linkage O 0 1.8193615503037108e-08
score O 0 3.982673746349974e-09
= O 0 1.831172991018093e-09
4 O 0 4.712424672703719e-09
. O 0 2.960686695807624e-10
05 O 0 1.179198676481974e-07
, O 0 9.336355022426801e-10
P O 0 1.8361882325734769e-07
= O 0 1.1687256495918064e-08
5 O 0 2.096177231791785e-09
. O 0 2.1071276667949945e-10
22 O 0 3.3826696999028627e-09
x O 0 1.956280648585107e-08
10 O 0 3.4692009265313573e-09
( O 0 7.389948653013789e-10
- O 0 1.2451038422511829e-08
4 O 0 2.11122905824368e-08
) O 0 4.021049881952621e-10
; O 0 8.035158649555285e-10
SIBPAL O 0 7.645895493624266e-06
Pempirical O 0 1.7232440541192773e-06
value O 0 1.4316031915484473e-08
< O 0 3.241093438077769e-08
3 O 0 9.082829599549314e-09
x O 0 8.844817322994913e-09
10 O 0 1.7540694452478078e-09
( O 0 3.0342173218400603e-10
- O 0 4.977597001243339e-09
5 O 0 4.413263976488224e-09
) O 0 1.416845807344913e-10
) O 0 6.069858504709202e-11
and O 0 1.126475301926888e-10
suggestive O 0 1.4416806637385093e-09
evidence O 0 3.109872581674722e-09
for O 0 7.379300503984609e-10
a O 0 4.985939661139582e-09
locus O 0 8.618057734111062e-08
on O 0 7.60000062882682e-08
chromosome O 0 6.402259344895356e-08
4q O 0 4.1411326492379885e-06
at O 0 8.718231470083992e-08
D4S397 O 0 4.3248650172245107e-07
( O 0 2.2798707366433746e-09
maximum O 0 4.945895781816034e-08
GENEHUNTER O 0 2.0857247363892384e-05
- O 0 1.8127634859865793e-07
PLUS O 0 1.1901167340511165e-07
nonparametric O 0 2.5369308787048794e-07
linkage O 0 3.56101601539649e-08
score O 0 1.4641053702746376e-08
= O 0 2.201812954183424e-09
3 O 0 2.615071492684251e-09
. O 0 2.2834206747646135e-10
29 O 0 6.063593183114335e-09
, O 0 5.426654681173204e-10
P O 0 1.5523188778843178e-07
= O 0 1.0844401820975236e-08
2 O 0 8.643487703352548e-09
. O 0 3.4199382215049923e-10
57 O 0 6.3507865633027905e-09
x O 0 2.2835015656141877e-08
10 O 0 6.021112497478498e-09
( O 0 7.374207355859141e-10
- O 0 7.692575465512164e-09
3 O 0 1.0988338239314999e-08
) O 0 1.5620005289207484e-10
; O 0 6.005602681824485e-10
SIBPAL O 0 8.668172995385248e-06
Pempirical O 0 7.893859788055124e-07
value O 0 6.610048508548516e-09
< O 0 1.5712291911995635e-08
1 O 0 7.55107176786396e-09
x O 0 1.2118336556454778e-08
10 O 0 1.7412027375485195e-09
( O 0 2.7091992538252896e-10
- O 0 4.834852518342814e-09
3 O 0 6.818781539408292e-09
) O 0 4.8756870069111e-11
) O 0 1.3291786941926897e-11
that O 0 5.055000688869438e-12
are O 0 6.800771751303003e-11
linked O 0 3.286443188699195e-07
to O 0 8.919055716205548e-08
mental O 1 0.9999899864196777
health O 0 0.0007020305492915213
wellness O 0 5.5622378567932174e-05
. O 0 2.6887249759965925e-07

These O 0 2.723481173916298e-08
findings O 0 1.6806426472726343e-08
are O 0 6.375368288846772e-11
consistent O 0 2.2424193613090893e-09
with O 0 9.672817408157286e-11
the O 0 7.698047199689029e-10
hypothesis O 0 4.115183749320295e-09
that O 0 1.5633647154622565e-11
certain O 0 1.003271354882429e-10
alleles O 0 2.7173399641533535e-10
could O 0 1.8215472186167148e-10
prevent O 0 8.350494740128056e-10
or O 0 4.712268908413364e-10
modify O 0 3.6944600712018882e-09
the O 0 1.136355121111876e-09
clinical O 0 3.6689551397017794e-09
manifestations O 0 2.5335432951578696e-07
of O 0 6.925179718564323e-07
BPAD B-Disease 1 1.0
and O 0 2.0267383327166044e-09
perhaps O 0 2.762654827126454e-10
other O 0 1.1959085111090673e-10
related O 0 7.4162471719319e-07
affective B-Disease 1 0.999987006187439
disorders I-Disease 1 0.9999998807907104
. O 0 1.0874645340663847e-05

Segregation O 0 9.524083725409582e-05
distortion O 0 0.0007014691364020109
in O 0 9.73670694293105e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.0005324470112100244

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9998785257339478
DM B-Disease 1 1.0
) O 0 4.0506023424313753e-07
is O 0 5.429981353444191e-09
an O 0 9.475046303109025e-10
autosomal B-Disease 0 0.0065355668775737286
dominant I-Disease 1 0.9999998807907104
disease I-Disease 1 0.9999966621398926
which O 0 3.74550257475903e-09
, O 0 1.6307515060542954e-10
in O 0 3.835946837948967e-10
the O 0 2.6590205592924576e-09
typical O 0 4.002162157235034e-08
pedigree O 0 4.1421014174147786e-08
, O 0 2.2484956951895896e-10
shows O 0 1.4116290081300775e-10
a O 0 1.593052023629582e-09
three O 0 5.303932848477189e-09
generation O 0 1.4050621075512026e-06
anticipation O 0 4.641590294340858e-06
cascade O 0 8.647664071759209e-05
. O 0 1.0078573495775345e-06

This O 0 3.983025465004175e-08
results O 0 4.5289585415275724e-08
in O 0 7.557127190693791e-08
infertility B-Disease 1 0.999864935874939
and O 0 0.00022315492969937623
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.8465592575012124e-06
CDM B-Disease 0 6.715406470902963e-06
) O 0 8.415214358681311e-11
with O 0 1.4462621204802684e-11
the O 0 6.470858515683631e-09
disappearance O 0 2.2784770692396705e-07
of O 0 6.634683359152405e-06
DM B-Disease 1 1.0
in O 0 1.5218734006339218e-07
that O 0 4.902679595630843e-09
pedigree O 0 5.550096489059797e-07
. O 0 9.076875784330696e-08

The O 0 4.985025157111522e-07
concept O 0 2.70421594450454e-07
of O 0 7.882382391244391e-08
segregation O 0 1.2123147996589978e-07
distortion O 0 1.4718436602834117e-07
, O 0 5.2249257004310934e-11
where O 0 1.8516825225911582e-11
there O 0 6.7483857044137174e-12
is O 0 9.698528438684129e-12
preferential O 0 2.3205399823922335e-09
transmission O 0 3.3134996968442465e-09
of O 0 9.8076591292795e-10
the O 0 7.478171415442603e-10
larger O 0 2.5759925303958653e-09
allele O 0 2.337571691768403e-09
at O 0 2.2123793907979916e-09
the O 0 4.4956318667743744e-09
DM B-Disease 1 0.9999997615814209
locus O 0 1.2733019616462116e-07
, O 0 6.94899748854283e-10
has O 0 1.8217521935426362e-10
been O 0 1.0713028242292921e-09
put O 0 8.089938496880222e-09
forward O 0 3.501530798644126e-08
to O 0 5.757057053301651e-09
explain O 0 7.559231818277112e-08
partially O 0 1.8206326046765753e-07
the O 0 1.2249729230973117e-08
maintenance O 0 1.2434708196451538e-06
of O 0 6.980446300985932e-07
DM B-Disease 1 1.0
in O 0 5.005800574053865e-08
the O 0 3.149546401459702e-08
population O 0 3.376505741670144e-10
. O 0 1.1572840463713874e-08

In O 0 3.3072728911065497e-07
a O 0 4.589508151298105e-08
survey O 0 1.4694706562679016e-09
of O 0 2.253121600404029e-08
DM B-Disease 1 1.0
in O 0 7.890865560966631e-08
Northern O 0 1.798911966943706e-06
Ireland O 0 2.646613381784846e-07
, O 0 4.767964245644407e-09
59 O 0 2.5123597424681066e-08
pedigrees O 0 6.513482730952092e-08
were O 0 8.707674581387437e-09
ascertained O 0 1.3849339666194282e-06
. O 0 1.5601671066178824e-07

Sibships O 0 0.0009345466387458146
where O 0 1.1647805564507507e-07
the O 0 1.1210065764544197e-08
status O 0 2.1558239637897714e-08
of O 0 1.2606460764175154e-08
all O 0 4.5229026079951495e-10
the O 0 1.0850728093814155e-09
members O 0 3.27401855626519e-11
had O 0 1.952450284781193e-10
been O 0 1.1121586984685905e-10
identified O 0 2.8977675814445547e-10
were O 0 6.321440038092874e-10
examined O 0 4.45489067857352e-09
to O 0 2.9896443654031657e-10
determine O 0 2.8896116610610534e-09
the O 0 4.8335615510097796e-09
transmission O 0 9.09979220864443e-08
of O 0 5.324847407450761e-08
the O 0 2.1168990826936351e-07
DM B-Disease 1 1.0
expansion O 0 1.977097326744115e-06
from O 0 1.4431395634062483e-08
affected O 0 2.2373267682951337e-09
parents O 0 3.23187948625403e-10
to O 0 4.088386018619161e-10
their O 0 2.8935716045452864e-09
offspring O 0 2.832416328146792e-07
. O 0 8.055206279777849e-08

Where O 0 5.882202458451502e-07
the O 0 2.913033085860661e-07
transmitting O 0 6.625894002354471e-06
parent O 0 9.635359532467191e-08
was O 0 1.5542254061529093e-07
male O 0 1.0786209259094903e-08
, O 0 3.1887623652693264e-09
58 O 0 3.024375416771363e-07
. O 0 2.5552557758601324e-07

3 O 0 2.0259392385924002e-06
% O 0 1.1036585867429949e-08
of O 0 1.3632264206364653e-08
the O 0 5.2783191151206665e-09
offspring O 0 9.147730573033641e-09
were O 0 8.760462355539289e-10
affected O 0 4.632244865465651e-10
, O 0 5.039966013975494e-11
and O 0 1.0805512734579636e-10
in O 0 7.818538871884329e-11
the O 0 6.496602700245546e-10
case O 0 3.0644859982942307e-09
of O 0 2.8511732974578763e-09
a O 0 1.395508375523491e-09
female O 0 1.1551178902280412e-09
transmitting O 0 3.8834333082604644e-08
parent O 0 1.0725730525962263e-08
, O 0 3.5813261245465355e-09
68 O 0 8.45930230752856e-07
. O 0 1.0326231176804868e-06

7 O 0 1.76973899215227e-05
% O 0 5.4636235091720664e-08
were O 0 1.892320256047242e-08
affected O 0 7.362914544728483e-08
. O 0 2.9663826239811897e-07

Studies O 0 1.9288616215362708e-07
on O 0 3.0377040616258455e-07
meiotic O 0 1.2260104085726198e-05
drive O 0 2.909029035436106e-06
in O 0 8.43293221919339e-08
DM B-Disease 1 1.0
have O 0 8.436661147470659e-09
shown O 0 7.184283723482565e-10
increased O 0 2.0203920481076665e-10
transmission O 0 2.2125903331726704e-09
of O 0 5.605871877811808e-10
the O 0 4.4056924775048856e-10
larger O 0 1.4112042645564316e-09
allele O 0 1.3695248268774662e-09
at O 0 2.5388526836422898e-09
the O 0 1.0811048944958657e-08
DM B-Disease 1 0.9999885559082031
locus O 0 1.1034926927777633e-07
in O 0 3.7159866295155553e-09
non O 0 2.641587855123362e-07
- O 0 4.687175987783121e-06
DM O 1 1.0
heterozygotes O 0 1.1784800335590262e-05
for O 0 7.833745740981612e-08
CTGn O 0 8.517615788150579e-05
. O 0 5.403111913437897e-07

This O 0 4.30919158134202e-08
study O 0 5.207678732688237e-09
provides O 0 4.509035089750313e-10
further O 0 6.280180542272973e-11
evidence O 0 4.232825756567138e-10
that O 0 1.292293910770681e-10
the O 0 2.4401115794603356e-08
DM B-Disease 1 1.0
expansion O 0 6.180292984936386e-06
tends O 0 4.594570768290396e-08
to O 0 1.2715266617391308e-09
be O 0 1.1915238795623395e-09
transmitted O 0 2.17978879391012e-08
preferentially O 0 4.063892333761032e-08
. O 0 5.077681208831564e-08

Diagnosis O 1 0.9999998807907104
of O 1 0.999969482421875
hemochromatosis B-Disease 1 1.0
. O 0 0.0012464390601962805

If O 0 4.0677427023183554e-05
untreated O 1 1.0
, O 0 4.1076764318859205e-06
hemochromatosis B-Disease 1 1.0
can O 0 5.178528226679191e-05
cause O 1 0.9868255257606506
serious O 1 0.6607492566108704
illness O 1 0.9989356398582458
and O 0 7.669223478501408e-09
early B-Disease 0 5.6523781211126334e-08
death I-Disease 0 1.2599939225310663e-07
, O 0 1.2206009813997554e-10
but O 0 1.5812842701912189e-10
the O 0 3.568772610762494e-09
disease O 0 3.9386199546243006e-07
is O 0 2.671851073721143e-10
still O 0 7.240879562608882e-10
substantially O 0 4.201941194992287e-08
under O 0 0.00016067568503785878
- O 1 0.9545477628707886
diagnosed O 0 0.041582196950912476
. O 0 1.363730461889645e-06

The O 0 2.058082600342459e-06
cornerstone O 0 0.00013141367526259273
of O 0 1.7016644449086016e-07
screening O 0 2.7383364908928343e-08
and O 0 2.5980573248318706e-10
case O 0 1.053200193723569e-09
detection O 0 2.984007778650266e-07
is O 0 1.8206856855496056e-10
the O 0 8.945079676969669e-10
measurement O 0 3.330418607561114e-08
of O 0 2.014625799517944e-08
serum O 0 1.0802792758113355e-06
transferrin O 0 2.1193452994339168e-05
saturation O 0 2.798298908146535e-07
and O 0 5.525198965017353e-09
the O 0 4.253351892913315e-09
serum O 0 3.029796857845213e-07
ferritin O 0 1.4163660125632305e-05
level O 0 6.801325866945263e-07
. O 0 8.012974461735212e-08

Once O 0 4.375534444989171e-06
the O 0 5.3244203712665694e-08
diagnosis O 0 4.3968884710920975e-05
is O 0 3.787630209473036e-09
suspected O 0 6.701158099531312e-07
, O 0 2.1808772565634627e-09
physicians O 0 1.4696899697241861e-08
must O 0 6.951453190850998e-09
use O 0 1.2924472514441732e-07
serum O 0 6.885197217343375e-05
ferritin O 1 0.6650555729866028
levels O 0 6.991438681325235e-07
and O 0 8.181682886743147e-08
hepatic O 1 0.9999967813491821
iron O 1 0.9999998807907104
stores O 0 2.337939264407396e-07
on O 0 4.321669777596071e-08
liver O 0 4.72175685217735e-08
biopsy O 0 6.3291651919428205e-09
specimens O 0 3.753231614389563e-10
to O 0 2.431008727654671e-10
assess O 0 2.250724762120626e-08
patients O 0 2.3591443465420525e-08
for O 0 5.2583031262543045e-09
the O 0 4.148252585878254e-08
presence O 0 3.676564475085797e-08
of O 0 7.621936674695462e-06
iron B-Disease 1 0.9999997615814209
overload I-Disease 0 0.0007409231620840728
. O 0 5.198590997679275e-07

Liver O 1 0.9990611672401428
biopsy O 0 0.0007270800415426493
is O 0 1.9027147857286764e-08
also O 0 4.0032652193211504e-10
used O 0 8.903665027482077e-10
to O 0 5.254771062723762e-10
establish O 0 1.4193032527032301e-08
the O 0 6.976956345994267e-09
presence O 0 1.3065255544120191e-09
or O 0 8.970165055188772e-09
absence O 0 4.6680287368872087e-07
of O 0 1.5663421208955697e-06
cirrhosis B-Disease 1 1.0
, O 0 3.5225206085343075e-10
which O 0 4.1601794925627544e-11
can O 0 9.260019834256283e-11
affect O 0 6.8292198562858175e-09
prognosis O 1 0.9995335340499878
and O 0 2.3261740977886802e-07
management O 0 3.2558602924837032e-06
. O 0 2.7383947553971666e-07

A O 0 3.0919231903681066e-06
DNA O 0 6.754991659363441e-07
- O 0 1.2219479117447918e-07
based O 0 7.2360788472281e-09
test O 0 8.177809540654835e-09
for O 0 1.0839289465991442e-09
the O 0 8.157012842957556e-09
HFE O 0 2.0931191102135926e-05
gene O 0 6.4030629687295004e-09
is O 0 1.5268880604324409e-10
commercially O 0 2.147475308689195e-09
available O 0 2.382211650164834e-10
, O 0 3.4943530707876036e-11
but O 0 2.7847779637824033e-11
its O 0 1.4234496914511396e-10
place O 0 1.3413000710116307e-09
in O 0 5.368690561557976e-11
the O 0 3.9405539942194423e-10
diagnosis O 0 1.5954846048771287e-06
of O 0 7.857379387132823e-07
hemochromatosis B-Disease 1 1.0
is O 0 1.7750513947589752e-08
still O 0 1.7104193617001329e-09
being O 0 3.626625444397291e-09
evaluated O 0 3.9973865995079905e-08
. O 0 7.695543757790801e-08

Currently O 0 1.6028155869207694e-07
, O 0 3.2664368987411763e-09
the O 0 3.4950835559044435e-09
most O 0 3.765485701023863e-10
useful O 0 1.2518994729759925e-09
role O 0 1.975179797497617e-09
for O 0 1.0668102512489952e-10
this O 0 7.950468755568707e-11
test O 0 1.9532671036159854e-09
is O 0 9.416183804900058e-11
in O 0 7.0477963742821e-11
the O 0 5.46547307411771e-10
detection O 0 2.679985072973068e-06
of O 0 5.558582074627338e-07
hemochromatosis B-Disease 1 1.0
in O 0 1.3580929270062825e-08
the O 0 7.2048984556261075e-09
family O 0 1.1215662842900542e-09
members O 0 1.8003418200684962e-11
of O 0 3.2207844724574386e-10
patients O 0 1.6142262526663842e-10
with O 0 1.9591193251011774e-11
a O 0 2.9250344368847436e-09
proven O 0 6.02966565566021e-07
case O 0 9.973447134825619e-08
of O 0 2.7710547101378324e-07
the O 0 2.871143465199566e-07
disease O 0 8.142766091623344e-06
. O 0 1.721266755794204e-07

It O 0 3.5055535363426316e-08
is O 0 6.2240439469007924e-09
crucial O 0 2.2780143638101435e-07
to O 0 3.65159387172298e-08
diagnose O 1 1.0
hemochromatosis B-Disease 1 1.0
before O 1 1.0
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 0 0.08140117675065994
because O 0 9.986125348859787e-08
phlebotomy O 1 0.972234308719635
therapy O 0 2.322707041457761e-05
can O 0 1.080191758262572e-08
avert O 0 0.33672255277633667
serious O 1 0.9999971389770508
chronic O 1 1.0
disease O 1 1.0
and O 0 8.236170145892174e-08
can O 0 2.0518455823292925e-09
even O 0 7.996954209943397e-09
lead O 0 1.5997393632005696e-08
to O 0 5.399553026919079e-10
normal O 0 1.1900776364370813e-08
life O 0 6.1599734202388845e-09
expectancy O 0 2.335708959577687e-09
. O 0 1.0315163168073127e-09
. O 0 1.985155506645242e-08

Prevalence O 0 9.629719897930045e-06
of O 0 9.507456297797034e-07
the O 0 1.9640820880795218e-07
I1307K O 0 1.5024112371975207e-06
APC B-Disease 0 7.928612433261151e-08
gene O 0 9.229853548120559e-10
variant O 0 1.6204809938358267e-08
in O 0 8.456892408581496e-10
Israeli O 0 3.52291387173409e-08
Jews O 0 3.6302518768849268e-09
of O 0 4.2521006160534114e-10
differing O 0 7.367764037757851e-11
ethnic O 0 9.497363832877692e-12
origin O 0 1.9407547791061575e-10
and O 0 2.2317168946184296e-10
risk O 0 4.715202894800541e-09
for O 0 1.8491041942070296e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 4.81031893286854e-05

BACKGROUND O 0 5.464469359139912e-05
& O 0 2.3374952434096485e-05
AIMS O 0 2.629167283885181e-07
Israeli O 0 1.2085148171081528e-07
Jews O 0 2.6054889801230274e-08
of O 0 1.0750717649443686e-08
European O 0 4.820285948170522e-09
birth O 0 1.4873432263584618e-08
, O 0 2.84162221531048e-10
i O 0 7.579364913468112e-10
. O 0 6.850582601192201e-11
e O 0 1.4569445649925683e-10
. O 0 3.9971366494473415e-11
, O 0 3.9088277753451806e-11
Ashkenazim O 0 2.794434692532377e-07
, O 0 1.1105900227237342e-10
have O 0 6.798100277149999e-11
the O 0 1.2188480447150596e-08
highest O 1 0.9873960614204407
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 0 7.730519087090215e-07
of O 0 5.729036800516951e-09
any O 0 2.4558546307673623e-09
Israeli O 0 9.955107316272915e-08
ethnic O 0 3.263721737312153e-09
group O 0 1.316486475388956e-09
. O 0 1.4628436240116116e-08

The O 0 3.3334774798277067e-06
I1307K O 0 7.607376119267428e-06
APC B-Disease 0 2.998522461439279e-07
gene O 0 2.509657148763722e-09
variant O 0 1.8591848061078053e-07
was O 0 2.9584947469629697e-07
found O 0 7.982918326376875e-09
in O 0 5.790115942261309e-09
6 O 0 8.341403372469358e-07
. O 0 2.1760422441730043e-07

1 O 0 1.2403949085637578e-06
% O 0 3.643591428570403e-09
of O 0 3.2965550289532075e-09
American O 0 1.3018961464439371e-09
Jews O 0 2.701904255886234e-09
, O 0 9.995334421253332e-11
28 O 0 1.1432467195149343e-09
% O 0 8.969985171303207e-11
of O 0 7.656270617495409e-10
their O 0 1.918753866902989e-08
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 1.6473133257477457e-07
, O 0 2.379532404450657e-10
but O 0 9.752587626365994e-11
not O 0 9.521437804860255e-11
in O 0 6.414145881095124e-10
non O 0 3.855623731396918e-08
- O 0 7.168494420284333e-08
Jews O 0 1.166735046354006e-07
. O 0 1.7302824062426225e-07

We O 0 7.147195333345735e-07
assessed O 0 2.0738189050462097e-06
the O 0 1.2525120496320596e-07
I1307K O 0 1.1764101373046287e-06
prevalence O 0 3.399883752308597e-08
in O 0 2.418779898594181e-10
Israeli O 0 8.952013352825361e-09
Jews O 0 4.7032204797403665e-09
of O 0 5.609572806264396e-10
differing O 0 5.936379166016081e-11
ethnic O 0 1.244757682344888e-11
origin O 0 7.250383626811185e-11
and O 0 1.4295224726179612e-10
risk O 0 3.1738354167032412e-09
for O 0 4.019130130927806e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 7.492391159757972e-05

METHODS O 0 5.318449439073447e-06
DNA O 0 6.331394502012699e-07
samples O 0 9.142829604513736e-09
from O 0 1.1781251529896508e-09
500 O 0 4.4472647786619746e-10
unrelated O 0 2.314439973005733e-09
Jews O 0 1.1272566879938495e-08
of O 0 2.669388443621301e-08
European O 0 2.049237934897974e-08
or O 0 8.646884985807901e-09
non O 0 1.5359738370079867e-08
- O 0 2.8792574990887942e-09
European O 0 6.227413584802832e-10
origin O 0 4.992437019346596e-10
, O 0 2.9736112877598586e-11
with O 0 3.330380025576285e-12
or O 0 1.4915889356981182e-10
without O 0 1.82907866630444e-09
a O 0 4.59409532638233e-09
personal O 0 1.3420881828096753e-07
and O 0 4.183516111311292e-08
/ O 0 0.00012055292609147727
or O 0 4.9808953406227374e-08
family O 0 2.347366567789777e-08
history O 0 2.798459686204069e-09
of O 0 5.198171670883767e-09
neoplasia B-Disease 0 7.952691589707683e-07
, O 0 3.1207564310520297e-10
were O 0 5.795703916788852e-10
examined O 0 6.439560440441028e-09
for O 0 3.199177867063696e-10
the O 0 4.230632288937386e-09
I1307K O 0 3.006086402024266e-08
variant O 0 1.069582200585728e-08
by O 0 5.713505779603167e-10
the O 0 2.021769196502987e-09
allele O 0 3.3714475655699516e-10
- O 0 8.019189201569077e-10
specific O 0 5.698986837998632e-10
oligonucleotide O 0 2.2770086616219487e-07
( O 0 9.836515602046347e-09
ASO O 0 3.8116422729217447e-06
) O 0 4.296089317623597e-10
method O 0 3.3274027089191804e-08
. O 0 2.7691886117509057e-08

RESULTS O 0 9.31020167627139e-07
In O 0 2.1890132373414417e-08
persons O 0 3.783875435203754e-09
at O 0 4.382713303385799e-09
average O 0 2.665213882924178e-10
risk O 0 3.68108166171055e-09
for O 0 6.96176556402861e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 7.095690079950145e-08
I1307K O 0 4.558498289952695e-07
was O 0 1.7846382149855344e-08
found O 0 3.1224239860350167e-10
in O 0 7.507898192038454e-10
5 O 0 3.346145760474428e-08
. O 0 3.3554066192209575e-08

0 O 0 8.841049634611409e-07
% O 0 1.2496195189726222e-08
of O 0 1.753990019892626e-08
120 O 0 2.1249974224701873e-08
European O 0 4.488035187932837e-08
and O 0 4.7519513657334755e-08
1 O 0 1.7562900893608457e-06
. O 0 3.729415425368643e-07

6 O 0 6.82350764691364e-06
% O 0 3.038204710037462e-08
of O 0 2.219451289420249e-08
188 O 0 1.1996723614515759e-08
non O 0 4.764730121564753e-08
- O 0 2.623275818791626e-08
European O 0 2.247232977481417e-08
Jews O 0 4.917676221793954e-08
( O 0 1.929310711190624e-09
P O 0 5.405049705586862e-07
= O 0 1.1771734698129421e-08
0 O 0 2.7413453729252524e-09
. O 0 1.0148904633355826e-10
08 O 0 9.746720763814665e-09
) O 0 1.5794553442916026e-09
. O 0 2.9484720442951584e-08

It O 0 1.896210193308434e-07
occurred O 0 9.506060791864002e-07
in O 0 9.848211135476959e-09
15 O 0 7.472589658163997e-08
. O 0 8.645173465993139e-08

4 O 0 7.402213668683544e-07
% O 0 3.1147759926852814e-09
of O 0 6.110637773559802e-09
52 O 0 1.6835365101997013e-08
Ashkenazi O 0 2.1078879797187255e-07
Israelis O 0 1.1513571429588865e-08
with O 0 6.499056293129968e-10
familial O 0 2.6202084768556233e-07
cancer B-Disease 0 1.0567551953499787e-06
( O 0 2.047744418476327e-09
P O 0 1.0311085816283594e-06
= O 0 1.0161078201065266e-08
0 O 0 1.4705668904824165e-09
. O 0 8.265239881399822e-11
02 O 0 5.40916289537563e-09
) O 0 6.520322476388785e-11
and O 0 2.0594627392345188e-10
was O 0 1.384057757292112e-08
not O 0 2.5685484295046024e-10
detected O 0 1.2278524863518214e-08
in O 0 1.747557654141474e-09
51 O 0 1.653740966389705e-08
non O 0 2.6004894237985354e-08
- O 0 3.805445913940275e-08
European O 0 1.4007438764451763e-08
Jews O 0 8.051796385188936e-08
at O 0 1.6502593069844806e-08
increased O 0 2.162077850087485e-09
cancer B-Disease 0 9.658193533823578e-08
risk O 0 2.242621555126334e-08
. O 0 1.2037619967486535e-07

Colorectal B-Disease 1 1.0
neoplasia I-Disease 1 0.9999991655349731
occurred O 0 0.0007423610077239573
personally O 0 3.935589916181925e-07
or O 0 5.354001686441734e-09
in O 0 4.3625444923200973e-10
the O 0 1.142002270526632e-09
families O 0 1.8533864720726712e-10
of O 0 2.2597397286716614e-09
13 O 0 4.728396785225186e-09
of O 0 1.1516688935842012e-08
20 O 0 8.688131103440355e-09
Ashkenazi O 0 4.406840048432059e-07
I1307K O 0 9.828173119785788e-08
carriers O 0 6.803720919990042e-10
, O 0 2.926026365646095e-10
8 O 0 3.797902881075288e-09
of O 0 6.171027688850472e-09
whom O 0 8.867084488883847e-08
also O 0 8.835307596655184e-09
had O 0 1.4648735557898362e-08
a O 0 4.530053221429853e-09
personal O 0 6.469256419450176e-08
or O 0 1.9489846181386383e-08
family O 0 4.946959730744993e-09
history O 0 8.31087021424537e-09
of O 0 8.333540790772531e-08
noncolonic O 0 5.805593900731765e-05
neoplasia B-Disease 0 0.007409741636365652
. O 0 1.1679873750836123e-05

CONCLUSIONS O 0 1.0076563739858102e-05
The O 0 1.2604905350599438e-06
I1307K O 0 5.427531959867338e-06
APC O 0 2.7288533033242857e-07
variant O 0 5.820458000016515e-07
may O 0 2.0940523981494152e-08
represent O 0 1.3592895697911445e-09
a O 0 5.139542125220942e-09
susceptibility O 0 1.1734883997860379e-07
gene O 0 9.862948679995043e-09
for O 0 1.9649789351205982e-08
colorectal B-Disease 1 1.0
, I-Disease 0 2.3780970082043495e-07
or I-Disease 0 1.46943716572423e-06
other I-Disease 0 4.4338868576687673e-08
, I-Disease 0 1.6264936064658286e-09
cancers I-Disease 0 6.188067800394492e-07
in O 0 1.0291050234201293e-09
Ashkenazi O 0 4.113583599973936e-06
Jews O 0 8.04367630280467e-08
, O 0 5.656114465679707e-10
and O 0 6.367569804766049e-10
partially O 0 6.570277655271184e-09
explains O 0 5.844993933301623e-10
the O 0 1.0680807627228006e-10
higher O 0 1.260198279062763e-09
incidence O 0 2.9968237669208975e-08
of O 0 7.16732902219519e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 2.91629547177763e-08
European O 0 5.7615750392869813e-08
Israelis O 0 7.775259547315727e-08
. O 0 9.898816699660529e-08

Systematic O 0 8.710386367738465e-08
analysis O 0 2.3030095164244813e-08
of O 0 9.210886275923258e-08
coproporphyrinogen O 0 2.586664049886167e-05
oxidase O 0 6.2320091274159495e-06
gene O 0 1.9675719613587717e-06
defects O 0 5.256141594145447e-05
in O 0 2.388023467858602e-08
hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 0.999998927116394
and O 0 5.109070002617955e-07
mutation O 0 7.694472259345275e-08
update O 0 1.3380501968640601e-06
. O 0 8.657628995933919e-07

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 0.9999595880508423
( O 0 9.388414241584542e-07
HC B-Disease 1 0.9999997615814209
) O 0 7.941402202504833e-08
is O 0 7.668843338137776e-09
an O 0 1.0008240458603268e-08
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 0 0.47228989005088806
autosomal O 1 1.0
dominant O 1 0.9999997615814209
inheritance O 0 0.003217813093215227
caused O 0 7.399333981084055e-07
by O 0 7.714759386878711e-10
deficient B-Disease 0 4.4949658217774413e-07
activity I-Disease 0 2.6815836218219147e-09
of I-Disease 0 4.2542954048485626e-08
coproporphyrinogen I-Disease 0 1.970875746337697e-05
III I-Disease 1 1.0
oxidase I-Disease 0 3.6345088574307738e-06
( O 0 1.6262834634517276e-08
CPO O 0 2.2318804440146778e-06
) O 0 4.7339465680806825e-09
. O 0 3.757411093374685e-08

Clinical O 0 3.0239678380894475e-05
manifestations O 0 0.2517440617084503
of O 0 0.0008881356916390359
the O 0 4.231746970617678e-06
disease O 0 0.0002270327677251771
are O 0 1.6000116162540046e-11
characterized O 0 8.200954915160708e-10
by O 0 1.1605676836223822e-10
acute O 1 0.9999991655349731
attacks O 0 0.003913269378244877
of O 1 1.0
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 0 3.489075472984382e-09
precipitated O 0 1.1520556064681386e-08
by O 0 3.148821134391078e-11
drugs O 0 2.0859749483292944e-09
, O 0 4.178392076781279e-10
fasting O 0 9.955066389011336e-07
, O 0 1.6726278140311024e-09
cyclical O 0 6.761462145732366e-07
hormonal O 0 1.5668919104427914e-06
changes O 0 2.280941835408612e-08
, O 0 1.978384789325105e-09
or O 0 3.357999744935114e-08
infectious B-Disease 0 0.0002410768938716501
diseases I-Disease 0 0.0002880110696423799
. O 0 3.239672139443428e-07

Skin O 1 1.0
photosensitivity O 1 1.0
may O 0 3.867589111905545e-05
also O 0 6.411607245127016e-08
be O 0 4.0615812935129725e-09
present O 0 5.996496810212193e-08
. O 0 2.985704554703261e-07

The O 0 3.0159415018715663e-06
seven O 0 3.0252263627517095e-07
exons O 0 1.6938923863563105e-06
, O 0 2.906359597432129e-09
the O 0 1.4753070765038956e-08
exon O 0 2.1267130989599536e-07
/ O 0 9.739068218550528e-08
intron O 0 2.9033981263637543e-07
boundaries O 0 3.003036042059648e-09
and O 0 3.594216591018551e-10
part O 0 1.685412032159661e-09
of O 0 1.8459305195506204e-08
3 O 0 2.6723228074843064e-08
noncoding O 0 6.972715027586673e-08
sequence O 0 7.731493778528886e-10
of O 0 4.335538150712637e-09
the O 0 6.128834773022618e-09
CPO O 0 2.8653610684159503e-07
gene O 0 7.98900723353313e-10
were O 0 6.421306819603956e-10
systematically O 0 6.500692761868265e-10
analyzed O 0 4.950355125821204e-10
by O 0 8.085209585173558e-11
an O 0 1.1193987403679273e-10
exon O 0 2.5048953133932628e-08
- O 0 1.2306120567018297e-08
by O 0 2.2569399682481617e-09
- O 0 5.798036681881058e-07
exon O 0 1.8679445474845124e-06
denaturing O 0 2.430918721074704e-05
gradient O 0 5.69803546568437e-07
gel O 0 3.7702612587509066e-08
electrophoresis O 0 5.48917284959316e-08
( O 0 1.4945257253984323e-09
DGGE O 0 1.642245024413569e-06
) O 0 3.239112311703707e-10
strategy O 0 1.5276229170524402e-09
followed O 0 2.2865326299026378e-10
by O 0 6.775405323594663e-12
direct O 0 2.4284738109336956e-10
sequencing O 0 1.7835211085781566e-09
in O 0 1.7960144482742635e-10
seven O 0 5.533126734569294e-10
unrelated O 0 5.6982178975317765e-09
heterozygous O 0 2.8800704043874248e-09
HC B-Disease 0 2.828859942383133e-05
patients O 0 3.5112016405491886e-08
from O 0 3.316042906931216e-08
France O 0 4.3380712355656215e-08
, O 0 1.7155489251408085e-09
Holland O 0 2.3033793183913076e-07
, O 0 6.230347349145404e-10
and O 0 2.5026447580955846e-09
Czech O 0 4.2249039324815385e-06
Republic O 0 1.4833939530944917e-05
. O 0 2.5716628442751244e-05

Seven O 0 2.185821870170912e-07
novel O 0 1.3643006724350926e-08
mutations O 0 9.536929024278606e-10
and O 0 1.238473656961503e-09
two O 0 6.366476790198305e-10
new O 0 8.127010175940086e-09
polymorphisms O 0 8.404863649502659e-08
were O 0 4.1783486892654764e-08
detected O 0 1.6831853599796887e-06
. O 0 4.81111271710688e-07

Among O 0 6.582661171705695e-08
these O 0 1.9404153839275295e-09
mutations O 0 2.053494041476256e-09
two O 0 1.0734280131430296e-09
are O 0 1.4596955588697114e-10
missense O 0 1.8021265191237035e-07
( O 0 2.602105420024259e-09
G197W O 0 7.959536105772713e-07
, O 0 1.4645207269126104e-09
W427R O 0 1.4007724757902906e-07
) O 0 6.066157576256614e-10
, O 0 1.6597877239288295e-10
two O 0 1.787798104002647e-10
are O 0 1.0045408949110879e-10
nonsense O 0 5.485562226681395e-08
( O 0 2.0519668186835816e-09
Q306X O 0 1.0233864600195375e-07
, O 0 2.709127089328689e-10
Q385X O 0 5.0239361115700376e-08
) O 0 1.957461831514351e-10
, O 0 1.332420840327586e-10
two O 0 1.0409255402077378e-10
are O 0 4.871782838256067e-11
small O 0 1.2554959294419632e-09
deletions O 0 2.564551593309261e-08
( O 0 2.816935129601461e-09
662de14bp O 0 4.922865741718851e-07
; O 0 5.91557691720368e-09
1168del3bp O 0 2.2275573883234756e-06
removing O 0 1.0459383048555537e-07
a O 0 1.2581070407691186e-08
glycine O 0 1.9435722364846697e-08
at O 0 1.327637733083975e-08
position O 0 9.95394522362858e-09
390 O 0 5.387796875311324e-09
) O 0 4.753793192424638e-11
, O 0 3.793330580204035e-11
and O 0 2.104308255423959e-10
one O 0 3.8040048888632327e-10
is O 0 2.179495334209136e-10
a O 0 1.4446315255156605e-09
splicing O 0 1.7230725291028648e-08
mutation O 0 9.652291188544382e-10
( O 0 2.6543980902182795e-10
IVS1 O 0 2.3742586563457735e-06
- O 0 6.82168490584445e-08
15c O 0 1.7386188346790732e-06
- O 0 1.3129093190400454e-07
- O 0 8.270203721849612e-08
> O 0 1.0662462557320396e-07
g O 0 1.079374190027238e-08
) O 0 6.554275178149993e-11
which O 0 7.451795257240601e-12
creates O 0 3.4402392046217756e-10
a O 0 3.3844879676614426e-10
new O 0 3.672649961927732e-10
acceptor O 0 4.771272821280093e-10
splice O 0 1.4232130070013227e-06
site O 0 1.8072518059852882e-07
. O 0 3.392285563563746e-08

The O 0 1.4409633877221495e-06
pathological O 0 5.447626335808309e-06
significance O 0 1.1622256579357781e-06
of O 0 9.814084478421137e-07
the O 0 1.9618656210695917e-07
point O 0 1.4887999100210436e-07
mutations O 0 3.505217671673222e-09
G197W O 0 1.1243432851415491e-07
, O 0 9.909046916334319e-10
W427R O 0 6.634972464780731e-07
, O 0 1.9006680673783194e-09
and O 0 2.9172118054532348e-09
the O 0 1.6258182355954887e-08
in O 0 7.197948459491954e-09
- O 0 4.655527163777151e-08
frame O 0 2.698620278351882e-07
deletion O 0 1.129572950731017e-07
390delGly O 0 3.0584324406390806e-08
were O 0 3.8234634902600817e-10
assessed O 0 1.7905086302505424e-09
by O 0 3.773248380412042e-11
their O 0 2.346844940603887e-10
respective O 0 3.629199607502187e-09
expression O 0 1.4409493598321887e-09
in O 0 2.2930050913583244e-10
a O 0 5.269464309343164e-10
prokaryotic O 0 4.590101188028939e-09
system O 0 1.6693903148734535e-08
using O 0 4.191389013641356e-09
site O 0 4.013636711874824e-08
- O 0 3.333468967525732e-08
directed O 0 2.4784432284263858e-08
mutagenesis O 0 6.531125109177083e-06
. O 0 1.684221331288427e-07

These O 0 1.9362829561941908e-08
mutations O 0 2.1711745290531326e-08
resulted O 0 3.771901191385041e-08
in O 0 1.443882235996341e-09
the O 0 5.24558085857052e-09
absence O 0 5.0550212904454384e-08
or O 0 6.188685119923321e-09
a O 0 5.625669263764621e-09
dramatic O 0 2.3088857048492173e-08
decrease O 0 2.026627043960616e-08
of O 0 5.787827035419468e-07
CPO O 0 8.772038563620299e-05
activity O 0 7.633283161112558e-08
. O 0 1.301604299897008e-07

The O 0 9.898889175019576e-07
two O 0 2.6557932741866352e-08
polymorphisms O 0 1.546374619465496e-07
were O 0 7.625494902185892e-09
localized O 0 9.38120408022769e-08
in O 0 4.483121873732898e-09
noncoding O 0 1.8204987100034487e-06
part O 0 2.0339344430908568e-08
of O 0 1.857068454569344e-08
the O 0 4.283450483200113e-09
gene O 0 2.6125276941790787e-10
1 O 0 1.5017866950017833e-09
) O 0 2.2262740262402048e-11
a O 0 6.340688529782312e-10
C O 0 1.3777238905277045e-07
/ O 0 1.5614516257755895e-07
G O 0 1.1697877511096522e-07
polymorphism O 0 2.5019350147204023e-08
in O 0 7.943333213411563e-10
the O 0 8.923238148383916e-09
promotor O 0 1.8240560848425957e-06
region O 0 3.1474446160473235e-08
, O 0 2.8512767702437714e-09
142 O 0 5.4623523482177916e-08
bp O 0 3.618157222717855e-07
upstream O 0 2.4365954587324268e-08
from O 0 1.1414034162271491e-09
the O 0 4.0110021970463094e-09
transcriptional O 0 1.3335210269360687e-07
initiation O 0 2.7765507226718e-08
site O 0 7.870315066327294e-09
( O 0 9.914485898931957e-11
- O 0 2.8158499976171925e-09
142C O 0 6.824170384334138e-08
/ O 0 1.0847442943884289e-08
G O 0 1.5413560205956855e-08
) O 0 1.3999651438112437e-10
, O 0 6.840880639735758e-11
and O 0 4.991446145297118e-10
2 O 0 2.1472102318398356e-08
) O 0 3.282085714317873e-10
a O 0 6.6026899503413006e-09
6 O 0 8.940278206637231e-08
bp O 0 1.857136311400609e-07
deletion O 0 9.591293981259241e-09
polymorphism O 0 4.8650461437205195e-09
in O 0 2.7035110261586226e-10
the O 0 1.7840110499989237e-09
3 O 0 6.975639177397852e-09
noncoding O 0 6.386257922486038e-08
part O 0 2.8994719958319592e-09
of O 0 1.888534306715428e-08
the O 0 2.0847032544679678e-08
CPO O 0 8.111369993457629e-07
gene O 0 6.440469935142801e-09
, O 0 1.31682298398772e-09
574 O 0 2.2826856138635776e-07
bp O 0 3.966839017266466e-07
downstream O 0 3.527593861463174e-08
of O 0 3.2492868395905816e-09
the O 0 1.459935616843211e-09
last O 0 1.8033886606261262e-09
base O 0 2.2808460897749683e-08
of O 0 4.648985196809008e-09
the O 0 2.3341055754855233e-09
normal O 0 1.7319284895123133e-09
termination O 0 2.184146197237169e-08
codon O 0 4.827563682141545e-09
( O 0 1.6616891196363781e-09
+ O 0 2.7705729266358503e-08
574 O 0 1.667171574126769e-07
delATTCTT O 0 4.715677732747281e-07
) O 0 7.567797943863752e-09
. O 0 6.663266560735792e-08

Five O 0 5.1665620048879646e-06
intragenic O 0 0.00013849344395566732
dimorphisms O 0 0.00010765340266516432
are O 0 1.5237525685662945e-09
now O 0 1.3780799834606228e-09
well O 0 3.289236105707971e-10
characterized O 0 4.740533299241179e-09
and O 0 9.201431283578643e-10
the O 0 1.4111962709506543e-09
high O 0 5.915746115192633e-09
degree O 0 1.8697496884101383e-08
of O 0 4.404770326260632e-09
allelic O 0 6.538488861451697e-08
heterogeneity O 0 7.959781100908003e-08
in O 0 5.533762781340101e-09
HC B-Disease 0 0.010253217071294785
is O 0 9.352008056850991e-09
demonstrated O 0 8.823990427231365e-09
with O 0 1.915292924259404e-10
seven O 0 4.616033943971587e-10
new O 0 1.176081593223799e-10
different O 0 2.6774152339648083e-11
mutations O 0 3.530550157782031e-11
making O 0 1.0839201064483106e-10
a O 0 1.750779521358936e-10
total O 0 1.1239043029576123e-10
of O 0 1.777171187988813e-09
nineteen O 0 5.137065173244082e-08
CPO O 0 3.2538207506149774e-06
gene B-Disease 0 1.2360406742573105e-07
defects I-Disease 0 2.1893488337809686e-06
reported O 0 2.5998134756122226e-09
so O 0 4.772128248120566e-10
far O 0 2.483192762525732e-09
. O 0 1.780435021636606e-09
. O 0 3.471923548659106e-08

Coincidence O 0 4.093121788173448e-06
of O 0 6.45797626930289e-07
two O 0 2.198368775907511e-08
novel O 0 6.579710998266819e-08
arylsulfatase O 0 1.970223365788115e-06
A O 0 9.043816362463986e-08
alleles O 0 1.770239288489961e-09
and O 0 1.1337442096248651e-09
mutation O 0 2.660319520231269e-09
459 O 0 2.2511885688913935e-08
+ O 0 3.9139809615562626e-08
1G O 0 2.046759391305386e-06
> O 0 6.611210778828536e-08
A O 0 1.954106387813681e-08
within O 0 2.356435935269019e-09
a O 0 2.439458857139698e-09
family O 0 6.308026101464748e-09
with O 0 1.2408689631371317e-09
metachromatic B-Disease 1 0.999941349029541
leukodystrophy I-Disease 1 0.9999961853027344
: O 0 5.498577149154471e-10
molecular O 0 2.6978976830349666e-09
basis O 0 2.208555116567368e-09
of O 0 1.500335855553203e-08
phenotypic O 0 4.804679747394403e-07
heterogeneity O 0 6.341931566566927e-06
. O 0 5.728339829147444e-07

In O 0 2.2419699519105052e-07
a O 0 2.4009024102156218e-08
family O 0 9.162311798149858e-09
with O 0 1.0922151377767975e-10
three O 0 6.486152726026262e-10
siblings O 0 2.4356106465006633e-08
, O 0 1.1667912469537356e-10
one O 0 1.0276922368657182e-10
developed O 0 3.941249460126528e-08
classical O 0 1.2843087233704864e-06
late O 0 0.18735229969024658
infantile O 1 0.9905349612236023
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 2.1271912231668466e-08
MLD B-Disease 1 1.0
) O 0 3.793906078186637e-09
, O 0 3.0128796679740333e-10
fatal O 0 8.136040463568861e-08
at O 0 9.320204163998369e-09
age O 0 1.2079882649729257e-09
5 O 0 2.525734510427924e-09
years O 0 8.019541142267883e-10
, O 0 1.0275511691526518e-10
with O 0 2.397847476132142e-10
deficient O 0 4.957733108312823e-05
arylsulfatase O 0 0.0006599496700800955
A O 0 2.557219340815209e-05
( O 0 8.673051610230686e-08
ARSA O 0 0.00013934292655903846
) O 0 4.888773275091296e-10
activity O 0 1.1098107849383254e-10
and O 0 1.5024477495462207e-10
increased O 0 2.345118987889805e-09
galactosylsulfatide O 0 1.2799509931937791e-06
( O 0 1.534711735473593e-08
GS O 1 0.8661125302314758
) O 0 3.542006465906411e-09
excretion O 0 1.909276647893421e-08
. O 0 1.4726278863008702e-08

The O 0 7.322271358134458e-07
two O 0 1.4047921048643275e-08
other O 0 3.2411657802100535e-09
siblings O 0 1.8702746729104547e-07
, O 0 1.629990586948793e-09
apparently O 0 5.3444949799086316e-08
healthy O 0 2.161233680908481e-08
at O 0 1.6880443709510473e-08
12 O 0 2.4009148003045766e-09
( O 0 4.749518001112563e-10
1 O 0 1.166860741363962e-07
/ O 0 3.388331890619156e-07
2 O 0 1.5755378512949392e-07
) O 0 2.771479157281931e-10
and O 0 4.398186259635395e-10
15 O 0 7.52030993034225e-10
years O 0 1.9393339711903934e-10
, O 0 1.1406579673856054e-11
respectively O 0 7.323853329355146e-11
, O 0 2.052156708454156e-11
and O 0 6.451220807557334e-11
their O 0 2.2176209479862763e-10
father O 0 1.8617967612044595e-07
, O 0 1.220610834629099e-09
apparently O 0 2.215754513201773e-08
healthy O 0 1.46644674181573e-09
as O 0 3.020739769432623e-10
well O 0 4.2638767516756104e-10
, O 0 2.5242694046134773e-10
presented O 0 5.763080679344057e-08
ARSA O 1 0.9088395237922668
and O 0 3.683591387471097e-07
GS O 1 0.9999998807907104
values O 0 6.5960437112266845e-09
within O 0 6.997730173097239e-10
the O 0 2.2533083732234616e-10
range O 0 5.63061774982998e-09
of O 0 3.20991411228988e-08
MLD B-Disease 1 1.0
patients O 0 4.556687144940952e-06
. O 0 2.7932330226576596e-07

Mutation O 0 1.1193362325911949e-07
screening O 0 4.635299077904165e-08
and O 0 1.0601211020144774e-09
sequence O 0 1.6033514793623027e-10
analysis O 0 9.621223262534784e-11
disclosed O 0 2.7233810762083976e-09
the O 0 4.340334480712471e-10
involvement O 0 4.345091397794931e-09
of O 0 8.975607812544695e-09
three O 0 4.226372030124992e-10
different O 0 6.095571269959521e-10
ARSA O 0 3.579662006814033e-05
mutations O 0 1.3350390792865596e-09
being O 0 7.395673518040269e-10
the O 0 3.78420572655358e-10
molecular O 0 2.5622131083480326e-09
basis O 0 5.215263332303266e-09
of O 0 7.0767136151062e-08
intrafamilial O 0 2.3970278562046587e-05
phenotypic O 0 6.411524736904539e-06
heterogeneity O 0 1.7596850739209913e-05
. O 0 1.7270757552978466e-06

The O 0 3.9010537875583395e-06
late O 0 0.00019179543596692383
infantile O 0 0.0005915770307183266
patient O 0 2.313573304491001e-06
inherited O 0 4.292795347282663e-05
from O 0 1.3787912678253633e-07
his O 0 1.3814603505579726e-07
mother O 0 6.490007109505314e-08
the O 0 1.337565702641541e-08
frequent O 0 1.1982248970809906e-08
0 O 0 1.1339286842826368e-08
- O 0 6.1305773790820695e-09
type O 0 2.1102668057437768e-08
mutation O 0 8.378386873175714e-09
459 O 0 1.0933292493575664e-08
+ O 0 7.122915590684897e-09
1G O 0 2.569232719906722e-07
> O 0 7.676746349716268e-09
A O 0 2.7023729920472306e-09
, O 0 2.4441976220757056e-11
and O 0 4.237234174642168e-11
from O 0 1.6533924229733543e-10
his O 0 1.521377024360504e-09
father O 0 1.60159867590437e-08
a O 0 8.434983822525055e-10
novel O 0 1.847394681675496e-09
, O 0 8.204674439848958e-11
single O 0 7.835292969993191e-10
basepair O 0 2.9662496103810554e-07
microdeletion O 0 5.423597144726955e-07
of O 0 4.6993491764624196e-08
guanine O 0 6.892296511296081e-08
at O 0 1.5621807847310265e-08
nucleotide O 0 3.741675858037752e-09
7 O 0 1.9546805063441752e-08
in O 0 1.3559335876323075e-09
exon O 0 1.7866142343336833e-07
1 O 0 6.58310099765913e-08
( O 0 1.4961515359956934e-09
7delG O 0 3.294712200840877e-07
) O 0 9.829201452760117e-09
. O 0 1.1125166565761901e-07

The O 0 1.61422224209673e-06
two O 0 6.227418936077811e-08
clinically O 0 3.1726456654723734e-05
unaffected O 0 1.678291300777346e-05
siblings O 0 4.5583288965644897e-07
carried O 0 4.949734400128136e-09
the O 0 6.019872156315387e-09
maternal O 0 7.36466958528581e-08
mutation O 0 5.063558461415596e-09
459 O 0 1.5659008312240985e-08
+ O 0 1.3984720936832673e-08
1G O 0 6.679929924757744e-07
> O 0 1.5630332583782547e-08
A O 0 7.076359942459476e-09
and O 0 6.365650784267984e-10
, O 0 5.332003935598628e-11
on O 0 1.1768674923473554e-09
their O 0 5.4113859226934125e-11
paternal O 0 8.33983460069021e-09
allele O 0 9.152805180434598e-10
, O 0 3.8132143276303765e-11
a O 0 2.5948532211828024e-10
novel O 0 2.4171347146051403e-09
cytosine O 0 2.7290294468684806e-08
to O 0 3.106469526059641e-09
thymidine O 0 2.4731930352572817e-06
transition O 0 8.724001077098364e-07
at O 0 2.994070058548459e-08
nucleotide O 0 1.6180504047724753e-08
2435 O 0 1.409439846611349e-06
in O 0 6.528003693162532e-10
exon O 0 4.0665753431312623e-08
8 O 0 4.258059682626936e-09
, O 0 1.0547591446086191e-11
resulting O 0 4.4660930509365926e-10
in O 0 1.9725246436230748e-10
substitution O 0 1.9254995820006116e-08
of O 0 1.6129723334756818e-08
alanine O 0 2.1948496353729752e-08
464 O 0 5.26460759431302e-08
by O 0 2.72205658014002e-09
valine O 0 4.811544158656034e-07
( O 0 1.0750430767814123e-08
A464V O 0 1.446258238502196e-06
) O 0 1.055368414881741e-08
. O 0 8.006526996950925e-08

The O 0 2.4886667233658955e-06
fathers O 0 1.0565183856670046e-06
genotype O 0 5.770758093603945e-07
thus O 0 8.248731120374941e-08
was O 0 4.019659058940306e-07
7delG O 0 6.805687462474452e-06
/ O 0 1.1883266779477708e-05
A464V O 0 2.121796387655195e-05
. O 0 3.6905078104609856e-07

Mutation O 0 8.139460305756074e-07
A464V O 0 6.912121989444131e-06
was O 0 2.5635839051574294e-07
not O 0 5.210547548983868e-10
found O 0 1.1522726106605319e-09
in O 0 6.039708178029457e-10
18 O 0 1.0668153471726782e-08
unrelated O 0 6.66508594804327e-06
MLD B-Disease 1 1.0
patients O 0 0.027476411312818527
and O 0 4.5294768824533094e-07
50 O 0 1.4177953744365368e-07
controls O 0 4.96959330575919e-07
. O 0 2.610981653106137e-07

A464V O 0 7.090652798069641e-05
, O 0 2.401218424097351e-08
although O 0 1.2093075874020087e-08
clearly O 0 4.8521119566657944e-08
modifying O 0 2.1180997009651037e-06
ARSA O 1 0.9999932050704956
and O 0 3.916904915968189e-06
GS O 1 1.0
levels O 0 1.513686527232494e-07
, O 0 4.5570550111229124e-10
apparently O 0 8.92974139077296e-09
bears O 0 1.534457005902823e-08
little O 0 2.7213820086302576e-09
significance O 0 5.551417547877691e-09
for O 0 1.7894560833120465e-10
clinical O 0 5.337056130372275e-09
manifestation O 0 8.607375639257953e-05
of O 0 0.0003237122728023678
MLD B-Disease 1 1.0
, O 0 3.722486141555237e-08
mimicking O 0 1.0587196896949536e-07
the O 0 7.596493389883108e-08
frequent O 0 4.4792696485274064e-07
ARSA O 0 0.00115561846178025
pseudodeficiency O 0 2.4302602469106205e-05
allele O 0 8.131996196425462e-07
. O 0 2.7769252142206824e-07

Our O 0 7.427319815178635e-06
results O 0 5.100628186482936e-08
demonstrate O 0 1.1200789629128849e-08
that O 0 3.624998634599308e-10
in O 0 4.1009368123567924e-10
certain O 0 1.990477782598532e-09
genetic O 0 7.507905053216746e-08
conditions O 0 1.576657723489916e-06
MLD B-Disease 1 1.0
- O 1 0.9997969269752502
like O 0 2.2431065644923365e-06
ARSA O 1 0.9999998807907104
and O 0 1.9280316791991936e-06
GS O 1 1.0
values O 0 3.5153073785210154e-09
need O 0 1.3586097524775909e-10
not O 0 8.753571652253544e-12
be O 0 9.135704345797357e-12
paralleled O 0 5.57626833597169e-10
by O 0 9.270389143833935e-12
clinical O 0 3.148079352754962e-09
disease O 0 2.425532130700958e-08
, O 0 2.1348376191832052e-11
a O 0 6.727428336628094e-11
finding O 0 3.197365983087508e-10
with O 0 2.225255049670416e-11
serious O 0 7.021398573670012e-09
diagnostic O 0 1.8077764252666384e-05
and O 0 2.883134015974065e-07
prognostic O 1 0.9999711513519287
implications O 0 1.4048413504497148e-05
. O 0 1.4361370404003537e-06

Moreover O 0 3.533941935529583e-06
, O 0 3.6793984747873765e-08
further O 0 1.3843117585565778e-07
ARSA O 0 0.0005360206123441458
alleles O 0 4.257534058638157e-08
functionally O 0 1.3911180474224238e-07
similar O 0 5.7704689915283325e-09
to O 0 6.821565090575632e-09
A464V O 0 4.5679115601160447e-07
might O 0 2.1213799605845907e-09
exist O 0 3.292770223151109e-10
which O 0 1.3310694213508611e-10
, O 0 1.9728059463819392e-11
together O 0 1.597340315573348e-11
with O 0 4.052075341931527e-11
0 O 0 1.016547912513488e-08
- O 0 7.66957519715561e-09
type O 0 1.1598047677807699e-07
mutations O 0 2.3804789250903013e-08
, O 0 6.550179287856395e-10
may O 0 1.9028053799274858e-08
cause O 0 1.022982905851677e-05
pathological O 1 0.8254836797714233
ARSA O 1 0.9999762773513794
and O 0 1.0020429641599549e-07
GS O 1 1.0
levels O 0 4.8413486553045004e-09
, O 0 1.6779334865990592e-11
but O 0 5.353850609374211e-12
not O 0 5.98400886134276e-12
clinical O 0 1.347058464773454e-09
outbreak O 0 9.819943969091582e-09
of O 0 1.3859438929841872e-08
the O 0 3.002556780984378e-08
disease O 0 3.066651572680712e-07
. O 0 3.04356251312754e-09
. O 0 4.574267009616051e-08

Human O 0 0.3915604054927826
MLH1 O 1 1.0
deficiency O 1 1.0
predisposes O 1 0.5432444214820862
to O 0 1.7100325067076483e-06
hematological B-Disease 1 1.0
malignancy I-Disease 1 1.0
and O 0 1.1137497494928539e-05
neurofibromatosis B-Disease 1 0.9999972581863403
type I-Disease 0 0.033865608274936676
1 I-Disease 0 4.642903877538629e-05
. O 0 2.3903251644696866e-07

Heterozygous O 0 3.5943278362537967e-06
germ O 0 0.0005558374687097967
- O 0 9.83474456006661e-06
line O 0 4.182598729585152e-07
mutations O 0 2.2658770415517893e-09
in O 0 2.170816304492007e-10
the O 0 1.060640908434607e-09
DNA O 0 8.395186057441606e-08
mismatch O 0 0.00023033996694721282
repair O 0 0.016883406788110733
genes O 0 6.12112671660725e-08
lead O 0 6.376398431484631e-08
to O 0 2.5346155396732684e-08
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.00040809973143041134

The O 0 2.0379786747071194e-06
disease O 0 1.5619876648997888e-05
susceptibility O 0 1.9115241229883395e-05
of O 0 1.241605673385493e-06
individuals O 0 4.335818815093262e-09
who O 0 2.5395036118425196e-07
constitutionally O 0 2.3757897906762082e-06
lack O 0 9.212925215251744e-05
both O 0 3.065820664005514e-08
wild O 0 5.6604370968216244e-08
- O 0 2.941741072959303e-09
type O 0 7.899100040731355e-09
alleles O 0 1.2308015717721332e-09
is O 0 2.3700019724515187e-10
unknown O 0 1.4787637780955265e-08
. O 0 2.7165242499904707e-08

We O 0 1.1328416604783342e-07
have O 0 1.1486870343802025e-09
identified O 0 5.012973591789205e-09
three O 0 4.3707651387059343e-10
offspring O 0 4.578891044104694e-09
in O 0 2.0501975117603877e-10
a O 0 2.580016023046028e-08
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.9996224641799927
who O 0 3.4534046733369905e-08
developed O 0 1.3399848057815689e-06
hematological B-Disease 1 0.9999936819076538
malignancy I-Disease 1 1.0
at O 0 1.0178631555390893e-06
a O 0 6.586136969133349e-09
very O 0 6.347174452692173e-10
early O 0 2.0721996563111134e-08
age O 0 2.113714092644159e-09
, O 0 7.447876343436022e-11
and O 0 1.1397016663750037e-10
at O 0 1.794466658600058e-10
least O 0 6.593517832415019e-12
two O 0 1.2807504189138452e-11
of O 0 2.3171685403777786e-10
them O 0 7.741139673722586e-11
displayed O 0 2.354306305463183e-09
signs O 0 1.3746705995743014e-08
of O 0 1.4009661697400588e-07
neurofibromatosis B-Disease 0 0.002540789544582367
type I-Disease 0 4.7347115469165146e-05
1 I-Disease 0 6.655424385826336e-06
( O 0 6.0791687239714065e-09
NF1 B-Disease 0 7.727296906523407e-05
) O 0 3.041590801444727e-08
. O 0 9.377124854381691e-08

DNA O 0 1.4269760129081988e-07
sequence O 0 1.913103231387936e-09
analysis O 0 2.7851088102437416e-10
and O 0 1.018567313826324e-10
allele O 0 2.040670549208201e-10
- O 0 2.0818560764190863e-10
specific O 0 6.026391191626956e-11
amplification O 0 2.5725567454060183e-08
in O 0 6.720416445560318e-10
two O 0 1.1943248612311663e-09
siblings O 0 5.288157112204317e-08
revealed O 0 3.770793455259991e-08
a O 0 1.8185117411917417e-08
homozygous O 0 6.267540442195241e-08
MLH1 O 0 4.3846870539709926e-05
mutation O 0 2.077593741489636e-08
( O 0 3.215911981158115e-09
C676T O 0 6.065180855330254e-07
- O 0 5.114886221235793e-07
- O 0 1.048340436682338e-06
> O 0 5.399127985583618e-06
Arg226Stop O 0 2.2869919121148996e-05
) O 0 1.1536674726642104e-08
. O 0 3.134145387662102e-08

Thus O 0 1.4367836911333143e-06
, O 0 2.6002910047395744e-08
a O 0 1.4266366754611681e-08
homozygous O 0 1.0022284158139882e-07
germ O 1 0.9992769360542297
- O 0 0.0042960005812346935
line O 0 0.00017630869115237147
MLH1 O 1 0.9999982118606567
mutation O 0 1.7194602719428076e-07
and O 0 7.667644297271181e-09
consequent O 0 0.001988351345062256
mismatch O 1 1.0
repair O 1 1.0
deficiency O 1 1.0
results O 0 5.353850696110385e-08
in O 0 8.140367491193956e-09
a O 0 2.5211152276938265e-08
mutator O 0 0.00017723521159496158
phenotype O 0 7.802371726484125e-08
characterized O 0 3.1317878845804614e-10
by O 0 3.3365362556159184e-11
leukemia B-Disease 1 0.9881488680839539
and O 0 9.149624020210467e-06
/ O 1 1.0
or O 1 0.7778971791267395
lymphoma B-Disease 1 1.0
associated O 0 7.058197866172122e-07
with O 0 1.1532400590041902e-09
neurofibromatosis B-Disease 0 7.354805711656809e-05
type I-Disease 0 3.177138410137559e-07
1 I-Disease 0 2.0292270619393094e-07
. O 0 2.5143622739420834e-09
. O 0 2.7211550346351032e-08

Missense O 0 0.00027371462783776224
mutations O 0 5.361362127587199e-07
in O 0 1.1897236085189888e-08
the O 0 1.0396210115004578e-08
most O 0 7.743004015736688e-10
ancient O 0 3.9791299144553705e-08
residues O 0 1.2396133897141226e-08
of O 0 9.731563999082482e-09
the O 0 1.857968356944184e-08
PAX6 O 0 0.00021324408589862287
paired O 0 4.197415393036863e-08
domain O 0 1.5971357569810607e-08
underlie O 0 6.994320500552931e-08
a O 0 1.0062946920186278e-08
spectrum O 0 1.3047551874478813e-06
of O 0 2.281999940123569e-07
human O 0 0.2510402500629425
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 0 0.016260916367173195

Mutations O 0 5.684769917024823e-07
of O 0 1.5329072766689933e-07
the O 0 5.57068275952588e-08
human O 0 1.0854484600031356e-07
PAX6 O 1 0.9959406852722168
gene O 0 6.786011454096297e-06
underlie O 1 0.9989770650863647
aniridia B-Disease 1 1.0
( O 0 0.0006191969150677323
congenital B-Disease 1 1.0
absence I-Disease 0 0.009921821765601635
of I-Disease 1 0.9579766988754272
the I-Disease 0 4.06265598940081e-06
iris I-Disease 0 7.148025906644762e-05
) O 0 8.183173583198311e-10
, O 0 2.42785319626293e-10
a O 0 1.282209183273153e-08
rare O 0 0.0004410680558066815
dominant O 1 1.0
malformation B-Disease 1 1.0
of I-Disease 1 1.0
the I-Disease 1 0.9998764991760254
eye I-Disease 1 1.0
. O 0 7.565457508462714e-06

The O 0 1.5220562090689782e-06
spectrum O 0 5.5940977290447336e-06
of O 0 6.017653504386544e-07
PAX6 O 1 0.9071545004844666
mutations O 0 3.895240183737769e-07
in O 0 1.273450038752344e-07
aniridia B-Disease 1 1.0
patients O 0 1.2703512766165659e-06
is O 0 9.966250047455105e-10
highly O 0 1.8197736650904517e-09
biased O 0 4.920901464089411e-09
, O 0 8.352577657300131e-11
with O 0 3.0749871399171624e-11
92 O 0 1.241584612898805e-08
% O 0 1.7721876743870268e-10
of O 0 7.299215121214786e-10
all O 0 1.1182121895103592e-10
reported O 0 4.220258031928381e-10
mutations O 0 2.1388653348441977e-10
leading O 0 9.017816493539499e-10
to O 0 2.5371038603339e-10
premature O 0 2.137790922063232e-08
truncation O 0 2.3041930035105906e-06
of O 0 7.02639795235882e-07
the O 0 3.3790602316230434e-08
protein O 0 3.1873699235518416e-09
( O 0 1.1550864431608687e-10
nonsense O 0 7.486424813407666e-09
, O 0 1.3956781563795317e-10
splicing O 0 6.282019349157508e-09
, O 0 1.3105330709528573e-10
insertions O 0 1.0577135833855777e-09
and O 0 2.0595844474335934e-10
deletions O 0 3.3392075771132568e-09
) O 0 2.377880947701527e-10
and O 0 6.445750599937128e-10
just O 0 2.5007313997349456e-09
2 O 0 9.7477999005946e-09
% O 0 2.35948371951622e-10
leading O 0 3.385985936077418e-10
to O 0 2.537146187586714e-11
substitution O 0 2.3337227705866326e-09
of O 0 6.857936885040772e-09
one O 0 1.1273480066131825e-10
amino O 0 2.6122274482398566e-11
acid O 0 6.073240521597967e-11
by O 0 4.348701954093315e-11
another O 0 1.466186505538758e-09
( O 0 1.9693942032716905e-09
missense O 0 1.714937241104053e-07
) O 0 8.764727610355294e-09
. O 0 4.412491705352295e-08

The O 0 5.344219857761345e-07
extraordinary O 0 1.6950076542343595e-07
conservation O 0 1.048412983095659e-07
of O 0 2.577438706907742e-08
the O 0 2.1147716466884958e-08
PAX6 O 0 4.338857615948655e-05
protein O 0 3.281675731159339e-08
at O 0 4.2905723418584785e-09
the O 0 1.4317116381334927e-09
amino O 0 1.05938182670684e-08
acid O 0 4.874169690083363e-08
level O 0 7.617531849746229e-08
amongst O 0 4.0217596364300334e-08
vertebrates O 0 4.643506201773562e-07
predicts O 0 6.039285516123982e-09
that O 0 1.937788401962237e-10
pathological O 0 3.166508975027682e-07
missense O 0 3.4631341350177536e-07
mutations O 0 1.3474747984076885e-09
should O 0 2.8295882303908115e-10
in O 0 1.5044149259679784e-10
fact O 0 1.4329730457784962e-10
be O 0 8.303256693320549e-11
common O 0 2.411102650867747e-09
even O 0 7.173767690993316e-10
though O 0 1.4322734664951042e-10
they O 0 8.704892362487726e-11
are O 0 6.969700511172405e-11
hardly O 0 1.9850078913918878e-08
ever O 0 1.027195573044537e-08
seen O 0 2.1395326399442638e-08
in O 0 2.851120406432983e-08
aniridia B-Disease 1 1.0
patients O 0 6.336412297969218e-06
. O 0 4.514039062541997e-07

This O 0 3.87078813446351e-08
indicates O 0 2.2054456039199977e-08
that O 0 3.193654507516186e-10
there O 0 2.1813503781054067e-10
is O 0 1.2631695689435674e-10
a O 0 9.083084839822675e-10
heavy O 0 7.996543445187854e-07
ascertainment O 0 3.127412492176518e-05
bias O 0 1.319106672781345e-07
in O 0 7.573194293897245e-10
the O 0 5.957832560632426e-10
selection O 0 6.582905887064783e-10
of O 0 1.748641231813508e-09
patients O 0 3.6968547667548535e-10
for O 0 1.6227989785289054e-10
PAX6 O 0 1.5018611065897858e-06
mutation O 0 1.906960006570202e-10
analysis O 0 8.681182162018075e-11
and O 0 5.3401255639684564e-11
that O 0 1.3630709408407604e-11
the O 0 2.4163140377453374e-09
missing O 0 3.897808085184806e-07
PAX6 O 1 0.9841789603233337
missense O 0 2.2000140234013088e-05
mutations O 0 4.7259376856345625e-08
frequently O 0 2.0868344829949592e-09
may O 0 7.701942195126321e-09
underlie O 0 9.740218729348271e-07
phenotypes O 0 3.6360407307256537e-07
distinct O 0 1.089355539107828e-08
from O 0 3.634777812067114e-08
textbook O 0 5.727019015466794e-06
aniridia B-Disease 1 1.0
. O 0 2.1206260498729534e-06

Here O 0 6.840198238933226e-07
we O 0 7.893195430597189e-09
present O 0 5.438874683960648e-09
four O 0 4.4984367342237874e-09
novel O 0 7.507905053216746e-08
PAX6 O 0 0.00015621633792761713
missense O 0 1.198079530695395e-06
mutations O 0 1.49358605483485e-08
, O 0 5.89290505281781e-10
two O 0 2.709809321377321e-10
in O 0 7.010127478501715e-10
association O 0 5.660701352105946e-10
with O 0 4.6306194989576e-10
atypical O 0 3.117903361271601e-06
phenotypes O 0 7.910453132353723e-05
ectopia B-Disease 0 0.0007436287705786526
pupillae I-Disease 0 7.863875362090766e-05
( O 0 4.275883647153478e-09
displaced B-Disease 0 6.530199048171426e-09
pupils I-Disease 0 5.071755460051008e-09
) O 0 2.7961599702308604e-09
and O 0 8.494032499584137e-08
congenital B-Disease 1 1.0
nystagmus I-Disease 0 0.00286217057146132
( O 0 3.647403445938835e-08
searching B-Disease 0 1.1997552462617023e-07
gaze I-Disease 0 3.3078813999054546e-07
) O 0 2.639474194765512e-10
, O 0 8.835349118996305e-11
and O 0 8.154940056570581e-10
two O 0 9.099002662438238e-10
in O 0 9.313589899306862e-10
association O 0 2.8606117474794246e-10
with O 0 9.748012813615148e-11
more O 0 3.9518743832900327e-10
recognizable O 0 7.074101176840486e-06
aniridia B-Disease 1 1.0
phenotypes O 0 3.0410041290451773e-05
. O 0 5.028796863371099e-07

Strikingly O 0 2.745990605035331e-05
, O 0 4.6591068780799105e-08
all O 0 1.912774827417252e-09
four O 0 8.627062397792429e-10
mutations O 0 3.9236941473674847e-10
are O 0 3.727567907119145e-11
located O 0 2.6601163494177626e-09
within O 0 2.2685839873304303e-09
the O 0 1.5229804972705097e-08
PAX6 O 0 3.630580977187492e-05
paired O 0 2.917246710865129e-08
domain O 0 7.05241598453199e-09
and O 0 1.8288440206681855e-10
affect O 0 1.1622335038818932e-10
amino O 0 1.0165798758343669e-10
acids O 0 5.170528935560803e-11
which O 0 1.759717371818681e-11
are O 0 8.182009757218278e-12
highly O 0 7.831318371565033e-10
conserved O 0 1.3358365524851479e-09
in O 0 1.6769745314615392e-10
all O 0 9.824580038397812e-11
known O 0 1.892571876993543e-09
paired O 0 1.1957151935249044e-09
domain O 0 2.705792478963076e-09
proteins O 0 2.5606192166627295e-10
. O 0 4.482574755826363e-09

Our O 0 4.93229254061589e-06
results O 0 4.704748235440093e-08
support O 0 2.319656111637869e-08
the O 0 6.143828112925576e-09
hypothesis O 0 6.319345935423826e-09
that O 0 2.977356902689188e-11
the O 0 2.46532461112281e-10
under O 0 4.175614076729062e-09
- O 0 3.535055137504628e-09
representation O 0 2.7215687481429995e-09
of O 0 1.5359562510752767e-08
missense O 0 4.077993764894927e-07
mutations O 0 2.0174202308709255e-09
is O 0 1.9793612582308384e-10
caused O 0 2.1468855582185142e-09
by O 0 6.892131865221529e-10
ascertainment O 0 4.4730997615261e-05
bias O 0 4.851695507568365e-07
and O 0 4.742025438986275e-09
suggest O 0 1.2618746048076446e-09
that O 0 4.9231591026099863e-11
a O 0 6.119568740636794e-10
substantial O 0 3.1312759052326555e-09
burden O 0 2.928961748693837e-07
of O 0 3.2313593578692235e-07
PAX6 B-Disease 1 0.9999998807907104
- I-Disease 0 0.00018460860883351415
related I-Disease 0 3.4109891657863045e-06
disease I-Disease 0 0.04245305433869362
remains O 0 1.9022998287709925e-07
to O 0 6.494224047415287e-10
be O 0 8.053478439684625e-10
uncovered O 0 6.341650049535019e-08
. O 0 2.5636797129635625e-09
. O 0 2.138989962929827e-08

The O 0 5.392569164541783e-07
chromosomal O 0 1.1798234709203825e-06
order O 0 1.8465753726104595e-07
of O 0 8.711114674042619e-07
genes O 0 3.837223871983042e-08
controlling O 0 2.713777291774022e-07
the O 0 2.1347720746689447e-07
major O 0 2.6747432002593996e-06
histocompatibility O 1 0.9999295473098755
complex O 0 3.863290839944966e-05
, O 0 1.9871775336355313e-09
properdin O 0 9.865153316468422e-08
factor O 0 1.8243679900109555e-09
B O 0 4.4171400759296375e-08
, O 0 1.2479414723820526e-10
and O 0 6.421625453612023e-10
deficiency B-Disease 0 4.4622593122767285e-06
of I-Disease 0 3.2337504762836033e-06
the I-Disease 0 3.2396474125562236e-07
second I-Disease 0 9.961792812873682e-08
component I-Disease 0 8.883657187652716e-08
of I-Disease 0 4.3856587694790505e-08
complement I-Disease 0 2.7691049808709067e-07
. O 0 3.0921600568944996e-07

The O 0 1.0672030157365953e-06
relationship O 0 1.3882329596981435e-07
of O 0 1.0770918379421346e-07
the O 0 9.942257683803746e-09
genes O 0 9.69018087992879e-10
coding O 0 1.388918313693921e-08
for O 0 4.972148248683084e-10
HLA O 0 5.82235664126074e-08
to O 0 3.526292036148959e-10
those O 0 5.260767932391275e-10
coding O 0 6.486072123834674e-08
for O 0 1.183201092658237e-09
properdin O 0 1.0745903722408912e-07
Factor O 0 2.655625053193944e-09
B O 0 3.200450748863659e-08
allotypes O 0 6.910026684181503e-08
and O 0 1.5456086410736702e-10
for O 0 2.0613019624526885e-10
deficiency B-Disease 0 2.027934868920056e-07
of I-Disease 0 2.844947459834657e-07
the I-Disease 0 5.304664085770128e-08
second I-Disease 0 7.635657084392733e-08
component I-Disease 0 1.6930229662648344e-08
of I-Disease 0 7.253240674742756e-09
complement I-Disease 0 5.471379793675624e-09
( O 0 1.3764697159857064e-09
C2 O 0 1.960131434941559e-08
) O 0 7.902738879961291e-11
was O 0 1.0376750569918158e-09
studied O 0 6.194362245359741e-10
in O 0 4.5171932167020756e-11
families O 0 7.125353779224852e-11
of O 0 1.085488920971045e-09
patients O 0 2.1746797695954e-09
with O 0 1.1679680333998022e-08
connective O 1 1.0
tissue O 1 1.0
disorders O 1 1.0
. O 0 2.1944739273749292e-05

Patients O 0 3.097613443969749e-06
were O 0 3.240747048494086e-08
selected O 0 2.0859749483292944e-09
because O 0 5.918214251998677e-10
they O 0 1.7839897614724265e-10
were O 0 1.0060753341534223e-09
heterozygous O 0 1.2544498773081614e-09
or O 0 1.696898399572433e-09
homozygous O 0 9.742078788121944e-08
for O 0 3.373143044882454e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 3.7299505493137985e-05

12 O 0 4.567133146338165e-06
families O 0 2.803098020365269e-08
with O 0 4.943677023305781e-09
15 O 0 2.84357710711447e-08
matings O 0 1.7435519339414896e-06
informative O 0 2.328886665736718e-07
for O 0 1.0241792836040986e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 4.938882511851261e-07
found O 0 5.8510902789521424e-08
. O 0 7.240554822374179e-08

Of O 0 1.0621642104524653e-05
57 O 0 1.1718807400029618e-06
informative O 0 1.6260788271438287e-08
meioses O 0 1.2912895499539445e-06
, O 0 1.7350497705237444e-09
two O 0 4.0868347594980037e-10
crossovers O 0 9.78464509415744e-09
were O 0 1.7971736321342746e-09
noted O 0 5.373173017630961e-09
between O 0 1.2765867474229253e-08
the O 0 1.1957292826991761e-06
C2 B-Disease 1 0.999996542930603
deficiency I-Disease 1 0.9979338645935059
gene O 0 7.307643379306228e-10
and O 0 1.6265019886496646e-10
the O 0 2.2295514046088982e-10
HLA O 0 4.650838381081712e-09
- O 0 1.4632781653034499e-09
B O 0 6.456828405276838e-09
gene O 0 8.192851952415481e-11
, O 0 1.256591879161828e-11
with O 0 6.052075507412269e-12
a O 0 3.394107495058307e-10
recombinant O 0 6.02282401729326e-09
fraction O 0 1.6077535747172078e-08
of O 0 5.03812849217411e-08
0 O 0 1.0686446216823242e-07
. O 0 8.829432118773184e-08

035 O 0 0.0463871955871582
. O 0 7.912415458122268e-05

A O 0 5.43614123671432e-06
lod O 0 0.0001576312497491017
score O 0 2.0295715330576058e-07
of O 0 3.3060902637771505e-07
13 O 0 5.51097230072628e-08
was O 0 3.3752534989162086e-08
calculated O 0 1.87747506430469e-09
for O 0 5.070127651052303e-10
linkage O 0 1.3917791648054845e-06
between O 0 1.3852549045623164e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 4.003750575520826e-08
HLA O 0 7.27657862853448e-08
- O 0 1.9163946873845816e-08
B O 0 4.327096903011807e-08
at O 0 4.299630651516395e-10
a O 0 2.1262712077141366e-11
maximum O 0 3.813315982426069e-11
likelihood O 0 1.465358251406812e-10
value O 0 6.411134123585072e-11
of O 0 2.3077650901370816e-10
the O 0 2.013010591550568e-10
recombinant O 0 4.947967036095235e-10
fraction O 0 7.514603383995677e-10
of O 0 9.803999390101126e-09
0 O 0 7.144184621665772e-08
. O 0 5.678398551367536e-08

04 O 0 0.010096709243953228
. O 0 3.924819247913547e-05

18 O 0 1.9359783891559346e-06
families O 0 2.3984538799481925e-08
with O 0 1.942451977043902e-09
21 O 0 2.0953429213932395e-08
informative O 0 2.0050450189046387e-09
matings O 0 1.4100513112680346e-07
for O 0 4.2798977695213125e-09
both O 0 2.1416750595193434e-09
properdin O 0 1.2180297517261351e-06
Factor O 0 2.3810374116806088e-08
B O 0 1.1320177151219468e-07
allotype O 0 1.3708235258036439e-07
and O 0 2.5787945112654143e-09
HLA O 0 1.089252066321933e-07
- O 0 5.52644543461156e-08
B O 0 1.7863162327103055e-07
were O 0 6.448582112739132e-09
found O 0 1.3349965577447165e-08
. O 0 3.63769103728373e-08

Of O 0 4.403283674037084e-05
72 O 0 7.358641596511006e-06
informative O 0 6.564155086152823e-08
meioses O 0 6.431635938497493e-06
, O 0 3.2696283458477637e-09
three O 0 1.8038083249294345e-09
recombinants O 0 3.6457697660807753e-07
were O 0 1.9699539777207065e-09
found O 0 4.064741321307963e-10
, O 0 2.4184971733620664e-11
giving O 0 1.3013914945680938e-10
a O 0 8.297972864390601e-10
recombinant O 0 1.118627235285885e-08
fraction O 0 3.9040351396124606e-08
of O 0 7.5383326247902e-07
0 O 0 1.181452716991771e-06
. O 0 4.3225233525845397e-07

042 O 0 0.00921634305268526
. O 0 4.607143273460679e-05

A O 0 1.2896113730676007e-05
lod O 0 0.00023604823218192905
score O 0 1.0102169198944466e-06
of O 0 5.142103987054725e-07
16 O 0 9.790697674816329e-08
between O 0 1.8038814886267573e-08
HLA O 0 4.180221822025487e-07
- O 0 4.156219901574332e-08
B O 0 6.362791538094825e-08
and O 0 8.622373370847924e-10
Factor O 0 1.4998258190956903e-09
B O 0 3.197936493393172e-08
allotypes O 0 1.5373345263469673e-07
was O 0 6.551307052404809e-09
calculated O 0 7.401995683053997e-10
at O 0 4.984311297029365e-10
a O 0 4.2400315897195284e-11
maximum O 0 2.013386818378038e-10
likelihood O 0 5.26840959746977e-10
value O 0 3.1997393623584003e-10
of O 0 6.360602600175014e-10
the O 0 4.4361156414929326e-10
recombinant O 0 2.1073938150095728e-09
fraction O 0 1.9327766054288986e-09
of O 0 1.154589845953069e-08
0 O 0 6.711941580306302e-08
. O 0 3.172106133320085e-08

04 O 0 0.009983023628592491
. O 0 8.269074896816164e-05

A O 0 5.7330466916027945e-06
crossover O 0 1.5402297321998049e-06
was O 0 1.1834266899768409e-07
shown O 0 6.360978410668849e-10
to O 0 4.674046705233081e-10
have O 0 1.8873225204885102e-10
occurred O 0 4.943497611265002e-09
between O 0 3.2449867792827547e-10
genes O 0 7.286720532517776e-11
for O 0 5.698429575429209e-11
Factor O 0 6.846875844068734e-10
B O 0 1.4445963536502404e-08
and O 0 1.1796227328275677e-09
HLA O 0 2.7981673866861456e-08
- O 0 4.728498481654242e-08
D O 0 1.2125657633532683e-07
, O 0 4.816138599039732e-10
in O 0 3.6216327159444006e-10
which O 0 3.185842700759167e-10
HLA O 0 4.0161026504392794e-08
- O 0 4.110651730115933e-08
D O 0 1.4260632497098413e-07
segregared O 0 4.101943034129363e-07
with O 0 1.0190263077802797e-09
HLA O 0 2.757394099717203e-07
- O 0 4.300816058844248e-08
A O 0 1.268698497369769e-07
and O 0 3.5531325437432315e-08
B O 0 2.6879197321250103e-06
. O 0 1.15188470317662e-07

These O 0 8.349033464583044e-09
studies O 0 1.1901815089032652e-09
suggest O 0 5.087428811556549e-10
that O 0 3.3821244416198937e-11
the O 0 5.36888811186742e-10
genes O 0 1.8948646818284232e-10
for O 0 1.6508022726569038e-10
Factor O 0 1.6058351093306555e-08
B O 0 0.006869552191346884
and O 0 9.835907803790178e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 1.5276521159179879e-09
located O 0 2.6989579460234836e-09
outside O 0 3.164476736206012e-10
those O 0 1.9153942321104012e-11
for O 0 4.8062529650616526e-11
HLA O 0 2.055454118021771e-08
, O 0 4.48816504794447e-11
that O 0 5.422955921124961e-12
the O 0 5.631979327347381e-10
order O 0 2.745039306972785e-09
of O 0 1.7239273120139842e-08
genese O 0 3.168811133491545e-07
is O 0 6.798700491472687e-10
HLA O 0 5.361104005174866e-09
- O 0 3.0272764295347088e-09
A O 0 1.146391603867869e-08
, O 0 1.7548112962728624e-10
- O 0 1.2681528049895974e-09
B O 0 2.3130819926109325e-08
, O 0 2.529479403712287e-10
- O 0 6.8188592550200156e-09
D O 0 5.1962611991029917e-08
, O 0 4.840718936804933e-10
Factor O 0 1.3639520624053603e-08
B O 0 4.995221843273612e-06
allotype O 0 0.00027867266908288
, O 0 4.699895939097587e-08
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 1.1919892850542624e-10
that O 0 7.232148907521108e-12
the O 0 2.9605848328451145e-10
genes O 0 7.073980845540007e-10
coding O 0 1.2545993399726285e-07
for O 0 3.344576171571134e-08
C2 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
and O 0 2.9468584017422472e-08
Factor O 0 1.2482092692778224e-08
B O 0 5.9025396126344276e-08
allotypes O 0 5.606561970239454e-08
are O 0 3.047079602525038e-11
approximately O 0 2.1008191020133182e-10
3 O 0 1.6267418523341348e-09
- O 0 1.4926883062926777e-09
- O 0 7.345265284897096e-09
5 O 0 7.776724153529813e-09
centimorgans O 0 1.349826987961933e-07
from O 0 2.7503637145542825e-09
the O 0 4.461540026312605e-09
HLA O 0 3.973085682673627e-08
- O 0 4.443756473904159e-09
A O 0 3.486004018782296e-08
and O 0 4.013512189260382e-09
HLA O 0 5.442925044008007e-08
- O 0 1.9071219270472284e-08
B O 0 3.714499996476661e-08
loci O 0 9.363640973703014e-10
, O 0 1.9542452725507253e-11
and O 0 2.0463485073118903e-11
that O 0 5.161323625435532e-12
the O 0 1.979165026311236e-10
apparent O 0 2.015813471700767e-08
lack O 0 5.011541759358806e-08
of O 0 9.586154980922856e-09
recombinants O 0 4.8184130463369e-08
between O 0 3.1413122103529645e-10
the O 0 4.62214849727971e-10
Factor O 0 4.037175038718033e-09
B O 0 3.685569822664547e-07
gene O 0 4.59329143609466e-08
and O 0 2.1752060774815618e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 5.09044051355545e-09
suggests O 0 1.2828732520731023e-10
that O 0 5.138672039967096e-12
these O 0 1.300735734399705e-11
two O 0 1.0438640923871034e-10
genes O 0 2.87486062733322e-10
lie O 0 1.1616496209398974e-08
in O 0 1.141669092596942e-09
close O 0 6.557360165970749e-08
proximity O 0 1.1230910104131908e-06
to O 0 9.065971084964985e-09
one O 0 1.0986996201722832e-08
another O 0 3.326710995565918e-08
. O 0 1.855454598853612e-07

Distribution O 0 2.608313991458999e-07
of O 0 5.003094543098996e-07
emerin O 0 5.482738561113365e-05
and O 0 3.224432632009666e-08
lamins O 0 0.0014494700590148568
in O 0 1.3928977082855454e-08
the O 0 1.4576207263417018e-07
heart O 0 7.0188016252359375e-06
and O 0 5.053524265719034e-09
implications O 0 2.0417392221361297e-08
for O 0 5.4382316427847854e-09
Emery B-Disease 1 0.9995747208595276
- I-Disease 1 0.9999991655349731
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.00013330200454220176

Emerin O 0 0.0014155887765809894
is O 0 1.9480076218769682e-07
a O 0 6.315288203495584e-08
nuclear O 0 4.840755991608603e-07
membrane O 0 1.4731925901401155e-08
protein O 0 2.0021406754722193e-09
which O 0 3.13233605719887e-11
is O 0 1.0577957954005512e-10
missing O 0 8.45421954664971e-09
or O 0 5.883956433194726e-09
defective O 0 1.413997324561933e-05
in O 0 2.424246758891968e-07
Emery B-Disease 1 0.9999990463256836
- I-Disease 1 0.9999996423721313
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 3.514024501782842e-05
EDMD B-Disease 1 1.0
) O 0 1.6909534394926595e-07
. O 0 2.0946401946275728e-07

It O 0 9.877918927259088e-08
is O 0 2.8303508425864266e-09
one O 0 1.3163961032347515e-09
member O 0 8.14388834147195e-10
of O 0 4.00676603007355e-09
a O 0 6.554881970544102e-09
family O 0 9.327994376917559e-09
of O 0 1.665802429329233e-08
lamina O 0 0.009157703258097172
- O 0 1.7608770122023998e-06
associated O 0 3.206940135669356e-08
proteins O 0 3.6380132240054763e-10
which O 0 1.1356568463405381e-10
includes O 0 3.905580581164969e-10
LAP1 O 0 1.2044700270053e-05
, O 0 2.488797390398645e-09
LAP2 O 0 9.71885965554975e-05
and O 0 2.797181082314637e-07
lamin O 0 4.1876541217789054e-05
B O 0 5.070633960713167e-06
receptor O 0 8.674921758711207e-08
( O 0 4.373494011389312e-09
LBR O 0 9.012868758873083e-06
) O 0 2.0866046668288618e-08
. O 0 1.2988527942070505e-07

A O 0 3.279477095929906e-05
panel O 0 2.9513216759369243e-06
of O 0 3.8314067296596477e-07
16 O 0 3.167692597116911e-08
monoclonal O 0 5.4493860091042734e-08
antibodies O 0 3.976990115006629e-08
( O 0 1.370892288576897e-08
mAbs O 0 1.7741310784913367e-06
) O 0 2.202518611937876e-09
has O 0 3.226853229065796e-10
been O 0 2.1937339444999537e-10
mapped O 0 1.592711629250232e-09
to O 0 1.434882074269339e-10
six O 0 1.7759164971931085e-10
specific O 0 3.995850317295435e-10
sites O 0 1.669402283077659e-09
throughout O 0 9.110081578000973e-10
the O 0 3.008178373065107e-09
emerin O 0 7.815419422740888e-08
molecule O 0 4.6200768211157595e-10
using O 0 8.937132700559403e-10
phage O 0 4.46312364843493e-09
- O 0 7.384457045844783e-09
displayed O 0 1.0822803764298783e-09
peptide O 0 2.607530857900997e-09
libraries O 0 1.7940159358076357e-09
and O 0 2.665803966461766e-10
has O 0 5.1296161762692805e-11
been O 0 5.1386058602664875e-11
used O 0 5.79579217951931e-10
to O 0 1.2326974996312856e-09
localize O 0 1.006540514936205e-06
emerin O 0 7.725515388301574e-06
in O 0 3.1139084644138393e-09
human O 0 6.8764314242741875e-09
and O 0 3.063727760377333e-08
rabbit O 0 5.309826883603819e-05
heart O 0 2.0772686184500344e-05
. O 0 4.1377754200766503e-07

Several O 0 1.016273472487228e-06
mAbs O 0 2.075514021271374e-05
against O 0 1.713441406536731e-07
different O 0 1.2791875114714912e-08
emerin O 0 1.4511113477055915e-05
epitopes O 0 1.5162003137447755e-06
did O 0 1.5519407980946198e-08
not O 0 9.558636104856078e-10
recognize O 0 5.75874858910197e-09
intercalated O 0 1.7651274220042978e-06
discs O 0 1.091696617550042e-06
in O 0 7.84070852688501e-09
the O 0 4.1955981799901565e-08
heart O 0 1.5887430890870746e-06
, O 0 3.3008440425419394e-10
though O 0 2.7231200627753083e-10
they O 0 1.2265474746975258e-10
recognized O 0 1.722775921919606e-09
cardiomyocyte O 0 2.011099979881692e-07
nuclei O 0 5.518124979175809e-08
strongly O 0 8.363043590975394e-09
, O 0 6.040445366117808e-10
both O 0 1.0407988915162036e-09
at O 0 1.0203611289227865e-08
the O 0 7.033850835114208e-09
rim O 0 5.96405129726918e-07
and O 0 2.040165592021026e-09
in O 0 3.5582445878645785e-09
intranuclear O 0 5.588738076767186e-06
spots O 0 2.155347402776897e-07
or O 0 6.500624749605777e-08
channels O 0 3.914067860932846e-07
. O 0 5.400237768071747e-08

A O 0 3.159930929541588e-05
polyclonal O 0 0.00044028632692061365
rabbit O 0 3.643376112449914e-05
antiserum O 0 1.925807009683922e-05
against O 0 7.210110766209255e-07
emerin O 0 0.0005084981094114482
did O 0 7.66045502587076e-08
recognize O 0 2.912987717706983e-08
both O 0 1.6129753532823088e-08
nuclear O 0 7.298477271433512e-07
membrane O 0 1.0577302589354076e-08
and O 0 2.758147876757988e-10
intercalated O 0 1.307346320089664e-08
discs O 0 6.486911008352081e-09
but O 0 2.0661197752680494e-10
, O 0 5.790551718676262e-11
after O 0 8.044819255204061e-10
affinity O 0 9.683861490472623e-10
purification O 0 1.7940440244501588e-08
against O 0 4.370158457334128e-09
a O 0 7.434627580238384e-09
pure O 0 1.6720423445804045e-07
- O 0 4.9377238298120574e-08
emerin O 0 3.954235410219553e-07
band O 0 2.737010262876538e-08
on O 0 1.6329350316368618e-08
a O 0 2.5231297051675483e-09
western O 0 2.733097836937759e-08
blot O 0 1.5739084346932941e-06
, O 0 1.8074933771927704e-09
it O 0 4.028081479479084e-10
stained O 0 2.641270839376375e-06
only O 0 8.991627886700826e-09
the O 0 5.6365202283359395e-08
nuclear O 0 1.8237274161947425e-06
membrane O 0 1.2802170203940477e-06
. O 0 1.3571094825692853e-07

These O 0 7.310828920026324e-08
results O 0 1.6034235272854858e-08
would O 0 4.788853313897334e-09
not O 0 5.966463989537374e-10
be O 0 6.542063557546385e-10
expected O 0 7.1745103191744874e-09
if O 0 6.563989796148917e-09
immunostaining O 0 8.127089131448884e-06
at O 0 2.6959083854194432e-08
intercalated O 0 6.018829878939869e-08
discs O 0 3.693545735927728e-08
were O 0 1.651225045584681e-09
due O 0 2.1258284021996587e-08
to O 0 1.0509887404808183e-09
a O 0 1.6131960212106833e-09
product O 0 3.6931493418990158e-09
of O 0 9.703983394615534e-09
the O 0 5.263480762351946e-09
emerin O 0 8.873072943060833e-08
gene O 0 2.7871810415192044e-10
and O 0 9.562624303516287e-11
, O 0 2.027285284089686e-11
therefore O 0 2.453756087206216e-10
, O 0 1.1615110262486184e-10
cast O 0 6.696080356860534e-10
some O 0 4.237072498414207e-11
doubt O 0 1.550401473870977e-09
upon O 0 1.2463149401398255e-09
the O 0 4.867178882150824e-10
hypothesis O 0 7.310267502447232e-09
that O 0 6.263650709215085e-10
cardiac B-Disease 1 0.8821943402290344
defects I-Disease 1 0.945592999458313
in O 0 6.166765729176404e-07
EDMD B-Disease 1 1.0
are O 0 4.208491777291101e-09
caused O 0 2.1650500059422484e-08
by O 0 3.8953359982052405e-10
absence O 0 3.711546980866842e-08
of O 0 1.7686276976291992e-07
emerin O 0 1.1330430425005034e-05
from O 0 7.344427643829476e-08
intercalated O 0 2.233121449535247e-06
discs O 0 5.424918981589144e-06
. O 0 4.0165971881833684e-07

Although O 0 4.214698037685594e-06
emerin O 0 0.0001892164582386613
was O 0 6.2504449260814e-07
abundant O 0 8.334622236816358e-08
in O 0 6.809133812346602e-10
the O 0 2.3198849508077046e-09
membranes O 0 1.2701166340889358e-08
of O 0 5.1227992514668585e-08
cardiomyocyte O 0 5.489156365001691e-07
nuclei O 0 1.349748544043905e-07
, O 0 8.453989730483613e-10
it O 0 4.945928666622024e-10
was O 0 1.4987405450028746e-07
absent O 0 1.0037187081479715e-07
from O 0 6.6272169974013195e-09
many O 0 9.32409371934284e-10
non O 0 4.978938505928454e-08
- O 0 2.479609406691452e-07
myocyte O 0 4.827032626053551e-06
cells O 0 1.7958004860929577e-08
in O 0 3.0019482455401203e-09
the O 0 3.153447636350393e-08
heart O 0 5.409931418398628e-06
. O 0 3.8233289956224326e-07

This O 0 3.311378193870951e-08
distribution O 0 2.387786501856226e-08
of O 0 4.4368984930542865e-08
emerin O 0 1.4618906334362691e-06
was O 0 1.3219875860670527e-08
similar O 0 1.918824960034371e-10
to O 0 1.0668102512489952e-10
that O 0 4.3568461338683306e-11
of O 0 7.952098535213281e-09
lamin O 0 3.0156938919390086e-06
A O 0 6.056521328900999e-08
, O 0 2.860568448781464e-10
a O 0 1.0592136057141488e-09
candidate O 0 2.065663862182987e-09
gene O 0 3.010300619887829e-10
for O 0 1.4153710148345766e-10
an O 0 7.575415295058008e-11
autosomal O 0 3.314409857679834e-09
form O 0 1.0387928739419294e-07
of O 1 0.9349871277809143
EDMD B-Disease 1 1.0
. O 0 3.75919698853977e-05

In O 0 7.287897574315139e-07
contrast O 0 1.7951826976059237e-06
, O 0 2.1686484785732318e-07
lamin O 0 0.00026633869856595993
B1 O 0 0.0006478435243479908
was O 0 1.1904339771717787e-06
absent O 0 2.6623925464264175e-07
from O 0 7.634779919385437e-09
cardiomyocyte O 0 4.7486625476267363e-07
nuclei O 0 1.438006052012497e-07
, O 0 2.0734638450647935e-09
showing O 0 5.526790580745455e-09
that O 0 8.236778370473985e-09
lamin O 0 0.0003232219605706632
B1 O 0 2.8419175578164868e-05
is O 0 7.273712743227634e-10
not O 0 7.233669913064844e-11
essential O 0 9.503662301568738e-10
for O 0 2.0474973105866212e-10
localization O 0 7.105805934770615e-07
of O 0 3.3699848245305475e-08
emerin O 0 1.2584606565724243e-06
to O 0 3.080860677684427e-09
the O 0 1.8654395361750176e-08
nuclear O 0 4.000306944362819e-06
lamina O 0 0.006860634777694941
. O 0 1.2550126484711654e-06

Lamin O 1 0.9989442229270935
B1 O 1 0.9858807325363159
is O 0 2.493053727903316e-07
also O 0 1.5691567156750352e-08
almost O 0 3.944406135047984e-09
completely O 0 3.5996126968029785e-08
absent O 0 4.4492122697192826e-07
from O 0 2.919462005479545e-08
skeletal O 0 1.1747703865694348e-05
muscle O 0 1.2375343203530065e-06
nuclei O 0 0.00020437299099285156
. O 0 6.115553333074786e-06

In O 0 5.321696789906127e-06
EDMD B-Disease 1 1.0
, O 0 2.514186014934694e-08
the O 0 3.553062954964048e-09
additional O 0 1.5154111299153783e-09
absence O 0 2.369098979215778e-07
of O 0 1.2390198662615148e-06
lamin O 1 0.8684723973274231
B1 O 1 0.9993410706520081
from O 0 2.9526504476962145e-06
heart O 1 0.9999842643737793
and O 0 3.5351117730897386e-06
skeletal O 1 0.9789159893989563
muscle O 0 3.3107392027886817e-06
nuclei O 0 0.00033262200304307044
which O 0 8.458238909270221e-08
already O 0 2.647675678701944e-08
lack O 0 1.284136146750825e-06
emerin O 0 2.574918653408531e-06
may O 0 1.1113915343585745e-09
offer O 0 5.857069274028959e-10
an O 0 6.569139763407117e-12
alternative O 0 7.884916053413349e-10
explanation O 0 1.5900375460731198e-09
of O 0 1.954776562840266e-09
why O 0 4.71011230018803e-10
these O 0 1.3292934808450951e-10
tissues O 0 1.434500518371351e-08
are O 0 1.227366541733943e-10
particularly O 0 4.159612210230534e-09
affected O 0 6.121696483063488e-09
. O 0 5.968584293469803e-09
. O 0 5.3653106846240917e-08

Genetic O 0 3.045886160180089e-06
mapping O 0 9.602973705113982e-07
of O 0 5.298132350617379e-07
the O 0 3.571079787434428e-07
copper B-Disease 0 0.0007577960495837033
toxicosis I-Disease 1 0.9994031190872192
locus O 0 7.92305581853725e-06
in O 0 4.723955271401792e-08
Bedlington O 0 3.6386260035214946e-05
terriers O 0 4.673744570027338e-06
to O 0 2.762662987265685e-08
dog O 0 2.696541514524142e-07
chromosome O 0 8.926472006010044e-09
10 O 0 2.516842734223701e-09
, O 0 2.51251047744816e-10
in O 0 1.021895346120516e-09
a O 0 3.590574948475478e-08
region O 0 3.245293953568762e-07
syntenic O 0 6.633462908212095e-05
to O 0 2.1039088693441954e-08
human O 0 2.312393831971349e-08
chromosome O 0 8.782504323789908e-08
region O 0 2.4695654587958416e-07
2p13 O 0 2.4616305381641723e-05
- O 0 5.896698894503061e-06
p16 O 0 2.3205161596706603e-06
. O 0 4.150897154886479e-07

Abnormal O 1 0.9775596857070923
hepatic B-Disease 1 1.0
copper I-Disease 1 0.9944887161254883
accumulation I-Disease 0 3.9867794839665294e-05
is O 0 4.435035005911914e-09
recognized O 0 2.780439212202168e-09
as O 0 2.864735781926697e-09
an O 0 1.6022303483964606e-09
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 2.326469257241115e-05
man O 0 4.392974005895667e-05
, O 0 1.5626635985199755e-08
mouse O 0 6.446226507250685e-06
, O 0 2.85801871058311e-08
rat O 0 0.11136521399021149
and O 0 9.164043603959726e-07
dog O 0 0.0002792780287563801
. O 0 1.6899134607228916e-06

The O 0 1.427583356417017e-06
major O 0 1.3146161563781789e-06
cause O 0 8.441495083388872e-06
of O 0 7.232720963656902e-05
hepatic B-Disease 1 1.0
copper I-Disease 1 0.9999966621398926
accumulation I-Disease 0 0.002132487017661333
in O 0 3.51257227748647e-07
man O 0 6.1695459407928865e-06
is O 0 8.116352034903684e-09
a O 0 5.9537377694596216e-08
dysfunctional O 0 4.09596441386384e-06
ATP7B O 0 0.2871236205101013
gene O 0 5.580317363751419e-08
, O 0 8.113763549921771e-10
causing O 0 2.7652092171592813e-08
Wilson B-Disease 0 4.213155079924036e-06
disease I-Disease 0 8.737092866795138e-05
( O 0 6.450823519799087e-08
WD B-Disease 1 0.9999957084655762
) O 0 1.8297048143267602e-07
. O 0 4.152544192947971e-07

Mutations O 0 1.00508623290807e-06
in O 0 4.8208587344333864e-08
the O 0 1.3966226219963573e-07
ATP7B O 0 0.07038936018943787
genes O 0 2.0802545463993738e-08
have O 0 1.4051289021210778e-09
also O 0 1.2822279904511902e-09
been O 0 1.8261505640992937e-09
demonstrated O 0 1.2903766055671895e-08
in O 0 1.5038597922512054e-08
mouse O 0 4.358142632554518e-06
and O 0 1.652633443427476e-07
rat O 0 0.0001368207740597427
. O 0 1.5042333245673944e-07

The O 0 1.898360460472759e-05
ATP7B O 1 0.6118156313896179
gene O 0 6.306897830654634e-07
has O 0 5.309783279727753e-09
been O 0 1.3752521343946e-09
excluded O 0 4.315571899837778e-09
in O 0 4.95660956723043e-10
the O 0 4.545823717450048e-09
much O 0 1.1638939589886377e-08
rarer O 0 0.0006656160694546998
human O 0 1.592417106621724e-06
copper B-Disease 1 0.9942318797111511
overload I-Disease 1 0.9029958844184875
disease O 0 0.014063460752367973
non B-Disease 0 2.0866179966105847e-06
- I-Disease 0 9.208916935676825e-07
Indian I-Disease 0 3.4726923558991984e-07
childhood I-Disease 0 2.881548243749421e-05
cirrhosis I-Disease 1 0.9999997615814209
, O 0 1.3174761281931069e-09
indicating O 0 1.7558310361209806e-08
genetic O 0 1.0677155870553179e-07
heterogeneity O 0 2.1034932160546305e-06
. O 0 5.326573955244385e-07

By O 0 2.997767367673987e-08
investigating O 0 1.5719598422947456e-07
the O 0 5.275725456499458e-08
common O 0 1.0089564966619946e-05
autosomal O 1 0.9783487915992737
recessive O 1 0.9656383991241455
copper B-Disease 1 0.999995231628418
toxicosis I-Disease 1 0.9999998807907104
( O 0 3.111556736712373e-07
CT B-Disease 0 0.0012481355806812644
) O 0 5.2671560446526655e-09
in O 0 1.511987690605565e-08
Bedlington O 0 0.00025085077504627407
terriers O 0 9.592991773388349e-06
, O 0 1.6265743196797189e-09
we O 0 2.0302504122327036e-10
have O 0 2.651370789585883e-11
identified O 0 1.844886743374019e-10
a O 0 2.1996332533191776e-10
new O 0 4.2724407345318127e-10
locus O 0 1.6001718838865031e-09
involved O 0 1.297559698576478e-10
in O 0 1.983962327756217e-09
progressive O 1 0.9999971389770508
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 4.768976396007929e-06

We O 0 3.3126929110949277e-07
examined O 0 3.739034468708269e-07
whether O 0 1.374958991107178e-08
the O 0 1.2097925150555966e-07
WD B-Disease 0 0.00017391718574799597
gene O 0 1.9196217238004465e-07
ATP7B O 0 0.0004114097391720861
was O 0 1.4655364566351636e-07
also O 0 9.646806686802734e-10
causative O 0 1.1232067720357009e-08
for O 0 1.2440444230321646e-09
CT B-Disease 0 4.073918717040215e-06
by O 0 2.7126239032781996e-09
investigating O 0 1.484848866084576e-08
the O 0 2.254359365849723e-08
chromosomal O 0 2.348621279679719e-07
co O 0 9.282894666284847e-07
- O 0 3.0012085971975466e-07
localization O 0 0.0004786981444340199
of O 0 8.016044148462242e-07
ATP7B O 0 0.00031486694933846593
and O 0 6.0236167165328425e-09
C04107 O 0 3.608377241448579e-08
, O 0 3.0827389252419124e-11
using O 0 1.2519800474120046e-10
fluorescence O 0 1.1290339330116694e-08
in O 0 1.6604313479717803e-09
situ O 0 1.6821473991512903e-07
hybridization O 0 3.248829472113357e-08
( O 0 1.5653593976594493e-09
FISH O 0 1.530593323195717e-07
) O 0 2.5484057086799794e-09
. O 0 4.210942705640264e-08

C04107 O 0 7.059738709358498e-05
is O 0 4.3349199785325254e-08
an O 0 5.507687639294545e-10
anonymous O 0 1.0967860397670393e-08
microsatellite O 0 3.5901930459658615e-06
marker O 0 9.578644721841556e-07
closely O 0 5.480657350176443e-08
linked O 0 3.4492027225496713e-06
to O 0 1.5890551594566205e-06
CT B-Disease 1 1.0
. O 0 0.00020504483836703002

However O 0 4.0084682950691786e-06
, O 0 3.5371516560189775e-07
BAC O 0 0.0017242183675989509
clones O 0 1.337942921963986e-05
containing O 0 7.648629463119505e-08
ATP7B O 0 0.004102135542780161
and O 0 9.891738983469622e-08
C04107 O 0 9.734014838613803e-07
mapped O 0 1.6277334680125932e-07
to O 0 9.989322258263655e-09
the O 0 3.94904517975192e-08
canine O 0 1.443887981622538e-06
chromosome O 0 1.0150196061431416e-07
regions O 0 7.446037564307062e-09
CFA22q11 O 0 3.927085799659835e-06
and O 0 6.9862915452745256e-09
CFA10q26 O 0 5.5788018471503165e-06
, O 0 8.46948344790377e-10
respectively O 0 1.865132714939932e-09
, O 0 2.6539678787962373e-10
demonstrating O 0 2.7258808543706436e-09
that O 0 1.0497226421435357e-09
WD B-Disease 0 3.7465099012479186e-05
cannot O 0 1.3583441926812156e-08
be O 0 1.5271043318776378e-09
homologous O 0 6.364367699518425e-09
to O 0 7.952766445384896e-09
CT B-Disease 0 0.00042817211942747235
. O 0 7.812786861904897e-07

The O 0 6.458903499151347e-06
copper O 0 2.53896778303897e-05
transport O 0 1.518703925285081e-06
genes O 0 8.860896372198113e-08
CTR1 O 0 0.0004707662737928331
and O 0 7.96424615145952e-08
CTR2 O 1 0.9579980969429016
were O 0 9.288795865813881e-08
also O 0 3.2057398957618943e-09
excluded O 0 7.0792487427695505e-09
as O 0 1.4053326280460965e-09
candidate O 0 2.459042081071061e-09
genes O 0 2.3321819475619066e-10
for O 0 2.8021915343678927e-10
CT B-Disease 0 3.0011140552232973e-05
since O 0 1.3865096626375362e-08
they O 0 4.968119249326719e-10
both O 0 1.3976181323371861e-09
mapped O 0 6.933380802820466e-08
to O 0 1.345000022467957e-08
canine O 0 1.7675750996204442e-06
chromosome O 0 1.745500526340038e-07
region O 0 1.0323891785901651e-07
CFA11q22 O 0 0.00019927202083636075
. O 0 5.368887627810182e-07

2 O 0 0.00017929977911990136
- O 0 3.466177440714091e-05
22 O 0 2.310744093847461e-06
. O 0 6.08934271895123e-07

5 O 0 0.0001248217886313796
. O 0 5.7073684729402885e-06

A O 0 6.006621333654039e-06
transcribed O 0 1.962340832051268e-07
sequence O 0 1.07079056732573e-08
identified O 0 1.2479473454618528e-08
from O 0 4.893244032189159e-09
the O 0 1.8100749343830103e-08
C04107 O 0 6.435548698391358e-07
- O 0 8.333255152592756e-08
containing O 0 9.571611947478686e-09
BAC O 0 0.00023433526803273708
was O 0 3.712580465276005e-08
found O 0 2.588294023553317e-10
to O 0 7.454641764992331e-11
be O 0 5.640942574158814e-11
homologous O 0 2.2594584536683726e-10
to O 0 4.394111186023508e-10
a O 0 2.8814990393755124e-09
gene O 0 2.2352539819081585e-09
expressed O 0 3.363985312532236e-09
from O 0 5.000806879706943e-09
human O 0 5.9274132269138136e-09
chromosome O 0 9.596308636616868e-09
2p13 O 0 2.651580359724903e-07
- O 0 2.9313023119925674e-08
p16 O 0 1.0921641369066037e-08
, O 0 1.619434863986413e-10
a O 0 4.259787800275916e-10
region O 0 2.3512638502865e-09
devoid O 0 8.67839702323181e-08
of O 0 2.368037765876352e-09
any O 0 8.611082957798999e-10
positional O 0 1.0155283689528005e-06
candidate O 0 1.9171922360783356e-07
genes O 0 2.986000069427064e-08
. O 0 1.0516414050698586e-07

Molecular O 0 7.140791780102518e-08
analysis O 0 6.004631902811752e-09
of O 0 3.595001984990631e-08
the O 0 1.686943740253355e-08
APC B-Disease 0 3.150309524357908e-08
gene O 0 1.433914320614349e-09
in O 0 9.597548311646165e-10
205 O 0 5.743588715745318e-09
families O 0 1.4692940197846838e-09
: O 0 8.75037597936057e-10
extended O 0 2.2223599671633565e-07
genotype O 0 6.4515525082242675e-06
- O 0 4.05660983915368e-07
phenotype O 0 4.565420042013102e-08
correlations O 0 9.871737205457976e-09
in O 0 4.0102962617361015e-10
FAP B-Disease 0 1.8358322861899978e-08
and O 0 1.179601832879129e-10
evidence O 0 5.997887186914852e-10
for O 0 5.5391007752758625e-11
the O 0 1.2817456818137174e-10
role O 0 3.721233321485329e-10
of O 0 1.4684226057326555e-09
APC B-Disease 0 6.326992263439024e-09
amino O 0 8.048349209310857e-10
acid O 0 1.7056369649992575e-09
changes O 0 2.9060605033492948e-09
in O 0 1.0231566193397157e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 1 0.9979396462440491
. O 0 7.705544931013719e-07

BACKGROUND O 0 4.201774936518632e-05
/ O 0 1.4744886357220821e-05
AIMS O 0 1.98102753756757e-07
The O 0 4.748831994305647e-09
development O 0 3.5117707852805324e-08
of O 0 1.3470737940224353e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 5.3004032274373e-09
a O 0 3.902021206148021e-10
variable O 0 2.314624186761094e-10
range O 0 3.207550225425848e-09
of O 0 9.970838377171276e-09
extracolonic O 0 2.99361295219569e-06
manifestations O 0 6.0677712099277414e-06
in O 0 3.9628235981581383e-07
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 8.069722667869428e-08
FAP B-Disease 0 2.0411363266248372e-07
) O 0 1.0207416162311134e-10
is O 0 2.2849444558659116e-11
the O 0 8.480698088231264e-11
result O 0 2.5074645138012386e-10
of O 0 9.714650417436133e-09
the O 0 1.0910356174065328e-08
dominant O 0 3.89144190648949e-07
inheritance O 0 6.523248430312378e-07
of O 0 1.5263807426890708e-06
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 0.9999994039535522
coli I-Disease 1 0.9999991655349731
( O 0 5.0814310981195376e-08
APC B-Disease 0 2.111789427772237e-07
) O 0 3.5229190675778455e-09
gene O 0 2.0159442115641468e-08
mutations O 0 3.8089460474566295e-08
. O 0 1.9088530223143607e-07

In O 0 5.248325862794445e-08
this O 0 6.58956389454346e-10
study O 0 2.1678121797652494e-10
, O 0 7.431568381510711e-12
direct O 0 3.7045887191222704e-11
mutation O 0 5.7323978897017014e-11
analysis O 0 1.0964376628841421e-10
of O 0 2.695012213393966e-09
the O 0 8.978175536356048e-09
APC B-Disease 0 2.921567876512654e-08
gene O 0 2.6029294275531356e-09
was O 0 3.075179577649578e-08
performed O 0 1.0392338101183896e-09
to O 0 3.188383723706778e-10
determine O 0 4.44804726384973e-09
genotype O 0 4.815142347069923e-07
- O 0 8.251280547710849e-08
phenotype O 0 2.779666452568108e-08
correlations O 0 8.855029598464625e-09
for O 0 1.0344598511125014e-09
nine O 0 9.27891186108809e-09
extracolonic O 0 5.389057946558751e-07
manifestations O 0 1.8988468752922927e-07
and O 0 3.440844498214801e-09
to O 0 3.6684633109018705e-10
investigate O 0 8.322731948062767e-10
the O 0 5.196404417873168e-10
incidence O 0 5.432975402897e-09
of O 0 6.545050279527231e-09
APC B-Disease 0 2.3967068329966423e-08
mutations O 0 1.2279619543420495e-09
in O 0 4.049498958380582e-09
non O 0 6.985271465964615e-05
- O 1 0.9999889135360718
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.5361019904958084e-05

METHODS O 0 8.664396773383487e-06
The O 0 7.253602234413847e-07
APC B-Disease 0 3.386229252555495e-07
gene O 0 9.950187340734828e-09
was O 0 2.4483632898864016e-08
analysed O 0 3.789776492624242e-09
in O 0 1.9681689611417141e-10
190 O 0 1.2763962109474392e-09
unrelated O 0 4.882671600370259e-09
FAP B-Disease 0 4.783251483786444e-07
and O 0 1.8555919467644344e-08
15 O 0 1.2102540836167464e-07
non O 0 0.00023731013061478734
- O 1 0.9999998807907104
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 7.202812639661715e-07
using O 0 1.834078666718142e-08
denaturing O 0 3.138362444587983e-06
gradient O 0 1.3230474849024176e-07
gel O 0 3.840677997857256e-09
electrophoresis O 0 3.7982359479826755e-09
, O 0 1.6963959403870632e-10
the O 0 1.0506260306186732e-09
protein O 0 5.977306982707375e-10
truncation O 0 1.8084461927969642e-08
test O 0 4.041929013709478e-09
, O 0 1.1226058971303132e-10
and O 0 1.8984459837501078e-10
direct O 0 3.674480497650734e-09
sequencing O 0 1.6014620030091464e-07
. O 0 7.14011108016166e-08

RESULTS O 0 5.842229711561231e-06
Chain O 0 1.7533228628963116e-06
terminating O 0 3.190352231285942e-07
signals O 0 8.775672455385575e-08
were O 0 9.505040088342298e-10
only O 0 2.1037532826895244e-11
identified O 0 3.605573617448954e-10
in O 0 1.2136644467197755e-10
patients O 0 2.9286167935183016e-10
belonging O 0 7.31113214413881e-09
to O 0 2.1345138989659063e-09
the O 0 4.014594168211261e-08
FAP B-Disease 0 3.3688784242258407e-06
group O 0 2.135124743674055e-09
( O 0 1.2427472384501925e-09
105 O 0 1.907671816070433e-07
patients O 0 4.53759625429484e-08
) O 0 1.683093309168271e-08
. O 0 1.6084582910025347e-07

Amino O 0 4.839223493036116e-07
acid O 0 1.6622731635607124e-08
changes O 0 5.617131759727556e-10
were O 0 9.195606498479947e-10
identified O 0 1.2678964544932114e-09
in O 0 2.8438343346870454e-10
four O 0 2.792214792712855e-10
patients O 0 5.519129597786332e-10
, O 0 1.0338459949243983e-10
three O 0 3.7611286307637215e-10
of O 0 1.755462619712489e-08
whom O 0 4.9471129415223913e-08
belonged O 0 7.861254402996565e-07
to O 0 1.0355915236459623e-08
the O 0 4.1768345226955716e-08
non O 0 1.8507043364479614e-07
- O 0 1.1313021985870364e-07
FAP O 0 9.684623591965646e-07
group O 0 6.0710920735118634e-09
of O 0 0.0017834259197115898
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 0.0007614237838424742
. O 0 8.278652785520535e-07

Genotype O 0 0.004148581530898809
- O 0 0.0001317245769314468
phenotype O 0 2.0513066374405753e-06
correlations O 0 1.0378877846051182e-07
identified O 0 4.571787837193142e-09
significant O 0 1.563709273177949e-09
differences O 0 2.909789209581959e-08
in O 0 1.81249237840575e-09
the O 0 4.796202990320353e-09
nature O 0 5.045203366194073e-09
of O 0 3.515213453653132e-09
certain O 0 1.8125683176606344e-09
extracolonic O 0 3.7753568449261365e-07
manifestations O 0 1.3122195241521695e-07
in O 0 1.9825172614673647e-09
FAP B-Disease 0 2.9597705974993005e-07
patients O 0 1.3156655764845482e-09
belonging O 0 3.4625176059677187e-09
to O 0 1.2679980398999646e-09
three O 0 4.353220450781237e-09
mutation O 0 1.558068341012131e-08
subgroups O 0 5.561446059232367e-08
. O 0 8.546964380684585e-08

CONCLUSIONS O 0 1.5860903658904135e-05
Extended O 0 6.3926586335583124e-06
genotype O 0 2.0582612705766223e-05
- O 0 5.996537311148131e-07
phenotype O 0 7.385080635913255e-08
correlations O 0 1.809288008303156e-08
made O 0 5.8226534704886035e-09
in O 0 2.680375366104215e-10
this O 0 1.7474234559333723e-10
study O 0 2.6234883709896906e-10
may O 0 3.222621891563193e-10
have O 0 1.0514254050741911e-10
the O 0 1.1435432600848117e-09
potential O 0 2.5013275894991693e-09
to O 0 3.3403013688371175e-10
determine O 0 1.5006613729440232e-09
the O 0 2.107434227127669e-09
most O 0 1.8338286444929963e-10
appropriate O 0 1.0665504035500817e-09
surveillance O 0 8.044731103495906e-09
and O 0 1.1260370413879173e-10
prophylactic O 0 1.4248479374145973e-07
treatment O 0 1.0775438852306252e-07
regimens O 0 1.2477848088110477e-07
for O 0 2.3515767111348396e-10
those O 0 1.2986811626092276e-10
patients O 0 1.3154967393180783e-10
with O 0 9.294680476668038e-12
mutations O 0 8.281335339699325e-11
associated O 0 5.006760006587285e-10
with O 0 3.161574890775398e-10
life O 0 4.8732211155311234e-08
threatening O 0 4.3935710891673807e-07
conditions O 0 2.903962194977794e-05
. O 0 9.91589672594273e-07

This O 0 3.908378687356162e-08
study O 0 5.7094671213064885e-09
also O 0 3.95908694716951e-10
provided O 0 1.9460703881701846e-10
evidence O 0 1.931748316863491e-09
for O 0 4.125697283807739e-10
the O 0 3.848252827509668e-09
pathological O 0 2.978185875690542e-07
nature O 0 4.4298613666171605e-09
of O 0 4.277302512178949e-09
amino O 0 9.631307973378966e-10
acid O 0 1.0723842924775795e-09
changes O 0 4.5070916443457065e-10
in O 0 4.0901412812210935e-10
APC O 0 8.152921893156417e-09
associated O 0 9.64321955621017e-10
with O 0 5.628261051660033e-11
both O 0 7.173740490529212e-10
FAP B-Disease 0 3.700816932905582e-07
and O 0 3.023890471354207e-08
non O 0 0.0003238252247683704
- O 1 0.9999939203262329
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 2.7136559310747543e-07
. O 0 3.4868934406517837e-09
. O 0 1.3055696967967378e-08

Inherited B-Disease 1 1.0
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 1 0.962412416934967
cancer B-Disease 1 0.9999589920043945
risk O 0 1.4183298162606661e-06
of O 0 8.905522008717526e-06
the O 0 1.921773900903645e-06
APC O 0 8.027742296690121e-06
I1307K O 0 4.792849722434767e-06
polymorphism O 0 2.252650574519066e-06
. O 0 3.581707517241739e-07

Germ O 0 0.05139738693833351
- O 0 3.806751556112431e-05
line O 0 1.0604250064716325e-06
and O 0 2.381413066743221e-09
somatic O 0 5.812647785319314e-08
truncating O 0 5.808225722603311e-08
mutations O 0 2.2828415546793934e-10
of O 0 2.622684291964106e-09
the O 0 4.320876545449437e-09
APC B-Disease 0 1.0818515860933076e-08
gene O 0 3.0778696258337845e-10
are O 0 2.0190810828824013e-11
thought O 0 1.4881653687126573e-09
to O 0 1.0478642398226157e-09
initiate O 0 8.707991696610407e-07
colorectal B-Disease 1 1.0
tumor I-Disease 0 1.082669314200757e-05
formation O 0 1.5671653841309308e-07
in O 0 7.88444225463536e-08
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 3.067106945309206e-06
sporadic O 0 0.3333536386489868
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 8.827529285326818e-08
respectively O 0 3.089321580773685e-07
. O 0 1.1150578984597814e-06

Recently O 0 6.380380000337027e-06
, O 0 3.946951920852371e-08
an O 0 5.217601017903917e-09
isoleucine O 0 1.5131929558265256e-06
- O 0 3.448028792263358e-06
- O 0 5.731395958719077e-06
> O 0 5.184538622415857e-06
lysine O 0 4.880895971837163e-07
polymorphism O 0 1.7394043538843107e-08
at O 0 2.4276367582842795e-09
codon O 0 1.0104176384473362e-09
1307 O 0 2.1798224736357952e-07
( O 0 3.9185635292149357e-10
I1307K O 0 3.278397286976542e-08
) O 0 9.683006479965783e-11
of O 0 1.7900816384752716e-09
the O 0 7.94182231089735e-09
APC B-Disease 0 2.4626668704286203e-08
gene O 0 1.614476552447286e-09
has O 0 2.3949678351620207e-10
been O 0 1.0781344567112328e-10
identified O 0 3.291363570578909e-10
in O 0 3.502235168539869e-10
6 O 0 7.410955848996537e-09
% O 0 6.697868926153205e-10
- O 0 6.5614109701073176e-09
7 O 0 1.4067171427711855e-08
% O 0 4.152967136850094e-10
of O 0 2.1372434932942497e-09
the O 0 3.4765601508723876e-09
Ashkenazi O 0 2.4701543566152395e-07
Jewish O 0 4.6346508852934676e-09
population O 0 7.336157376025554e-11
. O 0 4.1905896530636255e-09

To O 0 1.0759173107999231e-07
assess O 0 3.10884843202075e-07
the O 0 2.102316365437673e-08
risk O 0 2.0660626987023534e-08
of O 0 7.007697977456928e-09
this O 0 2.6018359688961823e-10
common O 0 1.6100861088830243e-08
APC B-Disease 0 4.274091480738207e-08
allelic O 0 2.1776054381916765e-07
variant O 0 7.728809578111395e-06
in O 0 3.020855672275502e-07
colorectal O 1 1.0
carcinogenesis O 1 0.9999998807907104
, O 0 6.475750780055023e-08
we O 0 1.4380719948192677e-09
have O 0 1.8719459315974518e-10
analyzed O 0 7.638038534985014e-10
a O 0 2.2392981913199606e-10
large O 0 2.0398456535009046e-10
cohort O 0 6.7822036875497815e-09
of O 0 1.0664899185997001e-08
unselected O 0 8.411185262957588e-06
Ashkenazi O 0 2.6344682737544645e-06
Jewish O 0 1.5779145101646463e-08
subjects O 0 1.2530636084306934e-08
with O 0 6.43799791255617e-10
adenomatous B-Disease 0 5.881624929315876e-06
polyps I-Disease 0 6.684817890345585e-07
and O 0 2.893433714845628e-09
. O 0 1.159900531177982e-08
or O 1 0.9999985694885254
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 1.095326762623472e-08
for O 0 3.2242832848083935e-09
the O 0 1.602934958100377e-07
APC O 0 1.8978325897478499e-06
I1307K O 0 1.939865114763961e-06
polymorphism O 0 1.1078830084443325e-06
. O 0 1.704937631075154e-07

The O 0 4.360229922895087e-06
APC O 0 3.3866565445350716e-06
I1307K O 0 3.1216939078149153e-06
allele O 0 4.295233324569381e-08
was O 0 3.6552801674361035e-08
identified O 0 2.838568491370097e-09
in O 0 9.998180061643325e-10
48 O 0 1.1030419244661971e-08
( O 0 3.6038341755251224e-10
10 O 0 1.214609857136395e-09
. O 0 3.951015348224729e-10
1 O 0 1.2323313924866852e-08
% O 0 3.402027271004471e-10
) O 0 1.5399852226760657e-10
of O 0 3.1273843514867394e-09
476 O 0 4.195266285478283e-07
patients O 0 2.549501516568853e-07
. O 0 4.30157115260954e-07

Compared O 0 1.8430547754633153e-07
with O 0 7.061444207145939e-10
the O 0 3.2610958378143096e-09
frequency O 0 6.628241067119234e-09
in O 0 1.6618975640092515e-10
two O 0 3.80352416229357e-11
separate O 0 6.416234904493834e-11
population O 0 4.50634798573879e-12
control O 0 2.8251714856430965e-10
groups O 0 4.437363670950489e-12
, O 0 4.8063081292681886e-11
the O 0 1.6339186670322192e-09
APC O 0 5.229998478739617e-08
I1307K O 0 1.6859569029747945e-07
allele O 0 9.501631703656699e-10
is O 0 1.3300130961846346e-11
associated O 0 4.5791315184118275e-11
with O 0 7.241037630612013e-12
an O 0 1.2202418762929934e-11
estimated O 0 2.5624157309889206e-11
relative O 0 2.56529499864655e-08
risk O 0 4.196398961653358e-08
of O 0 5.816262387270399e-07
1 O 0 3.737954557436751e-06
. O 0 2.6794535301633005e-07

5 O 0 3.2483974791830406e-05
- O 0 1.3431330444291234e-05
1 O 0 3.501228547975188e-06
. O 0 4.0127150668922695e-07

7 O 0 1.2230943866597954e-05
for O 0 2.547805024732952e-07
colorectal B-Disease 1 1.0
neoplasia I-Disease 1 0.9912137389183044
( O 0 1.1023904278317787e-07
both O 0 2.043379332405948e-08
P O 0 5.8536250435281545e-05
= O 0 5.731181929036211e-08
. O 0 2.7226798593460444e-09
01 O 0 1.0976465603107499e-07
) O 0 1.5931340691111018e-09
. O 0 2.9537350343389335e-08

Furthermore O 0 1.464118781768775e-06
, O 0 1.2155142670167152e-08
compared O 0 6.5735368259822735e-09
with O 0 7.812550051333744e-10
noncarriers O 0 6.826840035500936e-06
, O 0 9.689705038340435e-09
APC O 0 3.130788286398456e-07
I1307K O 0 8.48926106300496e-07
carriers O 0 6.652267625639752e-09
had O 0 2.2967749924163172e-09
increased O 0 1.9430994313562877e-10
numbers O 0 7.031870918883243e-11
of O 0 1.0895300661672991e-08
adenomas B-Disease 1 0.9886323809623718
and O 0 1.3062594007351436e-05
colorectal B-Disease 1 1.0
cancers I-Disease 1 0.9145681858062744
per O 0 2.8079513825218783e-08
patient O 0 6.472441071991852e-08
( O 0 9.943522671918004e-10
P O 0 3.852349266253441e-07
= O 0 2.2155337564555566e-09
. O 0 9.446386728395595e-11
03 O 0 5.849212669772896e-09
) O 0 2.8559980769227167e-11
, O 0 1.9320817515322553e-11
as O 0 7.090349141147811e-11
well O 0 3.020290406663406e-10
as O 0 5.93833038298186e-10
a O 0 2.10524042643101e-09
younger O 0 2.7386917622607143e-08
age O 0 6.888127401794009e-09
at O 0 1.0940906847167753e-08
diagnosis O 0 4.255626606664009e-07
. O 0 7.484914021915756e-08

We O 0 5.072029125585686e-07
conclude O 0 4.2538329125818564e-07
that O 0 4.881014259439098e-09
the O 0 4.700837408222469e-08
APC O 0 5.893697334613535e-07
I1307K O 0 1.8002798469751724e-06
variant O 0 6.297639174590586e-06
leads O 0 1.234531481486556e-07
to O 0 4.23814361383279e-09
increased O 0 4.95307084236174e-08
adenoma B-Disease 1 1.0
formation O 0 1.1453226989033283e-06
and O 0 6.8426753152550646e-09
directly O 0 1.4721412977536374e-09
contributes O 0 9.66968172200211e-11
to O 0 9.837631403941671e-11
3 O 0 3.2588141074541e-09
% O 0 2.1756245416337805e-10
- O 0 2.098321516541546e-09
4 O 0 2.7403939117931486e-09
% O 0 7.289792380849036e-11
of O 0 3.477951260322243e-10
all O 0 1.7055871992521787e-10
Ashkenazi O 0 4.79451364299166e-06
Jewish O 0 3.073782136198133e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.1191001426122966e-07

The O 0 3.520933091749612e-07
estimated O 0 5.269366720739299e-09
relative O 0 1.550201886857394e-07
risk O 0 1.4132252701415382e-08
for O 0 2.2423327084020173e-10
carriers O 0 1.2141118110875482e-09
may O 0 1.3341304727632064e-09
justify O 0 1.12133164975603e-08
specific O 0 3.2572400332497864e-10
clinical O 0 3.3647038488737735e-09
screening O 0 1.8275512214671608e-09
for O 0 1.6504494992908292e-10
the O 0 1.2358143397506183e-09
360 O 0 8.225867098587969e-09
, O 0 1.0357762564305872e-10
000 O 0 3.1327437866046637e-10
Americans O 0 6.005713981682703e-11
expected O 0 9.332224992775195e-10
to O 0 1.029969110000195e-09
harbor O 0 7.441021239174006e-07
this O 0 1.8000405332951885e-10
allele O 0 5.05402275585709e-10
, O 0 6.78121378494545e-11
and O 0 7.068299417989365e-11
genetic O 0 5.744079101255295e-10
testing O 0 1.053730658284735e-09
in O 0 2.600972770494536e-10
the O 0 2.0168315906232692e-09
setting O 0 3.3975420254961364e-09
of O 0 6.486775117053867e-09
long O 0 4.806973041837637e-09
- O 0 1.2933481841059802e-08
term O 0 1.0781441517337953e-07
- O 0 3.876343868114418e-08
outcome O 0 1.1141683131654645e-08
studies O 0 3.4812164262376655e-10
may O 0 1.569661067790662e-10
impact O 0 2.0138370970812502e-09
significantly O 0 1.5892477733814303e-07
on O 0 0.0026981837581843138
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 0 8.67358085088199e-06
in O 0 4.9979412969358705e-11
this O 0 1.9904756662358913e-11
population O 0 1.984535452637104e-11
. O 0 2.6932189811645912e-09

Localization O 0 0.0004053610027767718
of O 0 1.8879671870308812e-06
human O 0 9.336487494238099e-08
BRCA1 O 0 3.079305344044769e-08
and O 0 2.3994959352791057e-09
its O 0 2.6525874829985696e-09
loss O 0 1.016670410081133e-07
in O 0 2.0576155890239534e-08
high O 0 8.036457984417211e-06
- O 0 4.6932223085605074e-07
grade O 0 3.7039592371002072e-06
, O 0 5.462661878397057e-09
non B-Disease 0 1.0661780834197998e-05
- I-Disease 0 0.21960416436195374
inherited I-Disease 1 1.0
breast I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 1.934243755385978e-06

Although O 0 1.4065392406337196e-07
the O 0 3.762703926213362e-08
link O 0 8.135202023140664e-08
between O 0 2.2094495122360058e-08
the O 0 7.871820173477317e-08
BRCA1 O 0 3.9063411350070965e-07
tumour B-Disease 1 0.9999998807907104
- O 0 2.2652456266314402e-07
suppressor O 0 1.9135700313199777e-07
gene O 0 6.409245578709033e-09
and O 0 5.322671192686812e-09
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 2.2818881506569966e-10
established O 0 1.6717466300164574e-10
, O 0 7.976483189231498e-12
the O 0 5.2680148437955765e-11
role O 0 2.9584965033357946e-10
, O 0 2.4002530865652183e-11
if O 0 2.0568550335164915e-11
any O 0 3.328789466294779e-10
, O 0 2.428622025707483e-10
of O 0 6.112747641395799e-09
BRCA1 O 0 1.421074724561322e-08
in O 0 6.070744351660551e-09
non B-Disease 0 1.3720029528485611e-05
- I-Disease 0 0.004331197589635849
familial I-Disease 0 0.31274232268333435
cancers I-Disease 1 0.9996005892753601
is O 0 7.770259990991235e-09
unclear O 0 1.0408833617248092e-07
. O 0 7.158110548743934e-08

BRCA1 O 0 7.227650257846108e-06
mutations O 0 4.6641392970059314e-08
are O 0 2.387852415797198e-10
rare O 0 1.1496037899405565e-08
in O 0 2.1670196748146964e-09
sporadic B-Disease 0 6.575447514478583e-06
cancers I-Disease 1 1.0
, O 0 2.252295461246945e-09
but O 0 1.1999647941962621e-09
loss O 0 5.349365324036626e-07
of O 0 2.3179770778369857e-06
BRCA1 O 0 1.9150499852571556e-08
resulting O 0 7.298703863511946e-09
from O 0 1.6303699501563074e-09
reduced O 0 3.324628794487694e-09
expression O 0 1.0605417655185079e-09
or O 0 2.0991099969336346e-09
incorrect O 0 3.189189712315965e-08
subcellular O 0 3.824499685833871e-07
localization O 0 4.2006351463896863e-07
is O 0 3.529932735002461e-10
postulated O 0 6.1406177920275695e-09
to O 0 2.1142332329304736e-10
be O 0 1.9221363389831936e-10
important O 0 4.078986926003836e-09
in O 0 1.1862832938192014e-09
non B-Disease 0 5.204337867326103e-06
- I-Disease 0 0.00040081082261167467
familial I-Disease 1 0.9999998807907104
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 2.901988182202331e-06

Epigenetic O 0 0.0025214252527803183
loss O 0 0.0001265840110136196
, O 0 1.4058990416287998e-08
however O 0 6.987637579669581e-09
, O 0 3.8662978374404133e-10
has O 0 3.52563776784276e-11
not O 0 1.0320545633379918e-11
received O 0 1.700730667408834e-10
general O 0 4.232650230306945e-09
acceptance O 0 5.721177487316709e-08
due O 0 8.51114236866124e-08
to O 0 2.7591018358918973e-09
controversy O 0 8.572854426347476e-09
regarding O 0 3.6526859314989224e-09
the O 0 2.141961052970487e-09
subcellular O 0 1.7168632382436044e-07
localization O 0 8.951126346801175e-07
of O 0 2.4350716998355892e-08
BRCA1 O 0 1.641064839574824e-09
proteins O 0 4.1998675370802374e-11
, O 0 1.9469457296361625e-11
reports O 0 1.6229785571031385e-10
of O 0 4.203478010111894e-09
which O 0 6.736123880912714e-10
have O 0 1.8889251274245566e-10
ranged O 0 1.2934147086696157e-08
from O 0 1.0908269842957452e-09
exclusively O 0 3.1620511764529624e-10
nuclear O 0 2.8265111140513e-08
, O 0 1.7517749750783906e-10
to O 0 7.225014475586988e-10
conditionally O 0 2.2647034825240553e-07
nuclear O 0 9.071455338016676e-07
, O 0 8.452216149201774e-10
to O 0 1.31681532344885e-09
the O 0 5.982365536283396e-08
ER O 0 0.00012960872845724225
/ O 0 5.001811587135307e-07
golgi O 0 2.2371245904651005e-06
, O 0 7.067237905999946e-10
to O 0 7.11810332898466e-10
cytoplasmic O 0 1.2245808989064244e-07
invaginations O 0 7.341625973822374e-07
into O 0 1.553771156181938e-08
the O 0 1.3363978368374774e-08
nucleus O 0 1.7168697752367734e-07
. O 0 1.5557884580630343e-07

In O 0 4.813829264094238e-07
an O 0 7.582014127649472e-09
attempt O 0 1.8974999704823858e-07
to O 0 7.869474849542257e-09
resolve O 0 2.5955793603316124e-07
this O 0 3.0833651187833766e-09
issue O 0 1.7743879254794592e-08
, O 0 6.652758899328148e-10
we O 0 3.5510827611773266e-10
have O 0 7.493834996985527e-10
comprehensively O 0 6.329529611548423e-08
characterized O 0 6.217936032726357e-08
19 O 0 1.1142388700591255e-07
anti O 0 2.3033735487842932e-06
- O 0 6.033592853782466e-06
BRCA1 O 0 6.694834553400142e-08
antibodies O 0 5.1629978514711183e-08
. O 0 1.1908683461570035e-07

These O 0 1.691974631512494e-07
reagents O 0 5.927352958678966e-06
detect O 0 1.6714554931240855e-06
a O 0 3.204308711701742e-07
220 O 0 1.5434486044796358e-07
- O 0 1.201566703912249e-07
kD O 0 9.61928890319541e-07
protein O 0 6.73976430221046e-09
localized O 0 2.62572861231547e-08
in O 0 1.0832881258693305e-09
discrete O 0 1.6184547035891228e-08
nuclear O 0 2.6733584945759503e-07
foci O 0 1.1695065893491119e-07
in O 0 2.7411975467295235e-10
all O 0 1.421631701248316e-10
epithelial O 0 9.950338331066177e-09
cell O 0 1.3738370441274128e-08
lines O 0 7.59014240347966e-10
, O 0 6.8460597434094606e-12
including O 0 1.0663906389873912e-11
those O 0 3.6178959134103295e-11
derived O 0 4.7856602236606705e-08
from O 0 5.197995847083803e-07
breast B-Disease 0 0.0003049407678190619
malignancies I-Disease 0 7.773133256705478e-05
. O 0 6.60576517930167e-07

Immunohistochemical O 0 0.00013713059888686985
staining O 0 3.06600340991281e-05
of O 0 2.429858341201907e-06
human O 0 1.5019327292975504e-07
breast O 0 3.4635240808711387e-07
specimens O 0 1.1939905952829122e-08
also O 0 4.810430720425529e-09
revealed O 0 6.770121530053075e-08
BRCA1 O 0 1.230407065122563e-07
nuclear O 0 1.6885755030671135e-05
foci O 0 1.9115241229883395e-05
in O 0 5.185627927062342e-08
benign O 1 1.0
breast O 1 1.0
, O 0 5.548487251871848e-07
invasive B-Disease 1 0.9999992847442627
lobular I-Disease 1 1.0
cancers I-Disease 1 1.0
and O 0 0.00013641822442878038
low B-Disease 1 1.0
- I-Disease 1 0.9999513626098633
grade I-Disease 1 0.9999982118606567
ductal I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 7.731499636065564e-07

Conversely O 0 1.4704179193358868e-05
, O 0 8.599437961720469e-08
BRCA1 O 0 6.496237148212458e-08
expression O 0 1.0339494593836207e-08
was O 0 2.992072012375502e-08
reduced O 0 7.587425798760705e-09
or O 0 8.568371012707132e-10
undetectable O 0 2.477521654498105e-08
in O 0 4.935138964157204e-10
the O 0 1.5141110587535422e-09
majority O 0 4.749164950190732e-10
of O 0 2.640937424303047e-08
high O 0 1.7284186242250144e-06
- O 0 6.957550340302987e-07
grade O 0 1.01827777143626e-06
, O 0 9.876446327439226e-09
ductal B-Disease 1 0.9999996423721313
carcinomas I-Disease 1 1.0
, O 0 4.2625430962672795e-10
suggesting O 0 5.138422465300607e-10
that O 0 3.112421084749961e-11
absence O 0 3.365052236858901e-08
of O 0 1.379517300392763e-07
BRCA1 O 0 1.3052410707814488e-08
may O 0 4.0027767211903154e-10
contribute O 0 2.9738492918207626e-11
to O 0 7.61383109337821e-11
the O 0 1.1698804147641795e-09
pathogenesis O 0 3.151116834487766e-05
of O 0 3.982615126574274e-08
a O 0 2.039123092600903e-09
significant O 0 2.1104429315244033e-09
percentage O 0 2.638227192264253e-09
of O 0 8.811007035092189e-09
sporadic B-Disease 0 2.4684175514266826e-05
breast I-Disease 1 0.998222291469574
cancers I-Disease 0 0.0006366066518239677
. O 0 4.007639375913641e-08
. O 0 1.2193508780455886e-07

